data_2kvo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kvo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.458 ' H ' ' NH1' ' A' ' 99' ' ' ARG . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.544 0.688 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -155.75 163.08 40.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.85 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.1 mt -108.52 130.51 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.554 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 98.1 mt-30 -129.43 135.02 48.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.495 -0.753 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -95.54 -10.36 29.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.559 -0.713 . . . . 0.0 109.161 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LYS . 22.7 m -150.64 22.56 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.171 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 7' ' ' SER . 23.8 mtmm 56.53 120.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.806 0.812 . . . . 0.0 110.909 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.554 ' H ' ' NE2' ' A' ' 5' ' ' GLN . . . 99.13 -16.72 58.98 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.52 97.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -1.105 . . . . 0.0 109.611 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 131.73 40.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.641 -0.662 . . . . 0.0 109.874 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.87 122.39 47.73 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.618 0.723 . . . . 0.0 109.758 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -91.7 -3.74 55.92 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.53 157.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.503 -0.748 . . . . 0.0 110.156 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -115.68 80.97 8.77 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.599 -0.688 . . . . 0.0 110.069 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.33 151.64 29.82 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.795 2.33 . . . . 0.0 112.346 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -87.22 152.72 22.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 109.713 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.09 130.14 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.483 0.659 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -132.6 145.72 51.32 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -102.19 140.43 36.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.509 -0.744 . . . . 0.0 109.625 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.6 m -152.25 167.06 29.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -105.25 166.95 10.05 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.603 0.716 . . . . 0.0 109.812 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.706 0.765 . . . . 0.0 110.439 -179.374 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.596 ' CB ' HD21 ' A' ' 85' ' ' ASN . 22.1 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.696 0.76 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 162.01 43.45 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.1 ptm -159.87 171.56 19.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.531 -0.982 . . . . 0.0 109.227 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.79 148.9 48.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.487 -0.758 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.42 148.12 31.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.71 -0.619 . . . . 0.0 109.666 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.81 136.2 52.06 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.25 123.49 50.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.797 -0.564 . . . . 0.0 109.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -111.31 122.83 48.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.3 tp -103.67 124.95 49.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.776 0.798 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.409 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 56.4 mt-10 42.5 54.89 9.83 Favored Pre-proline 0 N--CA 1.492 1.665 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -66.79 149.33 83.49 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.264 1.976 . . . . 0.0 111.947 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.53 ' C ' ' H ' ' A' ' 41' ' ' LEU . 66.9 p -74.43 -19.9 60.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.2 tp -59.96 0.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.734 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.53 ' H ' ' C ' ' A' ' 39' ' ' THR . 94.1 mt -90.93 -9.66 45.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.955 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.36 -24.95 13.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 109.418 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -93.59 -73.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.248 -0.907 . . . . 0.0 109.977 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -104.36 148.11 26.76 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.824 0.821 . . . . 0.0 110.704 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.7 m -71.8 156.15 39.63 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.728 0.775 . . . . 0.0 110.449 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -65.86 -32.65 74.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.647 -0.658 . . . . 0.0 109.628 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -75.1 -8.05 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.688 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.89 -3.37 54.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 94.0 mt -95.47 122.94 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.943 . . . . 0.0 109.802 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.1 m -121.31 -3.12 9.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -172.97 170.39 43.53 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.637 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.414 ' SD ' ' CB ' ' A' ' 80' ' ' ALA . 63.1 mtp -128.17 143.82 51.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.711 -0.876 . . . . 0.0 109.076 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.86 108.78 19.7 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.515 0.674 . . . . 0.0 109.785 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -93.59 110.28 21.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 2.0 mp -98.05 111.81 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.05 176.91 6.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.603 0.716 . . . . 0.0 109.885 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.06 -39.08 93.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -88.91 -76.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.94 10.81 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.498 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.6 pm0 -142.79 153.73 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.635 -0.92 . . . . 0.0 109.108 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -119.22 135.5 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.491 -0.756 . . . . 0.0 109.939 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -100.12 126.9 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.733 . . . . 0.0 109.447 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.6 m -121.76 125.21 46.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -108.26 -6.25 16.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.09 78.64 7.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.474 -0.766 . . . . 0.0 109.056 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.7 t -121.86 133.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.714 -0.616 . . . . 0.0 109.715 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.22 142.9 50.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.495 0.664 . . . . 0.0 109.73 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.63 143.26 16.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.14 106.73 17.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.896 . . . . 0.0 108.667 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.55 143.81 30.29 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.371 0.605 . . . . 0.0 110.239 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.35 109.16 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.98 35.88 23.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 110.079 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.85 78.75 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -121.57 99.25 45.31 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.963 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.86 130.4 30.9 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.339 2.026 . . . . 0.0 112.561 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m -152.83 -29.9 0.14 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.644 -0.66 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.18 154.08 51.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.218 -0.926 . . . . 0.0 110.726 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.75 143.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 14.3 tm-20 -119.94 150.22 40.85 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.58 0.705 . . . . 0.0 109.909 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.457 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -139.4 145.35 38.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.7 m -125.29 132.62 52.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.698 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.08 130.48 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.667 -0.646 . . . . 0.0 109.307 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 32.3 mm -93.34 128.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.791 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.3 mt -108.4 55.3 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.596 HD21 ' CB ' ' A' ' 28' ' ' SER . 9.2 m120 -64.34 -40.65 96.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.616 -0.677 . . . . 0.0 109.31 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 m -84.27 154.96 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 0.0 110.452 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.443 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.9 mp0 -74.89 -59.43 1.42 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.799 -0.563 . . . . 0.0 110.914 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 2.8 Cg_endo -48.51 -17.48 1.05 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.713 1.608 . . . . 0.0 111.266 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -64.9 -37.02 86.24 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.27 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -60.61 -36.52 78.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.487 -0.758 . . . . 0.0 109.815 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -58.32 -47.0 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.509 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.35 -39.9 81.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -62.28 -47.89 82.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 110.39 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.7 mmm -64.05 -43.21 96.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.637 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.45 -43.67 89.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.778 . . . . 0.0 109.624 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -61.54 -47.67 84.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 tpt -65.71 -41.0 92.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -63.01 -53.16 58.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.702 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.458 ' NH1' ' H ' ' A' ' 2' ' ' ALA . 78.2 ttt-85 -68.99 -43.34 75.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.434 -0.791 . . . . 0.0 110.16 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -62.67 -46.01 90.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.96 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.03 -36.23 93.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.43 95.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 0.0 109.649 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.83 -43.59 71.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.875 . . . . 0.0 109.422 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.639 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.424 ' H ' ' HB2' ' A' ' 100' ' ' TYR . . . . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 120.922 0.392 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -124.61 134.12 53.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.473 -0.767 . . . . 0.0 108.991 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.39 128.84 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -141.06 150.21 42.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.33 -0.856 . . . . 0.0 109.826 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.66 -7.78 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 8' ' ' LYS . 9.9 t -155.21 80.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.37 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.7 mttm 43.14 -168.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.708 0.766 . . . . 0.0 111.229 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.27 88.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.0 t -78.01 -94.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -1.055 . . . . 0.0 109.221 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 175.67 55.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.445 -0.784 . . . . 0.0 108.935 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' OE1' ' OG1' ' A' ' 39' ' ' THR . 8.8 pt-20 -163.67 121.49 1.86 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.479 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.6 m -93.33 88.87 6.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.953 . . . . 0.0 109.279 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.6 t -78.64 135.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.592 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.94 80.88 15.1 Favored Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 109.754 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.72 158.73 24.89 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.733 2.289 . . . . 0.0 112.406 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.94 159.5 28.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.881 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -109.1 128.77 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.6 -0.687 . . . . 0.0 109.387 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -135.18 135.21 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt -102.28 135.74 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.426 -0.796 . . . . 0.0 109.735 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.09 129.42 45.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 110.503 -178.814 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.43 0.633 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.07 139.85 25.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.4 ptt? -162.19 165.16 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -1.128 . . . . 0.0 108.865 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.36 140.33 50.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 109.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.99 145.3 32.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.235 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -117.38 133.78 55.58 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -104.0 125.37 50.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.602 -0.686 . . . . 0.0 109.869 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.2 114.82 28.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.8 tp -97.58 121.64 39.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 109.611 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' LEU . 49.6 mt-10 39.35 58.88 6.3 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.74 -0.6 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.0 Cg_endo -63.81 145.14 90.36 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.514 2.143 . . . . 0.0 112.532 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.425 ' H ' ' HG1' ' A' ' 39' ' ' THR . 13.2 p -81.35 26.78 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.069 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 38' ' ' PRO . 10.5 tp -102.73 -21.99 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.14 -41.1 97.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.88 76.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.54 -0.725 . . . . 0.0 109.582 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -88.45 -65.65 1.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.041 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.26 143.0 45.15 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.7 t -80.27 167.8 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.438 0.637 . . . . 0.0 110.098 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.443 ' HG1' ' N ' ' A' ' 47' ' ' ASP . 68.9 p -65.01 -36.0 82.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 109.774 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.443 ' N ' ' HG1' ' A' ' 46' ' ' THR . 65.3 t0 -64.8 -39.1 93.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.814 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.02 -34.85 79.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.097 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.63 126.0 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 0.0 110.005 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 m -126.14 -0.17 7.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.97 -175.29 36.96 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.0 ttp -135.47 136.22 41.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.514 -0.992 . . . . 0.0 109.362 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -106.31 116.8 32.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.452 -0.78 . . . . 0.0 109.417 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.6 mt -96.89 115.06 26.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.893 . . . . 0.0 108.907 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.53 132.75 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.406 0.622 . . . . 0.0 109.713 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 99' ' ' ARG . 36.1 t0 -125.49 43.68 3.0 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 54.86 5.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.808 -0.558 . . . . 0.0 109.619 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.538 ' H ' ' C ' ' A' ' 56' ' ' ASP . 97.8 mt-10 -146.75 -105.46 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.514 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.23 164.36 52.58 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.29 153.27 47.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.27 -1.135 . . . . 0.0 110.232 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.4 135.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mm -104.37 125.57 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.386 -0.821 . . . . 0.0 109.177 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.8 m -123.13 124.44 43.08 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -100.56 -9.26 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.18 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -83.38 75.74 9.96 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.234 -0.916 . . . . 0.0 109.275 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.03 134.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.553 -0.717 . . . . 0.0 109.724 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -126.37 138.97 53.62 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.96 136.1 12.58 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.66 125.43 49.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.495 -1.003 . . . . 0.0 109.144 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -109.05 144.21 37.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.757 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 90.8 mt -120.27 129.44 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 m120 57.54 32.45 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -0.759 . . . . 0.0 109.285 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.89 22.75 75.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -136.88 127.93 16.47 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.296 -1.12 . . . . 0.0 109.704 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.21 136.19 30.89 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.078 1.852 . . . . 0.0 112.539 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -154.34 -34.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.712 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.66 152.32 42.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.023 . . . . 0.0 110.248 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 94.0 mt -130.86 163.51 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 45.5 tt0 -142.01 151.82 42.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.1 141.65 36.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.0 m -119.79 129.45 54.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.569 -0.707 . . . . 0.0 109.702 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.29 129.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.5 0.667 . . . . 0.0 109.518 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.2 mp -81.97 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.594 -0.691 . . . . 0.0 110.156 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 71.4 mt -119.07 40.12 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.95 -40.32 97.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -0.836 . . . . 0.0 109.497 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.0 139.84 41.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.016 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.1 mm100 -66.32 -40.63 36.4 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.73 . . . . 0.0 110.403 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.9 Cg_exo -58.88 -33.08 98.44 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.029 1.819 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -67.11 -38.27 85.32 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.441 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 46.5 m95 -61.22 -41.82 97.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.18 -47.15 87.51 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -70.15 -42.09 72.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.487 -0.758 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -61.54 -45.83 92.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 84.9 mmm -64.78 -41.79 95.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.031 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NH1' ' CZ ' ' A' ' 99' ' ' ARG . 70.2 ttp85 -64.62 -41.36 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.581 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.553 ' CD1' ' NH2' ' A' ' 99' ' ' ARG . 3.2 m-85 -59.63 -42.66 93.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.785 . . . . 0.0 109.008 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 97' ' ' MET . 11.0 tmm? -61.7 -39.69 92.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.491 -0.755 . . . . 0.0 110.017 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.96 -48.34 82.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.052 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' CD1' ' A' ' 96' ' ' PHE . 88.8 mtm180 -66.03 -37.77 86.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.205 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.596 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 90.6 t80 -60.67 -44.97 95.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.43 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.82 92.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -1.073 . . . . 0.0 109.603 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -84.96 -10.25 57.25 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 76.0 m-20 . . . . . 0 N--CA 1.499 2.005 0 O-C-N 121.349 -0.845 . . . . 0.0 109.473 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.142 0.496 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -154.83 161.81 41.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.373 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.618 -0.676 . . . . 0.0 109.524 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 7' ' ' SER . 4.2 pt20 -154.37 154.91 34.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.122 -0.986 . . . . 0.0 109.43 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -86.24 -4.52 59.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.504 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 42.8 t -167.82 147.09 4.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 109.285 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -65.21 138.82 58.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.54 -12.53 64.69 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 85.0 t -112.33 127.21 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.597 -0.943 . . . . 0.0 110.077 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 168.85 96.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 14' ' ' VAL . 51.1 tp10 -168.6 130.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.226 -0.921 . . . . 0.0 109.158 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m 70.08 -9.41 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.635 -0.666 . . . . 0.0 109.373 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' GLU . 6.6 t -80.98 130.27 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.6 t -142.59 83.5 11.75 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.253 -0.905 . . . . 0.0 108.722 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -79.69 145.62 18.32 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.392 2.061 . . . . 0.0 112.867 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -89.3 157.71 18.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.239 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.62 130.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 0.0 109.084 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -132.28 143.04 49.62 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.493 -0.755 . . . . 0.0 109.167 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.3 mt -103.72 132.55 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.421 -0.8 . . . . 0.0 108.918 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.9 m -129.81 153.6 48.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -109.02 143.95 37.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.524 -0.735 . . . . 0.0 109.108 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.484 ' CB ' ' OG ' ' A' ' 28' ' ' SER . 67.1 m . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.735 0.779 . . . . 0.0 110.992 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.484 ' OG ' ' CB ' ' A' ' 23' ' ' SER . 23.8 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.379 0.609 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.42 146.89 21.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.2 ttp -152.17 159.0 43.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -1.131 . . . . 0.0 109.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.23 150.09 36.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.9 145.66 46.49 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 0.0 109.88 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.41 137.24 54.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -119.42 127.22 52.9 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.4 122.17 46.79 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' GLU . 40.2 tp -93.45 125.5 38.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.497 -0.752 . . . . 0.0 110.009 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LEU . 30.9 mt-10 40.32 71.85 1.15 Allowed Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.756 -0.59 . . . . 0.0 110.551 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.23 142.85 97.67 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.829 2.353 . . . . 0.0 111.997 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.8 p -86.25 -17.3 35.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -70.61 1.79 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.917 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.58 -7.36 59.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 109.207 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.11 -23.96 16.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.333 -0.855 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -99.73 -73.18 0.64 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.466 -0.771 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.55 159.52 15.68 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.478 -0.763 . . . . 0.0 110.066 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -81.33 168.73 18.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -66.64 -37.28 84.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.554 -0.716 . . . . 0.0 109.804 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.27 -24.11 62.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -76.68 -5.54 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.572 -0.705 . . . . 0.0 109.706 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.3 mt -88.11 -87.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 m 66.94 -40.36 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -103.09 144.2 15.95 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -126.05 129.87 50.01 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -102.94 119.96 39.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.349 -0.845 . . . . 0.0 110.009 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.7 mt -102.78 113.7 27.34 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.551 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 2.0 mp -98.47 103.23 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 94.5 m-20 -95.12 176.24 6.31 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.644 0.735 . . . . 0.0 110.597 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.0 -36.61 84.96 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.729 -0.607 . . . . 0.0 109.786 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.19 -77.4 0.33 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.292 -0.88 . . . . 0.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.74 -145.52 6.79 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.66 153.51 43.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.394 -1.063 . . . . 0.0 109.799 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.04 133.25 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.4 mm -107.47 128.79 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 109.305 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.2 m -123.84 127.86 48.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.448 0.642 . . . . 0.0 109.691 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -96.03 -3.71 44.38 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.36 83.53 7.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 109.541 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.16 133.58 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -127.49 137.89 52.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.571 -0.705 . . . . 0.0 109.25 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.88 138.08 13.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -105.86 105.81 16.03 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -98.82 147.15 25.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.226 0.536 . . . . 0.0 109.595 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 41.5 mm -125.24 135.66 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 72' ' ' ASN . 12.2 p30 -38.89 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.697 0.761 . . . . 0.0 110.48 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 147.63 -60.77 0.46 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -175.26 154.53 1.66 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.184 -1.186 . . . . 0.0 109.43 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.33 129.98 8.68 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.745 1.63 . . . . 0.0 112.056 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.1 p -113.7 -35.07 5.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.686 -0.634 . . . . 0.0 109.604 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.39 169.41 22.03 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.363 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.54 128.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -111.18 150.07 30.03 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.518 0.675 . . . . 0.0 109.668 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.91 38.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -113.46 129.24 56.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.55 132.33 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.398 -0.814 . . . . 0.0 109.018 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.6 mm -92.59 127.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.856 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 78.6 mt -113.28 40.59 2.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.45 -39.72 94.31 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.491 0.663 . . . . 0.0 109.691 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.3 m -66.32 150.04 49.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 110.487 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.472 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 4.1 mp0 -73.04 -57.48 2.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.878 -0.514 . . . . 0.0 110.152 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 12.7 Cg_endo -54.02 -34.9 79.23 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.777 1.652 . . . . 0.0 111.35 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.66 -39.08 88.03 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.156 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -63.14 -44.82 94.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 108.933 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.11 -43.35 99.03 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.435 -0.791 . . . . 0.0 109.14 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.6 -42.39 95.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.083 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -59.76 -46.86 87.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.513 -0.742 . . . . 0.0 109.634 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.8 tpp -60.75 -46.42 90.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -65.09 -42.72 93.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.212 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.462 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 73.5 t80 -62.12 -43.82 98.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.28 -42.7 91.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.435 -0.791 . . . . 0.0 109.938 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.05 -47.08 75.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 110.137 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -67.91 -42.71 80.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.083 -1.011 . . . . 0.0 110.015 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 104' ' ' ASN . 89.6 t80 -62.05 -46.23 90.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.427 -0.795 . . . . 0.0 110.346 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.61 -36.33 93.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.65 -46.39 90.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.99 -1.3 . . . . 0.0 109.058 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -69.67 -50.35 44.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' TYR . 53.3 p30 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.445 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.67 0.747 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.9 145.39 37.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.305 -0.872 . . . . 0.0 109.727 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 4' ' ' ILE . 88.2 mt -108.18 127.29 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 110.0 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -152.28 158.68 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.534 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -103.99 -35.68 8.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -129.66 151.47 50.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.36 139.08 57.17 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.764 0.792 . . . . 0.0 110.717 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.09 28.94 26.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -111.15 133.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.441 -1.035 . . . . 0.0 109.844 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 142.71 52.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.849 0.833 . . . . 0.0 110.455 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.2 pm0 -101.32 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 p -95.03 -9.03 35.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.38 -0.825 . . . . 0.0 109.187 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -71.5 134.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.84 82.13 12.77 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.569 -0.707 . . . . 0.0 110.051 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.78 151.25 24.59 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.965 2.444 . . . . 0.0 112.459 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 56.2 mp0 -91.69 153.81 19.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.68 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.87 133.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.417 0.627 . . . . 0.0 109.569 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.481 ' NH2' ' OE2' ' A' ' 79' ' ' GLU . 90.5 mtm-85 -121.71 140.52 52.21 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.49 110.61 23.01 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.668 0.747 . . . . 0.0 109.295 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 86.3 p -83.82 168.34 16.24 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.706 -0.621 . . . . 0.0 109.815 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -111.37 122.51 48.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.823 0.821 . . . . 0.0 109.824 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 28' ' ' SER . 2.9 p . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.443 ' O ' ' OG ' ' A' ' 23' ' ' SER . 27.9 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.482 0.658 . . . . 0.0 109.75 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 141.17 41.8 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -162.91 168.95 20.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -1.102 . . . . 0.0 110.189 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.09 146.73 45.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -104.31 148.96 25.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.541 -0.724 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -117.66 129.92 56.04 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.99 123.48 43.32 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.53 0.681 . . . . 0.0 109.848 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.71 126.59 55.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.5 tp -117.29 117.97 30.99 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.341 0.591 . . . . 0.0 110.364 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 39' ' ' THR . 95.5 mt-10 31.91 70.4 0.71 Allowed Pre-proline 0 N--CA 1.497 1.905 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -65.53 12.48 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.769 2.313 . . . . 0.0 110.97 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.8 m 67.7 -3.35 1.15 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.415 0.626 . . . . 0.0 109.462 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 38' ' ' PRO . 20.3 tt -86.03 -0.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.27 -9.81 59.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 109.208 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.9 -18.92 21.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.898 . . . . 0.0 109.253 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -107.73 -41.76 4.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.502 -0.749 . . . . 0.0 109.82 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 48' ' ' ASP . 79.3 mm-40 -136.0 138.11 41.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.325 -0.859 . . . . 0.0 110.253 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -77.23 168.89 19.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.855 0.836 . . . . 0.0 110.521 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -64.8 -32.47 74.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.697 . . . . 0.0 109.713 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -65.22 -36.71 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.299 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.415 ' OD2' ' OE1' ' A' ' 44' ' ' GLU . 62.4 m-20 -64.41 -36.27 83.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 108.928 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.64 129.07 37.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.41 -0.807 . . . . 0.0 109.966 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 t -144.77 49.06 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.57 162.92 15.24 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.4 ttp -129.31 131.02 46.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.944 . . . . 0.0 108.932 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 53' ' ' TYR . 29.6 m-85 -108.6 109.62 20.88 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.76 0.791 . . . . 0.0 110.127 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.1 mt -100.58 121.72 42.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 2.5 mp -105.42 113.7 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.342 -0.848 . . . . 0.0 109.52 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 86.7 m-20 -92.39 171.98 8.69 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.459 0.647 . . . . 0.0 110.148 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' OD2' ' CZ ' ' A' ' 99' ' ' ARG . 39.6 p-10 -79.01 -4.76 51.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.877 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.44 -18.15 5.83 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ASP . . . -173.89 -151.06 7.97 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -152.34 145.05 24.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -1.157 . . . . 0.0 109.235 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.7 129.56 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.517 -0.739 . . . . 0.0 109.114 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -112.71 130.56 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.59 0.71 . . . . 0.0 109.765 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 t -138.99 145.27 39.5 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.535 0.683 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.1 mmm-85 -100.89 4.26 42.52 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.603 0.716 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.91 74.13 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.09 134.41 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.8 129.18 46.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.628 0.728 . . . . 0.0 109.177 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.95 130.44 10.17 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -106.46 130.89 54.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.676 -0.896 . . . . 0.0 108.901 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -105.37 145.3 30.96 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.603 0.716 . . . . 0.0 110.068 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.44 ' O ' ' CG ' ' A' ' 72' ' ' ASN . 7.1 mm -122.58 147.41 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.683 HD22 ' NE ' ' A' ' 74' ' ' ARG . 6.6 p30 51.53 13.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.721 0.772 . . . . 0.0 109.405 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 71' ' ' ILE . . . 88.82 28.87 20.04 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.683 ' NE ' HD22 ' A' ' 72' ' ' ASN . 16.3 ptt85 -153.87 163.99 22.13 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.198 -1.178 . . . . 0.0 109.45 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 142.34 99.23 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.421 2.081 . . . . 0.0 112.172 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.3 m -166.03 -32.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.181 -0.95 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.16 153.18 35.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.666 -1.271 . . . . 0.0 110.802 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 96.6 mt -128.52 163.36 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.376 0.608 . . . . 0.0 109.518 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.481 ' OE2' ' NH2' ' A' ' 19' ' ' ARG . 45.1 tt0 -139.99 152.06 45.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -0.839 . . . . 0.0 109.75 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.38 146.21 32.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.443 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.6 m -123.06 132.84 54.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.386 0.612 . . . . 0.0 109.726 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.12 132.4 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.724 0.773 . . . . 0.0 109.339 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.8 mm -76.16 130.67 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.446 0.641 . . . . 0.0 109.979 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.9 mt -122.81 35.77 4.8 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.57 -38.91 92.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 109.535 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.4 p -72.46 155.83 39.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.127 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.626 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -79.32 -42.59 1.63 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.646 -0.659 . . . . 0.0 110.823 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 39.9 Cg_endo -65.49 -24.88 56.03 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.859 1.706 . . . . 0.0 111.449 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -70.83 -36.97 73.14 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -61.73 -42.92 99.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.576 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.47 -50.21 74.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.867 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -69.02 -40.71 78.5 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.734 0.778 . . . . 0.0 109.459 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.93 -46.14 91.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 63.8 ttp -63.25 -44.64 94.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.546 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -65.12 -37.7 88.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.516 -0.74 . . . . 0.0 109.857 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 85.3 t80 -59.74 -45.42 92.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 91.5 mtp -64.77 -39.9 94.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.284 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.89 -45.05 71.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.768 . . . . 0.0 109.514 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.447 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 94.8 mtt-85 -67.04 -39.12 86.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.351 -0.843 . . . . 0.0 109.66 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CE2' ' OD1' ' A' ' 104' ' ' ASN . 90.1 t80 -61.15 -45.96 92.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.37 -34.51 89.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -38.77 90.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -1.128 . . . . 0.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.33 -38.28 78.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.476 ' OD1' ' CE2' ' A' ' 100' ' ' TYR . 15.2 m120 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 109.514 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.599 0.714 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.522 ' CD ' HE21 ' A' ' 5' ' ' GLN . 18.7 pt-20 -155.84 159.64 39.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.489 -0.757 . . . . 0.0 109.642 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.0 mm -106.78 128.13 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.744 0.783 . . . . 0.0 109.443 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.522 HE21 ' CD ' ' A' ' 3' ' ' GLU . 78.4 mt-30 -138.94 136.88 35.91 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.443 ' O ' ' OG ' ' A' ' 7' ' ' SER . 46.1 m-85 -103.61 -13.6 16.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 6' ' ' PHE . 61.8 m -167.9 169.84 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.52 -0.738 . . . . 0.0 110.172 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.49 141.86 41.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.67 0.747 . . . . 0.0 110.904 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.63 23.67 52.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -109.44 -34.42 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -1.001 . . . . 0.0 109.051 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.85 168.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.726 0.774 . . . . 0.0 110.43 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 13' ' ' THR . 17.6 pt-20 -80.47 139.39 36.44 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.586 0.708 . . . . 0.0 110.338 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 6.3 m -168.86 -35.17 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.7 t -81.49 135.85 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.634 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.01 82.78 13.93 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.585 -0.697 . . . . 0.0 109.265 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.37 156.19 25.35 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 123.048 2.499 . . . . 0.0 112.83 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -85.24 149.16 25.68 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.707 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.9 132.05 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.455 0.645 . . . . 0.0 109.787 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -130.06 144.8 51.54 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.479 0.657 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -111.28 134.56 52.78 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.677 0.751 . . . . 0.0 109.884 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -158.21 167.77 28.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -117.83 142.07 47.72 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.716 0.769 . . . . 0.0 109.6 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.765 0.793 . . . . 0.0 110.363 -179.469 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.618 ' HG ' ' ND2' ' A' ' 85' ' ' ASN . 12.6 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.99 0.9 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.77 156.68 49.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.4 ptm -154.32 172.69 17.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -147.12 140.23 25.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -107.27 141.14 39.06 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.586 0.708 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -117.32 126.36 52.58 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.48 128.53 46.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.451 0.644 . . . . 0.0 109.471 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -111.86 117.33 32.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.6 tp -95.63 127.74 41.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.634 0.731 . . . . 0.0 110.298 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 37.99 70.81 1.16 Allowed Pre-proline 0 N--CA 1.496 1.858 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.17 141.31 93.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.495 2.13 . . . . 0.0 111.855 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 41' ' ' LEU . 46.2 p -87.42 -18.66 29.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.597 -0.689 . . . . 0.0 110.358 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.7 tt -66.68 2.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 109.676 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 39' ' ' THR . 86.5 mt -80.86 -8.74 59.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.7 -17.47 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 109.17 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -105.38 -50.48 3.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.499 -0.75 . . . . 0.0 109.585 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.54 157.6 45.85 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.371 -0.831 . . . . 0.0 109.936 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.9 t -77.34 164.74 25.25 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.621 0.724 . . . . 0.0 110.562 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -37.51 87.42 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.442 0.639 . . . . 0.0 109.968 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.69 -16.64 63.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.458 -0.776 . . . . 0.0 109.776 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.74 -0.36 56.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 98.7 mt -94.51 118.0 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -0.93 . . . . 0.0 109.907 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -114.11 121.25 43.21 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.719 0.771 . . . . 0.0 109.458 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.82 177.25 3.47 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -132.66 137.33 46.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.77 -0.841 . . . . 0.0 109.042 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.18 111.48 23.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.816 0.817 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.93 125.95 46.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.752 -0.593 . . . . 0.0 109.566 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 2.7 mp -101.92 100.31 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.468 -0.77 . . . . 0.0 109.377 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -91.5 176.63 6.48 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.447 0.641 . . . . 0.0 109.89 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 45.8 p-10 -68.26 113.03 5.52 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.764 0.792 . . . . 0.0 110.297 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 57.38 31.5 20.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.756 0.788 . . . . 0.0 109.463 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.94 168.3 40.84 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.46 149.8 28.94 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.288 -1.125 . . . . 0.0 109.766 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.37 129.6 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.27 131.73 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 109.711 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 t -129.54 142.2 50.81 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.589 0.709 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -96.04 79.47 3.23 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.547 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 66' ' ' VAL . 79.7 mm-40 -141.57 -105.03 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.605 -0.684 . . . . 0.0 109.592 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' GLU . 4.8 t 57.92 113.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.603 0.716 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -126.97 116.53 20.92 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.687 0.756 . . . . 0.0 109.099 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.83 137.26 26.71 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -107.5 124.39 49.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.775 -0.838 . . . . 0.0 108.94 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -101.02 123.3 45.0 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.56 0.695 . . . . 0.0 110.3 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.539 ' N ' ' CD1' ' A' ' 71' ' ' ILE . 2.9 mp -107.74 119.81 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.671 0.748 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.21 33.75 22.83 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.455 0.645 . . . . 0.0 110.404 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.64 34.3 39.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.417 ' NH2' ' OG1' ' A' ' 76' ' ' THR . 56.5 ttp85 -152.44 132.75 7.43 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.151 -1.205 . . . . 0.0 109.723 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.81 89.54 0.75 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.6 2.2 . . . . 0.0 111.103 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.417 ' OG1' ' NH2' ' A' ' 74' ' ' ARG . 6.7 m -105.5 -15.02 15.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.476 -0.765 . . . . 0.0 109.754 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.27 42.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.091 -1.006 . . . . 0.0 110.307 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.61 158.59 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -139.42 156.76 46.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 110.142 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.82 148.3 31.75 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.368 0.604 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 m -122.0 132.75 54.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.54 0.686 . . . . 0.0 109.505 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.85 130.56 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.659 0.743 . . . . 0.0 109.469 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.7 mm -98.97 121.59 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.405 0.621 . . . . 0.0 109.559 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.7 mt -107.8 65.75 0.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.618 ' ND2' ' HG ' ' A' ' 28' ' ' SER . 13.8 m120 -64.99 -39.5 93.57 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.587 0.708 . . . . 0.0 109.647 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.8 m -72.36 152.51 42.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 110.535 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.494 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 21.1 mt-30 -76.26 -58.28 1.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.845 -0.534 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 19.6 Cg_endo -56.19 -29.67 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.24 1.96 . . . . 0.0 111.611 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.96 -34.95 78.87 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.436 0.636 . . . . 0.0 109.596 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -46.54 89.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.347 -0.846 . . . . 0.0 109.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.74 -42.7 97.83 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.528 -0.732 . . . . 0.0 109.394 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.43 -40.87 93.82 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.641 0.734 . . . . 0.0 109.049 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -60.94 -42.54 98.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.648 0.737 . . . . 0.0 109.244 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -61.72 -41.39 97.57 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.562 0.696 . . . . 0.0 109.624 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.56 -39.83 94.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.426 -0.796 . . . . 0.0 109.328 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.63 -44.5 90.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.625 -0.672 . . . . 0.0 109.645 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 13.4 ttt -61.5 -43.92 98.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.982 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.13 -43.33 71.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.328 -0.858 . . . . 0.0 109.637 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -66.27 -42.14 88.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.404 -0.81 . . . . 0.0 109.514 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.05 -43.62 98.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.8 . . . . 0.0 109.839 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.42 -36.73 93.54 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.44 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -1.034 . . . . 0.0 109.855 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.25 -37.07 71.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 -179.257 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -117.31 155.55 29.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.539 -0.725 . . . . 0.0 109.664 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.42 127.8 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.637 -0.665 . . . . 0.0 109.219 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -129.67 124.22 33.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.749 -0.594 . . . . 0.0 109.427 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -106.58 -11.32 15.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -168.36 -153.44 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.038 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -69.9 134.59 48.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 110.83 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.1 -88.76 0.05 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t 53.9 95.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.488 -1.007 . . . . 0.0 109.883 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.67 56.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 110.705 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -100.22 32.79 2.86 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 m -69.09 -20.49 64.08 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 p -71.15 -19.11 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.766 -0.584 . . . . 0.0 110.353 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' VAL . 1.4 p 34.05 95.53 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 122.105 -0.372 . . . . 0.0 110.311 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.67 157.31 31.89 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.238 1.959 . . . . 0.0 112.869 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -92.01 152.89 19.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.096 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.77 133.47 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.569 -0.707 . . . . 0.0 109.262 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -128.57 144.22 51.11 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.8 mt -110.81 132.37 54.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.678 -0.639 . . . . 0.0 109.413 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.3 m -154.57 164.38 38.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.55 -0.719 . . . . 0.0 109.598 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -89.61 141.9 28.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.608 -0.683 . . . . 0.0 109.861 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.686 0.755 . . . . 0.0 110.757 -179.524 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.451 ' CB ' HD21 ' A' ' 85' ' ' ASN . 5.6 t . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.864 0.84 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.18 161.2 53.31 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.72 175.95 12.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.288 -1.125 . . . . 0.0 109.577 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.55 146.34 34.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.61 145.15 38.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.501 0.667 . . . . 0.0 109.955 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -112.44 121.25 44.3 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -96.2 123.76 39.95 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.58 126.68 55.19 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.443 0.639 . . . . 0.0 109.308 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.2 tp -110.27 116.27 31.19 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 110.023 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 39' ' ' THR . 52.2 mm-40 30.5 66.62 0.83 Allowed Pre-proline 0 N--CA 1.501 2.119 0 CA-C-O 120.877 0.37 . . . . 0.0 111.891 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.437 ' C ' ' H ' ' A' ' 40' ' ' ILE . 33.3 Cg_exo -65.54 16.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.89 2.393 . . . . 0.0 111.404 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 37' ' ' GLU . 37.0 p 50.39 14.36 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.645 -0.66 . . . . 0.0 109.498 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.437 ' H ' ' C ' ' A' ' 38' ' ' PRO . 3.4 tp -90.88 -14.87 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.908 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.39 -41.79 96.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.17 -35.07 77.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.992 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.31 -64.25 1.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 40' ' ' ILE . 80.0 mm-40 -117.45 143.24 46.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.595 -0.691 . . . . 0.0 109.785 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.5 m -73.95 162.23 29.28 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.529 0.68 . . . . 0.0 110.325 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.2 p -65.83 -34.65 78.64 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 51.9 p-10 -67.96 -25.3 65.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.838 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 56.8 t0 -83.06 -9.15 59.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.067 -1.021 . . . . 0.0 109.302 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -96.59 111.07 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 108.748 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -126.82 126.26 43.07 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.567 0.698 . . . . 0.0 109.868 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 155.4 1.31 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.6 ttp -117.88 132.93 56.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.907 . . . . 0.0 109.291 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -108.71 119.65 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.69 -0.631 . . . . 0.0 109.497 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.7 mt -99.34 107.55 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 56' ' ' ASP . 96.5 mt -115.4 165.46 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.643 -0.661 . . . . 0.0 109.838 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 57' ' ' ASP . 64.2 t0 -151.9 -117.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 0.0 109.882 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.53 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 97.5 m-20 -79.48 -21.7 45.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.419 -0.8 . . . . 0.0 109.955 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -175.38 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 147.22 46.06 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.25 147.42 33.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -1.127 . . . . 0.0 109.64 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.7 mt -128.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 2.6 mp -105.04 129.77 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.839 . . . . 0.0 109.675 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.9 m -122.3 129.5 52.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 48.7 mmm-85 -112.17 46.47 1.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.9 mp0 -143.85 80.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.23 134.75 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.699 -0.626 . . . . 0.0 109.591 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -127.18 141.58 51.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.52 139.5 14.53 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -90.43 105.71 18.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 108.442 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -94.77 135.36 36.35 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.393 0.616 . . . . 0.0 110.119 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 45.9 mm -115.11 131.83 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.33 0.586 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 71' ' ' ILE . 23.2 p30 44.08 16.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.957 -0.464 . . . . 0.0 110.339 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 109.38 -24.15 21.04 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 71' ' ' ILE . 16.3 ptp180 -100.72 147.24 33.37 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.145 -1.209 . . . . 0.0 110.122 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.78 143.35 66.95 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.652 2.234 . . . . 0.0 112.715 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.406 ' OG1' ' CG1' ' A' ' 71' ' ' ILE . 4.3 m -140.87 -29.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.43 171.55 20.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 109.615 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 78' ' ' ILE . 96.2 mt -131.85 144.29 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.572 0.701 . . . . 0.0 110.34 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -128.07 142.7 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.41 143.89 32.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 0.0 108.966 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -123.63 134.39 53.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.631 . . . . 0.0 109.665 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.62 130.73 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.432 HD12 HG22 ' A' ' 83' ' ' ILE . 24.5 mm -88.25 123.87 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.512 -0.743 . . . . 0.0 110.04 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.8 mt -98.62 56.83 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.451 HD21 ' CB ' ' A' ' 28' ' ' SER . 11.3 m120 -64.42 -39.99 94.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.437 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -83.29 145.65 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 110.048 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -71.61 -46.49 12.85 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 46.3 Cg_exo -54.9 -28.45 58.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.152 1.901 . . . . 0.0 111.323 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -59.47 -37.54 78.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.457 -0.777 . . . . 0.0 109.421 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -57.87 -37.35 73.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -59.55 -45.0 93.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -64.76 -40.67 95.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.373 -0.829 . . . . 0.0 109.612 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -65.81 -39.58 91.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 54.7 ttp -59.87 -45.5 92.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.945 . . . . 0.0 110.171 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -64.83 -38.29 90.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.396 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 96' ' ' PHE . 17.6 t80 -59.69 -46.9 87.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 36.5 ttm -65.56 -39.5 91.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.01 -52.5 23.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.23 -54.43 29.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.533 -0.73 . . . . 0.0 109.846 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -64.05 -45.12 90.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.31 -34.34 89.17 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.62 95.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -1.12 . . . . 0.0 109.561 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -68.71 -38.38 80.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.3 p30 . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.399 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.482 0.658 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -155.57 153.24 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.414 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -111.13 128.52 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -152.41 161.37 42.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.045 -1.034 . . . . 0.0 109.615 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.37 -31.06 9.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 t -113.45 132.33 55.69 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.538 0.685 . . . . 0.0 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' NZ ' ' OE1' ' A' ' 60' ' ' GLU . 72.5 mmtt -67.26 135.65 53.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.766 . . . . 0.0 110.346 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.25 -13.28 67.09 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.27 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.77 90.36 8.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.632 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.22 136.68 46.44 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.881 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 5.28 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.246 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -55.97 141.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.975 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.92 84.32 13.1 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.554 -0.716 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.0 150.85 23.6 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.931 2.421 . . . . 0.0 112.893 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -92.96 139.25 30.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.03 129.71 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.291 -0.881 . . . . 0.0 109.953 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -132.23 145.76 51.54 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 3.6 mm? -96.67 121.39 38.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.3 m -109.1 167.52 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.573 -0.704 . . . . 0.0 109.651 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -126.31 138.65 53.61 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.594 0.711 . . . . 0.0 110.045 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 110.769 -179.424 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.418 0.627 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.43 149.09 44.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttp -151.87 144.75 24.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.178 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.08 147.77 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 108.691 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -119.4 144.55 46.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.319 0.58 . . . . 0.0 110.181 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -116.52 131.82 56.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -105.52 127.81 53.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.643 -0.66 . . . . 0.0 109.245 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.21 117.34 32.95 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 37' ' ' GLU . 50.4 tp -92.75 128.96 38.8 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.346 0.593 . . . . 0.0 110.517 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 36' ' ' LEU . 94.0 mt-10 35.84 71.78 0.84 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-O 121.083 0.468 . . . . 0.0 111.161 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.75 141.03 93.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.613 2.209 . . . . 0.0 112.217 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 41' ' ' LEU . 76.0 p -83.29 -18.61 38.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 0.0 109.74 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.18 1.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 109.736 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' THR . 95.3 mt -83.84 -9.41 58.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.035 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.64 -17.89 23.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.81 -47.92 3.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 109.449 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.6 153.6 48.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.398 -0.814 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -72.58 158.36 35.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.628 0.728 . . . . 0.0 110.327 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -64.23 -26.9 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 44.4 p30 -67.31 -19.82 65.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 94.5 m-20 -79.74 -5.09 54.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.11 118.46 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -0.33 14.69 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.26 179.4 42.47 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.9 ttp -132.5 141.61 48.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.434 -1.039 . . . . 0.0 109.763 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -111.35 118.64 36.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.416 0.627 . . . . 0.0 109.54 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.52 122.52 43.96 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.491 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 2.1 mp -105.77 120.83 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.509 -0.744 . . . . 0.0 109.012 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -102.12 -153.95 0.48 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 109.807 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -73.33 -6.06 43.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.891 . . . . 0.0 109.603 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -174.15 -54.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 108.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.96 166.21 54.39 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.428 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 17.1 pt-20 -145.62 147.58 32.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -1.128 . . . . 0.0 109.182 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 61' ' ' ILE . 96.6 mt -118.94 131.51 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.653 -0.654 . . . . 0.0 109.508 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -113.96 128.98 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.9 133.76 47.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.544 0.688 . . . . 0.0 109.679 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -94.94 -3.52 48.46 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -84.66 76.12 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.78 133.41 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.653 -0.654 . . . . 0.0 109.4 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -127.48 140.58 52.05 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.1 142.35 16.42 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -104.62 111.27 23.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.499 -1.001 . . . . 0.0 108.723 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 22.8 m-85 -101.93 125.81 48.7 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.5 mt -111.71 120.93 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.7 m120 57.13 33.44 23.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.578 -0.701 . . . . 0.0 109.323 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.46 25.38 74.86 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.459 HH21 ' HG1' ' A' ' 76' ' ' THR . 48.8 ttp180 -130.58 100.19 18.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.291 -1.123 . . . . 0.0 109.694 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -46.97 93.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.263 1.975 . . . . 0.0 112.055 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.459 ' HG1' HH21 ' A' ' 74' ' ' ARG . 17.9 m -112.65 -15.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.722 . . . . 0.0 109.754 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.86 157.89 43.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.736 -1.228 . . . . 0.0 110.737 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.85 138.05 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -117.7 147.05 43.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.293 -0.879 . . . . 0.0 109.758 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.59 143.18 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.6 m -126.36 130.93 51.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.666 -0.646 . . . . 0.0 109.465 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.0 t -115.56 129.95 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.534 0.683 . . . . 0.0 109.252 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.8 mp -94.44 123.1 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -0.76 . . . . 0.0 109.706 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.58 110.52 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -95.9 -0.92 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.143 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.07 152.85 48.23 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.474 -0.766 . . . . 0.0 109.998 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.584 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.6 tp-100 -76.69 -40.29 2.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.621 -0.674 . . . . 0.0 110.801 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.4 Cg_exo -55.25 -30.54 72.31 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.151 1.901 . . . . 0.0 111.413 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -64.99 -40.92 95.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.668 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -56.63 -36.74 69.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.4 -41.33 98.59 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.36 -44.31 91.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.179 -0.951 . . . . 0.0 109.473 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.25 -42.35 93.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.476 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.431 ' C ' ' SD ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -61.39 -46.09 91.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.594 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -68.84 -43.27 75.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 109.223 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -62.12 -46.05 90.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.456 -0.777 . . . . 0.0 109.411 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 63.7 ttp -63.99 -40.12 95.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.597 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.11 -49.8 68.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -66.19 -42.38 88.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 104' ' ' ASN . 79.0 t80 -63.72 -41.5 98.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.36 -36.81 93.06 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.16 95.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.362 -1.081 . . . . 0.0 109.536 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.08 -36.99 75.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.303 -0.873 . . . . 0.0 109.669 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 100' ' ' TYR . 7.8 m120 . . . . . 0 N--CA 1.501 2.102 0 O-C-N 121.5 -0.75 . . . . 0.0 109.884 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.782 0.801 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.79 149.9 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.33 130.41 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.72 -0.612 . . . . 0.0 109.418 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -127.81 133.37 49.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.565 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.34 -67.02 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -111.86 14.44 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 60.19 126.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.871 0.844 . . . . 0.0 111.187 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.33 7.96 69.01 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 m -110.73 141.73 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.586 -0.949 . . . . 0.0 110.011 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.638 ' H ' ' HZ1' ' A' ' 43' ' ' LYS . . . -61.86 140.9 58.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.635 0.731 . . . . 0.0 110.771 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' ' OG1' ' A' ' 13' ' ' THR . 49.9 tp10 -97.95 -65.95 0.93 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.548 -0.72 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 7.0 p 51.01 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.578 0.704 . . . . 0.0 110.432 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' THR . 53.2 t 57.73 148.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.582 0.706 . . . . 0.0 110.439 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.1 105.04 50.16 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.87 143.87 33.83 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.555 2.17 . . . . 0.0 112.692 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 56.4 mp0 -97.18 142.74 28.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.453 -0.78 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -106.15 126.53 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.409 0.623 . . . . 0.0 109.35 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -110.65 145.04 38.63 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.608 0.718 . . . . 0.0 109.654 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 3.9 mm? -95.39 139.74 31.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.666 0.746 . . . . 0.0 109.712 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -153.38 167.48 29.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.49 -0.756 . . . . 0.0 109.929 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.32 152.07 24.03 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.679 0.752 . . . . 0.0 109.97 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.857 0.837 . . . . 0.0 110.873 -179.078 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.423 ' OG ' ' ND2' ' A' ' 85' ' ' ASN . 41.1 t . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.772 0.796 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.74 149.63 48.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.2 ttt -141.66 130.21 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -1.11 . . . . 0.0 108.96 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 145.42 50.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 109.27 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.84 149.38 42.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -122.6 139.63 53.71 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -114.58 123.36 49.15 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 118.98 36.67 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.25 107.93 19.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.762 0.792 . . . . 0.0 110.185 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.55 ' C ' ' H ' ' A' ' 39' ' ' THR . 64.4 mm-40 47.83 61.81 13.1 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.842 -0.536 . . . . 0.0 110.625 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.83 15.38 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.335 2.023 . . . . 0.0 110.854 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.55 ' H ' ' C ' ' A' ' 37' ' ' GLU . 25.7 p 51.86 22.29 1.7 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.4 tt -97.08 -13.75 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.311 -0.868 . . . . 0.0 109.228 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.44 -40.14 89.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.383 -0.823 . . . . 0.0 109.475 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.59 -14.63 59.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.557 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.638 ' HZ1' ' H ' ' A' ' 11' ' ' ALA . 54.2 mtpt -99.55 -63.24 1.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.709 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -119.93 138.91 53.16 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.76 0.79 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 m -71.33 150.67 44.89 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.714 0.769 . . . . 0.0 110.709 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.4 p -59.27 -40.69 86.84 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.421 0.629 . . . . 0.0 109.819 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.17 -15.86 62.5 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -0.764 . . . . 0.0 109.691 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.52 -7.72 49.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 92.1 mt -91.46 114.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.123 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.83 125.4 35.6 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.883 0.849 . . . . 0.0 109.642 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.77 157.02 15.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.4 ttt -132.73 127.57 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -109.18 108.07 18.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.65 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.7 mt -99.28 129.03 45.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.623 -0.673 . . . . 0.0 109.325 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.88 127.95 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.353 0.597 . . . . 0.0 110.171 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 18.5 p-10 -99.21 -132.45 0.24 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.676 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.461 ' N ' ' CG ' ' A' ' 56' ' ' ASP . 99.7 m-20 -63.13 -43.21 99.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -149.25 -50.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.365 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.75 168.73 13.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -140.29 155.52 46.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -1.028 . . . . 0.0 110.283 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.05 136.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.72 132.52 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.604 -0.685 . . . . 0.0 109.761 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 t -143.63 151.59 40.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.832 . . . . 0.0 109.614 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -104.25 3.52 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -81.5 79.32 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 109.316 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.1 t -125.81 135.37 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.62 -0.675 . . . . 0.0 109.795 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.9 136.86 48.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.5 -0.75 . . . . 0.0 109.582 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.55 141.59 15.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.98 106.94 18.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.501 -1.0 . . . . 0.0 109.443 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.6 143.9 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.643 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 93.5 mt -120.88 134.12 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 71' ' ' ILE . 46.3 m-80 -37.74 92.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.65 0.738 . . . . 0.0 110.538 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 148.44 -60.6 0.45 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -174.84 154.45 1.8 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.61 138.77 10.74 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.09 1.86 . . . . 0.0 112.099 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.8 m -132.7 -30.01 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.691 . . . . 0.0 109.918 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.17 164.04 38.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.682 -1.262 . . . . 0.0 110.577 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -128.54 150.24 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.19 151.0 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.611 0.719 . . . . 0.0 109.695 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.87 144.56 35.36 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.6 m -123.21 133.5 54.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.666 -0.646 . . . . 0.0 109.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.63 130.31 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mm -98.83 123.91 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.625 0.726 . . . . 0.0 109.795 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.11 83.02 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.423 ' ND2' ' OG ' ' A' ' 28' ' ' SER . 11.9 m120 -91.54 8.14 37.99 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.18 44.48 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.823 . . . . 0.0 109.195 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.589 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.0 mm100 -65.5 -40.87 45.68 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.706 -0.621 . . . . 0.0 110.549 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.9 Cg_exo -56.72 -36.61 98.5 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.369 2.046 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -32.39 70.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.452 0.644 . . . . 0.0 109.646 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -60.36 -47.28 86.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.68 -44.5 90.14 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.488 -0.758 . . . . 0.0 109.666 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 56' ' ' ASP . 62.8 ttm-85 -66.63 -41.1 88.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.478 -0.764 . . . . 0.0 109.441 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -60.2 -44.75 94.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.488 -0.757 . . . . 0.0 109.952 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -63.82 -41.7 97.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.35 -0.844 . . . . 0.0 109.986 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.9 -44.14 86.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.0 -49.75 73.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.432 ' SD ' ' C ' ' A' ' 97' ' ' MET . 14.1 tmm? -68.44 -41.58 80.1 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.439 -0.788 . . . . 0.0 110.139 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 81.4 tt0 -66.54 -49.21 67.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 110.179 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.42 -43.28 81.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 110.265 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.39 -52.34 65.0 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.78 . . . . 0.0 110.329 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.489 ' O ' ' ND2' ' A' ' 104' ' ' ASN . . . -76.63 -33.32 47.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 98' ' ' GLU . . . -48.94 -50.35 35.81 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.906 -1.35 . . . . 0.0 108.492 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 104' ' ' ASN . 96.8 mt-10 -71.49 -36.69 71.21 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.635 0.731 . . . . 0.0 109.111 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 101' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 122.233 1.016 . . . . 0.0 111.019 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 121.737 0.78 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' THR . 17.1 pt-20 -155.68 165.25 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 mp -106.8 128.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.542 0.687 . . . . 0.0 109.617 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -150.01 131.38 14.67 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.734 0.778 . . . . 0.0 109.532 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -63.64 -43.78 95.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.7 m -119.19 120.48 37.2 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.813 0.816 . . . . 0.0 109.292 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.49 137.48 56.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.855 0.836 . . . . 0.0 111.043 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.66 -13.94 53.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.21 164.79 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.55 52.36 9.93 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.612 0.72 . . . . 0.0 109.642 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.499 ' O ' ' OG1' ' A' ' 13' ' ' THR . 17.8 pt-20 -76.24 174.28 10.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.213 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 72.0 p 55.24 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.612 0.72 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' THR . 2.4 t 56.6 155.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.839 0.828 . . . . 0.0 110.526 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.7 66.24 72.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.71 -0.619 . . . . 0.0 109.401 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.41 145.61 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.173 2.582 . . . . 0.0 112.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -88.82 147.65 24.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.679 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.4 t -117.1 130.97 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.648 0.737 . . . . 0.0 109.378 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.1 145.44 50.73 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.29 142.98 34.1 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.748 0.785 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.405 ' HG ' ' HZ1' ' A' ' 32' ' ' LYS . 13.6 p -151.79 162.86 40.34 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.711 -0.618 . . . . 0.0 109.512 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.43 135.06 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.767 0.794 . . . . 0.0 109.746 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.617 0.723 . . . . 0.0 110.246 -179.555 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.973 0.892 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.55 156.84 53.17 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -147.32 156.93 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.107 . . . . 0.0 110.345 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.26 141.94 48.5 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' HZ1' ' HG ' ' A' ' 21' ' ' SER . 2.4 ttmp? -111.86 134.16 53.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.454 0.645 . . . . 0.0 109.934 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -112.95 144.18 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.546 0.689 . . . . 0.0 109.713 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -131.33 125.04 31.69 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.416 0.627 . . . . 0.0 109.387 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 46.3 m-85 -110.98 119.79 40.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.66 0.743 . . . . 0.0 109.333 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.0 tp -93.76 119.36 32.63 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.901 0.858 . . . . 0.0 110.512 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 39.06 56.73 5.79 Favored Pre-proline 0 N--CA 1.492 1.672 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.042 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.86 149.58 72.66 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.275 1.983 . . . . 0.0 111.988 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 41' ' ' LEU . 39.1 p -71.29 -17.11 62.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.1 tp -63.44 2.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 109.79 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 39' ' ' THR . 91.1 mt -95.17 -18.42 20.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 108.87 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.64 -20.0 18.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.33 -75.02 0.53 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.321 -0.862 . . . . 0.0 109.639 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -101.96 141.81 34.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.5 t -68.42 157.0 36.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.782 0.801 . . . . 0.0 110.353 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -65.59 -32.74 74.49 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.501 0.667 . . . . 0.0 109.925 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.0 -17.18 62.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.395 -0.816 . . . . 0.0 109.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -85.65 -7.09 59.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.15 127.85 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.129 -0.982 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -151.14 32.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.77 5.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.2 ttm -114.11 133.27 55.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.617 -0.931 . . . . 0.0 109.451 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -112.22 121.16 44.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.685 0.755 . . . . 0.0 109.168 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.8 mt -99.45 125.38 45.17 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.501 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 2.1 mp -107.04 125.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 109.318 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 58' ' ' GLU . 65.5 t0 -125.85 17.4 7.98 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 64.31 -62.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.348 0.594 . . . . 0.0 110.242 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' ASP . 96.3 mt-10 -72.98 -0.85 14.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.83 173.57 36.71 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.92 148.57 34.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -1.077 . . . . 0.0 109.761 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.25 133.62 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.538 0.685 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.9 126.36 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.773 . . . . 0.0 109.264 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 64' ' ' ARG . 6.2 m -137.27 160.79 38.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.817 0.818 . . . . 0.0 109.316 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 63' ' ' THR . 84.5 mmt-85 -102.92 -116.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' ARG . 79.8 mm-40 35.75 77.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.601 0.715 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.92 131.95 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.83 138.58 52.13 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.582 0.706 . . . . 0.0 109.407 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -103.39 132.93 11.23 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -99.58 108.26 20.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -1.002 . . . . 0.0 108.685 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -102.61 145.09 30.16 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.679 0.752 . . . . 0.0 109.998 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.4 mt -122.71 135.13 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 71' ' ' ILE . 9.3 p30 -37.79 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.894 0.854 . . . . 0.0 110.735 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 150.69 -62.44 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -178.54 150.72 0.7 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.243 -1.151 . . . . 0.0 109.531 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -37.49 118.66 0.26 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.632 2.221 . . . . 0.0 111.779 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.1 m -110.93 -33.57 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 0.0 110.238 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.87 161.11 41.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.773 -1.204 . . . . 0.0 110.836 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -128.16 152.42 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.558 0.694 . . . . 0.0 109.376 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -137.93 153.15 49.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.578 0.704 . . . . 0.0 109.568 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -151.4 154.03 35.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.41 0.624 . . . . 0.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.9 131.94 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 83' ' ' ILE . 14.0 mm -96.25 122.63 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.927 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 81.2 mt -110.0 108.21 18.37 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.547 0.689 . . . . 0.0 109.497 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.26 -54.85 2.53 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.541 0.686 . . . . 0.0 109.524 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.02 145.82 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.683 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -67.02 -43.22 45.94 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.64 -0.663 . . . . 0.0 110.526 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 52.5 Cg_exo -53.78 -36.31 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.074 1.85 . . . . 0.0 111.317 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.86 -41.96 99.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.629 -0.67 . . . . 0.0 109.632 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.54 -38.92 91.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.27 -0.893 . . . . 0.0 110.009 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.64 -48.46 81.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 108.959 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -69.07 -41.89 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.728 0.775 . . . . 0.0 109.376 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -61.25 -45.35 94.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 53.9 mtt -64.19 -39.57 94.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -61.45 -41.38 97.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -60.44 -44.02 96.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.831 . . . . 0.0 109.73 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.7 mtp -63.46 -40.37 96.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.68 -46.47 72.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -66.63 -43.62 84.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 109.915 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -64.74 -42.05 95.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.481 -0.762 . . . . 0.0 109.691 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.98 -40.95 94.07 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.85 -39.76 94.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.514 -0.992 . . . . 0.0 109.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -39.69 76.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 109.517 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 N--CA 1.501 2.083 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.362 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.527 ' OE2' ' NE2' ' A' ' 5' ' ' GLN . 18.5 pt-20 -156.88 165.92 34.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.73 130.35 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.502 -0.749 . . . . 0.0 109.147 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.527 ' NE2' ' OE2' ' A' ' 3' ' ' GLU . 78.1 mt-30 -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.699 0.761 . . . . 0.0 109.886 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -70.97 -74.62 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.82 0.819 . . . . 0.0 110.055 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.6 t -94.63 136.01 35.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.72 138.52 57.45 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.75 0.786 . . . . 0.0 110.823 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.69 -11.94 69.29 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.4 t -97.41 113.28 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.286 -1.126 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.13 39.18 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.633 0.73 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -172.56 135.97 0.73 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 14' ' ' VAL . 62.1 m -92.18 -70.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.52 -0.738 . . . . 0.0 109.758 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' THR . 58.5 t 54.32 162.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.415 -0.803 . . . . 0.0 110.704 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.76 81.78 52.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.332 -0.855 . . . . 0.0 109.517 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.24 148.02 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.229 2.62 . . . . 0.0 112.615 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 58.7 mp0 -93.67 141.73 28.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.39 -0.818 . . . . 0.0 109.482 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.03 127.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.477 -0.765 . . . . 0.0 110.274 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -127.4 143.48 51.2 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 109.092 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -95.48 138.33 33.31 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.879 0.847 . . . . 0.0 110.378 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 t -134.54 144.18 47.85 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -123.43 142.16 51.27 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.931 0.872 . . . . 0.0 109.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 C--N 1.302 -1.458 0 CA-C-O 121.833 0.825 . . . . 0.0 110.472 -179.215 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.499 2.02 0 CA-C-O 121.93 0.871 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.81 143.24 36.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 40.6 ttm -155.96 144.39 20.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.292 -1.123 . . . . 0.0 109.933 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.62 144.93 36.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -116.94 149.18 40.59 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.606 0.717 . . . . 0.0 110.377 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -123.75 143.87 50.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -116.23 118.3 32.42 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.397 0.618 . . . . 0.0 109.628 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CE1' ' CE ' ' A' ' 52' ' ' MET . 63.9 m-85 -110.26 118.59 36.76 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.32 0.581 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.56 122.99 47.79 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.839 0.828 . . . . 0.0 110.094 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 39' ' ' THR . 85.9 mt-10 47.55 52.39 12.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.966 -0.459 . . . . 0.0 110.734 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 28.4 Cg_endo -63.57 9.09 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.57 2.18 . . . . 0.0 110.93 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 37' ' ' GLU . 71.4 p 51.01 19.21 0.63 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.764 -0.585 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 44' ' ' GLU . 15.2 tt -97.4 -13.61 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -66.29 -38.84 88.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.471 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.94 -12.9 59.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.478 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -105.48 -16.31 14.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.366 -0.834 . . . . 0.0 108.861 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' ILE . 80.4 tt0 -171.43 139.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.52 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.431 ' HG ' ' N ' ' A' ' 46' ' ' THR . 34.8 t -74.67 158.6 33.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.431 ' N ' ' HG ' ' A' ' 45' ' ' SER . 71.2 p -64.91 -31.2 72.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.636 -0.665 . . . . 0.0 110.284 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 109.912 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -72.4 -17.13 61.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 109.278 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.72 118.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -149.25 42.77 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.6 139.5 4.53 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.472 ' CE ' ' CE1' ' A' ' 35' ' ' PHE . 45.1 ttm -130.66 128.72 41.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.685 -0.891 . . . . 0.0 108.668 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -111.28 125.79 54.2 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.842 0.829 . . . . 0.0 109.969 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.56 124.08 40.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.661 -0.649 . . . . 0.0 109.276 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 2.1 mp -101.16 125.85 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.759 0.79 . . . . 0.0 109.785 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -108.92 -149.46 0.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.359 0.6 . . . . 0.0 109.641 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 58' ' ' GLU . 44.1 p-10 -64.1 -34.15 77.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.774 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.533 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 83.9 tt0 -156.63 -43.56 0.07 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 108.865 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.42 169.87 53.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.19 156.91 42.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -1.088 . . . . 0.0 110.142 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 61' ' ' ILE . 96.3 mt -112.41 134.64 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.504 0.669 . . . . 0.0 109.295 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.585 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 2.3 mp -100.04 122.87 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.8 m -124.3 127.28 47.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.516 0.674 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -107.87 -4.16 18.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 57.5 mp0 -89.48 78.93 7.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.18 132.38 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.649 -0.657 . . . . 0.0 109.372 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.95 142.58 51.51 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.866 0.841 . . . . 0.0 109.639 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.45 142.0 15.82 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' CE ' ' OE1' ' A' ' 79' ' ' GLU . 68.0 mmtt -103.97 113.04 26.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.654 -0.909 . . . . 0.0 108.79 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 23.9 m-85 -98.34 144.63 27.52 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.847 0.832 . . . . 0.0 110.113 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' GLY . 96.5 mt -122.17 136.93 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 71' ' ' ILE . 59.5 m-80 -38.49 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.854 0.835 . . . . 0.0 110.421 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 149.3 -62.36 0.42 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -177.62 154.94 1.07 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.575 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.5 134.59 21.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.337 2.025 . . . . 0.0 112.447 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -147.05 -25.11 0.4 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.484 -0.76 . . . . 0.0 109.817 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.38 51.81 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 110.411 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.93 135.32 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' OE1' ' CE ' ' A' ' 69' ' ' LYS . 46.2 tt0 -116.81 151.57 36.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.71 144.97 32.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.564 -0.71 . . . . 0.0 109.529 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -117.54 129.06 55.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.553 -0.717 . . . . 0.0 109.975 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.98 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.764 0.792 . . . . 0.0 109.543 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.423 ' O ' ' OE1' ' A' ' 89' ' ' GLU . 27.2 mm -85.69 126.23 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.653 -0.654 . . . . 0.0 109.699 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.48 36.9 2.91 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.46 -40.39 97.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.822 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -76.67 153.78 34.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.205 -0.934 . . . . 0.0 110.373 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -70.06 -48.78 20.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.467 -0.77 . . . . 0.0 110.497 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 40.9 Cg_exo -52.17 -37.87 70.38 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.9 1.733 . . . . 0.0 111.392 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 83' ' ' ILE . 97.6 mt-10 -64.55 -40.74 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.567 0.699 . . . . 0.0 109.851 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -61.69 -44.82 96.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.288 -0.882 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -60.99 -46.61 90.05 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.354 -0.841 . . . . 0.0 109.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -67.56 -39.52 84.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.668 0.747 . . . . 0.0 109.438 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -62.6 -48.14 80.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.408 -0.808 . . . . 0.0 110.07 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.92 -42.09 85.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.971 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -67.57 -44.52 78.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.901 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.22 -47.09 85.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.373 -0.829 . . . . 0.0 109.359 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.4 ttt -66.69 -39.15 87.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.659 0.743 . . . . 0.0 109.066 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.2 -51.53 60.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.0 109.686 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -68.23 -40.0 82.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -63.1 -48.63 77.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.502 -0.749 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 -35.15 89.44 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.53 94.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -1.108 . . . . 0.0 110.044 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.71 -56.53 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 109.819 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 109.742 -179.714 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.271 0.558 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.491 ' CD ' HE21 ' A' ' 5' ' ' GLN . 21.0 pt-20 -154.91 158.86 39.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.065 -1.022 . . . . 0.0 109.365 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -110.26 130.97 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.582 -0.699 . . . . 0.0 109.192 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.491 HE21 ' CD ' ' A' ' 3' ' ' GLU . 78.8 mt-30 -137.35 122.87 19.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.32 -39.32 85.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.845 . . . . 0.0 109.644 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.5 m -127.02 153.25 46.17 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.711 0.767 . . . . 0.0 110.223 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -71.47 137.5 48.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.592 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.22 -2.66 71.71 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 11' ' ' ALA . 69.2 t -70.84 -50.4 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -1.139 . . . . 0.0 109.682 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' VAL . . . 58.95 144.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 110.595 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 13' ' ' THR . 8.6 tm-20 58.14 -88.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.909 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.531 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 1.4 m 81.87 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -172.77 179.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 14' ' ' VAL . 96.3 t -115.13 86.35 13.84 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -78.25 154.15 28.38 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.984 2.456 . . . . 0.0 112.873 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -81.01 155.46 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -111.13 128.63 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.601 -0.687 . . . . 0.0 109.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -134.74 132.8 39.22 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.478 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 4.0 mm? -97.28 135.53 39.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.63 ' CB ' ' HZ2' ' A' ' 32' ' ' LYS . 40.3 m -123.99 150.0 45.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.25 142.9 50.53 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 109.823 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.523 -0.735 . . . . 0.0 110.089 -179.65 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.624 ' CB ' HD22 ' A' ' 85' ' ' ASN . 17.6 m . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.473 0.654 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.25 145.37 28.06 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -161.06 167.45 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.274 . . . . 0.0 109.147 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.14 143.71 38.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.351 -0.843 . . . . 0.0 108.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.63 ' HZ2' ' CB ' ' A' ' 21' ' ' SER . 64.4 mttp -111.83 146.37 37.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.74 131.69 54.21 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.36 128.3 53.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -112.25 114.95 28.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.49 -0.756 . . . . 0.0 109.428 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' GLU . 39.7 tp -95.4 122.43 38.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 36' ' ' LEU . 50.9 mm-40 39.45 57.25 6.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.751 -0.593 . . . . 0.0 111.034 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.69 145.78 91.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.449 2.099 . . . . 0.0 112.379 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.531 ' C ' ' H ' ' A' ' 41' ' ' LEU . 64.0 p -69.46 -24.38 63.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.379 -0.826 . . . . 0.0 110.292 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 tp -59.44 1.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.068 . . . . 0.0 109.859 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' H ' ' C ' ' A' ' 39' ' ' THR . 89.2 mt -91.24 -6.9 52.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 109.22 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.74 -26.63 13.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.457 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -96.06 -75.89 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.275 -0.891 . . . . 0.0 110.018 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.05 151.71 20.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.423 -0.798 . . . . 0.0 110.395 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -74.71 163.1 28.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 p -66.53 -32.69 74.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.565 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.34 -18.55 63.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -79.31 -5.18 53.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.05 117.83 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.2 p -114.25 0.2 14.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.51 178.22 45.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.3 ttp -130.32 137.99 50.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.591 -0.947 . . . . 0.0 108.716 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.18 123.12 47.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.32 -0.862 . . . . 0.0 110.035 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.15 125.95 44.82 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.552 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 2.9 mp -107.14 129.06 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.628 -0.67 . . . . 0.0 110.081 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 92' ' ' ARG . 41.9 p-10 -150.79 120.61 7.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.222 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.435 ' N ' HH12 ' A' ' 99' ' ' ARG . 66.4 t0 59.92 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.626 -0.671 . . . . 0.0 109.983 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' ASP . 81.1 tt0 -145.53 -38.64 0.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 108.886 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.83 171.85 53.38 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.5 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 2.2 pm0 -152.08 156.08 39.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.261 -1.14 . . . . 0.0 109.435 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.63 135.45 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.604 -0.685 . . . . 0.0 109.175 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.2 mm -101.78 125.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.3 m -123.45 125.97 45.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.568 -0.708 . . . . 0.0 109.258 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -97.72 -7.98 29.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -83.86 84.0 7.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 110.017 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.78 134.57 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.452 -0.78 . . . . 0.0 109.452 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -125.57 142.09 51.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.57 -0.706 . . . . 0.0 109.263 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.58 140.39 14.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -107.23 102.77 12.06 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -102.32 146.1 28.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.588 -0.695 . . . . 0.0 109.776 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.7 mt -121.17 133.09 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 7.9 p30 -38.03 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 154.09 -60.86 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -177.04 150.9 0.91 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.331 . . . . 0.0 109.158 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -40.16 118.68 0.57 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.267 1.978 . . . . 0.0 111.861 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.2 m -111.22 -33.85 6.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.28 164.39 37.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 110.901 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 94.4 mt -126.87 164.1 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.463 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 15.5 tm-20 -140.12 148.5 41.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.463 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.76 143.81 35.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.501 -0.749 . . . . 0.0 108.981 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -122.87 130.33 52.73 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.567 -0.708 . . . . 0.0 109.582 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.3 t -110.81 129.71 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.492 -0.755 . . . . 0.0 109.414 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.435 ' CG2' ' OD1' ' A' ' 85' ' ' ASN . 30.0 mm -82.66 129.0 38.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 86.9 mt -117.52 38.02 3.72 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.624 HD22 ' CB ' ' A' ' 28' ' ' SER . 13.4 m120 -63.36 -40.67 97.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.377 -0.827 . . . . 0.0 109.332 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 151.06 35.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.27 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.586 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -73.2 -41.12 6.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.517 -0.739 . . . . 0.0 110.437 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 47.0 Cg_exo -56.08 -35.81 95.38 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.203 1.935 . . . . 0.0 111.632 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.57 -39.27 88.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.43 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.8 m95 -60.28 -42.12 94.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.63 -49.33 78.15 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.749 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.51 ' NH2' ' OD1' ' A' ' 56' ' ' ASP . 17.4 mmm180 -69.06 -39.77 78.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -61.68 -44.66 96.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.336 -0.853 . . . . 0.0 109.282 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.1 mmm -62.64 -41.49 99.06 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 108.881 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -64.89 -45.39 86.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.056 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -61.22 -45.85 92.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.415 ' C ' ' SD ' ' A' ' 97' ' ' MET . 2.0 tmt? -62.14 -41.54 98.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.481 -0.762 . . . . 0.0 109.725 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.3 -46.15 77.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.121 -0.987 . . . . 0.0 109.318 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.435 HH12 ' N ' ' A' ' 57' ' ' ASP . 83.5 mtp180 -65.63 -41.68 92.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.143 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.47 -48.42 79.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.47 -0.769 . . . . 0.0 109.695 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.85 -36.31 86.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.09 98.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.07 -42.16 66.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.347 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.484 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.416 ' H ' ' HB2' ' A' ' 100' ' ' TYR . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.105 0.479 . . . . 0.0 109.868 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -134.79 136.98 42.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.784 0.802 . . . . 0.0 109.651 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.4 129.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.2 135.8 51.16 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.792 0.806 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -106.76 -56.08 2.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.537 0.684 . . . . 0.0 109.394 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' LYS . 32.5 t -93.42 11.21 29.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 109.359 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.6 mttm 57.88 124.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.771 0.796 . . . . 0.0 110.76 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.72 11.15 64.2 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -96.04 135.02 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.499 -1.0 . . . . 0.0 110.09 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -92.88 -159.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.437 0.637 . . . . 0.0 110.599 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.482 ' O ' ' OG1' ' A' ' 13' ' ' THR . 72.0 mm-40 56.53 -76.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 11' ' ' ALA . 4.5 p 65.29 6.38 3.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.562 ' CG2' ' H ' ' A' ' 15' ' ' VAL . 12.8 p 44.07 177.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.891 0.853 . . . . 0.0 111.202 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.562 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 81.9 t -115.14 91.8 28.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.878 . . . . 0.0 108.959 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.04 145.02 17.22 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.75 2.3 . . . . 0.0 112.673 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.12 149.7 39.0 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.571 -0.705 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.72 127.43 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -132.06 119.84 21.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 7.0 mp -104.79 132.5 50.96 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.9 m -127.37 152.29 47.68 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.378 0.608 . . . . 0.0 109.683 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.3 131.11 57.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.652 0.739 . . . . 0.0 109.559 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.622 ' HG ' ' HG ' ' A' ' 28' ' ' SER . 58.1 m . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.767 -0.583 . . . . 0.0 110.132 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.622 ' HG ' ' HG ' ' A' ' 23' ' ' SER . 1.5 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.734 0.778 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.4 ' HA3' ' HE1' ' A' ' 90' ' ' TRP . . . -67.92 140.42 36.27 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.33 149.54 41.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.423 -1.045 . . . . 0.0 109.993 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.0 144.89 45.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 142.46 51.49 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.652 0.739 . . . . 0.0 109.953 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.93 137.95 54.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -120.68 125.34 47.45 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.688 0.756 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 32.3 m-85 -110.12 114.39 27.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 37' ' ' GLU . 51.8 tp -88.77 132.31 34.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.397 0.618 . . . . 0.0 110.565 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' LEU . 41.0 mt-10 32.76 68.81 0.91 Allowed Pre-proline 0 N--CA 1.5 2.032 0 CA-C-O 121.177 0.513 . . . . 0.0 111.127 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.52 140.71 92.74 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.66 2.24 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -83.14 -19.4 36.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.561 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.43 1.87 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 109.398 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 39' ' ' THR . 95.2 mt -81.85 -13.27 57.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.19 -13.78 21.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.37 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -107.84 -44.84 4.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -134.62 147.59 50.22 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.6 m -75.79 158.39 32.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.753 0.787 . . . . 0.0 110.535 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -64.98 -32.16 73.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -72.45 -17.47 61.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -88.73 -7.56 56.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.235 -0.915 . . . . 0.0 109.251 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.86 122.14 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.754 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -124.42 122.77 38.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 109.562 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.14 -171.06 18.95 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.5 ttp -141.45 133.64 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.56 -0.965 . . . . 0.0 108.961 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -108.35 109.29 20.58 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.723 0.773 . . . . 0.0 109.726 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.69 111.47 23.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 mm -109.25 131.02 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.031 0.919 . . . . 0.0 110.366 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD1' ' CD2' ' A' ' 96' ' ' PHE . 2.7 m-20 -138.6 -160.73 1.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.486 0.66 . . . . 0.0 109.408 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -81.45 104.66 12.04 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.926 0.869 . . . . 0.0 110.319 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 60.62 89.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.643 0.735 . . . . 0.0 110.592 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.57 142.97 5.77 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.28 147.68 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.999 . . . . 0.0 109.108 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.77 133.7 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 109.578 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.2 mm -108.02 126.99 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 109.196 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.3 m -125.4 125.66 43.75 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.64 0.733 . . . . 0.0 109.295 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -97.8 -1.77 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -85.26 75.24 10.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.457 -0.777 . . . . 0.0 109.426 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.0 t -126.7 133.83 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.679 0.752 . . . . 0.0 109.338 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -132.82 141.13 48.3 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.97 141.24 15.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -106.01 119.23 38.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.604 -0.939 . . . . 0.0 108.875 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -107.98 144.59 35.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.583 0.706 . . . . 0.0 110.064 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mm -121.05 131.38 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 57.66 14.92 2.61 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.453 0.644 . . . . 0.0 110.07 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -17.86 58.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -100.4 150.37 36.88 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.452 -1.028 . . . . 0.0 110.05 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.92 143.25 90.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.576 2.184 . . . . 0.0 112.129 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 m -149.12 -41.47 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.973 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.85 164.59 35.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.762 -1.211 . . . . 0.0 111.077 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.02 152.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -135.34 145.28 47.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.011 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.22 46.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.689 1.233 . . . . 0.0 110.004 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.4 m -126.65 131.62 51.4 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.671 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.9 t -119.62 130.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 mm -87.7 126.71 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.542 0.687 . . . . 0.0 109.919 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.64 41.64 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -63.59 -39.75 95.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.73 . . . . 0.0 109.363 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.58 158.18 27.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.555 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 7.5 mm-40 -79.85 -41.42 1.43 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.802 -0.561 . . . . 0.0 110.832 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.8 Cg_exo -56.14 -37.5 96.39 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.823 1.682 . . . . 0.0 111.259 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -68.28 -39.04 82.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.637 -0.664 . . . . 0.0 109.433 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.4 ' HE1' ' HA3' ' A' ' 29' ' ' GLY . 1.8 m95 -61.32 -40.62 94.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.52 -44.56 95.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.189 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -69.55 -39.01 77.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 109.119 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.83 -45.97 91.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.37 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.6 ttt -62.56 -47.04 85.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.59 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -65.69 -41.72 92.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.461 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.48 ' CD2' ' OD1' ' A' ' 56' ' ' ASP . 3.4 m-85 -64.15 -46.89 82.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.2 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.8 ttp -63.03 -39.58 95.18 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -66.35 -40.45 89.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.507 -0.746 . . . . 0.0 109.443 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -65.88 -42.36 90.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.416 ' HB2' ' H ' ' A' ' 2' ' ' ALA . 81.8 t80 -60.05 -46.47 89.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.482 -0.761 . . . . 0.0 109.269 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.31 94.73 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.52 72.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -1.053 . . . . 0.0 109.849 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.78 -42.78 69.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.518 -0.739 . . . . 0.0 109.763 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.412 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 62.0 m-20 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.561 -0.712 . . . . 0.0 109.569 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.533 ' CD ' HE21 ' A' ' 5' ' ' GLN . 43.7 tt0 -145.16 134.05 22.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 109.095 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.38 129.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.634 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.533 HE21 ' CD ' ' A' ' 3' ' ' GLU . 76.5 mt-30 -140.31 124.87 17.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.298 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.41 -2.88 58.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.133 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 8' ' ' LYS . 29.6 t -155.86 43.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.436 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' SER . 47.2 pttt 31.81 43.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.433 0.635 . . . . 0.0 110.853 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.43 26.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -97.8 132.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -1.11 . . . . 0.0 110.092 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.16 142.26 58.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' A' ' 14' ' ' VAL . 57.4 mp0 -85.47 -116.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.597 -0.689 . . . . 0.0 110.379 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 16.3 p 57.35 0.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.584 ' H ' ' C ' ' A' ' 12' ' ' GLU . 74.9 t -67.91 -43.54 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.05 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 t 62.13 60.43 2.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.733 -0.604 . . . . 0.0 109.869 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -68.61 149.06 73.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.662 2.241 . . . . 0.0 112.256 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.82 154.09 23.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 110.087 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.88 132.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -127.63 140.69 51.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.14 143.0 43.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.604 -0.685 . . . . 0.0 109.684 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -149.92 151.86 34.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.042 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.61 133.58 55.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.688 0.756 . . . . 0.0 109.185 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.6 0.714 . . . . 0.0 110.724 -179.151 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.547 ' CB ' HD21 ' A' ' 85' ' ' ASN . 3.0 p . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.642 0.734 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.25 145.71 49.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.3 ttp -141.45 150.06 41.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -1.045 . . . . 0.0 109.796 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.35 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.444 -0.785 . . . . 0.0 109.01 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -125.61 140.72 52.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.541 -0.724 . . . . 0.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.53 119.33 38.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -95.99 124.43 39.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 109.138 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.92 124.8 52.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.644 -0.66 . . . . 0.0 109.709 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.8 tp -107.79 121.65 45.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.657 -0.652 . . . . 0.0 109.286 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 40.6 mt-10 42.65 55.43 10.39 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 110.315 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 36.0 Cg_endo -66.71 151.25 82.97 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.919 2.412 . . . . 0.0 112.749 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -84.28 90.85 7.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.638 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' GLU . 10.5 tp -173.48 -27.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -40.35 96.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.33 79.99 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 108.891 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -89.19 -69.58 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.619 -0.676 . . . . 0.0 109.286 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 40' ' ' ILE . 97.8 mt-10 -110.94 134.65 52.41 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.511 -0.743 . . . . 0.0 109.67 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -65.85 159.86 24.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.659 0.743 . . . . 0.0 110.436 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -33.46 75.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.648 -0.658 . . . . 0.0 109.65 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.2 -19.07 63.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.484 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -82.59 -5.62 58.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.1 mt -98.96 117.25 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.389 -0.819 . . . . 0.0 109.776 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.5 m -102.6 -7.11 22.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.63 -179.75 42.85 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.142 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.8 ttp -128.92 145.17 51.3 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.626 -0.926 . . . . 0.0 109.222 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.37 122.36 46.84 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.406 -0.809 . . . . 0.0 110.425 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.4 mt -98.89 109.5 22.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' A' ' 56' ' ' ASP . 2.6 mp -105.47 163.15 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.041 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' CE2' ' A' ' 96' ' ' PHE . 40.4 t0 -162.46 -179.2 6.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.541 -0.724 . . . . 0.0 109.407 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 97.8 m-20 -70.07 -15.64 63.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -169.55 97.71 0.32 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.374 -0.829 . . . . 0.0 109.285 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.3 146.15 8.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.78 144.45 23.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -124.08 131.51 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.549 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 2.0 mp -101.97 132.16 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.0 m -120.32 123.32 42.84 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -97.79 -1.57 42.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.64 72.29 7.77 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.77 132.78 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.3 144.01 51.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.26 137.97 14.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.19 128.12 53.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.634 -0.921 . . . . 0.0 108.98 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -102.47 122.29 44.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.93 140.05 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 58.96 32.92 22.71 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.35 23.66 74.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -151.06 148.32 22.47 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.078 -1.248 . . . . 0.0 109.435 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.85 107.39 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.198 1.932 . . . . 0.0 111.228 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m -131.45 -10.25 3.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.538 -0.727 . . . . 0.0 110.059 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.71 154.47 41.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.957 -1.089 . . . . 0.0 110.306 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.03 159.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 16.1 tm-20 -140.7 149.31 42.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.267 -0.895 . . . . 0.0 109.489 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.482 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.13 142.7 35.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.399 -0.813 . . . . 0.0 109.055 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -120.63 132.61 55.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.707 -0.621 . . . . 0.0 109.669 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.68 132.17 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 83' ' ' ILE . 21.1 mm -95.38 122.5 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.336 -0.853 . . . . 0.0 110.116 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.4 mt -101.12 79.25 1.99 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.547 HD21 ' CB ' ' A' ' 28' ' ' SER . 11.9 m120 -87.3 -5.6 58.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.497 -0.752 . . . . 0.0 110.048 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 t -115.72 134.33 55.14 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.731 0.776 . . . . 0.0 109.764 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.442 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.0 mp0 -58.85 -60.65 9.79 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.752 -0.592 . . . . 0.0 110.579 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 3.0 Cg_endo -49.52 -21.52 5.25 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.993 1.795 . . . . 0.0 111.715 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -65.92 -38.17 87.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.694 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -58.67 -38.19 77.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.329 -0.857 . . . . 0.0 109.749 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -60.39 -44.2 95.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -67.51 -40.67 85.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.842 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.6 -48.9 78.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.359 -0.838 . . . . 0.0 109.794 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.08 -40.75 78.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -63.37 -49.11 75.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.797 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.519 ' CE2' ' OD2' ' A' ' 56' ' ' ASP . 6.2 m-85 -66.31 -42.02 88.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.468 -0.77 . . . . 0.0 109.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 59.4 tpp -64.98 -34.07 77.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.629 -0.669 . . . . 0.0 109.267 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.65 -54.52 41.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.136 -0.978 . . . . 0.0 110.156 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -65.69 -46.83 77.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.947 . . . . 0.0 110.145 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -62.95 -44.78 95.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.21 -33.89 88.44 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.09 98.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.322 -1.105 . . . . 0.0 109.529 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.534 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 80.2 mm-40 -71.27 -56.35 6.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 103' ' ' GLU . 34.3 m120 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.218 -0.926 . . . . 0.0 109.811 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.628 0.728 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -153.14 149.26 27.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mp -110.34 130.45 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.469 0.652 . . . . 0.0 109.995 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -129.56 129.26 44.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.688 0.756 . . . . 0.0 109.513 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -88.09 -5.94 58.19 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 m -157.45 -168.85 2.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.6 133.74 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.865 0.84 . . . . 0.0 111.086 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 42.25 71.17 0.4 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.4 -47.92 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -1.001 . . . . 0.0 108.727 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.73 82.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.079 0.942 . . . . 0.0 109.152 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.11 124.22 30.89 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.738 0.78 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -96.4 -14.92 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 15' ' ' VAL . 59.3 t -55.66 159.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.292 -0.88 . . . . 0.0 110.091 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.438 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 12.4 t -112.39 81.42 4.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.534 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.6 148.76 54.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.611 2.208 . . . . 0.0 112.554 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 18' ' ' VAL . 7.0 tm-20 -84.37 155.17 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.592 -0.692 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 55.4 t -117.62 129.62 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.561 0.696 . . . . 0.0 109.768 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -128.68 137.88 51.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.24 131.18 47.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.585 -0.697 . . . . 0.0 109.351 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 m -108.01 149.09 28.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.612 -0.68 . . . . 0.0 109.619 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.05 141.53 46.15 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.654 0.74 . . . . 0.0 109.589 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.649 . . . . 0.0 109.538 179.772 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.821 0.82 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.89 143.56 41.91 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttp -165.09 153.02 11.46 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -1.052 . . . . 0.0 109.663 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' HA ' ' H ' ' A' ' 21' ' ' SER . . . -142.89 153.18 42.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.653 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.06 147.55 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.452 0.644 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.32 136.85 54.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -114.27 122.05 45.55 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.456 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.19 114.28 27.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.0 tp -95.87 121.22 37.37 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.708 0.766 . . . . 0.0 110.027 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 48.55 60.21 15.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.982 -0.449 . . . . 0.0 110.623 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 40' ' ' ILE . 38.1 Cg_endo -69.68 1.36 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.346 2.031 . . . . 0.0 110.479 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m 54.74 5.03 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.28 0.562 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 38' ' ' PRO . 2.8 tp -73.48 -1.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 109.655 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.7 mt -84.42 -9.55 58.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 108.953 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.8 -18.6 22.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.332 -0.855 . . . . 0.0 109.382 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.45 -47.15 4.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.32 -0.863 . . . . 0.0 109.089 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.78 153.09 48.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.33 -0.856 . . . . 0.0 110.148 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 t -80.69 167.04 20.47 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.694 0.759 . . . . 0.0 110.373 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -62.93 -39.92 96.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.642 0.734 . . . . 0.0 109.423 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 50.0 p-10 -70.98 -21.91 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.524 -0.735 . . . . 0.0 109.682 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 96.4 m-20 -80.26 -6.23 57.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.95 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.22 123.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.984 -1.073 . . . . 0.0 109.939 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.587 ' HG1' ' NH1' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -116.15 91.01 3.47 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 0.0 109.369 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.93 174.71 37.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -127.62 149.15 50.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.709 -0.877 . . . . 0.0 109.375 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.79 108.84 20.56 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.621 0.724 . . . . 0.0 109.726 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.35 115.81 30.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 55' ' ' ILE . 96.7 mt -116.89 125.15 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.53 0.681 . . . . 0.0 109.602 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -104.01 -167.36 1.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.592 0.71 . . . . 0.0 110.376 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 33.2 p-10 -77.78 -5.23 50.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.728 -0.607 . . . . 0.0 109.658 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -108.75 -94.18 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.417 -0.802 . . . . 0.0 109.884 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' H ' ' NH1' ' A' ' 92' ' ' ARG . . . -106.12 -147.59 15.16 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -137.38 155.09 49.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.98 . . . . 0.0 110.091 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.45 138.86 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.407 0.622 . . . . 0.0 109.804 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 62' ' ' ILE . 36.0 mm -110.34 129.27 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.8 m -120.18 123.85 44.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 109.581 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.587 ' NH1' ' HG1' ' A' ' 50' ' ' THR . 18.2 tpt85 -98.82 -12.6 20.69 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -84.83 79.3 9.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.441 -0.787 . . . . 0.0 109.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.93 133.21 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.403 0.621 . . . . 0.0 109.476 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.05 143.25 50.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.73 0.776 . . . . 0.0 109.727 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.79 140.42 15.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -101.52 121.58 42.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.984 . . . . 0.0 109.185 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -104.62 119.33 38.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.631 0.729 . . . . 0.0 110.121 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.31 138.84 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.42 33.75 20.65 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.603 0.716 . . . . 0.0 110.192 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.24 27.55 73.07 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -155.1 148.19 18.22 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.143 -1.21 . . . . 0.0 109.523 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.07 113.96 3.23 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.6 2.2 . . . . 0.0 111.926 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m -126.98 -15.69 5.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.22 158.26 43.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 110.269 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -129.01 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.378 0.609 . . . . 0.0 109.463 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -129.59 148.05 51.45 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.604 0.716 . . . . 0.0 109.689 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.4 145.94 39.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.21 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -121.47 131.71 54.31 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.432 0.634 . . . . 0.0 109.946 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.08 129.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.561 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.4 mp -82.15 127.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.533 0.682 . . . . 0.0 109.655 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.494 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 84.5 mt -120.68 33.77 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.68 -40.04 95.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.529 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.7 m -70.47 145.61 50.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.044 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.502 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -71.58 -47.67 12.56 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.303 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 43.7 Cg_exo -54.36 -33.67 77.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.123 1.882 . . . . 0.0 111.819 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -66.04 -37.24 85.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.578 -0.701 . . . . 0.0 109.872 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.494 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.1 m95 -60.97 -39.81 91.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 109.944 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.58 -51.1 69.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.434 ' NH1' ' H ' ' A' ' 59' ' ' GLY . 63.2 ttm-85 -68.27 -42.68 79.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.43 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.29 -43.25 99.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ttt -59.02 -41.98 89.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.308 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.36 -40.48 93.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.523 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.55 -48.21 82.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.266 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.8 ttt -67.86 -39.09 83.81 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.646 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -64.3 -47.95 77.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.453 -0.779 . . . . 0.0 109.434 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -67.23 -42.34 84.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.825 . . . . 0.0 109.546 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.6 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 60.6 t80 -60.94 -46.18 91.73 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.801 0.81 . . . . 0.0 109.314 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.09 -30.91 79.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.38 93.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 109.812 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -89.24 -16.89 30.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.6 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 68.7 m-80 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.59 0.71 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -155.39 138.98 15.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -0.814 . . . . 0.0 109.723 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.2 130.51 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.672 0.748 . . . . 0.0 109.399 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 10' ' ' VAL . 16.8 pt20 -149.05 145.71 27.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.511 -0.743 . . . . 0.0 109.674 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 53' ' ' TYR . 90.2 m-85 -63.39 -45.47 90.93 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.59 0.709 . . . . 0.0 109.404 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 m -104.99 158.06 16.8 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.672 0.748 . . . . 0.0 110.322 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -68.54 133.28 48.32 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.834 0.826 . . . . 0.0 110.507 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 45.37 86.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 44.4 t -101.96 -77.66 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -1.026 . . . . 0.0 109.296 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -178.06 -99.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.458 -0.776 . . . . 0.0 110.068 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.7 143.03 31.98 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 110.805 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' VAL . 70.9 m -75.72 -17.88 59.77 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.321 0.581 . . . . 0.0 109.968 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' THR . 3.7 t 55.51 158.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.485 -0.76 . . . . 0.0 110.572 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.25 74.53 41.83 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.299 -0.875 . . . . 0.0 109.892 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.05 147.36 23.72 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.921 2.414 . . . . 0.0 112.522 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -74.86 161.63 29.38 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.767 0.794 . . . . 0.0 110.045 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -113.06 131.33 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.543 0.687 . . . . 0.0 109.324 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -128.52 139.9 52.08 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.678 0.751 . . . . 0.0 109.579 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 4.1 mm? -97.42 135.22 39.61 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.641 0.734 . . . . 0.0 109.64 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.9 t -134.57 142.95 47.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.539 0.685 . . . . 0.0 109.714 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -100.77 159.08 15.48 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.054 0.931 . . . . 0.0 110.371 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.302 -1.468 0 CA-C-O 121.652 0.739 . . . . 0.0 110.295 -179.565 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.413 ' HG ' ' H ' ' A' ' 29' ' ' GLY . 4.8 p . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.74 0.781 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' H ' ' HG ' ' A' ' 28' ' ' SER . . . 147.84 172.85 18.3 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.0 ptp -159.26 175.69 13.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -1.132 . . . . 0.0 109.679 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.54 143.91 45.97 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' NZ ' ' OG1' ' A' ' 81' ' ' THR . 68.3 mttm -117.18 142.9 46.45 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.626 0.727 . . . . 0.0 110.166 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.86 128.12 54.95 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -103.76 131.87 50.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.577 -0.702 . . . . 0.0 109.627 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -112.43 126.44 55.3 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.0 tp -100.68 125.32 47.09 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.681 0.753 . . . . 0.0 110.677 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 37.04 58.17 3.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.22 150.68 81.74 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.574 2.182 . . . . 0.0 112.525 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.501 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -76.5 -18.69 58.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.746 -0.596 . . . . 0.0 110.219 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.78 1.52 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.03 . . . . 0.0 109.707 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.0 mt -89.28 -8.94 52.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.027 -1.045 . . . . 0.0 109.169 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.98 -26.88 11.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.414 -0.804 . . . . 0.0 109.263 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.47 -74.34 0.45 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -0.921 . . . . 0.0 109.9 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.05 143.67 36.46 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.87 0.843 . . . . 0.0 110.408 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -76.5 169.4 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.918 0.866 . . . . 0.0 110.52 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.5 p -65.36 -31.09 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.02 -36.61 84.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.67 -8.99 58.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.4 mt -101.6 118.35 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.238 -0.914 . . . . 0.0 109.989 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' A' ' 50' ' ' THR . 0.3 OUTLIER -140.38 26.04 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.99 164.97 34.72 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 44.3 ttm -135.63 133.58 38.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -1.09 . . . . 0.0 109.499 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 6' ' ' PHE . 4.3 m-85 -112.53 120.97 43.45 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.017 0.913 . . . . 0.0 109.723 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.0 mp -96.37 110.36 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 1.9 mp -98.81 126.99 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.508 -0.745 . . . . 0.0 109.623 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 66.4 t0 -172.5 134.99 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.557 0.694 . . . . 0.0 109.97 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 59' ' ' GLY . 97.8 m-20 57.97 42.86 22.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.974 -0.454 . . . . 0.0 110.077 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 67.82 -40.94 0.42 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.556 0.694 . . . . 0.0 109.543 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -69.66 153.48 52.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.62 149.03 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.463 -1.021 . . . . 0.0 109.91 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -119.36 133.34 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.532 0.682 . . . . 0.0 109.195 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mm -102.83 122.28 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.732 . . . . 0.0 109.698 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.0 m -123.41 126.07 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.63 0.729 . . . . 0.0 109.395 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -101.24 41.24 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.201 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -133.05 86.44 2.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.62 132.18 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -123.21 134.36 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.833 0.825 . . . . 0.0 109.021 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.7 133.37 11.54 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -105.76 110.4 22.69 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.631 -0.923 . . . . 0.0 108.604 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -104.42 139.75 38.91 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.423 0.63 . . . . 0.0 109.62 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.1 mt -117.96 126.15 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.58 0.705 . . . . 0.0 109.487 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.75 33.2 22.57 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.44 78.81 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 ttp85 -135.42 120.07 13.45 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.35 -1.088 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.55 138.2 32.0 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.321 2.014 . . . . 0.0 112.416 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -147.93 -34.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.32 158.96 44.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.841 -1.162 . . . . 0.0 110.533 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.0 mt -131.02 142.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -124.99 148.61 48.37 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.642 0.734 . . . . 0.0 109.464 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.88 147.7 41.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.528 ' OG1' ' NZ ' ' A' ' 32' ' ' LYS . 86.9 m -118.66 130.06 55.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.5 125.16 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.677 0.751 . . . . 0.0 109.531 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 25.0 mm -84.06 131.94 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 82.5 mt -121.72 47.94 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.411 HD21 ' CB ' ' A' ' 28' ' ' SER . 11.1 m120 -64.65 -40.38 95.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.41 -0.806 . . . . 0.0 109.447 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -74.19 145.32 44.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.488 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -73.34 -47.39 7.63 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.481 -0.762 . . . . 0.0 110.203 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 44.6 Cg_exo -54.72 -32.72 77.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.881 1.721 . . . . 0.0 111.306 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -67.03 -38.19 85.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.608 -0.682 . . . . 0.0 109.399 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.2 m95 -59.76 -41.46 91.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -62.73 -46.48 87.87 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -70.15 -41.69 73.51 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.802 0.81 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.36 -44.86 96.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 109.376 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.0 ttm -61.21 -41.84 97.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -66.94 -39.59 87.36 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.56 -46.52 85.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.296 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 62.6 ttp -66.45 -38.42 87.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.6 0.714 . . . . 0.0 109.663 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -61.76 -42.24 98.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.832 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.24 -39.46 86.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.73 -38.5 94.53 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.1 92.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -1.18 . . . . 0.0 110.371 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.75 -56.07 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.046 . . . . 0.0 109.961 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 . . . . . 0 N--CA 1.499 1.988 0 O-C-N 120.95 -1.094 . . . . 0.0 109.444 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.557 0.694 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -154.58 160.79 41.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.588 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.1 129.65 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -129.4 129.29 44.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 109.884 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.08 -5.67 59.16 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.4 t -161.1 -63.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.497 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.588 ' C ' ' H ' ' A' ' 10' ' ' VAL . 53.7 mtpt -143.02 -160.82 1.15 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.91 5.22 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.588 ' H ' ' C ' ' A' ' 8' ' ' LYS . 74.5 t -69.07 134.85 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.314 -1.109 . . . . 0.0 110.344 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 64.43 92.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.491 0.662 . . . . 0.0 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -130.33 -22.22 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -76.22 -1.0 24.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 108.924 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.95 136.52 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.551 -0.718 . . . . 0.0 109.898 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.46 79.41 29.08 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 109.272 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.04 153.21 32.2 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.918 2.412 . . . . 0.0 112.793 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -89.31 138.37 31.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.424 -0.797 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.7 t -88.26 131.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -127.37 144.43 51.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.621 0.724 . . . . 0.0 109.48 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.73 132.39 54.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.8 t -121.36 152.57 38.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.749 -0.594 . . . . 0.0 109.509 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -133.3 153.03 51.93 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.881 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.4 p . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.734 . . . . 0.0 109.426 -179.707 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 85' ' ' ASN . 4.7 t . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.644 0.735 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.88 141.26 28.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttm -153.34 151.43 29.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -1.171 . . . . 0.0 109.531 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.88 148.15 36.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.31 146.25 50.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.11 140.23 49.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -118.88 125.67 50.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.28 121.39 45.17 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.0 tp -95.62 123.17 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.449 0.643 . . . . 0.0 109.985 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 36' ' ' LEU . 13.9 mm-40 37.35 57.69 4.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-O 120.966 0.413 . . . . 0.0 111.096 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.95 148.98 71.46 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.254 1.969 . . . . 0.0 111.795 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 41' ' ' LEU . 5.1 t -75.92 -13.25 60.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 110.314 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.57 -1.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 109.738 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 39' ' ' THR . 84.6 mt -90.71 -12.69 35.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.08 -21.88 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -87.47 -75.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.63 160.85 14.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.855 0.836 . . . . 0.0 110.562 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.4 p -76.17 165.77 24.43 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.742 0.782 . . . . 0.0 110.762 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.9 p -65.84 -31.53 72.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.489 0.661 . . . . 0.0 109.882 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.27 -18.26 63.13 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -93.59 -6.69 46.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' THR . 86.8 mt -84.53 -7.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.142 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' ILE . 20.1 m -39.6 123.01 1.45 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.686 0.755 . . . . 0.0 110.834 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.27 160.26 32.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.6 ttm -135.19 143.94 46.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -118.12 109.82 16.87 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 0.0 109.522 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.04 131.44 34.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.176 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -121.37 133.69 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.503 0.668 . . . . 0.0 110.136 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' GLU . 97.0 m-20 -133.29 43.21 2.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 44.82 17.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.386 -0.821 . . . . 0.0 109.53 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' ASP . 79.8 tt0 -170.4 83.4 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.183 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.58 157.44 32.46 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.26 155.54 45.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -1.097 . . . . 0.0 109.829 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.8 132.62 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 62' ' ' ILE . 32.7 mm -103.31 120.7 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -127.81 125.49 39.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.46 0.648 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -98.74 50.37 0.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -138.81 81.66 1.86 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.04 136.05 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.629 . . . . 0.0 109.461 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -128.74 134.85 48.56 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.556 -0.715 . . . . 0.0 109.572 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.1 143.45 16.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -96.71 101.07 12.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.467 -1.02 . . . . 0.0 108.366 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -91.91 152.84 19.87 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.621 0.724 . . . . 0.0 110.514 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 73' ' ' GLY . 89.3 mt -135.87 148.3 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.35 -0.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.971 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' A' ' 71' ' ' ILE . . . -127.88 62.24 0.63 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 73' ' ' GLY . 68.9 ttp85 60.12 134.87 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.805 -0.82 . . . . 0.0 110.633 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -42.79 140.06 3.08 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.961 1.774 . . . . 0.0 112.102 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m -130.03 -16.84 3.58 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 166.69 30.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.708 -1.245 . . . . 0.0 110.72 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.7 mt -134.92 154.12 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -133.45 151.82 51.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.53 -0.731 . . . . 0.0 110.438 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.89 34.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.7 m -125.11 127.9 47.6 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.671 -0.643 . . . . 0.0 109.616 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.63 128.87 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.55 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.6 mp -87.21 127.59 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.654 -0.654 . . . . 0.0 109.579 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 82.5 mt -108.72 36.73 2.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.429 ' OD1' ' OG ' ' A' ' 28' ' ' SER . 93.0 m-20 -63.48 -39.37 94.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -68.13 153.49 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.421 -0.8 . . . . 0.0 110.297 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.468 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 5.5 mp0 -71.27 -57.3 4.71 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.713 -0.617 . . . . 0.0 110.774 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 11.7 Cg_endo -54.8 -33.28 80.45 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.653 1.568 . . . . 0.0 111.617 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.61 -39.88 88.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.737 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -64.53 -44.95 89.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.917 . . . . 0.0 109.773 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -62.46 -46.42 88.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.284 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -65.67 -38.4 89.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.498 -0.751 . . . . 0.0 109.275 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -62.22 -43.81 98.0 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.521 -0.737 . . . . 0.0 109.51 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.5 ttm -61.4 -38.14 85.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.823 . . . . 0.0 109.229 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.98 -38.71 92.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 109.236 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -61.24 -45.18 95.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 91.8 mtp -63.75 -41.23 98.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -71.29 -46.51 60.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -67.65 -41.89 83.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.474 -0.766 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 104' ' ' ASN . 59.3 t80 -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.143 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 -28.8 71.93 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.23 72.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.992 . . . . 0.0 110.168 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.27 -48.74 49.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.702 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 100' ' ' TYR . 3.4 p-10 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.747 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.491 ' N ' ' OE2' ' A' ' 103' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.507 0.67 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -155.64 148.7 24.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.819 . . . . 0.0 109.175 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 4' ' ' ILE . 91.2 mt -108.72 128.48 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.148 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 9' ' ' GLY . 5.8 pt20 -146.31 155.08 42.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.227 -0.921 . . . . 0.0 109.634 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -111.18 -37.44 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 t -90.64 22.97 3.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.921 . . . . 0.0 109.376 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.531 ' NZ ' ' CE2' ' A' ' 53' ' ' TYR . 68.0 mttm 50.78 33.78 9.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 109.663 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 5' ' ' GLN . . . 157.58 40.73 0.02 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.36 -86.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -1.031 . . . . 0.0 109.925 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 179.23 -105.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.629 0.728 . . . . 0.0 109.474 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.92 146.59 46.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.473 -0.767 . . . . 0.0 110.489 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 14' ' ' VAL . 49.1 m -76.07 -11.01 59.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 108.999 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' THR . 55.4 t 53.06 165.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.497 0.665 . . . . 0.0 110.711 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.423 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 3.5 m -123.89 75.08 57.08 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.555 -0.715 . . . . 0.0 109.232 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 151.94 35.36 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.558 2.172 . . . . 0.0 112.437 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.63 152.55 25.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.512 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.62 130.76 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.055 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -132.27 141.16 48.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -109.07 130.54 55.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.195 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 t -126.98 133.26 50.62 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -127.5 135.94 51.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.626 0.727 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.548 -0.72 . . . . 0.0 110.474 -179.45 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.498 1.955 0 CA-C-O 121.536 0.684 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.539 ' N ' ' ND2' ' A' ' 85' ' ' ASN . . . -79.58 151.87 34.84 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.9 ptm -153.6 167.93 27.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.247 -1.149 . . . . 0.0 109.364 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.76 145.17 37.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.481 -0.762 . . . . 0.0 109.036 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -112.07 143.23 43.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.92 131.83 52.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -105.49 126.22 51.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.406 -0.808 . . . . 0.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -109.43 116.21 31.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.641 -0.662 . . . . 0.0 109.257 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.5 tp -100.9 118.32 36.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.561 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.563 ' C ' ' H ' ' A' ' 39' ' ' THR . 57.4 mt-10 43.31 59.65 11.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.85 13.9 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.078 1.852 . . . . 0.0 110.202 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.563 ' H ' ' C ' ' A' ' 37' ' ' GLU . 72.6 p 48.88 32.17 3.61 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.273 0.559 . . . . 0.0 110.05 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.1 tp -99.06 -22.06 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.181 -0.95 . . . . 0.0 109.14 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.7 -40.7 92.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -23.2 67.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -98.22 -52.21 3.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -136.89 149.1 47.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.33 -0.856 . . . . 0.0 110.214 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 p -73.0 163.51 28.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.6 p -66.42 -30.72 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.485 -0.759 . . . . 0.0 109.444 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.22 -16.52 63.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.629 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -85.34 -7.81 58.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.2 mt -100.96 116.33 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -0.774 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 p -125.5 15.01 8.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.98 160.34 27.37 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -118.03 131.69 56.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.679 -0.895 . . . . 0.0 108.83 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.531 ' CE2' ' NZ ' ' A' ' 8' ' ' LYS . 94.9 m-85 -104.42 112.7 25.85 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.639 0.733 . . . . 0.0 109.721 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.6 mt -95.55 127.63 41.75 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.71 128.76 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.498 0.666 . . . . 0.0 109.504 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASP . 44.5 t0 -155.56 118.11 4.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.53 -0.731 . . . . 0.0 109.853 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 94.8 m-20 40.1 61.15 1.58 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.833 -0.542 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 68.81 -41.44 0.47 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -66.66 138.77 36.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.69 148.81 32.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -1.165 . . . . 0.0 109.997 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.48 130.85 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.566 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 2.8 mp -107.58 129.52 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.49 -0.756 . . . . 0.0 109.57 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -128.73 128.09 43.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.588 -0.695 . . . . 0.0 109.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -90.78 4.94 50.29 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.31 78.67 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 m -120.92 132.95 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.545 -0.722 . . . . 0.0 109.669 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -123.19 137.07 54.98 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.15 127.22 9.18 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -96.39 126.98 41.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -1.109 . . . . 0.0 108.907 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -102.46 138.29 39.58 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.374 0.607 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mm -115.37 132.46 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 57.5 32.37 21.71 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.496 0.665 . . . . 0.0 109.517 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -12.03 26.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -112.72 149.14 40.72 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.409 -1.053 . . . . 0.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.2 142.28 86.0 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.335 2.023 . . . . 0.0 112.215 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 m -157.95 -28.97 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.95 44.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.054 . . . . 0.0 110.207 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 78' ' ' ILE . 95.8 mt -130.4 153.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.522 0.677 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -132.68 152.65 51.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.17 44.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 109.237 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.4 m -125.17 129.97 51.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.57 130.92 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.224 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.92 121.46 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.47 -0.769 . . . . 0.0 109.859 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.8 mt -98.14 -75.63 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.937 0.875 . . . . 0.0 109.121 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.539 ' ND2' ' N ' ' A' ' 29' ' ' GLY . 3.2 m120 56.31 32.12 19.85 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.72 -0.613 . . . . 0.0 109.823 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 m -153.49 140.58 19.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.009 . . . . 0.0 109.335 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.482 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 9.6 mm-40 -62.38 -58.21 18.57 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.74 . . . . 0.0 110.32 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 13.0 Cg_endo -54.3 -36.04 85.53 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.955 1.77 . . . . 0.0 111.451 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -68.92 -38.76 79.76 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.349 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -62.02 -46.33 89.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -42.65 99.65 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.199 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.77 -44.01 91.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.501 -0.749 . . . . 0.0 109.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.16 -44.01 96.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 0.0 110.193 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 40.0 ttm -58.0 -43.8 86.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.316 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.489 HH21 ' NH2' ' A' ' 99' ' ' ARG . 79.5 mtp85 -65.79 -38.3 88.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.09 -46.71 86.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.399 -0.813 . . . . 0.0 110.31 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.27 -39.28 94.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.838 1.304 . . . . 0.0 109.175 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -45.63 79.95 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.337 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 99.7 mtt180 -63.99 -41.9 97.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.092 -1.005 . . . . 0.0 109.17 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.0 -44.85 91.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.548 -0.72 . . . . 0.0 109.16 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.0 91.44 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.13 -38.15 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -1.158 . . . . 0.0 109.469 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 2' ' ' ALA . 96.2 mt-10 -68.74 -36.27 78.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 110.024 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 p30 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.749 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.94 160.17 42.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.904 0.859 . . . . 0.0 110.386 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.0 mt -108.79 128.43 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.696 0.76 . . . . 0.0 109.449 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -148.51 149.65 32.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.926 0.87 . . . . 0.0 109.897 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.53 -65.75 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 9' ' ' GLY . 18.5 m -75.35 164.76 26.08 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.587 0.708 . . . . 0.0 109.821 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.98 29.21 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.482 0.658 . . . . 0.0 109.672 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 10' ' ' VAL . . . -159.4 -44.28 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 9' ' ' GLY . 28.5 m 31.46 -135.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.192 0.52 . . . . 0.0 110.642 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.95 -139.4 0.05 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.592 0.711 . . . . 0.0 109.597 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.62 144.08 56.6 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.464 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 p -68.9 139.14 55.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.753 0.787 . . . . 0.0 110.559 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.435 ' CG1' ' H ' ' A' ' 15' ' ' VAL . 1.6 t -87.22 -145.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.416 0.627 . . . . 0.0 110.815 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.435 ' H ' ' CG1' ' A' ' 14' ' ' VAL . 17.5 t -146.45 66.27 10.91 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.649 -0.657 . . . . 0.0 109.242 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.92 149.75 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.024 2.483 . . . . 0.0 112.605 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.4 145.84 25.77 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.89 0.853 . . . . 0.0 109.921 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 t -103.71 131.65 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.839 0.828 . . . . 0.0 110.421 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -135.26 141.52 45.75 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.307 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -103.93 125.53 50.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.867 0.842 . . . . 0.0 110.081 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 m -94.91 164.19 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.641 0.734 . . . . 0.0 109.899 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.2 139.31 43.07 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.776 0.798 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.3 -1.552 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.485 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.531 0.682 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.95 153.36 13.66 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -157.79 176.24 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.962 . . . . 0.0 110.281 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.57 148.79 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.757 0.789 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.526 ' NZ ' ' OG1' ' A' ' 81' ' ' THR . 72.3 mmtt -111.42 148.85 32.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.753 0.787 . . . . 0.0 110.035 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -126.37 135.98 52.13 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.608 0.718 . . . . 0.0 109.493 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -120.8 127.1 51.63 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.83 0.824 . . . . 0.0 109.747 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.67 120.23 41.73 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.726 0.774 . . . . 0.0 109.58 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' GLU . 37.2 tp -88.88 126.64 35.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.706 0.765 . . . . 0.0 110.404 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 36' ' ' LEU . 45.9 mm-40 36.53 68.7 1.4 Allowed Pre-proline 0 N--CA 1.493 1.691 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.785 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -58.94 145.38 97.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.273 1.982 . . . . 0.0 111.853 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 p -83.37 -17.43 42.33 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.016 0.436 . . . . 0.0 110.242 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.74 1.13 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.602 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.63 -11.59 58.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 109.281 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.45 -14.54 30.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.18 -58.39 1.89 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.795 . . . . 0.0 109.423 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.97 160.55 40.14 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.755 0.788 . . . . 0.0 110.242 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.656 ' HG ' ' H ' ' A' ' 46' ' ' THR . 26.7 t -63.57 -166.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.62 0.724 . . . . 0.0 110.476 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.656 ' H ' ' HG ' ' A' ' 45' ' ' SER . 60.3 p -99.03 -21.0 16.43 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -64.43 -36.9 85.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 109.163 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 45' ' ' SER . 25.1 p-10 -62.22 -40.3 95.67 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.537 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.2 mt -54.8 -88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.82 -0.55 . . . . 0.0 109.777 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.0 m 66.61 -43.18 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -96.9 144.68 17.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.4 ttp -126.37 125.65 42.58 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.581 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -108.51 111.01 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.958 0.885 . . . . 0.0 110.225 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.6 mt -97.43 121.6 39.51 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 2.1 mp -103.7 130.77 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.887 0.851 . . . . 0.0 110.404 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 38.0 m-20 -133.23 -156.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.726 0.774 . . . . 0.0 109.77 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.553 ' C ' ' H ' ' A' ' 59' ' ' GLY . 42.8 p-10 -71.72 96.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.964 -0.46 . . . . 0.0 110.339 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 66.08 -39.88 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -88.95 160.24 29.65 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.596 ' N ' ' NH2' ' A' ' 92' ' ' ARG . 17.2 pt-20 -151.51 148.72 28.38 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 110.067 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.04 130.09 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.674 0.75 . . . . 0.0 109.527 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -123.49 133.47 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.836 0.826 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -142.06 150.7 41.58 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.734 0.778 . . . . 0.0 109.848 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -97.58 0.89 48.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.35 81.39 3.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.479 0.657 . . . . 0.0 109.286 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.42 133.57 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.855 0.836 . . . . 0.0 109.814 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.29 137.37 47.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.834 0.826 . . . . 0.0 109.47 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.27 131.01 10.42 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -103.5 117.14 33.75 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.818 0.818 . . . . 0.0 109.472 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.61 137.09 47.13 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.858 0.837 . . . . 0.0 110.036 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -119.06 128.65 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.675 0.75 . . . . 0.0 109.201 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.7 m120 59.65 30.74 20.37 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.315 0.578 . . . . 0.0 109.731 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.51 24.7 73.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -136.01 113.38 10.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.749 -0.853 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.88 104.62 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.211 2.608 . . . . 0.0 112.568 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.6 m -109.71 -35.72 6.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.739 -0.601 . . . . 0.0 110.092 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.81 159.81 40.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.054 -1.029 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.21 150.97 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.694 0.759 . . . . 0.0 109.655 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -130.66 148.51 52.45 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.99 0.9 . . . . 0.0 110.018 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.64 152.57 39.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.649 0.737 . . . . 0.0 109.92 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.526 ' OG1' ' NZ ' ' A' ' 32' ' ' LYS . 96.1 m -120.57 132.59 55.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.776 0.798 . . . . 0.0 110.354 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.57 130.86 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.874 0.845 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.5 mm -87.22 124.85 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.771 0.796 . . . . 0.0 110.231 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -117.71 40.5 3.08 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -62.82 -39.93 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.598 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -81.26 152.81 27.44 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.75 0.786 . . . . 0.0 110.18 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.7 tt0 -70.48 -46.43 18.93 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.943 -0.473 . . . . 0.0 110.91 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 68.4 Cg_exo -52.52 -35.33 66.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.195 1.93 . . . . 0.0 111.512 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.88 -40.71 97.15 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -63.81 -41.95 97.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.644 -0.66 . . . . 0.0 109.512 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -59.36 -44.47 92.69 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.596 ' NH2' ' N ' ' A' ' 60' ' ' GLU . 83.3 mtp180 -66.23 -37.94 86.73 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -61.95 -46.6 88.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.74 -0.6 . . . . 0.0 109.84 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 97.5 mmm -62.76 -44.07 97.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.688 -0.632 . . . . 0.0 109.395 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -66.9 -41.74 86.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.309 0.576 . . . . 0.0 109.524 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 83.0 t80 -63.99 -44.91 91.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.359 0.6 . . . . 0.0 109.49 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.5 ttt -62.07 -41.66 98.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -67.15 -47.14 71.96 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.382 0.611 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.8 tpt85 -66.55 -44.56 81.99 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.844 -0.535 . . . . 0.0 109.657 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -63.14 -45.87 89.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.558 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.9 -34.54 90.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.12 92.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.806 -0.82 . . . . 0.0 109.338 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.39 -37.07 77.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.643 0.735 . . . . 0.0 109.847 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.486 0.66 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -148.28 157.25 43.37 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.807 0.813 . . . . 0.0 110.757 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.0 mt -109.31 131.4 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.51 0.671 . . . . 0.0 109.441 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -128.96 134.3 48.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.714 0.769 . . . . 0.0 109.624 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.83 -71.47 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' LYS . 44.9 m -107.0 122.95 47.46 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.863 0.84 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 7' ' ' SER . 25.8 mtmm 40.63 -168.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.818 0.818 . . . . 0.0 111.538 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.21 86.25 0.32 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -120.12 132.67 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.813 0.816 . . . . 0.0 109.632 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.77 143.66 46.42 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.6 0.714 . . . . 0.0 110.19 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' VAL . 48.6 tp10 -137.65 -77.57 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' GLU . 82.8 p 37.44 31.09 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.292 0.568 . . . . 0.0 110.217 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' GLU . 53.6 t -69.57 -19.93 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.725 -0.609 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.452 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 3.5 t 64.18 52.89 1.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.897 -0.502 . . . . 0.0 110.288 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 37.1 Cg_endo -65.14 150.81 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.617 2.211 . . . . 0.0 112.559 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.57 132.48 45.55 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.685 0.755 . . . . 0.0 110.211 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.13 128.3 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.62 0.724 . . . . 0.0 109.764 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -134.14 136.48 43.86 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.733 0.778 . . . . 0.0 109.765 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 1.1 mm? -104.92 124.52 49.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.606 0.717 . . . . 0.0 109.668 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.4 m -132.65 153.4 51.13 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.159 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -105.05 152.53 22.63 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.873 0.844 . . . . 0.0 110.223 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.746 0.784 . . . . 0.0 110.993 -179.164 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.705 0.764 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.57 142.55 23.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.7 ptp -153.84 166.42 32.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.946 -0.738 . . . . 0.0 110.298 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.25 143.18 49.74 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -109.63 143.61 39.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.793 0.806 . . . . 0.0 110.335 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -123.57 135.9 54.24 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.58 0.705 . . . . 0.0 109.626 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -120.04 126.81 51.71 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.783 0.801 . . . . 0.0 109.606 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 77' ' ' ALA . 45.8 m-85 -108.21 119.29 39.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.464 0.65 . . . . 0.0 109.366 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.79 122.71 43.17 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.62 0.724 . . . . 0.0 109.939 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 40.71 56.74 8.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-O 121.036 0.446 . . . . 0.0 110.097 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.74 144.03 82.44 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.445 2.097 . . . . 0.0 112.783 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.537 ' C ' ' H ' ' A' ' 41' ' ' LEU . 26.4 m -69.32 -21.64 63.84 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.108 0.48 . . . . 0.0 110.018 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 tp -60.61 0.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.424 -0.797 . . . . 0.0 109.594 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.2 mt -89.67 -12.25 40.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.09 -14.16 17.9 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.13 -49.82 3.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.488 -0.758 . . . . 0.0 109.488 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.0 155.47 48.82 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.779 0.799 . . . . 0.0 110.024 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -72.99 160.03 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 110.396 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -66.37 -34.55 78.23 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.39 -17.67 61.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.738 -0.601 . . . . 0.0 109.865 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -85.29 -1.7 57.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.11 123.78 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.448 -0.782 . . . . 0.0 110.391 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -119.52 91.85 3.65 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.802 0.81 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.24 54.37 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.7 ttp -134.19 132.22 39.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.917 -0.755 . . . . 0.0 109.643 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -106.5 110.65 22.92 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.911 0.862 . . . . 0.0 109.759 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.87 114.0 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.391 0.615 . . . . 0.0 109.483 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -111.42 129.72 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.63 0.729 . . . . 0.0 109.633 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 96' ' ' PHE . 99.0 m-20 -134.8 -80.88 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 59' ' ' GLY . 67.3 t0 -144.81 98.2 3.15 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.617 -0.677 . . . . 0.0 109.517 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 97.2 mt-10 65.05 -42.72 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.385 0.612 . . . . 0.0 109.684 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -87.43 137.35 14.55 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -143.26 144.45 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.897 -0.766 . . . . 0.0 109.99 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.2 132.97 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.548 0.69 . . . . 0.0 109.243 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.03 132.21 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.683 0.754 . . . . 0.0 109.804 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.7 m -117.86 122.35 43.12 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.782 0.801 . . . . 0.0 109.5 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -95.48 1.23 53.91 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.7 mp0 -96.25 71.07 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.03 132.87 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.653 0.739 . . . . 0.0 109.718 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -134.29 141.87 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.936 0.874 . . . . 0.0 109.826 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.73 142.21 28.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 22.8 tptt -109.47 119.9 40.85 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.788 0.804 . . . . 0.0 109.183 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.58 124.07 49.92 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.646 0.736 . . . . 0.0 109.811 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 95.6 mt -114.2 139.32 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.591 0.71 . . . . 0.0 109.304 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.8 m120 60.33 32.42 20.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.468 0.652 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.95 31.38 80.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -158.78 152.04 18.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 O-C-N 121.63 -0.924 . . . . 0.0 109.769 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -51.54 141.18 43.11 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.9 m -161.68 -35.63 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.512 -0.742 . . . . 0.0 109.874 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 35' ' ' PHE . . . -154.27 171.22 19.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 0.0 110.7 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 78' ' ' ILE . 96.4 mt -133.63 128.06 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.561 0.696 . . . . 0.0 109.331 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.478 ' OE1' ' NZ ' ' A' ' 69' ' ' LYS . 81.5 tt0 -109.4 143.82 38.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.644 0.735 . . . . 0.0 109.447 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.1 148.76 30.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.681 -0.637 . . . . 0.0 109.9 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -122.75 129.27 51.56 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.47 112.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.921 0.867 . . . . 0.0 109.296 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.5 mp -82.6 128.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.504 0.668 . . . . 0.0 109.768 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.6 mt -118.31 62.86 0.76 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.59 -38.82 90.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.73 -0.606 . . . . 0.0 109.544 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -62.08 148.42 44.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.457 -0.777 . . . . 0.0 110.212 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.428 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 1.8 mp0 -76.53 -62.28 0.68 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.982 -0.449 . . . . 0.0 110.479 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 87' ' ' GLN . 12.1 Cg_endo -57.25 -26.77 71.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.078 1.852 . . . . 0.0 111.522 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -67.01 -35.55 80.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.888 -0.508 . . . . 0.0 109.665 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -44.79 96.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.754 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.93 -47.81 83.23 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.214 0.531 . . . . 0.0 110.043 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -64.7 -42.13 95.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.592 -0.693 . . . . 0.0 110.062 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -61.66 -42.72 99.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.733 -0.604 . . . . 0.0 109.755 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 tpt -62.54 -39.23 92.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.625 -0.672 . . . . 0.0 109.764 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.8 -45.78 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.707 -0.621 . . . . 0.0 110.104 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.441 ' CD1' ' OD2' ' A' ' 56' ' ' ASP . 37.6 m-85 -68.7 -37.64 79.68 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 29.9 mmt -64.58 -39.77 94.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.18 -46.08 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.647 . . . . 0.0 109.865 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -67.09 -41.95 85.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.52 ' CD1' ' OD1' ' A' ' 104' ' ' ASN . 54.4 t80 -61.72 -45.9 91.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.574 -0.704 . . . . 0.0 110.027 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.24 -36.03 92.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.4 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -1.126 . . . . 0.0 109.026 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.28 -42.92 68.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.52 ' OD1' ' CD1' ' A' ' 100' ' ' TYR . 13.8 m120 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.354 0.597 . . . . 0.0 109.466 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.78 0.8 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -154.47 135.02 13.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.797 0.808 . . . . 0.0 110.276 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.2 mt -119.2 128.61 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.687 0.756 . . . . 0.0 109.698 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.585 HE22 ' H ' ' A' ' 9' ' ' GLY . 2.4 pt20 -153.63 159.51 42.11 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.676 0.75 . . . . 0.0 109.773 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -89.96 -1.57 58.0 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.584 ' HG ' ' N ' ' A' ' 8' ' ' LYS . 18.4 p -145.99 -134.07 0.08 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.376 -0.827 . . . . 0.0 110.001 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.584 ' N ' ' HG ' ' A' ' 7' ' ' SER . 8.6 mtmp? -146.52 102.2 3.55 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.874 0.845 . . . . 0.0 109.948 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.585 ' H ' HE22 ' A' ' 5' ' ' GLN . . . 104.91 3.65 42.37 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' A' ' 11' ' ' ALA . 11.6 p -96.18 20.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.766 -0.844 . . . . 0.0 109.446 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 10' ' ' VAL . . . -33.21 112.44 0.12 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.686 0.755 . . . . 0.0 110.746 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' ' OG1' ' A' ' 13' ' ' THR . 92.4 mt-10 -94.52 -8.01 39.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 43.8 p 53.26 14.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.405 0.621 . . . . 0.0 109.56 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.8 t -69.33 155.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.651 0.739 . . . . 0.0 110.556 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -115.36 84.88 12.26 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.68 153.33 26.3 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.943 2.429 . . . . 0.0 112.468 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.11 150.26 25.66 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.038 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 100.0 t -124.25 132.53 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.641 0.734 . . . . 0.0 109.837 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -131.65 139.76 49.18 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.853 0.835 . . . . 0.0 109.721 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 3.9 mm? -96.43 144.02 26.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.674 0.749 . . . . 0.0 110.035 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -155.69 170.45 22.0 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.74 0.781 . . . . 0.0 109.882 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' SER . 52.0 mtmt -141.46 124.27 16.1 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.684 0.754 . . . . 0.0 109.914 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 22' ' ' LYS . 33.6 t . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.321 0.581 . . . . 0.0 110.142 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.96 0.886 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.97 139.91 37.13 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.1 ttm -155.2 151.57 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.003 0.906 . . . . 0.0 110.212 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 131.34 23.51 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -114.05 132.56 55.97 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.846 0.831 . . . . 0.0 109.991 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -116.69 132.27 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -115.89 118.94 34.37 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -109.68 119.84 40.64 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.531 1.158 . . . . 0.0 109.915 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.36 113.78 25.87 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.011 0.91 . . . . 0.0 110.146 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 50.87 75.14 0.69 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.588 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' O ' ' N ' ' A' ' 40' ' ' ILE . 4.3 Cg_endo -82.13 15.13 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.808 2.338 . . . . 0.0 111.178 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' PRO . 4.1 p 39.63 22.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.266 0.555 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' PRO . 18.5 tt -92.79 -1.44 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.1 -18.56 20.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.91 -35.08 6.73 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.84 141.25 31.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.38 -0.825 . . . . 0.0 110.032 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -77.84 167.29 21.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.732 0.777 . . . . 0.0 109.928 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -64.83 -32.11 73.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.94 -35.44 80.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.86 -19.15 63.45 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 49' ' ' ILE . 96.9 mt -91.85 124.35 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.456 -0.778 . . . . 0.0 109.538 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.53 12.91 1.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.7 175.15 46.37 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 18.0 ttm -137.12 144.42 43.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.702 -0.881 . . . . 0.0 109.433 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -108.9 113.18 25.87 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.925 0.869 . . . . 0.0 109.898 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.06 114.69 26.52 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.52 0.676 . . . . 0.0 109.336 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 2.0 mp -99.17 109.4 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.776 0.798 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 96.1 m-20 -88.84 -87.85 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 66.2 m-20 -159.37 -62.23 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 109.246 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -104.22 13.96 31.27 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.14 -0.975 . . . . 0.0 108.614 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.42 174.02 45.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -147.95 147.73 30.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.57 -0.959 . . . . 0.0 109.823 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.3 131.44 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.652 0.739 . . . . 0.0 109.68 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.37 131.35 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.514 0.673 . . . . 0.0 109.441 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -125.24 131.15 53.18 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.839 0.828 . . . . 0.0 109.975 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -92.53 3.63 55.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -90.53 73.12 6.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.43 133.07 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.749 0.785 . . . . 0.0 109.521 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -133.83 142.88 48.03 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.746 0.784 . . . . 0.0 109.947 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.79 149.8 21.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -110.05 131.08 55.38 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.956 0.884 . . . . 0.0 109.67 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.75 125.41 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.53 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 96.8 mt -123.15 133.13 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.798 0.809 . . . . 0.0 109.572 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 71' ' ' ILE . 4.6 p30 58.33 25.76 13.17 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.888 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.32 31.37 16.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.137 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -168.81 150.52 4.63 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.073 -1.251 . . . . 0.0 110.588 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.8 87.49 0.44 Allowed 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.207 2.605 . . . . 0.0 112.257 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -104.68 -14.62 15.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.716 -0.615 . . . . 0.0 109.74 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.08 151.66 44.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.27 135.82 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.499 0.666 . . . . 0.0 109.982 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -126.28 164.45 21.0 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.947 0.879 . . . . 0.0 110.202 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.2 37.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.77 0.795 . . . . 0.0 109.634 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.0 m -124.97 127.21 46.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.67 0.748 . . . . 0.0 109.545 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.8 t -114.89 132.42 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.874 0.845 . . . . 0.0 109.81 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.42 HG23 HD12 ' A' ' 83' ' ' ILE . 24.3 mm -94.79 123.91 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.707 0.765 . . . . 0.0 109.825 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.5 mt -110.66 75.53 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -96.85 1.92 51.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -116.82 143.55 45.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.991 0.901 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 mt-30 -66.51 -48.57 55.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.633 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.6 Cg_exo -51.9 -38.25 68.15 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.866 1.71 . . . . 0.0 111.133 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -66.73 -39.5 88.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -63.29 -37.87 88.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.71 -0.619 . . . . 0.0 109.787 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.35 -50.94 71.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.664 -0.647 . . . . 0.0 109.853 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -75.35 -39.29 59.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.743 -0.598 . . . . 0.0 109.921 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -64.22 -44.79 90.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.508 -0.745 . . . . 0.0 109.221 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.1 tpp -60.72 -46.94 88.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -66.09 -40.57 90.92 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.273 0.558 . . . . 0.0 109.513 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 86.4 t80 -63.21 -44.24 95.88 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 11.3 tpt -62.6 -39.79 94.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.619 -0.675 . . . . 0.0 109.54 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -66.08 -52.73 46.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.759 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -66.34 -44.75 82.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -63.4 -46.99 83.89 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.419 0.628 . . . . 0.0 109.342 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.57 88.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.85 83.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.646 -0.914 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.63 -55.7 6.45 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 p30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.748 0.785 . . . . 0.0 109.832 179.937 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.624 ' H1 ' HH22 ' A' ' 99' ' ' ARG . 66.8 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' H ' ' NH1' ' A' ' 99' ' ' ARG . . . -66.79 135.98 54.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.591 -0.693 . . . . 0.0 110.013 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.542 ' CB ' ' NZ ' ' A' ' 110' ' ' LYS . 15.6 pt-20 -155.75 163.08 40.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.85 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.1 mt -108.52 130.51 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.554 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 98.1 mt-30 -129.43 135.02 48.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.495 -0.753 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -95.54 -10.36 29.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.559 -0.713 . . . . 0.0 109.161 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LYS . 22.7 m -150.64 22.56 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.171 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 7' ' ' SER . 23.8 mtmm 56.53 120.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.806 0.812 . . . . 0.0 110.909 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.554 ' H ' ' NE2' ' A' ' 5' ' ' GLN . . . 99.13 -16.72 58.98 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.52 97.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -1.105 . . . . 0.0 109.611 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 131.73 40.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.641 -0.662 . . . . 0.0 109.874 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.87 122.39 47.73 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.618 0.723 . . . . 0.0 109.758 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.58 ' HG1' ' H ' ' A' ' 111' ' ' SER . 9.9 t -91.7 -3.74 55.92 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.53 157.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.503 -0.748 . . . . 0.0 110.156 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -115.68 80.97 8.77 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.599 -0.688 . . . . 0.0 110.069 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.33 151.64 29.82 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.795 2.33 . . . . 0.0 112.346 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -87.22 152.72 22.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 109.713 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.09 130.14 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.483 0.659 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -132.6 145.72 51.32 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -102.19 140.43 36.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.509 -0.744 . . . . 0.0 109.625 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.6 m -152.25 167.06 29.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -105.25 166.95 10.05 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.603 0.716 . . . . 0.0 109.812 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -69.12 170.91 9.12 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.706 0.765 . . . . 0.0 110.439 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -61.8 -39.67 92.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.592 -0.692 . . . . 0.0 109.416 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -88.73 -2.18 58.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 109.016 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.65 16.88 77.82 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -80.23 -91.4 0.05 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -1.08 . . . . 0.0 110.645 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.596 ' CB ' HD21 ' A' ' 85' ' ' ASN . 22.1 m -78.93 149.27 32.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.558 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 162.01 43.45 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.1 ptm -159.87 171.56 19.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.531 -0.982 . . . . 0.0 109.227 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.79 148.9 48.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.487 -0.758 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.42 148.12 31.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.71 -0.619 . . . . 0.0 109.666 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.81 136.2 52.06 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.25 123.49 50.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.797 -0.564 . . . . 0.0 109.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -111.31 122.83 48.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.3 tp -103.67 124.95 49.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.776 0.798 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.409 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 56.4 mt-10 42.5 54.89 9.83 Favored Pre-proline 0 N--CA 1.492 1.665 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -66.79 149.33 83.49 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.264 1.976 . . . . 0.0 111.947 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.53 ' C ' ' H ' ' A' ' 41' ' ' LEU . 66.9 p -74.43 -19.9 60.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.2 tp -59.96 0.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.734 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.53 ' H ' ' C ' ' A' ' 39' ' ' THR . 94.1 mt -90.93 -9.66 45.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.955 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.36 -24.95 13.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 109.418 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -93.59 -73.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.248 -0.907 . . . . 0.0 109.977 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -104.36 148.11 26.76 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.824 0.821 . . . . 0.0 110.704 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.7 m -71.8 156.15 39.63 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.728 0.775 . . . . 0.0 110.449 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -65.86 -32.65 74.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.647 -0.658 . . . . 0.0 109.628 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -75.1 -8.05 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.688 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.89 -3.37 54.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 94.0 mt -95.47 122.94 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.943 . . . . 0.0 109.802 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.1 m -121.31 -3.12 9.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -172.97 170.39 43.53 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.637 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.414 ' SD ' ' CB ' ' A' ' 80' ' ' ALA . 63.1 mtp -128.17 143.82 51.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.711 -0.876 . . . . 0.0 109.076 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.86 108.78 19.7 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.515 0.674 . . . . 0.0 109.785 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -93.59 110.28 21.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 2.0 mp -98.05 111.81 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.05 176.91 6.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.603 0.716 . . . . 0.0 109.885 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.06 -39.08 93.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -88.91 -76.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.94 10.81 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 pm0 -142.79 153.73 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.635 -0.92 . . . . 0.0 109.108 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -119.22 135.5 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.491 -0.756 . . . . 0.0 109.939 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -100.12 126.9 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.733 . . . . 0.0 109.447 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.6 m -121.76 125.21 46.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -108.26 -6.25 16.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.09 78.64 7.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.474 -0.766 . . . . 0.0 109.056 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.7 t -121.86 133.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.714 -0.616 . . . . 0.0 109.715 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.22 142.9 50.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.495 0.664 . . . . 0.0 109.73 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.63 143.26 16.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.14 106.73 17.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.896 . . . . 0.0 108.667 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.55 143.81 30.29 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.371 0.605 . . . . 0.0 110.239 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.35 109.16 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.98 35.88 23.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 110.079 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.85 78.75 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -121.57 99.25 45.31 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.963 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.86 130.4 30.9 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.339 2.026 . . . . 0.0 112.561 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m -152.83 -29.9 0.14 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.644 -0.66 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.18 154.08 51.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.218 -0.926 . . . . 0.0 110.726 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.75 143.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 14.3 tm-20 -119.94 150.22 40.85 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.58 0.705 . . . . 0.0 109.909 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.457 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -139.4 145.35 38.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.7 m -125.29 132.62 52.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.698 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.08 130.48 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.667 -0.646 . . . . 0.0 109.307 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 32.3 mm -93.34 128.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.791 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.3 mt -108.4 55.3 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.596 HD21 ' CB ' ' A' ' 28' ' ' SER . 9.2 m120 -64.34 -40.65 96.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.616 -0.677 . . . . 0.0 109.31 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 m -84.27 154.96 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 0.0 110.452 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.443 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.9 mp0 -74.89 -59.43 1.42 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.799 -0.563 . . . . 0.0 110.914 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 2.8 Cg_endo -48.51 -17.48 1.05 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.713 1.608 . . . . 0.0 111.266 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -64.9 -37.02 86.24 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.27 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -60.61 -36.52 78.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.487 -0.758 . . . . 0.0 109.815 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -58.32 -47.0 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.509 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.35 -39.9 81.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -62.28 -47.89 82.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 110.39 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.7 mmm -64.05 -43.21 96.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.637 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.45 -43.67 89.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.778 . . . . 0.0 109.624 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -61.54 -47.67 84.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 tpt -65.71 -41.0 92.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -63.01 -53.16 58.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.702 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.624 HH22 ' H1 ' ' A' ' 1' ' ' MET . 78.2 ttt-85 -68.99 -43.34 75.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.434 -0.791 . . . . 0.0 110.16 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -62.67 -46.01 90.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.96 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.03 -36.23 93.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.43 95.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 0.0 109.649 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.83 -43.59 71.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.875 . . . . 0.0 109.422 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.479 HD22 ' CB ' ' A' ' 110' ' ' LYS . 87.1 m-20 -121.12 127.64 51.79 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.639 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 107' ' ' GLY . . . -90.84 47.26 2.96 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.4 mp 58.05 1.57 0.15 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.769 -0.842 . . . . 0.0 110.174 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 105' ' ' GLY . . . -135.42 -24.38 0.55 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -90.45 138.65 31.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -1.107 . . . . 0.0 110.476 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.5 m -76.32 145.71 39.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.703 0.763 . . . . 0.0 110.297 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.542 ' NZ ' ' CB ' ' A' ' 3' ' ' GLU . 31.0 ttpt -64.96 -35.68 81.96 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.566 0.698 . . . . 0.0 109.628 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.58 ' H ' ' HG1' ' A' ' 13' ' ' THR . 20.0 p -62.27 171.36 1.88 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.749 . . . . 0.0 110.136 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 65.31 -62.65 0.21 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.345 0.593 . . . . 0.0 109.557 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 111' ' ' SER . 89.4 mt -63.14 -41.87 99.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 0.0 109.597 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -95.52 122.43 38.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 109.793 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -74.18 140.89 45.45 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.571 0.701 . . . . 0.0 110.41 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.29 156.36 24.34 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.571 -0.706 . . . . 0.0 109.783 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -137.99 148.23 44.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -66.07 -40.85 91.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.544 -0.723 . . . . 0.0 109.881 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.49 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 6.8 t-80 -70.15 130.0 40.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.336 -0.852 . . . . 0.0 110.317 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.49 ' CD2' ' CE1' ' A' ' 119' ' ' HIS . 69.0 m-70 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.361 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 3' ' ' GLU . 39.1 mmt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 32.1 -89.7 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 120.922 0.392 . . . . 0.0 110.775 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 1' ' ' MET . 49.8 tp10 -124.61 134.12 53.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.473 -0.767 . . . . 0.0 108.991 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.39 128.84 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -141.06 150.21 42.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.33 -0.856 . . . . 0.0 109.826 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.66 -7.78 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 8' ' ' LYS . 9.9 t -155.21 80.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.37 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.7 mttm 43.14 -168.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.708 0.766 . . . . 0.0 111.229 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.27 88.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.0 t -78.01 -94.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -1.055 . . . . 0.0 109.221 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 175.67 55.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.445 -0.784 . . . . 0.0 108.935 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' OE1' ' OG1' ' A' ' 39' ' ' THR . 8.8 pt-20 -163.67 121.49 1.86 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.479 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.6 m -93.33 88.87 6.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.953 . . . . 0.0 109.279 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.6 t -78.64 135.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.592 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.94 80.88 15.1 Favored Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 109.754 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.72 158.73 24.89 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.733 2.289 . . . . 0.0 112.406 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.94 159.5 28.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.881 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -109.1 128.77 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.6 -0.687 . . . . 0.0 109.387 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -135.18 135.21 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt -102.28 135.74 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.426 -0.796 . . . . 0.0 109.735 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.09 129.42 45.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 25' ' ' ASN . 14.5 m -71.66 134.69 46.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 110.503 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 44.57 14.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.825 -0.547 . . . . 0.0 109.933 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 23' ' ' SER . 8.0 m120 52.29 34.1 14.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.666 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.47 55.66 0.03 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -151.06 -56.38 0.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -1.087 . . . . 0.0 109.475 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.8 p -150.9 119.5 6.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.055 . . . . 0.0 109.736 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.07 139.85 25.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.4 ptt? -162.19 165.16 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -1.128 . . . . 0.0 108.865 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.36 140.33 50.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 109.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.99 145.3 32.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.235 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -117.38 133.78 55.58 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -104.0 125.37 50.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.602 -0.686 . . . . 0.0 109.869 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.2 114.82 28.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.8 tp -97.58 121.64 39.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 109.611 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' LEU . 49.6 mt-10 39.35 58.88 6.3 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.74 -0.6 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.0 Cg_endo -63.81 145.14 90.36 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.514 2.143 . . . . 0.0 112.532 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.425 ' H ' ' HG1' ' A' ' 39' ' ' THR . 13.2 p -81.35 26.78 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.069 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 38' ' ' PRO . 10.5 tp -102.73 -21.99 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.14 -41.1 97.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.88 76.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.54 -0.725 . . . . 0.0 109.582 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -88.45 -65.65 1.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.041 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.26 143.0 45.15 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.7 t -80.27 167.8 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.438 0.637 . . . . 0.0 110.098 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.443 ' HG1' ' N ' ' A' ' 47' ' ' ASP . 68.9 p -65.01 -36.0 82.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 109.774 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.443 ' N ' ' HG1' ' A' ' 46' ' ' THR . 65.3 t0 -64.8 -39.1 93.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.814 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.02 -34.85 79.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.097 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.63 126.0 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 0.0 110.005 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 m -126.14 -0.17 7.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.97 -175.29 36.96 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.0 ttp -135.47 136.22 41.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.514 -0.992 . . . . 0.0 109.362 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -106.31 116.8 32.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.452 -0.78 . . . . 0.0 109.417 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.6 mt -96.89 115.06 26.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.893 . . . . 0.0 108.907 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.53 132.75 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.406 0.622 . . . . 0.0 109.713 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 99' ' ' ARG . 36.1 t0 -125.49 43.68 3.0 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 54.86 5.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.808 -0.558 . . . . 0.0 109.619 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.538 ' H ' ' C ' ' A' ' 56' ' ' ASP . 97.8 mt-10 -146.75 -105.46 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.514 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.23 164.36 52.58 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.29 153.27 47.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.27 -1.135 . . . . 0.0 110.232 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.4 135.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.2 mm -104.37 125.57 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.386 -0.821 . . . . 0.0 109.177 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.8 m -123.13 124.44 43.08 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -100.56 -9.26 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.18 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -83.38 75.74 9.96 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.234 -0.916 . . . . 0.0 109.275 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.03 134.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.553 -0.717 . . . . 0.0 109.724 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -126.37 138.97 53.62 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.96 136.1 12.58 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.66 125.43 49.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.495 -1.003 . . . . 0.0 109.144 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -109.05 144.21 37.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.757 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 90.8 mt -120.27 129.44 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 m120 57.54 32.45 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -0.759 . . . . 0.0 109.285 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.89 22.75 75.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -136.88 127.93 16.47 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.296 -1.12 . . . . 0.0 109.704 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.21 136.19 30.89 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.078 1.852 . . . . 0.0 112.539 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -154.34 -34.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.712 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.66 152.32 42.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.023 . . . . 0.0 110.248 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 94.0 mt -130.86 163.51 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 45.5 tt0 -142.01 151.82 42.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.1 141.65 36.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.0 m -119.79 129.45 54.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.569 -0.707 . . . . 0.0 109.702 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.29 129.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.5 0.667 . . . . 0.0 109.518 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.2 mp -81.97 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.594 -0.691 . . . . 0.0 110.156 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 71.4 mt -119.07 40.12 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.95 -40.32 97.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -0.836 . . . . 0.0 109.497 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.0 139.84 41.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.016 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.1 mm100 -66.32 -40.63 36.4 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.73 . . . . 0.0 110.403 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.9 Cg_exo -58.88 -33.08 98.44 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.029 1.819 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -67.11 -38.27 85.32 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.441 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 46.5 m95 -61.22 -41.82 97.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.18 -47.15 87.51 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -70.15 -42.09 72.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.487 -0.758 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -61.54 -45.83 92.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 84.9 mmm -64.78 -41.79 95.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.031 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NH1' ' CZ ' ' A' ' 99' ' ' ARG . 70.2 ttp85 -64.62 -41.36 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.581 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.553 ' CD1' ' NH2' ' A' ' 99' ' ' ARG . 3.2 m-85 -59.63 -42.66 93.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.785 . . . . 0.0 109.008 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 97' ' ' MET . 11.0 tmm? -61.7 -39.69 92.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.491 -0.755 . . . . 0.0 110.017 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.96 -48.34 82.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.052 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' CD1' ' A' ' 96' ' ' PHE . 88.8 mtm180 -66.03 -37.77 86.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.205 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.596 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 90.6 t80 -60.67 -44.97 95.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.43 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.82 92.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -1.073 . . . . 0.0 109.603 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -84.96 -10.25 57.25 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 76.0 m-20 -137.09 -150.45 0.36 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.349 -0.845 . . . . 0.0 109.473 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 107' ' ' GLY . . . -154.64 50.96 0.47 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 106' ' ' LEU . 3.0 mm? 39.07 26.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.737 -0.86 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 105' ' ' GLY . . . -165.32 -147.31 5.1 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -74.35 143.49 44.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -1.041 . . . . 0.0 110.656 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 110' ' ' LYS . 14.5 p -160.66 -137.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 110.172 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' N ' ' OG ' ' A' ' 109' ' ' SER . 65.3 mttp -66.77 81.56 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 110.397 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.9 p -160.4 -75.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.368 -0.833 . . . . 0.0 109.518 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -85.48 -16.73 38.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 114' ' ' GLU . 4.5 mp -99.85 -63.19 1.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.36 -0.837 . . . . 0.0 109.3 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 113' ' ' LEU . 96.2 mt-10 41.28 63.7 1.18 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.618 0.723 . . . . 0.0 110.011 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -67.54 -39.53 85.02 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.47 -0.769 . . . . 0.0 109.216 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 55.57 91.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.633 0.73 . . . . 0.0 110.216 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.494 ' O ' ' ND1' ' A' ' 119' ' ' HIS . 73.0 m80 -67.03 -41.94 85.72 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.504 -0.747 . . . . 0.0 109.501 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.551 ' O ' ' CG ' ' A' ' 119' ' ' HIS . 84.4 t60 -66.53 -42.22 87.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 109.514 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 118' ' ' HIS . 39.9 p-80 41.97 -167.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.551 0.691 . . . . 0.0 110.712 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.862 -179.553 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.384 0.611 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.75 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.541 -0.725 . . . . 0.0 109.901 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -154.83 161.81 41.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.373 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.618 -0.676 . . . . 0.0 109.524 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 7' ' ' SER . 4.2 pt20 -154.37 154.91 34.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.122 -0.986 . . . . 0.0 109.43 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -86.24 -4.52 59.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.504 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 42.8 t -167.82 147.09 4.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 109.285 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -65.21 138.82 58.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.54 -12.53 64.69 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 85.0 t -112.33 127.21 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.597 -0.943 . . . . 0.0 110.077 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 168.85 96.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 14' ' ' VAL . 51.1 tp10 -168.6 130.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.226 -0.921 . . . . 0.0 109.158 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m 70.08 -9.41 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.635 -0.666 . . . . 0.0 109.373 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' GLU . 6.6 t -80.98 130.27 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.6 t -142.59 83.5 11.75 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.253 -0.905 . . . . 0.0 108.722 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -79.69 145.62 18.32 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.392 2.061 . . . . 0.0 112.867 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -89.3 157.71 18.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.239 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.62 130.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 0.0 109.084 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -132.28 143.04 49.62 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.493 -0.755 . . . . 0.0 109.167 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.3 mt -103.72 132.55 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.421 -0.8 . . . . 0.0 108.918 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.9 m -129.81 153.6 48.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -109.02 143.95 37.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.524 -0.735 . . . . 0.0 109.108 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.484 ' CB ' ' OG ' ' A' ' 28' ' ' SER . 67.1 m -72.94 155.03 40.28 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.735 0.779 . . . . 0.0 110.992 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -39.45 128.71 1.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.694 0.759 . . . . 0.0 111.139 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 59.8 26.25 15.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.72 -0.613 . . . . 0.0 110.06 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 40.68 54.72 3.4 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -104.03 -11.75 17.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -1.06 . . . . 0.0 109.253 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.484 ' OG ' ' CB ' ' A' ' 23' ' ' SER . 23.8 p -152.83 160.72 43.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.177 -0.952 . . . . 0.0 109.716 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.42 146.89 21.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.2 ttp -152.17 159.0 43.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -1.131 . . . . 0.0 109.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.23 150.09 36.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.9 145.66 46.49 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 0.0 109.88 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.41 137.24 54.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -119.42 127.22 52.9 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.4 122.17 46.79 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' GLU . 40.2 tp -93.45 125.5 38.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.497 -0.752 . . . . 0.0 110.009 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LEU . 30.9 mt-10 40.32 71.85 1.15 Allowed Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.756 -0.59 . . . . 0.0 110.551 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.23 142.85 97.67 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.829 2.353 . . . . 0.0 111.997 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.8 p -86.25 -17.3 35.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -70.61 1.79 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.917 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.58 -7.36 59.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 109.207 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.11 -23.96 16.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.333 -0.855 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -99.73 -73.18 0.64 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.466 -0.771 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.55 159.52 15.68 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.478 -0.763 . . . . 0.0 110.066 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -81.33 168.73 18.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -66.64 -37.28 84.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.554 -0.716 . . . . 0.0 109.804 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.27 -24.11 62.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -76.68 -5.54 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.572 -0.705 . . . . 0.0 109.706 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.3 mt -88.11 -87.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 m 66.94 -40.36 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -103.09 144.2 15.95 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -126.05 129.87 50.01 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -102.94 119.96 39.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.349 -0.845 . . . . 0.0 110.009 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.7 mt -102.78 113.7 27.34 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.551 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 2.0 mp -98.47 103.23 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 94.5 m-20 -95.12 176.24 6.31 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.644 0.735 . . . . 0.0 110.597 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.0 -36.61 84.96 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.729 -0.607 . . . . 0.0 109.786 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.19 -77.4 0.33 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.292 -0.88 . . . . 0.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.74 -145.52 6.79 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.66 153.51 43.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.394 -1.063 . . . . 0.0 109.799 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.04 133.25 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.4 mm -107.47 128.79 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 109.305 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.2 m -123.84 127.86 48.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.448 0.642 . . . . 0.0 109.691 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -96.03 -3.71 44.38 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.36 83.53 7.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 109.541 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.16 133.58 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -127.49 137.89 52.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.571 -0.705 . . . . 0.0 109.25 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.88 138.08 13.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -105.86 105.81 16.03 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -98.82 147.15 25.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.226 0.536 . . . . 0.0 109.595 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 41.5 mm -125.24 135.66 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 72' ' ' ASN . 12.2 p30 -38.89 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.697 0.761 . . . . 0.0 110.48 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 147.63 -60.77 0.46 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -175.26 154.53 1.66 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.184 -1.186 . . . . 0.0 109.43 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.33 129.98 8.68 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.745 1.63 . . . . 0.0 112.056 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.1 p -113.7 -35.07 5.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.686 -0.634 . . . . 0.0 109.604 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.39 169.41 22.03 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.363 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.54 128.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -111.18 150.07 30.03 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.518 0.675 . . . . 0.0 109.668 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.91 38.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -113.46 129.24 56.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.55 132.33 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.398 -0.814 . . . . 0.0 109.018 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.6 mm -92.59 127.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.856 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 78.6 mt -113.28 40.59 2.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.45 -39.72 94.31 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.491 0.663 . . . . 0.0 109.691 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.3 m -66.32 150.04 49.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 110.487 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.472 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 4.1 mp0 -73.04 -57.48 2.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.878 -0.514 . . . . 0.0 110.152 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 12.7 Cg_endo -54.02 -34.9 79.23 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.777 1.652 . . . . 0.0 111.35 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.66 -39.08 88.03 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.156 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -63.14 -44.82 94.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 108.933 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.11 -43.35 99.03 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.435 -0.791 . . . . 0.0 109.14 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.6 -42.39 95.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.083 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -59.76 -46.86 87.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.513 -0.742 . . . . 0.0 109.634 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.8 tpp -60.75 -46.42 90.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -65.09 -42.72 93.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.212 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.462 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 73.5 t80 -62.12 -43.82 98.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.28 -42.7 91.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.435 -0.791 . . . . 0.0 109.938 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.05 -47.08 75.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 110.137 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -67.91 -42.71 80.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.083 -1.011 . . . . 0.0 110.015 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 104' ' ' ASN . 89.6 t80 -62.05 -46.23 90.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.427 -0.795 . . . . 0.0 110.346 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.61 -36.33 93.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.65 -46.39 90.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.99 -1.3 . . . . 0.0 109.058 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -69.67 -50.35 44.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' TYR . 53.3 p30 -172.54 175.71 3.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.445 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.81 -148.87 17.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 106' ' ' LEU . 3.4 mp 56.28 -159.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.845 -0.797 . . . . 0.0 110.789 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 108' ' ' PHE . . . -73.24 115.25 5.06 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 107' ' ' GLY . 96.6 m-85 39.55 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.906 -0.761 . . . . 0.0 110.174 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m -71.15 164.17 26.16 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.724 0.773 . . . . 0.0 110.378 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.0 pttm -96.37 -28.38 14.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.49 -0.756 . . . . 0.0 109.656 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 113' ' ' LEU . 40.6 t -73.21 138.51 45.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.0 110.131 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 64.52 -30.55 0.12 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.677 -0.639 . . . . 0.0 110.455 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.589 ' H ' ' C ' ' A' ' 111' ' ' SER . 0.2 OUTLIER -63.77 -43.75 95.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.168 -0.958 . . . . 0.0 110.009 -179.048 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -85.78 146.0 26.98 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.154 -0.966 . . . . 0.0 109.957 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -111.6 -171.18 1.79 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.685 -0.635 . . . . 0.0 109.837 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.6 m80 54.92 -176.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.599 0.714 . . . . 0.0 110.678 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -76.72 142.69 40.39 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.573 0.701 . . . . 0.0 110.398 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -66.75 -39.0 87.75 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.4 0.619 . . . . 0.0 109.549 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.1 t60 44.93 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.55 0.691 . . . . 0.0 110.325 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.876 -1.059 . . . . 0.0 108.959 179.17 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 41.77 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.67 0.747 . . . . 0.0 110.285 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.9 145.39 37.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.305 -0.872 . . . . 0.0 109.727 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 4' ' ' ILE . 88.2 mt -108.18 127.29 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 110.0 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -152.28 158.68 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.534 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -103.99 -35.68 8.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -129.66 151.47 50.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.36 139.08 57.17 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.764 0.792 . . . . 0.0 110.717 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.09 28.94 26.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -111.15 133.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.441 -1.035 . . . . 0.0 109.844 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 142.71 52.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.849 0.833 . . . . 0.0 110.455 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.2 pm0 -101.32 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 p -95.03 -9.03 35.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.38 -0.825 . . . . 0.0 109.187 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -71.5 134.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.84 82.13 12.77 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.569 -0.707 . . . . 0.0 110.051 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.78 151.25 24.59 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.965 2.444 . . . . 0.0 112.459 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 56.2 mp0 -91.69 153.81 19.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.68 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.87 133.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.417 0.627 . . . . 0.0 109.569 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.481 ' NH2' ' OE2' ' A' ' 79' ' ' GLU . 90.5 mtm-85 -121.71 140.52 52.21 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.49 110.61 23.01 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.668 0.747 . . . . 0.0 109.295 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 86.3 p -83.82 168.34 16.24 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.706 -0.621 . . . . 0.0 109.815 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -111.37 122.51 48.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.823 0.821 . . . . 0.0 109.824 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 28' ' ' SER . 2.9 p -178.3 3.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -63.84 -37.36 87.11 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -105.29 6.98 33.25 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.6 -59.63 0.67 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.433 ' O ' ' OG ' ' A' ' 28' ' ' SER . 15.6 pt20 -153.7 -36.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -1.093 . . . . 0.0 109.483 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.443 ' O ' ' OG ' ' A' ' 23' ' ' SER . 27.9 m -170.34 110.54 0.39 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.11 -0.993 . . . . 0.0 109.75 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 141.17 41.8 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -162.91 168.95 20.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -1.102 . . . . 0.0 110.189 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.09 146.73 45.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -104.31 148.96 25.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.541 -0.724 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -117.66 129.92 56.04 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.99 123.48 43.32 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.53 0.681 . . . . 0.0 109.848 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.71 126.59 55.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.5 tp -117.29 117.97 30.99 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.341 0.591 . . . . 0.0 110.364 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 39' ' ' THR . 95.5 mt-10 31.91 70.4 0.71 Allowed Pre-proline 0 N--CA 1.497 1.905 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -65.53 12.48 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.769 2.313 . . . . 0.0 110.97 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.8 m 67.7 -3.35 1.15 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.415 0.626 . . . . 0.0 109.462 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 38' ' ' PRO . 20.3 tt -86.03 -0.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.27 -9.81 59.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 109.208 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.9 -18.92 21.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.898 . . . . 0.0 109.253 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -107.73 -41.76 4.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.502 -0.749 . . . . 0.0 109.82 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 48' ' ' ASP . 79.3 mm-40 -136.0 138.11 41.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.325 -0.859 . . . . 0.0 110.253 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -77.23 168.89 19.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.855 0.836 . . . . 0.0 110.521 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -64.8 -32.47 74.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.697 . . . . 0.0 109.713 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -65.22 -36.71 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.299 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.415 ' OD2' ' OE1' ' A' ' 44' ' ' GLU . 62.4 m-20 -64.41 -36.27 83.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 108.928 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.64 129.07 37.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.41 -0.807 . . . . 0.0 109.966 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 t -144.77 49.06 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.57 162.92 15.24 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.4 ttp -129.31 131.02 46.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.944 . . . . 0.0 108.932 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 53' ' ' TYR . 29.6 m-85 -108.6 109.62 20.88 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.76 0.791 . . . . 0.0 110.127 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.1 mt -100.58 121.72 42.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 2.5 mp -105.42 113.7 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.342 -0.848 . . . . 0.0 109.52 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 86.7 m-20 -92.39 171.98 8.69 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.459 0.647 . . . . 0.0 110.148 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' OD2' ' CZ ' ' A' ' 99' ' ' ARG . 39.6 p-10 -79.01 -4.76 51.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.877 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.44 -18.15 5.83 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ASP . . . -173.89 -151.06 7.97 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -152.34 145.05 24.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -1.157 . . . . 0.0 109.235 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.7 129.56 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.517 -0.739 . . . . 0.0 109.114 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -112.71 130.56 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.59 0.71 . . . . 0.0 109.765 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 t -138.99 145.27 39.5 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.535 0.683 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.1 mmm-85 -100.89 4.26 42.52 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.603 0.716 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.91 74.13 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.09 134.41 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.8 129.18 46.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.628 0.728 . . . . 0.0 109.177 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.95 130.44 10.17 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -106.46 130.89 54.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.676 -0.896 . . . . 0.0 108.901 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -105.37 145.3 30.96 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.603 0.716 . . . . 0.0 110.068 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.44 ' O ' ' CG ' ' A' ' 72' ' ' ASN . 7.1 mm -122.58 147.41 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.683 HD22 ' NE ' ' A' ' 74' ' ' ARG . 6.6 p30 51.53 13.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.721 0.772 . . . . 0.0 109.405 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 71' ' ' ILE . . . 88.82 28.87 20.04 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.683 ' NE ' HD22 ' A' ' 72' ' ' ASN . 16.3 ptt85 -153.87 163.99 22.13 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.198 -1.178 . . . . 0.0 109.45 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 142.34 99.23 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.421 2.081 . . . . 0.0 112.172 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.3 m -166.03 -32.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.181 -0.95 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.16 153.18 35.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.666 -1.271 . . . . 0.0 110.802 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 96.6 mt -128.52 163.36 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.376 0.608 . . . . 0.0 109.518 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.481 ' OE2' ' NH2' ' A' ' 19' ' ' ARG . 45.1 tt0 -139.99 152.06 45.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -0.839 . . . . 0.0 109.75 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.38 146.21 32.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.443 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.6 m -123.06 132.84 54.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.386 0.612 . . . . 0.0 109.726 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.12 132.4 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.724 0.773 . . . . 0.0 109.339 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 27.8 mm -76.16 130.67 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.446 0.641 . . . . 0.0 109.979 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.9 mt -122.81 35.77 4.8 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -64.57 -38.91 92.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 109.535 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.4 p -72.46 155.83 39.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.127 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.626 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -79.32 -42.59 1.63 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.646 -0.659 . . . . 0.0 110.823 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 39.9 Cg_endo -65.49 -24.88 56.03 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.859 1.706 . . . . 0.0 111.449 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -70.83 -36.97 73.14 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -61.73 -42.92 99.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.576 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.47 -50.21 74.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.867 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -69.02 -40.71 78.5 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.734 0.778 . . . . 0.0 109.459 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.93 -46.14 91.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 63.8 ttp -63.25 -44.64 94.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.546 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -65.12 -37.7 88.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.516 -0.74 . . . . 0.0 109.857 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 85.3 t80 -59.74 -45.42 92.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 91.5 mtp -64.77 -39.9 94.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.284 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.89 -45.05 71.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.768 . . . . 0.0 109.514 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.447 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 94.8 mtt-85 -67.04 -39.12 86.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.351 -0.843 . . . . 0.0 109.66 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CE2' ' OD1' ' A' ' 104' ' ' ASN . 90.1 t80 -61.15 -45.96 92.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.37 -34.51 89.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -38.77 90.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -1.128 . . . . 0.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.33 -38.28 78.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.476 ' OD1' ' CE2' ' A' ' 100' ' ' TYR . 15.2 m120 -81.24 -74.21 0.34 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 109.514 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 147.62 44.06 0.03 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 pp -167.9 129.01 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -1.061 . . . . 0.0 109.607 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -98.3 -66.45 0.88 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -78.48 143.67 36.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -1.033 . . . . 0.0 110.46 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.7 p -116.92 -88.14 0.6 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.615 -0.678 . . . . 0.0 109.631 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -143.13 -57.65 0.42 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.27 -0.894 . . . . 0.0 109.869 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -65.82 -15.32 62.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.951 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.15 -42.55 79.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.18 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.496 ' O ' ' CG ' ' A' ' 115' ' ' HIS . 10.5 mp -67.24 -44.01 80.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.268 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 113' ' ' LEU . 13.5 pt-20 28.44 57.0 0.11 Allowed 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.437 0.637 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 113' ' ' LEU . 30.7 m170 -130.36 139.21 50.68 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.721 0.772 . . . . 0.0 109.556 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -150.74 49.96 0.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -67.1 -37.88 84.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.358 -0.839 . . . . 0.0 109.186 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 51.75 -104.5 0.18 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.527 -0.733 . . . . 0.0 110.339 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 120' ' ' HIS . 83.2 t60 -149.45 16.41 0.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.044 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 97.5 m-70 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' H3 ' ' H ' ' A' ' 2' ' ' ALA . 24.9 mmt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' H ' ' H3 ' ' A' ' 1' ' ' MET . . . -83.02 119.33 24.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.541 -0.724 . . . . 0.0 109.854 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.522 ' CD ' HE21 ' A' ' 5' ' ' GLN . 18.7 pt-20 -155.84 159.64 39.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.489 -0.757 . . . . 0.0 109.642 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.0 mm -106.78 128.13 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.744 0.783 . . . . 0.0 109.443 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.522 HE21 ' CD ' ' A' ' 3' ' ' GLU . 78.4 mt-30 -138.94 136.88 35.91 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.443 ' O ' ' OG ' ' A' ' 7' ' ' SER . 46.1 m-85 -103.61 -13.6 16.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 6' ' ' PHE . 61.8 m -167.9 169.84 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.52 -0.738 . . . . 0.0 110.172 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.49 141.86 41.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.67 0.747 . . . . 0.0 110.904 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.63 23.67 52.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -109.44 -34.42 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -1.001 . . . . 0.0 109.051 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.85 168.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.726 0.774 . . . . 0.0 110.43 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' O ' ' OG1' ' A' ' 13' ' ' THR . 17.6 pt-20 -80.47 139.39 36.44 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.586 0.708 . . . . 0.0 110.338 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 6.3 m -168.86 -35.17 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.7 t -81.49 135.85 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.634 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.01 82.78 13.93 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.585 -0.697 . . . . 0.0 109.265 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.37 156.19 25.35 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 123.048 2.499 . . . . 0.0 112.83 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -85.24 149.16 25.68 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.707 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.9 132.05 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.455 0.645 . . . . 0.0 109.787 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -130.06 144.8 51.54 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.479 0.657 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -111.28 134.56 52.78 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.677 0.751 . . . . 0.0 109.884 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -158.21 167.77 28.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -117.83 142.07 47.72 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.716 0.769 . . . . 0.0 109.6 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 t -63.15 129.96 42.55 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.765 0.793 . . . . 0.0 110.363 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -66.59 -39.64 88.51 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.612 0.72 . . . . 0.0 109.652 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -71.38 -0.32 9.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.344 -0.847 . . . . 0.0 109.496 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 28' ' ' SER . . . 83.74 20.59 59.49 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.448 ' O ' ' OG ' ' A' ' 28' ' ' SER . 39.1 tt0 -73.62 45.81 0.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.414 -1.05 . . . . 0.0 109.67 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.618 ' HG ' ' ND2' ' A' ' 85' ' ' ASN . 12.6 p 61.33 178.86 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.99 0.9 . . . . 0.0 111.158 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.77 156.68 49.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.4 ptm -154.32 172.69 17.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -147.12 140.23 25.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -107.27 141.14 39.06 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.586 0.708 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -117.32 126.36 52.58 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.48 128.53 46.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.451 0.644 . . . . 0.0 109.471 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -111.86 117.33 32.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.6 tp -95.63 127.74 41.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.634 0.731 . . . . 0.0 110.298 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 37.99 70.81 1.16 Allowed Pre-proline 0 N--CA 1.496 1.858 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.17 141.31 93.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.495 2.13 . . . . 0.0 111.855 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 41' ' ' LEU . 46.2 p -87.42 -18.66 29.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.597 -0.689 . . . . 0.0 110.358 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.7 tt -66.68 2.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 109.676 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 39' ' ' THR . 86.5 mt -80.86 -8.74 59.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.7 -17.47 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 109.17 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -105.38 -50.48 3.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.499 -0.75 . . . . 0.0 109.585 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.54 157.6 45.85 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.371 -0.831 . . . . 0.0 109.936 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.9 t -77.34 164.74 25.25 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.621 0.724 . . . . 0.0 110.562 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -37.51 87.42 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.442 0.639 . . . . 0.0 109.968 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.69 -16.64 63.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.458 -0.776 . . . . 0.0 109.776 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.74 -0.36 56.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 98.7 mt -94.51 118.0 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -0.93 . . . . 0.0 109.907 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -114.11 121.25 43.21 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.719 0.771 . . . . 0.0 109.458 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.82 177.25 3.47 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -132.66 137.33 46.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.77 -0.841 . . . . 0.0 109.042 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.18 111.48 23.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.816 0.817 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.93 125.95 46.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.752 -0.593 . . . . 0.0 109.566 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 2.7 mp -101.92 100.31 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.468 -0.77 . . . . 0.0 109.377 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -91.5 176.63 6.48 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.447 0.641 . . . . 0.0 109.89 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 45.8 p-10 -68.26 113.03 5.52 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.764 0.792 . . . . 0.0 110.297 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 57.38 31.5 20.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.756 0.788 . . . . 0.0 109.463 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.94 168.3 40.84 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.46 149.8 28.94 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.288 -1.125 . . . . 0.0 109.766 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.37 129.6 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.27 131.73 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 109.711 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 t -129.54 142.2 50.81 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.589 0.709 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -96.04 79.47 3.23 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.547 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 66' ' ' VAL . 79.7 mm-40 -141.57 -105.03 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.605 -0.684 . . . . 0.0 109.592 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' GLU . 4.8 t 57.92 113.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.603 0.716 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -126.97 116.53 20.92 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.687 0.756 . . . . 0.0 109.099 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.83 137.26 26.71 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -107.5 124.39 49.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.775 -0.838 . . . . 0.0 108.94 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -101.02 123.3 45.0 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.56 0.695 . . . . 0.0 110.3 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.539 ' N ' ' CD1' ' A' ' 71' ' ' ILE . 2.9 mp -107.74 119.81 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.671 0.748 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.21 33.75 22.83 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.455 0.645 . . . . 0.0 110.404 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.64 34.3 39.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.417 ' NH2' ' OG1' ' A' ' 76' ' ' THR . 56.5 ttp85 -152.44 132.75 7.43 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.151 -1.205 . . . . 0.0 109.723 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.81 89.54 0.75 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.6 2.2 . . . . 0.0 111.103 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.417 ' OG1' ' NH2' ' A' ' 74' ' ' ARG . 6.7 m -105.5 -15.02 15.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.476 -0.765 . . . . 0.0 109.754 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.27 42.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.091 -1.006 . . . . 0.0 110.307 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.61 158.59 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -139.42 156.76 46.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 110.142 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.82 148.3 31.75 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.368 0.604 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 m -122.0 132.75 54.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.54 0.686 . . . . 0.0 109.505 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.85 130.56 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.659 0.743 . . . . 0.0 109.469 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.7 mm -98.97 121.59 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.405 0.621 . . . . 0.0 109.559 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.7 mt -107.8 65.75 0.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.618 ' ND2' ' HG ' ' A' ' 28' ' ' SER . 13.8 m120 -64.99 -39.5 93.57 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.587 0.708 . . . . 0.0 109.647 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.8 m -72.36 152.51 42.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 110.535 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.494 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 21.1 mt-30 -76.26 -58.28 1.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.845 -0.534 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 19.6 Cg_endo -56.19 -29.67 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.24 1.96 . . . . 0.0 111.611 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.96 -34.95 78.87 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.436 0.636 . . . . 0.0 109.596 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -46.54 89.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.347 -0.846 . . . . 0.0 109.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.74 -42.7 97.83 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.528 -0.732 . . . . 0.0 109.394 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.43 -40.87 93.82 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.641 0.734 . . . . 0.0 109.049 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -60.94 -42.54 98.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.648 0.737 . . . . 0.0 109.244 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -61.72 -41.39 97.57 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.562 0.696 . . . . 0.0 109.624 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.56 -39.83 94.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.426 -0.796 . . . . 0.0 109.328 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -58.63 -44.5 90.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.625 -0.672 . . . . 0.0 109.645 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 13.4 ttt -61.5 -43.92 98.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.982 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.13 -43.33 71.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.328 -0.858 . . . . 0.0 109.637 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -66.27 -42.14 88.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.404 -0.81 . . . . 0.0 109.514 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.05 -43.62 98.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.8 . . . . 0.0 109.839 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.42 -36.73 93.54 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.44 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -1.034 . . . . 0.0 109.855 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.25 -37.07 71.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -118.68 -130.83 0.3 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.55 125.71 1.37 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 106' ' ' LEU . 3.9 mm? -86.56 137.61 32.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.58 -0.953 . . . . 0.0 110.14 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.03 2.15 90.49 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -102.76 140.15 37.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.518 -0.989 . . . . 0.0 109.982 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.4 p -78.55 165.86 23.23 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.825 0.821 . . . . 0.0 110.648 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.402 ' O ' ' OG ' ' A' ' 111' ' ' SER . 68.7 mttm -59.43 129.37 41.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.65 0.738 . . . . 0.0 110.333 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 110' ' ' LYS . 15.9 m -172.73 -101.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.465 0.65 . . . . 0.0 109.686 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.82 -10.24 59.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.476 -0.765 . . . . 0.0 109.519 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 114' ' ' GLU . 53.1 mt -64.93 -38.82 92.25 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.61 0.719 . . . . 0.0 109.351 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 113' ' ' LEU . 79.9 mm-40 -56.93 -110.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.548 -0.72 . . . . 0.0 110.168 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -155.23 152.05 28.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 0.0 110.066 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -141.95 151.47 42.6 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.613 0.72 . . . . 0.0 110.072 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -74.48 -7.39 52.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.697 -0.627 . . . . 0.0 109.685 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 76.2 m80 41.25 -117.39 0.34 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.69 0.757 . . . . 0.0 110.575 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 120' ' ' HIS . 85.4 t60 -164.94 100.84 0.77 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.407 -0.808 . . . . 0.0 109.128 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 119' ' ' HIS . 56.6 m170 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.768 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' N ' ' C ' ' A' ' 55' ' ' ILE . 6.8 ptm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.63 -43.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.633 -0.667 . . . . 0.0 109.316 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -117.31 155.55 29.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.539 -0.725 . . . . 0.0 109.664 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.42 127.8 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.637 -0.665 . . . . 0.0 109.219 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -129.67 124.22 33.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.749 -0.594 . . . . 0.0 109.427 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -106.58 -11.32 15.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -168.36 -153.44 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.038 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -69.9 134.59 48.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 110.83 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.1 -88.76 0.05 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t 53.9 95.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.488 -1.007 . . . . 0.0 109.883 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.67 56.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 110.705 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -100.22 32.79 2.86 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 m -69.09 -20.49 64.08 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 p -71.15 -19.11 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.766 -0.584 . . . . 0.0 110.353 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.52 ' O ' ' NZ ' ' A' ' 110' ' ' LYS . 1.4 p 34.05 95.53 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 122.105 -0.372 . . . . 0.0 110.311 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.67 157.31 31.89 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.238 1.959 . . . . 0.0 112.869 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' A' ' 109' ' ' SER . 83.8 tt0 -92.01 152.89 19.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.096 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.77 133.47 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.569 -0.707 . . . . 0.0 109.262 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -128.57 144.22 51.11 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.8 mt -110.81 132.37 54.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.678 -0.639 . . . . 0.0 109.413 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.3 m -154.57 164.38 38.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.55 -0.719 . . . . 0.0 109.598 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -89.61 141.9 28.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.608 -0.683 . . . . 0.0 109.861 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 t -61.71 140.31 58.21 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.686 0.755 . . . . 0.0 110.757 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.86 -16.13 45.59 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.636 -0.665 . . . . 0.0 109.342 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -96.46 5.67 50.36 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.147 -0.97 . . . . 0.0 108.762 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.54 15.1 81.37 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -79.39 46.37 0.73 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.146 -1.208 . . . . 0.0 109.847 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.451 ' CB ' HD21 ' A' ' 85' ' ' ASN . 5.6 t 62.03 -169.3 0.18 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.864 0.84 . . . . 0.0 111.213 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.18 161.2 53.31 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.72 175.95 12.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.288 -1.125 . . . . 0.0 109.577 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.55 146.34 34.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.61 145.15 38.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.501 0.667 . . . . 0.0 109.955 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -112.44 121.25 44.3 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -96.2 123.76 39.95 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.58 126.68 55.19 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.443 0.639 . . . . 0.0 109.308 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.2 tp -110.27 116.27 31.19 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 110.023 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 39' ' ' THR . 52.2 mm-40 30.5 66.62 0.83 Allowed Pre-proline 0 N--CA 1.501 2.119 0 CA-C-O 120.877 0.37 . . . . 0.0 111.891 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' C ' ' H ' ' A' ' 40' ' ' ILE . 33.3 Cg_exo -65.54 16.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.89 2.393 . . . . 0.0 111.404 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.551 ' H ' ' C ' ' A' ' 37' ' ' GLU . 37.0 p 50.39 14.36 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.645 -0.66 . . . . 0.0 109.498 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.437 ' H ' ' C ' ' A' ' 38' ' ' PRO . 3.4 tp -90.88 -14.87 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.908 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.39 -41.79 96.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.17 -35.07 77.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.992 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.31 -64.25 1.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 40' ' ' ILE . 80.0 mm-40 -117.45 143.24 46.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.595 -0.691 . . . . 0.0 109.785 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.5 m -73.95 162.23 29.28 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.529 0.68 . . . . 0.0 110.325 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.2 p -65.83 -34.65 78.64 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 51.9 p-10 -67.96 -25.3 65.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.838 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 56.8 t0 -83.06 -9.15 59.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.067 -1.021 . . . . 0.0 109.302 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -96.59 111.07 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 108.748 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -126.82 126.26 43.07 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.567 0.698 . . . . 0.0 109.868 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 155.4 1.31 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.6 ttp -117.88 132.93 56.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.907 . . . . 0.0 109.291 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -108.71 119.65 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.69 -0.631 . . . . 0.0 109.497 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.7 mt -99.34 107.55 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.472 ' C ' ' N ' ' A' ' 1' ' ' MET . 96.5 mt -115.4 165.46 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.643 -0.661 . . . . 0.0 109.838 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' CG ' ' H ' ' A' ' 57' ' ' ASP . 64.2 t0 -151.9 -117.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 0.0 109.882 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.53 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 97.5 m-20 -79.48 -21.7 45.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.419 -0.8 . . . . 0.0 109.955 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -175.38 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 147.22 46.06 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.25 147.42 33.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -1.127 . . . . 0.0 109.64 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.7 mt -128.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 2.6 mp -105.04 129.77 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.839 . . . . 0.0 109.675 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.9 m -122.3 129.5 52.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 48.7 mmm-85 -112.17 46.47 1.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.9 mp0 -143.85 80.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.23 134.75 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.699 -0.626 . . . . 0.0 109.591 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -127.18 141.58 51.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.52 139.5 14.53 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -90.43 105.71 18.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 108.442 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -94.77 135.36 36.35 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.393 0.616 . . . . 0.0 110.119 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 45.9 mm -115.11 131.83 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.33 0.586 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 71' ' ' ILE . 23.2 p30 44.08 16.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.957 -0.464 . . . . 0.0 110.339 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 109.38 -24.15 21.04 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 71' ' ' ILE . 16.3 ptp180 -100.72 147.24 33.37 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.145 -1.209 . . . . 0.0 110.122 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.78 143.35 66.95 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.652 2.234 . . . . 0.0 112.715 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.406 ' OG1' ' CG1' ' A' ' 71' ' ' ILE . 4.3 m -140.87 -29.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.43 171.55 20.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 109.615 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 78' ' ' ILE . 96.2 mt -131.85 144.29 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.572 0.701 . . . . 0.0 110.34 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -128.07 142.7 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.41 143.89 32.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 0.0 108.966 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -123.63 134.39 53.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.631 . . . . 0.0 109.665 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.62 130.73 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.432 HD12 HG22 ' A' ' 83' ' ' ILE . 24.5 mm -88.25 123.87 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.512 -0.743 . . . . 0.0 110.04 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.8 mt -98.62 56.83 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.451 HD21 ' CB ' ' A' ' 28' ' ' SER . 11.3 m120 -64.42 -39.99 94.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.437 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -83.29 145.65 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 110.048 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -71.61 -46.49 12.85 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 46.3 Cg_exo -54.9 -28.45 58.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.152 1.901 . . . . 0.0 111.323 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -59.47 -37.54 78.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.457 -0.777 . . . . 0.0 109.421 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -57.87 -37.35 73.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -59.55 -45.0 93.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -64.76 -40.67 95.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.373 -0.829 . . . . 0.0 109.612 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -65.81 -39.58 91.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 54.7 ttp -59.87 -45.5 92.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.945 . . . . 0.0 110.171 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -64.83 -38.29 90.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.396 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 96' ' ' PHE . 17.6 t80 -59.69 -46.9 87.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 36.5 ttm -65.56 -39.5 91.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.01 -52.5 23.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.23 -54.43 29.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.533 -0.73 . . . . 0.0 109.846 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -64.05 -45.12 90.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.31 -34.34 89.17 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.62 95.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -1.12 . . . . 0.0 109.561 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -68.71 -38.38 80.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -160.57 117.13 2.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.399 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.72 144.13 48.65 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -100.84 -14.85 17.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.711 -0.876 . . . . 0.0 108.746 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 50.11 -175.14 0.05 OUTLIER Glycine 0 N--CA 1.487 2.048 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.464 ' C ' ' H ' ' A' ' 110' ' ' LYS . 61.9 m-85 -95.82 128.62 42.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.519 -0.989 . . . . 0.0 109.982 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.544 ' N ' ' OE2' ' A' ' 17' ' ' GLU . 2.9 p 71.67 -43.02 0.55 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.738 -0.601 . . . . 0.0 109.446 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 15' ' ' VAL . 28.4 ttpt 52.35 6.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 109.945 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 109' ' ' SER . 26.9 t -90.4 -16.26 29.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.337 -0.852 . . . . 0.0 109.038 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -139.46 -8.75 1.27 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.42 -0.8 . . . . 0.0 109.308 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.5 mp -85.4 -5.48 59.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.342 -0.849 . . . . 0.0 109.538 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -118.14 72.09 0.85 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.468 -0.77 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -67.28 -41.87 84.77 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -131.37 123.04 27.39 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.429 ' CG ' ' O ' ' A' ' 117' ' ' HIS . 84.3 t60 -151.45 28.16 0.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -66.34 -38.78 88.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.611 -0.681 . . . . 0.0 109.239 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -72.27 136.46 46.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.295 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 61.9 m170 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.709 -179.92 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.43 0.634 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.82 121.55 23.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -0.822 . . . . 0.0 110.091 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -155.57 153.24 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.414 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -111.13 128.52 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -152.41 161.37 42.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.045 -1.034 . . . . 0.0 109.615 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.37 -31.06 9.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 t -113.45 132.33 55.69 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.538 0.685 . . . . 0.0 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' NZ ' ' OE1' ' A' ' 60' ' ' GLU . 72.5 mmtt -67.26 135.65 53.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.766 . . . . 0.0 110.346 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.25 -13.28 67.09 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.27 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.77 90.36 8.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.632 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.22 136.68 46.44 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.881 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 5.28 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.246 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -55.97 141.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.975 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.92 84.32 13.1 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.554 -0.716 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.0 150.85 23.6 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.931 2.421 . . . . 0.0 112.893 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -92.96 139.25 30.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.03 129.71 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.291 -0.881 . . . . 0.0 109.953 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -132.23 145.76 51.54 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 3.6 mm? -96.67 121.39 38.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.3 m -109.1 167.52 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.573 -0.704 . . . . 0.0 109.651 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -126.31 138.65 53.61 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.594 0.711 . . . . 0.0 110.045 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.9 m -58.91 175.23 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 110.769 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.4 -43.99 92.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.373 -0.83 . . . . 0.0 109.888 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.522 ' H ' HE22 ' A' ' 27' ' ' GLN . 13.0 m120 -108.1 -4.28 17.86 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.125 -0.984 . . . . 0.0 108.816 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.8 31.78 64.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.671 ' NE2' ' H ' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -80.35 -8.18 59.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.087 -1.243 . . . . 0.0 109.547 -179.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -160.4 160.23 32.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.003 -1.061 . . . . 0.0 110.135 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.43 149.09 44.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttp -151.87 144.75 24.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.178 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.08 147.77 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 108.691 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -119.4 144.55 46.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.319 0.58 . . . . 0.0 110.181 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -116.52 131.82 56.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -105.52 127.81 53.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.643 -0.66 . . . . 0.0 109.245 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.21 117.34 32.95 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 37' ' ' GLU . 50.4 tp -92.75 128.96 38.8 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.346 0.593 . . . . 0.0 110.517 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 36' ' ' LEU . 94.0 mt-10 35.84 71.78 0.84 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-O 121.083 0.468 . . . . 0.0 111.161 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.75 141.03 93.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.613 2.209 . . . . 0.0 112.217 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 41' ' ' LEU . 76.0 p -83.29 -18.61 38.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 0.0 109.74 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.18 1.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 109.736 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 39' ' ' THR . 95.3 mt -83.84 -9.41 58.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.035 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.64 -17.89 23.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.81 -47.92 3.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 109.449 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.6 153.6 48.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.398 -0.814 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -72.58 158.36 35.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.628 0.728 . . . . 0.0 110.327 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -64.23 -26.9 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 44.4 p30 -67.31 -19.82 65.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 94.5 m-20 -79.74 -5.09 54.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.11 118.46 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -0.33 14.69 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.26 179.4 42.47 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.9 ttp -132.5 141.61 48.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.434 -1.039 . . . . 0.0 109.763 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -111.35 118.64 36.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.416 0.627 . . . . 0.0 109.54 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.52 122.52 43.96 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.491 ' N ' ' CD1' ' A' ' 55' ' ' ILE . 2.1 mp -105.77 120.83 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.509 -0.744 . . . . 0.0 109.012 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -102.12 -153.95 0.48 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 109.807 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -73.33 -6.06 43.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.891 . . . . 0.0 109.603 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -174.15 -54.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 108.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.96 166.21 54.39 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.428 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 17.1 pt-20 -145.62 147.58 32.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -1.128 . . . . 0.0 109.182 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 61' ' ' ILE . 96.6 mt -118.94 131.51 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.653 -0.654 . . . . 0.0 109.508 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -113.96 128.98 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.9 133.76 47.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.544 0.688 . . . . 0.0 109.679 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -94.94 -3.52 48.46 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -84.66 76.12 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.78 133.41 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.653 -0.654 . . . . 0.0 109.4 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -127.48 140.58 52.05 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.1 142.35 16.42 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -104.62 111.27 23.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.499 -1.001 . . . . 0.0 108.723 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 22.8 m-85 -101.93 125.81 48.7 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.5 mt -111.71 120.93 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.7 m120 57.13 33.44 23.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.578 -0.701 . . . . 0.0 109.323 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.46 25.38 74.86 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.459 HH21 ' HG1' ' A' ' 76' ' ' THR . 48.8 ttp180 -130.58 100.19 18.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.291 -1.123 . . . . 0.0 109.694 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -46.97 93.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.263 1.975 . . . . 0.0 112.055 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.459 ' HG1' HH21 ' A' ' 74' ' ' ARG . 17.9 m -112.65 -15.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.722 . . . . 0.0 109.754 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.86 157.89 43.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.736 -1.228 . . . . 0.0 110.737 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.85 138.05 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -117.7 147.05 43.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.293 -0.879 . . . . 0.0 109.758 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.59 143.18 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.6 m -126.36 130.93 51.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.666 -0.646 . . . . 0.0 109.465 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.0 t -115.56 129.95 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.534 0.683 . . . . 0.0 109.252 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.8 mp -94.44 123.1 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -0.76 . . . . 0.0 109.706 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.58 110.52 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -95.9 -0.92 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.143 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.07 152.85 48.23 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.474 -0.766 . . . . 0.0 109.998 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.584 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.6 tp-100 -76.69 -40.29 2.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.621 -0.674 . . . . 0.0 110.801 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.4 Cg_exo -55.25 -30.54 72.31 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.151 1.901 . . . . 0.0 111.413 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -64.99 -40.92 95.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.668 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 25.3 m95 -56.63 -36.74 69.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.4 -41.33 98.59 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.36 -44.31 91.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.179 -0.951 . . . . 0.0 109.473 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.25 -42.35 93.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.476 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.431 ' C ' ' SD ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -61.39 -46.09 91.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.594 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -68.84 -43.27 75.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 109.223 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -62.12 -46.05 90.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.456 -0.777 . . . . 0.0 109.411 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 63.7 ttp -63.99 -40.12 95.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.597 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.11 -49.8 68.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -66.19 -42.38 88.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 104' ' ' ASN . 79.0 t80 -63.72 -41.5 98.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.36 -36.81 93.06 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.16 95.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.362 -1.081 . . . . 0.0 109.536 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.08 -36.99 75.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.303 -0.873 . . . . 0.0 109.669 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 100' ' ' TYR . 7.8 m120 -115.05 -140.42 0.38 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.5 -0.75 . . . . 0.0 109.884 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 106' ' ' LEU . . . -156.52 43.57 0.53 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 106' ' ' LEU . 3.4 mm? 39.14 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.679 -0.894 . . . . 0.0 110.914 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.67 -168.93 46.32 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.564 ' C ' ' H ' ' A' ' 110' ' ' LYS . 83.3 t80 -89.64 87.19 6.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.42 -1.047 . . . . 0.0 109.413 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 111' ' ' SER . 1.8 m 61.36 -5.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.617 -0.677 . . . . 0.0 109.881 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.564 ' H ' ' C ' ' A' ' 108' ' ' PHE . 23.1 pttm 33.77 30.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.608 0.718 . . . . 0.0 110.552 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 109' ' ' SER . 79.9 p -89.7 -8.72 51.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.769 . . . . 0.0 109.429 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.52 -28.92 2.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.28 -41.19 97.02 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.53 -0.731 . . . . 0.0 109.113 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -76.06 140.48 41.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 110.665 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -86.71 138.83 31.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.41 -0.806 . . . . 0.0 110.32 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 43.4 81.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.765 . . . . 0.0 110.014 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -90.66 130.19 36.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.437 -0.789 . . . . 0.0 110.308 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -72.31 144.32 48.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.749 -0.594 . . . . 0.0 110.407 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -105.04 127.55 52.92 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.544 -0.722 . . . . 0.0 110.192 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.377 179.678 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 2' ' ' ALA . 77.6 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 56.39 113.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.782 0.801 . . . . 0.0 110.114 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.79 149.9 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.33 130.41 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.72 -0.612 . . . . 0.0 109.418 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.525 ' NE2' ' HG ' ' A' ' 111' ' ' SER . 62.3 mm-40 -127.81 133.37 49.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.565 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.34 -67.02 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -111.86 14.44 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 60.19 126.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.871 0.844 . . . . 0.0 111.187 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.33 7.96 69.01 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 m -110.73 141.73 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.586 -0.949 . . . . 0.0 110.011 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.638 ' H ' ' HZ1' ' A' ' 43' ' ' LYS . . . -61.86 140.9 58.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.635 0.731 . . . . 0.0 110.771 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' ' OG1' ' A' ' 13' ' ' THR . 49.9 tp10 -97.95 -65.95 0.93 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.548 -0.72 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.503 ' CG2' ' CZ ' ' A' ' 108' ' ' PHE . 7.0 p 51.01 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.578 0.704 . . . . 0.0 110.432 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' THR . 53.2 t 57.73 148.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.582 0.706 . . . . 0.0 110.439 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.1 105.04 50.16 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.87 143.87 33.83 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.555 2.17 . . . . 0.0 112.692 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 56.4 mp0 -97.18 142.74 28.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.453 -0.78 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -106.15 126.53 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.409 0.623 . . . . 0.0 109.35 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -110.65 145.04 38.63 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.608 0.718 . . . . 0.0 109.654 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.9 mm? -95.39 139.74 31.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.666 0.746 . . . . 0.0 109.712 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -153.38 167.48 29.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.49 -0.756 . . . . 0.0 109.929 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.32 152.07 24.03 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.679 0.752 . . . . 0.0 109.97 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 p -73.43 165.85 24.3 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.857 0.837 . . . . 0.0 110.873 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -62.54 -35.82 80.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.764 -0.585 . . . . 0.0 109.623 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -85.11 -0.26 53.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.17 -0.956 . . . . 0.0 108.921 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.85 62.98 5.39 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -155.1 -68.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -1.126 . . . . 0.0 109.351 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.423 ' OG ' ' ND2' ' A' ' 85' ' ' ASN . 41.1 t -71.25 148.8 46.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.848 . . . . 0.0 110.774 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.74 149.63 48.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.2 ttt -141.66 130.21 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -1.11 . . . . 0.0 108.96 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 145.42 50.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 109.27 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.84 149.38 42.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -122.6 139.63 53.71 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -114.58 123.36 49.15 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 118.98 36.67 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.25 107.93 19.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.762 0.792 . . . . 0.0 110.185 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.55 ' C ' ' H ' ' A' ' 39' ' ' THR . 64.4 mm-40 47.83 61.81 13.1 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.842 -0.536 . . . . 0.0 110.625 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.83 15.38 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.335 2.023 . . . . 0.0 110.854 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.55 ' H ' ' C ' ' A' ' 37' ' ' GLU . 25.7 p 51.86 22.29 1.7 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.4 tt -97.08 -13.75 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.311 -0.868 . . . . 0.0 109.228 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.44 -40.14 89.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.383 -0.823 . . . . 0.0 109.475 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.59 -14.63 59.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.557 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.638 ' HZ1' ' H ' ' A' ' 11' ' ' ALA . 54.2 mtpt -99.55 -63.24 1.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.709 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -119.93 138.91 53.16 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.76 0.79 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 m -71.33 150.67 44.89 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.714 0.769 . . . . 0.0 110.709 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.4 p -59.27 -40.69 86.84 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.421 0.629 . . . . 0.0 109.819 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.17 -15.86 62.5 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -0.764 . . . . 0.0 109.691 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.52 -7.72 49.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 92.1 mt -91.46 114.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.123 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.83 125.4 35.6 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.883 0.849 . . . . 0.0 109.642 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.77 157.02 15.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.4 ttt -132.73 127.57 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -109.18 108.07 18.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.65 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.7 mt -99.28 129.03 45.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.623 -0.673 . . . . 0.0 109.325 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.88 127.95 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.353 0.597 . . . . 0.0 110.171 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 18.5 p-10 -99.21 -132.45 0.24 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.676 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.461 ' N ' ' CG ' ' A' ' 56' ' ' ASP . 99.7 m-20 -63.13 -43.21 99.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -149.25 -50.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.365 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.75 168.73 13.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -140.29 155.52 46.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -1.028 . . . . 0.0 110.283 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.05 136.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.72 132.52 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.604 -0.685 . . . . 0.0 109.761 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 t -143.63 151.59 40.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.832 . . . . 0.0 109.614 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -104.25 3.52 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -81.5 79.32 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 109.316 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.1 t -125.81 135.37 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.62 -0.675 . . . . 0.0 109.795 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.9 136.86 48.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.5 -0.75 . . . . 0.0 109.582 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.55 141.59 15.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.98 106.94 18.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.501 -1.0 . . . . 0.0 109.443 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.6 143.9 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.643 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 93.5 mt -120.88 134.12 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 71' ' ' ILE . 46.3 m-80 -37.74 92.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.65 0.738 . . . . 0.0 110.538 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 148.44 -60.6 0.45 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -174.84 154.45 1.8 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.61 138.77 10.74 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.09 1.86 . . . . 0.0 112.099 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.8 m -132.7 -30.01 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.691 . . . . 0.0 109.918 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.17 164.04 38.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.682 -1.262 . . . . 0.0 110.577 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -128.54 150.24 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.19 151.0 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.611 0.719 . . . . 0.0 109.695 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.87 144.56 35.36 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.6 m -123.21 133.5 54.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.666 -0.646 . . . . 0.0 109.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.63 130.31 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mm -98.83 123.91 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.625 0.726 . . . . 0.0 109.795 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.11 83.02 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.423 ' ND2' ' OG ' ' A' ' 28' ' ' SER . 11.9 m120 -91.54 8.14 37.99 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.18 44.48 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.823 . . . . 0.0 109.195 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.589 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.0 mm100 -65.5 -40.87 45.68 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.706 -0.621 . . . . 0.0 110.549 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.9 Cg_exo -56.72 -36.61 98.5 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.369 2.046 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -32.39 70.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.452 0.644 . . . . 0.0 109.646 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -60.36 -47.28 86.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.68 -44.5 90.14 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.488 -0.758 . . . . 0.0 109.666 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 56' ' ' ASP . 62.8 ttm-85 -66.63 -41.1 88.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.478 -0.764 . . . . 0.0 109.441 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -60.2 -44.75 94.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.488 -0.757 . . . . 0.0 109.952 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -63.82 -41.7 97.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.35 -0.844 . . . . 0.0 109.986 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.9 -44.14 86.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.0 -49.75 73.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.432 ' C ' ' SD ' ' A' ' 97' ' ' MET . 14.1 tmm? -68.44 -41.58 80.1 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.439 -0.788 . . . . 0.0 110.139 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 81.4 tt0 -66.54 -49.21 67.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 110.179 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.42 -43.28 81.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 110.265 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.39 -52.34 65.0 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.78 . . . . 0.0 110.329 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.489 ' O ' ' ND2' ' A' ' 104' ' ' ASN . . . -76.63 -33.32 47.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 98' ' ' GLU . . . -48.94 -50.35 35.81 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.906 -1.35 . . . . 0.0 108.492 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 104' ' ' ASN . 96.8 mt-10 -71.49 -36.69 71.21 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.635 0.731 . . . . 0.0 109.111 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 101' ' ' GLY . 0.3 OUTLIER 56.18 157.22 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.233 1.016 . . . . 0.0 111.019 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.48 12.07 78.98 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 106' ' ' LEU . 10.1 mp -77.57 138.99 39.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.391 -1.064 . . . . 0.0 111.024 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.33 -55.51 0.01 OUTLIER Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.503 ' CZ ' ' CG2' ' A' ' 13' ' ' THR . 51.5 m-85 -99.01 119.34 37.63 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.194 -1.18 . . . . 0.0 110.417 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 p -100.88 -115.83 0.17 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.609 -0.682 . . . . 0.0 109.435 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -129.19 -19.4 3.53 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.514 -0.741 . . . . 0.0 109.76 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.525 ' HG ' ' NE2' ' A' ' 5' ' ' GLN . 23.6 p -65.62 157.25 30.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.057 -1.027 . . . . 0.0 110.348 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 66.44 -43.01 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.407 0.623 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 111' ' ' SER . 65.4 mt -64.54 -41.65 96.21 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.271 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 116' ' ' HIS . 9.2 pt-20 -64.59 131.17 46.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.457 -0.777 . . . . 0.0 109.995 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.417 ' O ' ' O ' ' A' ' 116' ' ' HIS . 50.4 p-80 -102.65 -11.44 18.43 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.716 0.769 . . . . 0.0 109.047 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.48 ' NE2' ' CD ' ' A' ' 114' ' ' GLU . 93.4 m-70 43.64 -169.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.913 0.863 . . . . 0.0 111.411 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 50.94 46.83 25.77 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.672 0.749 . . . . 0.0 110.346 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 119' ' ' HIS . 11.0 p80 -67.68 -41.18 84.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.619 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.674 ' HD1' ' CD2' ' A' ' 120' ' ' HIS . 39.5 t-80 -74.77 175.24 8.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.352 -0.843 . . . . 0.0 110.752 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.674 ' CD2' ' HD1' ' A' ' 119' ' ' HIS . 96.6 m-70 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.851 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.31 104.97 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.737 0.78 . . . . 0.0 110.329 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' THR . 17.1 pt-20 -155.68 165.25 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 mp -106.8 128.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.542 0.687 . . . . 0.0 109.617 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -150.01 131.38 14.67 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.734 0.778 . . . . 0.0 109.532 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -63.64 -43.78 95.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.7 m -119.19 120.48 37.2 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.813 0.816 . . . . 0.0 109.292 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.49 137.48 56.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.855 0.836 . . . . 0.0 111.043 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.66 -13.94 53.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.21 164.79 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.55 52.36 9.93 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.612 0.72 . . . . 0.0 109.642 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.499 ' O ' ' OG1' ' A' ' 13' ' ' THR . 17.8 pt-20 -76.24 174.28 10.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.213 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 72.0 p 55.24 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.612 0.72 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' THR . 2.4 t 56.6 155.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.839 0.828 . . . . 0.0 110.526 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.7 66.24 72.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.71 -0.619 . . . . 0.0 109.401 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.41 145.61 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.173 2.582 . . . . 0.0 112.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -88.82 147.65 24.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.679 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.4 t -117.1 130.97 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.648 0.737 . . . . 0.0 109.378 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.1 145.44 50.73 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.29 142.98 34.1 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.748 0.785 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.405 ' HG ' ' HZ1' ' A' ' 32' ' ' LYS . 13.6 p -151.79 162.86 40.34 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.711 -0.618 . . . . 0.0 109.512 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.43 135.06 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.767 0.794 . . . . 0.0 109.746 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t -64.5 135.84 56.44 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.617 0.723 . . . . 0.0 110.246 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -83.28 -14.65 52.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.495 -0.753 . . . . 0.0 109.147 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -92.91 6.62 47.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.285 -0.884 . . . . 0.0 108.851 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 28' ' ' SER . . . 80.57 14.82 79.34 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -74.03 40.51 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -1.094 . . . . 0.0 109.095 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 26' ' ' GLY . 11.9 t 58.45 -179.18 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.973 0.892 . . . . 0.0 110.891 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.55 156.84 53.17 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -147.32 156.93 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.107 . . . . 0.0 110.345 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.26 141.94 48.5 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' HZ1' ' HG ' ' A' ' 21' ' ' SER . 2.4 ttmp? -111.86 134.16 53.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.454 0.645 . . . . 0.0 109.934 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -112.95 144.18 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.546 0.689 . . . . 0.0 109.713 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -131.33 125.04 31.69 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.416 0.627 . . . . 0.0 109.387 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 46.3 m-85 -110.98 119.79 40.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.66 0.743 . . . . 0.0 109.333 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.0 tp -93.76 119.36 32.63 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.901 0.858 . . . . 0.0 110.512 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 39.06 56.73 5.79 Favored Pre-proline 0 N--CA 1.492 1.672 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.042 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.86 149.58 72.66 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.275 1.983 . . . . 0.0 111.988 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.502 ' C ' ' H ' ' A' ' 41' ' ' LEU . 39.1 p -71.29 -17.11 62.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.1 tp -63.44 2.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 109.79 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 39' ' ' THR . 91.1 mt -95.17 -18.42 20.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 108.87 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.64 -20.0 18.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.33 -75.02 0.53 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.321 -0.862 . . . . 0.0 109.639 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -101.96 141.81 34.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.5 t -68.42 157.0 36.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.782 0.801 . . . . 0.0 110.353 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -65.59 -32.74 74.49 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.501 0.667 . . . . 0.0 109.925 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.0 -17.18 62.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.395 -0.816 . . . . 0.0 109.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -85.65 -7.09 59.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.15 127.85 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.129 -0.982 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -151.14 32.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.77 5.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.2 ttm -114.11 133.27 55.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.617 -0.931 . . . . 0.0 109.451 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -112.22 121.16 44.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.685 0.755 . . . . 0.0 109.168 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.8 mt -99.45 125.38 45.17 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.501 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 2.1 mp -107.04 125.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 109.318 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 58' ' ' GLU . 65.5 t0 -125.85 17.4 7.98 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 64.31 -62.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.348 0.594 . . . . 0.0 110.242 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' ASP . 96.3 mt-10 -72.98 -0.85 14.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.83 173.57 36.71 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.92 148.57 34.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -1.077 . . . . 0.0 109.761 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.25 133.62 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.538 0.685 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.9 126.36 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.773 . . . . 0.0 109.264 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 64' ' ' ARG . 6.2 m -137.27 160.79 38.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.817 0.818 . . . . 0.0 109.316 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.46 ' N ' ' CG2' ' A' ' 63' ' ' THR . 84.5 mmt-85 -102.92 -116.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' ARG . 79.8 mm-40 35.75 77.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.601 0.715 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.92 131.95 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.83 138.58 52.13 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.582 0.706 . . . . 0.0 109.407 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -103.39 132.93 11.23 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -99.58 108.26 20.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -1.002 . . . . 0.0 108.685 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -102.61 145.09 30.16 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.679 0.752 . . . . 0.0 109.998 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.4 mt -122.71 135.13 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 71' ' ' ILE . 9.3 p30 -37.79 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.894 0.854 . . . . 0.0 110.735 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 150.69 -62.44 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -178.54 150.72 0.7 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.243 -1.151 . . . . 0.0 109.531 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -37.49 118.66 0.26 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.632 2.221 . . . . 0.0 111.779 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.1 m -110.93 -33.57 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 0.0 110.238 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.87 161.11 41.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.773 -1.204 . . . . 0.0 110.836 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -128.16 152.42 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.558 0.694 . . . . 0.0 109.376 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -137.93 153.15 49.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.578 0.704 . . . . 0.0 109.568 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -151.4 154.03 35.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.41 0.624 . . . . 0.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.9 131.94 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 83' ' ' ILE . 14.0 mm -96.25 122.63 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.927 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 81.2 mt -110.0 108.21 18.37 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.547 0.689 . . . . 0.0 109.497 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.26 -54.85 2.53 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.541 0.686 . . . . 0.0 109.524 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.02 145.82 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.683 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -67.02 -43.22 45.94 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.64 -0.663 . . . . 0.0 110.526 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 52.5 Cg_exo -53.78 -36.31 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.074 1.85 . . . . 0.0 111.317 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.86 -41.96 99.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.629 -0.67 . . . . 0.0 109.632 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.54 -38.92 91.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.27 -0.893 . . . . 0.0 110.009 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.64 -48.46 81.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 108.959 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -69.07 -41.89 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.728 0.775 . . . . 0.0 109.376 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -61.25 -45.35 94.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 53.9 mtt -64.19 -39.57 94.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -61.45 -41.38 97.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -60.44 -44.02 96.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.831 . . . . 0.0 109.73 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.7 mtp -63.46 -40.37 96.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.68 -46.47 72.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -66.63 -43.62 84.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 109.915 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -64.74 -42.05 95.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.481 -0.762 . . . . 0.0 109.691 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.98 -40.95 94.07 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.85 -39.76 94.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.514 -0.992 . . . . 0.0 109.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -39.69 76.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 109.517 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.69 -94.23 0.49 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 149.05 95.27 0.14 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -104.17 129.44 51.91 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.48 -1.012 . . . . 0.0 109.647 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.48 -71.13 1.09 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -174.84 -127.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.62 -0.929 . . . . 0.0 109.928 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -72.64 148.91 44.36 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.9 0.857 . . . . 0.0 110.865 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -64.38 -39.83 94.63 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.422 0.63 . . . . 0.0 109.94 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.5 p -65.18 -20.1 66.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 0.0 109.3 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -88.52 -6.72 57.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.328 -0.857 . . . . 0.0 109.113 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -120.46 -132.39 0.3 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.613 0.72 . . . . 0.0 109.805 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 56.4 25.5 9.62 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.86 0.838 . . . . 0.0 109.438 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.701 ' H ' ' HD1' ' A' ' 115' ' ' HIS . 0.1 OUTLIER -76.24 162.42 27.96 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.881 0.848 . . . . 0.0 110.262 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -66.57 -37.5 85.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.67 -0.644 . . . . 0.0 109.583 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.441 ' O ' ' NE2' ' A' ' 115' ' ' HIS . 5.2 t-160 -67.86 126.48 29.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 109.974 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -67.05 -41.13 87.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.679 -0.638 . . . . 0.0 109.426 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -139.69 143.91 37.3 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.305 -0.872 . . . . 0.0 109.876 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.09 -0.957 . . . . 0.0 108.991 179.668 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' ALA . 97.4 mtp . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.961 0.886 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -0.94 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.527 ' OE2' ' NE2' ' A' ' 5' ' ' GLN . 18.5 pt-20 -156.88 165.92 34.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.73 130.35 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.502 -0.749 . . . . 0.0 109.147 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' NE2' ' OE2' ' A' ' 3' ' ' GLU . 78.1 mt-30 -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.699 0.761 . . . . 0.0 109.886 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -70.97 -74.62 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.82 0.819 . . . . 0.0 110.055 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.6 t -94.63 136.01 35.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.72 138.52 57.45 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.75 0.786 . . . . 0.0 110.823 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.69 -11.94 69.29 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.4 t -97.41 113.28 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.286 -1.126 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.13 39.18 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.633 0.73 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -172.56 135.97 0.73 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 14' ' ' VAL . 62.1 m -92.18 -70.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.52 -0.738 . . . . 0.0 109.758 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 13' ' ' THR . 58.5 t 54.32 162.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.415 -0.803 . . . . 0.0 110.704 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -133.76 81.78 52.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.332 -0.855 . . . . 0.0 109.517 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.24 148.02 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.229 2.62 . . . . 0.0 112.615 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 17' ' ' GLU . 58.7 mp0 -93.67 141.73 28.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.39 -0.818 . . . . 0.0 109.482 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.03 127.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.477 -0.765 . . . . 0.0 110.274 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -127.4 143.48 51.2 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 109.092 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 4.0 mm? -95.48 138.33 33.31 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.879 0.847 . . . . 0.0 110.378 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 t -134.54 144.18 47.85 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -123.43 142.16 51.27 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.931 0.872 . . . . 0.0 109.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 m -70.36 169.99 12.78 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.833 0.825 . . . . 0.0 110.472 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.21 -42.97 99.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.68 . . . . 0.0 109.39 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -65.95 -40.28 91.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.129 -0.982 . . . . 0.0 109.516 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.45 -3.66 85.26 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -94.92 -5.76 44.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.206 -1.173 . . . . 0.0 109.259 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -111.36 122.64 48.37 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.93 0.871 . . . . 0.0 110.143 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.81 143.24 36.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 40.6 ttm -155.96 144.39 20.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.292 -1.123 . . . . 0.0 109.933 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.62 144.93 36.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -116.94 149.18 40.59 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.606 0.717 . . . . 0.0 110.377 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -123.75 143.87 50.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -116.23 118.3 32.42 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.397 0.618 . . . . 0.0 109.628 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CE1' ' CE ' ' A' ' 52' ' ' MET . 63.9 m-85 -110.26 118.59 36.76 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.32 0.581 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.56 122.99 47.79 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.839 0.828 . . . . 0.0 110.094 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 39' ' ' THR . 85.9 mt-10 47.55 52.39 12.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.966 -0.459 . . . . 0.0 110.734 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 28.4 Cg_endo -63.57 9.09 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.57 2.18 . . . . 0.0 110.93 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 37' ' ' GLU . 71.4 p 51.01 19.21 0.63 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.764 -0.585 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 44' ' ' GLU . 15.2 tt -97.4 -13.61 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -66.29 -38.84 88.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.471 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.94 -12.9 59.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.478 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -105.48 -16.31 14.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.366 -0.834 . . . . 0.0 108.861 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' ILE . 80.4 tt0 -171.43 139.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.52 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.431 ' HG ' ' N ' ' A' ' 46' ' ' THR . 34.8 t -74.67 158.6 33.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.431 ' N ' ' HG ' ' A' ' 45' ' ' SER . 71.2 p -64.91 -31.2 72.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.636 -0.665 . . . . 0.0 110.284 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 109.912 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -72.4 -17.13 61.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 109.278 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.72 118.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -149.25 42.77 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.6 139.5 4.53 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.472 ' CE ' ' CE1' ' A' ' 35' ' ' PHE . 45.1 ttm -130.66 128.72 41.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.685 -0.891 . . . . 0.0 108.668 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -111.28 125.79 54.2 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.842 0.829 . . . . 0.0 109.969 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.9 mp -96.56 124.08 40.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.661 -0.649 . . . . 0.0 109.276 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 2.1 mp -101.16 125.85 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.759 0.79 . . . . 0.0 109.785 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -108.92 -149.46 0.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.359 0.6 . . . . 0.0 109.641 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 58' ' ' GLU . 44.1 p-10 -64.1 -34.15 77.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.774 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.533 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 83.9 tt0 -156.63 -43.56 0.07 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 108.865 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.42 169.87 53.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.19 156.91 42.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -1.088 . . . . 0.0 110.142 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 61' ' ' ILE . 96.3 mt -112.41 134.64 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.504 0.669 . . . . 0.0 109.295 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.585 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 2.3 mp -100.04 122.87 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.8 m -124.3 127.28 47.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.516 0.674 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -107.87 -4.16 18.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.5 mp0 -89.48 78.93 7.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.18 132.38 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.649 -0.657 . . . . 0.0 109.372 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.95 142.58 51.51 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.866 0.841 . . . . 0.0 109.639 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.45 142.0 15.82 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' CE ' ' OE1' ' A' ' 79' ' ' GLU . 68.0 mmtt -103.97 113.04 26.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.654 -0.909 . . . . 0.0 108.79 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 70' ' ' PHE . 23.9 m-85 -98.34 144.63 27.52 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.847 0.832 . . . . 0.0 110.113 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' GLY . 96.5 mt -122.17 136.93 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 71' ' ' ILE . 59.5 m-80 -38.49 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.854 0.835 . . . . 0.0 110.421 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 149.3 -62.36 0.42 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -177.62 154.94 1.07 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.575 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.5 134.59 21.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.337 2.025 . . . . 0.0 112.447 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -147.05 -25.11 0.4 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.484 -0.76 . . . . 0.0 109.817 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.38 51.81 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 110.411 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.93 135.32 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' OE1' ' CE ' ' A' ' 69' ' ' LYS . 46.2 tt0 -116.81 151.57 36.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.71 144.97 32.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.564 -0.71 . . . . 0.0 109.529 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -117.54 129.06 55.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.553 -0.717 . . . . 0.0 109.975 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.98 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.764 0.792 . . . . 0.0 109.543 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.423 ' O ' ' OE1' ' A' ' 89' ' ' GLU . 27.2 mm -85.69 126.23 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.653 -0.654 . . . . 0.0 109.699 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.48 36.9 2.91 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -63.46 -40.39 97.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.822 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -76.67 153.78 34.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.205 -0.934 . . . . 0.0 110.373 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -70.06 -48.78 20.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.467 -0.77 . . . . 0.0 110.497 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 40.9 Cg_exo -52.17 -37.87 70.38 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.9 1.733 . . . . 0.0 111.392 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 83' ' ' ILE . 97.6 mt-10 -64.55 -40.74 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.567 0.699 . . . . 0.0 109.851 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -61.69 -44.82 96.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.288 -0.882 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -60.99 -46.61 90.05 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.354 -0.841 . . . . 0.0 109.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -67.56 -39.52 84.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.668 0.747 . . . . 0.0 109.438 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -62.6 -48.14 80.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.408 -0.808 . . . . 0.0 110.07 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.92 -42.09 85.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.971 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -67.57 -44.52 78.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.901 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.22 -47.09 85.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.373 -0.829 . . . . 0.0 109.359 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.4 ttt -66.69 -39.15 87.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.659 0.743 . . . . 0.0 109.066 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.2 -51.53 60.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.0 109.686 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -68.23 -40.0 82.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -63.1 -48.63 77.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.502 -0.749 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 -35.15 89.44 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.53 94.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -1.108 . . . . 0.0 110.044 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.71 -56.53 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 109.819 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -85.92 -85.11 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 45.59 91.35 0.01 OUTLIER Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mp -138.76 -160.39 1.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.461 -1.023 . . . . 0.0 110.288 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -138.9 -91.95 0.24 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.525 ' C ' ' HG ' ' A' ' 111' ' ' SER . 82.1 m-85 -99.24 17.45 19.99 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.243 -1.151 . . . . 0.0 109.606 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.1 t -66.77 145.74 55.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 111.033 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 39.48 32.48 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.271 0.558 . . . . 0.0 110.523 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.525 ' HG ' ' C ' ' A' ' 108' ' ' PHE . 93.0 p -129.21 -77.24 0.55 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.544 0.688 . . . . 0.0 109.664 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' N ' ' OG ' ' A' ' 111' ' ' SER . 97.6 mt-10 -84.86 -9.93 57.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 115' ' ' HIS . 41.0 mt -96.75 -80.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 43.79 13.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.6 -0.687 . . . . 0.0 110.241 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 113' ' ' LEU . 87.7 m-70 -104.25 -3.58 24.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.126 -0.984 . . . . 0.0 108.985 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.9 150.55 48.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.435 -0.79 . . . . 0.0 110.826 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 119' ' ' HIS . 20.5 t60 49.37 99.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.986 0.898 . . . . 0.0 110.193 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -62.39 -41.61 98.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.527 -0.733 . . . . 0.0 109.139 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 61.9 t-80 -71.37 146.73 48.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.483 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.943 179.635 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.561 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.421 0.629 . . . . 0.0 109.775 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.03 110.65 18.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.287 -0.883 . . . . 0.0 109.538 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' CD ' HE21 ' A' ' 5' ' ' GLN . 21.0 pt-20 -154.91 158.86 39.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.065 -1.022 . . . . 0.0 109.365 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -110.26 130.97 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.582 -0.699 . . . . 0.0 109.192 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.491 HE21 ' CD ' ' A' ' 3' ' ' GLU . 78.8 mt-30 -137.35 122.87 19.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.32 -39.32 85.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.845 . . . . 0.0 109.644 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.5 m -127.02 153.25 46.17 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.711 0.767 . . . . 0.0 110.223 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -71.47 137.5 48.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.592 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.22 -2.66 71.71 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 11' ' ' ALA . 69.2 t -70.84 -50.4 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -1.139 . . . . 0.0 109.682 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' VAL . . . 58.95 144.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 110.595 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 13' ' ' THR . 8.6 tm-20 58.14 -88.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.909 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.531 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 1.4 m 81.87 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -172.77 179.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 14' ' ' VAL . 96.3 t -115.13 86.35 13.84 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -78.25 154.15 28.38 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.984 2.456 . . . . 0.0 112.873 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -81.01 155.46 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -111.13 128.63 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.601 -0.687 . . . . 0.0 109.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -134.74 132.8 39.22 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.478 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 4.0 mm? -97.28 135.53 39.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.63 ' CB ' ' HZ2' ' A' ' 32' ' ' LYS . 40.3 m -123.99 150.0 45.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.25 142.9 50.53 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 109.823 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.6 m -75.9 -177.33 3.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.523 -0.735 . . . . 0.0 110.089 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.97 135.1 57.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -0.846 . . . . 0.0 110.183 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 56.82 15.68 2.36 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.49 18.64 78.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -46.85 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.528 -0.984 . . . . 0.0 110.473 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.624 ' CB ' HD22 ' A' ' 85' ' ' ASN . 17.6 m -98.32 123.68 42.56 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.222 -0.923 . . . . 0.0 110.221 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.25 145.37 28.06 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -161.06 167.45 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.274 . . . . 0.0 109.147 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.14 143.71 38.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.351 -0.843 . . . . 0.0 108.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.63 ' HZ2' ' CB ' ' A' ' 21' ' ' SER . 64.4 mttp -111.83 146.37 37.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.74 131.69 54.21 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.36 128.3 53.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -112.25 114.95 28.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.49 -0.756 . . . . 0.0 109.428 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' GLU . 39.7 tp -95.4 122.43 38.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 36' ' ' LEU . 50.9 mm-40 39.45 57.25 6.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.751 -0.593 . . . . 0.0 111.034 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.69 145.78 91.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.449 2.099 . . . . 0.0 112.379 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.531 ' C ' ' H ' ' A' ' 41' ' ' LEU . 64.0 p -69.46 -24.38 63.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.379 -0.826 . . . . 0.0 110.292 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 tp -59.44 1.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.068 . . . . 0.0 109.859 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' H ' ' C ' ' A' ' 39' ' ' THR . 89.2 mt -91.24 -6.9 52.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 109.22 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.74 -26.63 13.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.457 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -96.06 -75.89 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.275 -0.891 . . . . 0.0 110.018 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.05 151.71 20.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.423 -0.798 . . . . 0.0 110.395 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -74.71 163.1 28.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 p -66.53 -32.69 74.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.565 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.34 -18.55 63.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -79.31 -5.18 53.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.05 117.83 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.2 p -114.25 0.2 14.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.51 178.22 45.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.3 ttp -130.32 137.99 50.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.591 -0.947 . . . . 0.0 108.716 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.18 123.12 47.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.32 -0.862 . . . . 0.0 110.035 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.15 125.95 44.82 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.552 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 2.9 mp -107.14 129.06 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.628 -0.67 . . . . 0.0 110.081 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 92' ' ' ARG . 41.9 p-10 -150.79 120.61 7.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.222 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.435 ' N ' HH12 ' A' ' 99' ' ' ARG . 66.4 t0 59.92 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.626 -0.671 . . . . 0.0 109.983 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' ASP . 81.1 tt0 -145.53 -38.64 0.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 108.886 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.83 171.85 53.38 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.5 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 2.2 pm0 -152.08 156.08 39.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.261 -1.14 . . . . 0.0 109.435 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.63 135.45 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.604 -0.685 . . . . 0.0 109.175 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.2 mm -101.78 125.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.3 m -123.45 125.97 45.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.568 -0.708 . . . . 0.0 109.258 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -97.72 -7.98 29.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -83.86 84.0 7.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 110.017 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.78 134.57 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.452 -0.78 . . . . 0.0 109.452 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -125.57 142.09 51.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.57 -0.706 . . . . 0.0 109.263 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.58 140.39 14.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -107.23 102.77 12.06 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -102.32 146.1 28.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.588 -0.695 . . . . 0.0 109.776 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.7 mt -121.17 133.09 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 7.9 p30 -38.03 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 154.09 -60.86 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -177.04 150.9 0.91 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.331 . . . . 0.0 109.158 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -40.16 118.68 0.57 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.267 1.978 . . . . 0.0 111.861 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.2 m -111.22 -33.85 6.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.28 164.39 37.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 110.901 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 94.4 mt -126.87 164.1 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 15.5 tm-20 -140.12 148.5 41.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.463 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.76 143.81 35.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.501 -0.749 . . . . 0.0 108.981 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -122.87 130.33 52.73 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.567 -0.708 . . . . 0.0 109.582 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.3 t -110.81 129.71 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.492 -0.755 . . . . 0.0 109.414 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.435 ' CG2' ' OD1' ' A' ' 85' ' ' ASN . 30.0 mm -82.66 129.0 38.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 86.9 mt -117.52 38.02 3.72 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.624 HD22 ' CB ' ' A' ' 28' ' ' SER . 13.4 m120 -63.36 -40.67 97.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.377 -0.827 . . . . 0.0 109.332 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 151.06 35.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.27 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.586 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -73.2 -41.12 6.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.517 -0.739 . . . . 0.0 110.437 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 47.0 Cg_exo -56.08 -35.81 95.38 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.203 1.935 . . . . 0.0 111.632 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.57 -39.27 88.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.43 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.8 m95 -60.28 -42.12 94.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.63 -49.33 78.15 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.749 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.51 ' NH2' ' OD1' ' A' ' 56' ' ' ASP . 17.4 mmm180 -69.06 -39.77 78.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -61.68 -44.66 96.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.336 -0.853 . . . . 0.0 109.282 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.1 mmm -62.64 -41.49 99.06 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 108.881 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -64.89 -45.39 86.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.056 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -61.22 -45.85 92.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.415 ' C ' ' SD ' ' A' ' 97' ' ' MET . 2.0 tmt? -62.14 -41.54 98.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.481 -0.762 . . . . 0.0 109.725 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.3 -46.15 77.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.121 -0.987 . . . . 0.0 109.318 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.435 HH12 ' N ' ' A' ' 57' ' ' ASP . 83.5 mtp180 -65.63 -41.68 92.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.143 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.47 -48.42 79.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.47 -0.769 . . . . 0.0 109.695 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -67.85 -36.31 86.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.09 98.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.07 -42.16 66.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.347 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -94.12 -70.98 0.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.484 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 101' ' ' GLY . . . 83.89 45.3 6.4 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.5 mt -63.33 -43.5 97.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -1.199 . . . . 0.0 109.498 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.51 8.66 80.27 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 110' ' ' LYS . 26.3 m-85 -105.78 17.5 23.62 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.238 -1.154 . . . . 0.0 108.575 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.636 ' C ' ' H ' ' A' ' 111' ' ' SER . 48.2 t -63.25 71.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 109.238 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 108' ' ' PHE . 86.3 tttt 61.1 -23.94 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.621 -0.675 . . . . 0.0 110.245 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 109' ' ' SER . 15.2 m -71.95 137.36 47.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.815 -1.178 . . . . 0.0 109.6 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 111' ' ' SER . 16.8 tp10 84.69 -31.89 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' A' ' 113' ' ' LEU . 4.1 mm? -63.92 -42.27 97.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.817 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 115' ' ' HIS . 97.1 mt-10 -98.16 -5.51 33.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.161 -0.962 . . . . 0.0 109.277 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 114' ' ' GLU . 98.7 m-70 58.18 116.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.608 0.718 . . . . 0.0 110.385 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.491 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 51.3 p-80 -60.74 -44.92 96.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 109.305 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.47 ' N ' ' CG ' ' A' ' 116' ' ' HIS . 49.1 t-80 51.86 75.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.49 -0.756 . . . . 0.0 109.812 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 116' ' ' HIS . 53.0 m80 -150.58 -40.31 0.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -67.42 -40.31 85.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.5 ' C ' ' HD1' ' A' ' 120' ' ' HIS . 2.2 p80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.247 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.572 ' O ' ' N ' ' A' ' 3' ' ' GLU . 12.7 mmt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.416 ' H ' ' HB2' ' A' ' 100' ' ' TYR . . . 58.71 -72.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.105 0.479 . . . . 0.0 109.868 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 1' ' ' MET . 17.6 pt-20 -134.79 136.98 42.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.784 0.802 . . . . 0.0 109.651 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.4 129.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.2 135.8 51.16 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.792 0.806 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -106.76 -56.08 2.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.537 0.684 . . . . 0.0 109.394 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' LYS . 32.5 t -93.42 11.21 29.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 109.359 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.6 mttm 57.88 124.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.771 0.796 . . . . 0.0 110.76 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.72 11.15 64.2 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -96.04 135.02 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.499 -1.0 . . . . 0.0 110.09 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -92.88 -159.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.437 0.637 . . . . 0.0 110.599 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.482 ' O ' ' OG1' ' A' ' 13' ' ' THR . 72.0 mm-40 56.53 -76.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 11' ' ' ALA . 4.5 p 65.29 6.38 3.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.562 ' CG2' ' H ' ' A' ' 15' ' ' VAL . 12.8 p 44.07 177.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.891 0.853 . . . . 0.0 111.202 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.562 ' H ' ' CG2' ' A' ' 14' ' ' VAL . 81.9 t -115.14 91.8 28.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.878 . . . . 0.0 108.959 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.04 145.02 17.22 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.75 2.3 . . . . 0.0 112.673 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.12 149.7 39.0 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.571 -0.705 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.72 127.43 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -132.06 119.84 21.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 7.0 mp -104.79 132.5 50.96 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.9 m -127.37 152.29 47.68 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.378 0.608 . . . . 0.0 109.683 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.3 131.11 57.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.652 0.739 . . . . 0.0 109.559 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.622 ' HG ' ' HG ' ' A' ' 28' ' ' SER . 58.1 m -57.87 -86.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.767 -0.583 . . . . 0.0 110.132 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -107.07 -109.9 0.3 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.57 -0.707 . . . . 0.0 110.209 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -96.31 11.98 32.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.435 -0.791 . . . . 0.0 109.113 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.55 21.32 5.5 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -84.31 -7.3 59.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.473 -1.016 . . . . 0.0 109.189 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.622 ' HG ' ' HG ' ' A' ' 23' ' ' SER . 1.5 t -159.77 101.23 1.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.4 ' HA3' ' HE1' ' A' ' 90' ' ' TRP . . . -67.92 140.42 36.27 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.33 149.54 41.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.423 -1.045 . . . . 0.0 109.993 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.0 144.89 45.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 142.46 51.49 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.652 0.739 . . . . 0.0 109.953 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.93 137.95 54.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -120.68 125.34 47.45 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.688 0.756 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 32.3 m-85 -110.12 114.39 27.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 37' ' ' GLU . 51.8 tp -88.77 132.31 34.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.397 0.618 . . . . 0.0 110.565 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' LEU . 41.0 mt-10 32.76 68.81 0.91 Allowed Pre-proline 0 N--CA 1.5 2.032 0 CA-C-O 121.177 0.513 . . . . 0.0 111.127 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.52 140.71 92.74 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.66 2.24 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -83.14 -19.4 36.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.561 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.43 1.87 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 109.398 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 39' ' ' THR . 95.2 mt -81.85 -13.27 57.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.19 -13.78 21.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.37 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -107.84 -44.84 4.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -134.62 147.59 50.22 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.6 m -75.79 158.39 32.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.753 0.787 . . . . 0.0 110.535 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -64.98 -32.16 73.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -72.45 -17.47 61.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -88.73 -7.56 56.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.235 -0.915 . . . . 0.0 109.251 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.86 122.14 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.754 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -124.42 122.77 38.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 109.562 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.14 -171.06 18.95 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.5 ttp -141.45 133.64 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.56 -0.965 . . . . 0.0 108.961 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -108.35 109.29 20.58 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.723 0.773 . . . . 0.0 109.726 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.69 111.47 23.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 mm -109.25 131.02 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.031 0.919 . . . . 0.0 110.366 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD1' ' CD2' ' A' ' 96' ' ' PHE . 2.7 m-20 -138.6 -160.73 1.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.486 0.66 . . . . 0.0 109.408 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -81.45 104.66 12.04 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.926 0.869 . . . . 0.0 110.319 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 60.62 89.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.643 0.735 . . . . 0.0 110.592 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.57 142.97 5.77 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.28 147.68 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.999 . . . . 0.0 109.108 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.77 133.7 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 109.578 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.2 mm -108.02 126.99 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 109.196 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.3 m -125.4 125.66 43.75 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.64 0.733 . . . . 0.0 109.295 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -97.8 -1.77 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -85.26 75.24 10.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.457 -0.777 . . . . 0.0 109.426 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.0 t -126.7 133.83 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.679 0.752 . . . . 0.0 109.338 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -132.82 141.13 48.3 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.97 141.24 15.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -106.01 119.23 38.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.604 -0.939 . . . . 0.0 108.875 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -107.98 144.59 35.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.583 0.706 . . . . 0.0 110.064 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mm -121.05 131.38 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 57.66 14.92 2.61 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.453 0.644 . . . . 0.0 110.07 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -17.86 58.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -100.4 150.37 36.88 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.452 -1.028 . . . . 0.0 110.05 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.92 143.25 90.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.576 2.184 . . . . 0.0 112.129 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 m -149.12 -41.47 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.973 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.85 164.59 35.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.762 -1.211 . . . . 0.0 111.077 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.02 152.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -135.34 145.28 47.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.011 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.22 46.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.689 1.233 . . . . 0.0 110.004 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.4 m -126.65 131.62 51.4 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.671 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.9 t -119.62 130.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 mm -87.7 126.71 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.542 0.687 . . . . 0.0 109.919 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.64 41.64 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -63.59 -39.75 95.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.73 . . . . 0.0 109.363 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.58 158.18 27.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.555 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 7.5 mm-40 -79.85 -41.42 1.43 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.802 -0.561 . . . . 0.0 110.832 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.8 Cg_exo -56.14 -37.5 96.39 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.823 1.682 . . . . 0.0 111.259 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -68.28 -39.04 82.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.637 -0.664 . . . . 0.0 109.433 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.4 ' HE1' ' HA3' ' A' ' 29' ' ' GLY . 1.8 m95 -61.32 -40.62 94.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.52 -44.56 95.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.189 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -69.55 -39.01 77.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 109.119 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.83 -45.97 91.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.37 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.6 ttt -62.56 -47.04 85.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.59 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -65.69 -41.72 92.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.461 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' A' ' 1' ' ' MET . 3.4 m-85 -64.15 -46.89 82.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.2 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.8 ttp -63.03 -39.58 95.18 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -66.35 -40.45 89.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.507 -0.746 . . . . 0.0 109.443 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -65.88 -42.36 90.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.416 ' HB2' ' H ' ' A' ' 2' ' ' ALA . 81.8 t80 -60.05 -46.47 89.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.482 -0.761 . . . . 0.0 109.269 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.31 94.73 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.52 72.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -1.053 . . . . 0.0 109.849 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.78 -42.78 69.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.518 -0.739 . . . . 0.0 109.763 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.412 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 62.0 m-20 -107.66 115.2 29.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.561 -0.712 . . . . 0.0 109.569 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 106' ' ' LEU . . . -94.17 45.12 2.27 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 106' ' ' LEU . 9.9 mp 44.71 100.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.75 -0.853 . . . . 0.0 110.715 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.98 3.69 90.5 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CE2' ' O ' ' A' ' 109' ' ' SER . 88.3 t80 -72.37 141.62 48.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.526 -0.984 . . . . 0.0 110.237 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.49 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 8.2 p -77.48 132.04 38.23 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.488 -0.758 . . . . 0.0 110.263 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 112' ' ' GLU . 66.2 tttm -172.86 73.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 110' ' ' LYS . 79.2 p 47.0 -82.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.666 0.746 . . . . 0.0 110.919 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 110' ' ' LYS . 73.0 mm-40 -53.72 -48.07 69.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.511 -0.743 . . . . 0.0 109.773 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 115' ' ' HIS . 93.9 mt -68.23 -93.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 110.351 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 41.75 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.491 0.662 . . . . 0.0 110.191 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 113' ' ' LEU . 59.8 t-80 43.35 83.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.634 0.731 . . . . 0.0 110.023 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.413 ' ND1' ' C ' ' A' ' 116' ' ' HIS . 6.1 p80 -153.39 165.89 34.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.468 -0.77 . . . . 0.0 110.059 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 118' ' ' HIS . 54.2 t-80 -74.64 171.64 13.52 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.592 0.71 . . . . 0.0 110.591 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.508 ' N ' ' CG ' ' A' ' 117' ' ' HIS . 59.8 m170 -68.67 137.47 54.19 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.761 0.791 . . . . 0.0 110.559 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.403 ' O ' ' OXT' ' A' ' 120' ' ' HIS . 62.6 t-80 -84.38 128.99 34.9 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.734 0.778 . . . . 0.0 110.069 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.403 ' OXT' ' O ' ' A' ' 119' ' ' HIS . 99.5 m-70 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.96 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.14 -18.52 16.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.518 -0.739 . . . . 0.0 109.205 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.533 ' CD ' HE21 ' A' ' 5' ' ' GLN . 43.7 tt0 -145.16 134.05 22.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 109.095 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.38 129.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.634 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.533 HE21 ' CD ' ' A' ' 3' ' ' GLU . 76.5 mt-30 -140.31 124.87 17.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.298 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.41 -2.88 58.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.133 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 8' ' ' LYS . 29.6 t -155.86 43.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.436 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' SER . 47.2 pttt 31.81 43.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.433 0.635 . . . . 0.0 110.853 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.43 26.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -97.8 132.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -1.11 . . . . 0.0 110.092 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.16 142.26 58.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' A' ' 14' ' ' VAL . 57.4 mp0 -85.47 -116.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.597 -0.689 . . . . 0.0 110.379 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 16.3 p 57.35 0.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.584 ' H ' ' C ' ' A' ' 12' ' ' GLU . 74.9 t -67.91 -43.54 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.05 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 t 62.13 60.43 2.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.733 -0.604 . . . . 0.0 109.869 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -68.61 149.06 73.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.662 2.241 . . . . 0.0 112.256 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.82 154.09 23.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 110.087 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.88 132.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -127.63 140.69 51.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.14 143.0 43.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.604 -0.685 . . . . 0.0 109.684 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -149.92 151.86 34.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.042 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.61 133.58 55.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.688 0.756 . . . . 0.0 109.185 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.432 ' CB ' ' N ' ' A' ' 27' ' ' GLN . 90.7 p -43.9 108.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.6 0.714 . . . . 0.0 110.724 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -64.73 -40.55 95.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.599 -0.688 . . . . 0.0 109.418 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -90.02 6.25 43.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 109.216 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.07 107.06 0.49 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -163.16 28.21 0.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.51 -0.994 . . . . 0.0 108.93 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.547 ' CB ' HD21 ' A' ' 85' ' ' ASN . 3.0 p 79.58 -172.62 0.05 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.642 0.734 . . . . 0.0 110.684 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.25 145.71 49.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.3 ttp -141.45 150.06 41.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -1.045 . . . . 0.0 109.796 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.35 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.444 -0.785 . . . . 0.0 109.01 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -125.61 140.72 52.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.541 -0.724 . . . . 0.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.53 119.33 38.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -95.99 124.43 39.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 109.138 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.92 124.8 52.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.644 -0.66 . . . . 0.0 109.709 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.8 tp -107.79 121.65 45.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.657 -0.652 . . . . 0.0 109.286 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 40.6 mt-10 42.65 55.43 10.39 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 110.315 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 36.0 Cg_endo -66.71 151.25 82.97 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.919 2.412 . . . . 0.0 112.749 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -84.28 90.85 7.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.638 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' GLU . 10.5 tp -173.48 -27.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -40.35 96.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.33 79.99 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 108.891 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -89.19 -69.58 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.619 -0.676 . . . . 0.0 109.286 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 40' ' ' ILE . 97.8 mt-10 -110.94 134.65 52.41 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.511 -0.743 . . . . 0.0 109.67 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -65.85 159.86 24.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.659 0.743 . . . . 0.0 110.436 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -33.46 75.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.648 -0.658 . . . . 0.0 109.65 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.2 -19.07 63.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.484 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -82.59 -5.62 58.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.1 mt -98.96 117.25 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.389 -0.819 . . . . 0.0 109.776 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 88.5 m -102.6 -7.11 22.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.63 -179.75 42.85 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.142 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.8 ttp -128.92 145.17 51.3 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.626 -0.926 . . . . 0.0 109.222 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.37 122.36 46.84 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.406 -0.809 . . . . 0.0 110.425 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.4 mt -98.89 109.5 22.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' A' ' 56' ' ' ASP . 2.6 mp -105.47 163.15 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.041 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' OD2' ' CE2' ' A' ' 96' ' ' PHE . 40.4 t0 -162.46 -179.2 6.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.541 -0.724 . . . . 0.0 109.407 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 97.8 m-20 -70.07 -15.64 63.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -169.55 97.71 0.32 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.374 -0.829 . . . . 0.0 109.285 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.3 146.15 8.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.78 144.45 23.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -124.08 131.51 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.549 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 2.0 mp -101.97 132.16 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.0 m -120.32 123.32 42.84 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -97.79 -1.57 42.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.64 72.29 7.77 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.77 132.78 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.3 144.01 51.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.26 137.97 14.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.19 128.12 53.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.634 -0.921 . . . . 0.0 108.98 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -102.47 122.29 44.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.93 140.05 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 58.96 32.92 22.71 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.35 23.66 74.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -151.06 148.32 22.47 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.078 -1.248 . . . . 0.0 109.435 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.85 107.39 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.198 1.932 . . . . 0.0 111.228 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m -131.45 -10.25 3.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.538 -0.727 . . . . 0.0 110.059 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.71 154.47 41.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.957 -1.089 . . . . 0.0 110.306 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.03 159.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 16.1 tm-20 -140.7 149.31 42.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.267 -0.895 . . . . 0.0 109.489 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.482 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.13 142.7 35.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.399 -0.813 . . . . 0.0 109.055 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -120.63 132.61 55.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.707 -0.621 . . . . 0.0 109.669 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.68 132.17 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 83' ' ' ILE . 21.1 mm -95.38 122.5 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.336 -0.853 . . . . 0.0 110.116 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.4 mt -101.12 79.25 1.99 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.547 HD21 ' CB ' ' A' ' 28' ' ' SER . 11.9 m120 -87.3 -5.6 58.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.497 -0.752 . . . . 0.0 110.048 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 t -115.72 134.33 55.14 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.731 0.776 . . . . 0.0 109.764 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.442 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.0 mp0 -58.85 -60.65 9.79 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.752 -0.592 . . . . 0.0 110.579 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 3.0 Cg_endo -49.52 -21.52 5.25 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.993 1.795 . . . . 0.0 111.715 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -65.92 -38.17 87.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.694 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -58.67 -38.19 77.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.329 -0.857 . . . . 0.0 109.749 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -60.39 -44.2 95.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -67.51 -40.67 85.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.842 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.6 -48.9 78.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.359 -0.838 . . . . 0.0 109.794 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.08 -40.75 78.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.3 ttm-85 -63.37 -49.11 75.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.797 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.519 ' CE2' ' OD2' ' A' ' 56' ' ' ASP . 6.2 m-85 -66.31 -42.02 88.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.468 -0.77 . . . . 0.0 109.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 59.4 tpp -64.98 -34.07 77.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.629 -0.669 . . . . 0.0 109.267 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.65 -54.52 41.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.136 -0.978 . . . . 0.0 110.156 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtm-85 -65.69 -46.83 77.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.947 . . . . 0.0 110.145 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -62.95 -44.78 95.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.21 -33.89 88.44 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.09 98.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.322 -1.105 . . . . 0.0 109.529 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.534 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 80.2 mm-40 -71.27 -56.35 6.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 103' ' ' GLU . 34.3 m120 -159.59 -148.28 0.18 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.218 -0.926 . . . . 0.0 109.811 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.48 -160.57 50.91 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.512 ' CD1' ' N ' ' A' ' 106' ' ' LEU . 7.7 mp 56.1 -95.11 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.295 0.569 . . . . 0.0 110.122 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.38 -2.09 73.8 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -98.03 146.65 25.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.455 -1.026 . . . . 0.0 109.808 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 86.8 p -103.09 -4.83 23.97 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.583 -0.698 . . . . 0.0 109.63 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -174.61 -30.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.396 -0.815 . . . . 0.0 109.408 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.8 m -45.86 137.05 5.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.515 -0.74 . . . . 0.0 109.729 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 59.08 -68.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.103 0.478 . . . . 0.0 109.82 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 111' ' ' SER . 0.1 OUTLIER -87.23 116.51 25.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.049 -1.032 . . . . 0.0 109.684 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -169.87 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.724 ' HD1' ' H ' ' A' ' 117' ' ' HIS . 57.5 t-80 41.64 -116.44 0.32 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.716 -0.615 . . . . 0.0 110.198 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.63 ' H ' ' HD1' ' A' ' 115' ' ' HIS . 97.0 m-70 -156.49 -49.81 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.724 ' H ' ' HD1' ' A' ' 115' ' ' HIS . 98.6 m-70 -142.61 53.73 1.41 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.146 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -74.4 -26.21 59.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.663 -0.648 . . . . 0.0 109.449 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.446 ' ND1' ' OXT' ' A' ' 120' ' ' HIS . 29.8 t-80 -68.32 131.66 45.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.408 -0.807 . . . . 0.0 110.266 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.446 ' OXT' ' ND1' ' A' ' 119' ' ' HIS . 52.4 p-80 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.86 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -45.17 115.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.628 0.728 . . . . 0.0 109.992 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -153.14 149.26 27.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mp -110.34 130.45 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.469 0.652 . . . . 0.0 109.995 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -129.56 129.26 44.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.688 0.756 . . . . 0.0 109.513 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -88.09 -5.94 58.19 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 m -157.45 -168.85 2.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.6 133.74 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.865 0.84 . . . . 0.0 111.086 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 42.25 71.17 0.4 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.4 -47.92 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -1.001 . . . . 0.0 108.727 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.73 82.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.079 0.942 . . . . 0.0 109.152 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.11 124.22 30.89 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.738 0.78 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -96.4 -14.92 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 15' ' ' VAL . 59.3 t -55.66 159.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.292 -0.88 . . . . 0.0 110.091 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.438 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 12.4 t -112.39 81.42 4.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.534 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.6 148.76 54.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.611 2.208 . . . . 0.0 112.554 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 18' ' ' VAL . 7.0 tm-20 -84.37 155.17 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.592 -0.692 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 55.4 t -117.62 129.62 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.561 0.696 . . . . 0.0 109.768 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -128.68 137.88 51.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.24 131.18 47.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.585 -0.697 . . . . 0.0 109.351 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 m -108.01 149.09 28.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.612 -0.68 . . . . 0.0 109.619 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 24' ' ' LYS . 88.3 tttt -135.05 141.53 46.15 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.654 0.74 . . . . 0.0 109.589 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 p -71.51 14.57 0.17 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.649 . . . . 0.0 109.538 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.531 ' C ' ' H ' ' A' ' 26' ' ' GLY . 36.6 ttmt 64.89 91.8 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.662 0.744 . . . . 0.0 110.739 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 m120 55.05 6.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.611 0.72 . . . . 0.0 109.185 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 24' ' ' LYS . . . -83.82 165.39 41.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -99.6 74.07 1.86 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.296 -1.12 . . . . 0.0 109.686 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 p -164.11 101.14 0.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.361 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.89 143.56 41.91 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttp -165.09 153.02 11.46 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -1.052 . . . . 0.0 109.663 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' HA ' ' H ' ' A' ' 21' ' ' SER . . . -142.89 153.18 42.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.653 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.06 147.55 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.452 0.644 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.32 136.85 54.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -114.27 122.05 45.55 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.456 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.19 114.28 27.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.0 tp -95.87 121.22 37.37 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.708 0.766 . . . . 0.0 110.027 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 48.55 60.21 15.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.982 -0.449 . . . . 0.0 110.623 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 40' ' ' ILE . 38.1 Cg_endo -69.68 1.36 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.346 2.031 . . . . 0.0 110.479 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m 54.74 5.03 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.28 0.562 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.522 ' H ' ' C ' ' A' ' 38' ' ' PRO . 2.8 tp -73.48 -1.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 109.655 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.7 mt -84.42 -9.55 58.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 108.953 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.8 -18.6 22.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.332 -0.855 . . . . 0.0 109.382 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.45 -47.15 4.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.32 -0.863 . . . . 0.0 109.089 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.78 153.09 48.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.33 -0.856 . . . . 0.0 110.148 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 t -80.69 167.04 20.47 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.694 0.759 . . . . 0.0 110.373 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -62.93 -39.92 96.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.642 0.734 . . . . 0.0 109.423 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 50.0 p-10 -70.98 -21.91 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.524 -0.735 . . . . 0.0 109.682 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 96.4 m-20 -80.26 -6.23 57.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.95 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.22 123.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.984 -1.073 . . . . 0.0 109.939 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.587 ' HG1' ' NH1' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -116.15 91.01 3.47 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 0.0 109.369 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.93 174.71 37.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -127.62 149.15 50.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.709 -0.877 . . . . 0.0 109.375 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.79 108.84 20.56 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.621 0.724 . . . . 0.0 109.726 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.35 115.81 30.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 55' ' ' ILE . 96.7 mt -116.89 125.15 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.53 0.681 . . . . 0.0 109.602 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -104.01 -167.36 1.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.592 0.71 . . . . 0.0 110.376 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 33.2 p-10 -77.78 -5.23 50.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.728 -0.607 . . . . 0.0 109.658 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -108.75 -94.18 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.417 -0.802 . . . . 0.0 109.884 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' H ' ' NH1' ' A' ' 92' ' ' ARG . . . -106.12 -147.59 15.16 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -137.38 155.09 49.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.98 . . . . 0.0 110.091 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.45 138.86 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.407 0.622 . . . . 0.0 109.804 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 62' ' ' ILE . 36.0 mm -110.34 129.27 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.8 m -120.18 123.85 44.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 109.581 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.587 ' NH1' ' HG1' ' A' ' 50' ' ' THR . 18.2 tpt85 -98.82 -12.6 20.69 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -84.83 79.3 9.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.441 -0.787 . . . . 0.0 109.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.93 133.21 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.403 0.621 . . . . 0.0 109.476 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.05 143.25 50.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.73 0.776 . . . . 0.0 109.727 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.79 140.42 15.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -101.52 121.58 42.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.984 . . . . 0.0 109.185 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -104.62 119.33 38.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.631 0.729 . . . . 0.0 110.121 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.31 138.84 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.42 33.75 20.65 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.603 0.716 . . . . 0.0 110.192 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.24 27.55 73.07 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -155.1 148.19 18.22 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.143 -1.21 . . . . 0.0 109.523 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.07 113.96 3.23 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.6 2.2 . . . . 0.0 111.926 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m -126.98 -15.69 5.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.22 158.26 43.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 110.269 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -129.01 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.378 0.609 . . . . 0.0 109.463 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -129.59 148.05 51.45 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.604 0.716 . . . . 0.0 109.689 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.4 145.94 39.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.21 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -121.47 131.71 54.31 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.432 0.634 . . . . 0.0 109.946 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.08 129.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.561 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.4 mp -82.15 127.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.533 0.682 . . . . 0.0 109.655 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.494 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 84.5 mt -120.68 33.77 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.68 -40.04 95.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.529 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.7 m -70.47 145.61 50.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.044 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.502 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -71.58 -47.67 12.56 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.303 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 43.7 Cg_exo -54.36 -33.67 77.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.123 1.882 . . . . 0.0 111.819 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -66.04 -37.24 85.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.578 -0.701 . . . . 0.0 109.872 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.494 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.1 m95 -60.97 -39.81 91.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 109.944 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.58 -51.1 69.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.434 ' NH1' ' H ' ' A' ' 59' ' ' GLY . 63.2 ttm-85 -68.27 -42.68 79.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.43 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.29 -43.25 99.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ttt -59.02 -41.98 89.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.308 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.36 -40.48 93.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.523 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.55 -48.21 82.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.266 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.8 ttt -67.86 -39.09 83.81 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.646 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -64.3 -47.95 77.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.453 -0.779 . . . . 0.0 109.434 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -67.23 -42.34 84.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.825 . . . . 0.0 109.546 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.6 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 60.6 t80 -60.94 -46.18 91.73 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.801 0.81 . . . . 0.0 109.314 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.09 -30.91 79.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.38 93.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 109.812 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -89.24 -16.89 30.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.6 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 68.7 m-80 -103.69 145.16 30.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.43 6.89 42.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.409 ' CD1' ' N ' ' A' ' 106' ' ' LEU . 10.4 mp 56.32 164.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.029 0.919 . . . . 0.0 110.658 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' SER . . . 175.37 129.58 1.22 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 40.73 22.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.876 -0.779 . . . . 0.0 110.011 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 107' ' ' GLY . 31.1 t -61.65 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.115 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -152.06 -55.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 109.893 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' A' ' 112' ' ' GLU . 78.4 p -62.27 -30.49 71.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.362 -0.836 . . . . 0.0 109.414 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 57.4 mp0 -95.54 -27.54 15.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 108.954 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.62 -42.72 91.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 0.0 109.716 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.56 6.15 24.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.092 -1.005 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.85 154.02 50.74 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.403 -0.811 . . . . 0.0 110.164 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -108.03 123.08 48.13 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.585 0.707 . . . . 0.0 109.939 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -66.98 -41.94 85.95 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.682 0.753 . . . . 0.0 109.481 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -89.36 127.41 35.81 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 0.0 109.981 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 48.6 p-80 -74.54 62.89 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.713 0.768 . . . . 0.0 109.828 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 119' ' ' HIS . 84.1 t60 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.314 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.541 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.671 0.748 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.64 139.06 56.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 110.395 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -155.39 138.98 15.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -0.814 . . . . 0.0 109.723 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.2 130.51 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.672 0.748 . . . . 0.0 109.399 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 10' ' ' VAL . 16.8 pt20 -149.05 145.71 27.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.511 -0.743 . . . . 0.0 109.674 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 53' ' ' TYR . 90.2 m-85 -63.39 -45.47 90.93 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.59 0.709 . . . . 0.0 109.404 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 m -104.99 158.06 16.8 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.672 0.748 . . . . 0.0 110.322 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -68.54 133.28 48.32 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.834 0.826 . . . . 0.0 110.507 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 45.37 86.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.512 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 44.4 t -101.96 -77.66 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -1.026 . . . . 0.0 109.296 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -178.06 -99.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.458 -0.776 . . . . 0.0 110.068 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.7 143.03 31.98 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 110.805 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' VAL . 70.9 m -75.72 -17.88 59.77 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.321 0.581 . . . . 0.0 109.968 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' THR . 3.7 t 55.51 158.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.485 -0.76 . . . . 0.0 110.572 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.25 74.53 41.83 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.299 -0.875 . . . . 0.0 109.892 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.05 147.36 23.72 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.921 2.414 . . . . 0.0 112.522 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 106' ' ' LEU . 79.2 mm-40 -74.86 161.63 29.38 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.767 0.794 . . . . 0.0 110.045 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -113.06 131.33 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.543 0.687 . . . . 0.0 109.324 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -128.52 139.9 52.08 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.678 0.751 . . . . 0.0 109.579 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 4.1 mm? -97.42 135.22 39.61 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.641 0.734 . . . . 0.0 109.64 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.9 t -134.57 142.95 47.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.539 0.685 . . . . 0.0 109.714 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -100.77 159.08 15.48 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.054 0.931 . . . . 0.0 110.371 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 p -67.03 165.75 15.09 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.652 0.739 . . . . 0.0 110.295 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -62.01 -40.08 94.44 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.649 0.738 . . . . 0.0 109.378 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -91.52 -6.26 52.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.909 . . . . 0.0 109.025 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.85 16.23 78.16 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -76.14 -78.11 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.484 -1.009 . . . . 0.0 109.957 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.413 ' HG ' ' H ' ' A' ' 29' ' ' GLY . 4.8 p -78.44 -97.25 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 110.055 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' H ' ' HG ' ' A' ' 28' ' ' SER . . . 147.84 172.85 18.3 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.0 ptp -159.26 175.69 13.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -1.132 . . . . 0.0 109.679 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.54 143.91 45.97 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' NZ ' ' OG1' ' A' ' 81' ' ' THR . 68.3 mttm -117.18 142.9 46.45 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.626 0.727 . . . . 0.0 110.166 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.86 128.12 54.95 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -103.76 131.87 50.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.577 -0.702 . . . . 0.0 109.627 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -112.43 126.44 55.3 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.0 tp -100.68 125.32 47.09 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.681 0.753 . . . . 0.0 110.677 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 37.04 58.17 3.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.22 150.68 81.74 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.574 2.182 . . . . 0.0 112.525 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.501 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -76.5 -18.69 58.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.746 -0.596 . . . . 0.0 110.219 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.78 1.52 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.03 . . . . 0.0 109.707 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.501 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.0 mt -89.28 -8.94 52.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.027 -1.045 . . . . 0.0 109.169 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.98 -26.88 11.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.414 -0.804 . . . . 0.0 109.263 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.47 -74.34 0.45 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -0.921 . . . . 0.0 109.9 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.05 143.67 36.46 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.87 0.843 . . . . 0.0 110.408 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -76.5 169.4 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.918 0.866 . . . . 0.0 110.52 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.5 p -65.36 -31.09 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.02 -36.61 84.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.67 -8.99 58.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.4 mt -101.6 118.35 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.238 -0.914 . . . . 0.0 109.989 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' A' ' 50' ' ' THR . 0.3 OUTLIER -140.38 26.04 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.99 164.97 34.72 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 44.3 ttm -135.63 133.58 38.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -1.09 . . . . 0.0 109.499 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 6' ' ' PHE . 4.3 m-85 -112.53 120.97 43.45 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.017 0.913 . . . . 0.0 109.723 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.0 mp -96.37 110.36 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 1.9 mp -98.81 126.99 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.508 -0.745 . . . . 0.0 109.623 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 66.4 t0 -172.5 134.99 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.557 0.694 . . . . 0.0 109.97 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 59' ' ' GLY . 97.8 m-20 57.97 42.86 22.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.974 -0.454 . . . . 0.0 110.077 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 67.82 -40.94 0.42 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.556 0.694 . . . . 0.0 109.543 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -69.66 153.48 52.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.62 149.03 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.463 -1.021 . . . . 0.0 109.91 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -119.36 133.34 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.532 0.682 . . . . 0.0 109.195 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mm -102.83 122.28 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.732 . . . . 0.0 109.698 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.0 m -123.41 126.07 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.63 0.729 . . . . 0.0 109.395 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -101.24 41.24 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.201 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -133.05 86.44 2.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.1 m -121.62 132.18 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -123.21 134.36 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.833 0.825 . . . . 0.0 109.021 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.7 133.37 11.54 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -105.76 110.4 22.69 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.631 -0.923 . . . . 0.0 108.604 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -104.42 139.75 38.91 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.423 0.63 . . . . 0.0 109.62 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.1 mt -117.96 126.15 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.58 0.705 . . . . 0.0 109.487 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.75 33.2 22.57 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.44 78.81 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 ttp85 -135.42 120.07 13.45 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.35 -1.088 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.55 138.2 32.0 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.321 2.014 . . . . 0.0 112.416 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -147.93 -34.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.32 158.96 44.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.841 -1.162 . . . . 0.0 110.533 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.0 mt -131.02 142.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -124.99 148.61 48.37 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.642 0.734 . . . . 0.0 109.464 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.88 147.7 41.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.528 ' OG1' ' NZ ' ' A' ' 32' ' ' LYS . 86.9 m -118.66 130.06 55.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.5 125.16 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.677 0.751 . . . . 0.0 109.531 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 25.0 mm -84.06 131.94 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 82.5 mt -121.72 47.94 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.411 HD21 ' CB ' ' A' ' 28' ' ' SER . 11.1 m120 -64.65 -40.38 95.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.41 -0.806 . . . . 0.0 109.447 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -74.19 145.32 44.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.488 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -73.34 -47.39 7.63 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.481 -0.762 . . . . 0.0 110.203 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 44.6 Cg_exo -54.72 -32.72 77.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.881 1.721 . . . . 0.0 111.306 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -67.03 -38.19 85.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.608 -0.682 . . . . 0.0 109.399 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.2 m95 -59.76 -41.46 91.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -62.73 -46.48 87.87 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -70.15 -41.69 73.51 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.802 0.81 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.36 -44.86 96.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 109.376 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.0 ttm -61.21 -41.84 97.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -66.94 -39.59 87.36 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.56 -46.52 85.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.296 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 62.6 ttp -66.45 -38.42 87.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.6 0.714 . . . . 0.0 109.663 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -61.76 -42.24 98.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.832 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.24 -39.46 86.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.73 -38.5 94.53 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.1 92.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -1.18 . . . . 0.0 110.371 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.75 -56.07 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.046 . . . . 0.0 109.961 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -93.18 -79.43 0.4 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.95 -1.094 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 140.87 143.85 4.36 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 106' ' ' LEU . 8.5 mp -74.12 -79.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.373 -1.075 . . . . 0.0 109.659 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 50.44 65.29 3.06 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -59.74 128.12 35.36 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.997 . . . . 0.0 110.276 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.3 m -75.55 149.8 38.26 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.789 0.804 . . . . 0.0 110.791 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.456 ' O ' ' OG ' ' A' ' 111' ' ' SER . 22.9 pttp -72.72 170.19 15.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.992 0.901 . . . . 0.0 111.414 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 110' ' ' LYS . 4.2 p 77.93 -7.56 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -104.84 -27.04 11.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.363 -0.836 . . . . 0.0 109.576 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.625 ' CD2' ' H ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -79.1 -43.28 24.43 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.923 0.868 . . . . 0.0 109.692 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.03 108.45 1.82 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.56 -0.713 . . . . 0.0 110.12 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -173.46 83.58 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.692 0.758 . . . . 0.0 109.013 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.677 ' HD1' ' HD1' ' A' ' 117' ' ' HIS . 63.3 t-80 -154.35 -50.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.677 ' HD1' ' HD1' ' A' ' 116' ' ' HIS . 31.3 p-80 -150.41 168.2 24.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -0.952 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -151.12 157.88 43.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 109.849 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -153.88 161.7 41.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.987 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.554 -179.759 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 96.6 mtp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.42 143.14 55.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.562 -0.712 . . . . 0.0 110.499 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -154.58 160.79 41.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.588 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.1 129.65 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -129.4 129.29 44.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 109.884 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.08 -5.67 59.16 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.4 t -161.1 -63.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.497 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.588 ' C ' ' H ' ' A' ' 10' ' ' VAL . 53.7 mtpt -143.02 -160.82 1.15 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.91 5.22 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.588 ' H ' ' C ' ' A' ' 8' ' ' LYS . 74.5 t -69.07 134.85 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.314 -1.109 . . . . 0.0 110.344 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 64.43 92.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.491 0.662 . . . . 0.0 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -130.33 -22.22 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -76.22 -1.0 24.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 108.924 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.95 136.52 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.551 -0.718 . . . . 0.0 109.898 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.46 79.41 29.08 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 109.272 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.04 153.21 32.2 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.918 2.412 . . . . 0.0 112.793 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -89.31 138.37 31.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.424 -0.797 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.7 t -88.26 131.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -127.37 144.43 51.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.621 0.724 . . . . 0.0 109.48 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.73 132.39 54.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.8 t -121.36 152.57 38.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.749 -0.594 . . . . 0.0 109.509 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 26' ' ' GLY . 65.8 tttm -133.3 153.03 51.93 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.881 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 25' ' ' ASN . 97.4 p -65.52 0.74 1.43 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.734 . . . . 0.0 109.426 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 22' ' ' LYS . 28.8 tptt 40.53 22.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.528 0.68 . . . . 0.0 110.079 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 23' ' ' SER . 64.8 t30 -167.45 23.71 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.483 ' O ' ' NZ ' ' A' ' 22' ' ' LYS . . . 179.9 175.76 46.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 28' ' ' SER . 55.9 tt0 -88.3 -9.65 52.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -1.094 . . . . 0.0 109.588 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.429 ' OG ' ' OD1' ' A' ' 85' ' ' ASN . 4.7 t -42.23 117.23 0.95 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 110.617 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.88 141.26 28.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttm -153.34 151.43 29.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -1.171 . . . . 0.0 109.531 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.88 148.15 36.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.31 146.25 50.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.11 140.23 49.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -118.88 125.67 50.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.28 121.39 45.17 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.0 tp -95.62 123.17 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.449 0.643 . . . . 0.0 109.985 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 36' ' ' LEU . 13.9 mm-40 37.35 57.69 4.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-O 120.966 0.413 . . . . 0.0 111.096 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.95 148.98 71.46 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.254 1.969 . . . . 0.0 111.795 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 41' ' ' LEU . 5.1 t -75.92 -13.25 60.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 110.314 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.57 -1.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 109.738 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 39' ' ' THR . 84.6 mt -90.71 -12.69 35.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.08 -21.88 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -87.47 -75.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.63 160.85 14.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.855 0.836 . . . . 0.0 110.562 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.4 p -76.17 165.77 24.43 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.742 0.782 . . . . 0.0 110.762 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.9 p -65.84 -31.53 72.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.489 0.661 . . . . 0.0 109.882 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.27 -18.26 63.13 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -93.59 -6.69 46.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' THR . 86.8 mt -84.53 -7.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.142 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' ILE . 20.1 m -39.6 123.01 1.45 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.686 0.755 . . . . 0.0 110.834 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.27 160.26 32.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.6 ttm -135.19 143.94 46.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -118.12 109.82 16.87 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 0.0 109.522 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.04 131.44 34.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.176 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -121.37 133.69 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.503 0.668 . . . . 0.0 110.136 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' GLU . 97.0 m-20 -133.29 43.21 2.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 44.82 17.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.386 -0.821 . . . . 0.0 109.53 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' ASP . 79.8 tt0 -170.4 83.4 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.183 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.58 157.44 32.46 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.26 155.54 45.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -1.097 . . . . 0.0 109.829 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.8 132.62 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 62' ' ' ILE . 32.7 mm -103.31 120.7 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 t -127.81 125.49 39.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.46 0.648 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -98.74 50.37 0.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -138.81 81.66 1.86 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.04 136.05 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.629 . . . . 0.0 109.461 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -128.74 134.85 48.56 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.556 -0.715 . . . . 0.0 109.572 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.1 143.45 16.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -96.71 101.07 12.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.467 -1.02 . . . . 0.0 108.366 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -91.91 152.84 19.87 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.621 0.724 . . . . 0.0 110.514 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.613 ' C ' ' H ' ' A' ' 73' ' ' GLY . 89.3 mt -135.87 148.3 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.35 -0.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.971 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' A' ' 71' ' ' ILE . . . -127.88 62.24 0.63 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 73' ' ' GLY . 68.9 ttp85 60.12 134.87 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.805 -0.82 . . . . 0.0 110.633 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -42.79 140.06 3.08 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.961 1.774 . . . . 0.0 112.102 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m -130.03 -16.84 3.58 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 166.69 30.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.708 -1.245 . . . . 0.0 110.72 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.7 mt -134.92 154.12 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -133.45 151.82 51.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.53 -0.731 . . . . 0.0 110.438 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.89 34.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.7 m -125.11 127.9 47.6 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.671 -0.643 . . . . 0.0 109.616 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.63 128.87 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.55 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.6 mp -87.21 127.59 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.654 -0.654 . . . . 0.0 109.579 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 82.5 mt -108.72 36.73 2.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.429 ' OD1' ' OG ' ' A' ' 28' ' ' SER . 93.0 m-20 -63.48 -39.37 94.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -68.13 153.49 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.421 -0.8 . . . . 0.0 110.297 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.468 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 5.5 mp0 -71.27 -57.3 4.71 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.713 -0.617 . . . . 0.0 110.774 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 11.7 Cg_endo -54.8 -33.28 80.45 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.653 1.568 . . . . 0.0 111.617 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.61 -39.88 88.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.737 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -64.53 -44.95 89.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.917 . . . . 0.0 109.773 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -62.46 -46.42 88.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.284 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -65.67 -38.4 89.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.498 -0.751 . . . . 0.0 109.275 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -62.22 -43.81 98.0 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.521 -0.737 . . . . 0.0 109.51 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.5 ttm -61.4 -38.14 85.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.823 . . . . 0.0 109.229 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.98 -38.71 92.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 109.236 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -61.24 -45.18 95.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 91.8 mtp -63.75 -41.23 98.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -71.29 -46.51 60.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.612 ' NH2' ' N ' ' A' ' 1' ' ' MET . 10.1 tpt180 -67.65 -41.89 83.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.474 -0.766 . . . . 0.0 110.13 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 104' ' ' ASN . 59.3 t80 -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.143 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 -28.8 71.93 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.23 72.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.992 . . . . 0.0 110.168 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -71.27 -48.74 49.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.702 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 100' ' ' TYR . 3.4 p-10 176.78 -166.91 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.747 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 107' ' ' GLY . . . 77.6 -51.46 3.38 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.53 ' CD1' ' N ' ' A' ' 106' ' ' LEU . 7.4 mp 44.65 22.14 0.05 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.532 -0.981 . . . . 0.0 109.406 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 105' ' ' GLY . . . -47.19 107.75 0.24 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -94.23 132.66 38.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -1.063 . . . . 0.0 110.089 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.6 p -86.09 113.44 22.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.441 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 111' ' ' SER . 88.6 tttt -70.03 123.93 22.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.583 -0.698 . . . . 0.0 110.147 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER 163.11 -72.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.378 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -100.02 -25.11 14.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.455 -0.778 . . . . 0.0 109.676 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.9 mt -64.52 -40.98 96.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.792 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -94.18 119.53 33.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -0.941 . . . . 0.0 110.059 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -155.61 -56.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.19 137.33 41.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.488 -0.757 . . . . 0.0 110.706 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -150.12 149.72 30.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.4 -0.812 . . . . 0.0 109.725 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.439 ' C ' ' H ' ' A' ' 120' ' ' HIS . 0.4 OUTLIER -156.16 163.79 39.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.326 -0.859 . . . . 0.0 110.431 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 83.5 t60 53.51 11.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.64 -0.662 . . . . 0.0 109.492 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.439 ' H ' ' C ' ' A' ' 118' ' ' HIS . 58.3 t-80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.905 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 tpp . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.491 ' N ' ' OE2' ' A' ' 103' ' ' GLU . . . -69.38 139.18 54.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.347 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -155.64 148.7 24.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.819 . . . . 0.0 109.175 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 4' ' ' ILE . 91.2 mt -108.72 128.48 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.148 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 9' ' ' GLY . 5.8 pt20 -146.31 155.08 42.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.227 -0.921 . . . . 0.0 109.634 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -111.18 -37.44 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 t -90.64 22.97 3.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.921 . . . . 0.0 109.376 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.531 ' NZ ' ' CE2' ' A' ' 53' ' ' TYR . 68.0 mttm 50.78 33.78 9.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 109.663 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 5' ' ' GLN . . . 157.58 40.73 0.02 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.36 -86.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -1.031 . . . . 0.0 109.925 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 179.23 -105.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.629 0.728 . . . . 0.0 109.474 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.92 146.59 46.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.473 -0.767 . . . . 0.0 110.489 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 14' ' ' VAL . 49.1 m -76.07 -11.01 59.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 108.999 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 13' ' ' THR . 55.4 t 53.06 165.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.497 0.665 . . . . 0.0 110.711 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.423 ' N ' ' CG1' ' A' ' 14' ' ' VAL . 3.5 m -123.89 75.08 57.08 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.555 -0.715 . . . . 0.0 109.232 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 151.94 35.36 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.558 2.172 . . . . 0.0 112.437 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.63 152.55 25.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.512 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.62 130.76 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.055 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -132.27 141.16 48.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -109.07 130.54 55.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.195 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 t -126.98 133.26 50.62 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -127.5 135.94 51.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.626 0.727 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.527 ' C ' ' H ' ' A' ' 25' ' ' ASN . 55.8 m -61.69 -129.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.548 -0.72 . . . . 0.0 110.474 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -72.39 19.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.67 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 23' ' ' SER . 71.7 m-20 57.9 35.15 25.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.393 -0.817 . . . . 0.0 109.7 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.72 26.36 0.09 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -135.73 -113.22 0.19 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.46 -1.024 . . . . 0.0 109.744 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.7 m -105.09 120.37 41.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.333 -0.854 . . . . 0.0 109.943 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.539 ' N ' ' ND2' ' A' ' 85' ' ' ASN . . . -79.58 151.87 34.84 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.9 ptm -153.6 167.93 27.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.247 -1.149 . . . . 0.0 109.364 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.76 145.17 37.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.481 -0.762 . . . . 0.0 109.036 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -112.07 143.23 43.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.92 131.83 52.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -105.49 126.22 51.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.406 -0.808 . . . . 0.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -109.43 116.21 31.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.641 -0.662 . . . . 0.0 109.257 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.5 tp -100.9 118.32 36.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.561 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.563 ' C ' ' H ' ' A' ' 39' ' ' THR . 57.4 mt-10 43.31 59.65 11.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.85 13.9 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.078 1.852 . . . . 0.0 110.202 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.563 ' H ' ' C ' ' A' ' 37' ' ' GLU . 72.6 p 48.88 32.17 3.61 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.273 0.559 . . . . 0.0 110.05 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 11.1 tp -99.06 -22.06 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.181 -0.95 . . . . 0.0 109.14 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.7 -40.7 92.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -23.2 67.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -98.22 -52.21 3.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -136.89 149.1 47.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.33 -0.856 . . . . 0.0 110.214 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 p -73.0 163.51 28.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.6 p -66.42 -30.72 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.485 -0.759 . . . . 0.0 109.444 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.22 -16.52 63.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.629 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -85.34 -7.81 58.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.2 mt -100.96 116.33 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -0.774 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 p -125.5 15.01 8.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.98 160.34 27.37 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -118.03 131.69 56.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.679 -0.895 . . . . 0.0 108.83 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.531 ' CE2' ' NZ ' ' A' ' 8' ' ' LYS . 94.9 m-85 -104.42 112.7 25.85 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.639 0.733 . . . . 0.0 109.721 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.6 mt -95.55 127.63 41.75 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.71 128.76 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.498 0.666 . . . . 0.0 109.504 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASP . 44.5 t0 -155.56 118.11 4.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.53 -0.731 . . . . 0.0 109.853 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 94.8 m-20 40.1 61.15 1.58 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.833 -0.542 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 68.81 -41.44 0.47 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -66.66 138.77 36.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.69 148.81 32.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -1.165 . . . . 0.0 109.997 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.48 130.85 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.566 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 2.8 mp -107.58 129.52 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.49 -0.756 . . . . 0.0 109.57 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -128.73 128.09 43.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.588 -0.695 . . . . 0.0 109.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -90.78 4.94 50.29 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.31 78.67 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 m -120.92 132.95 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.545 -0.722 . . . . 0.0 109.669 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -123.19 137.07 54.98 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.15 127.22 9.18 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -96.39 126.98 41.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -1.109 . . . . 0.0 108.907 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -102.46 138.29 39.58 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.374 0.607 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mm -115.37 132.46 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 57.5 32.37 21.71 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.496 0.665 . . . . 0.0 109.517 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -12.03 26.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -112.72 149.14 40.72 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.409 -1.053 . . . . 0.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.2 142.28 86.0 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.335 2.023 . . . . 0.0 112.215 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 m -157.95 -28.97 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.95 44.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.054 . . . . 0.0 110.207 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 78' ' ' ILE . 95.8 mt -130.4 153.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.522 0.677 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -132.68 152.65 51.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.17 44.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 109.237 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.4 m -125.17 129.97 51.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.57 130.92 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.224 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.92 121.46 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.47 -0.769 . . . . 0.0 109.859 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.8 mt -98.14 -75.63 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.937 0.875 . . . . 0.0 109.121 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.539 ' ND2' ' N ' ' A' ' 29' ' ' GLY . 3.2 m120 56.31 32.12 19.85 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.72 -0.613 . . . . 0.0 109.823 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 m -153.49 140.58 19.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.009 . . . . 0.0 109.335 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.482 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 9.6 mm-40 -62.38 -58.21 18.57 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.74 . . . . 0.0 110.32 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 13.0 Cg_endo -54.3 -36.04 85.53 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.955 1.77 . . . . 0.0 111.451 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -68.92 -38.76 79.76 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.349 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -62.02 -46.33 89.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -42.65 99.65 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.199 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.77 -44.01 91.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.501 -0.749 . . . . 0.0 109.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.16 -44.01 96.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 0.0 110.193 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 40.0 ttm -58.0 -43.8 86.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.316 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.489 HH21 ' NH2' ' A' ' 99' ' ' ARG . 79.5 mtp85 -65.79 -38.3 88.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.09 -46.71 86.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.399 -0.813 . . . . 0.0 110.31 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.43 ' C ' ' SD ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.27 -39.28 94.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.838 1.304 . . . . 0.0 109.175 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -45.63 79.95 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.337 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 99.7 mtt180 -63.99 -41.9 97.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.092 -1.005 . . . . 0.0 109.17 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.0 -44.85 91.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.548 -0.72 . . . . 0.0 109.16 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.0 91.44 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.13 -38.15 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -1.158 . . . . 0.0 109.469 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 2' ' ' ALA . 96.2 mt-10 -68.74 -36.27 78.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 110.024 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -140.15 83.32 1.91 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -50.18 102.79 0.07 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.94 150.68 35.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -1.073 . . . . 0.0 110.498 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.12 -6.28 88.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -146.31 97.99 3.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.207 -1.172 . . . . 0.0 109.147 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 110' ' ' LYS . 34.0 t -167.18 97.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.817 . . . . 0.0 109.266 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 109' ' ' SER . 73.3 tttt 52.06 168.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.037 0.922 . . . . 0.0 111.602 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.556 ' C ' ' H ' ' A' ' 113' ' ' LEU . 2.2 t 61.53 136.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.361 0.601 . . . . 0.0 109.854 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 49.3 mp0 56.1 5.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.556 ' H ' ' C ' ' A' ' 111' ' ' SER . 1.0 OUTLIER -95.73 -43.33 7.94 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.5 151.0 38.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.633 -0.667 . . . . 0.0 110.315 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -137.14 146.38 44.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 109.532 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.468 ' O ' ' NE2' ' A' ' 119' ' ' HIS . 37.6 m80 -133.48 140.32 47.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.637 -0.664 . . . . 0.0 109.231 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 116' ' ' HIS . 78.2 m80 54.57 163.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.777 0.798 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -84.6 -6.76 59.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.468 ' NE2' ' O ' ' A' ' 116' ' ' HIS . 96.8 m-70 51.96 -174.44 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.684 0.754 . . . . 0.0 110.858 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.702 -179.747 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.5 mtp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.14 88.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.94 160.17 42.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.904 0.859 . . . . 0.0 110.386 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.0 mt -108.79 128.43 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.696 0.76 . . . . 0.0 109.449 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -148.51 149.65 32.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.926 0.87 . . . . 0.0 109.897 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.53 -65.75 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 9' ' ' GLY . 18.5 m -75.35 164.76 26.08 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.587 0.708 . . . . 0.0 109.821 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.98 29.21 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.482 0.658 . . . . 0.0 109.672 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 10' ' ' VAL . . . -159.4 -44.28 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 9' ' ' GLY . 28.5 m 31.46 -135.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.192 0.52 . . . . 0.0 110.642 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.95 -139.4 0.05 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.592 0.711 . . . . 0.0 109.597 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.62 144.08 56.6 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.464 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 p -68.9 139.14 55.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.753 0.787 . . . . 0.0 110.559 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.435 ' CG1' ' H ' ' A' ' 15' ' ' VAL . 1.6 t -87.22 -145.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.416 0.627 . . . . 0.0 110.815 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.435 ' H ' ' CG1' ' A' ' 14' ' ' VAL . 17.5 t -146.45 66.27 10.91 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.649 -0.657 . . . . 0.0 109.242 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.92 149.75 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.024 2.483 . . . . 0.0 112.605 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.4 145.84 25.77 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.89 0.853 . . . . 0.0 109.921 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 t -103.71 131.65 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.839 0.828 . . . . 0.0 110.421 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -135.26 141.52 45.75 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.307 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -103.93 125.53 50.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.867 0.842 . . . . 0.0 110.081 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 m -94.91 164.19 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.641 0.734 . . . . 0.0 109.899 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.2 139.31 43.07 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.776 0.798 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -159.23 25.35 0.2 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.65 -45.69 91.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.614 -0.679 . . . . 0.0 109.403 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -89.74 -1.63 58.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.67 -66.02 1.05 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.443 ' O ' ' OG ' ' A' ' 28' ' ' SER . 6.9 pt20 -145.44 -42.78 0.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.938 . . . . 0.0 108.943 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 27' ' ' GLN . 13.4 m -175.98 -85.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.691 . . . . 0.0 109.365 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.95 153.36 13.66 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -157.79 176.24 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.962 . . . . 0.0 110.281 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.57 148.79 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.757 0.789 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.526 ' NZ ' ' OG1' ' A' ' 81' ' ' THR . 72.3 mmtt -111.42 148.85 32.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.753 0.787 . . . . 0.0 110.035 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -126.37 135.98 52.13 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.608 0.718 . . . . 0.0 109.493 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -120.8 127.1 51.63 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.83 0.824 . . . . 0.0 109.747 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.67 120.23 41.73 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.726 0.774 . . . . 0.0 109.58 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' GLU . 37.2 tp -88.88 126.64 35.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.706 0.765 . . . . 0.0 110.404 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 36' ' ' LEU . 45.9 mm-40 36.53 68.7 1.4 Allowed Pre-proline 0 N--CA 1.493 1.691 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.785 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -58.94 145.38 97.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.273 1.982 . . . . 0.0 111.853 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 p -83.37 -17.43 42.33 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.016 0.436 . . . . 0.0 110.242 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.74 1.13 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.602 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.63 -11.59 58.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 109.281 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.45 -14.54 30.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.18 -58.39 1.89 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.795 . . . . 0.0 109.423 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.97 160.55 40.14 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.755 0.788 . . . . 0.0 110.242 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.656 ' HG ' ' H ' ' A' ' 46' ' ' THR . 26.7 t -63.57 -166.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.62 0.724 . . . . 0.0 110.476 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.656 ' H ' ' HG ' ' A' ' 45' ' ' SER . 60.3 p -99.03 -21.0 16.43 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -64.43 -36.9 85.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 109.163 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 45' ' ' SER . 25.1 p-10 -62.22 -40.3 95.67 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.537 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.2 mt -54.8 -88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.82 -0.55 . . . . 0.0 109.777 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.0 m 66.61 -43.18 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -96.9 144.68 17.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.4 ttp -126.37 125.65 42.58 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.581 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -108.51 111.01 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.958 0.885 . . . . 0.0 110.225 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.6 mt -97.43 121.6 39.51 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 2.1 mp -103.7 130.77 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.887 0.851 . . . . 0.0 110.404 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 38.0 m-20 -133.23 -156.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.726 0.774 . . . . 0.0 109.77 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.553 ' C ' ' H ' ' A' ' 59' ' ' GLY . 42.8 p-10 -71.72 96.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.964 -0.46 . . . . 0.0 110.339 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 66.08 -39.88 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -88.95 160.24 29.65 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' N ' ' NH2' ' A' ' 92' ' ' ARG . 17.2 pt-20 -151.51 148.72 28.38 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 110.067 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.04 130.09 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.674 0.75 . . . . 0.0 109.527 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -123.49 133.47 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.836 0.826 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -142.06 150.7 41.58 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.734 0.778 . . . . 0.0 109.848 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -97.58 0.89 48.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.35 81.39 3.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.479 0.657 . . . . 0.0 109.286 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.42 133.57 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.855 0.836 . . . . 0.0 109.814 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.29 137.37 47.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.834 0.826 . . . . 0.0 109.47 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.27 131.01 10.42 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -103.5 117.14 33.75 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.818 0.818 . . . . 0.0 109.472 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.61 137.09 47.13 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.858 0.837 . . . . 0.0 110.036 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -119.06 128.65 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.675 0.75 . . . . 0.0 109.201 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.7 m120 59.65 30.74 20.37 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.315 0.578 . . . . 0.0 109.731 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.51 24.7 73.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -136.01 113.38 10.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.749 -0.853 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.88 104.62 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.211 2.608 . . . . 0.0 112.568 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.6 m -109.71 -35.72 6.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.739 -0.601 . . . . 0.0 110.092 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.81 159.81 40.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.054 -1.029 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.21 150.97 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.694 0.759 . . . . 0.0 109.655 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -130.66 148.51 52.45 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.99 0.9 . . . . 0.0 110.018 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.64 152.57 39.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.649 0.737 . . . . 0.0 109.92 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.526 ' OG1' ' NZ ' ' A' ' 32' ' ' LYS . 96.1 m -120.57 132.59 55.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.776 0.798 . . . . 0.0 110.354 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.57 130.86 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.874 0.845 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.5 mm -87.22 124.85 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.771 0.796 . . . . 0.0 110.231 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -117.71 40.5 3.08 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -62.82 -39.93 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.598 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -81.26 152.81 27.44 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.75 0.786 . . . . 0.0 110.18 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.7 tt0 -70.48 -46.43 18.93 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.943 -0.473 . . . . 0.0 110.91 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 68.4 Cg_exo -52.52 -35.33 66.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.195 1.93 . . . . 0.0 111.512 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.88 -40.71 97.15 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -63.81 -41.95 97.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.644 -0.66 . . . . 0.0 109.512 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -59.36 -44.47 92.69 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.596 ' NH2' ' N ' ' A' ' 60' ' ' GLU . 83.3 mtp180 -66.23 -37.94 86.73 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -61.95 -46.6 88.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.74 -0.6 . . . . 0.0 109.84 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 97.5 mmm -62.76 -44.07 97.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.688 -0.632 . . . . 0.0 109.395 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -66.9 -41.74 86.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.309 0.576 . . . . 0.0 109.524 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 83.0 t80 -63.99 -44.91 91.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.359 0.6 . . . . 0.0 109.49 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.5 ttt -62.07 -41.66 98.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -67.15 -47.14 71.96 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.382 0.611 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.8 tpt85 -66.55 -44.56 81.99 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.844 -0.535 . . . . 0.0 109.657 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -63.14 -45.87 89.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.558 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.9 -34.54 90.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.12 92.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.806 -0.82 . . . . 0.0 109.338 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.39 -37.07 77.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -151.74 92.49 1.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.643 0.735 . . . . 0.0 109.847 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.12 98.35 0.26 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 108' ' ' PHE . 40.7 mt -77.12 148.57 35.96 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.773 0.797 . . . . 0.0 110.064 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.23 4.56 17.95 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' O ' ' OG ' ' A' ' 109' ' ' SER . 94.6 m-85 -133.4 -129.8 0.17 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.697 -0.884 . . . . 0.0 109.973 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 110' ' ' LYS . 5.0 p 70.58 -60.75 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.537 ' N ' ' OG ' ' A' ' 109' ' ' SER . 20.6 ptmt -127.86 -38.1 1.88 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 113' ' ' LEU . 86.8 p -74.0 163.46 27.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.715 -0.616 . . . . 0.0 110.405 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 67.36 -58.38 0.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 111' ' ' SER . 86.0 mt -63.43 -42.73 98.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.579 -0.701 . . . . 0.0 109.915 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -83.69 160.96 21.2 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.67 0.748 . . . . 0.0 110.399 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -66.22 129.32 39.42 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.537 0.684 . . . . 0.0 110.14 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -88.3 122.88 32.32 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.632 0.729 . . . . 0.0 110.289 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -113.37 133.51 55.12 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.867 0.842 . . . . 0.0 110.161 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -71.45 134.81 46.85 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.684 0.754 . . . . 0.0 110.263 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.574 ' HD1' ' HD1' ' A' ' 120' ' ' HIS . 48.5 t-80 -73.03 148.35 44.21 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.628 0.728 . . . . 0.0 110.129 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.574 ' HD1' ' HD1' ' A' ' 119' ' ' HIS . 51.3 p-80 . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.076 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.603 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 49.75 99.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.486 0.66 . . . . 0.0 109.696 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -148.28 157.25 43.37 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.807 0.813 . . . . 0.0 110.757 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.0 mt -109.31 131.4 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.51 0.671 . . . . 0.0 109.441 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -128.96 134.3 48.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.714 0.769 . . . . 0.0 109.624 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.83 -71.47 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' LYS . 44.9 m -107.0 122.95 47.46 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.863 0.84 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 7' ' ' SER . 25.8 mtmm 40.63 -168.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.818 0.818 . . . . 0.0 111.538 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.21 86.25 0.32 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -120.12 132.67 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.813 0.816 . . . . 0.0 109.632 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.77 143.66 46.42 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.6 0.714 . . . . 0.0 110.19 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' VAL . 48.6 tp10 -137.65 -77.57 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' GLU . 82.8 p 37.44 31.09 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.292 0.568 . . . . 0.0 110.217 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' GLU . 53.6 t -69.57 -19.93 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.725 -0.609 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.452 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 3.5 t 64.18 52.89 1.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.897 -0.502 . . . . 0.0 110.288 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 37.1 Cg_endo -65.14 150.81 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.617 2.211 . . . . 0.0 112.559 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.57 132.48 45.55 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.685 0.755 . . . . 0.0 110.211 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.491 ' H ' ' CD1' ' A' ' 106' ' ' LEU . 24.4 t -105.13 128.3 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.62 0.724 . . . . 0.0 109.764 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -134.14 136.48 43.86 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.733 0.778 . . . . 0.0 109.765 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 1.1 mm? -104.92 124.52 49.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.606 0.717 . . . . 0.0 109.668 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.4 m -132.65 153.4 51.13 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.159 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -105.05 152.53 22.63 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.873 0.844 . . . . 0.0 110.223 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.519 ' HG ' ' N ' ' A' ' 24' ' ' LYS . 19.0 t -52.15 176.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.746 0.784 . . . . 0.0 110.993 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.519 ' N ' ' HG ' ' A' ' 23' ' ' SER . 14.0 mptt -64.32 -42.3 96.39 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.71 -3.57 38.93 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.25 19.92 76.23 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -89.29 -4.45 58.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.788 -0.831 . . . . 0.0 109.073 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.7 m -146.22 121.19 10.02 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.705 0.764 . . . . 0.0 109.603 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.57 142.55 23.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.7 ptp -153.84 166.42 32.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.946 -0.738 . . . . 0.0 110.298 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.25 143.18 49.74 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -109.63 143.61 39.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.793 0.806 . . . . 0.0 110.335 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -123.57 135.9 54.24 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.58 0.705 . . . . 0.0 109.626 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -120.04 126.81 51.71 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.783 0.801 . . . . 0.0 109.606 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 77' ' ' ALA . 45.8 m-85 -108.21 119.29 39.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.464 0.65 . . . . 0.0 109.366 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.79 122.71 43.17 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.62 0.724 . . . . 0.0 109.939 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 40.71 56.74 8.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-O 121.036 0.446 . . . . 0.0 110.097 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.74 144.03 82.44 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.445 2.097 . . . . 0.0 112.783 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.537 ' C ' ' H ' ' A' ' 41' ' ' LEU . 26.4 m -69.32 -21.64 63.84 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.108 0.48 . . . . 0.0 110.018 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 tp -60.61 0.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.424 -0.797 . . . . 0.0 109.594 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.2 mt -89.67 -12.25 40.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.09 -14.16 17.9 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.13 -49.82 3.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.488 -0.758 . . . . 0.0 109.488 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.0 155.47 48.82 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.779 0.799 . . . . 0.0 110.024 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -72.99 160.03 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 110.396 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -66.37 -34.55 78.23 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.39 -17.67 61.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.738 -0.601 . . . . 0.0 109.865 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -85.29 -1.7 57.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.11 123.78 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.448 -0.782 . . . . 0.0 110.391 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -119.52 91.85 3.65 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.802 0.81 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.24 54.37 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.7 ttp -134.19 132.22 39.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.917 -0.755 . . . . 0.0 109.643 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -106.5 110.65 22.92 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.911 0.862 . . . . 0.0 109.759 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.87 114.0 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.391 0.615 . . . . 0.0 109.483 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -111.42 129.72 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.63 0.729 . . . . 0.0 109.633 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 96' ' ' PHE . 99.0 m-20 -134.8 -80.88 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 59' ' ' GLY . 67.3 t0 -144.81 98.2 3.15 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.617 -0.677 . . . . 0.0 109.517 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 97.2 mt-10 65.05 -42.72 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.385 0.612 . . . . 0.0 109.684 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -87.43 137.35 14.55 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -143.26 144.45 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.897 -0.766 . . . . 0.0 109.99 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.2 132.97 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.548 0.69 . . . . 0.0 109.243 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.03 132.21 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.683 0.754 . . . . 0.0 109.804 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.7 m -117.86 122.35 43.12 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.782 0.801 . . . . 0.0 109.5 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -95.48 1.23 53.91 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.7 mp0 -96.25 71.07 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.03 132.87 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.653 0.739 . . . . 0.0 109.718 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -134.29 141.87 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.936 0.874 . . . . 0.0 109.826 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.73 142.21 28.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 22.8 tptt -109.47 119.9 40.85 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.788 0.804 . . . . 0.0 109.183 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.58 124.07 49.92 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.646 0.736 . . . . 0.0 109.811 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 95.6 mt -114.2 139.32 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.591 0.71 . . . . 0.0 109.304 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.8 m120 60.33 32.42 20.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.468 0.652 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.95 31.38 80.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -158.78 152.04 18.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 O-C-N 121.63 -0.924 . . . . 0.0 109.769 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -51.54 141.18 43.11 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.9 m -161.68 -35.63 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.512 -0.742 . . . . 0.0 109.874 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 35' ' ' PHE . . . -154.27 171.22 19.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 0.0 110.7 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 78' ' ' ILE . 96.4 mt -133.63 128.06 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.561 0.696 . . . . 0.0 109.331 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.478 ' OE1' ' NZ ' ' A' ' 69' ' ' LYS . 81.5 tt0 -109.4 143.82 38.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.644 0.735 . . . . 0.0 109.447 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.1 148.76 30.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.681 -0.637 . . . . 0.0 109.9 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -122.75 129.27 51.56 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.47 112.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.921 0.867 . . . . 0.0 109.296 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.5 mp -82.6 128.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.504 0.668 . . . . 0.0 109.768 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.6 mt -118.31 62.86 0.76 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.59 -38.82 90.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.73 -0.606 . . . . 0.0 109.544 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -62.08 148.42 44.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.457 -0.777 . . . . 0.0 110.212 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.428 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 1.8 mp0 -76.53 -62.28 0.68 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.982 -0.449 . . . . 0.0 110.479 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 87' ' ' GLN . 12.1 Cg_endo -57.25 -26.77 71.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.078 1.852 . . . . 0.0 111.522 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -67.01 -35.55 80.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.888 -0.508 . . . . 0.0 109.665 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -44.79 96.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.754 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.93 -47.81 83.23 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.214 0.531 . . . . 0.0 110.043 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -64.7 -42.13 95.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.592 -0.693 . . . . 0.0 110.062 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -61.66 -42.72 99.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.733 -0.604 . . . . 0.0 109.755 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 tpt -62.54 -39.23 92.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.625 -0.672 . . . . 0.0 109.764 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.8 -45.78 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.707 -0.621 . . . . 0.0 110.104 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.441 ' CD1' ' OD2' ' A' ' 56' ' ' ASP . 37.6 m-85 -68.7 -37.64 79.68 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 29.9 mmt -64.58 -39.77 94.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.18 -46.08 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.647 . . . . 0.0 109.865 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -67.09 -41.95 85.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.52 ' CD1' ' OD1' ' A' ' 104' ' ' ASN . 54.4 t80 -61.72 -45.9 91.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.574 -0.704 . . . . 0.0 110.027 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -63.24 -36.03 92.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.4 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -1.126 . . . . 0.0 109.026 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.28 -42.92 68.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.52 ' OD1' ' CD1' ' A' ' 100' ' ' TYR . 13.8 m120 -80.73 -75.69 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.354 0.597 . . . . 0.0 109.466 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 101' ' ' GLY . . . 92.61 46.24 3.51 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 106' ' ' LEU . 3.3 mm? 41.25 98.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.985 -0.715 . . . . 0.0 110.326 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 106' ' ' LEU . . . -39.72 100.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -64.64 -43.76 92.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.879 -0.777 . . . . 0.0 109.625 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' LYS . 55.2 p -162.06 50.38 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.564 -0.71 . . . . 0.0 109.519 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 111' ' ' SER . 51.7 mtmt 41.42 -168.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.713 0.768 . . . . 0.0 111.183 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 113' ' ' LEU . 2.0 m 55.2 158.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.188 0.518 . . . . 0.0 110.755 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 61.35 -63.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.39 0.614 . . . . 0.0 110.203 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 111' ' ' SER . 56.9 mt -62.08 -41.46 98.21 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.566 -0.709 . . . . 0.0 109.908 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -55.78 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.564 -0.71 . . . . 0.0 109.943 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -81.02 137.28 36.06 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.746 0.784 . . . . 0.0 110.28 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -147.4 141.46 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.573 0.701 . . . . 0.0 109.795 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -104.99 130.91 53.09 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.804 0.811 . . . . 0.0 110.057 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -101.55 132.75 47.03 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.558 0.694 . . . . 0.0 109.755 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -105.39 135.12 47.35 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.66 0.743 . . . . 0.0 110.042 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.381 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.745 ' H2 ' HH21 ' A' ' 99' ' ' ARG . 4.4 mpp? . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.421 0.629 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.57 147.91 0.68 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.78 0.8 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -154.47 135.02 13.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.797 0.808 . . . . 0.0 110.276 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.2 mt -119.2 128.61 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.687 0.756 . . . . 0.0 109.698 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.585 HE22 ' H ' ' A' ' 9' ' ' GLY . 2.4 pt20 -153.63 159.51 42.11 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.676 0.75 . . . . 0.0 109.773 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -89.96 -1.57 58.0 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.584 ' HG ' ' N ' ' A' ' 8' ' ' LYS . 18.4 p -145.99 -134.07 0.08 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.376 -0.827 . . . . 0.0 110.001 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.584 ' N ' ' HG ' ' A' ' 7' ' ' SER . 8.6 mtmp? -146.52 102.2 3.55 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.874 0.845 . . . . 0.0 109.948 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.585 ' H ' HE22 ' A' ' 5' ' ' GLN . . . 104.91 3.65 42.37 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.455 ' O ' ' C ' ' A' ' 11' ' ' ALA . 11.6 p -96.18 20.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.766 -0.844 . . . . 0.0 109.446 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 10' ' ' VAL . . . -33.21 112.44 0.12 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.686 0.755 . . . . 0.0 110.746 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' ' OG1' ' A' ' 13' ' ' THR . 92.4 mt-10 -94.52 -8.01 39.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 43.8 p 53.26 14.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.405 0.621 . . . . 0.0 109.56 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.8 t -69.33 155.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.651 0.739 . . . . 0.0 110.556 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -115.36 84.88 12.26 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.68 153.33 26.3 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.943 2.429 . . . . 0.0 112.468 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.11 150.26 25.66 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.038 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 100.0 t -124.25 132.53 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.641 0.734 . . . . 0.0 109.837 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -131.65 139.76 49.18 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.853 0.835 . . . . 0.0 109.721 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 3.9 mm? -96.43 144.02 26.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.674 0.749 . . . . 0.0 110.035 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -155.69 170.45 22.0 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.74 0.781 . . . . 0.0 109.882 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 24' ' ' LYS . 52.0 mtmt -141.46 124.27 16.1 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.684 0.754 . . . . 0.0 109.914 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 25' ' ' ASN . 33.6 t 36.89 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.321 0.581 . . . . 0.0 110.142 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 22' ' ' LYS . 69.6 mmtt 58.91 1.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 23' ' ' SER . 4.8 p30 -153.28 -53.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 25' ' ' ASN . . . 149.95 98.16 0.18 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -172.79 -27.68 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.629 -0.924 . . . . 0.0 108.997 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -151.52 161.07 43.33 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.96 0.886 . . . . 0.0 110.045 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.97 139.91 37.13 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.1 ttm -155.2 151.57 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.003 0.906 . . . . 0.0 110.212 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 131.34 23.51 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -114.05 132.56 55.97 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.846 0.831 . . . . 0.0 109.991 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -116.69 132.27 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -115.89 118.94 34.37 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -109.68 119.84 40.64 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.531 1.158 . . . . 0.0 109.915 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.36 113.78 25.87 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.011 0.91 . . . . 0.0 110.146 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 50.87 75.14 0.69 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.588 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' O ' ' N ' ' A' ' 40' ' ' ILE . 4.3 Cg_endo -82.13 15.13 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.808 2.338 . . . . 0.0 111.178 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' PRO . 4.1 p 39.63 22.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.266 0.555 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' PRO . 18.5 tt -92.79 -1.44 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.1 -18.56 20.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.91 -35.08 6.73 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.84 141.25 31.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.38 -0.825 . . . . 0.0 110.032 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -77.84 167.29 21.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.732 0.777 . . . . 0.0 109.928 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -64.83 -32.11 73.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.94 -35.44 80.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.86 -19.15 63.45 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 49' ' ' ILE . 96.9 mt -91.85 124.35 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.456 -0.778 . . . . 0.0 109.538 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.53 12.91 1.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.7 175.15 46.37 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 18.0 ttm -137.12 144.42 43.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.702 -0.881 . . . . 0.0 109.433 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -108.9 113.18 25.87 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.925 0.869 . . . . 0.0 109.898 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.06 114.69 26.52 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.52 0.676 . . . . 0.0 109.336 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 55' ' ' ILE . 2.0 mp -99.17 109.4 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.776 0.798 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 96.1 m-20 -88.84 -87.85 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 66.2 m-20 -159.37 -62.23 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 109.246 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -104.22 13.96 31.27 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.14 -0.975 . . . . 0.0 108.614 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.42 174.02 45.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -147.95 147.73 30.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.57 -0.959 . . . . 0.0 109.823 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.3 131.44 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.652 0.739 . . . . 0.0 109.68 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.37 131.35 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.514 0.673 . . . . 0.0 109.441 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -125.24 131.15 53.18 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.839 0.828 . . . . 0.0 109.975 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -92.53 3.63 55.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -90.53 73.12 6.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.43 133.07 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.749 0.785 . . . . 0.0 109.521 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -133.83 142.88 48.03 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.746 0.784 . . . . 0.0 109.947 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.79 149.8 21.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -110.05 131.08 55.38 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.956 0.884 . . . . 0.0 109.67 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.75 125.41 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.53 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 96.8 mt -123.15 133.13 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.798 0.809 . . . . 0.0 109.572 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 71' ' ' ILE . 4.6 p30 58.33 25.76 13.17 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.888 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.32 31.37 16.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.137 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -168.81 150.52 4.63 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.073 -1.251 . . . . 0.0 110.588 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.8 87.49 0.44 Allowed 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.207 2.605 . . . . 0.0 112.257 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -104.68 -14.62 15.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.716 -0.615 . . . . 0.0 109.74 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.08 151.66 44.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.27 135.82 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.499 0.666 . . . . 0.0 109.982 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -126.28 164.45 21.0 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.947 0.879 . . . . 0.0 110.202 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.2 37.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.77 0.795 . . . . 0.0 109.634 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.0 m -124.97 127.21 46.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.67 0.748 . . . . 0.0 109.545 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.8 t -114.89 132.42 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.874 0.845 . . . . 0.0 109.81 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.42 HD12 HG23 ' A' ' 83' ' ' ILE . 24.3 mm -94.79 123.91 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.707 0.765 . . . . 0.0 109.825 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.5 mt -110.66 75.53 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -96.85 1.92 51.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -116.82 143.55 45.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.991 0.901 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 mt-30 -66.51 -48.57 55.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.633 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.6 Cg_exo -51.9 -38.25 68.15 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.866 1.71 . . . . 0.0 111.133 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -66.73 -39.5 88.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -63.29 -37.87 88.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.71 -0.619 . . . . 0.0 109.787 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.35 -50.94 71.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.664 -0.647 . . . . 0.0 109.853 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -75.35 -39.29 59.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.743 -0.598 . . . . 0.0 109.921 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -64.22 -44.79 90.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.508 -0.745 . . . . 0.0 109.221 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.1 tpp -60.72 -46.94 88.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -66.09 -40.57 90.92 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.273 0.558 . . . . 0.0 109.513 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 86.4 t80 -63.21 -44.24 95.88 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 11.3 tpt -62.6 -39.79 94.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.619 -0.675 . . . . 0.0 109.54 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -66.08 -52.73 46.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.759 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.745 HH21 ' H2 ' ' A' ' 1' ' ' MET . 83.4 mtp180 -66.34 -44.75 82.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -63.4 -46.99 83.89 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.419 0.628 . . . . 0.0 109.342 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.57 88.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.85 83.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.646 -0.914 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.63 -55.7 6.45 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -177.87 -160.69 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.748 0.785 . . . . 0.0 109.832 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.22 14.88 53.38 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' A' ' 106' ' ' LEU . 10.5 mp -85.08 3.73 37.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.66 -0.906 . . . . 0.0 109.138 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.82 -137.23 13.22 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 54.07 167.64 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.887 -0.772 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.2 t -66.2 140.17 58.16 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.937 0.875 . . . . 0.0 110.643 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -77.4 143.23 38.8 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.715 0.769 . . . . 0.0 110.887 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 112' ' ' GLU . 0.7 OUTLIER 172.79 -84.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.442 0.639 . . . . 0.0 109.82 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.453 ' N ' ' OG ' ' A' ' 111' ' ' SER . 96.0 mt-10 -85.37 -12.43 52.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 109.728 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.48 -34.26 76.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.635 -0.666 . . . . 0.0 110.107 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.42 -42.42 99.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.425 -0.797 . . . . 0.0 109.399 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' A' ' 116' ' ' HIS . 70.1 t60 -153.13 -130.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.681 0.753 . . . . 0.0 109.756 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.685 ' H ' ' CG ' ' A' ' 115' ' ' HIS . 58.0 t-80 -158.96 -60.06 0.07 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.52 -0.738 . . . . 0.0 109.058 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -77.95 141.47 38.97 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.885 0.85 . . . . 0.0 110.581 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -81.18 -3.3 51.78 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -59.19 -41.22 87.98 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.399 0.619 . . . . 0.0 109.567 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.904 -179.658 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.544 0.688 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -155.75 163.08 40.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.85 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.1 mt -108.52 130.51 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.632 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 98.1 mt-30 -129.43 135.02 48.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.495 -0.753 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -95.54 -10.36 29.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.559 -0.713 . . . . 0.0 109.161 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LYS . 22.7 m -150.64 22.56 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.171 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 7' ' ' SER . 23.8 mtmm 56.53 120.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.806 0.812 . . . . 0.0 110.909 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.632 ' H ' ' NE2' ' A' ' 5' ' ' GLN . . . 99.13 -16.72 58.98 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.52 97.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -1.105 . . . . 0.0 109.611 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 131.73 40.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.641 -0.662 . . . . 0.0 109.874 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.87 122.39 47.73 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.618 0.723 . . . . 0.0 109.758 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -91.7 -3.74 55.92 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 15' ' ' VAL . 54.3 t -51.53 157.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.503 -0.748 . . . . 0.0 110.156 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.434 ' N ' HG12 ' A' ' 14' ' ' VAL . 60.0 t -115.68 80.97 8.77 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.599 -0.688 . . . . 0.0 110.069 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.33 151.64 29.82 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.795 2.33 . . . . 0.0 112.346 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -87.22 152.72 22.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 109.713 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.09 130.14 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.483 0.659 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -132.6 145.72 51.32 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -102.19 140.43 36.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.509 -0.744 . . . . 0.0 109.625 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.6 m -152.25 167.06 29.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -105.25 166.95 10.05 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.603 0.716 . . . . 0.0 109.812 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.706 0.765 . . . . 0.0 110.439 -179.374 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.428 ' CB ' ' OD1' ' A' ' 85' ' ' ASN . 22.1 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.696 0.76 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 162.01 43.45 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.1 ptm -159.87 171.56 19.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.531 -0.982 . . . . 0.0 109.227 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.79 148.9 48.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.487 -0.758 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.42 148.12 31.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.71 -0.619 . . . . 0.0 109.666 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.81 136.2 52.06 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.25 123.49 50.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.797 -0.564 . . . . 0.0 109.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -111.31 122.83 48.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.3 tp -103.67 124.95 49.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.776 0.798 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.409 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 56.4 mt-10 42.5 54.89 9.83 Favored Pre-proline 0 N--CA 1.492 1.665 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -66.79 149.33 83.49 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.264 1.976 . . . . 0.0 111.947 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' LEU . 66.9 p -74.43 -19.9 60.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' HA ' HD12 ' A' ' 40' ' ' ILE . 9.2 tp -59.96 0.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.734 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 39' ' ' THR . 94.1 mt -90.93 -9.66 45.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.955 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.36 -24.95 13.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 109.418 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -93.59 -73.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.248 -0.907 . . . . 0.0 109.977 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -104.36 148.11 26.76 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.824 0.821 . . . . 0.0 110.704 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.7 m -71.8 156.15 39.63 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.728 0.775 . . . . 0.0 110.449 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -65.86 -32.65 74.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.647 -0.658 . . . . 0.0 109.628 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -75.1 -8.05 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.688 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.89 -3.37 54.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 94.0 mt -95.47 122.94 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.943 . . . . 0.0 109.802 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.1 m -121.31 -3.12 9.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -172.97 170.39 43.53 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.637 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.514 ' SD ' ' HB2' ' A' ' 80' ' ' ALA . 63.1 mtp -128.17 143.82 51.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.711 -0.876 . . . . 0.0 109.076 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.86 108.78 19.7 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.515 0.674 . . . . 0.0 109.785 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 55' ' ' ILE . 78.3 mt -93.59 110.28 21.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -98.05 111.81 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.05 176.91 6.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.603 0.716 . . . . 0.0 109.885 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.06 -39.08 93.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -88.91 -76.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.94 10.81 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 pm0 -142.79 153.73 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.635 -0.92 . . . . 0.0 109.108 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.452 HD13 ' OE2' ' A' ' 89' ' ' GLU . 96.4 mt -119.22 135.5 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.491 -0.756 . . . . 0.0 109.939 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -100.12 126.9 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.733 . . . . 0.0 109.447 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.6 m -121.76 125.21 46.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -108.26 -6.25 16.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.09 78.64 7.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.474 -0.766 . . . . 0.0 109.056 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.7 t -121.86 133.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.714 -0.616 . . . . 0.0 109.715 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.22 142.9 50.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.495 0.664 . . . . 0.0 109.73 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.63 143.26 16.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.14 106.73 17.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.896 . . . . 0.0 108.667 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.55 143.81 30.29 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.371 0.605 . . . . 0.0 110.239 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.35 109.16 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 53.98 35.88 23.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 110.079 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.85 78.75 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -121.57 99.25 45.31 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.963 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.86 130.4 30.9 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.339 2.026 . . . . 0.0 112.561 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m -152.83 -29.9 0.14 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.644 -0.66 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.18 154.08 51.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.218 -0.926 . . . . 0.0 110.726 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.75 143.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 14.3 tm-20 -119.94 150.22 40.85 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.58 0.705 . . . . 0.0 109.909 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HB2' ' SD ' ' A' ' 52' ' ' MET . . . -139.4 145.35 38.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.7 m -125.29 132.62 52.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.698 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.08 130.48 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.667 -0.646 . . . . 0.0 109.307 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 32.3 mm -93.34 128.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.791 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.3 mt -108.4 55.3 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' CB ' ' A' ' 28' ' ' SER . 86.0 m-20 -64.34 -40.65 96.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.616 -0.677 . . . . 0.0 109.31 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 m -84.27 154.96 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 0.0 110.452 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.9 mp0 -74.89 -59.43 1.42 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.799 -0.563 . . . . 0.0 110.914 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 2.8 Cg_endo -48.51 -17.48 1.05 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.713 1.608 . . . . 0.0 111.266 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.452 ' OE2' HD13 ' A' ' 61' ' ' ILE . 34.1 tp10 -64.9 -37.02 86.24 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.27 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -60.61 -36.52 78.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.487 -0.758 . . . . 0.0 109.815 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -58.32 -47.0 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.509 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.35 -39.9 81.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -62.28 -47.89 82.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 110.39 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.7 mmm -64.05 -43.21 96.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.637 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.45 -43.67 89.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.778 . . . . 0.0 109.624 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -61.54 -47.67 84.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 tpt -65.71 -41.0 92.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -63.01 -53.16 58.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.702 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -68.99 -43.34 75.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.434 -0.791 . . . . 0.0 110.16 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -62.67 -46.01 90.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.96 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.03 -36.23 93.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.43 95.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 0.0 109.649 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.83 -43.59 71.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.875 . . . . 0.0 109.422 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.639 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 120.922 0.392 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -124.61 134.12 53.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.473 -0.767 . . . . 0.0 108.991 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.39 128.84 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -141.06 150.21 42.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.33 -0.856 . . . . 0.0 109.826 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.66 -7.78 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 8' ' ' LYS . 9.9 t -155.21 80.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.37 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.7 mttm 43.14 -168.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.708 0.766 . . . . 0.0 111.229 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.27 88.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 75.0 t -78.01 -94.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -1.055 . . . . 0.0 109.221 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 175.67 55.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.445 -0.784 . . . . 0.0 108.935 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -163.67 121.49 1.86 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.6 m -93.33 88.87 6.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.953 . . . . 0.0 109.279 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.6 t -78.64 135.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.592 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.94 80.88 15.1 Favored Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 109.754 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.72 158.73 24.89 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.733 2.289 . . . . 0.0 112.406 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.94 159.5 28.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.881 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -109.1 128.77 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.6 -0.687 . . . . 0.0 109.387 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -135.18 135.21 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt -102.28 135.74 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.426 -0.796 . . . . 0.0 109.735 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.09 129.42 45.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 110.503 -178.814 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.43 0.633 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.07 139.85 25.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.4 ptt? -162.19 165.16 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -1.128 . . . . 0.0 108.865 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.36 140.33 50.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 109.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.99 145.3 32.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.235 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -117.38 133.78 55.58 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -104.0 125.37 50.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.602 -0.686 . . . . 0.0 109.869 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.2 114.82 28.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.8 tp -97.58 121.64 39.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 109.611 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' LEU . 49.6 mt-10 39.35 58.88 6.3 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.74 -0.6 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.0 Cg_endo -63.81 145.14 90.36 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.514 2.143 . . . . 0.0 112.532 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 p -81.35 26.78 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.069 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 40' ' ' ILE . 10.5 tp -102.73 -21.99 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.14 -41.1 97.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.88 76.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.54 -0.725 . . . . 0.0 109.582 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -88.45 -65.65 1.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.041 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.26 143.0 45.15 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.7 t -80.27 167.8 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.438 0.637 . . . . 0.0 110.098 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -65.01 -36.0 82.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 109.774 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -64.8 -39.1 93.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.814 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.02 -34.85 79.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.097 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.63 126.0 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 0.0 110.005 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 m -126.14 -0.17 7.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.97 -175.29 36.96 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.451 ' CE ' HD21 ' A' ' 54' ' ' LEU . 63.0 ttp -135.47 136.22 41.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.514 -0.992 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.421 ' CE2' HD12 ' A' ' 62' ' ' ILE . 92.4 m-85 -106.31 116.8 32.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.452 -0.78 . . . . 0.0 109.417 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.451 HD21 ' CE ' ' A' ' 52' ' ' MET . 91.6 mt -96.89 115.06 26.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.893 . . . . 0.0 108.907 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 55' ' ' ILE . 3.3 mp -108.53 132.75 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.406 0.622 . . . . 0.0 109.713 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 99' ' ' ARG . 36.1 t0 -125.49 43.68 3.0 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.456 ' H ' HG22 ' A' ' 55' ' ' ILE . 66.9 m-20 54.86 5.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.808 -0.558 . . . . 0.0 109.619 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 56' ' ' ASP . 97.8 mt-10 -146.75 -105.46 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.514 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.23 164.36 52.58 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.29 153.27 47.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.27 -1.135 . . . . 0.0 110.232 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.4 135.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' CE2' ' A' ' 53' ' ' TYR . 37.2 mm -104.37 125.57 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.386 -0.821 . . . . 0.0 109.177 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.8 m -123.13 124.44 43.08 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -100.56 -9.26 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.18 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -83.38 75.74 9.96 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.234 -0.916 . . . . 0.0 109.275 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.03 134.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.553 -0.717 . . . . 0.0 109.724 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -126.37 138.97 53.62 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.96 136.1 12.58 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.66 125.43 49.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.495 -1.003 . . . . 0.0 109.144 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -109.05 144.21 37.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.757 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 90.8 mt -120.27 129.44 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 m120 57.54 32.45 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -0.759 . . . . 0.0 109.285 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.89 22.75 75.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -136.88 127.93 16.47 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.296 -1.12 . . . . 0.0 109.704 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.21 136.19 30.89 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.078 1.852 . . . . 0.0 112.539 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -154.34 -34.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.712 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.66 152.32 42.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.023 . . . . 0.0 110.248 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 79' ' ' GLU . 94.0 mt -130.86 163.51 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 78' ' ' ILE . 45.5 tt0 -142.01 151.82 42.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.1 141.65 36.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.0 m -119.79 129.45 54.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.569 -0.707 . . . . 0.0 109.702 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.29 129.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.5 0.667 . . . . 0.0 109.518 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.2 mp -81.97 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.594 -0.691 . . . . 0.0 110.156 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 71.4 mt -119.07 40.12 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.95 -40.32 97.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -0.836 . . . . 0.0 109.497 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.0 139.84 41.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.016 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 4.2 mm-40 -66.32 -40.63 36.4 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.73 . . . . 0.0 110.403 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.9 Cg_exo -58.88 -33.08 98.44 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.029 1.819 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -67.11 -38.27 85.32 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.441 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 46.5 m95 -61.22 -41.82 97.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.18 -47.15 87.51 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -70.15 -42.09 72.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.487 -0.758 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -61.54 -45.83 92.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 84.9 mmm -64.78 -41.79 95.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.031 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NH1' ' CZ ' ' A' ' 99' ' ' ARG . 70.2 ttp85 -64.62 -41.36 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.581 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.553 ' CD1' ' NH2' ' A' ' 99' ' ' ARG . 3.2 m-85 -59.63 -42.66 93.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.785 . . . . 0.0 109.008 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.42 ' SD ' ' C ' ' A' ' 97' ' ' MET . 11.0 tmm? -61.7 -39.69 92.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.491 -0.755 . . . . 0.0 110.017 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.96 -48.34 82.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.052 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' CD1' ' A' ' 96' ' ' PHE . 88.8 mtm180 -66.03 -37.77 86.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.205 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.446 ' CE1' ' OD1' ' A' ' 104' ' ' ASN . 90.6 t80 -60.67 -44.97 95.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.43 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.82 92.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -1.073 . . . . 0.0 109.603 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -84.96 -10.25 57.25 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.446 ' OD1' ' CE1' ' A' ' 100' ' ' TYR . 31.4 m120 . . . . . 0 N--CA 1.499 2.005 0 O-C-N 121.349 -0.845 . . . . 0.0 109.473 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.142 0.496 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -154.83 161.81 41.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.373 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.618 -0.676 . . . . 0.0 109.524 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -154.37 154.91 34.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.122 -0.986 . . . . 0.0 109.43 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -86.24 -4.52 59.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 t -167.82 147.09 4.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 109.285 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -65.21 138.82 58.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.54 -12.53 64.69 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 85.0 t -112.33 127.21 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.597 -0.943 . . . . 0.0 110.077 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 168.85 96.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' VAL . 51.1 tp10 -168.6 130.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.226 -0.921 . . . . 0.0 109.158 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m 70.08 -9.41 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.635 -0.666 . . . . 0.0 109.373 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.446 ' H ' ' C ' ' A' ' 12' ' ' GLU . 6.6 t -80.98 130.27 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.6 t -142.59 83.5 11.75 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.253 -0.905 . . . . 0.0 108.722 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -79.69 145.62 18.32 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.392 2.061 . . . . 0.0 112.867 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -89.3 157.71 18.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.239 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.62 130.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 0.0 109.084 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -132.28 143.04 49.62 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.493 -0.755 . . . . 0.0 109.167 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.3 mt -103.72 132.55 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.421 -0.8 . . . . 0.0 108.918 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.9 m -129.81 153.6 48.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -109.02 143.95 37.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.524 -0.735 . . . . 0.0 109.108 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.484 ' CB ' ' OG ' ' A' ' 28' ' ' SER . 67.1 m . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.735 0.779 . . . . 0.0 110.992 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.484 ' OG ' ' CB ' ' A' ' 23' ' ' SER . 23.8 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.379 0.609 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.42 146.89 21.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.2 ttp -152.17 159.0 43.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -1.131 . . . . 0.0 109.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.23 150.09 36.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.9 145.66 46.49 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 0.0 109.88 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.41 137.24 54.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -119.42 127.22 52.9 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.4 122.17 46.79 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' GLU . 40.2 tp -93.45 125.5 38.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.497 -0.752 . . . . 0.0 110.009 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LEU . 30.9 mt-10 40.32 71.85 1.15 Allowed Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.756 -0.59 . . . . 0.0 110.551 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.23 142.85 97.67 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.829 2.353 . . . . 0.0 111.997 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.8 p -86.25 -17.3 35.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -70.61 1.79 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.917 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.58 -7.36 59.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 109.207 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.11 -23.96 16.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.333 -0.855 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -99.73 -73.18 0.64 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.466 -0.771 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.55 159.52 15.68 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.478 -0.763 . . . . 0.0 110.066 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -81.33 168.73 18.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -66.64 -37.28 84.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.554 -0.716 . . . . 0.0 109.804 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.27 -24.11 62.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -76.68 -5.54 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.572 -0.705 . . . . 0.0 109.706 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.3 mt -88.11 -87.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 m 66.94 -40.36 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -103.09 144.2 15.95 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -126.05 129.87 50.01 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -102.94 119.96 39.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.349 -0.845 . . . . 0.0 110.009 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 55' ' ' ILE . 24.7 mt -102.78 113.7 27.34 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.759 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -98.47 103.23 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 94.5 m-20 -95.12 176.24 6.31 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.644 0.735 . . . . 0.0 110.597 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.0 -36.61 84.96 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.729 -0.607 . . . . 0.0 109.786 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.19 -77.4 0.33 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.292 -0.88 . . . . 0.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.74 -145.52 6.79 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.66 153.51 43.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.394 -1.063 . . . . 0.0 109.799 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.04 133.25 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.4 mm -107.47 128.79 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 109.305 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 65' ' ' GLU . 53.2 m -123.84 127.86 48.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.448 0.642 . . . . 0.0 109.691 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -96.03 -3.71 44.38 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' H ' HG22 ' A' ' 63' ' ' THR . 96.2 mt-10 -86.36 83.53 7.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 109.541 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.16 133.58 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -127.49 137.89 52.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.571 -0.705 . . . . 0.0 109.25 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.88 138.08 13.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -105.86 105.81 16.03 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -98.82 147.15 25.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.226 0.536 . . . . 0.0 109.595 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 41.5 mm -125.24 135.66 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 12.2 p30 -38.89 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.697 0.761 . . . . 0.0 110.48 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 147.63 -60.77 0.46 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -175.26 154.53 1.66 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.184 -1.186 . . . . 0.0 109.43 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.33 129.98 8.68 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.745 1.63 . . . . 0.0 112.056 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.1 p -113.7 -35.07 5.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.686 -0.634 . . . . 0.0 109.604 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.39 169.41 22.03 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.363 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.54 128.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -111.18 150.07 30.03 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.518 0.675 . . . . 0.0 109.668 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.91 38.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -113.46 129.24 56.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.55 132.33 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.398 -0.814 . . . . 0.0 109.018 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.6 mm -92.59 127.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.856 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 78.6 mt -113.28 40.59 2.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.45 -39.72 94.31 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.491 0.663 . . . . 0.0 109.691 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.3 m -66.32 150.04 49.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 110.487 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.493 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 4.1 mp0 -73.04 -57.48 2.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.878 -0.514 . . . . 0.0 110.152 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 12.7 Cg_endo -54.02 -34.9 79.23 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.777 1.652 . . . . 0.0 111.35 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.66 -39.08 88.03 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.156 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -63.14 -44.82 94.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 108.933 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.11 -43.35 99.03 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.435 -0.791 . . . . 0.0 109.14 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.6 -42.39 95.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.083 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -59.76 -46.86 87.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.513 -0.742 . . . . 0.0 109.634 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.8 tpp -60.75 -46.42 90.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -65.09 -42.72 93.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.212 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.462 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 73.5 t80 -62.12 -43.82 98.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.28 -42.7 91.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.435 -0.791 . . . . 0.0 109.938 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.05 -47.08 75.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 110.137 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -67.91 -42.71 80.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.083 -1.011 . . . . 0.0 110.015 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 104' ' ' ASN . 89.6 t80 -62.05 -46.23 90.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.427 -0.795 . . . . 0.0 110.346 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.61 -36.33 93.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.422 ' HB3' ' OE1' ' A' ' 103' ' ' GLU . . . -60.65 -46.39 90.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.99 -1.3 . . . . 0.0 109.058 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -69.67 -50.35 44.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' TYR . 53.3 p30 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.445 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.67 0.747 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.9 145.39 37.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.305 -0.872 . . . . 0.0 109.727 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 88.2 mt -108.18 127.29 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 110.0 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -152.28 158.68 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.534 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -103.99 -35.68 8.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -129.66 151.47 50.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.36 139.08 57.17 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.764 0.792 . . . . 0.0 110.717 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.09 28.94 26.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -111.15 133.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.441 -1.035 . . . . 0.0 109.844 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 142.71 52.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.849 0.833 . . . . 0.0 110.455 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 1.2 pm0 -101.32 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 p -95.03 -9.03 35.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.38 -0.825 . . . . 0.0 109.187 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -71.5 134.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.84 82.13 12.77 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.569 -0.707 . . . . 0.0 110.051 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.78 151.25 24.59 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.965 2.444 . . . . 0.0 112.459 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 56.2 mp0 -91.69 153.81 19.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.68 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' A' ' 33' ' ' PHE . 60.7 t -116.87 133.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.417 0.627 . . . . 0.0 109.569 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.481 ' NH2' ' OE2' ' A' ' 79' ' ' GLU . 90.5 mtm-85 -121.71 140.52 52.21 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.49 110.61 23.01 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.668 0.747 . . . . 0.0 109.295 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 86.3 p -83.82 168.34 16.24 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.706 -0.621 . . . . 0.0 109.815 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -111.37 122.51 48.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.823 0.821 . . . . 0.0 109.824 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 28' ' ' SER . 2.9 p . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 23' ' ' SER . 27.9 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.482 0.658 . . . . 0.0 109.75 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 141.17 41.8 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -162.91 168.95 20.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -1.102 . . . . 0.0 110.189 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.09 146.73 45.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -104.31 148.96 25.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.541 -0.724 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.543 ' CE2' HG22 ' A' ' 18' ' ' VAL . 30.1 m-85 -117.66 129.92 56.04 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.99 123.48 43.32 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.53 0.681 . . . . 0.0 109.848 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.71 126.59 55.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.5 tp -117.29 117.97 30.99 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.341 0.591 . . . . 0.0 110.364 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 39' ' ' THR . 95.5 mt-10 31.91 70.4 0.71 Allowed Pre-proline 0 N--CA 1.497 1.905 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -65.53 12.48 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.769 2.313 . . . . 0.0 110.97 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.8 m 67.7 -3.35 1.15 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.415 0.626 . . . . 0.0 109.462 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 38' ' ' PRO . 20.3 tt -86.03 -0.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.27 -9.81 59.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 109.208 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.9 -18.92 21.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.898 . . . . 0.0 109.253 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -107.73 -41.76 4.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.502 -0.749 . . . . 0.0 109.82 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 48' ' ' ASP . 79.3 mm-40 -136.0 138.11 41.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.325 -0.859 . . . . 0.0 110.253 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -77.23 168.89 19.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.855 0.836 . . . . 0.0 110.521 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -64.8 -32.47 74.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.697 . . . . 0.0 109.713 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -65.22 -36.71 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.299 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.415 ' OD2' ' OE1' ' A' ' 44' ' ' GLU . 62.4 m-20 -64.41 -36.27 83.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 108.928 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.64 129.07 37.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.41 -0.807 . . . . 0.0 109.966 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 t -144.77 49.06 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' N ' HG21 ' A' ' 66' ' ' VAL . . . 163.57 162.92 15.24 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.4 ttp -129.31 131.02 46.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.944 . . . . 0.0 108.932 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 53' ' ' TYR . 29.6 m-85 -108.6 109.62 20.88 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.76 0.791 . . . . 0.0 110.127 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 55' ' ' ILE . 75.1 mt -100.58 121.72 42.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.756 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.5 mp -105.42 113.7 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.342 -0.848 . . . . 0.0 109.52 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 86.7 m-20 -92.39 171.98 8.69 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.459 0.647 . . . . 0.0 110.148 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' OD2' ' CZ ' ' A' ' 99' ' ' ARG . 39.6 p-10 -79.01 -4.76 51.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.877 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.44 -18.15 5.83 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ASP . . . -173.89 -151.06 7.97 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -152.34 145.05 24.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -1.157 . . . . 0.0 109.235 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.481 HD13 ' OE2' ' A' ' 89' ' ' GLU . 96.3 mt -114.7 129.56 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.517 -0.739 . . . . 0.0 109.114 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -112.71 130.56 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.59 0.71 . . . . 0.0 109.765 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 t -138.99 145.27 39.5 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.535 0.683 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.1 mmm-85 -100.89 4.26 42.52 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.603 0.716 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.91 74.13 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 51' ' ' GLY . 3.7 m -123.09 134.41 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.8 129.18 46.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.628 0.728 . . . . 0.0 109.177 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.95 130.44 10.17 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -106.46 130.89 54.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.676 -0.896 . . . . 0.0 108.901 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -105.37 145.3 30.96 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.603 0.716 . . . . 0.0 110.068 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.44 ' O ' ' CG ' ' A' ' 72' ' ' ASN . 7.1 mm -122.58 147.41 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.671 HD22 ' HD3' ' A' ' 74' ' ' ARG . 0.1 OUTLIER 51.53 13.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.721 0.772 . . . . 0.0 109.405 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 71' ' ' ILE . . . 88.82 28.87 20.04 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.671 ' HD3' HD22 ' A' ' 72' ' ' ASN . 16.3 ptt85 -153.87 163.99 22.13 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.198 -1.178 . . . . 0.0 109.45 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 142.34 99.23 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.421 2.081 . . . . 0.0 112.172 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.3 m -166.03 -32.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.181 -0.95 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.16 153.18 35.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.666 -1.271 . . . . 0.0 110.802 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.6 mt -128.52 163.36 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.376 0.608 . . . . 0.0 109.518 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 78' ' ' ILE . 45.1 tt0 -139.99 152.06 45.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -0.839 . . . . 0.0 109.75 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.38 146.21 32.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.443 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.6 m -123.06 132.84 54.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.386 0.612 . . . . 0.0 109.726 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.12 132.4 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.724 0.773 . . . . 0.0 109.339 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 85' ' ' ASN . 27.8 mm -76.16 130.67 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.446 0.641 . . . . 0.0 109.979 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.9 mt -122.81 35.77 4.8 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 83' ' ' ILE . 99.2 m-20 -64.57 -38.91 92.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 109.535 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.4 p -72.46 155.83 39.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.127 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.671 ' CD ' ' H ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -79.32 -42.59 1.63 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.646 -0.659 . . . . 0.0 110.823 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 39.9 Cg_endo -65.49 -24.88 56.03 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.859 1.706 . . . . 0.0 111.449 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' OE2' HD13 ' A' ' 61' ' ' ILE . 52.8 tp10 -70.83 -36.97 73.14 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -61.73 -42.92 99.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.576 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.47 -50.21 74.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.867 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -69.02 -40.71 78.5 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.734 0.778 . . . . 0.0 109.459 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.93 -46.14 91.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 63.8 ttp -63.25 -44.64 94.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.546 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -65.12 -37.7 88.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.516 -0.74 . . . . 0.0 109.857 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 85.3 t80 -59.74 -45.42 92.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.42 ' SD ' HG11 ' A' ' 18' ' ' VAL . 91.5 mtp -64.77 -39.9 94.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.284 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.89 -45.05 71.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.768 . . . . 0.0 109.514 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.447 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 94.8 mtt-85 -67.04 -39.12 86.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.351 -0.843 . . . . 0.0 109.66 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.626 ' CE2' ' ND2' ' A' ' 104' ' ' ASN . 90.1 t80 -61.15 -45.96 92.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.37 -34.51 89.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -38.77 90.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -1.128 . . . . 0.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.33 -38.28 78.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.626 ' ND2' ' CE2' ' A' ' 100' ' ' TYR . 73.4 m-20 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 109.514 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.528 ' HB1' ' CE2' ' A' ' 96' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.599 0.714 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -155.84 159.64 39.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.489 -0.757 . . . . 0.0 109.642 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.0 mm -106.78 128.13 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.744 0.783 . . . . 0.0 109.443 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -138.94 136.88 35.91 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.425 ' O ' ' OG ' ' A' ' 7' ' ' SER . 46.1 m-85 -103.61 -13.6 16.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 6' ' ' PHE . 61.8 m -167.9 169.84 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.52 -0.738 . . . . 0.0 110.172 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.49 141.86 41.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.67 0.747 . . . . 0.0 110.904 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.63 23.67 52.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -109.44 -34.42 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -1.001 . . . . 0.0 109.051 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.85 168.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.726 0.774 . . . . 0.0 110.43 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' OG1' ' A' ' 13' ' ' THR . 17.6 pt-20 -80.47 139.39 36.44 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.586 0.708 . . . . 0.0 110.338 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 6.3 m -168.86 -35.17 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.7 t -81.49 135.85 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.634 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.01 82.78 13.93 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.585 -0.697 . . . . 0.0 109.265 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.37 156.19 25.35 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 123.048 2.499 . . . . 0.0 112.83 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -85.24 149.16 25.68 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.707 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.9 132.05 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.455 0.645 . . . . 0.0 109.787 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -130.06 144.8 51.54 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.479 0.657 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -111.28 134.56 52.78 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.677 0.751 . . . . 0.0 109.884 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -158.21 167.77 28.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -117.83 142.07 47.72 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.716 0.769 . . . . 0.0 109.6 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.765 0.793 . . . . 0.0 110.363 -179.469 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.99 0.9 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.77 156.68 49.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.4 ptm -154.32 172.69 17.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -147.12 140.23 25.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -107.27 141.14 39.06 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.586 0.708 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -117.32 126.36 52.58 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.48 128.53 46.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.451 0.644 . . . . 0.0 109.471 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -111.86 117.33 32.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.6 tp -95.63 127.74 41.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.634 0.731 . . . . 0.0 110.298 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 37.99 70.81 1.16 Allowed Pre-proline 0 N--CA 1.496 1.858 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.17 141.31 93.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.495 2.13 . . . . 0.0 111.855 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 46.2 p -87.42 -18.66 29.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.597 -0.689 . . . . 0.0 110.358 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.7 tt -66.68 2.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 109.676 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' THR . 86.5 mt -80.86 -8.74 59.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.7 -17.47 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 109.17 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -105.38 -50.48 3.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.499 -0.75 . . . . 0.0 109.585 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.54 157.6 45.85 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.371 -0.831 . . . . 0.0 109.936 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.9 t -77.34 164.74 25.25 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.621 0.724 . . . . 0.0 110.562 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -65.27 -37.51 87.42 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.442 0.639 . . . . 0.0 109.968 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.69 -16.64 63.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.458 -0.776 . . . . 0.0 109.776 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.74 -0.36 56.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 98.7 mt -94.51 118.0 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -0.93 . . . . 0.0 109.907 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -114.11 121.25 43.21 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.719 0.771 . . . . 0.0 109.458 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.82 177.25 3.47 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -132.66 137.33 46.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.77 -0.841 . . . . 0.0 109.042 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.18 111.48 23.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.816 0.817 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.418 ' C ' HD12 ' A' ' 55' ' ' ILE . 89.6 mt -99.93 125.95 46.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.752 -0.593 . . . . 0.0 109.566 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.703 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.7 mp -101.92 100.31 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.468 -0.77 . . . . 0.0 109.377 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -91.5 176.63 6.48 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.447 0.641 . . . . 0.0 109.89 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 45.8 p-10 -68.26 113.03 5.52 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.764 0.792 . . . . 0.0 110.297 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 57.38 31.5 20.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.756 0.788 . . . . 0.0 109.463 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.94 168.3 40.84 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.46 149.8 28.94 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.288 -1.125 . . . . 0.0 109.766 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.37 129.6 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.27 131.73 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 109.711 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 t -129.54 142.2 50.81 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.589 0.709 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -96.04 79.47 3.23 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.547 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 66' ' ' VAL . 79.7 mm-40 -141.57 -105.03 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.605 -0.684 . . . . 0.0 109.592 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' GLU . 4.8 t 57.92 113.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.603 0.716 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -126.97 116.53 20.92 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.687 0.756 . . . . 0.0 109.099 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.83 137.26 26.71 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -107.5 124.39 49.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.775 -0.838 . . . . 0.0 108.94 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' C ' HD12 ' A' ' 71' ' ' ILE . 78.7 m-85 -101.02 123.3 45.0 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.56 0.695 . . . . 0.0 110.3 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 71' ' ' ILE . 2.9 mp -107.74 119.81 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.671 0.748 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.0 m120 59.21 33.75 22.83 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.455 0.645 . . . . 0.0 110.404 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.64 34.3 39.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.417 ' NH2' ' OG1' ' A' ' 76' ' ' THR . 56.5 ttp85 -152.44 132.75 7.43 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.151 -1.205 . . . . 0.0 109.723 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.81 89.54 0.75 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.6 2.2 . . . . 0.0 111.103 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.433 ' HB ' HD13 ' A' ' 71' ' ' ILE . 6.7 m -105.5 -15.02 15.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.476 -0.765 . . . . 0.0 109.754 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.27 42.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.091 -1.006 . . . . 0.0 110.307 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.6 mt -133.61 158.59 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 78' ' ' ILE . 43.0 tt0 -139.42 156.76 46.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 110.142 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.82 148.3 31.75 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.368 0.604 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 m -122.0 132.75 54.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.54 0.686 . . . . 0.0 109.505 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 93' ' ' PHE . 47.2 t -109.85 130.56 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.659 0.743 . . . . 0.0 109.469 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.7 mm -98.97 121.59 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.405 0.621 . . . . 0.0 109.559 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.466 HD11 ' CD2' ' A' ' 93' ' ' PHE . 69.7 mt -107.8 65.75 0.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -64.99 -39.5 93.57 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.587 0.708 . . . . 0.0 109.647 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.8 m -72.36 152.51 42.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 110.535 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.513 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 21.1 mt-30 -76.26 -58.28 1.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.845 -0.534 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 19.6 Cg_endo -56.19 -29.67 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.24 1.96 . . . . 0.0 111.611 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.96 -34.95 78.87 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.436 0.636 . . . . 0.0 109.596 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -46.54 89.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.347 -0.846 . . . . 0.0 109.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.74 -42.7 97.83 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.528 -0.732 . . . . 0.0 109.394 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.43 -40.87 93.82 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.641 0.734 . . . . 0.0 109.049 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CD2' HD11 ' A' ' 84' ' ' LEU . 9.7 t80 -60.94 -42.54 98.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.648 0.737 . . . . 0.0 109.244 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -61.72 -41.39 97.57 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.562 0.696 . . . . 0.0 109.624 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.56 -39.83 94.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.426 -0.796 . . . . 0.0 109.328 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.528 ' CE2' ' HB1' ' A' ' 2' ' ' ALA . 28.3 t80 -58.63 -44.5 90.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.625 -0.672 . . . . 0.0 109.645 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 13.4 ttt -61.5 -43.92 98.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.982 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.13 -43.33 71.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.328 -0.858 . . . . 0.0 109.637 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -66.27 -42.14 88.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.404 -0.81 . . . . 0.0 109.514 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.05 -43.62 98.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.8 . . . . 0.0 109.839 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.42 -36.73 93.54 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.44 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -1.034 . . . . 0.0 109.855 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.25 -37.07 71.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 -179.257 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -117.31 155.55 29.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.539 -0.725 . . . . 0.0 109.664 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.42 127.8 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.637 -0.665 . . . . 0.0 109.219 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -129.67 124.22 33.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.749 -0.594 . . . . 0.0 109.427 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -106.58 -11.32 15.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -168.36 -153.44 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.038 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -69.9 134.59 48.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 110.83 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.1 -88.76 0.05 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t 53.9 95.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.488 -1.007 . . . . 0.0 109.883 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.67 56.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 110.705 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -100.22 32.79 2.86 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 m -69.09 -20.49 64.08 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 p -71.15 -19.11 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.766 -0.584 . . . . 0.0 110.353 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' VAL . 1.4 p 34.05 95.53 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 122.105 -0.372 . . . . 0.0 110.311 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.67 157.31 31.89 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.238 1.959 . . . . 0.0 112.869 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -92.01 152.89 19.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.096 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.77 133.47 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.569 -0.707 . . . . 0.0 109.262 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -128.57 144.22 51.11 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.8 mt -110.81 132.37 54.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.678 -0.639 . . . . 0.0 109.413 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.3 m -154.57 164.38 38.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.55 -0.719 . . . . 0.0 109.598 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -89.61 141.9 28.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.608 -0.683 . . . . 0.0 109.861 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.686 0.755 . . . . 0.0 110.757 -179.524 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.864 0.84 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.18 161.2 53.31 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.72 175.95 12.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.288 -1.125 . . . . 0.0 109.577 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.55 146.34 34.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.61 145.15 38.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.501 0.667 . . . . 0.0 109.955 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -112.44 121.25 44.3 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -96.2 123.76 39.95 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.445 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 2.1 m-85 -114.58 126.68 55.19 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.443 0.639 . . . . 0.0 109.308 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.2 tp -110.27 116.27 31.19 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 110.023 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' A' ' 39' ' ' THR . 52.2 mm-40 30.5 66.62 0.83 Allowed Pre-proline 0 N--CA 1.501 2.119 0 CA-C-O 120.877 0.37 . . . . 0.0 111.891 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 40' ' ' ILE . 33.3 Cg_exo -65.54 16.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.89 2.393 . . . . 0.0 111.404 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.528 ' H ' ' C ' ' A' ' 37' ' ' GLU . 37.0 p 50.39 14.36 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.645 -0.66 . . . . 0.0 109.498 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.427 ' N ' ' C ' ' A' ' 38' ' ' PRO . 3.4 tp -90.88 -14.87 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.908 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.39 -41.79 96.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.17 -35.07 77.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.992 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.31 -64.25 1.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 40' ' ' ILE . 80.0 mm-40 -117.45 143.24 46.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.595 -0.691 . . . . 0.0 109.785 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.5 m -73.95 162.23 29.28 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.529 0.68 . . . . 0.0 110.325 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.417 ' HG1' ' HZ ' ' A' ' 70' ' ' PHE . 44.2 p -65.83 -34.65 78.64 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 51.9 p-10 -67.96 -25.3 65.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.838 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 56.8 t0 -83.06 -9.15 59.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.067 -1.021 . . . . 0.0 109.302 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -96.59 111.07 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 108.748 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -126.82 126.26 43.07 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.567 0.698 . . . . 0.0 109.868 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 155.4 1.31 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.6 ttp -117.88 132.93 56.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.907 . . . . 0.0 109.291 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -108.71 119.65 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.69 -0.631 . . . . 0.0 109.497 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.7 mt -99.34 107.55 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.598 HG22 ' N ' ' A' ' 56' ' ' ASP . 96.5 mt -115.4 165.46 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.643 -0.661 . . . . 0.0 109.838 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.598 ' N ' HG22 ' A' ' 55' ' ' ILE . 64.2 t0 -151.9 -117.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 0.0 109.882 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 97.5 m-20 -79.48 -21.7 45.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.419 -0.8 . . . . 0.0 109.955 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -175.38 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 147.22 46.06 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.25 147.42 33.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -1.127 . . . . 0.0 109.64 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.494 ' C ' HD12 ' A' ' 62' ' ' ILE . 87.7 mt -128.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.837 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.6 mp -105.04 129.77 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.839 . . . . 0.0 109.675 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 65' ' ' GLU . 94.9 m -122.3 129.5 52.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 48.7 mmm-85 -112.17 46.47 1.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.9 mp0 -143.85 80.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.23 134.75 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.699 -0.626 . . . . 0.0 109.591 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -127.18 141.58 51.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.52 139.5 14.53 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -90.43 105.71 18.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 108.442 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.417 ' HZ ' ' HG1' ' A' ' 46' ' ' THR . 66.4 m-85 -94.77 135.36 36.35 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.393 0.616 . . . . 0.0 110.119 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 45.9 mm -115.11 131.83 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.33 0.586 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 71' ' ' ILE . 23.2 p30 44.08 16.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.957 -0.464 . . . . 0.0 110.339 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 109.38 -24.15 21.04 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 71' ' ' ILE . 16.3 ptp180 -100.72 147.24 33.37 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.145 -1.209 . . . . 0.0 110.122 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.78 143.35 66.95 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.652 2.234 . . . . 0.0 112.715 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.406 ' OG1' ' CG1' ' A' ' 71' ' ' ILE . 4.3 m -140.87 -29.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 35' ' ' PHE . . . -156.43 171.55 20.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 109.615 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.2 mt -131.85 144.29 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.572 0.701 . . . . 0.0 110.34 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -128.07 142.7 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.41 143.89 32.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 0.0 108.966 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -123.63 134.39 53.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.631 . . . . 0.0 109.665 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.62 130.73 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.5 mm -88.25 123.87 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.512 -0.743 . . . . 0.0 110.04 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.8 mt -98.62 56.83 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -64.42 -39.99 94.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.437 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -83.29 145.65 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 110.048 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.3 tm0? -71.61 -46.49 12.85 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 46.3 Cg_exo -54.9 -28.45 58.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.152 1.901 . . . . 0.0 111.323 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -59.47 -37.54 78.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.457 -0.777 . . . . 0.0 109.421 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -57.87 -37.35 73.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -59.55 -45.0 93.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -64.76 -40.67 95.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.373 -0.829 . . . . 0.0 109.612 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -65.81 -39.58 91.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 54.7 ttp -59.87 -45.5 92.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.945 . . . . 0.0 110.171 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -64.83 -38.29 90.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.396 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 96' ' ' PHE . 17.6 t80 -59.69 -46.9 87.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 36.5 ttm -65.56 -39.5 91.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.01 -52.5 23.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.23 -54.43 29.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.533 -0.73 . . . . 0.0 109.846 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -64.05 -45.12 90.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.31 -34.34 89.17 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.62 95.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -1.12 . . . . 0.0 109.561 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -68.71 -38.38 80.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.399 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.452 ' HB1' ' CE1' ' A' ' 96' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.482 0.658 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -155.57 153.24 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.414 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -111.13 128.52 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' HG2' HD13 ' A' ' 55' ' ' ILE . 21.5 pt20 -152.41 161.37 42.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.045 -1.034 . . . . 0.0 109.615 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.37 -31.06 9.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 t -113.45 132.33 55.69 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.538 0.685 . . . . 0.0 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -67.26 135.65 53.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.766 . . . . 0.0 110.346 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.25 -13.28 67.09 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.27 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.77 90.36 8.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.632 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.22 136.68 46.44 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.881 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 5.28 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.246 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -55.97 141.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.975 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.92 84.32 13.1 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.554 -0.716 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.0 150.85 23.6 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.931 2.421 . . . . 0.0 112.893 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -92.96 139.25 30.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 33' ' ' PHE . 21.8 t -99.03 129.71 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.291 -0.881 . . . . 0.0 109.953 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.464 ' C ' HD22 ' A' ' 20' ' ' LEU . 1.3 mpp_? -132.23 145.76 51.54 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.622 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.6 mm? -96.67 121.39 38.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 31' ' ' ALA . 53.3 m -109.1 167.52 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.573 -0.704 . . . . 0.0 109.651 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -126.31 138.65 53.61 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.594 0.711 . . . . 0.0 110.045 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 110.769 -179.424 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.418 0.627 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.43 149.09 44.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttp -151.87 144.75 24.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.178 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 21' ' ' SER . . . -143.08 147.77 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 108.691 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -119.4 144.55 46.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.319 0.58 . . . . 0.0 110.181 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 18' ' ' VAL . 81.3 m-85 -116.52 131.82 56.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -105.52 127.81 53.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.643 -0.66 . . . . 0.0 109.245 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.21 117.34 32.95 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 37' ' ' GLU . 50.4 tp -92.75 128.96 38.8 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.346 0.593 . . . . 0.0 110.517 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 36' ' ' LEU . 94.0 mt-10 35.84 71.78 0.84 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-O 121.083 0.468 . . . . 0.0 111.161 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.75 141.03 93.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.613 2.209 . . . . 0.0 112.217 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.0 p -83.29 -18.61 38.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 0.0 109.74 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.18 1.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 109.736 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.84 -9.41 58.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.035 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.64 -17.89 23.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.81 -47.92 3.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 109.449 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.6 153.6 48.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.398 -0.814 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -72.58 158.36 35.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.628 0.728 . . . . 0.0 110.327 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -64.23 -26.9 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 44.4 p30 -67.31 -19.82 65.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 94.5 m-20 -79.74 -5.09 54.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.11 118.46 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -0.33 14.69 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.26 179.4 42.47 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.421 ' CE ' HD21 ' A' ' 54' ' ' LEU . 63.9 ttp -132.5 141.61 48.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.434 -1.039 . . . . 0.0 109.763 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -111.35 118.64 36.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.416 0.627 . . . . 0.0 109.54 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 55' ' ' ILE . 78.4 mt -101.52 122.52 43.96 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -105.77 120.83 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.509 -0.744 . . . . 0.0 109.012 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -102.12 -153.95 0.48 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 109.807 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -73.33 -6.06 43.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.891 . . . . 0.0 109.603 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -174.15 -54.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 108.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.96 166.21 54.39 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -145.62 147.58 32.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -1.128 . . . . 0.0 109.182 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.94 131.51 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.653 -0.654 . . . . 0.0 109.508 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -113.96 128.98 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.9 133.76 47.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.544 0.688 . . . . 0.0 109.679 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -94.94 -3.52 48.46 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -84.66 76.12 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.78 133.41 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.653 -0.654 . . . . 0.0 109.4 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -127.48 140.58 52.05 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.1 142.35 16.42 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -104.62 111.27 23.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.499 -1.001 . . . . 0.0 108.723 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 22.8 m-85 -101.93 125.81 48.7 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.5 mt -111.71 120.93 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 57.13 33.44 23.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.578 -0.701 . . . . 0.0 109.323 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.46 25.38 74.86 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -130.58 100.19 18.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.291 -1.123 . . . . 0.0 109.694 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -46.97 93.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.263 1.975 . . . . 0.0 112.055 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 m -112.65 -15.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.722 . . . . 0.0 109.754 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.86 157.89 43.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.736 -1.228 . . . . 0.0 110.737 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.85 138.05 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -117.7 147.05 43.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.293 -0.879 . . . . 0.0 109.758 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.59 143.18 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.6 m -126.36 130.93 51.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.666 -0.646 . . . . 0.0 109.465 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.451 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.0 t -115.56 129.95 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.534 0.683 . . . . 0.0 109.252 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.722 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.8 mp -94.44 123.1 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -0.76 . . . . 0.0 109.706 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.58 110.52 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -95.9 -0.92 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.143 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.07 152.85 48.23 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.474 -0.766 . . . . 0.0 109.998 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.584 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.6 tp-100 -76.69 -40.29 2.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.621 -0.674 . . . . 0.0 110.801 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.4 Cg_exo -55.25 -30.54 72.31 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.151 1.901 . . . . 0.0 111.413 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -64.99 -40.92 95.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.668 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.617 ' CZ3' HD12 ' A' ' 20' ' ' LEU . 25.3 m95 -56.63 -36.74 69.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.488 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.4 -41.33 98.59 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.36 -44.31 91.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.179 -0.951 . . . . 0.0 109.473 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.25 -42.35 93.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.476 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -61.39 -46.09 91.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.594 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -68.84 -43.27 75.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 109.223 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.452 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 91.2 t80 -62.12 -46.05 90.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.456 -0.777 . . . . 0.0 109.411 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 63.7 ttp -63.99 -40.12 95.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.597 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.11 -49.8 68.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -66.19 -42.38 88.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 104' ' ' ASN . 79.0 t80 -63.72 -41.5 98.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.36 -36.81 93.06 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.16 95.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.362 -1.081 . . . . 0.0 109.536 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.08 -36.99 75.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.303 -0.873 . . . . 0.0 109.669 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 100' ' ' TYR . 7.8 m120 . . . . . 0 N--CA 1.501 2.102 0 O-C-N 121.5 -0.75 . . . . 0.0 109.884 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.782 0.801 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.79 149.9 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.33 130.41 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.72 -0.612 . . . . 0.0 109.418 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -127.81 133.37 49.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.565 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.34 -67.02 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -111.86 14.44 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 60.19 126.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.871 0.844 . . . . 0.0 111.187 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.33 7.96 69.01 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 m -110.73 141.73 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.586 -0.949 . . . . 0.0 110.011 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.584 ' H ' ' HZ3' ' A' ' 43' ' ' LYS . . . -61.86 140.9 58.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.635 0.731 . . . . 0.0 110.771 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' O ' ' OG1' ' A' ' 13' ' ' THR . 49.9 tp10 -97.95 -65.95 0.93 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.548 -0.72 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 7.0 p 51.01 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.578 0.704 . . . . 0.0 110.432 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' THR . 53.2 t 57.73 148.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.582 0.706 . . . . 0.0 110.439 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 15' ' ' VAL . 7.4 p -105.1 105.04 50.16 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.87 143.87 33.83 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.555 2.17 . . . . 0.0 112.692 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 56.4 mp0 -97.18 142.74 28.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.453 -0.78 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.512 HG22 ' CE2' ' A' ' 33' ' ' PHE . 3.7 t -106.15 126.53 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.409 0.623 . . . . 0.0 109.35 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -110.65 145.04 38.63 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.608 0.718 . . . . 0.0 109.654 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.9 mm? -95.39 139.74 31.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.666 0.746 . . . . 0.0 109.712 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -153.38 167.48 29.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.49 -0.756 . . . . 0.0 109.929 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.32 152.07 24.03 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.679 0.752 . . . . 0.0 109.97 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.857 0.837 . . . . 0.0 110.873 -179.078 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.772 0.796 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.74 149.63 48.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.2 ttt -141.66 130.21 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -1.11 . . . . 0.0 108.96 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 145.42 50.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 109.27 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.84 149.38 42.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.512 ' CE2' HG22 ' A' ' 18' ' ' VAL . 58.1 m-85 -122.6 139.63 53.71 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -114.58 123.36 49.15 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 118.98 36.67 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.25 107.93 19.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.762 0.792 . . . . 0.0 110.185 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 39' ' ' THR . 64.4 mm-40 47.83 61.81 13.1 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.842 -0.536 . . . . 0.0 110.625 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HG2' HG22 ' A' ' 40' ' ' ILE . 37.6 Cg_endo -66.83 15.38 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.335 2.023 . . . . 0.0 110.854 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 37' ' ' GLU . 25.7 p 51.86 22.29 1.7 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.518 HG22 ' HG2' ' A' ' 38' ' ' PRO . 14.4 tt -97.08 -13.75 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.311 -0.868 . . . . 0.0 109.228 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.44 -40.14 89.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.383 -0.823 . . . . 0.0 109.475 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.59 -14.63 59.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.557 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.584 ' HZ3' ' H ' ' A' ' 11' ' ' ALA . 54.2 mtpt -99.55 -63.24 1.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.709 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -119.93 138.91 53.16 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.76 0.79 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 m -71.33 150.67 44.89 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.714 0.769 . . . . 0.0 110.709 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.4 p -59.27 -40.69 86.84 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.421 0.629 . . . . 0.0 109.819 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.17 -15.86 62.5 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -0.764 . . . . 0.0 109.691 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.52 -7.72 49.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 92.1 mt -91.46 114.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.123 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.83 125.4 35.6 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.883 0.849 . . . . 0.0 109.642 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.77 157.02 15.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.4 ttt -132.73 127.57 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -109.18 108.07 18.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.65 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.7 mt -99.28 129.03 45.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.623 -0.673 . . . . 0.0 109.325 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.88 127.95 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.353 0.597 . . . . 0.0 110.171 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 18.5 p-10 -99.21 -132.45 0.24 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.676 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.461 ' N ' ' CG ' ' A' ' 56' ' ' ASP . 99.7 m-20 -63.13 -43.21 99.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -149.25 -50.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.365 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.75 168.73 13.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -140.29 155.52 46.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -1.028 . . . . 0.0 110.283 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.05 136.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.72 132.52 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.604 -0.685 . . . . 0.0 109.761 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 t -143.63 151.59 40.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.832 . . . . 0.0 109.614 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -104.25 3.52 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -81.5 79.32 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 109.316 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.1 t -125.81 135.37 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.62 -0.675 . . . . 0.0 109.795 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.9 136.86 48.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.5 -0.75 . . . . 0.0 109.582 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.55 141.59 15.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.98 106.94 18.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.501 -1.0 . . . . 0.0 109.443 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.6 143.9 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.643 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 93.5 mt -120.88 134.12 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 71' ' ' ILE . 46.3 m-80 -37.74 92.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.65 0.738 . . . . 0.0 110.538 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 148.44 -60.6 0.45 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -174.84 154.45 1.8 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.61 138.77 10.74 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.09 1.86 . . . . 0.0 112.099 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.442 ' CB ' HD12 ' A' ' 71' ' ' ILE . 66.8 m -132.7 -30.01 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.691 . . . . 0.0 109.918 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.17 164.04 38.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.682 -1.262 . . . . 0.0 110.577 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -128.54 150.24 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.19 151.0 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.611 0.719 . . . . 0.0 109.695 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.87 144.56 35.36 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.6 m -123.21 133.5 54.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.666 -0.646 . . . . 0.0 109.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.63 130.31 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mm -98.83 123.91 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.625 0.726 . . . . 0.0 109.795 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.11 83.02 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -91.54 8.14 37.99 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.18 44.48 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.823 . . . . 0.0 109.195 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.589 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.0 mm100 -65.5 -40.87 45.68 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.706 -0.621 . . . . 0.0 110.549 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.9 Cg_exo -56.72 -36.61 98.5 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.369 2.046 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -32.39 70.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.452 0.644 . . . . 0.0 109.646 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -60.36 -47.28 86.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.68 -44.5 90.14 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.488 -0.758 . . . . 0.0 109.666 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 56' ' ' ASP . 62.8 ttm-85 -66.63 -41.1 88.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.478 -0.764 . . . . 0.0 109.441 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -60.2 -44.75 94.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.488 -0.757 . . . . 0.0 109.952 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -63.82 -41.7 97.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.35 -0.844 . . . . 0.0 109.986 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.9 -44.14 86.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.0 -49.75 73.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.432 ' SD ' ' C ' ' A' ' 97' ' ' MET . 14.1 tmm? -68.44 -41.58 80.1 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.439 -0.788 . . . . 0.0 110.139 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 81.4 tt0 -66.54 -49.21 67.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 110.179 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.42 -43.28 81.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 110.265 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.39 -52.34 65.0 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.78 . . . . 0.0 110.329 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.63 -33.32 47.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 98' ' ' GLU . . . -48.94 -50.35 35.81 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.906 -1.35 . . . . 0.0 108.492 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 104' ' ' ASN . 96.8 mt-10 -71.49 -36.69 71.21 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.635 0.731 . . . . 0.0 109.111 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.421 ' O ' ' O ' ' A' ' 103' ' ' GLU . 1.1 m-20 . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 122.233 1.016 . . . . 0.0 111.019 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 121.737 0.78 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' THR . 17.1 pt-20 -155.68 165.25 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 mp -106.8 128.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.542 0.687 . . . . 0.0 109.617 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -150.01 131.38 14.67 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.734 0.778 . . . . 0.0 109.532 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -63.64 -43.78 95.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.7 m -119.19 120.48 37.2 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.813 0.816 . . . . 0.0 109.292 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.49 137.48 56.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.855 0.836 . . . . 0.0 111.043 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.66 -13.94 53.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.21 164.79 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.55 52.36 9.93 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.612 0.72 . . . . 0.0 109.642 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.564 ' C ' ' HG1' ' A' ' 13' ' ' THR . 17.8 pt-20 -76.24 174.28 10.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.213 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.564 ' HG1' ' C ' ' A' ' 12' ' ' GLU . 72.0 p 55.24 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.612 0.72 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 12' ' ' GLU . 2.4 t 56.6 155.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.839 0.828 . . . . 0.0 110.526 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.7 66.24 72.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.71 -0.619 . . . . 0.0 109.401 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.41 145.61 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.173 2.582 . . . . 0.0 112.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -88.82 147.65 24.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.679 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.435 HG22 ' CE2' ' A' ' 33' ' ' PHE . 71.4 t -117.1 130.97 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.648 0.737 . . . . 0.0 109.378 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.1 145.44 50.73 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.29 142.98 34.1 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.748 0.785 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 p -151.79 162.86 40.34 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.711 -0.618 . . . . 0.0 109.512 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.43 135.06 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.767 0.794 . . . . 0.0 109.746 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.617 0.723 . . . . 0.0 110.246 -179.555 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.973 0.892 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.55 156.84 53.17 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -147.32 156.93 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.107 . . . . 0.0 110.345 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.26 141.94 48.5 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -111.86 134.16 53.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.454 0.645 . . . . 0.0 109.934 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CE2' HG22 ' A' ' 18' ' ' VAL . 74.2 m-85 -112.95 144.18 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.546 0.689 . . . . 0.0 109.713 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -131.33 125.04 31.69 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.416 0.627 . . . . 0.0 109.387 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 46.3 m-85 -110.98 119.79 40.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.66 0.743 . . . . 0.0 109.333 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.0 tp -93.76 119.36 32.63 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.901 0.858 . . . . 0.0 110.512 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 39.06 56.73 5.79 Favored Pre-proline 0 N--CA 1.492 1.672 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.042 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.86 149.58 72.66 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.275 1.983 . . . . 0.0 111.988 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 41' ' ' LEU . 39.1 p -71.29 -17.11 62.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.1 tp -63.44 2.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 109.79 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 39' ' ' THR . 91.1 mt -95.17 -18.42 20.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 108.87 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.64 -20.0 18.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.33 -75.02 0.53 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.321 -0.862 . . . . 0.0 109.639 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -101.96 141.81 34.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.5 t -68.42 157.0 36.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.782 0.801 . . . . 0.0 110.353 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -65.59 -32.74 74.49 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.501 0.667 . . . . 0.0 109.925 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.0 -17.18 62.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.395 -0.816 . . . . 0.0 109.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -85.65 -7.09 59.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.15 127.85 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.129 -0.982 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -151.14 32.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.77 5.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.2 ttm -114.11 133.27 55.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.617 -0.931 . . . . 0.0 109.451 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -112.22 121.16 44.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.685 0.755 . . . . 0.0 109.168 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.558 ' C ' HD12 ' A' ' 55' ' ' ILE . 73.8 mt -99.45 125.38 45.17 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.728 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -107.04 125.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 109.318 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 58' ' ' GLU . 65.5 t0 -125.85 17.4 7.98 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 64.31 -62.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.348 0.594 . . . . 0.0 110.242 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' ASP . 96.3 mt-10 -72.98 -0.85 14.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.83 173.57 36.71 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.92 148.57 34.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -1.077 . . . . 0.0 109.761 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.25 133.62 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.538 0.685 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.9 126.36 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.773 . . . . 0.0 109.264 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' N ' ' A' ' 64' ' ' ARG . 6.2 m -137.27 160.79 38.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.817 0.818 . . . . 0.0 109.316 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.475 ' N ' HG22 ' A' ' 63' ' ' THR . 84.5 mmt-85 -102.92 -116.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' ARG . 79.8 mm-40 35.75 77.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.601 0.715 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.92 131.95 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.83 138.58 52.13 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.582 0.706 . . . . 0.0 109.407 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -103.39 132.93 11.23 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -99.58 108.26 20.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -1.002 . . . . 0.0 108.685 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -102.61 145.09 30.16 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.679 0.752 . . . . 0.0 109.998 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.4 mt -122.71 135.13 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.573 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -37.79 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.894 0.854 . . . . 0.0 110.735 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 150.69 -62.44 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -178.54 150.72 0.7 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.243 -1.151 . . . . 0.0 109.531 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -37.49 118.66 0.26 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.632 2.221 . . . . 0.0 111.779 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.446 ' CB ' HD12 ' A' ' 71' ' ' ILE . 45.1 m -110.93 -33.57 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 0.0 110.238 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.87 161.11 41.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.773 -1.204 . . . . 0.0 110.836 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.426 HD11 HD21 ' A' ' 41' ' ' LEU . 96.7 mt -128.16 152.42 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.558 0.694 . . . . 0.0 109.376 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -137.93 153.15 49.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.578 0.704 . . . . 0.0 109.568 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -151.4 154.03 35.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.41 0.624 . . . . 0.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.9 131.94 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.419 HG22 ' OD1' ' A' ' 85' ' ' ASN . 14.0 mm -96.25 122.63 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.927 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 81.2 mt -110.0 108.21 18.37 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.547 0.689 . . . . 0.0 109.497 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.419 ' OD1' HG22 ' A' ' 83' ' ' ILE . 6.9 m120 -110.26 -54.85 2.53 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.541 0.686 . . . . 0.0 109.524 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.02 145.82 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.683 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -67.02 -43.22 45.94 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.64 -0.663 . . . . 0.0 110.526 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 52.5 Cg_exo -53.78 -36.31 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.074 1.85 . . . . 0.0 111.317 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.86 -41.96 99.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.629 -0.67 . . . . 0.0 109.632 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.54 -38.92 91.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.27 -0.893 . . . . 0.0 110.009 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.64 -48.46 81.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 108.959 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -69.07 -41.89 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.728 0.775 . . . . 0.0 109.376 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -61.25 -45.35 94.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 53.9 mtt -64.19 -39.57 94.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -61.45 -41.38 97.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -60.44 -44.02 96.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.831 . . . . 0.0 109.73 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.7 mtp -63.46 -40.37 96.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.68 -46.47 72.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -66.63 -43.62 84.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 109.915 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -64.74 -42.05 95.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.481 -0.762 . . . . 0.0 109.691 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.98 -40.95 94.07 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.85 -39.76 94.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.514 -0.992 . . . . 0.0 109.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -39.69 76.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 109.517 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 N--CA 1.501 2.083 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.362 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -156.88 165.92 34.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.73 130.35 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.502 -0.749 . . . . 0.0 109.147 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 10' ' ' VAL . 34.2 mt-30 -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.699 0.761 . . . . 0.0 109.886 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -70.97 -74.62 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.82 0.819 . . . . 0.0 110.055 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.6 t -94.63 136.01 35.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.72 138.52 57.45 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.75 0.786 . . . . 0.0 110.823 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.69 -11.94 69.29 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 22.4 t -97.41 113.28 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.286 -1.126 . . . . 0.0 110.267 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.13 39.18 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.633 0.73 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -172.56 135.97 0.73 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 14' ' ' VAL . 62.1 m -92.18 -70.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.52 -0.738 . . . . 0.0 109.758 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 15' ' ' VAL . 58.5 t 54.32 162.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.415 -0.803 . . . . 0.0 110.704 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.535 ' N ' HG12 ' A' ' 14' ' ' VAL . 57.9 t -133.76 81.78 52.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.332 -0.855 . . . . 0.0 109.517 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.24 148.02 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.229 2.62 . . . . 0.0 112.615 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 58.7 mp0 -93.67 141.73 28.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.39 -0.818 . . . . 0.0 109.482 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.03 127.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.477 -0.765 . . . . 0.0 110.274 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 20' ' ' LEU . 48.2 mmm-85 -127.4 143.48 51.2 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 109.092 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -95.48 138.33 33.31 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.879 0.847 . . . . 0.0 110.378 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 t -134.54 144.18 47.85 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -123.43 142.16 51.27 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.931 0.872 . . . . 0.0 109.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 C--N 1.302 -1.458 0 CA-C-O 121.833 0.825 . . . . 0.0 110.472 -179.215 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.499 2.02 0 CA-C-O 121.93 0.871 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.81 143.24 36.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 40.6 ttm -155.96 144.39 20.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.292 -1.123 . . . . 0.0 109.933 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.62 144.93 36.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -116.94 149.18 40.59 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.606 0.717 . . . . 0.0 110.377 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -123.75 143.87 50.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -116.23 118.3 32.42 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.397 0.618 . . . . 0.0 109.628 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CE1' ' CE ' ' A' ' 52' ' ' MET . 63.9 m-85 -110.26 118.59 36.76 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.32 0.581 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.56 122.99 47.79 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.839 0.828 . . . . 0.0 110.094 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 39' ' ' THR . 85.9 mt-10 47.55 52.39 12.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.966 -0.459 . . . . 0.0 110.734 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 28.4 Cg_endo -63.57 9.09 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.57 2.18 . . . . 0.0 110.93 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 37' ' ' GLU . 71.4 p 51.01 19.21 0.63 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.764 -0.585 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.439 HG22 ' HG2' ' A' ' 38' ' ' PRO . 15.2 tt -97.4 -13.61 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -66.29 -38.84 88.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.471 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.94 -12.9 59.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.478 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -105.48 -16.31 14.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.366 -0.834 . . . . 0.0 108.861 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' ILE . 80.4 tt0 -171.43 139.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.52 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -74.67 158.6 33.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -64.91 -31.2 72.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.636 -0.665 . . . . 0.0 110.284 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 109.912 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -72.4 -17.13 61.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 109.278 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.72 118.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -149.25 42.77 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.6 139.5 4.53 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.472 ' CE ' ' CE1' ' A' ' 35' ' ' PHE . 45.1 ttm -130.66 128.72 41.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.685 -0.891 . . . . 0.0 108.668 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -111.28 125.79 54.2 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.842 0.829 . . . . 0.0 109.969 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -96.56 124.08 40.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.661 -0.649 . . . . 0.0 109.276 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.759 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -101.16 125.85 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.759 0.79 . . . . 0.0 109.785 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -108.92 -149.46 0.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.359 0.6 . . . . 0.0 109.641 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 58' ' ' GLU . 44.1 p-10 -64.1 -34.15 77.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.774 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.533 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 83.9 tt0 -156.63 -43.56 0.07 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 108.865 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.42 169.87 53.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.19 156.91 42.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -1.088 . . . . 0.0 110.142 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.475 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.3 mt -112.41 134.64 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.504 0.669 . . . . 0.0 109.295 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.829 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.3 mp -100.04 122.87 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.8 m -124.3 127.28 47.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.516 0.674 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -107.87 -4.16 18.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.5 mp0 -89.48 78.93 7.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.18 132.38 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.649 -0.657 . . . . 0.0 109.372 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.95 142.58 51.51 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.866 0.841 . . . . 0.0 109.639 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.45 142.0 15.82 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' CE ' ' OE1' ' A' ' 79' ' ' GLU . 68.0 mmtt -103.97 113.04 26.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.654 -0.909 . . . . 0.0 108.79 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 23.9 m-85 -98.34 144.63 27.52 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.847 0.832 . . . . 0.0 110.113 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' GLY . 96.5 mt -122.17 136.93 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 71' ' ' ILE . 59.5 m-80 -38.49 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.854 0.835 . . . . 0.0 110.421 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 149.3 -62.36 0.42 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -177.62 154.94 1.07 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.575 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.5 134.59 21.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.337 2.025 . . . . 0.0 112.447 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -147.05 -25.11 0.4 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.484 -0.76 . . . . 0.0 109.817 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.38 51.81 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 110.411 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.93 135.32 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' OE1' ' CE ' ' A' ' 69' ' ' LYS . 46.2 tt0 -116.81 151.57 36.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.71 144.97 32.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.564 -0.71 . . . . 0.0 109.529 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -117.54 129.06 55.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.553 -0.717 . . . . 0.0 109.975 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.98 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.764 0.792 . . . . 0.0 109.543 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 85' ' ' ASN . 27.2 mm -85.69 126.23 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.653 -0.654 . . . . 0.0 109.699 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.48 36.9 2.91 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.425 ' H ' HG22 ' A' ' 83' ' ' ILE . 79.8 m-20 -63.46 -40.39 97.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.822 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -76.67 153.78 34.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.205 -0.934 . . . . 0.0 110.373 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.1 mp0 -70.06 -48.78 20.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.467 -0.77 . . . . 0.0 110.497 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 40.9 Cg_exo -52.17 -37.87 70.38 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.9 1.733 . . . . 0.0 111.392 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 83' ' ' ILE . 97.6 mt-10 -64.55 -40.74 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.567 0.699 . . . . 0.0 109.851 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -61.69 -44.82 96.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.288 -0.882 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -60.99 -46.61 90.05 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.354 -0.841 . . . . 0.0 109.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -67.56 -39.52 84.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.668 0.747 . . . . 0.0 109.438 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -62.6 -48.14 80.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.408 -0.808 . . . . 0.0 110.07 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.92 -42.09 85.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.971 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -67.57 -44.52 78.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.901 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.22 -47.09 85.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.373 -0.829 . . . . 0.0 109.359 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.4 ttt -66.69 -39.15 87.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.659 0.743 . . . . 0.0 109.066 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.2 -51.53 60.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.0 109.686 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -68.23 -40.0 82.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -63.1 -48.63 77.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.502 -0.749 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 -35.15 89.44 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.53 94.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -1.108 . . . . 0.0 110.044 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.71 -56.53 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 109.819 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 109.742 -179.714 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 96' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.271 0.558 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.516 ' CD ' HE21 ' A' ' 5' ' ' GLN . 21.0 pt-20 -154.91 158.86 39.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.065 -1.022 . . . . 0.0 109.365 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -110.26 130.97 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.582 -0.699 . . . . 0.0 109.192 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.516 HE21 ' CD ' ' A' ' 3' ' ' GLU . 78.8 mt-30 -137.35 122.87 19.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.32 -39.32 85.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.845 . . . . 0.0 109.644 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 10' ' ' VAL . 72.5 m -127.02 153.25 46.17 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.711 0.767 . . . . 0.0 110.223 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -71.47 137.5 48.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.592 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.22 -2.66 71.71 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 7' ' ' SER . 69.2 t -70.84 -50.4 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -1.139 . . . . 0.0 109.682 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' VAL . . . 58.95 144.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 110.595 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 13' ' ' THR . 8.6 tm-20 58.14 -88.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.909 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.531 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 1.4 m 81.87 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -172.77 179.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.482 ' H ' HG22 ' A' ' 14' ' ' VAL . 96.3 t -115.13 86.35 13.84 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -78.25 154.15 28.38 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.984 2.456 . . . . 0.0 112.873 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -81.01 155.46 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -111.13 128.63 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.601 -0.687 . . . . 0.0 109.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.413 ' C ' HD22 ' A' ' 20' ' ' LEU . 79.2 ttt-85 -134.74 132.8 39.22 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -97.28 135.53 39.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.511 ' CB ' ' HZ3' ' A' ' 32' ' ' LYS . 40.3 m -123.99 150.0 45.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.25 142.9 50.53 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 109.823 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.523 -0.735 . . . . 0.0 110.089 -179.65 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.473 0.654 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.25 145.37 28.06 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -161.06 167.45 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.274 . . . . 0.0 109.147 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.14 143.71 38.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.351 -0.843 . . . . 0.0 108.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.511 ' HZ3' ' CB ' ' A' ' 21' ' ' SER . 64.4 mttp -111.83 146.37 37.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.74 131.69 54.21 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.36 128.3 53.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -112.25 114.95 28.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.49 -0.756 . . . . 0.0 109.428 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' GLU . 39.7 tp -95.4 122.43 38.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 36' ' ' LEU . 50.9 mm-40 39.45 57.25 6.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.751 -0.593 . . . . 0.0 111.034 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.69 145.78 91.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.449 2.099 . . . . 0.0 112.379 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 41' ' ' LEU . 64.0 p -69.46 -24.38 63.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.379 -0.826 . . . . 0.0 110.292 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 tp -59.44 1.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.068 . . . . 0.0 109.859 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 39' ' ' THR . 89.2 mt -91.24 -6.9 52.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 109.22 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.74 -26.63 13.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.457 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HZ1' HG22 ' A' ' 10' ' ' VAL . 52.0 mtmt -96.06 -75.89 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.275 -0.891 . . . . 0.0 110.018 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.05 151.71 20.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.423 -0.798 . . . . 0.0 110.395 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -74.71 163.1 28.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 p -66.53 -32.69 74.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.565 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.34 -18.55 63.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -79.31 -5.18 53.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.05 117.83 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.41 ' HB ' ' HE ' ' A' ' 64' ' ' ARG . 19.2 p -114.25 0.2 14.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.51 178.22 45.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.3 ttp -130.32 137.99 50.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.591 -0.947 . . . . 0.0 108.716 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.409 ' CE2' HD12 ' A' ' 62' ' ' ILE . 91.2 m-85 -106.18 123.12 47.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.32 -0.862 . . . . 0.0 110.035 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.521 ' C ' HD12 ' A' ' 55' ' ' ILE . 88.6 mt -99.15 125.95 44.82 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.803 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.9 mp -107.14 129.06 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.628 -0.67 . . . . 0.0 110.081 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 92' ' ' ARG . 41.9 p-10 -150.79 120.61 7.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.222 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' N ' HH12 ' A' ' 99' ' ' ARG . 66.4 t0 59.92 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.626 -0.671 . . . . 0.0 109.983 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' ASP . 81.1 tt0 -145.53 -38.64 0.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 108.886 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.83 171.85 53.38 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.5 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 2.2 pm0 -152.08 156.08 39.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.261 -1.14 . . . . 0.0 109.435 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.63 135.45 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.604 -0.685 . . . . 0.0 109.175 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.409 HD12 ' CE2' ' A' ' 53' ' ' TYR . 21.2 mm -101.78 125.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.3 m -123.45 125.97 45.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.568 -0.708 . . . . 0.0 109.258 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.41 ' HE ' ' HB ' ' A' ' 50' ' ' THR . 7.7 tpt180 -97.72 -7.98 29.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE1' HD11 ' A' ' 83' ' ' ILE . 96.2 mt-10 -83.86 84.0 7.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 110.017 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.78 134.57 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.452 -0.78 . . . . 0.0 109.452 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -125.57 142.09 51.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.57 -0.706 . . . . 0.0 109.263 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.58 140.39 14.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -107.23 102.77 12.06 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -102.32 146.1 28.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.588 -0.695 . . . . 0.0 109.776 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.7 mt -121.17 133.09 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 0.5 OUTLIER -38.03 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 154.09 -60.86 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -177.04 150.9 0.91 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.331 . . . . 0.0 109.158 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -40.16 118.68 0.57 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.267 1.978 . . . . 0.0 111.861 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.404 ' CB ' HD12 ' A' ' 71' ' ' ILE . 12.2 m -111.22 -33.85 6.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.28 164.39 37.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 110.901 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 79' ' ' GLU . 94.4 mt -126.87 164.1 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.54 ' N ' HG22 ' A' ' 78' ' ' ILE . 15.5 tm-20 -140.12 148.5 41.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.463 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.76 143.81 35.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.501 -0.749 . . . . 0.0 108.981 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -122.87 130.33 52.73 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.567 -0.708 . . . . 0.0 109.582 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.3 t -110.81 129.71 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.492 -0.755 . . . . 0.0 109.414 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.585 ' CG2' ' ND2' ' A' ' 85' ' ' ASN . 30.0 mm -82.66 129.0 38.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 86.9 mt -117.52 38.02 3.72 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.585 ' ND2' ' CG2' ' A' ' 83' ' ' ILE . 61.0 m-20 -63.36 -40.67 97.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.377 -0.827 . . . . 0.0 109.332 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 151.06 35.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.27 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.586 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -73.2 -41.12 6.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.517 -0.739 . . . . 0.0 110.437 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 47.0 Cg_exo -56.08 -35.81 95.38 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.203 1.935 . . . . 0.0 111.632 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.57 -39.27 88.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.43 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.8 m95 -60.28 -42.12 94.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.63 -49.33 78.15 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.749 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.51 ' NH2' ' OD1' ' A' ' 56' ' ' ASP . 17.4 mmm180 -69.06 -39.77 78.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -61.68 -44.66 96.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.336 -0.853 . . . . 0.0 109.282 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.1 mmm -62.64 -41.49 99.06 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 108.881 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -64.89 -45.39 86.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.056 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.415 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 74.3 t80 -61.22 -45.85 92.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.415 ' SD ' ' C ' ' A' ' 97' ' ' MET . 2.0 tmt? -62.14 -41.54 98.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.481 -0.762 . . . . 0.0 109.725 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.3 -46.15 77.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.121 -0.987 . . . . 0.0 109.318 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.448 HH12 ' N ' ' A' ' 57' ' ' ASP . 83.5 mtp180 -65.63 -41.68 92.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.143 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.47 -48.42 79.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.47 -0.769 . . . . 0.0 109.695 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.85 -36.31 86.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.09 98.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.07 -42.16 66.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.347 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.484 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.105 0.479 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -134.79 136.98 42.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.784 0.802 . . . . 0.0 109.651 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.4 129.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.2 135.8 51.16 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.792 0.806 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -106.76 -56.08 2.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.537 0.684 . . . . 0.0 109.394 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' LYS . 32.5 t -93.42 11.21 29.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 109.359 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.6 mttm 57.88 124.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.771 0.796 . . . . 0.0 110.76 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.72 11.15 64.2 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 10' ' ' VAL . 3.0 m -96.04 135.02 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.499 -1.0 . . . . 0.0 110.09 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -92.88 -159.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.437 0.637 . . . . 0.0 110.599 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 56.53 -76.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 11' ' ' ALA . 4.5 p 65.29 6.38 3.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.745 HG22 ' H ' ' A' ' 15' ' ' VAL . 12.8 p 44.07 177.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.891 0.853 . . . . 0.0 111.202 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.745 ' H ' HG22 ' A' ' 14' ' ' VAL . 81.9 t -115.14 91.8 28.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.878 . . . . 0.0 108.959 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.04 145.02 17.22 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.75 2.3 . . . . 0.0 112.673 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.12 149.7 39.0 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.571 -0.705 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.72 127.43 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.462 ' C ' HD12 ' A' ' 20' ' ' LEU . 59.1 ttp180 -132.06 119.84 21.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 19' ' ' ARG . 7.0 mp -104.79 132.5 50.96 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.9 m -127.37 152.29 47.68 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.378 0.608 . . . . 0.0 109.683 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.3 131.11 57.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.652 0.739 . . . . 0.0 109.559 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.767 -0.583 . . . . 0.0 110.132 -179.634 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.734 0.778 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.45 ' HA3' ' HE1' ' A' ' 90' ' ' TRP . . . -67.92 140.42 36.27 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.33 149.54 41.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.423 -1.045 . . . . 0.0 109.993 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.0 144.89 45.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 142.46 51.49 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.652 0.739 . . . . 0.0 109.953 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.93 137.95 54.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -120.68 125.34 47.45 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.688 0.756 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 32.3 m-85 -110.12 114.39 27.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 37' ' ' GLU . 51.8 tp -88.77 132.31 34.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.397 0.618 . . . . 0.0 110.565 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' LEU . 41.0 mt-10 32.76 68.81 0.91 Allowed Pre-proline 0 N--CA 1.5 2.032 0 CA-C-O 121.177 0.513 . . . . 0.0 111.127 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.52 140.71 92.74 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.66 2.24 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -83.14 -19.4 36.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.561 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.43 1.87 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 109.398 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' THR . 95.2 mt -81.85 -13.27 57.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.19 -13.78 21.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.37 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -107.84 -44.84 4.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -134.62 147.59 50.22 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.6 m -75.79 158.39 32.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.753 0.787 . . . . 0.0 110.535 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -64.98 -32.16 73.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -72.45 -17.47 61.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -88.73 -7.56 56.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.235 -0.915 . . . . 0.0 109.251 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.86 122.14 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.754 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -124.42 122.77 38.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 109.562 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.14 -171.06 18.95 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.5 ttp -141.45 133.64 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.56 -0.965 . . . . 0.0 108.961 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.421 ' CD2' HD12 ' A' ' 62' ' ' ILE . 70.3 m-85 -108.35 109.29 20.58 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.723 0.773 . . . . 0.0 109.726 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.69 111.47 23.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 mm -109.25 131.02 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.031 0.919 . . . . 0.0 110.366 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD1' ' CD2' ' A' ' 96' ' ' PHE . 2.7 m-20 -138.6 -160.73 1.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.486 0.66 . . . . 0.0 109.408 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -81.45 104.66 12.04 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.926 0.869 . . . . 0.0 110.319 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 60.62 89.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.643 0.735 . . . . 0.0 110.592 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.57 142.97 5.77 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.28 147.68 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.999 . . . . 0.0 109.108 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.77 133.7 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 109.578 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' CD2' ' A' ' 53' ' ' TYR . 30.2 mm -108.02 126.99 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 109.196 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 65' ' ' GLU . 76.3 m -125.4 125.66 43.75 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.64 0.733 . . . . 0.0 109.295 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -97.8 -1.77 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' H ' HG22 ' A' ' 63' ' ' THR . 96.8 mt-10 -85.26 75.24 10.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.457 -0.777 . . . . 0.0 109.426 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.0 t -126.7 133.83 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.679 0.752 . . . . 0.0 109.338 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -132.82 141.13 48.3 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.97 141.24 15.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -106.01 119.23 38.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.604 -0.939 . . . . 0.0 108.875 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -107.98 144.59 35.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.583 0.706 . . . . 0.0 110.064 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mm -121.05 131.38 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 57.66 14.92 2.61 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.453 0.644 . . . . 0.0 110.07 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -17.86 58.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -100.4 150.37 36.88 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.452 -1.028 . . . . 0.0 110.05 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.92 143.25 90.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.576 2.184 . . . . 0.0 112.129 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 m -149.12 -41.47 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.973 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.85 164.59 35.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.762 -1.211 . . . . 0.0 111.077 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.02 152.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -135.34 145.28 47.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.011 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.22 46.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.689 1.233 . . . . 0.0 110.004 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.4 m -126.65 131.62 51.4 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.671 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.9 t -119.62 130.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 mm -87.7 126.71 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.542 0.687 . . . . 0.0 109.919 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.64 41.64 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -63.59 -39.75 95.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.73 . . . . 0.0 109.363 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.58 158.18 27.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.555 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 7.5 mm-40 -79.85 -41.42 1.43 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.802 -0.561 . . . . 0.0 110.832 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.8 Cg_exo -56.14 -37.5 96.39 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.823 1.682 . . . . 0.0 111.259 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -68.28 -39.04 82.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.637 -0.664 . . . . 0.0 109.433 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.45 ' HE1' ' HA3' ' A' ' 29' ' ' GLY . 1.8 m95 -61.32 -40.62 94.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.52 -44.56 95.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.189 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -69.55 -39.01 77.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 109.119 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.83 -45.97 91.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.37 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.6 ttt -62.56 -47.04 85.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.59 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -65.69 -41.72 92.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.461 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.48 ' CD2' ' OD1' ' A' ' 56' ' ' ASP . 3.4 m-85 -64.15 -46.89 82.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.2 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.8 ttp -63.03 -39.58 95.18 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -66.35 -40.45 89.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.507 -0.746 . . . . 0.0 109.443 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -65.88 -42.36 90.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 81.8 t80 -60.05 -46.47 89.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.482 -0.761 . . . . 0.0 109.269 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.31 94.73 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.52 72.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -1.053 . . . . 0.0 109.849 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.78 -42.78 69.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.518 -0.739 . . . . 0.0 109.763 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.412 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 62.0 m-20 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.561 -0.712 . . . . 0.0 109.569 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.563 ' CD ' HE21 ' A' ' 5' ' ' GLN . 43.7 tt0 -145.16 134.05 22.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 109.095 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.38 129.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.634 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.563 HE21 ' CD ' ' A' ' 3' ' ' GLU . 76.5 mt-30 -140.31 124.87 17.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.298 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.41 -2.88 58.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.133 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 8' ' ' LYS . 29.6 t -155.86 43.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.436 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' SER . 47.2 pttt 31.81 43.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.433 0.635 . . . . 0.0 110.853 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.43 26.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -97.8 132.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -1.11 . . . . 0.0 110.092 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.16 142.26 58.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 14' ' ' VAL . 57.4 mp0 -85.47 -116.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.597 -0.689 . . . . 0.0 110.379 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.3 p 57.35 0.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.566 ' H ' ' C ' ' A' ' 12' ' ' GLU . 74.9 t -67.91 -43.54 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.05 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 t 62.13 60.43 2.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.733 -0.604 . . . . 0.0 109.869 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -68.61 149.06 73.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.662 2.241 . . . . 0.0 112.256 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.82 154.09 23.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 110.087 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.88 132.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -127.63 140.69 51.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.14 143.0 43.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.604 -0.685 . . . . 0.0 109.684 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -149.92 151.86 34.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.042 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.61 133.58 55.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.688 0.756 . . . . 0.0 109.185 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.6 0.714 . . . . 0.0 110.724 -179.151 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.642 0.734 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.25 145.71 49.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.3 ttp -141.45 150.06 41.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -1.045 . . . . 0.0 109.796 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.35 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.444 -0.785 . . . . 0.0 109.01 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -125.61 140.72 52.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.541 -0.724 . . . . 0.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.53 119.33 38.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -95.99 124.43 39.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 109.138 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.92 124.8 52.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.644 -0.66 . . . . 0.0 109.709 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.8 tp -107.79 121.65 45.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.657 -0.652 . . . . 0.0 109.286 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 40.6 mt-10 42.65 55.43 10.39 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 110.315 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 36.0 Cg_endo -66.71 151.25 82.97 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.919 2.412 . . . . 0.0 112.749 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -84.28 90.85 7.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.638 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' GLU . 10.5 tp -173.48 -27.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -40.35 96.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.33 79.99 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 108.891 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -89.19 -69.58 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.619 -0.676 . . . . 0.0 109.286 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 40' ' ' ILE . 97.8 mt-10 -110.94 134.65 52.41 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.511 -0.743 . . . . 0.0 109.67 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -65.85 159.86 24.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.659 0.743 . . . . 0.0 110.436 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.435 ' H ' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -66.07 -33.46 75.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.648 -0.658 . . . . 0.0 109.65 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.2 -19.07 63.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.484 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -82.59 -5.62 58.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.1 mt -98.96 117.25 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.389 -0.819 . . . . 0.0 109.776 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 50' ' ' THR . 88.5 m -102.6 -7.11 22.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.63 -179.75 42.85 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.142 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.8 ttp -128.92 145.17 51.3 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.626 -0.926 . . . . 0.0 109.222 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.37 122.36 46.84 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.406 -0.809 . . . . 0.0 110.425 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 55' ' ' ILE . 52.4 mt -98.89 109.5 22.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.6 mp -105.47 163.15 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.041 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 55' ' ' ILE . 40.4 t0 -162.46 -179.2 6.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.541 -0.724 . . . . 0.0 109.407 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.481 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 97.8 m-20 -70.07 -15.64 63.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -169.55 97.71 0.32 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.374 -0.829 . . . . 0.0 109.285 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.3 146.15 8.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.78 144.45 23.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.5 mt -124.08 131.51 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.767 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.0 mp -101.97 132.16 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.0 m -120.32 123.32 42.84 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -97.79 -1.57 42.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.64 72.29 7.77 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.77 132.78 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.3 144.01 51.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.26 137.97 14.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.19 128.12 53.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.634 -0.921 . . . . 0.0 108.98 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -102.47 122.29 44.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.93 140.05 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 58.96 32.92 22.71 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.35 23.66 74.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -151.06 148.32 22.47 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.078 -1.248 . . . . 0.0 109.435 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.85 107.39 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.198 1.932 . . . . 0.0 111.228 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m -131.45 -10.25 3.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.538 -0.727 . . . . 0.0 110.059 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.71 154.47 41.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.957 -1.089 . . . . 0.0 110.306 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.7 mt -131.03 159.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 16.1 tm-20 -140.7 149.31 42.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.267 -0.895 . . . . 0.0 109.489 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.482 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.13 142.7 35.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.399 -0.813 . . . . 0.0 109.055 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -120.63 132.61 55.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.707 -0.621 . . . . 0.0 109.669 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.68 132.17 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.1 mm -95.38 122.5 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.336 -0.853 . . . . 0.0 110.116 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.4 mt -101.12 79.25 1.99 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -87.3 -5.6 58.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.497 -0.752 . . . . 0.0 110.048 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 t -115.72 134.33 55.14 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.731 0.776 . . . . 0.0 109.764 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.0 mp0 -58.85 -60.65 9.79 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.752 -0.592 . . . . 0.0 110.579 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 3.0 Cg_endo -49.52 -21.52 5.25 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.993 1.795 . . . . 0.0 111.715 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -65.92 -38.17 87.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.694 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -58.67 -38.19 77.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.329 -0.857 . . . . 0.0 109.749 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -60.39 -44.2 95.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -67.51 -40.67 85.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.842 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.6 -48.9 78.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.359 -0.838 . . . . 0.0 109.794 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.08 -40.75 78.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CG ' HH12 ' A' ' 99' ' ' ARG . 63.3 ttm-85 -63.37 -49.11 75.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.797 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.519 ' CE2' ' OD2' ' A' ' 56' ' ' ASP . 6.2 m-85 -66.31 -42.02 88.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.468 -0.77 . . . . 0.0 109.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 59.4 tpp -64.98 -34.07 77.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.629 -0.669 . . . . 0.0 109.267 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.65 -54.52 41.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.136 -0.978 . . . . 0.0 110.156 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.411 HH12 ' CG ' ' A' ' 95' ' ' ARG . 95.9 mtm-85 -65.69 -46.83 77.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.947 . . . . 0.0 110.145 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -62.95 -44.78 95.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.21 -33.89 88.44 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.09 98.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.322 -1.105 . . . . 0.0 109.529 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -71.27 -56.35 6.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.218 -0.926 . . . . 0.0 109.811 -179.636 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.628 0.728 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -153.14 149.26 27.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mp -110.34 130.45 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.469 0.652 . . . . 0.0 109.995 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -129.56 129.26 44.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.688 0.756 . . . . 0.0 109.513 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -88.09 -5.94 58.19 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 m -157.45 -168.85 2.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.6 133.74 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.865 0.84 . . . . 0.0 111.086 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 42.25 71.17 0.4 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.4 -47.92 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -1.001 . . . . 0.0 108.727 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.73 82.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.079 0.942 . . . . 0.0 109.152 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.11 124.22 30.89 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.738 0.78 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -96.4 -14.92 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 15' ' ' VAL . 59.3 t -55.66 159.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.292 -0.88 . . . . 0.0 110.091 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' N ' HG12 ' A' ' 14' ' ' VAL . 12.4 t -112.39 81.42 4.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.534 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.6 148.76 54.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.611 2.208 . . . . 0.0 112.554 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 18' ' ' VAL . 7.0 tm-20 -84.37 155.17 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.592 -0.692 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 55.4 t -117.62 129.62 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.561 0.696 . . . . 0.0 109.768 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -128.68 137.88 51.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.24 131.18 47.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.585 -0.697 . . . . 0.0 109.351 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 m -108.01 149.09 28.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.612 -0.68 . . . . 0.0 109.619 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.05 141.53 46.15 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.654 0.74 . . . . 0.0 109.589 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.649 . . . . 0.0 109.538 179.772 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.821 0.82 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.89 143.56 41.91 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttp -165.09 153.02 11.46 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -1.052 . . . . 0.0 109.663 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 21' ' ' SER . . . -142.89 153.18 42.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.653 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.06 147.55 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.452 0.644 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.32 136.85 54.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -114.27 122.05 45.55 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.456 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.19 114.28 27.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.0 tp -95.87 121.22 37.37 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.708 0.766 . . . . 0.0 110.027 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 48.55 60.21 15.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.982 -0.449 . . . . 0.0 110.623 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 40' ' ' ILE . 38.1 Cg_endo -69.68 1.36 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.346 2.031 . . . . 0.0 110.479 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m 54.74 5.03 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.28 0.562 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 38' ' ' PRO . 2.8 tp -73.48 -1.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 109.655 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.7 mt -84.42 -9.55 58.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 108.953 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.8 -18.6 22.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.332 -0.855 . . . . 0.0 109.382 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.45 -47.15 4.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.32 -0.863 . . . . 0.0 109.089 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.78 153.09 48.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.33 -0.856 . . . . 0.0 110.148 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 t -80.69 167.04 20.47 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.694 0.759 . . . . 0.0 110.373 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -62.93 -39.92 96.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.642 0.734 . . . . 0.0 109.423 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 50.0 p-10 -70.98 -21.91 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.524 -0.735 . . . . 0.0 109.682 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 96.4 m-20 -80.26 -6.23 57.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.95 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.22 123.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.984 -1.073 . . . . 0.0 109.939 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.418 ' OG1' ' CZ ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -116.15 91.01 3.47 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 0.0 109.369 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.93 174.71 37.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -127.62 149.15 50.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.709 -0.877 . . . . 0.0 109.375 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.79 108.84 20.56 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.621 0.724 . . . . 0.0 109.726 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.35 115.81 30.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.89 125.15 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.53 0.681 . . . . 0.0 109.602 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -104.01 -167.36 1.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.592 0.71 . . . . 0.0 110.376 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 33.2 p-10 -77.78 -5.23 50.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.728 -0.607 . . . . 0.0 109.658 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -108.75 -94.18 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.417 -0.802 . . . . 0.0 109.884 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' H ' ' NH1' ' A' ' 92' ' ' ARG . . . -106.12 -147.59 15.16 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -137.38 155.09 49.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.98 . . . . 0.0 110.091 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.45 138.86 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.407 0.622 . . . . 0.0 109.804 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.0 mm -110.34 129.27 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.8 m -120.18 123.85 44.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 109.581 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.418 ' CZ ' ' OG1' ' A' ' 50' ' ' THR . 18.2 tpt85 -98.82 -12.6 20.69 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -84.83 79.3 9.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.441 -0.787 . . . . 0.0 109.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.93 133.21 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.403 0.621 . . . . 0.0 109.476 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.05 143.25 50.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.73 0.776 . . . . 0.0 109.727 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.79 140.42 15.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -101.52 121.58 42.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.984 . . . . 0.0 109.185 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -104.62 119.33 38.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.631 0.729 . . . . 0.0 110.121 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.31 138.84 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.42 33.75 20.65 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.603 0.716 . . . . 0.0 110.192 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.24 27.55 73.07 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -155.1 148.19 18.22 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.143 -1.21 . . . . 0.0 109.523 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.07 113.96 3.23 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.6 2.2 . . . . 0.0 111.926 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m -126.98 -15.69 5.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.22 158.26 43.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 110.269 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -129.01 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.378 0.609 . . . . 0.0 109.463 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -129.59 148.05 51.45 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.604 0.716 . . . . 0.0 109.689 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.4 145.94 39.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.21 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -121.47 131.71 54.31 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.432 0.634 . . . . 0.0 109.946 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.08 129.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.612 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.4 mp -82.15 127.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.533 0.682 . . . . 0.0 109.655 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.494 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 84.5 mt -120.68 33.77 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.68 -40.04 95.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.529 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.7 m -70.47 145.61 50.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.044 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.502 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -71.58 -47.67 12.56 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.303 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 43.7 Cg_exo -54.36 -33.67 77.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.123 1.882 . . . . 0.0 111.819 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -66.04 -37.24 85.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.578 -0.701 . . . . 0.0 109.872 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.494 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.1 m95 -60.97 -39.81 91.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 109.944 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.58 -51.1 69.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.488 ' NH1' ' H ' ' A' ' 59' ' ' GLY . 63.2 ttm-85 -68.27 -42.68 79.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.43 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.29 -43.25 99.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ttt -59.02 -41.98 89.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.308 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.36 -40.48 93.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.523 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.55 -48.21 82.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.266 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.8 ttt -67.86 -39.09 83.81 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.646 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -64.3 -47.95 77.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.453 -0.779 . . . . 0.0 109.434 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -67.23 -42.34 84.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.825 . . . . 0.0 109.546 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.6 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 60.6 t80 -60.94 -46.18 91.73 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.801 0.81 . . . . 0.0 109.314 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.09 -30.91 79.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.38 93.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 109.812 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -89.24 -16.89 30.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.6 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 68.7 m-80 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.409 ' HB2' ' OD2' ' A' ' 56' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.59 0.71 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -155.39 138.98 15.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -0.814 . . . . 0.0 109.723 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.2 130.51 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.672 0.748 . . . . 0.0 109.399 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 10' ' ' VAL . 16.8 pt20 -149.05 145.71 27.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.511 -0.743 . . . . 0.0 109.674 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 53' ' ' TYR . 90.2 m-85 -63.39 -45.47 90.93 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.59 0.709 . . . . 0.0 109.404 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 m -104.99 158.06 16.8 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.672 0.748 . . . . 0.0 110.322 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -68.54 133.28 48.32 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.834 0.826 . . . . 0.0 110.507 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 45.37 86.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 44.4 t -101.96 -77.66 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -1.026 . . . . 0.0 109.296 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' N ' HG12 ' A' ' 10' ' ' VAL . . . -178.06 -99.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.458 -0.776 . . . . 0.0 110.068 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.7 143.03 31.98 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 110.805 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' VAL . 70.9 m -75.72 -17.88 59.77 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.321 0.581 . . . . 0.0 109.968 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' THR . 3.7 t 55.51 158.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.485 -0.76 . . . . 0.0 110.572 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.25 74.53 41.83 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.299 -0.875 . . . . 0.0 109.892 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.05 147.36 23.72 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.921 2.414 . . . . 0.0 112.522 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -74.86 161.63 29.38 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.767 0.794 . . . . 0.0 110.045 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -113.06 131.33 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.543 0.687 . . . . 0.0 109.324 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.425 ' C ' HD22 ' A' ' 20' ' ' LEU . 83.7 mtp180 -128.52 139.9 52.08 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.678 0.751 . . . . 0.0 109.579 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.1 mm? -97.42 135.22 39.61 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.641 0.734 . . . . 0.0 109.64 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.9 t -134.57 142.95 47.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.539 0.685 . . . . 0.0 109.714 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -100.77 159.08 15.48 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.054 0.931 . . . . 0.0 110.371 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.302 -1.468 0 CA-C-O 121.652 0.739 . . . . 0.0 110.295 -179.565 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.74 0.781 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.84 172.85 18.3 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.0 ptp -159.26 175.69 13.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -1.132 . . . . 0.0 109.679 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.54 143.91 45.97 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' NZ ' ' OG1' ' A' ' 81' ' ' THR . 68.3 mttm -117.18 142.9 46.45 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.626 0.727 . . . . 0.0 110.166 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.86 128.12 54.95 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -103.76 131.87 50.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.577 -0.702 . . . . 0.0 109.627 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -112.43 126.44 55.3 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.0 tp -100.68 125.32 47.09 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.681 0.753 . . . . 0.0 110.677 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 37.04 58.17 3.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.22 150.68 81.74 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.574 2.182 . . . . 0.0 112.525 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -76.5 -18.69 58.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.746 -0.596 . . . . 0.0 110.219 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.78 1.52 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.03 . . . . 0.0 109.707 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.0 mt -89.28 -8.94 52.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.027 -1.045 . . . . 0.0 109.169 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.98 -26.88 11.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.414 -0.804 . . . . 0.0 109.263 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.47 -74.34 0.45 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -0.921 . . . . 0.0 109.9 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.05 143.67 36.46 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.87 0.843 . . . . 0.0 110.408 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -76.5 169.4 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.918 0.866 . . . . 0.0 110.52 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.5 p -65.36 -31.09 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.02 -36.61 84.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.67 -8.99 58.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.4 mt -101.6 118.35 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.238 -0.914 . . . . 0.0 109.989 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.38 26.04 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.452 ' N ' HG21 ' A' ' 66' ' ' VAL . . . -176.99 164.97 34.72 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 44.3 ttm -135.63 133.58 38.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -1.09 . . . . 0.0 109.499 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 6' ' ' PHE . 4.3 m-85 -112.53 120.97 43.45 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.017 0.913 . . . . 0.0 109.723 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.489 ' C ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -96.37 110.36 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.753 ' N ' HD12 ' A' ' 55' ' ' ILE . 1.9 mp -98.81 126.99 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.508 -0.745 . . . . 0.0 109.623 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 66.4 t0 -172.5 134.99 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.557 0.694 . . . . 0.0 109.97 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 59' ' ' GLY . 97.8 m-20 57.97 42.86 22.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.974 -0.454 . . . . 0.0 110.077 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 67.82 -40.94 0.42 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.556 0.694 . . . . 0.0 109.543 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -69.66 153.48 52.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.62 149.03 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.463 -1.021 . . . . 0.0 109.91 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -119.36 133.34 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.532 0.682 . . . . 0.0 109.195 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mm -102.83 122.28 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.732 . . . . 0.0 109.698 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 65' ' ' GLU . 98.0 m -123.41 126.07 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.63 0.729 . . . . 0.0 109.395 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -101.24 41.24 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.201 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' H ' HG22 ' A' ' 63' ' ' THR . 96.2 mt-10 -133.05 86.44 2.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG21 ' N ' ' A' ' 51' ' ' GLY . 1.1 m -121.62 132.18 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -123.21 134.36 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.833 0.825 . . . . 0.0 109.021 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.7 133.37 11.54 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -105.76 110.4 22.69 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.631 -0.923 . . . . 0.0 108.604 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -104.42 139.75 38.91 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.423 0.63 . . . . 0.0 109.62 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.1 mt -117.96 126.15 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.58 0.705 . . . . 0.0 109.487 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.75 33.2 22.57 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.44 78.81 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 ttp85 -135.42 120.07 13.45 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.35 -1.088 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.55 138.2 32.0 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.321 2.014 . . . . 0.0 112.416 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -147.93 -34.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.32 158.96 44.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.841 -1.162 . . . . 0.0 110.533 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.0 mt -131.02 142.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -124.99 148.61 48.37 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.642 0.734 . . . . 0.0 109.464 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.88 147.7 41.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.505 ' OG1' ' NZ ' ' A' ' 32' ' ' LYS . 86.9 m -118.66 130.06 55.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.5 125.16 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.677 0.751 . . . . 0.0 109.531 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 25.0 mm -84.06 131.94 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 82.5 mt -121.72 47.94 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.65 -40.38 95.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.41 -0.806 . . . . 0.0 109.447 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -74.19 145.32 44.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.488 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -73.34 -47.39 7.63 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.481 -0.762 . . . . 0.0 110.203 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 44.6 Cg_exo -54.72 -32.72 77.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.881 1.721 . . . . 0.0 111.306 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -67.03 -38.19 85.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.608 -0.682 . . . . 0.0 109.399 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.2 m95 -59.76 -41.46 91.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -62.73 -46.48 87.87 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -70.15 -41.69 73.51 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.802 0.81 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.36 -44.86 96.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 109.376 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.0 ttm -61.21 -41.84 97.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -66.94 -39.59 87.36 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.56 -46.52 85.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.296 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 62.6 ttp -66.45 -38.42 87.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.6 0.714 . . . . 0.0 109.663 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -61.76 -42.24 98.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.832 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.24 -39.46 86.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.73 -38.5 94.53 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.1 92.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -1.18 . . . . 0.0 110.371 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.75 -56.07 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.046 . . . . 0.0 109.961 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 . . . . . 0 N--CA 1.499 1.988 0 O-C-N 120.95 -1.094 . . . . 0.0 109.444 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.557 0.694 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -154.58 160.79 41.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.588 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.1 129.65 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -129.4 129.29 44.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 109.884 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.08 -5.67 59.16 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.4 t -161.1 -63.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.497 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 10' ' ' VAL . 53.7 mtpt -143.02 -160.82 1.15 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.91 5.22 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 8' ' ' LYS . 74.5 t -69.07 134.85 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.314 -1.109 . . . . 0.0 110.344 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 64.43 92.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.491 0.662 . . . . 0.0 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -130.33 -22.22 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -76.22 -1.0 24.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 108.924 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.95 136.52 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.551 -0.718 . . . . 0.0 109.898 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.46 79.41 29.08 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 109.272 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.04 153.21 32.2 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.918 2.412 . . . . 0.0 112.793 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -89.31 138.37 31.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.424 -0.797 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.7 t -88.26 131.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -127.37 144.43 51.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.621 0.724 . . . . 0.0 109.48 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.73 132.39 54.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.8 t -121.36 152.57 38.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.749 -0.594 . . . . 0.0 109.509 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -133.3 153.03 51.93 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.881 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.4 p . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.734 . . . . 0.0 109.426 -179.707 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.644 0.735 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.88 141.26 28.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttm -153.34 151.43 29.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -1.171 . . . . 0.0 109.531 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.88 148.15 36.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.31 146.25 50.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.11 140.23 49.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -118.88 125.67 50.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.28 121.39 45.17 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.0 tp -95.62 123.17 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.449 0.643 . . . . 0.0 109.985 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 36' ' ' LEU . 13.9 mm-40 37.35 57.69 4.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-O 120.966 0.413 . . . . 0.0 111.096 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.95 148.98 71.46 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.254 1.969 . . . . 0.0 111.795 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 t -75.92 -13.25 60.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 110.314 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.57 -1.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 109.738 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 78' ' ' ILE . 84.6 mt -90.71 -12.69 35.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.08 -21.88 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -87.47 -75.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.63 160.85 14.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.855 0.836 . . . . 0.0 110.562 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.4 p -76.17 165.77 24.43 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.742 0.782 . . . . 0.0 110.762 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.407 ' HA ' HD12 ' A' ' 49' ' ' ILE . 20.9 p -65.84 -31.53 72.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.489 0.661 . . . . 0.0 109.882 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.27 -18.26 63.13 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -93.59 -6.69 46.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 49' ' ' ILE . 86.8 mt -84.53 -7.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.142 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' ILE . 20.1 m -39.6 123.01 1.45 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.686 0.755 . . . . 0.0 110.834 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.27 160.26 32.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.6 ttm -135.19 143.94 46.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 62' ' ' ILE . 83.0 m-85 -118.12 109.82 16.87 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 0.0 109.522 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.04 131.44 34.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.176 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -121.37 133.69 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.503 0.668 . . . . 0.0 110.136 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' GLU . 97.0 m-20 -133.29 43.21 2.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 44.82 17.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.386 -0.821 . . . . 0.0 109.53 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' ASP . 79.8 tt0 -170.4 83.4 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.183 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.58 157.44 32.46 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.26 155.54 45.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -1.097 . . . . 0.0 109.829 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.8 132.62 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 53' ' ' TYR . 32.7 mm -103.31 120.7 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 63' ' ' THR . 4.3 t -127.81 125.49 39.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.46 0.648 . . . . 0.0 109.401 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -98.74 50.37 0.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -138.81 81.66 1.86 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.04 136.05 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.629 . . . . 0.0 109.461 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -128.74 134.85 48.56 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.556 -0.715 . . . . 0.0 109.572 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.1 143.45 16.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -96.71 101.07 12.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.467 -1.02 . . . . 0.0 108.366 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -91.91 152.84 19.87 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.621 0.724 . . . . 0.0 110.514 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 73' ' ' GLY . 89.3 mt -135.87 148.3 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.35 -0.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.971 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 71' ' ' ILE . . . -127.88 62.24 0.63 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 73' ' ' GLY . 68.9 ttp85 60.12 134.87 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.805 -0.82 . . . . 0.0 110.633 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -42.79 140.06 3.08 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.961 1.774 . . . . 0.0 112.102 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m -130.03 -16.84 3.58 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 166.69 30.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.708 -1.245 . . . . 0.0 110.72 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.552 HD11 HD21 ' A' ' 41' ' ' LEU . 83.7 mt -134.92 154.12 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -133.45 151.82 51.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.53 -0.731 . . . . 0.0 110.438 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.89 34.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.7 m -125.11 127.9 47.6 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.671 -0.643 . . . . 0.0 109.616 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.63 128.87 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.6 mp -87.21 127.59 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.654 -0.654 . . . . 0.0 109.579 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 82.5 mt -108.72 36.73 2.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.61 ' H ' HG22 ' A' ' 83' ' ' ILE . 93.0 m-20 -63.48 -39.37 94.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -68.13 153.49 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.421 -0.8 . . . . 0.0 110.297 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.489 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 5.5 mp0 -71.27 -57.3 4.71 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.713 -0.617 . . . . 0.0 110.774 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 11.7 Cg_endo -54.8 -33.28 80.45 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.653 1.568 . . . . 0.0 111.617 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.61 -39.88 88.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.737 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -64.53 -44.95 89.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.917 . . . . 0.0 109.773 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -62.46 -46.42 88.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.284 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -65.67 -38.4 89.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.498 -0.751 . . . . 0.0 109.275 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -62.22 -43.81 98.0 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.521 -0.737 . . . . 0.0 109.51 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.5 ttm -61.4 -38.14 85.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.823 . . . . 0.0 109.229 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.98 -38.71 92.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 109.236 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -61.24 -45.18 95.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 91.8 mtp -63.75 -41.23 98.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -71.29 -46.51 60.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -67.65 -41.89 83.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.474 -0.766 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 104' ' ' ASN . 59.3 t80 -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.143 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 -28.8 71.93 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.23 72.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.992 . . . . 0.0 110.168 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 104' ' ' ASN . 11.8 pt-20 -71.27 -48.74 49.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.702 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 103' ' ' GLU . 3.4 p-10 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.747 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.493 ' N ' ' OE2' ' A' ' 103' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.507 0.67 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -155.64 148.7 24.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.819 . . . . 0.0 109.175 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.2 mt -108.72 128.48 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.148 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 9' ' ' GLY . 5.8 pt20 -146.31 155.08 42.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.227 -0.921 . . . . 0.0 109.634 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -111.18 -37.44 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 t -90.64 22.97 3.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.921 . . . . 0.0 109.376 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.416 ' NZ ' ' CE2' ' A' ' 53' ' ' TYR . 68.0 mttm 50.78 33.78 9.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 109.663 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 5' ' ' GLN . . . 157.58 40.73 0.02 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 98.8 t -57.36 -86.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -1.031 . . . . 0.0 109.925 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 179.23 -105.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.629 0.728 . . . . 0.0 109.474 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.92 146.59 46.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.473 -0.767 . . . . 0.0 110.489 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 14' ' ' VAL . 49.1 m -76.07 -11.01 59.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 108.999 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 15' ' ' VAL . 55.4 t 53.06 165.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.497 0.665 . . . . 0.0 110.711 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.592 ' N ' HG12 ' A' ' 14' ' ' VAL . 3.5 m -123.89 75.08 57.08 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.555 -0.715 . . . . 0.0 109.232 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 151.94 35.36 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.558 2.172 . . . . 0.0 112.437 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.63 152.55 25.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.512 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.62 130.76 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.055 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -132.27 141.16 48.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -109.07 130.54 55.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.195 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 t -126.98 133.26 50.62 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -127.5 135.94 51.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.626 0.727 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.548 -0.72 . . . . 0.0 110.474 -179.45 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.47 ' HB3' HD22 ' A' ' 85' ' ' ASN . 22.7 m . . . . . 0 N--CA 1.498 1.955 0 CA-C-O 121.536 0.684 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.58 151.87 34.84 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.9 ptm -153.6 167.93 27.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.247 -1.149 . . . . 0.0 109.364 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.76 145.17 37.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.481 -0.762 . . . . 0.0 109.036 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -112.07 143.23 43.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.92 131.83 52.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -105.49 126.22 51.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.406 -0.808 . . . . 0.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -109.43 116.21 31.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.641 -0.662 . . . . 0.0 109.257 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.5 tp -100.9 118.32 36.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.561 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 39' ' ' THR . 57.4 mt-10 43.31 59.65 11.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HG2' HG22 ' A' ' 40' ' ' ILE . 37.4 Cg_endo -68.85 13.9 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.078 1.852 . . . . 0.0 110.202 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 37' ' ' GLU . 72.6 p 48.88 32.17 3.61 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.273 0.559 . . . . 0.0 110.05 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.4 HG22 ' HG2' ' A' ' 38' ' ' PRO . 11.1 tp -99.06 -22.06 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.181 -0.95 . . . . 0.0 109.14 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.7 -40.7 92.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -23.2 67.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -98.22 -52.21 3.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -136.89 149.1 47.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.33 -0.856 . . . . 0.0 110.214 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 p -73.0 163.51 28.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.6 p -66.42 -30.72 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.485 -0.759 . . . . 0.0 109.444 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.22 -16.52 63.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.629 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -85.34 -7.81 58.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.2 mt -100.96 116.33 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -0.774 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 p -125.5 15.01 8.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' N ' HG21 ' A' ' 66' ' ' VAL . . . -176.98 160.34 27.37 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -118.03 131.69 56.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.679 -0.895 . . . . 0.0 108.83 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.416 ' CE2' ' NZ ' ' A' ' 8' ' ' LYS . 94.9 m-85 -104.42 112.7 25.85 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.639 0.733 . . . . 0.0 109.721 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.6 mt -95.55 127.63 41.75 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.71 128.76 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.498 0.666 . . . . 0.0 109.504 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASP . 44.5 t0 -155.56 118.11 4.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.53 -0.731 . . . . 0.0 109.853 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 94.8 m-20 40.1 61.15 1.58 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.833 -0.542 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 68.81 -41.44 0.47 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -66.66 138.77 36.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.69 148.81 32.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -1.165 . . . . 0.0 109.997 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.7 mt -122.48 130.85 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.803 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.8 mp -107.58 129.52 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.49 -0.756 . . . . 0.0 109.57 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -128.73 128.09 43.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.588 -0.695 . . . . 0.0 109.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -90.78 4.94 50.29 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.31 78.67 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG21 ' N ' ' A' ' 51' ' ' GLY . 1.6 m -120.92 132.95 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.545 -0.722 . . . . 0.0 109.669 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -123.19 137.07 54.98 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.15 127.22 9.18 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -96.39 126.98 41.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -1.109 . . . . 0.0 108.907 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -102.46 138.29 39.58 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.374 0.607 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mm -115.37 132.46 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 57.5 32.37 21.71 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.496 0.665 . . . . 0.0 109.517 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -12.03 26.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -112.72 149.14 40.72 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.409 -1.053 . . . . 0.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.2 142.28 86.0 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.335 2.023 . . . . 0.0 112.215 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 m -157.95 -28.97 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.95 44.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.054 . . . . 0.0 110.207 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.4 153.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.522 0.677 . . . . 0.0 109.601 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -132.68 152.65 51.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.17 44.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 109.237 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.4 m -125.17 129.97 51.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.57 130.92 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.224 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.92 121.46 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.47 -0.769 . . . . 0.0 109.859 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.403 HD12 ' CZ2' ' A' ' 90' ' ' TRP . 55.8 mt -98.14 -75.63 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.937 0.875 . . . . 0.0 109.121 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.47 HD22 ' HB3' ' A' ' 28' ' ' SER . 13.7 m-20 56.31 32.12 19.85 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.72 -0.613 . . . . 0.0 109.823 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 m -153.49 140.58 19.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.009 . . . . 0.0 109.335 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.504 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 9.6 mm-40 -62.38 -58.21 18.57 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.74 . . . . 0.0 110.32 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 13.0 Cg_endo -54.3 -36.04 85.53 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.955 1.77 . . . . 0.0 111.451 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -68.92 -38.76 79.76 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.349 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.403 ' CZ2' HD12 ' A' ' 84' ' ' LEU . 17.0 m95 -62.02 -46.33 89.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -42.65 99.65 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.199 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.77 -44.01 91.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.501 -0.749 . . . . 0.0 109.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.16 -44.01 96.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 0.0 110.193 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 40.0 ttm -58.0 -43.8 86.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.316 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.507 HH21 ' NH2' ' A' ' 99' ' ' ARG . 79.5 mtp85 -65.79 -38.3 88.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.09 -46.71 86.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.399 -0.813 . . . . 0.0 110.31 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.27 -39.28 94.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.838 1.304 . . . . 0.0 109.175 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -45.63 79.95 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.337 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 99.7 mtt180 -63.99 -41.9 97.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.092 -1.005 . . . . 0.0 109.17 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.0 -44.85 91.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.548 -0.72 . . . . 0.0 109.16 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.0 91.44 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.13 -38.15 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -1.158 . . . . 0.0 109.469 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.493 ' OE2' ' N ' ' A' ' 2' ' ' ALA . 96.2 mt-10 -68.74 -36.27 78.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 110.024 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 p30 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.749 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.94 160.17 42.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.904 0.859 . . . . 0.0 110.386 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.0 mt -108.79 128.43 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.696 0.76 . . . . 0.0 109.449 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.471 ' HG2' HD13 ' A' ' 55' ' ' ILE . 18.2 pt20 -148.51 149.65 32.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.926 0.87 . . . . 0.0 109.897 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.53 -65.75 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 m -75.35 164.76 26.08 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.587 0.708 . . . . 0.0 109.821 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.98 29.21 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.482 0.658 . . . . 0.0 109.672 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 10' ' ' VAL . . . -159.4 -44.28 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 9' ' ' GLY . 28.5 m 31.46 -135.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.192 0.52 . . . . 0.0 110.642 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.95 -139.4 0.05 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.592 0.711 . . . . 0.0 109.597 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.62 144.08 56.6 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.464 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 p -68.9 139.14 55.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.753 0.787 . . . . 0.0 110.559 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 15' ' ' VAL . 1.6 t -87.22 -145.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.416 0.627 . . . . 0.0 110.815 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.567 ' H ' HG12 ' A' ' 14' ' ' VAL . 17.5 t -146.45 66.27 10.91 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.649 -0.657 . . . . 0.0 109.242 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.92 149.75 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.024 2.483 . . . . 0.0 112.605 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.4 145.84 25.77 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.89 0.853 . . . . 0.0 109.921 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 t -103.71 131.65 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.839 0.828 . . . . 0.0 110.421 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -135.26 141.52 45.75 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.307 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 93' ' ' PHE . 84.6 mt -103.93 125.53 50.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.867 0.842 . . . . 0.0 110.081 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 m -94.91 164.19 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.641 0.734 . . . . 0.0 109.899 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.2 139.31 43.07 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.776 0.798 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.3 -1.552 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.485 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.531 0.682 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.95 153.36 13.66 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -157.79 176.24 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.962 . . . . 0.0 110.281 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.57 148.79 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.757 0.789 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -111.42 148.85 32.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.753 0.787 . . . . 0.0 110.035 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -126.37 135.98 52.13 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.608 0.718 . . . . 0.0 109.493 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -120.8 127.1 51.63 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.83 0.824 . . . . 0.0 109.747 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.67 120.23 41.73 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.726 0.774 . . . . 0.0 109.58 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' GLU . 37.2 tp -88.88 126.64 35.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.706 0.765 . . . . 0.0 110.404 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 36' ' ' LEU . 45.9 mm-40 36.53 68.7 1.4 Allowed Pre-proline 0 N--CA 1.493 1.691 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.785 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -58.94 145.38 97.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.273 1.982 . . . . 0.0 111.853 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 p -83.37 -17.43 42.33 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.016 0.436 . . . . 0.0 110.242 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.74 1.13 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.602 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.63 -11.59 58.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 109.281 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.45 -14.54 30.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.18 -58.39 1.89 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.795 . . . . 0.0 109.423 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.97 160.55 40.14 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.755 0.788 . . . . 0.0 110.242 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 26.7 t -63.57 -166.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.62 0.724 . . . . 0.0 110.476 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 p -99.03 -21.0 16.43 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -64.43 -36.9 85.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 109.163 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 45' ' ' SER . 25.1 p-10 -62.22 -40.3 95.67 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.514 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.2 mt -54.8 -88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.82 -0.55 . . . . 0.0 109.777 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.0 m 66.61 -43.18 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -96.9 144.68 17.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.4 ttp -126.37 125.65 42.58 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.581 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -108.51 111.01 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.958 0.885 . . . . 0.0 110.225 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 55' ' ' ILE . 58.6 mt -97.43 121.6 39.51 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.749 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -103.7 130.77 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.887 0.851 . . . . 0.0 110.404 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 38.0 m-20 -133.23 -156.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.726 0.774 . . . . 0.0 109.77 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 59' ' ' GLY . 42.8 p-10 -71.72 96.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.964 -0.46 . . . . 0.0 110.339 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 66.08 -39.88 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -88.95 160.24 29.65 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.596 ' N ' ' NH2' ' A' ' 92' ' ' ARG . 17.2 pt-20 -151.51 148.72 28.38 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 110.067 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.04 130.09 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.674 0.75 . . . . 0.0 109.527 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -123.49 133.47 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.836 0.826 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -142.06 150.7 41.58 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.734 0.778 . . . . 0.0 109.848 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -97.58 0.89 48.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.35 81.39 3.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.479 0.657 . . . . 0.0 109.286 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.42 133.57 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.855 0.836 . . . . 0.0 109.814 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.29 137.37 47.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.834 0.826 . . . . 0.0 109.47 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.27 131.01 10.42 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -103.5 117.14 33.75 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.818 0.818 . . . . 0.0 109.472 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.61 137.09 47.13 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.858 0.837 . . . . 0.0 110.036 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -119.06 128.65 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.675 0.75 . . . . 0.0 109.201 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 59.65 30.74 20.37 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.315 0.578 . . . . 0.0 109.731 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.51 24.7 73.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -136.01 113.38 10.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.749 -0.853 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.88 104.62 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.211 2.608 . . . . 0.0 112.568 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.6 m -109.71 -35.72 6.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.739 -0.601 . . . . 0.0 110.092 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.81 159.81 40.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.054 -1.029 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.21 150.97 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.694 0.759 . . . . 0.0 109.655 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -130.66 148.51 52.45 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.99 0.9 . . . . 0.0 110.018 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.64 152.57 39.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.649 0.737 . . . . 0.0 109.92 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.1 m -120.57 132.59 55.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.776 0.798 . . . . 0.0 110.354 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.57 130.86 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.874 0.845 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.5 mm -87.22 124.85 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.771 0.796 . . . . 0.0 110.231 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -117.71 40.5 3.08 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -62.82 -39.93 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.598 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -81.26 152.81 27.44 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.75 0.786 . . . . 0.0 110.18 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.7 tt0 -70.48 -46.43 18.93 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.943 -0.473 . . . . 0.0 110.91 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 68.4 Cg_exo -52.52 -35.33 66.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.195 1.93 . . . . 0.0 111.512 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.88 -40.71 97.15 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -63.81 -41.95 97.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.644 -0.66 . . . . 0.0 109.512 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -59.36 -44.47 92.69 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.596 ' NH2' ' N ' ' A' ' 60' ' ' GLU . 83.3 mtp180 -66.23 -37.94 86.73 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 60.5 t80 -61.95 -46.6 88.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.74 -0.6 . . . . 0.0 109.84 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 97.5 mmm -62.76 -44.07 97.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.688 -0.632 . . . . 0.0 109.395 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -66.9 -41.74 86.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.309 0.576 . . . . 0.0 109.524 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 83.0 t80 -63.99 -44.91 91.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.359 0.6 . . . . 0.0 109.49 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.5 ttt -62.07 -41.66 98.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -67.15 -47.14 71.96 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.382 0.611 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.8 tpt85 -66.55 -44.56 81.99 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.844 -0.535 . . . . 0.0 109.657 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -63.14 -45.87 89.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.558 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.9 -34.54 90.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.12 92.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.806 -0.82 . . . . 0.0 109.338 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.39 -37.07 77.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.643 0.735 . . . . 0.0 109.847 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.486 0.66 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -148.28 157.25 43.37 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.807 0.813 . . . . 0.0 110.757 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.0 mt -109.31 131.4 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.51 0.671 . . . . 0.0 109.441 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -128.96 134.3 48.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.714 0.769 . . . . 0.0 109.624 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.83 -71.47 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 10' ' ' VAL . 44.9 m -107.0 122.95 47.46 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.863 0.84 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 7' ' ' SER . 25.8 mtmm 40.63 -168.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.818 0.818 . . . . 0.0 111.538 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.21 86.25 0.32 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 7' ' ' SER . 54.7 t -120.12 132.67 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.813 0.816 . . . . 0.0 109.632 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.77 143.66 46.42 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.6 0.714 . . . . 0.0 110.19 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' VAL . 48.6 tp10 -137.65 -77.57 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' GLU . 82.8 p 37.44 31.09 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.292 0.568 . . . . 0.0 110.217 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' GLU . 53.6 t -69.57 -19.93 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.725 -0.609 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.452 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 3.5 t 64.18 52.89 1.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.897 -0.502 . . . . 0.0 110.288 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 37.1 Cg_endo -65.14 150.81 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.617 2.211 . . . . 0.0 112.559 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.57 132.48 45.55 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.685 0.755 . . . . 0.0 110.211 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.13 128.3 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.62 0.724 . . . . 0.0 109.764 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.451 ' C ' HD22 ' A' ' 20' ' ' LEU . 42.1 ttm180 -134.14 136.48 43.86 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.733 0.778 . . . . 0.0 109.765 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.895 HD22 ' N ' ' A' ' 20' ' ' LEU . 1.1 mm? -104.92 124.52 49.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.606 0.717 . . . . 0.0 109.668 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.4 m -132.65 153.4 51.13 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.159 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -105.05 152.53 22.63 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.873 0.844 . . . . 0.0 110.223 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.746 0.784 . . . . 0.0 110.993 -179.164 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.705 0.764 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.57 142.55 23.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.7 ptp -153.84 166.42 32.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.946 -0.738 . . . . 0.0 110.298 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.25 143.18 49.74 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -109.63 143.61 39.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.793 0.806 . . . . 0.0 110.335 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -123.57 135.9 54.24 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.58 0.705 . . . . 0.0 109.626 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -120.04 126.81 51.71 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.783 0.801 . . . . 0.0 109.606 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 45.8 m-85 -108.21 119.29 39.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.464 0.65 . . . . 0.0 109.366 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.79 122.71 43.17 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.62 0.724 . . . . 0.0 109.939 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 40.71 56.74 8.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-O 121.036 0.446 . . . . 0.0 110.097 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.74 144.03 82.44 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.445 2.097 . . . . 0.0 112.783 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 41' ' ' LEU . 26.4 m -69.32 -21.64 63.84 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.108 0.48 . . . . 0.0 110.018 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 tp -60.61 0.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.424 -0.797 . . . . 0.0 109.594 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.2 mt -89.67 -12.25 40.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.09 -14.16 17.9 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.13 -49.82 3.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.488 -0.758 . . . . 0.0 109.488 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.0 155.47 48.82 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.779 0.799 . . . . 0.0 110.024 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -72.99 160.03 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 110.396 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -66.37 -34.55 78.23 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.39 -17.67 61.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.738 -0.601 . . . . 0.0 109.865 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -85.29 -1.7 57.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.11 123.78 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.448 -0.782 . . . . 0.0 110.391 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -119.52 91.85 3.65 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.802 0.81 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.24 54.37 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.7 ttp -134.19 132.22 39.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.917 -0.755 . . . . 0.0 109.643 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -106.5 110.65 22.92 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.911 0.862 . . . . 0.0 109.759 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.87 114.0 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.391 0.615 . . . . 0.0 109.483 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -111.42 129.72 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.63 0.729 . . . . 0.0 109.633 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 96' ' ' PHE . 99.0 m-20 -134.8 -80.88 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' GLY . 67.3 t0 -144.81 98.2 3.15 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.617 -0.677 . . . . 0.0 109.517 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 97.2 mt-10 65.05 -42.72 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.385 0.612 . . . . 0.0 109.684 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -87.43 137.35 14.55 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -143.26 144.45 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.897 -0.766 . . . . 0.0 109.99 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.2 132.97 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.548 0.69 . . . . 0.0 109.243 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.9 mp -107.03 132.21 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.683 0.754 . . . . 0.0 109.804 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 65' ' ' GLU . 87.7 m -117.86 122.35 43.12 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.782 0.801 . . . . 0.0 109.5 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -95.48 1.23 53.91 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.7 mp0 -96.25 71.07 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.03 132.87 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.653 0.739 . . . . 0.0 109.718 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -134.29 141.87 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.936 0.874 . . . . 0.0 109.826 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.73 142.21 28.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -109.47 119.9 40.85 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.788 0.804 . . . . 0.0 109.183 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.58 124.07 49.92 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.646 0.736 . . . . 0.0 109.811 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 95.6 mt -114.2 139.32 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.591 0.71 . . . . 0.0 109.304 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 60.33 32.42 20.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.468 0.652 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.95 31.38 80.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -158.78 152.04 18.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 O-C-N 121.63 -0.924 . . . . 0.0 109.769 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -51.54 141.18 43.11 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.9 m -161.68 -35.63 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.512 -0.742 . . . . 0.0 109.874 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 35' ' ' PHE . . . -154.27 171.22 19.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 0.0 110.7 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.63 128.06 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.561 0.696 . . . . 0.0 109.331 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -109.4 143.82 38.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.644 0.735 . . . . 0.0 109.447 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.1 148.76 30.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.681 -0.637 . . . . 0.0 109.9 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -122.75 129.27 51.56 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.47 112.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.921 0.867 . . . . 0.0 109.296 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.629 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.5 mp -82.6 128.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.504 0.668 . . . . 0.0 109.768 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.6 mt -118.31 62.86 0.76 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.59 -38.82 90.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.73 -0.606 . . . . 0.0 109.544 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -62.08 148.42 44.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.457 -0.777 . . . . 0.0 110.212 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.429 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 1.8 mp0 -76.53 -62.28 0.68 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.982 -0.449 . . . . 0.0 110.479 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 12.1 Cg_endo -57.25 -26.77 71.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.078 1.852 . . . . 0.0 111.522 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -67.01 -35.55 80.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.888 -0.508 . . . . 0.0 109.665 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -44.79 96.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.754 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.93 -47.81 83.23 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.214 0.531 . . . . 0.0 110.043 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -64.7 -42.13 95.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.592 -0.693 . . . . 0.0 110.062 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -61.66 -42.72 99.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.733 -0.604 . . . . 0.0 109.755 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 tpt -62.54 -39.23 92.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.625 -0.672 . . . . 0.0 109.764 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.8 -45.78 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.707 -0.621 . . . . 0.0 110.104 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.441 ' CD1' ' OD2' ' A' ' 56' ' ' ASP . 37.6 m-85 -68.7 -37.64 79.68 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 29.9 mmt -64.58 -39.77 94.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.18 -46.08 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.647 . . . . 0.0 109.865 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -67.09 -41.95 85.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.67 ' CD1' ' ND2' ' A' ' 104' ' ' ASN . 54.4 t80 -61.72 -45.9 91.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.574 -0.704 . . . . 0.0 110.027 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.24 -36.03 92.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.4 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -1.126 . . . . 0.0 109.026 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.28 -42.92 68.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.67 ' ND2' ' CD1' ' A' ' 100' ' ' TYR . 17.6 m-80 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.354 0.597 . . . . 0.0 109.466 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.78 0.8 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -154.47 135.02 13.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.797 0.808 . . . . 0.0 110.276 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.453 HD12 ' CZ ' ' A' ' 100' ' ' TYR . 97.2 mt -119.2 128.61 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.687 0.756 . . . . 0.0 109.698 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -153.63 159.51 42.11 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.676 0.75 . . . . 0.0 109.773 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -89.96 -1.57 58.0 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.544 ' OG ' ' N ' ' A' ' 8' ' ' LYS . 18.4 p -145.99 -134.07 0.08 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.376 -0.827 . . . . 0.0 110.001 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.544 ' N ' ' OG ' ' A' ' 7' ' ' SER . 8.6 mtmp? -146.52 102.2 3.55 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.874 0.845 . . . . 0.0 109.948 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.91 3.65 42.37 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 10' ' ' VAL . 11.6 p -96.18 20.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.766 -0.844 . . . . 0.0 109.446 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 10' ' ' VAL . . . -33.21 112.44 0.12 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.686 0.755 . . . . 0.0 110.746 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.426 ' HB3' HG23 ' A' ' 14' ' ' VAL . 92.4 mt-10 -94.52 -8.01 39.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.8 p 53.26 14.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.405 0.621 . . . . 0.0 109.56 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 12' ' ' GLU . 55.8 t -69.33 155.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.651 0.739 . . . . 0.0 110.556 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 14' ' ' VAL . 11.0 t -115.36 84.88 12.26 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.68 153.33 26.3 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.943 2.429 . . . . 0.0 112.468 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.11 150.26 25.66 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.038 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 100.0 t -124.25 132.53 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.641 0.734 . . . . 0.0 109.837 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' C ' HD22 ' A' ' 20' ' ' LEU . 90.0 mtm180 -131.65 139.76 49.18 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.853 0.835 . . . . 0.0 109.721 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.9 mm? -96.43 144.02 26.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.674 0.749 . . . . 0.0 110.035 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -155.69 170.45 22.0 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.74 0.781 . . . . 0.0 109.882 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' SER . 52.0 mtmt -141.46 124.27 16.1 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.684 0.754 . . . . 0.0 109.914 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 22' ' ' LYS . 33.6 t . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.321 0.581 . . . . 0.0 110.142 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.96 0.886 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.97 139.91 37.13 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.1 ttm -155.2 151.57 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.003 0.906 . . . . 0.0 110.212 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 131.34 23.51 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -114.05 132.56 55.97 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.846 0.831 . . . . 0.0 109.991 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -116.69 132.27 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -115.89 118.94 34.37 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -109.68 119.84 40.64 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.531 1.158 . . . . 0.0 109.915 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.36 113.78 25.87 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.011 0.91 . . . . 0.0 110.146 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 50.87 75.14 0.69 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.588 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' O ' ' N ' ' A' ' 40' ' ' ILE . 4.3 Cg_endo -82.13 15.13 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.808 2.338 . . . . 0.0 111.178 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' PRO . 4.1 p 39.63 22.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.266 0.555 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' PRO . 18.5 tt -92.79 -1.44 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.1 -18.56 20.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.91 -35.08 6.73 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.84 141.25 31.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.38 -0.825 . . . . 0.0 110.032 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -77.84 167.29 21.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.732 0.777 . . . . 0.0 109.928 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -64.83 -32.11 73.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.94 -35.44 80.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.86 -19.15 63.45 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.85 124.35 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.456 -0.778 . . . . 0.0 109.538 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.53 12.91 1.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.7 175.15 46.37 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.596 ' SD ' HD21 ' A' ' 54' ' ' LEU . 18.0 ttm -137.12 144.42 43.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.702 -0.881 . . . . 0.0 109.433 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -108.9 113.18 25.87 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.925 0.869 . . . . 0.0 109.898 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.596 HD21 ' SD ' ' A' ' 52' ' ' MET . 75.4 mt -95.06 114.69 26.52 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.52 0.676 . . . . 0.0 109.336 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.741 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -99.17 109.4 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.776 0.798 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 96.1 m-20 -88.84 -87.85 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 66.2 m-20 -159.37 -62.23 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 109.246 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -104.22 13.96 31.27 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.14 -0.975 . . . . 0.0 108.614 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.42 174.02 45.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -147.95 147.73 30.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.57 -0.959 . . . . 0.0 109.823 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.3 131.44 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.652 0.739 . . . . 0.0 109.68 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.8 mp -115.37 131.35 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.514 0.673 . . . . 0.0 109.441 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -125.24 131.15 53.18 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.839 0.828 . . . . 0.0 109.975 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -92.53 3.63 55.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -90.53 73.12 6.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.43 133.07 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.749 0.785 . . . . 0.0 109.521 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -133.83 142.88 48.03 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.746 0.784 . . . . 0.0 109.947 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.79 149.8 21.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -110.05 131.08 55.38 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.956 0.884 . . . . 0.0 109.67 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.75 125.41 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.53 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 96.8 mt -123.15 133.13 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.798 0.809 . . . . 0.0 109.572 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 71' ' ' ILE . 4.6 p30 58.33 25.76 13.17 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.888 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.32 31.37 16.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.137 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -168.81 150.52 4.63 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.073 -1.251 . . . . 0.0 110.588 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.8 87.49 0.44 Allowed 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.207 2.605 . . . . 0.0 112.257 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -104.68 -14.62 15.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.716 -0.615 . . . . 0.0 109.74 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.08 151.66 44.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.27 135.82 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.499 0.666 . . . . 0.0 109.982 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -126.28 164.45 21.0 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.947 0.879 . . . . 0.0 110.202 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.2 37.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.77 0.795 . . . . 0.0 109.634 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.0 m -124.97 127.21 46.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.67 0.748 . . . . 0.0 109.545 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.8 t -114.89 132.42 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.874 0.845 . . . . 0.0 109.81 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.3 mm -94.79 123.91 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.707 0.765 . . . . 0.0 109.825 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.5 mt -110.66 75.53 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -96.85 1.92 51.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -116.82 143.55 45.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.991 0.901 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 mt-30 -66.51 -48.57 55.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.633 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.6 Cg_exo -51.9 -38.25 68.15 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.866 1.71 . . . . 0.0 111.133 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -66.73 -39.5 88.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -63.29 -37.87 88.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.71 -0.619 . . . . 0.0 109.787 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.35 -50.94 71.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.664 -0.647 . . . . 0.0 109.853 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 93' ' ' PHE . 18.7 ptp180 -75.35 -39.29 59.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.743 -0.598 . . . . 0.0 109.921 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.417 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 69.1 t80 -64.22 -44.79 90.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.508 -0.745 . . . . 0.0 109.221 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.1 tpp -60.72 -46.94 88.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -66.09 -40.57 90.92 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.273 0.558 . . . . 0.0 109.513 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 86.4 t80 -63.21 -44.24 95.88 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 11.3 tpt -62.6 -39.79 94.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.619 -0.675 . . . . 0.0 109.54 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -66.08 -52.73 46.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.759 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -66.34 -44.75 82.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.453 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 81.0 t80 -63.4 -46.99 83.89 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.419 0.628 . . . . 0.0 109.342 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.57 88.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.85 83.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.646 -0.914 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.63 -55.7 6.45 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 p30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.748 0.785 . . . . 0.0 109.832 179.937 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 66.8 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' H ' ' NH1' ' A' ' 99' ' ' ARG . . . -66.79 135.98 54.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.591 -0.693 . . . . 0.0 110.013 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.542 ' CB ' ' NZ ' ' A' ' 110' ' ' LYS . 15.6 pt-20 -155.75 163.08 40.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.85 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.1 mt -108.52 130.51 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.632 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 98.1 mt-30 -129.43 135.02 48.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.495 -0.753 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -95.54 -10.36 29.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.559 -0.713 . . . . 0.0 109.161 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LYS . 22.7 m -150.64 22.56 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.171 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 7' ' ' SER . 23.8 mtmm 56.53 120.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.806 0.812 . . . . 0.0 110.909 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.632 ' H ' ' NE2' ' A' ' 5' ' ' GLN . . . 99.13 -16.72 58.98 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.52 97.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -1.105 . . . . 0.0 109.611 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 131.73 40.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.641 -0.662 . . . . 0.0 109.874 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.87 122.39 47.73 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.618 0.723 . . . . 0.0 109.758 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -91.7 -3.74 55.92 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 15' ' ' VAL . 54.3 t -51.53 157.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.503 -0.748 . . . . 0.0 110.156 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.434 ' N ' HG12 ' A' ' 14' ' ' VAL . 60.0 t -115.68 80.97 8.77 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.599 -0.688 . . . . 0.0 110.069 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.33 151.64 29.82 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.795 2.33 . . . . 0.0 112.346 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -87.22 152.72 22.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 109.713 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.09 130.14 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.483 0.659 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -132.6 145.72 51.32 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -102.19 140.43 36.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.509 -0.744 . . . . 0.0 109.625 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.6 m -152.25 167.06 29.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -105.25 166.95 10.05 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.603 0.716 . . . . 0.0 109.812 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -69.12 170.91 9.12 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.706 0.765 . . . . 0.0 110.439 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -61.8 -39.67 92.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.592 -0.692 . . . . 0.0 109.416 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -88.73 -2.18 58.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 109.016 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.65 16.88 77.82 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -80.23 -91.4 0.05 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -1.08 . . . . 0.0 110.645 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.428 ' CB ' ' OD1' ' A' ' 85' ' ' ASN . 22.1 m -78.93 149.27 32.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.558 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 162.01 43.45 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.1 ptm -159.87 171.56 19.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.531 -0.982 . . . . 0.0 109.227 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.79 148.9 48.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.487 -0.758 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.42 148.12 31.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.71 -0.619 . . . . 0.0 109.666 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.81 136.2 52.06 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.25 123.49 50.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.797 -0.564 . . . . 0.0 109.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -111.31 122.83 48.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.3 tp -103.67 124.95 49.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.776 0.798 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.409 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 56.4 mt-10 42.5 54.89 9.83 Favored Pre-proline 0 N--CA 1.492 1.665 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -66.79 149.33 83.49 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.264 1.976 . . . . 0.0 111.947 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' LEU . 66.9 p -74.43 -19.9 60.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 40' ' ' ILE . 9.2 tp -59.96 0.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.734 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 39' ' ' THR . 94.1 mt -90.93 -9.66 45.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.955 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.36 -24.95 13.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 109.418 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -93.59 -73.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.248 -0.907 . . . . 0.0 109.977 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -104.36 148.11 26.76 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.824 0.821 . . . . 0.0 110.704 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.7 m -71.8 156.15 39.63 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.728 0.775 . . . . 0.0 110.449 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -65.86 -32.65 74.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.647 -0.658 . . . . 0.0 109.628 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -75.1 -8.05 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.688 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.89 -3.37 54.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 94.0 mt -95.47 122.94 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.943 . . . . 0.0 109.802 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.1 m -121.31 -3.12 9.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -172.97 170.39 43.53 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.637 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.514 ' SD ' ' HB2' ' A' ' 80' ' ' ALA . 63.1 mtp -128.17 143.82 51.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.711 -0.876 . . . . 0.0 109.076 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.86 108.78 19.7 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.515 0.674 . . . . 0.0 109.785 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 55' ' ' ILE . 78.3 mt -93.59 110.28 21.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -98.05 111.81 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.05 176.91 6.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.603 0.716 . . . . 0.0 109.885 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.06 -39.08 93.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -88.91 -76.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.94 10.81 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.498 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.6 pm0 -142.79 153.73 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.635 -0.92 . . . . 0.0 109.108 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.452 HD13 ' OE2' ' A' ' 89' ' ' GLU . 96.4 mt -119.22 135.5 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.491 -0.756 . . . . 0.0 109.939 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -100.12 126.9 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.733 . . . . 0.0 109.447 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.6 m -121.76 125.21 46.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -108.26 -6.25 16.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.09 78.64 7.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.474 -0.766 . . . . 0.0 109.056 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.7 t -121.86 133.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.714 -0.616 . . . . 0.0 109.715 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.22 142.9 50.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.495 0.664 . . . . 0.0 109.73 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.63 143.26 16.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.14 106.73 17.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.896 . . . . 0.0 108.667 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.55 143.81 30.29 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.371 0.605 . . . . 0.0 110.239 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.35 109.16 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 53.98 35.88 23.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 110.079 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.85 78.75 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -121.57 99.25 45.31 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.963 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.86 130.4 30.9 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.339 2.026 . . . . 0.0 112.561 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m -152.83 -29.9 0.14 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.644 -0.66 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.18 154.08 51.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.218 -0.926 . . . . 0.0 110.726 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.75 143.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 14.3 tm-20 -119.94 150.22 40.85 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.58 0.705 . . . . 0.0 109.909 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HB2' ' SD ' ' A' ' 52' ' ' MET . . . -139.4 145.35 38.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.7 m -125.29 132.62 52.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.698 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.08 130.48 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.667 -0.646 . . . . 0.0 109.307 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 32.3 mm -93.34 128.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.791 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.3 mt -108.4 55.3 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' CB ' ' A' ' 28' ' ' SER . 86.0 m-20 -64.34 -40.65 96.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.616 -0.677 . . . . 0.0 109.31 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 m -84.27 154.96 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 0.0 110.452 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.9 mp0 -74.89 -59.43 1.42 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.799 -0.563 . . . . 0.0 110.914 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 2.8 Cg_endo -48.51 -17.48 1.05 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.713 1.608 . . . . 0.0 111.266 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.452 ' OE2' HD13 ' A' ' 61' ' ' ILE . 34.1 tp10 -64.9 -37.02 86.24 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.27 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -60.61 -36.52 78.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.487 -0.758 . . . . 0.0 109.815 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -58.32 -47.0 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.509 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.35 -39.9 81.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -62.28 -47.89 82.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 110.39 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.7 mmm -64.05 -43.21 96.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.637 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.45 -43.67 89.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.778 . . . . 0.0 109.624 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -61.54 -47.67 84.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 tpt -65.71 -41.0 92.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -63.01 -53.16 58.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.702 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.587 ' NH2' ' N ' ' A' ' 1' ' ' MET . 78.2 ttt-85 -68.99 -43.34 75.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.434 -0.791 . . . . 0.0 110.16 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -62.67 -46.01 90.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.96 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.03 -36.23 93.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.43 95.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 0.0 109.649 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.83 -43.59 71.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.875 . . . . 0.0 109.422 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.513 HD21 ' CB ' ' A' ' 110' ' ' LYS . 87.1 m-20 -121.12 127.64 51.79 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.639 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 107' ' ' GLY . . . -90.84 47.26 2.96 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 106' ' ' LEU . 10.4 mp 58.05 1.57 0.15 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.769 -0.842 . . . . 0.0 110.174 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 105' ' ' GLY . . . -135.42 -24.38 0.55 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -90.45 138.65 31.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -1.107 . . . . 0.0 110.476 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.5 m -76.32 145.71 39.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.703 0.763 . . . . 0.0 110.297 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.542 ' NZ ' ' CB ' ' A' ' 3' ' ' GLU . 31.0 ttpt -64.96 -35.68 81.96 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.566 0.698 . . . . 0.0 109.628 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 113' ' ' LEU . 20.0 p -62.27 171.36 1.88 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.749 . . . . 0.0 110.136 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 65.31 -62.65 0.21 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.345 0.593 . . . . 0.0 109.557 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 111' ' ' SER . 89.4 mt -63.14 -41.87 99.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 0.0 109.597 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -95.52 122.43 38.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 109.793 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -74.18 140.89 45.45 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.571 0.701 . . . . 0.0 110.41 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.29 156.36 24.34 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.571 -0.706 . . . . 0.0 109.783 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -137.99 148.23 44.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -66.07 -40.85 91.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.544 -0.723 . . . . 0.0 109.881 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -70.15 130.0 40.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.336 -0.852 . . . . 0.0 110.317 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 35.4 m80 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.361 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 3' ' ' GLU . 39.1 mmt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 32.1 -89.7 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 120.922 0.392 . . . . 0.0 110.775 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 1' ' ' MET . 49.8 tp10 -124.61 134.12 53.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.473 -0.767 . . . . 0.0 108.991 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.39 128.84 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -141.06 150.21 42.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.33 -0.856 . . . . 0.0 109.826 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.66 -7.78 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 8' ' ' LYS . 9.9 t -155.21 80.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.37 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.7 mttm 43.14 -168.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.708 0.766 . . . . 0.0 111.229 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.27 88.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 75.0 t -78.01 -94.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -1.055 . . . . 0.0 109.221 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 175.67 55.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.445 -0.784 . . . . 0.0 108.935 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -163.67 121.49 1.86 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.6 m -93.33 88.87 6.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.953 . . . . 0.0 109.279 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.6 t -78.64 135.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.592 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.94 80.88 15.1 Favored Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 109.754 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.72 158.73 24.89 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.733 2.289 . . . . 0.0 112.406 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.94 159.5 28.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.881 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -109.1 128.77 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.6 -0.687 . . . . 0.0 109.387 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -135.18 135.21 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt -102.28 135.74 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.426 -0.796 . . . . 0.0 109.735 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.09 129.42 45.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 25' ' ' ASN . 14.5 m -71.66 134.69 46.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 110.503 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 44.57 14.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.825 -0.547 . . . . 0.0 109.933 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 23' ' ' SER . 94.2 m-20 52.29 34.1 14.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.666 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.47 55.66 0.03 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -151.06 -56.38 0.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -1.087 . . . . 0.0 109.475 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.8 p -150.9 119.5 6.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.055 . . . . 0.0 109.736 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.07 139.85 25.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.4 ptt? -162.19 165.16 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -1.128 . . . . 0.0 108.865 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.36 140.33 50.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 109.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.99 145.3 32.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.235 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -117.38 133.78 55.58 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -104.0 125.37 50.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.602 -0.686 . . . . 0.0 109.869 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.2 114.82 28.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.8 tp -97.58 121.64 39.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 109.611 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' LEU . 49.6 mt-10 39.35 58.88 6.3 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.74 -0.6 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.0 Cg_endo -63.81 145.14 90.36 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.514 2.143 . . . . 0.0 112.532 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 p -81.35 26.78 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.069 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 40' ' ' ILE . 10.5 tp -102.73 -21.99 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.14 -41.1 97.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.88 76.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.54 -0.725 . . . . 0.0 109.582 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -88.45 -65.65 1.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.041 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.26 143.0 45.15 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.7 t -80.27 167.8 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.438 0.637 . . . . 0.0 110.098 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -65.01 -36.0 82.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 109.774 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -64.8 -39.1 93.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.814 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.02 -34.85 79.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.097 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.63 126.0 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 0.0 110.005 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 m -126.14 -0.17 7.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.97 -175.29 36.96 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.451 ' CE ' HD21 ' A' ' 54' ' ' LEU . 63.0 ttp -135.47 136.22 41.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.514 -0.992 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.421 ' CE2' HD12 ' A' ' 62' ' ' ILE . 92.4 m-85 -106.31 116.8 32.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.452 -0.78 . . . . 0.0 109.417 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.451 HD21 ' CE ' ' A' ' 52' ' ' MET . 91.6 mt -96.89 115.06 26.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.893 . . . . 0.0 108.907 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 55' ' ' ILE . 3.3 mp -108.53 132.75 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.406 0.622 . . . . 0.0 109.713 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 99' ' ' ARG . 36.1 t0 -125.49 43.68 3.0 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.456 ' H ' HG22 ' A' ' 55' ' ' ILE . 66.9 m-20 54.86 5.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.808 -0.558 . . . . 0.0 109.619 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 56' ' ' ASP . 97.8 mt-10 -146.75 -105.46 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.514 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.23 164.36 52.58 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.29 153.27 47.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.27 -1.135 . . . . 0.0 110.232 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.4 135.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' CE2' ' A' ' 53' ' ' TYR . 37.2 mm -104.37 125.57 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.386 -0.821 . . . . 0.0 109.177 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.8 m -123.13 124.44 43.08 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -100.56 -9.26 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.18 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -83.38 75.74 9.96 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.234 -0.916 . . . . 0.0 109.275 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.03 134.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.553 -0.717 . . . . 0.0 109.724 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -126.37 138.97 53.62 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.96 136.1 12.58 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.66 125.43 49.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.495 -1.003 . . . . 0.0 109.144 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -109.05 144.21 37.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.757 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 90.8 mt -120.27 129.44 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 m120 57.54 32.45 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -0.759 . . . . 0.0 109.285 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.89 22.75 75.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -136.88 127.93 16.47 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.296 -1.12 . . . . 0.0 109.704 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.21 136.19 30.89 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.078 1.852 . . . . 0.0 112.539 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -154.34 -34.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.712 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.66 152.32 42.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.023 . . . . 0.0 110.248 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 79' ' ' GLU . 94.0 mt -130.86 163.51 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 78' ' ' ILE . 45.5 tt0 -142.01 151.82 42.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.1 141.65 36.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.0 m -119.79 129.45 54.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.569 -0.707 . . . . 0.0 109.702 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.29 129.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.5 0.667 . . . . 0.0 109.518 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.2 mp -81.97 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.594 -0.691 . . . . 0.0 110.156 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 71.4 mt -119.07 40.12 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.95 -40.32 97.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -0.836 . . . . 0.0 109.497 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.0 139.84 41.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.016 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 4.2 mm-40 -66.32 -40.63 36.4 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.73 . . . . 0.0 110.403 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.9 Cg_exo -58.88 -33.08 98.44 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.029 1.819 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -67.11 -38.27 85.32 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.441 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 46.5 m95 -61.22 -41.82 97.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.18 -47.15 87.51 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -70.15 -42.09 72.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.487 -0.758 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -61.54 -45.83 92.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 84.9 mmm -64.78 -41.79 95.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.031 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NH1' ' CZ ' ' A' ' 99' ' ' ARG . 70.2 ttp85 -64.62 -41.36 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.581 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.553 ' CD1' ' NH2' ' A' ' 99' ' ' ARG . 3.2 m-85 -59.63 -42.66 93.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.785 . . . . 0.0 109.008 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.42 ' SD ' ' C ' ' A' ' 97' ' ' MET . 11.0 tmm? -61.7 -39.69 92.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.491 -0.755 . . . . 0.0 110.017 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.96 -48.34 82.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.052 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' CD1' ' A' ' 96' ' ' PHE . 88.8 mtm180 -66.03 -37.77 86.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.205 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.596 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 90.6 t80 -60.67 -44.97 95.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.43 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.82 92.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -1.073 . . . . 0.0 109.603 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -84.96 -10.25 57.25 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 76.0 m-20 -137.09 -150.45 0.36 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.349 -0.845 . . . . 0.0 109.473 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 107' ' ' GLY . . . -154.64 50.96 0.47 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 106' ' ' LEU . 3.0 mm? 39.07 26.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.737 -0.86 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 105' ' ' GLY . . . -165.32 -147.31 5.1 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -74.35 143.49 44.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -1.041 . . . . 0.0 110.656 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 110' ' ' LYS . 14.5 p -160.66 -137.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 110.172 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' N ' ' OG ' ' A' ' 109' ' ' SER . 65.3 mttp -66.77 81.56 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 110.397 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.9 p -160.4 -75.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.368 -0.833 . . . . 0.0 109.518 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -85.48 -16.73 38.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 114' ' ' GLU . 4.5 mp -99.85 -63.19 1.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.36 -0.837 . . . . 0.0 109.3 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 113' ' ' LEU . 96.2 mt-10 41.28 63.7 1.18 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.618 0.723 . . . . 0.0 110.011 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -67.54 -39.53 85.02 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.47 -0.769 . . . . 0.0 109.216 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 55.57 91.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.633 0.73 . . . . 0.0 110.216 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.494 ' O ' ' ND1' ' A' ' 119' ' ' HIS . 73.0 m80 -67.03 -41.94 85.72 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.504 -0.747 . . . . 0.0 109.501 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.551 ' O ' ' CG ' ' A' ' 119' ' ' HIS . 84.4 t60 -66.53 -42.22 87.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 109.514 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 118' ' ' HIS . 39.9 p-80 41.97 -167.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.551 0.691 . . . . 0.0 110.712 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.862 -179.553 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.384 0.611 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.75 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.541 -0.725 . . . . 0.0 109.901 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -154.83 161.81 41.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.373 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.618 -0.676 . . . . 0.0 109.524 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -154.37 154.91 34.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.122 -0.986 . . . . 0.0 109.43 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -86.24 -4.52 59.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 t -167.82 147.09 4.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 109.285 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -65.21 138.82 58.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.54 -12.53 64.69 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 85.0 t -112.33 127.21 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.597 -0.943 . . . . 0.0 110.077 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 168.85 96.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' VAL . 51.1 tp10 -168.6 130.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.226 -0.921 . . . . 0.0 109.158 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m 70.08 -9.41 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.635 -0.666 . . . . 0.0 109.373 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' H ' ' C ' ' A' ' 12' ' ' GLU . 6.6 t -80.98 130.27 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.6 t -142.59 83.5 11.75 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.253 -0.905 . . . . 0.0 108.722 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -79.69 145.62 18.32 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.392 2.061 . . . . 0.0 112.867 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -89.3 157.71 18.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.239 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.62 130.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 0.0 109.084 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -132.28 143.04 49.62 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.493 -0.755 . . . . 0.0 109.167 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.3 mt -103.72 132.55 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.421 -0.8 . . . . 0.0 108.918 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.9 m -129.81 153.6 48.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -109.02 143.95 37.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.524 -0.735 . . . . 0.0 109.108 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.484 ' CB ' ' OG ' ' A' ' 28' ' ' SER . 67.1 m -72.94 155.03 40.28 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.735 0.779 . . . . 0.0 110.992 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -39.45 128.71 1.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.694 0.759 . . . . 0.0 111.139 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 59.8 26.25 15.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.72 -0.613 . . . . 0.0 110.06 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 40.68 54.72 3.4 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -104.03 -11.75 17.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -1.06 . . . . 0.0 109.253 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.484 ' OG ' ' CB ' ' A' ' 23' ' ' SER . 23.8 p -152.83 160.72 43.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.177 -0.952 . . . . 0.0 109.716 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.42 146.89 21.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.2 ttp -152.17 159.0 43.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -1.131 . . . . 0.0 109.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.23 150.09 36.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.9 145.66 46.49 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 0.0 109.88 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.41 137.24 54.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -119.42 127.22 52.9 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.4 122.17 46.79 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' GLU . 40.2 tp -93.45 125.5 38.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.497 -0.752 . . . . 0.0 110.009 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LEU . 30.9 mt-10 40.32 71.85 1.15 Allowed Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.756 -0.59 . . . . 0.0 110.551 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.23 142.85 97.67 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.829 2.353 . . . . 0.0 111.997 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.8 p -86.25 -17.3 35.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -70.61 1.79 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.917 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.58 -7.36 59.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 109.207 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.11 -23.96 16.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.333 -0.855 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -99.73 -73.18 0.64 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.466 -0.771 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.55 159.52 15.68 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.478 -0.763 . . . . 0.0 110.066 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -81.33 168.73 18.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -66.64 -37.28 84.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.554 -0.716 . . . . 0.0 109.804 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.27 -24.11 62.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -76.68 -5.54 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.572 -0.705 . . . . 0.0 109.706 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.3 mt -88.11 -87.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 m 66.94 -40.36 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -103.09 144.2 15.95 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -126.05 129.87 50.01 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -102.94 119.96 39.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.349 -0.845 . . . . 0.0 110.009 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 55' ' ' ILE . 24.7 mt -102.78 113.7 27.34 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.759 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -98.47 103.23 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 94.5 m-20 -95.12 176.24 6.31 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.644 0.735 . . . . 0.0 110.597 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.0 -36.61 84.96 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.729 -0.607 . . . . 0.0 109.786 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.19 -77.4 0.33 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.292 -0.88 . . . . 0.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.74 -145.52 6.79 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.66 153.51 43.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.394 -1.063 . . . . 0.0 109.799 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.04 133.25 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.4 mm -107.47 128.79 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 109.305 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 65' ' ' GLU . 53.2 m -123.84 127.86 48.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.448 0.642 . . . . 0.0 109.691 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -96.03 -3.71 44.38 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' H ' HG22 ' A' ' 63' ' ' THR . 96.2 mt-10 -86.36 83.53 7.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 109.541 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.16 133.58 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -127.49 137.89 52.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.571 -0.705 . . . . 0.0 109.25 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.88 138.08 13.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -105.86 105.81 16.03 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -98.82 147.15 25.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.226 0.536 . . . . 0.0 109.595 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 41.5 mm -125.24 135.66 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 12.2 p30 -38.89 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.697 0.761 . . . . 0.0 110.48 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 147.63 -60.77 0.46 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -175.26 154.53 1.66 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.184 -1.186 . . . . 0.0 109.43 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.33 129.98 8.68 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.745 1.63 . . . . 0.0 112.056 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.1 p -113.7 -35.07 5.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.686 -0.634 . . . . 0.0 109.604 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.39 169.41 22.03 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.363 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.54 128.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -111.18 150.07 30.03 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.518 0.675 . . . . 0.0 109.668 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.91 38.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -113.46 129.24 56.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.55 132.33 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.398 -0.814 . . . . 0.0 109.018 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.6 mm -92.59 127.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.856 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 78.6 mt -113.28 40.59 2.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.45 -39.72 94.31 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.491 0.663 . . . . 0.0 109.691 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.3 m -66.32 150.04 49.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 110.487 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.493 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 4.1 mp0 -73.04 -57.48 2.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.878 -0.514 . . . . 0.0 110.152 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 12.7 Cg_endo -54.02 -34.9 79.23 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.777 1.652 . . . . 0.0 111.35 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.66 -39.08 88.03 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.156 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -63.14 -44.82 94.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 108.933 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.11 -43.35 99.03 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.435 -0.791 . . . . 0.0 109.14 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.6 -42.39 95.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.083 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -59.76 -46.86 87.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.513 -0.742 . . . . 0.0 109.634 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.8 tpp -60.75 -46.42 90.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -65.09 -42.72 93.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.212 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.462 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 73.5 t80 -62.12 -43.82 98.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.28 -42.7 91.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.435 -0.791 . . . . 0.0 109.938 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.05 -47.08 75.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 110.137 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -67.91 -42.71 80.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.083 -1.011 . . . . 0.0 110.015 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 104' ' ' ASN . 89.6 t80 -62.05 -46.23 90.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.427 -0.795 . . . . 0.0 110.346 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.61 -36.33 93.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.422 ' HB3' ' OE1' ' A' ' 103' ' ' GLU . . . -60.65 -46.39 90.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.99 -1.3 . . . . 0.0 109.058 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -69.67 -50.35 44.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' TYR . 53.3 p30 -172.54 175.71 3.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.445 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.612 ' C ' HD12 ' A' ' 106' ' ' LEU . . . 126.81 -148.87 17.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 106' ' ' LEU . 3.4 mp 56.28 -159.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.845 -0.797 . . . . 0.0 110.789 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 108' ' ' PHE . . . -73.24 115.25 5.06 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 107' ' ' GLY . 96.6 m-85 39.55 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.906 -0.761 . . . . 0.0 110.174 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m -71.15 164.17 26.16 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.724 0.773 . . . . 0.0 110.378 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.0 pttm -96.37 -28.38 14.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.49 -0.756 . . . . 0.0 109.656 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 113' ' ' LEU . 40.6 t -73.21 138.51 45.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.0 110.131 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 64.52 -30.55 0.12 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.677 -0.639 . . . . 0.0 110.455 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.557 ' H ' ' C ' ' A' ' 111' ' ' SER . 0.2 OUTLIER -63.77 -43.75 95.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.168 -0.958 . . . . 0.0 110.009 -179.048 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -85.78 146.0 26.98 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.154 -0.966 . . . . 0.0 109.957 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -111.6 -171.18 1.79 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.685 -0.635 . . . . 0.0 109.837 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.6 m80 54.92 -176.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.599 0.714 . . . . 0.0 110.678 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -76.72 142.69 40.39 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.573 0.701 . . . . 0.0 110.398 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -66.75 -39.0 87.75 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.4 0.619 . . . . 0.0 109.549 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.1 t60 44.93 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.55 0.691 . . . . 0.0 110.325 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.876 -1.059 . . . . 0.0 108.959 179.17 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 41.77 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.67 0.747 . . . . 0.0 110.285 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.9 145.39 37.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.305 -0.872 . . . . 0.0 109.727 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 88.2 mt -108.18 127.29 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 110.0 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -152.28 158.68 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.534 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -103.99 -35.68 8.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -129.66 151.47 50.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.36 139.08 57.17 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.764 0.792 . . . . 0.0 110.717 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.09 28.94 26.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -111.15 133.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.441 -1.035 . . . . 0.0 109.844 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 142.71 52.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.849 0.833 . . . . 0.0 110.455 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 1.2 pm0 -101.32 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 p -95.03 -9.03 35.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.38 -0.825 . . . . 0.0 109.187 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -71.5 134.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.84 82.13 12.77 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.569 -0.707 . . . . 0.0 110.051 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.78 151.25 24.59 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.965 2.444 . . . . 0.0 112.459 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 56.2 mp0 -91.69 153.81 19.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.68 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' A' ' 33' ' ' PHE . 60.7 t -116.87 133.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.417 0.627 . . . . 0.0 109.569 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.481 ' NH2' ' OE2' ' A' ' 79' ' ' GLU . 90.5 mtm-85 -121.71 140.52 52.21 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.49 110.61 23.01 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.668 0.747 . . . . 0.0 109.295 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 86.3 p -83.82 168.34 16.24 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.706 -0.621 . . . . 0.0 109.815 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -111.37 122.51 48.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.823 0.821 . . . . 0.0 109.824 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.446 ' H ' ' H ' ' A' ' 24' ' ' LYS . 2.9 p -178.3 3.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' H ' ' H ' ' A' ' 23' ' ' SER . 26.1 pttm -63.84 -37.36 87.11 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -105.29 6.98 33.25 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.6 -59.63 0.67 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -153.7 -36.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -1.093 . . . . 0.0 109.483 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 23' ' ' SER . 27.9 m -170.34 110.54 0.39 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.11 -0.993 . . . . 0.0 109.75 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 141.17 41.8 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -162.91 168.95 20.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -1.102 . . . . 0.0 110.189 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.09 146.73 45.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -104.31 148.96 25.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.541 -0.724 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.543 ' CE2' HG22 ' A' ' 18' ' ' VAL . 30.1 m-85 -117.66 129.92 56.04 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.99 123.48 43.32 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.53 0.681 . . . . 0.0 109.848 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.71 126.59 55.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.5 tp -117.29 117.97 30.99 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.341 0.591 . . . . 0.0 110.364 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 39' ' ' THR . 95.5 mt-10 31.91 70.4 0.71 Allowed Pre-proline 0 N--CA 1.497 1.905 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -65.53 12.48 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.769 2.313 . . . . 0.0 110.97 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.8 m 67.7 -3.35 1.15 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.415 0.626 . . . . 0.0 109.462 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 38' ' ' PRO . 20.3 tt -86.03 -0.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.27 -9.81 59.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 109.208 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.9 -18.92 21.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.898 . . . . 0.0 109.253 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -107.73 -41.76 4.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.502 -0.749 . . . . 0.0 109.82 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 48' ' ' ASP . 79.3 mm-40 -136.0 138.11 41.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.325 -0.859 . . . . 0.0 110.253 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -77.23 168.89 19.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.855 0.836 . . . . 0.0 110.521 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -64.8 -32.47 74.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.697 . . . . 0.0 109.713 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -65.22 -36.71 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.299 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.415 ' OD2' ' OE1' ' A' ' 44' ' ' GLU . 62.4 m-20 -64.41 -36.27 83.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 108.928 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.64 129.07 37.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.41 -0.807 . . . . 0.0 109.966 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 t -144.77 49.06 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' N ' HG21 ' A' ' 66' ' ' VAL . . . 163.57 162.92 15.24 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.4 ttp -129.31 131.02 46.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.944 . . . . 0.0 108.932 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 53' ' ' TYR . 29.6 m-85 -108.6 109.62 20.88 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.76 0.791 . . . . 0.0 110.127 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 55' ' ' ILE . 75.1 mt -100.58 121.72 42.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.756 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.5 mp -105.42 113.7 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.342 -0.848 . . . . 0.0 109.52 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 86.7 m-20 -92.39 171.98 8.69 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.459 0.647 . . . . 0.0 110.148 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' OD2' ' CZ ' ' A' ' 99' ' ' ARG . 39.6 p-10 -79.01 -4.76 51.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.877 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.44 -18.15 5.83 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ASP . . . -173.89 -151.06 7.97 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -152.34 145.05 24.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -1.157 . . . . 0.0 109.235 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.481 HD13 ' OE2' ' A' ' 89' ' ' GLU . 96.3 mt -114.7 129.56 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.517 -0.739 . . . . 0.0 109.114 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -112.71 130.56 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.59 0.71 . . . . 0.0 109.765 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 t -138.99 145.27 39.5 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.535 0.683 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.1 mmm-85 -100.89 4.26 42.52 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.603 0.716 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.91 74.13 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 51' ' ' GLY . 3.7 m -123.09 134.41 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.8 129.18 46.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.628 0.728 . . . . 0.0 109.177 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.95 130.44 10.17 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -106.46 130.89 54.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.676 -0.896 . . . . 0.0 108.901 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -105.37 145.3 30.96 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.603 0.716 . . . . 0.0 110.068 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.44 ' O ' ' CG ' ' A' ' 72' ' ' ASN . 7.1 mm -122.58 147.41 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.671 HD22 ' HD3' ' A' ' 74' ' ' ARG . 0.1 OUTLIER 51.53 13.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.721 0.772 . . . . 0.0 109.405 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 71' ' ' ILE . . . 88.82 28.87 20.04 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.671 ' HD3' HD22 ' A' ' 72' ' ' ASN . 16.3 ptt85 -153.87 163.99 22.13 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.198 -1.178 . . . . 0.0 109.45 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 142.34 99.23 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.421 2.081 . . . . 0.0 112.172 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.3 m -166.03 -32.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.181 -0.95 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.16 153.18 35.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.666 -1.271 . . . . 0.0 110.802 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.6 mt -128.52 163.36 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.376 0.608 . . . . 0.0 109.518 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 78' ' ' ILE . 45.1 tt0 -139.99 152.06 45.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -0.839 . . . . 0.0 109.75 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.38 146.21 32.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.443 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.6 m -123.06 132.84 54.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.386 0.612 . . . . 0.0 109.726 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.12 132.4 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.724 0.773 . . . . 0.0 109.339 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 85' ' ' ASN . 27.8 mm -76.16 130.67 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.446 0.641 . . . . 0.0 109.979 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.9 mt -122.81 35.77 4.8 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 83' ' ' ILE . 99.2 m-20 -64.57 -38.91 92.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 109.535 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.4 p -72.46 155.83 39.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.127 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.671 ' CD ' ' H ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -79.32 -42.59 1.63 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.646 -0.659 . . . . 0.0 110.823 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 39.9 Cg_endo -65.49 -24.88 56.03 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.859 1.706 . . . . 0.0 111.449 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' OE2' HD13 ' A' ' 61' ' ' ILE . 52.8 tp10 -70.83 -36.97 73.14 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -61.73 -42.92 99.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.576 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.47 -50.21 74.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.867 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -69.02 -40.71 78.5 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.734 0.778 . . . . 0.0 109.459 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.93 -46.14 91.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 63.8 ttp -63.25 -44.64 94.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.546 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -65.12 -37.7 88.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.516 -0.74 . . . . 0.0 109.857 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 85.3 t80 -59.74 -45.42 92.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.42 ' SD ' HG11 ' A' ' 18' ' ' VAL . 91.5 mtp -64.77 -39.9 94.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.284 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.89 -45.05 71.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.768 . . . . 0.0 109.514 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.447 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 94.8 mtt-85 -67.04 -39.12 86.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.351 -0.843 . . . . 0.0 109.66 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.626 ' CE2' ' ND2' ' A' ' 104' ' ' ASN . 90.1 t80 -61.15 -45.96 92.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.37 -34.51 89.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -38.77 90.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -1.128 . . . . 0.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.33 -38.28 78.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.626 ' ND2' ' CE2' ' A' ' 100' ' ' TYR . 73.4 m-20 -81.24 -74.21 0.34 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 109.514 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 147.62 44.06 0.03 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 pp -167.9 129.01 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -1.061 . . . . 0.0 109.607 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -98.3 -66.45 0.88 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -78.48 143.67 36.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -1.033 . . . . 0.0 110.46 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.7 p -116.92 -88.14 0.6 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.615 -0.678 . . . . 0.0 109.631 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -143.13 -57.65 0.42 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.27 -0.894 . . . . 0.0 109.869 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -65.82 -15.32 62.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.951 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.15 -42.55 79.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.18 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 113' ' ' LEU . 10.5 mp -67.24 -44.01 80.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.268 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 113' ' ' LEU . 13.5 pt-20 28.44 57.0 0.11 Allowed 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.437 0.637 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 113' ' ' LEU . 30.7 m170 -130.36 139.21 50.68 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.721 0.772 . . . . 0.0 109.556 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -150.74 49.96 0.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -67.1 -37.88 84.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.358 -0.839 . . . . 0.0 109.186 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 51.75 -104.5 0.18 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.527 -0.733 . . . . 0.0 110.339 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 120' ' ' HIS . 83.2 t60 -149.45 16.41 0.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.044 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 97.5 m-70 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.528 ' HB1' ' CE2' ' A' ' 96' ' ' PHE . . . -83.02 119.33 24.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.541 -0.724 . . . . 0.0 109.854 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -155.84 159.64 39.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.489 -0.757 . . . . 0.0 109.642 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.0 mm -106.78 128.13 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.744 0.783 . . . . 0.0 109.443 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -138.94 136.88 35.91 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.425 ' O ' ' OG ' ' A' ' 7' ' ' SER . 46.1 m-85 -103.61 -13.6 16.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 6' ' ' PHE . 61.8 m -167.9 169.84 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.52 -0.738 . . . . 0.0 110.172 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.49 141.86 41.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.67 0.747 . . . . 0.0 110.904 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.63 23.67 52.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -109.44 -34.42 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -1.001 . . . . 0.0 109.051 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.85 168.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.726 0.774 . . . . 0.0 110.43 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' OG1' ' A' ' 13' ' ' THR . 17.6 pt-20 -80.47 139.39 36.44 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.586 0.708 . . . . 0.0 110.338 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.467 HG23 ' OE1' ' A' ' 114' ' ' GLU . 6.3 m -168.86 -35.17 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.7 t -81.49 135.85 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.634 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.01 82.78 13.93 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.585 -0.697 . . . . 0.0 109.265 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.37 156.19 25.35 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 123.048 2.499 . . . . 0.0 112.83 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -85.24 149.16 25.68 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.707 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.9 132.05 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.455 0.645 . . . . 0.0 109.787 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -130.06 144.8 51.54 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.479 0.657 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -111.28 134.56 52.78 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.677 0.751 . . . . 0.0 109.884 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -158.21 167.77 28.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -117.83 142.07 47.72 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.716 0.769 . . . . 0.0 109.6 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 t -63.15 129.96 42.55 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.765 0.793 . . . . 0.0 110.363 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -66.59 -39.64 88.51 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.612 0.72 . . . . 0.0 109.652 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -71.38 -0.32 9.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.344 -0.847 . . . . 0.0 109.496 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 28' ' ' SER . . . 83.74 20.59 59.49 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.448 ' O ' ' OG ' ' A' ' 28' ' ' SER . 39.1 tt0 -73.62 45.81 0.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.414 -1.05 . . . . 0.0 109.67 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 27' ' ' GLN . 12.6 p 61.33 178.86 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.99 0.9 . . . . 0.0 111.158 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.77 156.68 49.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.4 ptm -154.32 172.69 17.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -147.12 140.23 25.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -107.27 141.14 39.06 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.586 0.708 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -117.32 126.36 52.58 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.48 128.53 46.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.451 0.644 . . . . 0.0 109.471 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -111.86 117.33 32.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.6 tp -95.63 127.74 41.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.634 0.731 . . . . 0.0 110.298 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 37.99 70.81 1.16 Allowed Pre-proline 0 N--CA 1.496 1.858 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.17 141.31 93.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.495 2.13 . . . . 0.0 111.855 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 46.2 p -87.42 -18.66 29.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.597 -0.689 . . . . 0.0 110.358 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.7 tt -66.68 2.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 109.676 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' THR . 86.5 mt -80.86 -8.74 59.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.7 -17.47 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 109.17 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -105.38 -50.48 3.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.499 -0.75 . . . . 0.0 109.585 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.54 157.6 45.85 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.371 -0.831 . . . . 0.0 109.936 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.9 t -77.34 164.74 25.25 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.621 0.724 . . . . 0.0 110.562 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -65.27 -37.51 87.42 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.442 0.639 . . . . 0.0 109.968 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.69 -16.64 63.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.458 -0.776 . . . . 0.0 109.776 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.74 -0.36 56.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 98.7 mt -94.51 118.0 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -0.93 . . . . 0.0 109.907 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -114.11 121.25 43.21 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.719 0.771 . . . . 0.0 109.458 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.82 177.25 3.47 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -132.66 137.33 46.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.77 -0.841 . . . . 0.0 109.042 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.18 111.48 23.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.816 0.817 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.418 ' C ' HD12 ' A' ' 55' ' ' ILE . 89.6 mt -99.93 125.95 46.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.752 -0.593 . . . . 0.0 109.566 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.703 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.7 mp -101.92 100.31 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.468 -0.77 . . . . 0.0 109.377 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -91.5 176.63 6.48 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.447 0.641 . . . . 0.0 109.89 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 45.8 p-10 -68.26 113.03 5.52 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.764 0.792 . . . . 0.0 110.297 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 57.38 31.5 20.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.756 0.788 . . . . 0.0 109.463 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.94 168.3 40.84 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.46 149.8 28.94 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.288 -1.125 . . . . 0.0 109.766 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.37 129.6 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.27 131.73 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 109.711 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 t -129.54 142.2 50.81 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.589 0.709 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -96.04 79.47 3.23 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.547 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 66' ' ' VAL . 79.7 mm-40 -141.57 -105.03 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.605 -0.684 . . . . 0.0 109.592 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' GLU . 4.8 t 57.92 113.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.603 0.716 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -126.97 116.53 20.92 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.687 0.756 . . . . 0.0 109.099 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.83 137.26 26.71 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -107.5 124.39 49.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.775 -0.838 . . . . 0.0 108.94 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' C ' HD12 ' A' ' 71' ' ' ILE . 78.7 m-85 -101.02 123.3 45.0 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.56 0.695 . . . . 0.0 110.3 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 71' ' ' ILE . 2.9 mp -107.74 119.81 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.671 0.748 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.0 m120 59.21 33.75 22.83 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.455 0.645 . . . . 0.0 110.404 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.64 34.3 39.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.417 ' NH2' ' OG1' ' A' ' 76' ' ' THR . 56.5 ttp85 -152.44 132.75 7.43 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.151 -1.205 . . . . 0.0 109.723 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.81 89.54 0.75 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.6 2.2 . . . . 0.0 111.103 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.433 ' HB ' HD13 ' A' ' 71' ' ' ILE . 6.7 m -105.5 -15.02 15.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.476 -0.765 . . . . 0.0 109.754 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.27 42.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.091 -1.006 . . . . 0.0 110.307 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.6 mt -133.61 158.59 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 78' ' ' ILE . 43.0 tt0 -139.42 156.76 46.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 110.142 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.82 148.3 31.75 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.368 0.604 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 m -122.0 132.75 54.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.54 0.686 . . . . 0.0 109.505 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 93' ' ' PHE . 47.2 t -109.85 130.56 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.659 0.743 . . . . 0.0 109.469 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.7 mm -98.97 121.59 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.405 0.621 . . . . 0.0 109.559 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.466 HD11 ' CD2' ' A' ' 93' ' ' PHE . 69.7 mt -107.8 65.75 0.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -64.99 -39.5 93.57 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.587 0.708 . . . . 0.0 109.647 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.8 m -72.36 152.51 42.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 110.535 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.513 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 21.1 mt-30 -76.26 -58.28 1.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.845 -0.534 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 19.6 Cg_endo -56.19 -29.67 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.24 1.96 . . . . 0.0 111.611 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.96 -34.95 78.87 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.436 0.636 . . . . 0.0 109.596 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -46.54 89.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.347 -0.846 . . . . 0.0 109.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.74 -42.7 97.83 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.528 -0.732 . . . . 0.0 109.394 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.43 -40.87 93.82 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.641 0.734 . . . . 0.0 109.049 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CD2' HD11 ' A' ' 84' ' ' LEU . 9.7 t80 -60.94 -42.54 98.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.648 0.737 . . . . 0.0 109.244 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -61.72 -41.39 97.57 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.562 0.696 . . . . 0.0 109.624 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.56 -39.83 94.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.426 -0.796 . . . . 0.0 109.328 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.528 ' CE2' ' HB1' ' A' ' 2' ' ' ALA . 28.3 t80 -58.63 -44.5 90.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.625 -0.672 . . . . 0.0 109.645 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 13.4 ttt -61.5 -43.92 98.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.982 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.13 -43.33 71.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.328 -0.858 . . . . 0.0 109.637 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -66.27 -42.14 88.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.404 -0.81 . . . . 0.0 109.514 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.05 -43.62 98.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.8 . . . . 0.0 109.839 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.42 -36.73 93.54 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.44 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -1.034 . . . . 0.0 109.855 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.25 -37.07 71.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -118.68 -130.83 0.3 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.55 125.71 1.37 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 106' ' ' LEU . 3.9 mm? -86.56 137.61 32.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.58 -0.953 . . . . 0.0 110.14 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.03 2.15 90.49 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -102.76 140.15 37.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.518 -0.989 . . . . 0.0 109.982 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.4 p -78.55 165.86 23.23 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.825 0.821 . . . . 0.0 110.648 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -59.43 129.37 41.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.65 0.738 . . . . 0.0 110.333 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -172.73 -101.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.465 0.65 . . . . 0.0 109.686 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.82 -10.24 59.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.476 -0.765 . . . . 0.0 109.519 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 114' ' ' GLU . 53.1 mt -64.93 -38.82 92.25 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.61 0.719 . . . . 0.0 109.351 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.467 ' OE1' HG23 ' A' ' 13' ' ' THR . 79.9 mm-40 -56.93 -110.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.548 -0.72 . . . . 0.0 110.168 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -155.23 152.05 28.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 0.0 110.066 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -141.95 151.47 42.6 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.613 0.72 . . . . 0.0 110.072 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -74.48 -7.39 52.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.697 -0.627 . . . . 0.0 109.685 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 76.2 m80 41.25 -117.39 0.34 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.69 0.757 . . . . 0.0 110.575 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 120' ' ' HIS . 85.4 t60 -164.94 100.84 0.77 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.407 -0.808 . . . . 0.0 109.128 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 119' ' ' HIS . 56.6 m170 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.768 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.598 ' H2 ' ' C ' ' A' ' 55' ' ' ILE . 6.8 ptm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.63 -43.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.633 -0.667 . . . . 0.0 109.316 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -117.31 155.55 29.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.539 -0.725 . . . . 0.0 109.664 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.42 127.8 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.637 -0.665 . . . . 0.0 109.219 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -129.67 124.22 33.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.749 -0.594 . . . . 0.0 109.427 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -106.58 -11.32 15.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -168.36 -153.44 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.038 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -69.9 134.59 48.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 110.83 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.1 -88.76 0.05 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t 53.9 95.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.488 -1.007 . . . . 0.0 109.883 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.67 56.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 110.705 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -100.22 32.79 2.86 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 m -69.09 -20.49 64.08 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 p -71.15 -19.11 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.766 -0.584 . . . . 0.0 110.353 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.52 ' O ' ' NZ ' ' A' ' 110' ' ' LYS . 1.4 p 34.05 95.53 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 122.105 -0.372 . . . . 0.0 110.311 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.67 157.31 31.89 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.238 1.959 . . . . 0.0 112.869 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' A' ' 109' ' ' SER . 83.8 tt0 -92.01 152.89 19.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.096 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.77 133.47 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.569 -0.707 . . . . 0.0 109.262 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -128.57 144.22 51.11 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.8 mt -110.81 132.37 54.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.678 -0.639 . . . . 0.0 109.413 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.3 m -154.57 164.38 38.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.55 -0.719 . . . . 0.0 109.598 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -89.61 141.9 28.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.608 -0.683 . . . . 0.0 109.861 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 t -61.71 140.31 58.21 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.686 0.755 . . . . 0.0 110.757 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.86 -16.13 45.59 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.636 -0.665 . . . . 0.0 109.342 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -96.46 5.67 50.36 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.147 -0.97 . . . . 0.0 108.762 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.54 15.1 81.37 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -79.39 46.37 0.73 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.146 -1.208 . . . . 0.0 109.847 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 t 62.03 -169.3 0.18 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.864 0.84 . . . . 0.0 111.213 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.18 161.2 53.31 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.72 175.95 12.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.288 -1.125 . . . . 0.0 109.577 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.55 146.34 34.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.61 145.15 38.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.501 0.667 . . . . 0.0 109.955 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -112.44 121.25 44.3 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -96.2 123.76 39.95 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.445 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 2.1 m-85 -114.58 126.68 55.19 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.443 0.639 . . . . 0.0 109.308 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.2 tp -110.27 116.27 31.19 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 110.023 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' A' ' 39' ' ' THR . 52.2 mm-40 30.5 66.62 0.83 Allowed Pre-proline 0 N--CA 1.501 2.119 0 CA-C-O 120.877 0.37 . . . . 0.0 111.891 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 40' ' ' ILE . 33.3 Cg_exo -65.54 16.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.89 2.393 . . . . 0.0 111.404 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.528 ' H ' ' C ' ' A' ' 37' ' ' GLU . 37.0 p 50.39 14.36 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.645 -0.66 . . . . 0.0 109.498 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.427 ' N ' ' C ' ' A' ' 38' ' ' PRO . 3.4 tp -90.88 -14.87 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.908 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.39 -41.79 96.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.17 -35.07 77.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.992 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.31 -64.25 1.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 40' ' ' ILE . 80.0 mm-40 -117.45 143.24 46.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.595 -0.691 . . . . 0.0 109.785 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.5 m -73.95 162.23 29.28 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.529 0.68 . . . . 0.0 110.325 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.417 ' HG1' ' HZ ' ' A' ' 70' ' ' PHE . 44.2 p -65.83 -34.65 78.64 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 51.9 p-10 -67.96 -25.3 65.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.838 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 56.8 t0 -83.06 -9.15 59.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.067 -1.021 . . . . 0.0 109.302 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -96.59 111.07 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 108.748 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -126.82 126.26 43.07 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.567 0.698 . . . . 0.0 109.868 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 155.4 1.31 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.6 ttp -117.88 132.93 56.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.907 . . . . 0.0 109.291 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -108.71 119.65 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.69 -0.631 . . . . 0.0 109.497 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.7 mt -99.34 107.55 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.598 ' C ' ' H2 ' ' A' ' 1' ' ' MET . 96.5 mt -115.4 165.46 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.643 -0.661 . . . . 0.0 109.838 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.598 ' N ' HG22 ' A' ' 55' ' ' ILE . 64.2 t0 -151.9 -117.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 0.0 109.882 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 97.5 m-20 -79.48 -21.7 45.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.419 -0.8 . . . . 0.0 109.955 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -175.38 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 147.22 46.06 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.25 147.42 33.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -1.127 . . . . 0.0 109.64 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.494 ' C ' HD12 ' A' ' 62' ' ' ILE . 87.7 mt -128.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.837 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.6 mp -105.04 129.77 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.839 . . . . 0.0 109.675 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 65' ' ' GLU . 94.9 m -122.3 129.5 52.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 48.7 mmm-85 -112.17 46.47 1.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.9 mp0 -143.85 80.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.23 134.75 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.699 -0.626 . . . . 0.0 109.591 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -127.18 141.58 51.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.52 139.5 14.53 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -90.43 105.71 18.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 108.442 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.417 ' HZ ' ' HG1' ' A' ' 46' ' ' THR . 66.4 m-85 -94.77 135.36 36.35 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.393 0.616 . . . . 0.0 110.119 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 45.9 mm -115.11 131.83 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.33 0.586 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 71' ' ' ILE . 23.2 p30 44.08 16.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.957 -0.464 . . . . 0.0 110.339 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 109.38 -24.15 21.04 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 71' ' ' ILE . 16.3 ptp180 -100.72 147.24 33.37 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.145 -1.209 . . . . 0.0 110.122 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.78 143.35 66.95 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.652 2.234 . . . . 0.0 112.715 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.406 ' OG1' ' CG1' ' A' ' 71' ' ' ILE . 4.3 m -140.87 -29.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 35' ' ' PHE . . . -156.43 171.55 20.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 109.615 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.2 mt -131.85 144.29 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.572 0.701 . . . . 0.0 110.34 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -128.07 142.7 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.41 143.89 32.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 0.0 108.966 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -123.63 134.39 53.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.631 . . . . 0.0 109.665 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.62 130.73 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.5 mm -88.25 123.87 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.512 -0.743 . . . . 0.0 110.04 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.8 mt -98.62 56.83 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -64.42 -39.99 94.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.437 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -83.29 145.65 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 110.048 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.3 tm0? -71.61 -46.49 12.85 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 46.3 Cg_exo -54.9 -28.45 58.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.152 1.901 . . . . 0.0 111.323 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -59.47 -37.54 78.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.457 -0.777 . . . . 0.0 109.421 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -57.87 -37.35 73.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -59.55 -45.0 93.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -64.76 -40.67 95.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.373 -0.829 . . . . 0.0 109.612 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -65.81 -39.58 91.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 54.7 ttp -59.87 -45.5 92.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.945 . . . . 0.0 110.171 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -64.83 -38.29 90.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.396 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 96' ' ' PHE . 17.6 t80 -59.69 -46.9 87.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 36.5 ttm -65.56 -39.5 91.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.01 -52.5 23.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.23 -54.43 29.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.533 -0.73 . . . . 0.0 109.846 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -64.05 -45.12 90.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.31 -34.34 89.17 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.62 95.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -1.12 . . . . 0.0 109.561 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -68.71 -38.38 80.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 0.6 OUTLIER -160.57 117.13 2.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.399 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.72 144.13 48.65 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -100.84 -14.85 17.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.711 -0.876 . . . . 0.0 108.746 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 50.11 -175.14 0.05 OUTLIER Glycine 0 N--CA 1.487 2.048 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' C ' ' H ' ' A' ' 110' ' ' LYS . 61.9 m-85 -95.82 128.62 42.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.519 -0.989 . . . . 0.0 109.982 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.544 ' N ' ' OE2' ' A' ' 17' ' ' GLU . 2.9 p 71.67 -43.02 0.55 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.738 -0.601 . . . . 0.0 109.446 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 15' ' ' VAL . 28.4 ttpt 52.35 6.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 109.945 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 109' ' ' SER . 26.9 t -90.4 -16.26 29.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.337 -0.852 . . . . 0.0 109.038 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -139.46 -8.75 1.27 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.42 -0.8 . . . . 0.0 109.308 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 113' ' ' LEU . 10.5 mp -85.4 -5.48 59.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.342 -0.849 . . . . 0.0 109.538 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -118.14 72.09 0.85 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.468 -0.77 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -67.28 -41.87 84.77 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -131.37 123.04 27.39 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.429 ' CG ' ' O ' ' A' ' 117' ' ' HIS . 84.3 t60 -151.45 28.16 0.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -66.34 -38.78 88.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.611 -0.681 . . . . 0.0 109.239 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -72.27 136.46 46.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.295 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 61.9 m170 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.709 -179.92 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.43 0.634 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.452 ' HB1' ' CE1' ' A' ' 96' ' ' PHE . . . -76.82 121.55 23.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -0.822 . . . . 0.0 110.091 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -155.57 153.24 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.414 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -111.13 128.52 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' HG2' HD13 ' A' ' 55' ' ' ILE . 21.5 pt20 -152.41 161.37 42.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.045 -1.034 . . . . 0.0 109.615 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.37 -31.06 9.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 t -113.45 132.33 55.69 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.538 0.685 . . . . 0.0 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -67.26 135.65 53.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.766 . . . . 0.0 110.346 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.25 -13.28 67.09 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.27 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.77 90.36 8.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.632 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.22 136.68 46.44 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.881 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 5.28 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.246 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -55.97 141.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.975 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.92 84.32 13.1 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.554 -0.716 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.0 150.85 23.6 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.931 2.421 . . . . 0.0 112.893 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -92.96 139.25 30.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 33' ' ' PHE . 21.8 t -99.03 129.71 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.291 -0.881 . . . . 0.0 109.953 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.464 ' C ' HD22 ' A' ' 20' ' ' LEU . 1.3 mpp_? -132.23 145.76 51.54 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.622 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.6 mm? -96.67 121.39 38.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 31' ' ' ALA . 53.3 m -109.1 167.52 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.573 -0.704 . . . . 0.0 109.651 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -126.31 138.65 53.61 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.594 0.711 . . . . 0.0 110.045 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.9 m -58.91 175.23 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 110.769 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.4 -43.99 92.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.373 -0.83 . . . . 0.0 109.888 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -108.1 -4.28 17.86 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.125 -0.984 . . . . 0.0 108.816 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.8 31.78 64.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.35 -8.18 59.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.087 -1.243 . . . . 0.0 109.547 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -160.4 160.23 32.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.003 -1.061 . . . . 0.0 110.135 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.43 149.09 44.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttp -151.87 144.75 24.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.178 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 21' ' ' SER . . . -143.08 147.77 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 108.691 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -119.4 144.55 46.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.319 0.58 . . . . 0.0 110.181 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 18' ' ' VAL . 81.3 m-85 -116.52 131.82 56.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -105.52 127.81 53.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.643 -0.66 . . . . 0.0 109.245 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.21 117.34 32.95 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 37' ' ' GLU . 50.4 tp -92.75 128.96 38.8 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.346 0.593 . . . . 0.0 110.517 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 36' ' ' LEU . 94.0 mt-10 35.84 71.78 0.84 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-O 121.083 0.468 . . . . 0.0 111.161 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.75 141.03 93.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.613 2.209 . . . . 0.0 112.217 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.0 p -83.29 -18.61 38.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 0.0 109.74 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.18 1.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 109.736 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.84 -9.41 58.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.035 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.64 -17.89 23.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.81 -47.92 3.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 109.449 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.6 153.6 48.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.398 -0.814 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -72.58 158.36 35.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.628 0.728 . . . . 0.0 110.327 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -64.23 -26.9 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 44.4 p30 -67.31 -19.82 65.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 94.5 m-20 -79.74 -5.09 54.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.11 118.46 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -0.33 14.69 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.26 179.4 42.47 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.421 ' CE ' HD21 ' A' ' 54' ' ' LEU . 63.9 ttp -132.5 141.61 48.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.434 -1.039 . . . . 0.0 109.763 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -111.35 118.64 36.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.416 0.627 . . . . 0.0 109.54 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 55' ' ' ILE . 78.4 mt -101.52 122.52 43.96 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -105.77 120.83 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.509 -0.744 . . . . 0.0 109.012 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -102.12 -153.95 0.48 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 109.807 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -73.33 -6.06 43.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.891 . . . . 0.0 109.603 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -174.15 -54.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 108.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.96 166.21 54.39 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -145.62 147.58 32.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -1.128 . . . . 0.0 109.182 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.94 131.51 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.653 -0.654 . . . . 0.0 109.508 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -113.96 128.98 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.9 133.76 47.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.544 0.688 . . . . 0.0 109.679 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -94.94 -3.52 48.46 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -84.66 76.12 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.78 133.41 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.653 -0.654 . . . . 0.0 109.4 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -127.48 140.58 52.05 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.1 142.35 16.42 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -104.62 111.27 23.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.499 -1.001 . . . . 0.0 108.723 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 22.8 m-85 -101.93 125.81 48.7 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.5 mt -111.71 120.93 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 57.13 33.44 23.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.578 -0.701 . . . . 0.0 109.323 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.46 25.38 74.86 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -130.58 100.19 18.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.291 -1.123 . . . . 0.0 109.694 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -46.97 93.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.263 1.975 . . . . 0.0 112.055 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 m -112.65 -15.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.722 . . . . 0.0 109.754 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.86 157.89 43.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.736 -1.228 . . . . 0.0 110.737 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.85 138.05 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -117.7 147.05 43.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.293 -0.879 . . . . 0.0 109.758 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.59 143.18 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.6 m -126.36 130.93 51.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.666 -0.646 . . . . 0.0 109.465 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.451 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.0 t -115.56 129.95 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.534 0.683 . . . . 0.0 109.252 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.722 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.8 mp -94.44 123.1 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -0.76 . . . . 0.0 109.706 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.58 110.52 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -95.9 -0.92 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.143 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.07 152.85 48.23 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.474 -0.766 . . . . 0.0 109.998 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.584 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.6 tp-100 -76.69 -40.29 2.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.621 -0.674 . . . . 0.0 110.801 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.4 Cg_exo -55.25 -30.54 72.31 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.151 1.901 . . . . 0.0 111.413 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -64.99 -40.92 95.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.668 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.617 ' CZ3' HD12 ' A' ' 20' ' ' LEU . 25.3 m95 -56.63 -36.74 69.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.488 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.4 -41.33 98.59 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.36 -44.31 91.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.179 -0.951 . . . . 0.0 109.473 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.25 -42.35 93.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.476 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -61.39 -46.09 91.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.594 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -68.84 -43.27 75.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 109.223 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.452 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 91.2 t80 -62.12 -46.05 90.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.456 -0.777 . . . . 0.0 109.411 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 63.7 ttp -63.99 -40.12 95.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.597 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.11 -49.8 68.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -66.19 -42.38 88.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 104' ' ' ASN . 79.0 t80 -63.72 -41.5 98.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.36 -36.81 93.06 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.16 95.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.362 -1.081 . . . . 0.0 109.536 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.08 -36.99 75.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.303 -0.873 . . . . 0.0 109.669 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 100' ' ' TYR . 7.8 m120 -115.05 -140.42 0.38 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.5 -0.75 . . . . 0.0 109.884 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 106' ' ' LEU . . . -156.52 43.57 0.53 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.647 ' H ' HD22 ' A' ' 106' ' ' LEU . 3.4 mm? 39.14 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.679 -0.894 . . . . 0.0 110.914 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.67 -168.93 46.32 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.545 ' C ' ' H ' ' A' ' 110' ' ' LYS . 83.3 t80 -89.64 87.19 6.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.42 -1.047 . . . . 0.0 109.413 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 111' ' ' SER . 1.8 m 61.36 -5.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.617 -0.677 . . . . 0.0 109.881 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 108' ' ' PHE . 23.1 pttm 33.77 30.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.608 0.718 . . . . 0.0 110.552 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 109' ' ' SER . 79.9 p -89.7 -8.72 51.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.769 . . . . 0.0 109.429 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.52 -28.92 2.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.28 -41.19 97.02 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.53 -0.731 . . . . 0.0 109.113 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -76.06 140.48 41.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 110.665 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -86.71 138.83 31.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.41 -0.806 . . . . 0.0 110.32 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 43.4 81.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.765 . . . . 0.0 110.014 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -90.66 130.19 36.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.437 -0.789 . . . . 0.0 110.308 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -72.31 144.32 48.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.749 -0.594 . . . . 0.0 110.407 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -105.04 127.55 52.92 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.544 -0.722 . . . . 0.0 110.192 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.377 179.678 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 2' ' ' ALA . 77.6 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 56.39 113.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.782 0.801 . . . . 0.0 110.114 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.79 149.9 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.33 130.41 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.72 -0.612 . . . . 0.0 109.418 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -127.81 133.37 49.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.565 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.34 -67.02 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -111.86 14.44 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 60.19 126.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.871 0.844 . . . . 0.0 111.187 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.33 7.96 69.01 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 m -110.73 141.73 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.586 -0.949 . . . . 0.0 110.011 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.584 ' H ' ' HZ3' ' A' ' 43' ' ' LYS . . . -61.86 140.9 58.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.635 0.731 . . . . 0.0 110.771 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' O ' ' OG1' ' A' ' 13' ' ' THR . 49.9 tp10 -97.95 -65.95 0.93 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.548 -0.72 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.503 ' CG2' ' CZ ' ' A' ' 108' ' ' PHE . 7.0 p 51.01 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.578 0.704 . . . . 0.0 110.432 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' THR . 53.2 t 57.73 148.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.582 0.706 . . . . 0.0 110.439 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 15' ' ' VAL . 7.4 p -105.1 105.04 50.16 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.87 143.87 33.83 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.555 2.17 . . . . 0.0 112.692 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 56.4 mp0 -97.18 142.74 28.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.453 -0.78 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.512 HG22 ' CE2' ' A' ' 33' ' ' PHE . 3.7 t -106.15 126.53 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.409 0.623 . . . . 0.0 109.35 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -110.65 145.04 38.63 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.608 0.718 . . . . 0.0 109.654 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.9 mm? -95.39 139.74 31.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.666 0.746 . . . . 0.0 109.712 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -153.38 167.48 29.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.49 -0.756 . . . . 0.0 109.929 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.32 152.07 24.03 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.679 0.752 . . . . 0.0 109.97 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 p -73.43 165.85 24.3 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.857 0.837 . . . . 0.0 110.873 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -62.54 -35.82 80.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.764 -0.585 . . . . 0.0 109.623 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -85.11 -0.26 53.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.17 -0.956 . . . . 0.0 108.921 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.85 62.98 5.39 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -155.1 -68.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -1.126 . . . . 0.0 109.351 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.1 t -71.25 148.8 46.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.848 . . . . 0.0 110.774 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.74 149.63 48.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.2 ttt -141.66 130.21 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -1.11 . . . . 0.0 108.96 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 145.42 50.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 109.27 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.84 149.38 42.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.512 ' CE2' HG22 ' A' ' 18' ' ' VAL . 58.1 m-85 -122.6 139.63 53.71 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -114.58 123.36 49.15 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 118.98 36.67 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.25 107.93 19.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.762 0.792 . . . . 0.0 110.185 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 39' ' ' THR . 64.4 mm-40 47.83 61.81 13.1 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.842 -0.536 . . . . 0.0 110.625 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HG2' HG22 ' A' ' 40' ' ' ILE . 37.6 Cg_endo -66.83 15.38 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.335 2.023 . . . . 0.0 110.854 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 37' ' ' GLU . 25.7 p 51.86 22.29 1.7 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.518 HG22 ' HG2' ' A' ' 38' ' ' PRO . 14.4 tt -97.08 -13.75 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.311 -0.868 . . . . 0.0 109.228 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.44 -40.14 89.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.383 -0.823 . . . . 0.0 109.475 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.59 -14.63 59.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.557 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.584 ' HZ3' ' H ' ' A' ' 11' ' ' ALA . 54.2 mtpt -99.55 -63.24 1.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.709 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -119.93 138.91 53.16 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.76 0.79 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 m -71.33 150.67 44.89 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.714 0.769 . . . . 0.0 110.709 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.4 p -59.27 -40.69 86.84 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.421 0.629 . . . . 0.0 109.819 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.17 -15.86 62.5 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -0.764 . . . . 0.0 109.691 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.52 -7.72 49.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 92.1 mt -91.46 114.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.123 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.83 125.4 35.6 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.883 0.849 . . . . 0.0 109.642 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.77 157.02 15.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.4 ttt -132.73 127.57 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -109.18 108.07 18.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.65 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.7 mt -99.28 129.03 45.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.623 -0.673 . . . . 0.0 109.325 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.88 127.95 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.353 0.597 . . . . 0.0 110.171 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 18.5 p-10 -99.21 -132.45 0.24 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.676 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.461 ' N ' ' CG ' ' A' ' 56' ' ' ASP . 99.7 m-20 -63.13 -43.21 99.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -149.25 -50.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.365 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.75 168.73 13.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -140.29 155.52 46.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -1.028 . . . . 0.0 110.283 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.05 136.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.72 132.52 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.604 -0.685 . . . . 0.0 109.761 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 t -143.63 151.59 40.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.832 . . . . 0.0 109.614 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -104.25 3.52 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -81.5 79.32 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 109.316 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.1 t -125.81 135.37 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.62 -0.675 . . . . 0.0 109.795 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.9 136.86 48.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.5 -0.75 . . . . 0.0 109.582 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.55 141.59 15.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.98 106.94 18.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.501 -1.0 . . . . 0.0 109.443 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.6 143.9 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.643 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 93.5 mt -120.88 134.12 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 71' ' ' ILE . 46.3 m-80 -37.74 92.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.65 0.738 . . . . 0.0 110.538 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 148.44 -60.6 0.45 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -174.84 154.45 1.8 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.61 138.77 10.74 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.09 1.86 . . . . 0.0 112.099 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.442 ' CB ' HD12 ' A' ' 71' ' ' ILE . 66.8 m -132.7 -30.01 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.691 . . . . 0.0 109.918 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.17 164.04 38.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.682 -1.262 . . . . 0.0 110.577 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -128.54 150.24 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.19 151.0 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.611 0.719 . . . . 0.0 109.695 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.87 144.56 35.36 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.6 m -123.21 133.5 54.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.666 -0.646 . . . . 0.0 109.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.63 130.31 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mm -98.83 123.91 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.625 0.726 . . . . 0.0 109.795 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.11 83.02 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -91.54 8.14 37.99 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.18 44.48 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.823 . . . . 0.0 109.195 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.589 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.0 mm100 -65.5 -40.87 45.68 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.706 -0.621 . . . . 0.0 110.549 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.9 Cg_exo -56.72 -36.61 98.5 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.369 2.046 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -32.39 70.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.452 0.644 . . . . 0.0 109.646 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -60.36 -47.28 86.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.68 -44.5 90.14 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.488 -0.758 . . . . 0.0 109.666 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 56' ' ' ASP . 62.8 ttm-85 -66.63 -41.1 88.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.478 -0.764 . . . . 0.0 109.441 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -60.2 -44.75 94.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.488 -0.757 . . . . 0.0 109.952 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -63.82 -41.7 97.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.35 -0.844 . . . . 0.0 109.986 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.9 -44.14 86.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.0 -49.75 73.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.432 ' SD ' ' C ' ' A' ' 97' ' ' MET . 14.1 tmm? -68.44 -41.58 80.1 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.439 -0.788 . . . . 0.0 110.139 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 81.4 tt0 -66.54 -49.21 67.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 110.179 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.42 -43.28 81.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 110.265 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.39 -52.34 65.0 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.78 . . . . 0.0 110.329 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.63 -33.32 47.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 98' ' ' GLU . . . -48.94 -50.35 35.81 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.906 -1.35 . . . . 0.0 108.492 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 104' ' ' ASN . 96.8 mt-10 -71.49 -36.69 71.21 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.635 0.731 . . . . 0.0 109.111 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.421 ' O ' ' O ' ' A' ' 103' ' ' GLU . 1.1 m-20 56.18 157.22 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.233 1.016 . . . . 0.0 111.019 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.48 12.07 78.98 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 106' ' ' LEU . 10.1 mp -77.57 138.99 39.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.391 -1.064 . . . . 0.0 111.024 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.33 -55.51 0.01 OUTLIER Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.503 ' CZ ' ' CG2' ' A' ' 13' ' ' THR . 51.5 m-85 -99.01 119.34 37.63 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.194 -1.18 . . . . 0.0 110.417 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 p -100.88 -115.83 0.17 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.609 -0.682 . . . . 0.0 109.435 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -129.19 -19.4 3.53 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.514 -0.741 . . . . 0.0 109.76 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 113' ' ' LEU . 23.6 p -65.62 157.25 30.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.057 -1.027 . . . . 0.0 110.348 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 66.44 -43.01 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.407 0.623 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 111' ' ' SER . 65.4 mt -64.54 -41.65 96.21 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.271 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 116' ' ' HIS . 9.2 pt-20 -64.59 131.17 46.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.457 -0.777 . . . . 0.0 109.995 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.417 ' O ' ' O ' ' A' ' 116' ' ' HIS . 50.4 p-80 -102.65 -11.44 18.43 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.716 0.769 . . . . 0.0 109.047 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.48 ' NE2' ' CD ' ' A' ' 114' ' ' GLU . 93.4 m-70 43.64 -169.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.913 0.863 . . . . 0.0 111.411 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 50.94 46.83 25.77 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.672 0.749 . . . . 0.0 110.346 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 119' ' ' HIS . 11.0 p80 -67.68 -41.18 84.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.619 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.465 ' N ' ' CG ' ' A' ' 118' ' ' HIS . 39.5 t-80 -74.77 175.24 8.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.352 -0.843 . . . . 0.0 110.752 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.464 ' H ' ' CG ' ' A' ' 119' ' ' HIS . 49.0 m80 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.851 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.31 104.97 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.737 0.78 . . . . 0.0 110.329 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' THR . 17.1 pt-20 -155.68 165.25 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 mp -106.8 128.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.542 0.687 . . . . 0.0 109.617 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -150.01 131.38 14.67 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.734 0.778 . . . . 0.0 109.532 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -63.64 -43.78 95.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.7 m -119.19 120.48 37.2 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.813 0.816 . . . . 0.0 109.292 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.49 137.48 56.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.855 0.836 . . . . 0.0 111.043 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.66 -13.94 53.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.21 164.79 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.55 52.36 9.93 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.612 0.72 . . . . 0.0 109.642 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.564 ' C ' ' HG1' ' A' ' 13' ' ' THR . 17.8 pt-20 -76.24 174.28 10.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.213 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.564 ' HG1' ' C ' ' A' ' 12' ' ' GLU . 72.0 p 55.24 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.612 0.72 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 12' ' ' GLU . 2.4 t 56.6 155.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.839 0.828 . . . . 0.0 110.526 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.7 66.24 72.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.71 -0.619 . . . . 0.0 109.401 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.41 145.61 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.173 2.582 . . . . 0.0 112.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -88.82 147.65 24.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.679 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG22 ' CE2' ' A' ' 33' ' ' PHE . 71.4 t -117.1 130.97 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.648 0.737 . . . . 0.0 109.378 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.1 145.44 50.73 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.29 142.98 34.1 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.748 0.785 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 p -151.79 162.86 40.34 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.711 -0.618 . . . . 0.0 109.512 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.43 135.06 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.767 0.794 . . . . 0.0 109.746 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t -64.5 135.84 56.44 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.617 0.723 . . . . 0.0 110.246 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -83.28 -14.65 52.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.495 -0.753 . . . . 0.0 109.147 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -92.91 6.62 47.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.285 -0.884 . . . . 0.0 108.851 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 28' ' ' SER . . . 80.57 14.82 79.34 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -74.03 40.51 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -1.094 . . . . 0.0 109.095 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 26' ' ' GLY . 11.9 t 58.45 -179.18 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.973 0.892 . . . . 0.0 110.891 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.55 156.84 53.17 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -147.32 156.93 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.107 . . . . 0.0 110.345 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.26 141.94 48.5 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -111.86 134.16 53.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.454 0.645 . . . . 0.0 109.934 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CE2' HG22 ' A' ' 18' ' ' VAL . 74.2 m-85 -112.95 144.18 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.546 0.689 . . . . 0.0 109.713 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -131.33 125.04 31.69 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.416 0.627 . . . . 0.0 109.387 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 46.3 m-85 -110.98 119.79 40.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.66 0.743 . . . . 0.0 109.333 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.0 tp -93.76 119.36 32.63 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.901 0.858 . . . . 0.0 110.512 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 39.06 56.73 5.79 Favored Pre-proline 0 N--CA 1.492 1.672 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.042 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.86 149.58 72.66 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.275 1.983 . . . . 0.0 111.988 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 41' ' ' LEU . 39.1 p -71.29 -17.11 62.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.1 tp -63.44 2.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 109.79 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 39' ' ' THR . 91.1 mt -95.17 -18.42 20.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 108.87 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.64 -20.0 18.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.33 -75.02 0.53 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.321 -0.862 . . . . 0.0 109.639 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -101.96 141.81 34.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.5 t -68.42 157.0 36.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.782 0.801 . . . . 0.0 110.353 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -65.59 -32.74 74.49 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.501 0.667 . . . . 0.0 109.925 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.0 -17.18 62.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.395 -0.816 . . . . 0.0 109.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -85.65 -7.09 59.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.15 127.85 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.129 -0.982 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -151.14 32.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.77 5.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.2 ttm -114.11 133.27 55.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.617 -0.931 . . . . 0.0 109.451 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -112.22 121.16 44.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.685 0.755 . . . . 0.0 109.168 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.558 ' C ' HD12 ' A' ' 55' ' ' ILE . 73.8 mt -99.45 125.38 45.17 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.728 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -107.04 125.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 109.318 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 58' ' ' GLU . 65.5 t0 -125.85 17.4 7.98 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 64.31 -62.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.348 0.594 . . . . 0.0 110.242 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' ASP . 96.3 mt-10 -72.98 -0.85 14.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.83 173.57 36.71 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.92 148.57 34.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -1.077 . . . . 0.0 109.761 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.25 133.62 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.538 0.685 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.9 126.36 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.773 . . . . 0.0 109.264 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' N ' ' A' ' 64' ' ' ARG . 6.2 m -137.27 160.79 38.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.817 0.818 . . . . 0.0 109.316 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.475 ' N ' HG22 ' A' ' 63' ' ' THR . 84.5 mmt-85 -102.92 -116.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' ARG . 79.8 mm-40 35.75 77.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.601 0.715 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.92 131.95 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.83 138.58 52.13 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.582 0.706 . . . . 0.0 109.407 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -103.39 132.93 11.23 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -99.58 108.26 20.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -1.002 . . . . 0.0 108.685 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -102.61 145.09 30.16 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.679 0.752 . . . . 0.0 109.998 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.4 mt -122.71 135.13 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.573 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -37.79 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.894 0.854 . . . . 0.0 110.735 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 150.69 -62.44 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -178.54 150.72 0.7 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.243 -1.151 . . . . 0.0 109.531 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -37.49 118.66 0.26 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.632 2.221 . . . . 0.0 111.779 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.446 ' CB ' HD12 ' A' ' 71' ' ' ILE . 45.1 m -110.93 -33.57 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 0.0 110.238 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.87 161.11 41.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.773 -1.204 . . . . 0.0 110.836 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.426 HD11 HD21 ' A' ' 41' ' ' LEU . 96.7 mt -128.16 152.42 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.558 0.694 . . . . 0.0 109.376 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -137.93 153.15 49.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.578 0.704 . . . . 0.0 109.568 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -151.4 154.03 35.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.41 0.624 . . . . 0.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.9 131.94 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.419 HG22 ' OD1' ' A' ' 85' ' ' ASN . 14.0 mm -96.25 122.63 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.927 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 81.2 mt -110.0 108.21 18.37 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.547 0.689 . . . . 0.0 109.497 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.419 ' OD1' HG22 ' A' ' 83' ' ' ILE . 6.9 m120 -110.26 -54.85 2.53 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.541 0.686 . . . . 0.0 109.524 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.02 145.82 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.683 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -67.02 -43.22 45.94 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.64 -0.663 . . . . 0.0 110.526 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 52.5 Cg_exo -53.78 -36.31 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.074 1.85 . . . . 0.0 111.317 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.86 -41.96 99.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.629 -0.67 . . . . 0.0 109.632 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.54 -38.92 91.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.27 -0.893 . . . . 0.0 110.009 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.64 -48.46 81.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 108.959 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -69.07 -41.89 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.728 0.775 . . . . 0.0 109.376 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -61.25 -45.35 94.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 53.9 mtt -64.19 -39.57 94.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -61.45 -41.38 97.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -60.44 -44.02 96.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.831 . . . . 0.0 109.73 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.7 mtp -63.46 -40.37 96.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.68 -46.47 72.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -66.63 -43.62 84.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 109.915 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.494 ' CE1' HD11 ' A' ' 106' ' ' LEU . 48.6 t80 -64.74 -42.05 95.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.481 -0.762 . . . . 0.0 109.691 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.98 -40.95 94.07 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.85 -39.76 94.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.514 -0.992 . . . . 0.0 109.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -39.69 76.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 109.517 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.69 -94.23 0.49 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 149.05 95.27 0.14 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.494 HD11 ' CE1' ' A' ' 100' ' ' TYR . 82.9 mt -104.17 129.44 51.91 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.48 -1.012 . . . . 0.0 109.647 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.48 -71.13 1.09 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -174.84 -127.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.62 -0.929 . . . . 0.0 109.928 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -72.64 148.91 44.36 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.9 0.857 . . . . 0.0 110.865 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -64.38 -39.83 94.63 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.422 0.63 . . . . 0.0 109.94 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.5 p -65.18 -20.1 66.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 0.0 109.3 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -88.52 -6.72 57.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.328 -0.857 . . . . 0.0 109.113 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -120.46 -132.39 0.3 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.613 0.72 . . . . 0.0 109.805 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 56.4 25.5 9.62 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.86 0.838 . . . . 0.0 109.438 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.527 ' ND1' ' N ' ' A' ' 115' ' ' HIS . 0.1 OUTLIER -76.24 162.42 27.96 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.881 0.848 . . . . 0.0 110.262 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -66.57 -37.5 85.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.67 -0.644 . . . . 0.0 109.583 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.441 ' O ' ' NE2' ' A' ' 115' ' ' HIS . 5.2 t-160 -67.86 126.48 29.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 109.974 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -67.05 -41.13 87.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.679 -0.638 . . . . 0.0 109.426 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -139.69 143.91 37.3 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.305 -0.872 . . . . 0.0 109.876 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.09 -0.957 . . . . 0.0 108.991 179.668 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' ALA . 97.4 mtp . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.961 0.886 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -0.94 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -156.88 165.92 34.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.73 130.35 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.502 -0.749 . . . . 0.0 109.147 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 10' ' ' VAL . 34.2 mt-30 -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.699 0.761 . . . . 0.0 109.886 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -70.97 -74.62 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.82 0.819 . . . . 0.0 110.055 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.6 t -94.63 136.01 35.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.72 138.52 57.45 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.75 0.786 . . . . 0.0 110.823 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.69 -11.94 69.29 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 22.4 t -97.41 113.28 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.286 -1.126 . . . . 0.0 110.267 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.13 39.18 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.633 0.73 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -172.56 135.97 0.73 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 14' ' ' VAL . 62.1 m -92.18 -70.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.52 -0.738 . . . . 0.0 109.758 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 15' ' ' VAL . 58.5 t 54.32 162.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.415 -0.803 . . . . 0.0 110.704 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.535 ' N ' HG12 ' A' ' 14' ' ' VAL . 57.9 t -133.76 81.78 52.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.332 -0.855 . . . . 0.0 109.517 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.24 148.02 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.229 2.62 . . . . 0.0 112.615 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 58.7 mp0 -93.67 141.73 28.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.39 -0.818 . . . . 0.0 109.482 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.03 127.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.477 -0.765 . . . . 0.0 110.274 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 20' ' ' LEU . 48.2 mmm-85 -127.4 143.48 51.2 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 109.092 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -95.48 138.33 33.31 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.879 0.847 . . . . 0.0 110.378 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 t -134.54 144.18 47.85 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -123.43 142.16 51.27 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.931 0.872 . . . . 0.0 109.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 m -70.36 169.99 12.78 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.833 0.825 . . . . 0.0 110.472 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.21 -42.97 99.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.68 . . . . 0.0 109.39 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -65.95 -40.28 91.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.129 -0.982 . . . . 0.0 109.516 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.45 -3.66 85.26 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -94.92 -5.76 44.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.206 -1.173 . . . . 0.0 109.259 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -111.36 122.64 48.37 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.93 0.871 . . . . 0.0 110.143 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.81 143.24 36.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 40.6 ttm -155.96 144.39 20.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.292 -1.123 . . . . 0.0 109.933 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.62 144.93 36.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -116.94 149.18 40.59 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.606 0.717 . . . . 0.0 110.377 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -123.75 143.87 50.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -116.23 118.3 32.42 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.397 0.618 . . . . 0.0 109.628 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CE1' ' CE ' ' A' ' 52' ' ' MET . 63.9 m-85 -110.26 118.59 36.76 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.32 0.581 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.56 122.99 47.79 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.839 0.828 . . . . 0.0 110.094 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 39' ' ' THR . 85.9 mt-10 47.55 52.39 12.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.966 -0.459 . . . . 0.0 110.734 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 28.4 Cg_endo -63.57 9.09 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.57 2.18 . . . . 0.0 110.93 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 37' ' ' GLU . 71.4 p 51.01 19.21 0.63 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.764 -0.585 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.439 HG22 ' HG2' ' A' ' 38' ' ' PRO . 15.2 tt -97.4 -13.61 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -66.29 -38.84 88.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.471 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.94 -12.9 59.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.478 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -105.48 -16.31 14.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.366 -0.834 . . . . 0.0 108.861 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' ILE . 80.4 tt0 -171.43 139.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.52 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -74.67 158.6 33.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -64.91 -31.2 72.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.636 -0.665 . . . . 0.0 110.284 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 109.912 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -72.4 -17.13 61.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 109.278 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.72 118.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -149.25 42.77 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.6 139.5 4.53 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.472 ' CE ' ' CE1' ' A' ' 35' ' ' PHE . 45.1 ttm -130.66 128.72 41.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.685 -0.891 . . . . 0.0 108.668 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -111.28 125.79 54.2 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.842 0.829 . . . . 0.0 109.969 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -96.56 124.08 40.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.661 -0.649 . . . . 0.0 109.276 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.759 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -101.16 125.85 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.759 0.79 . . . . 0.0 109.785 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -108.92 -149.46 0.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.359 0.6 . . . . 0.0 109.641 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 58' ' ' GLU . 44.1 p-10 -64.1 -34.15 77.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.774 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.533 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 83.9 tt0 -156.63 -43.56 0.07 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 108.865 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.42 169.87 53.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.19 156.91 42.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -1.088 . . . . 0.0 110.142 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.475 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.3 mt -112.41 134.64 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.504 0.669 . . . . 0.0 109.295 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.829 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.3 mp -100.04 122.87 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.8 m -124.3 127.28 47.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.516 0.674 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -107.87 -4.16 18.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.5 mp0 -89.48 78.93 7.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.18 132.38 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.649 -0.657 . . . . 0.0 109.372 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.95 142.58 51.51 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.866 0.841 . . . . 0.0 109.639 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.45 142.0 15.82 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' CE ' ' OE1' ' A' ' 79' ' ' GLU . 68.0 mmtt -103.97 113.04 26.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.654 -0.909 . . . . 0.0 108.79 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 23.9 m-85 -98.34 144.63 27.52 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.847 0.832 . . . . 0.0 110.113 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' GLY . 96.5 mt -122.17 136.93 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 71' ' ' ILE . 59.5 m-80 -38.49 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.854 0.835 . . . . 0.0 110.421 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 149.3 -62.36 0.42 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -177.62 154.94 1.07 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.575 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.5 134.59 21.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.337 2.025 . . . . 0.0 112.447 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -147.05 -25.11 0.4 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.484 -0.76 . . . . 0.0 109.817 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.38 51.81 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 110.411 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.93 135.32 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' OE1' ' CE ' ' A' ' 69' ' ' LYS . 46.2 tt0 -116.81 151.57 36.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.71 144.97 32.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.564 -0.71 . . . . 0.0 109.529 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -117.54 129.06 55.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.553 -0.717 . . . . 0.0 109.975 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.98 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.764 0.792 . . . . 0.0 109.543 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 85' ' ' ASN . 27.2 mm -85.69 126.23 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.653 -0.654 . . . . 0.0 109.699 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.48 36.9 2.91 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.425 ' H ' HG22 ' A' ' 83' ' ' ILE . 79.8 m-20 -63.46 -40.39 97.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.822 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -76.67 153.78 34.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.205 -0.934 . . . . 0.0 110.373 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.1 mp0 -70.06 -48.78 20.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.467 -0.77 . . . . 0.0 110.497 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 40.9 Cg_exo -52.17 -37.87 70.38 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.9 1.733 . . . . 0.0 111.392 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 83' ' ' ILE . 97.6 mt-10 -64.55 -40.74 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.567 0.699 . . . . 0.0 109.851 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -61.69 -44.82 96.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.288 -0.882 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -60.99 -46.61 90.05 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.354 -0.841 . . . . 0.0 109.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -67.56 -39.52 84.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.668 0.747 . . . . 0.0 109.438 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -62.6 -48.14 80.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.408 -0.808 . . . . 0.0 110.07 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.92 -42.09 85.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.971 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -67.57 -44.52 78.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.901 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.22 -47.09 85.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.373 -0.829 . . . . 0.0 109.359 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.4 ttt -66.69 -39.15 87.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.659 0.743 . . . . 0.0 109.066 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.2 -51.53 60.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.0 109.686 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -68.23 -40.0 82.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -63.1 -48.63 77.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.502 -0.749 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 -35.15 89.44 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.53 94.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -1.108 . . . . 0.0 110.044 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.71 -56.53 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 109.819 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -85.92 -85.11 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 45.59 91.35 0.01 OUTLIER Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mp -138.76 -160.39 1.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.461 -1.023 . . . . 0.0 110.288 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -138.9 -91.95 0.24 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -99.24 17.45 19.99 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.243 -1.151 . . . . 0.0 109.606 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.1 t -66.77 145.74 55.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 111.033 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 39.48 32.48 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.271 0.558 . . . . 0.0 110.523 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 112' ' ' GLU . 93.0 p -129.21 -77.24 0.55 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.544 0.688 . . . . 0.0 109.664 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.52 ' N ' ' OG ' ' A' ' 111' ' ' SER . 97.6 mt-10 -84.86 -9.93 57.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 115' ' ' HIS . 41.0 mt -96.75 -80.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 43.79 13.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.6 -0.687 . . . . 0.0 110.241 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 113' ' ' LEU . 36.7 m80 -104.25 -3.58 24.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.126 -0.984 . . . . 0.0 108.985 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -67.9 150.55 48.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.435 -0.79 . . . . 0.0 110.826 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 119' ' ' HIS . 20.5 t60 49.37 99.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.986 0.898 . . . . 0.0 110.193 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -62.39 -41.61 98.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.527 -0.733 . . . . 0.0 109.139 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 61.9 t-80 -71.37 146.73 48.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.483 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.943 179.635 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.421 0.629 . . . . 0.0 109.775 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 96' ' ' PHE . . . -83.03 110.65 18.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.287 -0.883 . . . . 0.0 109.538 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.516 ' CD ' HE21 ' A' ' 5' ' ' GLN . 21.0 pt-20 -154.91 158.86 39.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.065 -1.022 . . . . 0.0 109.365 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -110.26 130.97 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.582 -0.699 . . . . 0.0 109.192 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.516 HE21 ' CD ' ' A' ' 3' ' ' GLU . 78.8 mt-30 -137.35 122.87 19.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.32 -39.32 85.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.845 . . . . 0.0 109.644 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 10' ' ' VAL . 72.5 m -127.02 153.25 46.17 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.711 0.767 . . . . 0.0 110.223 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -71.47 137.5 48.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.592 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.22 -2.66 71.71 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 7' ' ' SER . 69.2 t -70.84 -50.4 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -1.139 . . . . 0.0 109.682 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' VAL . . . 58.95 144.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 110.595 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 13' ' ' THR . 8.6 tm-20 58.14 -88.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.909 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.531 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 1.4 m 81.87 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -172.77 179.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.482 ' H ' HG22 ' A' ' 14' ' ' VAL . 96.3 t -115.13 86.35 13.84 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -78.25 154.15 28.38 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.984 2.456 . . . . 0.0 112.873 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -81.01 155.46 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -111.13 128.63 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.601 -0.687 . . . . 0.0 109.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' C ' HD22 ' A' ' 20' ' ' LEU . 79.2 ttt-85 -134.74 132.8 39.22 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -97.28 135.53 39.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.511 ' CB ' ' HZ3' ' A' ' 32' ' ' LYS . 40.3 m -123.99 150.0 45.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.25 142.9 50.53 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 109.823 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.418 ' HB2' ' H ' ' A' ' 28' ' ' SER . 26.6 m -75.9 -177.33 3.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.523 -0.735 . . . . 0.0 110.089 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.426 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 0.5 OUTLIER -61.97 135.1 57.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -0.846 . . . . 0.0 110.183 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 56.82 15.68 2.36 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.49 18.64 78.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -46.85 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.528 -0.984 . . . . 0.0 110.473 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' A' ' 23' ' ' SER . 17.6 m -98.32 123.68 42.56 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.222 -0.923 . . . . 0.0 110.221 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.25 145.37 28.06 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -161.06 167.45 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.274 . . . . 0.0 109.147 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.14 143.71 38.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.351 -0.843 . . . . 0.0 108.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.511 ' HZ3' ' CB ' ' A' ' 21' ' ' SER . 64.4 mttp -111.83 146.37 37.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.74 131.69 54.21 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.36 128.3 53.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -112.25 114.95 28.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.49 -0.756 . . . . 0.0 109.428 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' GLU . 39.7 tp -95.4 122.43 38.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 36' ' ' LEU . 50.9 mm-40 39.45 57.25 6.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.751 -0.593 . . . . 0.0 111.034 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.69 145.78 91.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.449 2.099 . . . . 0.0 112.379 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 41' ' ' LEU . 64.0 p -69.46 -24.38 63.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.379 -0.826 . . . . 0.0 110.292 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 tp -59.44 1.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.068 . . . . 0.0 109.859 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 39' ' ' THR . 89.2 mt -91.24 -6.9 52.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 109.22 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.74 -26.63 13.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.457 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HZ1' HG22 ' A' ' 10' ' ' VAL . 52.0 mtmt -96.06 -75.89 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.275 -0.891 . . . . 0.0 110.018 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.05 151.71 20.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.423 -0.798 . . . . 0.0 110.395 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -74.71 163.1 28.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 p -66.53 -32.69 74.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.565 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.34 -18.55 63.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -79.31 -5.18 53.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.05 117.83 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.41 ' HB ' ' HE ' ' A' ' 64' ' ' ARG . 19.2 p -114.25 0.2 14.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.51 178.22 45.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.3 ttp -130.32 137.99 50.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.591 -0.947 . . . . 0.0 108.716 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' CE2' HD12 ' A' ' 62' ' ' ILE . 91.2 m-85 -106.18 123.12 47.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.32 -0.862 . . . . 0.0 110.035 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.521 ' C ' HD12 ' A' ' 55' ' ' ILE . 88.6 mt -99.15 125.95 44.82 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.803 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.9 mp -107.14 129.06 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.628 -0.67 . . . . 0.0 110.081 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 92' ' ' ARG . 41.9 p-10 -150.79 120.61 7.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.222 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' N ' HH12 ' A' ' 99' ' ' ARG . 66.4 t0 59.92 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.626 -0.671 . . . . 0.0 109.983 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' ASP . 81.1 tt0 -145.53 -38.64 0.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 108.886 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.83 171.85 53.38 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.5 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 2.2 pm0 -152.08 156.08 39.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.261 -1.14 . . . . 0.0 109.435 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.63 135.45 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.604 -0.685 . . . . 0.0 109.175 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.409 HD12 ' CE2' ' A' ' 53' ' ' TYR . 21.2 mm -101.78 125.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.3 m -123.45 125.97 45.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.568 -0.708 . . . . 0.0 109.258 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.41 ' HE ' ' HB ' ' A' ' 50' ' ' THR . 7.7 tpt180 -97.72 -7.98 29.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE1' HD11 ' A' ' 83' ' ' ILE . 96.2 mt-10 -83.86 84.0 7.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 110.017 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.78 134.57 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.452 -0.78 . . . . 0.0 109.452 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -125.57 142.09 51.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.57 -0.706 . . . . 0.0 109.263 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.58 140.39 14.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -107.23 102.77 12.06 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -102.32 146.1 28.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.588 -0.695 . . . . 0.0 109.776 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.7 mt -121.17 133.09 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.529 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 0.5 OUTLIER -38.03 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 -178.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 154.09 -60.86 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -177.04 150.9 0.91 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.331 . . . . 0.0 109.158 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -40.16 118.68 0.57 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.267 1.978 . . . . 0.0 111.861 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.404 ' CB ' HD12 ' A' ' 71' ' ' ILE . 12.2 m -111.22 -33.85 6.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.28 164.39 37.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 110.901 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 79' ' ' GLU . 94.4 mt -126.87 164.1 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.54 ' N ' HG22 ' A' ' 78' ' ' ILE . 15.5 tm-20 -140.12 148.5 41.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.463 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.76 143.81 35.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.501 -0.749 . . . . 0.0 108.981 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -122.87 130.33 52.73 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.567 -0.708 . . . . 0.0 109.582 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.3 t -110.81 129.71 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.492 -0.755 . . . . 0.0 109.414 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.585 ' CG2' ' ND2' ' A' ' 85' ' ' ASN . 30.0 mm -82.66 129.0 38.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 86.9 mt -117.52 38.02 3.72 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.585 ' ND2' ' CG2' ' A' ' 83' ' ' ILE . 61.0 m-20 -63.36 -40.67 97.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.377 -0.827 . . . . 0.0 109.332 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 151.06 35.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.27 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.586 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -73.2 -41.12 6.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.517 -0.739 . . . . 0.0 110.437 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 47.0 Cg_exo -56.08 -35.81 95.38 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.203 1.935 . . . . 0.0 111.632 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.57 -39.27 88.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.43 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.8 m95 -60.28 -42.12 94.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.63 -49.33 78.15 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.749 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.51 ' NH2' ' OD1' ' A' ' 56' ' ' ASP . 17.4 mmm180 -69.06 -39.77 78.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -61.68 -44.66 96.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.336 -0.853 . . . . 0.0 109.282 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.1 mmm -62.64 -41.49 99.06 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 108.881 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -64.89 -45.39 86.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.056 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.415 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 74.3 t80 -61.22 -45.85 92.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.415 ' SD ' ' C ' ' A' ' 97' ' ' MET . 2.0 tmt? -62.14 -41.54 98.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.481 -0.762 . . . . 0.0 109.725 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.3 -46.15 77.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.121 -0.987 . . . . 0.0 109.318 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.448 HH12 ' N ' ' A' ' 57' ' ' ASP . 83.5 mtp180 -65.63 -41.68 92.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.143 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.47 -48.42 79.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.47 -0.769 . . . . 0.0 109.695 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -67.85 -36.31 86.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.09 98.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.07 -42.16 66.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.347 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -94.12 -70.98 0.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.484 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 101' ' ' GLY . . . 83.89 45.3 6.4 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.5 mt -63.33 -43.5 97.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -1.199 . . . . 0.0 109.498 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.51 8.66 80.27 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 110' ' ' LYS . 26.3 m-85 -105.78 17.5 23.62 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.238 -1.154 . . . . 0.0 108.575 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.618 ' C ' ' H ' ' A' ' 111' ' ' SER . 48.2 t -63.25 71.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 109.238 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 108' ' ' PHE . 86.3 tttt 61.1 -23.94 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.621 -0.675 . . . . 0.0 110.245 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.618 ' H ' ' C ' ' A' ' 109' ' ' SER . 15.2 m -71.95 137.36 47.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.815 -1.178 . . . . 0.0 109.6 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 111' ' ' SER . 16.8 tp10 84.69 -31.89 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 113' ' ' LEU . 4.1 mm? -63.92 -42.27 97.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.817 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 115' ' ' HIS . 97.1 mt-10 -98.16 -5.51 33.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.161 -0.962 . . . . 0.0 109.277 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 114' ' ' GLU . 98.7 m-70 58.18 116.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.608 0.718 . . . . 0.0 110.385 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.491 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 51.3 p-80 -60.74 -44.92 96.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 109.305 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.47 ' N ' ' CG ' ' A' ' 116' ' ' HIS . 49.1 t-80 51.86 75.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.49 -0.756 . . . . 0.0 109.812 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 116' ' ' HIS . 53.0 m80 -150.58 -40.31 0.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -67.42 -40.31 85.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.471 ' ND1' ' C ' ' A' ' 120' ' ' HIS . 2.2 p80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.247 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.572 ' O ' ' N ' ' A' ' 3' ' ' GLU . 12.7 mmt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.427 ' H ' ' HB2' ' A' ' 100' ' ' TYR . . . 58.71 -72.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.105 0.479 . . . . 0.0 109.868 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 1' ' ' MET . 17.6 pt-20 -134.79 136.98 42.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.784 0.802 . . . . 0.0 109.651 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.4 129.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.2 135.8 51.16 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.792 0.806 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -106.76 -56.08 2.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.537 0.684 . . . . 0.0 109.394 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' LYS . 32.5 t -93.42 11.21 29.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 109.359 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.6 mttm 57.88 124.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.771 0.796 . . . . 0.0 110.76 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.72 11.15 64.2 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 10' ' ' VAL . 3.0 m -96.04 135.02 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.499 -1.0 . . . . 0.0 110.09 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -92.88 -159.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.437 0.637 . . . . 0.0 110.599 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 56.53 -76.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 11' ' ' ALA . 4.5 p 65.29 6.38 3.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.745 HG22 ' H ' ' A' ' 15' ' ' VAL . 12.8 p 44.07 177.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.891 0.853 . . . . 0.0 111.202 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.745 ' H ' HG22 ' A' ' 14' ' ' VAL . 81.9 t -115.14 91.8 28.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.878 . . . . 0.0 108.959 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.04 145.02 17.22 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.75 2.3 . . . . 0.0 112.673 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.12 149.7 39.0 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.571 -0.705 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.72 127.43 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.462 ' C ' HD12 ' A' ' 20' ' ' LEU . 59.1 ttp180 -132.06 119.84 21.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 19' ' ' ARG . 7.0 mp -104.79 132.5 50.96 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.9 m -127.37 152.29 47.68 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.378 0.608 . . . . 0.0 109.683 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.3 131.11 57.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.652 0.739 . . . . 0.0 109.559 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -57.87 -86.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.767 -0.583 . . . . 0.0 110.132 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -107.07 -109.9 0.3 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.57 -0.707 . . . . 0.0 110.209 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -96.31 11.98 32.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.435 -0.791 . . . . 0.0 109.113 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.55 21.32 5.5 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -84.31 -7.3 59.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.473 -1.016 . . . . 0.0 109.189 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 t -159.77 101.23 1.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.45 ' HA3' ' HE1' ' A' ' 90' ' ' TRP . . . -67.92 140.42 36.27 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.33 149.54 41.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.423 -1.045 . . . . 0.0 109.993 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.0 144.89 45.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 142.46 51.49 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.652 0.739 . . . . 0.0 109.953 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.93 137.95 54.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -120.68 125.34 47.45 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.688 0.756 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 32.3 m-85 -110.12 114.39 27.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 37' ' ' GLU . 51.8 tp -88.77 132.31 34.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.397 0.618 . . . . 0.0 110.565 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' LEU . 41.0 mt-10 32.76 68.81 0.91 Allowed Pre-proline 0 N--CA 1.5 2.032 0 CA-C-O 121.177 0.513 . . . . 0.0 111.127 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.52 140.71 92.74 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.66 2.24 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -83.14 -19.4 36.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.561 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.43 1.87 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 109.398 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' THR . 95.2 mt -81.85 -13.27 57.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.19 -13.78 21.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.37 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -107.84 -44.84 4.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -134.62 147.59 50.22 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.6 m -75.79 158.39 32.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.753 0.787 . . . . 0.0 110.535 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -64.98 -32.16 73.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -72.45 -17.47 61.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -88.73 -7.56 56.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.235 -0.915 . . . . 0.0 109.251 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.86 122.14 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.754 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -124.42 122.77 38.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 109.562 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.14 -171.06 18.95 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.5 ttp -141.45 133.64 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.56 -0.965 . . . . 0.0 108.961 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.421 ' CD2' HD12 ' A' ' 62' ' ' ILE . 70.3 m-85 -108.35 109.29 20.58 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.723 0.773 . . . . 0.0 109.726 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.69 111.47 23.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 mm -109.25 131.02 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.031 0.919 . . . . 0.0 110.366 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD1' ' CD2' ' A' ' 96' ' ' PHE . 2.7 m-20 -138.6 -160.73 1.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.486 0.66 . . . . 0.0 109.408 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -81.45 104.66 12.04 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.926 0.869 . . . . 0.0 110.319 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 60.62 89.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.643 0.735 . . . . 0.0 110.592 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.57 142.97 5.77 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.28 147.68 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.999 . . . . 0.0 109.108 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.77 133.7 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 109.578 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' CD2' ' A' ' 53' ' ' TYR . 30.2 mm -108.02 126.99 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 109.196 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 65' ' ' GLU . 76.3 m -125.4 125.66 43.75 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.64 0.733 . . . . 0.0 109.295 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -97.8 -1.77 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' H ' HG22 ' A' ' 63' ' ' THR . 96.8 mt-10 -85.26 75.24 10.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.457 -0.777 . . . . 0.0 109.426 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.0 t -126.7 133.83 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.679 0.752 . . . . 0.0 109.338 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -132.82 141.13 48.3 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.97 141.24 15.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -106.01 119.23 38.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.604 -0.939 . . . . 0.0 108.875 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -107.98 144.59 35.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.583 0.706 . . . . 0.0 110.064 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mm -121.05 131.38 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 57.66 14.92 2.61 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.453 0.644 . . . . 0.0 110.07 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -17.86 58.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -100.4 150.37 36.88 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.452 -1.028 . . . . 0.0 110.05 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.92 143.25 90.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.576 2.184 . . . . 0.0 112.129 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 m -149.12 -41.47 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.973 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.85 164.59 35.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.762 -1.211 . . . . 0.0 111.077 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.02 152.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -135.34 145.28 47.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.011 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.22 46.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.689 1.233 . . . . 0.0 110.004 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.4 m -126.65 131.62 51.4 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.671 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.9 t -119.62 130.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 mm -87.7 126.71 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.542 0.687 . . . . 0.0 109.919 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.64 41.64 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -63.59 -39.75 95.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.73 . . . . 0.0 109.363 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.58 158.18 27.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.555 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 7.5 mm-40 -79.85 -41.42 1.43 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.802 -0.561 . . . . 0.0 110.832 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.8 Cg_exo -56.14 -37.5 96.39 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.823 1.682 . . . . 0.0 111.259 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -68.28 -39.04 82.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.637 -0.664 . . . . 0.0 109.433 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.45 ' HE1' ' HA3' ' A' ' 29' ' ' GLY . 1.8 m95 -61.32 -40.62 94.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.52 -44.56 95.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.189 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -69.55 -39.01 77.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 109.119 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.83 -45.97 91.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.37 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.6 ttt -62.56 -47.04 85.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.59 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -65.69 -41.72 92.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.461 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.56 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 3.4 m-85 -64.15 -46.89 82.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.2 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.8 ttp -63.03 -39.58 95.18 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -66.35 -40.45 89.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.507 -0.746 . . . . 0.0 109.443 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -65.88 -42.36 90.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.427 ' HB2' ' H ' ' A' ' 2' ' ' ALA . 81.8 t80 -60.05 -46.47 89.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.482 -0.761 . . . . 0.0 109.269 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.31 94.73 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.52 72.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -1.053 . . . . 0.0 109.849 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.78 -42.78 69.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.518 -0.739 . . . . 0.0 109.763 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.412 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 62.0 m-20 -107.66 115.2 29.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.561 -0.712 . . . . 0.0 109.569 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 106' ' ' LEU . . . -94.17 45.12 2.27 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 106' ' ' LEU . 9.9 mp 44.71 100.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.75 -0.853 . . . . 0.0 110.715 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.98 3.69 90.5 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CE2' ' O ' ' A' ' 109' ' ' SER . 88.3 t80 -72.37 141.62 48.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.526 -0.984 . . . . 0.0 110.237 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.49 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 8.2 p -77.48 132.04 38.23 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.488 -0.758 . . . . 0.0 110.263 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 112' ' ' GLU . 66.2 tttm -172.86 73.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 112' ' ' GLU . 79.2 p 47.0 -82.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.666 0.746 . . . . 0.0 110.919 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 110' ' ' LYS . 73.0 mm-40 -53.72 -48.07 69.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.511 -0.743 . . . . 0.0 109.773 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 115' ' ' HIS . 93.9 mt -68.23 -93.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 110.351 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 41.75 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.491 0.662 . . . . 0.0 110.191 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 113' ' ' LEU . 59.8 t-80 43.35 83.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.634 0.731 . . . . 0.0 110.023 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.413 ' ND1' ' C ' ' A' ' 116' ' ' HIS . 6.1 p80 -153.39 165.89 34.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.468 -0.77 . . . . 0.0 110.059 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 118' ' ' HIS . 54.2 t-80 -74.64 171.64 13.52 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.592 0.71 . . . . 0.0 110.591 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.508 ' N ' ' CG ' ' A' ' 117' ' ' HIS . 59.8 m170 -68.67 137.47 54.19 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.761 0.791 . . . . 0.0 110.559 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.403 ' O ' ' OXT' ' A' ' 120' ' ' HIS . 62.6 t-80 -84.38 128.99 34.9 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.734 0.778 . . . . 0.0 110.069 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.403 ' OXT' ' O ' ' A' ' 119' ' ' HIS . 99.5 m-70 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.96 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.14 -18.52 16.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.518 -0.739 . . . . 0.0 109.205 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.563 ' CD ' HE21 ' A' ' 5' ' ' GLN . 43.7 tt0 -145.16 134.05 22.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 109.095 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.38 129.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.634 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.563 HE21 ' CD ' ' A' ' 3' ' ' GLU . 76.5 mt-30 -140.31 124.87 17.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.298 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.41 -2.88 58.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.133 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 8' ' ' LYS . 29.6 t -155.86 43.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.436 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' SER . 47.2 pttt 31.81 43.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.433 0.635 . . . . 0.0 110.853 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.43 26.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -97.8 132.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -1.11 . . . . 0.0 110.092 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.16 142.26 58.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 14' ' ' VAL . 57.4 mp0 -85.47 -116.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.597 -0.689 . . . . 0.0 110.379 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.3 p 57.35 0.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.566 ' H ' ' C ' ' A' ' 12' ' ' GLU . 74.9 t -67.91 -43.54 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.05 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 105' ' ' GLY . 9.8 t 62.13 60.43 2.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.733 -0.604 . . . . 0.0 109.869 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -68.61 149.06 73.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.662 2.241 . . . . 0.0 112.256 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.82 154.09 23.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 110.087 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.88 132.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -127.63 140.69 51.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.14 143.0 43.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.604 -0.685 . . . . 0.0 109.684 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -149.92 151.86 34.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.042 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.61 133.58 55.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.688 0.756 . . . . 0.0 109.185 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 27' ' ' GLN . 90.7 p -43.9 108.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.6 0.714 . . . . 0.0 110.724 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -64.73 -40.55 95.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.599 -0.688 . . . . 0.0 109.418 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -90.02 6.25 43.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 109.216 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.07 107.06 0.49 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -163.16 28.21 0.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.51 -0.994 . . . . 0.0 108.93 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 27' ' ' GLN . 3.0 p 79.58 -172.62 0.05 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.642 0.734 . . . . 0.0 110.684 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.25 145.71 49.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.3 ttp -141.45 150.06 41.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -1.045 . . . . 0.0 109.796 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.35 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.444 -0.785 . . . . 0.0 109.01 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -125.61 140.72 52.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.541 -0.724 . . . . 0.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.53 119.33 38.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -95.99 124.43 39.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 109.138 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.92 124.8 52.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.644 -0.66 . . . . 0.0 109.709 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.8 tp -107.79 121.65 45.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.657 -0.652 . . . . 0.0 109.286 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 40.6 mt-10 42.65 55.43 10.39 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 110.315 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 36.0 Cg_endo -66.71 151.25 82.97 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.919 2.412 . . . . 0.0 112.749 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -84.28 90.85 7.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.638 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' GLU . 10.5 tp -173.48 -27.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -40.35 96.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.33 79.99 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 108.891 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -89.19 -69.58 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.619 -0.676 . . . . 0.0 109.286 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 40' ' ' ILE . 97.8 mt-10 -110.94 134.65 52.41 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.511 -0.743 . . . . 0.0 109.67 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -65.85 159.86 24.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.659 0.743 . . . . 0.0 110.436 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.435 ' H ' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -66.07 -33.46 75.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.648 -0.658 . . . . 0.0 109.65 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.2 -19.07 63.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.484 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -82.59 -5.62 58.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.1 mt -98.96 117.25 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.389 -0.819 . . . . 0.0 109.776 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 50' ' ' THR . 88.5 m -102.6 -7.11 22.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.63 -179.75 42.85 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.142 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.8 ttp -128.92 145.17 51.3 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.626 -0.926 . . . . 0.0 109.222 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.37 122.36 46.84 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.406 -0.809 . . . . 0.0 110.425 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 55' ' ' ILE . 52.4 mt -98.89 109.5 22.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.6 mp -105.47 163.15 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.041 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 55' ' ' ILE . 40.4 t0 -162.46 -179.2 6.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.541 -0.724 . . . . 0.0 109.407 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.481 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 97.8 m-20 -70.07 -15.64 63.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -169.55 97.71 0.32 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.374 -0.829 . . . . 0.0 109.285 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.3 146.15 8.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.78 144.45 23.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.5 mt -124.08 131.51 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.767 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.0 mp -101.97 132.16 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.0 m -120.32 123.32 42.84 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -97.79 -1.57 42.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.64 72.29 7.77 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.77 132.78 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.3 144.01 51.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.26 137.97 14.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.19 128.12 53.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.634 -0.921 . . . . 0.0 108.98 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -102.47 122.29 44.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.93 140.05 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 58.96 32.92 22.71 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.35 23.66 74.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -151.06 148.32 22.47 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.078 -1.248 . . . . 0.0 109.435 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.85 107.39 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.198 1.932 . . . . 0.0 111.228 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m -131.45 -10.25 3.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.538 -0.727 . . . . 0.0 110.059 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.71 154.47 41.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.957 -1.089 . . . . 0.0 110.306 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.7 mt -131.03 159.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 16.1 tm-20 -140.7 149.31 42.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.267 -0.895 . . . . 0.0 109.489 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.482 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.13 142.7 35.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.399 -0.813 . . . . 0.0 109.055 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -120.63 132.61 55.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.707 -0.621 . . . . 0.0 109.669 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.68 132.17 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.1 mm -95.38 122.5 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.336 -0.853 . . . . 0.0 110.116 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.4 mt -101.12 79.25 1.99 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -87.3 -5.6 58.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.497 -0.752 . . . . 0.0 110.048 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 t -115.72 134.33 55.14 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.731 0.776 . . . . 0.0 109.764 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.0 mp0 -58.85 -60.65 9.79 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.752 -0.592 . . . . 0.0 110.579 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 3.0 Cg_endo -49.52 -21.52 5.25 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.993 1.795 . . . . 0.0 111.715 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -65.92 -38.17 87.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.694 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -58.67 -38.19 77.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.329 -0.857 . . . . 0.0 109.749 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -60.39 -44.2 95.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -67.51 -40.67 85.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.842 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.6 -48.9 78.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.359 -0.838 . . . . 0.0 109.794 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.08 -40.75 78.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CG ' HH12 ' A' ' 99' ' ' ARG . 63.3 ttm-85 -63.37 -49.11 75.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.797 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.519 ' CE2' ' OD2' ' A' ' 56' ' ' ASP . 6.2 m-85 -66.31 -42.02 88.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.468 -0.77 . . . . 0.0 109.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 59.4 tpp -64.98 -34.07 77.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.629 -0.669 . . . . 0.0 109.267 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.65 -54.52 41.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.136 -0.978 . . . . 0.0 110.156 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.411 HH12 ' CG ' ' A' ' 95' ' ' ARG . 95.9 mtm-85 -65.69 -46.83 77.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.947 . . . . 0.0 110.145 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -62.95 -44.78 95.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.21 -33.89 88.44 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.09 98.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.322 -1.105 . . . . 0.0 109.529 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -71.27 -56.35 6.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -159.59 -148.28 0.18 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.218 -0.926 . . . . 0.0 109.811 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.49 ' H ' HG13 ' A' ' 15' ' ' VAL . . . 76.48 -160.57 50.91 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 106' ' ' LEU . 7.7 mp 56.1 -95.11 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.295 0.569 . . . . 0.0 110.122 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.38 -2.09 73.8 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -98.03 146.65 25.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.455 -1.026 . . . . 0.0 109.808 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 86.8 p -103.09 -4.83 23.97 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.583 -0.698 . . . . 0.0 109.63 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -174.61 -30.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.396 -0.815 . . . . 0.0 109.408 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.8 m -45.86 137.05 5.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.515 -0.74 . . . . 0.0 109.729 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 59.08 -68.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.103 0.478 . . . . 0.0 109.82 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 111' ' ' SER . 0.1 OUTLIER -87.23 116.51 25.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.049 -1.032 . . . . 0.0 109.684 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -169.87 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.558 ' ND1' ' N ' ' A' ' 116' ' ' HIS . 57.5 t-80 41.64 -116.44 0.32 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.716 -0.615 . . . . 0.0 110.198 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.558 ' N ' ' ND1' ' A' ' 115' ' ' HIS . 97.0 m-70 -156.49 -49.81 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -142.61 53.73 1.41 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.146 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -74.4 -26.21 59.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.663 -0.648 . . . . 0.0 109.449 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.446 ' ND1' ' OXT' ' A' ' 120' ' ' HIS . 29.8 t-80 -68.32 131.66 45.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.408 -0.807 . . . . 0.0 110.266 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.446 ' OXT' ' ND1' ' A' ' 119' ' ' HIS . 52.4 p-80 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.86 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -45.17 115.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.628 0.728 . . . . 0.0 109.992 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -153.14 149.26 27.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mp -110.34 130.45 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.469 0.652 . . . . 0.0 109.995 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -129.56 129.26 44.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.688 0.756 . . . . 0.0 109.513 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -88.09 -5.94 58.19 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 m -157.45 -168.85 2.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.6 133.74 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.865 0.84 . . . . 0.0 111.086 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 42.25 71.17 0.4 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.4 -47.92 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -1.001 . . . . 0.0 108.727 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.73 82.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.079 0.942 . . . . 0.0 109.152 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.11 124.22 30.89 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.738 0.78 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -96.4 -14.92 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 15' ' ' VAL . 59.3 t -55.66 159.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.292 -0.88 . . . . 0.0 110.091 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' N ' HG12 ' A' ' 14' ' ' VAL . 12.4 t -112.39 81.42 4.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.534 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.6 148.76 54.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.611 2.208 . . . . 0.0 112.554 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 18' ' ' VAL . 7.0 tm-20 -84.37 155.17 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.592 -0.692 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 55.4 t -117.62 129.62 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.561 0.696 . . . . 0.0 109.768 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -128.68 137.88 51.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.24 131.18 47.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.585 -0.697 . . . . 0.0 109.351 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 m -108.01 149.09 28.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.612 -0.68 . . . . 0.0 109.619 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 24' ' ' LYS . 88.3 tttt -135.05 141.53 46.15 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.654 0.74 . . . . 0.0 109.589 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 p -71.51 14.57 0.17 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.649 . . . . 0.0 109.538 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 26' ' ' GLY . 36.6 ttmt 64.89 91.8 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.662 0.744 . . . . 0.0 110.739 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 55.05 6.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.611 0.72 . . . . 0.0 109.185 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 24' ' ' LYS . . . -83.82 165.39 41.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -99.6 74.07 1.86 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.296 -1.12 . . . . 0.0 109.686 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 p -164.11 101.14 0.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.361 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.89 143.56 41.91 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttp -165.09 153.02 11.46 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -1.052 . . . . 0.0 109.663 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 21' ' ' SER . . . -142.89 153.18 42.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.653 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.06 147.55 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.452 0.644 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.32 136.85 54.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -114.27 122.05 45.55 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.456 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.19 114.28 27.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.0 tp -95.87 121.22 37.37 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.708 0.766 . . . . 0.0 110.027 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 48.55 60.21 15.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.982 -0.449 . . . . 0.0 110.623 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 40' ' ' ILE . 38.1 Cg_endo -69.68 1.36 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.346 2.031 . . . . 0.0 110.479 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m 54.74 5.03 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.28 0.562 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 38' ' ' PRO . 2.8 tp -73.48 -1.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 109.655 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.7 mt -84.42 -9.55 58.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 108.953 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.8 -18.6 22.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.332 -0.855 . . . . 0.0 109.382 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.45 -47.15 4.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.32 -0.863 . . . . 0.0 109.089 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.78 153.09 48.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.33 -0.856 . . . . 0.0 110.148 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 t -80.69 167.04 20.47 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.694 0.759 . . . . 0.0 110.373 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -62.93 -39.92 96.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.642 0.734 . . . . 0.0 109.423 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 50.0 p-10 -70.98 -21.91 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.524 -0.735 . . . . 0.0 109.682 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 96.4 m-20 -80.26 -6.23 57.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.95 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.22 123.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.984 -1.073 . . . . 0.0 109.939 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.418 ' OG1' ' CZ ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -116.15 91.01 3.47 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 0.0 109.369 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.93 174.71 37.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -127.62 149.15 50.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.709 -0.877 . . . . 0.0 109.375 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.79 108.84 20.56 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.621 0.724 . . . . 0.0 109.726 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.35 115.81 30.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.89 125.15 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.53 0.681 . . . . 0.0 109.602 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -104.01 -167.36 1.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.592 0.71 . . . . 0.0 110.376 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 33.2 p-10 -77.78 -5.23 50.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.728 -0.607 . . . . 0.0 109.658 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -108.75 -94.18 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.417 -0.802 . . . . 0.0 109.884 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' H ' ' NH1' ' A' ' 92' ' ' ARG . . . -106.12 -147.59 15.16 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -137.38 155.09 49.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.98 . . . . 0.0 110.091 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.45 138.86 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.407 0.622 . . . . 0.0 109.804 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.0 mm -110.34 129.27 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.8 m -120.18 123.85 44.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 109.581 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' CZ ' ' OG1' ' A' ' 50' ' ' THR . 18.2 tpt85 -98.82 -12.6 20.69 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -84.83 79.3 9.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.441 -0.787 . . . . 0.0 109.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.93 133.21 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.403 0.621 . . . . 0.0 109.476 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.05 143.25 50.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.73 0.776 . . . . 0.0 109.727 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.79 140.42 15.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -101.52 121.58 42.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.984 . . . . 0.0 109.185 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -104.62 119.33 38.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.631 0.729 . . . . 0.0 110.121 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.31 138.84 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.42 33.75 20.65 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.603 0.716 . . . . 0.0 110.192 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.24 27.55 73.07 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -155.1 148.19 18.22 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.143 -1.21 . . . . 0.0 109.523 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.07 113.96 3.23 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.6 2.2 . . . . 0.0 111.926 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m -126.98 -15.69 5.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.22 158.26 43.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 110.269 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -129.01 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.378 0.609 . . . . 0.0 109.463 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -129.59 148.05 51.45 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.604 0.716 . . . . 0.0 109.689 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.4 145.94 39.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.21 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -121.47 131.71 54.31 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.432 0.634 . . . . 0.0 109.946 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.08 129.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.612 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.4 mp -82.15 127.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.533 0.682 . . . . 0.0 109.655 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.494 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 84.5 mt -120.68 33.77 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.68 -40.04 95.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.529 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.7 m -70.47 145.61 50.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.044 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.502 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -71.58 -47.67 12.56 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.303 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 43.7 Cg_exo -54.36 -33.67 77.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.123 1.882 . . . . 0.0 111.819 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -66.04 -37.24 85.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.578 -0.701 . . . . 0.0 109.872 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.494 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.1 m95 -60.97 -39.81 91.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 109.944 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.58 -51.1 69.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.488 ' NH1' ' H ' ' A' ' 59' ' ' GLY . 63.2 ttm-85 -68.27 -42.68 79.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.43 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.29 -43.25 99.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ttt -59.02 -41.98 89.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.308 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.36 -40.48 93.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.523 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.55 -48.21 82.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.266 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.8 ttt -67.86 -39.09 83.81 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.646 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -64.3 -47.95 77.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.453 -0.779 . . . . 0.0 109.434 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -67.23 -42.34 84.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.825 . . . . 0.0 109.546 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.6 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 60.6 t80 -60.94 -46.18 91.73 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.801 0.81 . . . . 0.0 109.314 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.464 ' CA ' HD11 ' A' ' 106' ' ' LEU . . . -65.09 -30.91 79.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.38 93.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 109.812 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -89.24 -16.89 30.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.6 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 68.7 m-80 -103.69 145.16 30.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.43 6.89 42.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 106' ' ' LEU . 10.4 mp 56.32 164.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.029 0.919 . . . . 0.0 110.658 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' SER . . . 175.37 129.58 1.22 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 40.73 22.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.876 -0.779 . . . . 0.0 110.011 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 107' ' ' GLY . 31.1 t -61.65 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.115 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -152.06 -55.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 109.893 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' A' ' 112' ' ' GLU . 78.4 p -62.27 -30.49 71.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.362 -0.836 . . . . 0.0 109.414 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 57.4 mp0 -95.54 -27.54 15.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 108.954 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.526 ' O ' HD23 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -65.62 -42.72 91.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 0.0 109.716 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.56 6.15 24.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.092 -1.005 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.85 154.02 50.74 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.403 -0.811 . . . . 0.0 110.164 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -108.03 123.08 48.13 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.585 0.707 . . . . 0.0 109.939 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -66.98 -41.94 85.95 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.682 0.753 . . . . 0.0 109.481 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -89.36 127.41 35.81 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 0.0 109.981 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 48.6 p-80 -74.54 62.89 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.713 0.768 . . . . 0.0 109.828 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 119' ' ' HIS . 84.1 t60 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.314 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.671 0.748 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' HB2' ' OD2' ' A' ' 56' ' ' ASP . . . -67.64 139.06 56.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 110.395 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -155.39 138.98 15.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -0.814 . . . . 0.0 109.723 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.2 130.51 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.672 0.748 . . . . 0.0 109.399 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 10' ' ' VAL . 16.8 pt20 -149.05 145.71 27.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.511 -0.743 . . . . 0.0 109.674 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 53' ' ' TYR . 90.2 m-85 -63.39 -45.47 90.93 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.59 0.709 . . . . 0.0 109.404 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 m -104.99 158.06 16.8 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.672 0.748 . . . . 0.0 110.322 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -68.54 133.28 48.32 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.834 0.826 . . . . 0.0 110.507 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 45.37 86.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.512 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 44.4 t -101.96 -77.66 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -1.026 . . . . 0.0 109.296 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' N ' HG12 ' A' ' 10' ' ' VAL . . . -178.06 -99.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.458 -0.776 . . . . 0.0 110.068 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.7 143.03 31.98 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 110.805 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' VAL . 70.9 m -75.72 -17.88 59.77 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.321 0.581 . . . . 0.0 109.968 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' THR . 3.7 t 55.51 158.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.485 -0.76 . . . . 0.0 110.572 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.25 74.53 41.83 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.299 -0.875 . . . . 0.0 109.892 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.05 147.36 23.72 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.921 2.414 . . . . 0.0 112.522 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 106' ' ' LEU . 79.2 mm-40 -74.86 161.63 29.38 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.767 0.794 . . . . 0.0 110.045 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -113.06 131.33 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.543 0.687 . . . . 0.0 109.324 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.425 ' C ' HD22 ' A' ' 20' ' ' LEU . 83.7 mtp180 -128.52 139.9 52.08 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.678 0.751 . . . . 0.0 109.579 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.1 mm? -97.42 135.22 39.61 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.641 0.734 . . . . 0.0 109.64 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.9 t -134.57 142.95 47.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.539 0.685 . . . . 0.0 109.714 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -100.77 159.08 15.48 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.054 0.931 . . . . 0.0 110.371 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 p -67.03 165.75 15.09 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.652 0.739 . . . . 0.0 110.295 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -62.01 -40.08 94.44 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.649 0.738 . . . . 0.0 109.378 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -91.52 -6.26 52.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.909 . . . . 0.0 109.025 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.85 16.23 78.16 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -76.14 -78.11 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.484 -1.009 . . . . 0.0 109.957 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.8 p -78.44 -97.25 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 110.055 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.84 172.85 18.3 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.0 ptp -159.26 175.69 13.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -1.132 . . . . 0.0 109.679 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.54 143.91 45.97 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' NZ ' ' OG1' ' A' ' 81' ' ' THR . 68.3 mttm -117.18 142.9 46.45 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.626 0.727 . . . . 0.0 110.166 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.86 128.12 54.95 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -103.76 131.87 50.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.577 -0.702 . . . . 0.0 109.627 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -112.43 126.44 55.3 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.0 tp -100.68 125.32 47.09 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.681 0.753 . . . . 0.0 110.677 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 37.04 58.17 3.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.22 150.68 81.74 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.574 2.182 . . . . 0.0 112.525 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -76.5 -18.69 58.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.746 -0.596 . . . . 0.0 110.219 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.78 1.52 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.03 . . . . 0.0 109.707 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.0 mt -89.28 -8.94 52.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.027 -1.045 . . . . 0.0 109.169 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.98 -26.88 11.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.414 -0.804 . . . . 0.0 109.263 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.47 -74.34 0.45 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -0.921 . . . . 0.0 109.9 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.05 143.67 36.46 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.87 0.843 . . . . 0.0 110.408 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -76.5 169.4 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.918 0.866 . . . . 0.0 110.52 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.5 p -65.36 -31.09 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.02 -36.61 84.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.67 -8.99 58.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.4 mt -101.6 118.35 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.238 -0.914 . . . . 0.0 109.989 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.38 26.04 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.452 ' N ' HG21 ' A' ' 66' ' ' VAL . . . -176.99 164.97 34.72 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 44.3 ttm -135.63 133.58 38.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -1.09 . . . . 0.0 109.499 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 6' ' ' PHE . 4.3 m-85 -112.53 120.97 43.45 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.017 0.913 . . . . 0.0 109.723 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.489 ' C ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -96.37 110.36 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.753 ' N ' HD12 ' A' ' 55' ' ' ILE . 1.9 mp -98.81 126.99 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.508 -0.745 . . . . 0.0 109.623 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 66.4 t0 -172.5 134.99 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.557 0.694 . . . . 0.0 109.97 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 59' ' ' GLY . 97.8 m-20 57.97 42.86 22.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.974 -0.454 . . . . 0.0 110.077 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 67.82 -40.94 0.42 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.556 0.694 . . . . 0.0 109.543 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -69.66 153.48 52.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.62 149.03 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.463 -1.021 . . . . 0.0 109.91 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -119.36 133.34 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.532 0.682 . . . . 0.0 109.195 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mm -102.83 122.28 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.732 . . . . 0.0 109.698 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 65' ' ' GLU . 98.0 m -123.41 126.07 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.63 0.729 . . . . 0.0 109.395 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -101.24 41.24 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.201 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' H ' HG22 ' A' ' 63' ' ' THR . 96.2 mt-10 -133.05 86.44 2.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG21 ' N ' ' A' ' 51' ' ' GLY . 1.1 m -121.62 132.18 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -123.21 134.36 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.833 0.825 . . . . 0.0 109.021 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.7 133.37 11.54 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -105.76 110.4 22.69 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.631 -0.923 . . . . 0.0 108.604 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -104.42 139.75 38.91 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.423 0.63 . . . . 0.0 109.62 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.1 mt -117.96 126.15 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.58 0.705 . . . . 0.0 109.487 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.75 33.2 22.57 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.44 78.81 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 ttp85 -135.42 120.07 13.45 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.35 -1.088 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.55 138.2 32.0 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.321 2.014 . . . . 0.0 112.416 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -147.93 -34.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.32 158.96 44.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.841 -1.162 . . . . 0.0 110.533 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.0 mt -131.02 142.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -124.99 148.61 48.37 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.642 0.734 . . . . 0.0 109.464 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.88 147.7 41.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.505 ' OG1' ' NZ ' ' A' ' 32' ' ' LYS . 86.9 m -118.66 130.06 55.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.5 125.16 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.677 0.751 . . . . 0.0 109.531 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 25.0 mm -84.06 131.94 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 82.5 mt -121.72 47.94 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.65 -40.38 95.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.41 -0.806 . . . . 0.0 109.447 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -74.19 145.32 44.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.488 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -73.34 -47.39 7.63 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.481 -0.762 . . . . 0.0 110.203 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 44.6 Cg_exo -54.72 -32.72 77.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.881 1.721 . . . . 0.0 111.306 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -67.03 -38.19 85.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.608 -0.682 . . . . 0.0 109.399 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.2 m95 -59.76 -41.46 91.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -62.73 -46.48 87.87 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -70.15 -41.69 73.51 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.802 0.81 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.36 -44.86 96.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 109.376 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.0 ttm -61.21 -41.84 97.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -66.94 -39.59 87.36 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.56 -46.52 85.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.296 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 62.6 ttp -66.45 -38.42 87.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.6 0.714 . . . . 0.0 109.663 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -61.76 -42.24 98.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.832 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.24 -39.46 86.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.73 -38.5 94.53 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.1 92.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -1.18 . . . . 0.0 110.371 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.75 -56.07 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.046 . . . . 0.0 109.961 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -93.18 -79.43 0.4 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.95 -1.094 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 140.87 143.85 4.36 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 106' ' ' LEU . 8.5 mp -74.12 -79.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.373 -1.075 . . . . 0.0 109.659 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 50.44 65.29 3.06 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -59.74 128.12 35.36 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.997 . . . . 0.0 110.276 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.3 m -75.55 149.8 38.26 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.789 0.804 . . . . 0.0 110.791 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.443 ' O ' ' CB ' ' A' ' 111' ' ' SER . 22.9 pttp -72.72 170.19 15.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.992 0.901 . . . . 0.0 111.414 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 4.2 p 77.93 -7.56 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -104.84 -27.04 11.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.363 -0.836 . . . . 0.0 109.576 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.968 ' H ' HD22 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -79.1 -43.28 24.43 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.923 0.868 . . . . 0.0 109.692 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.03 108.45 1.82 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.56 -0.713 . . . . 0.0 110.12 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -173.46 83.58 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.692 0.758 . . . . 0.0 109.013 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -154.35 -50.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -150.41 168.2 24.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -0.952 . . . . 0.0 110.597 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -151.12 157.88 43.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 109.849 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -153.88 161.7 41.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.987 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.554 -179.759 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 96.6 mtp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.42 143.14 55.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.562 -0.712 . . . . 0.0 110.499 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -154.58 160.79 41.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.588 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.1 129.65 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -129.4 129.29 44.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 109.884 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.08 -5.67 59.16 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.4 t -161.1 -63.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.497 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 10' ' ' VAL . 53.7 mtpt -143.02 -160.82 1.15 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.91 5.22 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 8' ' ' LYS . 74.5 t -69.07 134.85 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.314 -1.109 . . . . 0.0 110.344 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 64.43 92.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.491 0.662 . . . . 0.0 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -130.33 -22.22 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -76.22 -1.0 24.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 108.924 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.95 136.52 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.551 -0.718 . . . . 0.0 109.898 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.46 79.41 29.08 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 109.272 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.04 153.21 32.2 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.918 2.412 . . . . 0.0 112.793 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -89.31 138.37 31.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.424 -0.797 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.7 t -88.26 131.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -127.37 144.43 51.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.621 0.724 . . . . 0.0 109.48 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.73 132.39 54.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.8 t -121.36 152.57 38.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.749 -0.594 . . . . 0.0 109.509 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 24' ' ' LYS . 65.8 tttm -133.3 153.03 51.93 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.881 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 25' ' ' ASN . 97.4 p -65.52 0.74 1.43 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.734 . . . . 0.0 109.426 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 22' ' ' LYS . 28.8 tptt 40.53 22.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.528 0.68 . . . . 0.0 110.079 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 23' ' ' SER . 64.8 t30 -167.45 23.71 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 179.9 175.76 46.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 28' ' ' SER . 55.9 tt0 -88.3 -9.65 52.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -1.094 . . . . 0.0 109.588 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 27' ' ' GLN . 4.7 t -42.23 117.23 0.95 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 110.617 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.88 141.26 28.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttm -153.34 151.43 29.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -1.171 . . . . 0.0 109.531 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.88 148.15 36.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.31 146.25 50.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.11 140.23 49.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -118.88 125.67 50.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.28 121.39 45.17 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.0 tp -95.62 123.17 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.449 0.643 . . . . 0.0 109.985 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 36' ' ' LEU . 13.9 mm-40 37.35 57.69 4.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-O 120.966 0.413 . . . . 0.0 111.096 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.95 148.98 71.46 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.254 1.969 . . . . 0.0 111.795 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 t -75.92 -13.25 60.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 110.314 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.57 -1.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 109.738 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 78' ' ' ILE . 84.6 mt -90.71 -12.69 35.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.08 -21.88 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -87.47 -75.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.63 160.85 14.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.855 0.836 . . . . 0.0 110.562 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.4 p -76.17 165.77 24.43 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.742 0.782 . . . . 0.0 110.762 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.407 ' HA ' HD12 ' A' ' 49' ' ' ILE . 20.9 p -65.84 -31.53 72.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.489 0.661 . . . . 0.0 109.882 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.27 -18.26 63.13 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -93.59 -6.69 46.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 49' ' ' ILE . 86.8 mt -84.53 -7.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.142 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' ILE . 20.1 m -39.6 123.01 1.45 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.686 0.755 . . . . 0.0 110.834 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.27 160.26 32.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.6 ttm -135.19 143.94 46.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 62' ' ' ILE . 83.0 m-85 -118.12 109.82 16.87 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 0.0 109.522 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.04 131.44 34.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.176 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -121.37 133.69 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.503 0.668 . . . . 0.0 110.136 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' GLU . 97.0 m-20 -133.29 43.21 2.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 44.82 17.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.386 -0.821 . . . . 0.0 109.53 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' ASP . 79.8 tt0 -170.4 83.4 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.183 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.58 157.44 32.46 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.26 155.54 45.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -1.097 . . . . 0.0 109.829 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.8 132.62 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 53' ' ' TYR . 32.7 mm -103.31 120.7 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 63' ' ' THR . 4.3 t -127.81 125.49 39.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.46 0.648 . . . . 0.0 109.401 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -98.74 50.37 0.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -138.81 81.66 1.86 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.04 136.05 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.629 . . . . 0.0 109.461 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -128.74 134.85 48.56 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.556 -0.715 . . . . 0.0 109.572 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.1 143.45 16.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -96.71 101.07 12.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.467 -1.02 . . . . 0.0 108.366 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -91.91 152.84 19.87 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.621 0.724 . . . . 0.0 110.514 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 73' ' ' GLY . 89.3 mt -135.87 148.3 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.35 -0.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.971 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 71' ' ' ILE . . . -127.88 62.24 0.63 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 73' ' ' GLY . 68.9 ttp85 60.12 134.87 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.805 -0.82 . . . . 0.0 110.633 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -42.79 140.06 3.08 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.961 1.774 . . . . 0.0 112.102 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m -130.03 -16.84 3.58 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 166.69 30.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.708 -1.245 . . . . 0.0 110.72 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.552 HD11 HD21 ' A' ' 41' ' ' LEU . 83.7 mt -134.92 154.12 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -133.45 151.82 51.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.53 -0.731 . . . . 0.0 110.438 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.89 34.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.7 m -125.11 127.9 47.6 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.671 -0.643 . . . . 0.0 109.616 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.63 128.87 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.6 mp -87.21 127.59 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.654 -0.654 . . . . 0.0 109.579 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 82.5 mt -108.72 36.73 2.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.61 ' H ' HG22 ' A' ' 83' ' ' ILE . 93.0 m-20 -63.48 -39.37 94.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -68.13 153.49 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.421 -0.8 . . . . 0.0 110.297 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.489 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 5.5 mp0 -71.27 -57.3 4.71 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.713 -0.617 . . . . 0.0 110.774 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 11.7 Cg_endo -54.8 -33.28 80.45 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.653 1.568 . . . . 0.0 111.617 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.61 -39.88 88.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.737 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -64.53 -44.95 89.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.917 . . . . 0.0 109.773 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -62.46 -46.42 88.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.284 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -65.67 -38.4 89.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.498 -0.751 . . . . 0.0 109.275 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -62.22 -43.81 98.0 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.521 -0.737 . . . . 0.0 109.51 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.5 ttm -61.4 -38.14 85.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.823 . . . . 0.0 109.229 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.98 -38.71 92.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 109.236 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -61.24 -45.18 95.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 91.8 mtp -63.75 -41.23 98.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -71.29 -46.51 60.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.612 ' NH2' ' N ' ' A' ' 1' ' ' MET . 10.1 tpt180 -67.65 -41.89 83.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.474 -0.766 . . . . 0.0 110.13 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 104' ' ' ASN . 59.3 t80 -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.143 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 -28.8 71.93 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.23 72.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.992 . . . . 0.0 110.168 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 104' ' ' ASN . 11.8 pt-20 -71.27 -48.74 49.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.702 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 103' ' ' GLU . 3.4 p-10 176.78 -166.91 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.747 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 107' ' ' GLY . . . 77.6 -51.46 3.38 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 106' ' ' LEU . 7.4 mp 44.65 22.14 0.05 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.532 -0.981 . . . . 0.0 109.406 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 105' ' ' GLY . . . -47.19 107.75 0.24 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -94.23 132.66 38.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -1.063 . . . . 0.0 110.089 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.6 p -86.09 113.44 22.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.441 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 111' ' ' SER . 88.6 tttt -70.03 123.93 22.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.583 -0.698 . . . . 0.0 110.147 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER 163.11 -72.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.378 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -100.02 -25.11 14.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.455 -0.778 . . . . 0.0 109.676 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.9 mt -64.52 -40.98 96.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.792 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -94.18 119.53 33.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -0.941 . . . . 0.0 110.059 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -155.61 -56.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.19 137.33 41.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.488 -0.757 . . . . 0.0 110.706 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -150.12 149.72 30.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.4 -0.812 . . . . 0.0 109.725 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.421 ' C ' ' N ' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -156.16 163.79 39.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.326 -0.859 . . . . 0.0 110.431 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 55.1 t-80 53.51 11.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.64 -0.662 . . . . 0.0 109.492 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.421 ' N ' ' C ' ' A' ' 118' ' ' HIS . 58.3 t-80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.905 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 tpp . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.491 ' N ' ' OE2' ' A' ' 103' ' ' GLU . . . -69.38 139.18 54.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.347 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -155.64 148.7 24.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.819 . . . . 0.0 109.175 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.2 mt -108.72 128.48 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.148 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 9' ' ' GLY . 5.8 pt20 -146.31 155.08 42.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.227 -0.921 . . . . 0.0 109.634 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -111.18 -37.44 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 t -90.64 22.97 3.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.921 . . . . 0.0 109.376 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' NZ ' ' CE2' ' A' ' 53' ' ' TYR . 68.0 mttm 50.78 33.78 9.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 109.663 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 5' ' ' GLN . . . 157.58 40.73 0.02 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 98.8 t -57.36 -86.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -1.031 . . . . 0.0 109.925 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 179.23 -105.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.629 0.728 . . . . 0.0 109.474 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.92 146.59 46.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.473 -0.767 . . . . 0.0 110.489 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 14' ' ' VAL . 49.1 m -76.07 -11.01 59.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 108.999 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 15' ' ' VAL . 55.4 t 53.06 165.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.497 0.665 . . . . 0.0 110.711 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.592 ' N ' HG12 ' A' ' 14' ' ' VAL . 3.5 m -123.89 75.08 57.08 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.555 -0.715 . . . . 0.0 109.232 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 151.94 35.36 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.558 2.172 . . . . 0.0 112.437 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.63 152.55 25.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.512 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.62 130.76 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.055 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -132.27 141.16 48.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -109.07 130.54 55.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.195 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 t -126.98 133.26 50.62 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -127.5 135.94 51.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.626 0.727 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 25' ' ' ASN . 55.8 m -61.69 -129.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.548 -0.72 . . . . 0.0 110.474 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -72.39 19.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.67 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 23' ' ' SER . 71.7 m-20 57.9 35.15 25.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.393 -0.817 . . . . 0.0 109.7 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.72 26.36 0.09 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -135.73 -113.22 0.19 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.46 -1.024 . . . . 0.0 109.744 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.47 ' HB3' HD22 ' A' ' 85' ' ' ASN . 22.7 m -105.09 120.37 41.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.333 -0.854 . . . . 0.0 109.943 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.58 151.87 34.84 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.9 ptm -153.6 167.93 27.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.247 -1.149 . . . . 0.0 109.364 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.76 145.17 37.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.481 -0.762 . . . . 0.0 109.036 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -112.07 143.23 43.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.92 131.83 52.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -105.49 126.22 51.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.406 -0.808 . . . . 0.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -109.43 116.21 31.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.641 -0.662 . . . . 0.0 109.257 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.5 tp -100.9 118.32 36.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.561 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 39' ' ' THR . 57.4 mt-10 43.31 59.65 11.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HG2' HG22 ' A' ' 40' ' ' ILE . 37.4 Cg_endo -68.85 13.9 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.078 1.852 . . . . 0.0 110.202 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 37' ' ' GLU . 72.6 p 48.88 32.17 3.61 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.273 0.559 . . . . 0.0 110.05 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.4 HG22 ' HG2' ' A' ' 38' ' ' PRO . 11.1 tp -99.06 -22.06 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.181 -0.95 . . . . 0.0 109.14 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.7 -40.7 92.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -23.2 67.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -98.22 -52.21 3.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -136.89 149.1 47.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.33 -0.856 . . . . 0.0 110.214 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 p -73.0 163.51 28.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.6 p -66.42 -30.72 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.485 -0.759 . . . . 0.0 109.444 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.22 -16.52 63.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.629 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -85.34 -7.81 58.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.2 mt -100.96 116.33 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -0.774 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 p -125.5 15.01 8.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' N ' HG21 ' A' ' 66' ' ' VAL . . . -176.98 160.34 27.37 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -118.03 131.69 56.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.679 -0.895 . . . . 0.0 108.83 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.416 ' CE2' ' NZ ' ' A' ' 8' ' ' LYS . 94.9 m-85 -104.42 112.7 25.85 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.639 0.733 . . . . 0.0 109.721 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.6 mt -95.55 127.63 41.75 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.71 128.76 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.498 0.666 . . . . 0.0 109.504 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASP . 44.5 t0 -155.56 118.11 4.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.53 -0.731 . . . . 0.0 109.853 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 94.8 m-20 40.1 61.15 1.58 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.833 -0.542 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 68.81 -41.44 0.47 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -66.66 138.77 36.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.69 148.81 32.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -1.165 . . . . 0.0 109.997 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.7 mt -122.48 130.85 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.803 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.8 mp -107.58 129.52 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.49 -0.756 . . . . 0.0 109.57 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -128.73 128.09 43.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.588 -0.695 . . . . 0.0 109.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -90.78 4.94 50.29 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.31 78.67 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG21 ' N ' ' A' ' 51' ' ' GLY . 1.6 m -120.92 132.95 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.545 -0.722 . . . . 0.0 109.669 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -123.19 137.07 54.98 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.15 127.22 9.18 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -96.39 126.98 41.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -1.109 . . . . 0.0 108.907 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -102.46 138.29 39.58 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.374 0.607 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mm -115.37 132.46 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 57.5 32.37 21.71 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.496 0.665 . . . . 0.0 109.517 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -12.03 26.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -112.72 149.14 40.72 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.409 -1.053 . . . . 0.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.2 142.28 86.0 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.335 2.023 . . . . 0.0 112.215 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 m -157.95 -28.97 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.95 44.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.054 . . . . 0.0 110.207 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.4 153.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.522 0.677 . . . . 0.0 109.601 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -132.68 152.65 51.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.17 44.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 109.237 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.4 m -125.17 129.97 51.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.57 130.92 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.224 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.92 121.46 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.47 -0.769 . . . . 0.0 109.859 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD12 ' CZ2' ' A' ' 90' ' ' TRP . 55.8 mt -98.14 -75.63 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.937 0.875 . . . . 0.0 109.121 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.47 HD22 ' HB3' ' A' ' 28' ' ' SER . 13.7 m-20 56.31 32.12 19.85 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.72 -0.613 . . . . 0.0 109.823 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 m -153.49 140.58 19.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.009 . . . . 0.0 109.335 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.504 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 9.6 mm-40 -62.38 -58.21 18.57 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.74 . . . . 0.0 110.32 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 13.0 Cg_endo -54.3 -36.04 85.53 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.955 1.77 . . . . 0.0 111.451 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -68.92 -38.76 79.76 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.349 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.403 ' CZ2' HD12 ' A' ' 84' ' ' LEU . 17.0 m95 -62.02 -46.33 89.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -42.65 99.65 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.199 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.77 -44.01 91.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.501 -0.749 . . . . 0.0 109.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.16 -44.01 96.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 0.0 110.193 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 40.0 ttm -58.0 -43.8 86.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.316 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.507 HH21 ' NH2' ' A' ' 99' ' ' ARG . 79.5 mtp85 -65.79 -38.3 88.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.09 -46.71 86.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.399 -0.813 . . . . 0.0 110.31 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.27 -39.28 94.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.838 1.304 . . . . 0.0 109.175 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -45.63 79.95 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.337 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 99.7 mtt180 -63.99 -41.9 97.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.092 -1.005 . . . . 0.0 109.17 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.0 -44.85 91.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.548 -0.72 . . . . 0.0 109.16 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.0 91.44 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.13 -38.15 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -1.158 . . . . 0.0 109.469 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 2' ' ' ALA . 96.2 mt-10 -68.74 -36.27 78.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 110.024 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -140.15 83.32 1.91 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -50.18 102.79 0.07 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.94 150.68 35.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -1.073 . . . . 0.0 110.498 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.12 -6.28 88.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -146.31 97.99 3.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.207 -1.172 . . . . 0.0 109.147 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 110' ' ' LYS . 34.0 t -167.18 97.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.817 . . . . 0.0 109.266 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 111' ' ' SER . 73.3 tttt 52.06 168.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.037 0.922 . . . . 0.0 111.602 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 113' ' ' LEU . 2.2 t 61.53 136.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.361 0.601 . . . . 0.0 109.854 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 49.3 mp0 56.1 5.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 111' ' ' SER . 1.0 OUTLIER -95.73 -43.33 7.94 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.5 151.0 38.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.633 -0.667 . . . . 0.0 110.315 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -137.14 146.38 44.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 109.532 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.468 ' O ' ' NE2' ' A' ' 119' ' ' HIS . 37.6 m80 -133.48 140.32 47.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.637 -0.664 . . . . 0.0 109.231 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 116' ' ' HIS . 78.2 m80 54.57 163.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.777 0.798 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -84.6 -6.76 59.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.468 ' NE2' ' O ' ' A' ' 116' ' ' HIS . 96.8 m-70 51.96 -174.44 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.684 0.754 . . . . 0.0 110.858 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.702 -179.747 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.5 mtp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.14 88.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.94 160.17 42.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.904 0.859 . . . . 0.0 110.386 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.0 mt -108.79 128.43 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.696 0.76 . . . . 0.0 109.449 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.471 ' HG2' HD13 ' A' ' 55' ' ' ILE . 18.2 pt20 -148.51 149.65 32.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.926 0.87 . . . . 0.0 109.897 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.53 -65.75 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 m -75.35 164.76 26.08 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.587 0.708 . . . . 0.0 109.821 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.98 29.21 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.482 0.658 . . . . 0.0 109.672 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 10' ' ' VAL . . . -159.4 -44.28 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 9' ' ' GLY . 28.5 m 31.46 -135.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.192 0.52 . . . . 0.0 110.642 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.95 -139.4 0.05 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.592 0.711 . . . . 0.0 109.597 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.62 144.08 56.6 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.464 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 p -68.9 139.14 55.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.753 0.787 . . . . 0.0 110.559 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 15' ' ' VAL . 1.6 t -87.22 -145.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.416 0.627 . . . . 0.0 110.815 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.567 ' H ' HG12 ' A' ' 14' ' ' VAL . 17.5 t -146.45 66.27 10.91 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.649 -0.657 . . . . 0.0 109.242 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.92 149.75 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.024 2.483 . . . . 0.0 112.605 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.4 145.84 25.77 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.89 0.853 . . . . 0.0 109.921 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 t -103.71 131.65 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.839 0.828 . . . . 0.0 110.421 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -135.26 141.52 45.75 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.307 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 93' ' ' PHE . 84.6 mt -103.93 125.53 50.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.867 0.842 . . . . 0.0 110.081 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 m -94.91 164.19 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.641 0.734 . . . . 0.0 109.899 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.2 139.31 43.07 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.776 0.798 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -159.23 25.35 0.2 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.65 -45.69 91.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.614 -0.679 . . . . 0.0 109.403 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -89.74 -1.63 58.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.67 -66.02 1.05 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -145.44 -42.78 0.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.938 . . . . 0.0 108.943 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.4 m -175.98 -85.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.691 . . . . 0.0 109.365 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.95 153.36 13.66 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -157.79 176.24 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.962 . . . . 0.0 110.281 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.57 148.79 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.757 0.789 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -111.42 148.85 32.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.753 0.787 . . . . 0.0 110.035 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -126.37 135.98 52.13 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.608 0.718 . . . . 0.0 109.493 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -120.8 127.1 51.63 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.83 0.824 . . . . 0.0 109.747 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.67 120.23 41.73 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.726 0.774 . . . . 0.0 109.58 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' GLU . 37.2 tp -88.88 126.64 35.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.706 0.765 . . . . 0.0 110.404 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 36' ' ' LEU . 45.9 mm-40 36.53 68.7 1.4 Allowed Pre-proline 0 N--CA 1.493 1.691 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.785 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -58.94 145.38 97.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.273 1.982 . . . . 0.0 111.853 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 p -83.37 -17.43 42.33 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.016 0.436 . . . . 0.0 110.242 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.74 1.13 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.602 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.63 -11.59 58.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 109.281 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.45 -14.54 30.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.18 -58.39 1.89 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.795 . . . . 0.0 109.423 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.97 160.55 40.14 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.755 0.788 . . . . 0.0 110.242 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 26.7 t -63.57 -166.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.62 0.724 . . . . 0.0 110.476 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 p -99.03 -21.0 16.43 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -64.43 -36.9 85.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 109.163 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 45' ' ' SER . 25.1 p-10 -62.22 -40.3 95.67 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.514 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.2 mt -54.8 -88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.82 -0.55 . . . . 0.0 109.777 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.0 m 66.61 -43.18 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -96.9 144.68 17.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.4 ttp -126.37 125.65 42.58 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.581 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -108.51 111.01 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.958 0.885 . . . . 0.0 110.225 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 55' ' ' ILE . 58.6 mt -97.43 121.6 39.51 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.749 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -103.7 130.77 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.887 0.851 . . . . 0.0 110.404 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 38.0 m-20 -133.23 -156.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.726 0.774 . . . . 0.0 109.77 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 59' ' ' GLY . 42.8 p-10 -71.72 96.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.964 -0.46 . . . . 0.0 110.339 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 66.08 -39.88 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -88.95 160.24 29.65 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' N ' ' NH2' ' A' ' 92' ' ' ARG . 17.2 pt-20 -151.51 148.72 28.38 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 110.067 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.04 130.09 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.674 0.75 . . . . 0.0 109.527 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -123.49 133.47 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.836 0.826 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -142.06 150.7 41.58 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.734 0.778 . . . . 0.0 109.848 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -97.58 0.89 48.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.35 81.39 3.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.479 0.657 . . . . 0.0 109.286 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.42 133.57 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.855 0.836 . . . . 0.0 109.814 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.29 137.37 47.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.834 0.826 . . . . 0.0 109.47 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.27 131.01 10.42 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -103.5 117.14 33.75 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.818 0.818 . . . . 0.0 109.472 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.61 137.09 47.13 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.858 0.837 . . . . 0.0 110.036 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -119.06 128.65 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.675 0.75 . . . . 0.0 109.201 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 59.65 30.74 20.37 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.315 0.578 . . . . 0.0 109.731 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.51 24.7 73.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -136.01 113.38 10.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.749 -0.853 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.88 104.62 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.211 2.608 . . . . 0.0 112.568 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.6 m -109.71 -35.72 6.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.739 -0.601 . . . . 0.0 110.092 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.81 159.81 40.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.054 -1.029 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.21 150.97 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.694 0.759 . . . . 0.0 109.655 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -130.66 148.51 52.45 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.99 0.9 . . . . 0.0 110.018 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.64 152.57 39.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.649 0.737 . . . . 0.0 109.92 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.1 m -120.57 132.59 55.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.776 0.798 . . . . 0.0 110.354 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.57 130.86 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.874 0.845 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.5 mm -87.22 124.85 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.771 0.796 . . . . 0.0 110.231 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -117.71 40.5 3.08 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -62.82 -39.93 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.598 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -81.26 152.81 27.44 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.75 0.786 . . . . 0.0 110.18 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.7 tt0 -70.48 -46.43 18.93 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.943 -0.473 . . . . 0.0 110.91 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 68.4 Cg_exo -52.52 -35.33 66.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.195 1.93 . . . . 0.0 111.512 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.88 -40.71 97.15 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -63.81 -41.95 97.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.644 -0.66 . . . . 0.0 109.512 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -59.36 -44.47 92.69 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.596 ' NH2' ' N ' ' A' ' 60' ' ' GLU . 83.3 mtp180 -66.23 -37.94 86.73 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 60.5 t80 -61.95 -46.6 88.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.74 -0.6 . . . . 0.0 109.84 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 97.5 mmm -62.76 -44.07 97.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.688 -0.632 . . . . 0.0 109.395 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -66.9 -41.74 86.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.309 0.576 . . . . 0.0 109.524 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 83.0 t80 -63.99 -44.91 91.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.359 0.6 . . . . 0.0 109.49 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.5 ttt -62.07 -41.66 98.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -67.15 -47.14 71.96 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.382 0.611 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.8 tpt85 -66.55 -44.56 81.99 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.844 -0.535 . . . . 0.0 109.657 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -63.14 -45.87 89.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.558 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.9 -34.54 90.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.12 92.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.806 -0.82 . . . . 0.0 109.338 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.39 -37.07 77.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -151.74 92.49 1.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.643 0.735 . . . . 0.0 109.847 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.12 98.35 0.26 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.7 mt -77.12 148.57 35.96 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.773 0.797 . . . . 0.0 110.064 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.23 4.56 17.95 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.428 ' O ' ' OG ' ' A' ' 109' ' ' SER . 94.6 m-85 -133.4 -129.8 0.17 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.697 -0.884 . . . . 0.0 109.973 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 110' ' ' LYS . 5.0 p 70.58 -60.75 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.537 ' N ' ' OG ' ' A' ' 109' ' ' SER . 20.6 ptmt -127.86 -38.1 1.88 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 113' ' ' LEU . 86.8 p -74.0 163.46 27.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.715 -0.616 . . . . 0.0 110.405 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 67.36 -58.38 0.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 111' ' ' SER . 86.0 mt -63.43 -42.73 98.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.579 -0.701 . . . . 0.0 109.915 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -83.69 160.96 21.2 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.67 0.748 . . . . 0.0 110.399 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -66.22 129.32 39.42 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.537 0.684 . . . . 0.0 110.14 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -88.3 122.88 32.32 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.632 0.729 . . . . 0.0 110.289 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -113.37 133.51 55.12 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.867 0.842 . . . . 0.0 110.161 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -71.45 134.81 46.85 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.684 0.754 . . . . 0.0 110.263 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.536 ' O ' ' CG ' ' A' ' 120' ' ' HIS . 48.5 t-80 -73.03 148.35 44.21 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.628 0.728 . . . . 0.0 110.129 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 51.3 p-80 . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.076 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.603 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 49.75 99.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.486 0.66 . . . . 0.0 109.696 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -148.28 157.25 43.37 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.807 0.813 . . . . 0.0 110.757 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.0 mt -109.31 131.4 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.51 0.671 . . . . 0.0 109.441 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -128.96 134.3 48.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.714 0.769 . . . . 0.0 109.624 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.83 -71.47 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 10' ' ' VAL . 44.9 m -107.0 122.95 47.46 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.863 0.84 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 7' ' ' SER . 25.8 mtmm 40.63 -168.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.818 0.818 . . . . 0.0 111.538 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.21 86.25 0.32 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 7' ' ' SER . 54.7 t -120.12 132.67 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.813 0.816 . . . . 0.0 109.632 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.77 143.66 46.42 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.6 0.714 . . . . 0.0 110.19 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' VAL . 48.6 tp10 -137.65 -77.57 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' GLU . 82.8 p 37.44 31.09 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.292 0.568 . . . . 0.0 110.217 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' GLU . 53.6 t -69.57 -19.93 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.725 -0.609 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.452 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 3.5 t 64.18 52.89 1.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.897 -0.502 . . . . 0.0 110.288 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 37.1 Cg_endo -65.14 150.81 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.617 2.211 . . . . 0.0 112.559 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.57 132.48 45.55 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.685 0.755 . . . . 0.0 110.211 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.558 ' H ' ' CD1' ' A' ' 106' ' ' LEU . 24.4 t -105.13 128.3 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.62 0.724 . . . . 0.0 109.764 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.451 ' C ' HD22 ' A' ' 20' ' ' LEU . 42.1 ttm180 -134.14 136.48 43.86 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.733 0.778 . . . . 0.0 109.765 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.895 HD22 ' N ' ' A' ' 20' ' ' LEU . 1.1 mm? -104.92 124.52 49.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.606 0.717 . . . . 0.0 109.668 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.4 m -132.65 153.4 51.13 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.159 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -105.05 152.53 22.63 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.873 0.844 . . . . 0.0 110.223 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 t -52.15 176.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.746 0.784 . . . . 0.0 110.993 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.32 -42.3 96.39 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -97.71 -3.57 38.93 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.25 19.92 76.23 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -89.29 -4.45 58.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.788 -0.831 . . . . 0.0 109.073 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.7 m -146.22 121.19 10.02 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.705 0.764 . . . . 0.0 109.603 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.57 142.55 23.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.7 ptp -153.84 166.42 32.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.946 -0.738 . . . . 0.0 110.298 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.25 143.18 49.74 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -109.63 143.61 39.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.793 0.806 . . . . 0.0 110.335 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -123.57 135.9 54.24 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.58 0.705 . . . . 0.0 109.626 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -120.04 126.81 51.71 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.783 0.801 . . . . 0.0 109.606 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 45.8 m-85 -108.21 119.29 39.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.464 0.65 . . . . 0.0 109.366 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.79 122.71 43.17 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.62 0.724 . . . . 0.0 109.939 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 40.71 56.74 8.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-O 121.036 0.446 . . . . 0.0 110.097 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.74 144.03 82.44 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.445 2.097 . . . . 0.0 112.783 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 41' ' ' LEU . 26.4 m -69.32 -21.64 63.84 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.108 0.48 . . . . 0.0 110.018 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 tp -60.61 0.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.424 -0.797 . . . . 0.0 109.594 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.2 mt -89.67 -12.25 40.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.09 -14.16 17.9 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.13 -49.82 3.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.488 -0.758 . . . . 0.0 109.488 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.0 155.47 48.82 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.779 0.799 . . . . 0.0 110.024 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -72.99 160.03 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 110.396 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -66.37 -34.55 78.23 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.39 -17.67 61.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.738 -0.601 . . . . 0.0 109.865 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -85.29 -1.7 57.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.11 123.78 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.448 -0.782 . . . . 0.0 110.391 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -119.52 91.85 3.65 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.802 0.81 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.24 54.37 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.7 ttp -134.19 132.22 39.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.917 -0.755 . . . . 0.0 109.643 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -106.5 110.65 22.92 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.911 0.862 . . . . 0.0 109.759 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.87 114.0 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.391 0.615 . . . . 0.0 109.483 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -111.42 129.72 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.63 0.729 . . . . 0.0 109.633 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 96' ' ' PHE . 99.0 m-20 -134.8 -80.88 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' GLY . 67.3 t0 -144.81 98.2 3.15 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.617 -0.677 . . . . 0.0 109.517 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 97.2 mt-10 65.05 -42.72 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.385 0.612 . . . . 0.0 109.684 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -87.43 137.35 14.55 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -143.26 144.45 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.897 -0.766 . . . . 0.0 109.99 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.2 132.97 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.548 0.69 . . . . 0.0 109.243 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.9 mp -107.03 132.21 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.683 0.754 . . . . 0.0 109.804 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 65' ' ' GLU . 87.7 m -117.86 122.35 43.12 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.782 0.801 . . . . 0.0 109.5 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -95.48 1.23 53.91 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.7 mp0 -96.25 71.07 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.03 132.87 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.653 0.739 . . . . 0.0 109.718 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -134.29 141.87 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.936 0.874 . . . . 0.0 109.826 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.73 142.21 28.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -109.47 119.9 40.85 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.788 0.804 . . . . 0.0 109.183 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.58 124.07 49.92 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.646 0.736 . . . . 0.0 109.811 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 95.6 mt -114.2 139.32 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.591 0.71 . . . . 0.0 109.304 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 60.33 32.42 20.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.468 0.652 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.95 31.38 80.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -158.78 152.04 18.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 O-C-N 121.63 -0.924 . . . . 0.0 109.769 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -51.54 141.18 43.11 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.9 m -161.68 -35.63 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.512 -0.742 . . . . 0.0 109.874 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 35' ' ' PHE . . . -154.27 171.22 19.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 0.0 110.7 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.63 128.06 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.561 0.696 . . . . 0.0 109.331 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -109.4 143.82 38.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.644 0.735 . . . . 0.0 109.447 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.1 148.76 30.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.681 -0.637 . . . . 0.0 109.9 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -122.75 129.27 51.56 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.47 112.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.921 0.867 . . . . 0.0 109.296 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.629 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.5 mp -82.6 128.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.504 0.668 . . . . 0.0 109.768 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.6 mt -118.31 62.86 0.76 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -65.59 -38.82 90.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.73 -0.606 . . . . 0.0 109.544 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -62.08 148.42 44.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.457 -0.777 . . . . 0.0 110.212 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.429 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 1.8 mp0 -76.53 -62.28 0.68 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.982 -0.449 . . . . 0.0 110.479 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 12.1 Cg_endo -57.25 -26.77 71.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.078 1.852 . . . . 0.0 111.522 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -67.01 -35.55 80.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.888 -0.508 . . . . 0.0 109.665 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -44.79 96.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.754 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.93 -47.81 83.23 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.214 0.531 . . . . 0.0 110.043 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -64.7 -42.13 95.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.592 -0.693 . . . . 0.0 110.062 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -61.66 -42.72 99.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.733 -0.604 . . . . 0.0 109.755 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 tpt -62.54 -39.23 92.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.625 -0.672 . . . . 0.0 109.764 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.8 -45.78 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.707 -0.621 . . . . 0.0 110.104 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.441 ' CD1' ' OD2' ' A' ' 56' ' ' ASP . 37.6 m-85 -68.7 -37.64 79.68 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 29.9 mmt -64.58 -39.77 94.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.18 -46.08 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.647 . . . . 0.0 109.865 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -67.09 -41.95 85.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.67 ' CD1' ' ND2' ' A' ' 104' ' ' ASN . 54.4 t80 -61.72 -45.9 91.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.574 -0.704 . . . . 0.0 110.027 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -63.24 -36.03 92.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.4 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -1.126 . . . . 0.0 109.026 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.28 -42.92 68.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.67 ' ND2' ' CD1' ' A' ' 100' ' ' TYR . 17.6 m-80 -80.73 -75.69 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.354 0.597 . . . . 0.0 109.466 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 101' ' ' GLY . . . 92.61 46.24 3.51 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.666 ' H ' HD22 ' A' ' 106' ' ' LEU . 3.3 mm? 41.25 98.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.985 -0.715 . . . . 0.0 110.326 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 106' ' ' LEU . . . -39.72 100.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -64.64 -43.76 92.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.879 -0.777 . . . . 0.0 109.625 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' LYS . 55.2 p -162.06 50.38 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.564 -0.71 . . . . 0.0 109.519 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 111' ' ' SER . 51.7 mtmt 41.42 -168.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.713 0.768 . . . . 0.0 111.183 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 113' ' ' LEU . 2.0 m 55.2 158.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.188 0.518 . . . . 0.0 110.755 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 61.35 -63.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.39 0.614 . . . . 0.0 110.203 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 111' ' ' SER . 56.9 mt -62.08 -41.46 98.21 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.566 -0.709 . . . . 0.0 109.908 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -55.78 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.564 -0.71 . . . . 0.0 109.943 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -81.02 137.28 36.06 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.746 0.784 . . . . 0.0 110.28 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -147.4 141.46 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.573 0.701 . . . . 0.0 109.795 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -104.99 130.91 53.09 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.804 0.811 . . . . 0.0 110.057 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -101.55 132.75 47.03 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.558 0.694 . . . . 0.0 109.755 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -105.39 135.12 47.35 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.66 0.743 . . . . 0.0 110.042 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.381 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.483 ' N ' HH21 ' A' ' 99' ' ' ARG . 4.4 mpp? . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.421 0.629 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.57 147.91 0.68 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.78 0.8 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -154.47 135.02 13.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.797 0.808 . . . . 0.0 110.276 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.453 HD12 ' CZ ' ' A' ' 100' ' ' TYR . 97.2 mt -119.2 128.61 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.687 0.756 . . . . 0.0 109.698 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -153.63 159.51 42.11 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.676 0.75 . . . . 0.0 109.773 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -89.96 -1.57 58.0 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.544 ' OG ' ' N ' ' A' ' 8' ' ' LYS . 18.4 p -145.99 -134.07 0.08 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.376 -0.827 . . . . 0.0 110.001 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' N ' ' OG ' ' A' ' 7' ' ' SER . 8.6 mtmp? -146.52 102.2 3.55 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.874 0.845 . . . . 0.0 109.948 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.91 3.65 42.37 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 10' ' ' VAL . 11.6 p -96.18 20.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.766 -0.844 . . . . 0.0 109.446 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 10' ' ' VAL . . . -33.21 112.44 0.12 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.686 0.755 . . . . 0.0 110.746 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' HB3' HG23 ' A' ' 14' ' ' VAL . 92.4 mt-10 -94.52 -8.01 39.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.8 p 53.26 14.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.405 0.621 . . . . 0.0 109.56 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 12' ' ' GLU . 55.8 t -69.33 155.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.651 0.739 . . . . 0.0 110.556 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG13 ' H ' ' A' ' 105' ' ' GLY . 11.0 t -115.36 84.88 12.26 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.68 153.33 26.3 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.943 2.429 . . . . 0.0 112.468 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.11 150.26 25.66 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.038 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 100.0 t -124.25 132.53 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.641 0.734 . . . . 0.0 109.837 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' C ' HD22 ' A' ' 20' ' ' LEU . 90.0 mtm180 -131.65 139.76 49.18 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.853 0.835 . . . . 0.0 109.721 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.9 mm? -96.43 144.02 26.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.674 0.749 . . . . 0.0 110.035 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -155.69 170.45 22.0 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.74 0.781 . . . . 0.0 109.882 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 24' ' ' LYS . 52.0 mtmt -141.46 124.27 16.1 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.684 0.754 . . . . 0.0 109.914 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 25' ' ' ASN . 33.6 t 36.89 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.321 0.581 . . . . 0.0 110.142 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 22' ' ' LYS . 69.6 mmtt 58.91 1.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 23' ' ' SER . 4.8 p30 -153.28 -53.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 25' ' ' ASN . . . 149.95 98.16 0.18 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -172.79 -27.68 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.629 -0.924 . . . . 0.0 108.997 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -151.52 161.07 43.33 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.96 0.886 . . . . 0.0 110.045 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.97 139.91 37.13 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.1 ttm -155.2 151.57 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.003 0.906 . . . . 0.0 110.212 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 131.34 23.51 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -114.05 132.56 55.97 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.846 0.831 . . . . 0.0 109.991 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -116.69 132.27 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -115.89 118.94 34.37 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -109.68 119.84 40.64 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.531 1.158 . . . . 0.0 109.915 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.36 113.78 25.87 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.011 0.91 . . . . 0.0 110.146 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 50.87 75.14 0.69 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.588 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' O ' ' N ' ' A' ' 40' ' ' ILE . 4.3 Cg_endo -82.13 15.13 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.808 2.338 . . . . 0.0 111.178 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' PRO . 4.1 p 39.63 22.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.266 0.555 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' PRO . 18.5 tt -92.79 -1.44 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.1 -18.56 20.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.91 -35.08 6.73 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.84 141.25 31.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.38 -0.825 . . . . 0.0 110.032 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -77.84 167.29 21.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.732 0.777 . . . . 0.0 109.928 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -64.83 -32.11 73.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.94 -35.44 80.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.86 -19.15 63.45 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.85 124.35 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.456 -0.778 . . . . 0.0 109.538 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.53 12.91 1.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.7 175.15 46.37 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.596 ' SD ' HD21 ' A' ' 54' ' ' LEU . 18.0 ttm -137.12 144.42 43.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.702 -0.881 . . . . 0.0 109.433 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -108.9 113.18 25.87 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.925 0.869 . . . . 0.0 109.898 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.596 HD21 ' SD ' ' A' ' 52' ' ' MET . 75.4 mt -95.06 114.69 26.52 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.52 0.676 . . . . 0.0 109.336 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.741 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -99.17 109.4 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.776 0.798 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 96.1 m-20 -88.84 -87.85 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 66.2 m-20 -159.37 -62.23 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 109.246 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -104.22 13.96 31.27 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.14 -0.975 . . . . 0.0 108.614 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.42 174.02 45.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -147.95 147.73 30.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.57 -0.959 . . . . 0.0 109.823 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.3 131.44 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.652 0.739 . . . . 0.0 109.68 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.8 mp -115.37 131.35 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.514 0.673 . . . . 0.0 109.441 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -125.24 131.15 53.18 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.839 0.828 . . . . 0.0 109.975 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -92.53 3.63 55.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -90.53 73.12 6.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.43 133.07 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.749 0.785 . . . . 0.0 109.521 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -133.83 142.88 48.03 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.746 0.784 . . . . 0.0 109.947 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.79 149.8 21.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -110.05 131.08 55.38 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.956 0.884 . . . . 0.0 109.67 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.75 125.41 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.53 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 96.8 mt -123.15 133.13 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.798 0.809 . . . . 0.0 109.572 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 71' ' ' ILE . 4.6 p30 58.33 25.76 13.17 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.888 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.32 31.37 16.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.137 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -168.81 150.52 4.63 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.073 -1.251 . . . . 0.0 110.588 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.8 87.49 0.44 Allowed 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.207 2.605 . . . . 0.0 112.257 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -104.68 -14.62 15.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.716 -0.615 . . . . 0.0 109.74 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.08 151.66 44.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.27 135.82 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.499 0.666 . . . . 0.0 109.982 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -126.28 164.45 21.0 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.947 0.879 . . . . 0.0 110.202 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.2 37.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.77 0.795 . . . . 0.0 109.634 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.0 m -124.97 127.21 46.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.67 0.748 . . . . 0.0 109.545 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.8 t -114.89 132.42 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.874 0.845 . . . . 0.0 109.81 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.3 mm -94.79 123.91 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.707 0.765 . . . . 0.0 109.825 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.5 mt -110.66 75.53 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -96.85 1.92 51.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -116.82 143.55 45.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.991 0.901 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 mt-30 -66.51 -48.57 55.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.633 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.6 Cg_exo -51.9 -38.25 68.15 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.866 1.71 . . . . 0.0 111.133 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -66.73 -39.5 88.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -63.29 -37.87 88.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.71 -0.619 . . . . 0.0 109.787 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.35 -50.94 71.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.664 -0.647 . . . . 0.0 109.853 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 93' ' ' PHE . 18.7 ptp180 -75.35 -39.29 59.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.743 -0.598 . . . . 0.0 109.921 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.417 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 69.1 t80 -64.22 -44.79 90.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.508 -0.745 . . . . 0.0 109.221 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.1 tpp -60.72 -46.94 88.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -66.09 -40.57 90.92 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.273 0.558 . . . . 0.0 109.513 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 86.4 t80 -63.21 -44.24 95.88 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 11.3 tpt -62.6 -39.79 94.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.619 -0.675 . . . . 0.0 109.54 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -66.08 -52.73 46.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.759 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.483 HH21 ' N ' ' A' ' 1' ' ' MET . 83.4 mtp180 -66.34 -44.75 82.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.453 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 81.0 t80 -63.4 -46.99 83.89 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.419 0.628 . . . . 0.0 109.342 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.57 88.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.85 83.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.646 -0.914 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.63 -55.7 6.45 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -177.87 -160.69 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.748 0.785 . . . . 0.0 109.832 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.434 ' H ' HG13 ' A' ' 15' ' ' VAL . . . 93.22 14.88 53.38 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 106' ' ' LEU . 10.5 mp -85.08 3.73 37.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.66 -0.906 . . . . 0.0 109.138 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.82 -137.23 13.22 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 54.07 167.64 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.887 -0.772 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.2 t -66.2 140.17 58.16 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.937 0.875 . . . . 0.0 110.643 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -77.4 143.23 38.8 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.715 0.769 . . . . 0.0 110.887 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 112' ' ' GLU . 0.7 OUTLIER 172.79 -84.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.442 0.639 . . . . 0.0 109.82 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.453 ' N ' ' OG ' ' A' ' 111' ' ' SER . 96.0 mt-10 -85.37 -12.43 52.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 109.728 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.48 -34.26 76.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.635 -0.666 . . . . 0.0 110.107 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.42 -42.42 99.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.425 -0.797 . . . . 0.0 109.399 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.642 ' CG ' ' H ' ' A' ' 116' ' ' HIS . 21.6 t-80 -153.13 -130.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.681 0.753 . . . . 0.0 109.756 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.642 ' H ' ' CG ' ' A' ' 115' ' ' HIS . 58.0 t-80 -158.96 -60.06 0.07 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.52 -0.738 . . . . 0.0 109.058 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -77.95 141.47 38.97 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.885 0.85 . . . . 0.0 110.581 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -81.18 -3.3 51.78 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -59.19 -41.22 87.98 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.399 0.619 . . . . 0.0 109.567 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.904 -179.658 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.544 0.688 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -155.75 163.08 40.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.85 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.1 mt -108.52 130.51 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.632 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 98.1 mt-30 -129.43 135.02 48.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.495 -0.753 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -95.54 -10.36 29.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.559 -0.713 . . . . 0.0 109.161 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LYS . 22.7 m -150.64 22.56 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.171 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 7' ' ' SER . 23.8 mtmm 56.53 120.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.806 0.812 . . . . 0.0 110.909 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.632 ' H ' ' NE2' ' A' ' 5' ' ' GLN . . . 99.13 -16.72 58.98 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.52 97.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -1.105 . . . . 0.0 109.611 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 131.73 40.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.641 -0.662 . . . . 0.0 109.874 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.87 122.39 47.73 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.618 0.723 . . . . 0.0 109.758 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -91.7 -3.74 55.92 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 15' ' ' VAL . 54.3 t -51.53 157.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.503 -0.748 . . . . 0.0 110.156 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.434 ' N ' HG12 ' A' ' 14' ' ' VAL . 60.0 t -115.68 80.97 8.77 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.599 -0.688 . . . . 0.0 110.069 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.33 151.64 29.82 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.795 2.33 . . . . 0.0 112.346 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -87.22 152.72 22.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 109.713 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.09 130.14 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.483 0.659 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -132.6 145.72 51.32 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -102.19 140.43 36.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.509 -0.744 . . . . 0.0 109.625 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.6 m -152.25 167.06 29.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -105.25 166.95 10.05 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.603 0.716 . . . . 0.0 109.812 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.706 0.765 . . . . 0.0 110.439 -179.374 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.611 ' CB ' HD22 ' A' ' 85' ' ' ASN . 22.1 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.696 0.76 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 162.01 43.45 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.1 ptm -159.87 171.56 19.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.531 -0.982 . . . . 0.0 109.227 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.79 148.9 48.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.487 -0.758 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.42 148.12 31.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.71 -0.619 . . . . 0.0 109.666 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.81 136.2 52.06 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.25 123.49 50.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.797 -0.564 . . . . 0.0 109.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -111.31 122.83 48.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.3 tp -103.67 124.95 49.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.776 0.798 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.409 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 56.4 mt-10 42.5 54.89 9.83 Favored Pre-proline 0 N--CA 1.492 1.665 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -66.79 149.33 83.49 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.264 1.976 . . . . 0.0 111.947 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' LEU . 66.9 p -74.43 -19.9 60.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' HA ' HD12 ' A' ' 40' ' ' ILE . 9.2 tp -59.96 0.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.734 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 39' ' ' THR . 94.1 mt -90.93 -9.66 45.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.955 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.36 -24.95 13.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 109.418 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -93.59 -73.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.248 -0.907 . . . . 0.0 109.977 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -104.36 148.11 26.76 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.824 0.821 . . . . 0.0 110.704 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.7 m -71.8 156.15 39.63 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.728 0.775 . . . . 0.0 110.449 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -65.86 -32.65 74.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.647 -0.658 . . . . 0.0 109.628 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -75.1 -8.05 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.688 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.89 -3.37 54.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 94.0 mt -95.47 122.94 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.943 . . . . 0.0 109.802 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.1 m -121.31 -3.12 9.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -172.97 170.39 43.53 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.637 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.514 ' SD ' ' HB2' ' A' ' 80' ' ' ALA . 63.1 mtp -128.17 143.82 51.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.711 -0.876 . . . . 0.0 109.076 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.86 108.78 19.7 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.515 0.674 . . . . 0.0 109.785 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 55' ' ' ILE . 78.3 mt -93.59 110.28 21.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -98.05 111.81 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.05 176.91 6.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.603 0.716 . . . . 0.0 109.885 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.06 -39.08 93.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -88.91 -76.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.94 10.81 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.498 ' N ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 pm0 -142.79 153.73 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.635 -0.92 . . . . 0.0 109.108 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.452 HD13 ' OE2' ' A' ' 89' ' ' GLU . 96.4 mt -119.22 135.5 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.491 -0.756 . . . . 0.0 109.939 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -100.12 126.9 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.733 . . . . 0.0 109.447 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.6 m -121.76 125.21 46.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -108.26 -6.25 16.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.09 78.64 7.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.474 -0.766 . . . . 0.0 109.056 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.7 t -121.86 133.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.714 -0.616 . . . . 0.0 109.715 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.22 142.9 50.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.495 0.664 . . . . 0.0 109.73 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.63 143.26 16.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.14 106.73 17.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.896 . . . . 0.0 108.667 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.55 143.81 30.29 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.371 0.605 . . . . 0.0 110.239 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.35 109.16 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.98 35.88 23.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 110.079 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.85 78.75 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -121.57 99.25 45.31 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.963 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.86 130.4 30.9 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.339 2.026 . . . . 0.0 112.561 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m -152.83 -29.9 0.14 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.644 -0.66 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.18 154.08 51.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.218 -0.926 . . . . 0.0 110.726 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.75 143.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 14.3 tm-20 -119.94 150.22 40.85 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.58 0.705 . . . . 0.0 109.909 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HB2' ' SD ' ' A' ' 52' ' ' MET . . . -139.4 145.35 38.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.7 m -125.29 132.62 52.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.698 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.08 130.48 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.667 -0.646 . . . . 0.0 109.307 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 32.3 mm -93.34 128.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.791 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.3 mt -108.4 55.3 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.611 HD22 ' CB ' ' A' ' 28' ' ' SER . 9.2 m120 -64.34 -40.65 96.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.616 -0.677 . . . . 0.0 109.31 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 m -84.27 154.96 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 0.0 110.452 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.9 mp0 -74.89 -59.43 1.42 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.799 -0.563 . . . . 0.0 110.914 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 2.8 Cg_endo -48.51 -17.48 1.05 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.713 1.608 . . . . 0.0 111.266 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.452 ' OE2' HD13 ' A' ' 61' ' ' ILE . 34.1 tp10 -64.9 -37.02 86.24 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.27 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -60.61 -36.52 78.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.487 -0.758 . . . . 0.0 109.815 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -58.32 -47.0 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.509 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.35 -39.9 81.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -62.28 -47.89 82.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 110.39 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.7 mmm -64.05 -43.21 96.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.637 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.45 -43.67 89.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.778 . . . . 0.0 109.624 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -61.54 -47.67 84.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 tpt -65.71 -41.0 92.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -63.01 -53.16 58.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.702 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 78.2 ttt-85 -68.99 -43.34 75.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.434 -0.791 . . . . 0.0 110.16 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -62.67 -46.01 90.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.96 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.03 -36.23 93.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.43 95.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 0.0 109.649 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.83 -43.59 71.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.875 . . . . 0.0 109.422 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.639 179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 120.922 0.392 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -124.61 134.12 53.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.473 -0.767 . . . . 0.0 108.991 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.39 128.84 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -141.06 150.21 42.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.33 -0.856 . . . . 0.0 109.826 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.66 -7.78 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 8' ' ' LYS . 9.9 t -155.21 80.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.37 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.7 mttm 43.14 -168.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.708 0.766 . . . . 0.0 111.229 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.27 88.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 75.0 t -78.01 -94.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -1.055 . . . . 0.0 109.221 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 175.67 55.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.445 -0.784 . . . . 0.0 108.935 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -163.67 121.49 1.86 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.6 m -93.33 88.87 6.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.953 . . . . 0.0 109.279 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.6 t -78.64 135.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.592 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.94 80.88 15.1 Favored Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 109.754 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.72 158.73 24.89 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.733 2.289 . . . . 0.0 112.406 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.94 159.5 28.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.881 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -109.1 128.77 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.6 -0.687 . . . . 0.0 109.387 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -135.18 135.21 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt -102.28 135.74 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.426 -0.796 . . . . 0.0 109.735 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.09 129.42 45.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 110.503 -178.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.43 0.633 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.07 139.85 25.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.4 ptt? -162.19 165.16 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -1.128 . . . . 0.0 108.865 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.36 140.33 50.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 109.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.99 145.3 32.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.235 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -117.38 133.78 55.58 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -104.0 125.37 50.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.602 -0.686 . . . . 0.0 109.869 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.2 114.82 28.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.8 tp -97.58 121.64 39.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 109.611 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' LEU . 49.6 mt-10 39.35 58.88 6.3 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.74 -0.6 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.0 Cg_endo -63.81 145.14 90.36 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.514 2.143 . . . . 0.0 112.532 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 p -81.35 26.78 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.069 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 40' ' ' ILE . 10.5 tp -102.73 -21.99 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.14 -41.1 97.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.88 76.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.54 -0.725 . . . . 0.0 109.582 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -88.45 -65.65 1.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.041 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.26 143.0 45.15 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.7 t -80.27 167.8 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.438 0.637 . . . . 0.0 110.098 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -65.01 -36.0 82.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 109.774 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -64.8 -39.1 93.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.814 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.02 -34.85 79.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.097 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.63 126.0 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 0.0 110.005 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 m -126.14 -0.17 7.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.97 -175.29 36.96 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.451 ' CE ' HD21 ' A' ' 54' ' ' LEU . 63.0 ttp -135.47 136.22 41.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.514 -0.992 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.421 ' CE2' HD12 ' A' ' 62' ' ' ILE . 92.4 m-85 -106.31 116.8 32.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.452 -0.78 . . . . 0.0 109.417 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.451 HD21 ' CE ' ' A' ' 52' ' ' MET . 91.6 mt -96.89 115.06 26.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.893 . . . . 0.0 108.907 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 55' ' ' ILE . 3.3 mp -108.53 132.75 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.406 0.622 . . . . 0.0 109.713 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 99' ' ' ARG . 36.1 t0 -125.49 43.68 3.0 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.456 ' H ' HG22 ' A' ' 55' ' ' ILE . 66.9 m-20 54.86 5.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.808 -0.558 . . . . 0.0 109.619 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 56' ' ' ASP . 97.8 mt-10 -146.75 -105.46 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.514 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.23 164.36 52.58 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.29 153.27 47.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.27 -1.135 . . . . 0.0 110.232 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.4 135.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' CE2' ' A' ' 53' ' ' TYR . 37.2 mm -104.37 125.57 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.386 -0.821 . . . . 0.0 109.177 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.8 m -123.13 124.44 43.08 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -100.56 -9.26 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.18 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -83.38 75.74 9.96 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.234 -0.916 . . . . 0.0 109.275 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.03 134.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.553 -0.717 . . . . 0.0 109.724 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -126.37 138.97 53.62 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.96 136.1 12.58 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.66 125.43 49.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.495 -1.003 . . . . 0.0 109.144 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -109.05 144.21 37.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.757 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 90.8 mt -120.27 129.44 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 m120 57.54 32.45 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -0.759 . . . . 0.0 109.285 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.89 22.75 75.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -136.88 127.93 16.47 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.296 -1.12 . . . . 0.0 109.704 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.21 136.19 30.89 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.078 1.852 . . . . 0.0 112.539 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -154.34 -34.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.712 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.66 152.32 42.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.023 . . . . 0.0 110.248 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 79' ' ' GLU . 94.0 mt -130.86 163.51 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 78' ' ' ILE . 45.5 tt0 -142.01 151.82 42.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.1 141.65 36.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.0 m -119.79 129.45 54.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.569 -0.707 . . . . 0.0 109.702 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.29 129.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.5 0.667 . . . . 0.0 109.518 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.2 mp -81.97 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.594 -0.691 . . . . 0.0 110.156 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 71.4 mt -119.07 40.12 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.95 -40.32 97.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -0.836 . . . . 0.0 109.497 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.0 139.84 41.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.016 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.1 mm100 -66.32 -40.63 36.4 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.73 . . . . 0.0 110.403 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.9 Cg_exo -58.88 -33.08 98.44 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.029 1.819 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -67.11 -38.27 85.32 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.441 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 46.5 m95 -61.22 -41.82 97.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.18 -47.15 87.51 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -70.15 -42.09 72.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.487 -0.758 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -61.54 -45.83 92.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 84.9 mmm -64.78 -41.79 95.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.031 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NH1' ' CZ ' ' A' ' 99' ' ' ARG . 70.2 ttp85 -64.62 -41.36 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.581 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.553 ' CD1' ' NH2' ' A' ' 99' ' ' ARG . 3.2 m-85 -59.63 -42.66 93.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.785 . . . . 0.0 109.008 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.42 ' SD ' ' C ' ' A' ' 97' ' ' MET . 11.0 tmm? -61.7 -39.69 92.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.491 -0.755 . . . . 0.0 110.017 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.96 -48.34 82.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.052 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' CD1' ' A' ' 96' ' ' PHE . 88.8 mtm180 -66.03 -37.77 86.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.205 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.596 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 90.6 t80 -60.67 -44.97 95.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.43 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.82 92.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -1.073 . . . . 0.0 109.603 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -84.96 -10.25 57.25 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 76.0 m-20 . . . . . 0 N--CA 1.499 2.005 0 O-C-N 121.349 -0.845 . . . . 0.0 109.473 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.142 0.496 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -154.83 161.81 41.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.373 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.618 -0.676 . . . . 0.0 109.524 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 7' ' ' SER . 4.2 pt20 -154.37 154.91 34.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.122 -0.986 . . . . 0.0 109.43 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -86.24 -4.52 59.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.504 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 42.8 t -167.82 147.09 4.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 109.285 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -65.21 138.82 58.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.54 -12.53 64.69 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 85.0 t -112.33 127.21 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.597 -0.943 . . . . 0.0 110.077 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 168.85 96.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' VAL . 51.1 tp10 -168.6 130.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.226 -0.921 . . . . 0.0 109.158 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m 70.08 -9.41 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.635 -0.666 . . . . 0.0 109.373 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.446 ' H ' ' C ' ' A' ' 12' ' ' GLU . 6.6 t -80.98 130.27 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.6 t -142.59 83.5 11.75 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.253 -0.905 . . . . 0.0 108.722 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -79.69 145.62 18.32 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.392 2.061 . . . . 0.0 112.867 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -89.3 157.71 18.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.239 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.62 130.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 0.0 109.084 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -132.28 143.04 49.62 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.493 -0.755 . . . . 0.0 109.167 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.3 mt -103.72 132.55 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.421 -0.8 . . . . 0.0 108.918 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.9 m -129.81 153.6 48.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -109.02 143.95 37.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.524 -0.735 . . . . 0.0 109.108 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.484 ' CB ' ' OG ' ' A' ' 28' ' ' SER . 67.1 m . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.735 0.779 . . . . 0.0 110.992 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.484 ' OG ' ' CB ' ' A' ' 23' ' ' SER . 23.8 p . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.379 0.609 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.42 146.89 21.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.2 ttp -152.17 159.0 43.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -1.131 . . . . 0.0 109.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.23 150.09 36.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.9 145.66 46.49 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 0.0 109.88 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.41 137.24 54.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -119.42 127.22 52.9 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.4 122.17 46.79 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' GLU . 40.2 tp -93.45 125.5 38.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.497 -0.752 . . . . 0.0 110.009 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LEU . 30.9 mt-10 40.32 71.85 1.15 Allowed Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.756 -0.59 . . . . 0.0 110.551 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.23 142.85 97.67 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.829 2.353 . . . . 0.0 111.997 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.8 p -86.25 -17.3 35.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -70.61 1.79 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.917 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.58 -7.36 59.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 109.207 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.11 -23.96 16.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.333 -0.855 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -99.73 -73.18 0.64 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.466 -0.771 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.55 159.52 15.68 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.478 -0.763 . . . . 0.0 110.066 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -81.33 168.73 18.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -66.64 -37.28 84.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.554 -0.716 . . . . 0.0 109.804 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.27 -24.11 62.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -76.68 -5.54 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.572 -0.705 . . . . 0.0 109.706 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.3 mt -88.11 -87.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 m 66.94 -40.36 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -103.09 144.2 15.95 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -126.05 129.87 50.01 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -102.94 119.96 39.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.349 -0.845 . . . . 0.0 110.009 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 55' ' ' ILE . 24.7 mt -102.78 113.7 27.34 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.759 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -98.47 103.23 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 94.5 m-20 -95.12 176.24 6.31 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.644 0.735 . . . . 0.0 110.597 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.0 -36.61 84.96 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.729 -0.607 . . . . 0.0 109.786 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.19 -77.4 0.33 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.292 -0.88 . . . . 0.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.74 -145.52 6.79 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.66 153.51 43.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.394 -1.063 . . . . 0.0 109.799 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.04 133.25 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.4 mm -107.47 128.79 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 109.305 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 65' ' ' GLU . 53.2 m -123.84 127.86 48.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.448 0.642 . . . . 0.0 109.691 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -96.03 -3.71 44.38 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' H ' HG22 ' A' ' 63' ' ' THR . 96.2 mt-10 -86.36 83.53 7.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 109.541 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.16 133.58 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -127.49 137.89 52.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.571 -0.705 . . . . 0.0 109.25 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.88 138.08 13.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -105.86 105.81 16.03 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -98.82 147.15 25.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.226 0.536 . . . . 0.0 109.595 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 41.5 mm -125.24 135.66 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 12.2 p30 -38.89 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.697 0.761 . . . . 0.0 110.48 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 147.63 -60.77 0.46 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -175.26 154.53 1.66 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.184 -1.186 . . . . 0.0 109.43 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.33 129.98 8.68 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.745 1.63 . . . . 0.0 112.056 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.1 p -113.7 -35.07 5.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.686 -0.634 . . . . 0.0 109.604 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.39 169.41 22.03 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.363 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.54 128.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -111.18 150.07 30.03 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.518 0.675 . . . . 0.0 109.668 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.91 38.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -113.46 129.24 56.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.55 132.33 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.398 -0.814 . . . . 0.0 109.018 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.6 mm -92.59 127.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.856 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 78.6 mt -113.28 40.59 2.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.45 -39.72 94.31 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.491 0.663 . . . . 0.0 109.691 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.3 m -66.32 150.04 49.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 110.487 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.493 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 4.1 mp0 -73.04 -57.48 2.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.878 -0.514 . . . . 0.0 110.152 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 12.7 Cg_endo -54.02 -34.9 79.23 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.777 1.652 . . . . 0.0 111.35 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.66 -39.08 88.03 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.156 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -63.14 -44.82 94.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 108.933 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.11 -43.35 99.03 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.435 -0.791 . . . . 0.0 109.14 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.6 -42.39 95.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.083 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -59.76 -46.86 87.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.513 -0.742 . . . . 0.0 109.634 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.8 tpp -60.75 -46.42 90.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -65.09 -42.72 93.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.212 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.462 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 73.5 t80 -62.12 -43.82 98.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.28 -42.7 91.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.435 -0.791 . . . . 0.0 109.938 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.05 -47.08 75.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 110.137 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -67.91 -42.71 80.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.083 -1.011 . . . . 0.0 110.015 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 104' ' ' ASN . 89.6 t80 -62.05 -46.23 90.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.427 -0.795 . . . . 0.0 110.346 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.61 -36.33 93.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.422 ' HB3' ' OE1' ' A' ' 103' ' ' GLU . . . -60.65 -46.39 90.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.99 -1.3 . . . . 0.0 109.058 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -69.67 -50.35 44.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' TYR . 53.3 p30 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.445 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.67 0.747 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.9 145.39 37.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.305 -0.872 . . . . 0.0 109.727 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 88.2 mt -108.18 127.29 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 110.0 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -152.28 158.68 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.534 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -103.99 -35.68 8.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -129.66 151.47 50.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.36 139.08 57.17 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.764 0.792 . . . . 0.0 110.717 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.09 28.94 26.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -111.15 133.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.441 -1.035 . . . . 0.0 109.844 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 142.71 52.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.849 0.833 . . . . 0.0 110.455 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 1.2 pm0 -101.32 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 p -95.03 -9.03 35.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.38 -0.825 . . . . 0.0 109.187 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -71.5 134.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.84 82.13 12.77 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.569 -0.707 . . . . 0.0 110.051 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.78 151.25 24.59 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.965 2.444 . . . . 0.0 112.459 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 56.2 mp0 -91.69 153.81 19.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.68 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' A' ' 33' ' ' PHE . 60.7 t -116.87 133.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.417 0.627 . . . . 0.0 109.569 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.481 ' NH2' ' OE2' ' A' ' 79' ' ' GLU . 90.5 mtm-85 -121.71 140.52 52.21 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.49 110.61 23.01 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.668 0.747 . . . . 0.0 109.295 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 86.3 p -83.82 168.34 16.24 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.706 -0.621 . . . . 0.0 109.815 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -111.37 122.51 48.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.823 0.821 . . . . 0.0 109.824 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 28' ' ' SER . 2.9 p . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 23' ' ' SER . 27.9 m . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.482 0.658 . . . . 0.0 109.75 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 141.17 41.8 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -162.91 168.95 20.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -1.102 . . . . 0.0 110.189 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.09 146.73 45.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -104.31 148.96 25.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.541 -0.724 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.543 ' CE2' HG22 ' A' ' 18' ' ' VAL . 30.1 m-85 -117.66 129.92 56.04 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.99 123.48 43.32 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.53 0.681 . . . . 0.0 109.848 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.71 126.59 55.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.5 tp -117.29 117.97 30.99 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.341 0.591 . . . . 0.0 110.364 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 39' ' ' THR . 95.5 mt-10 31.91 70.4 0.71 Allowed Pre-proline 0 N--CA 1.497 1.905 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -65.53 12.48 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.769 2.313 . . . . 0.0 110.97 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.8 m 67.7 -3.35 1.15 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.415 0.626 . . . . 0.0 109.462 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 38' ' ' PRO . 20.3 tt -86.03 -0.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.27 -9.81 59.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 109.208 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.9 -18.92 21.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.898 . . . . 0.0 109.253 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -107.73 -41.76 4.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.502 -0.749 . . . . 0.0 109.82 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 48' ' ' ASP . 79.3 mm-40 -136.0 138.11 41.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.325 -0.859 . . . . 0.0 110.253 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -77.23 168.89 19.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.855 0.836 . . . . 0.0 110.521 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -64.8 -32.47 74.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.697 . . . . 0.0 109.713 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -65.22 -36.71 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.299 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.415 ' OD2' ' OE1' ' A' ' 44' ' ' GLU . 62.4 m-20 -64.41 -36.27 83.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 108.928 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.64 129.07 37.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.41 -0.807 . . . . 0.0 109.966 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 t -144.77 49.06 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' N ' HG21 ' A' ' 66' ' ' VAL . . . 163.57 162.92 15.24 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.4 ttp -129.31 131.02 46.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.944 . . . . 0.0 108.932 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 53' ' ' TYR . 29.6 m-85 -108.6 109.62 20.88 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.76 0.791 . . . . 0.0 110.127 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 55' ' ' ILE . 75.1 mt -100.58 121.72 42.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.756 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.5 mp -105.42 113.7 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.342 -0.848 . . . . 0.0 109.52 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 86.7 m-20 -92.39 171.98 8.69 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.459 0.647 . . . . 0.0 110.148 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' OD2' ' CZ ' ' A' ' 99' ' ' ARG . 39.6 p-10 -79.01 -4.76 51.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.877 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.44 -18.15 5.83 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ASP . . . -173.89 -151.06 7.97 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -152.34 145.05 24.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -1.157 . . . . 0.0 109.235 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.481 HD13 ' OE2' ' A' ' 89' ' ' GLU . 96.3 mt -114.7 129.56 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.517 -0.739 . . . . 0.0 109.114 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -112.71 130.56 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.59 0.71 . . . . 0.0 109.765 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 t -138.99 145.27 39.5 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.535 0.683 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.1 mmm-85 -100.89 4.26 42.52 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.603 0.716 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.91 74.13 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 51' ' ' GLY . 3.7 m -123.09 134.41 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.8 129.18 46.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.628 0.728 . . . . 0.0 109.177 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.95 130.44 10.17 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -106.46 130.89 54.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.676 -0.896 . . . . 0.0 108.901 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -105.37 145.3 30.96 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.603 0.716 . . . . 0.0 110.068 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.44 ' O ' ' CG ' ' A' ' 72' ' ' ASN . 7.1 mm -122.58 147.41 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.721 HD21 ' NE ' ' A' ' 74' ' ' ARG . 6.6 p30 51.53 13.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.721 0.772 . . . . 0.0 109.405 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 71' ' ' ILE . . . 88.82 28.87 20.04 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.721 ' NE ' HD21 ' A' ' 72' ' ' ASN . 16.3 ptt85 -153.87 163.99 22.13 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.198 -1.178 . . . . 0.0 109.45 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 142.34 99.23 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.421 2.081 . . . . 0.0 112.172 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.3 m -166.03 -32.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.181 -0.95 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.16 153.18 35.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.666 -1.271 . . . . 0.0 110.802 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.6 mt -128.52 163.36 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.376 0.608 . . . . 0.0 109.518 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 78' ' ' ILE . 45.1 tt0 -139.99 152.06 45.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -0.839 . . . . 0.0 109.75 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.38 146.21 32.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.443 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.6 m -123.06 132.84 54.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.386 0.612 . . . . 0.0 109.726 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.12 132.4 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.724 0.773 . . . . 0.0 109.339 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 85' ' ' ASN . 27.8 mm -76.16 130.67 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.446 0.641 . . . . 0.0 109.979 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.9 mt -122.81 35.77 4.8 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 83' ' ' ILE . 99.2 m-20 -64.57 -38.91 92.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 109.535 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.4 p -72.46 155.83 39.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.127 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.671 ' CD ' ' H ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -79.32 -42.59 1.63 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.646 -0.659 . . . . 0.0 110.823 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 39.9 Cg_endo -65.49 -24.88 56.03 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.859 1.706 . . . . 0.0 111.449 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.481 ' OE2' HD13 ' A' ' 61' ' ' ILE . 52.8 tp10 -70.83 -36.97 73.14 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -61.73 -42.92 99.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.576 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.47 -50.21 74.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.867 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -69.02 -40.71 78.5 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.734 0.778 . . . . 0.0 109.459 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.93 -46.14 91.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 63.8 ttp -63.25 -44.64 94.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.546 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -65.12 -37.7 88.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.516 -0.74 . . . . 0.0 109.857 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 85.3 t80 -59.74 -45.42 92.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.42 ' SD ' HG11 ' A' ' 18' ' ' VAL . 91.5 mtp -64.77 -39.9 94.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.284 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.89 -45.05 71.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.768 . . . . 0.0 109.514 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.447 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 94.8 mtt-85 -67.04 -39.12 86.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.351 -0.843 . . . . 0.0 109.66 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CE2' ' OD1' ' A' ' 104' ' ' ASN . 90.1 t80 -61.15 -45.96 92.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.37 -34.51 89.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -38.77 90.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -1.128 . . . . 0.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.33 -38.28 78.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.476 ' OD1' ' CE2' ' A' ' 100' ' ' TYR . 15.2 m120 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 109.514 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.528 ' HB1' ' CE2' ' A' ' 96' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.599 0.714 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.547 ' CD ' HE21 ' A' ' 5' ' ' GLN . 18.7 pt-20 -155.84 159.64 39.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.489 -0.757 . . . . 0.0 109.642 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.0 mm -106.78 128.13 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.744 0.783 . . . . 0.0 109.443 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.547 HE21 ' CD ' ' A' ' 3' ' ' GLU . 78.4 mt-30 -138.94 136.88 35.91 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.425 ' O ' ' OG ' ' A' ' 7' ' ' SER . 46.1 m-85 -103.61 -13.6 16.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 6' ' ' PHE . 61.8 m -167.9 169.84 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.52 -0.738 . . . . 0.0 110.172 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.49 141.86 41.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.67 0.747 . . . . 0.0 110.904 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.63 23.67 52.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -109.44 -34.42 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -1.001 . . . . 0.0 109.051 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.85 168.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.726 0.774 . . . . 0.0 110.43 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' OG1' ' A' ' 13' ' ' THR . 17.6 pt-20 -80.47 139.39 36.44 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.586 0.708 . . . . 0.0 110.338 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 6.3 m -168.86 -35.17 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.7 t -81.49 135.85 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.634 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.01 82.78 13.93 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.585 -0.697 . . . . 0.0 109.265 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.37 156.19 25.35 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 123.048 2.499 . . . . 0.0 112.83 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -85.24 149.16 25.68 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.707 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.9 132.05 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.455 0.645 . . . . 0.0 109.787 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -130.06 144.8 51.54 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.479 0.657 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -111.28 134.56 52.78 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.677 0.751 . . . . 0.0 109.884 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -158.21 167.77 28.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -117.83 142.07 47.72 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.716 0.769 . . . . 0.0 109.6 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 121.765 0.793 . . . . 0.0 110.363 -179.469 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.576 ' CB ' HD22 ' A' ' 85' ' ' ASN . 12.6 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.99 0.9 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.77 156.68 49.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.4 ptm -154.32 172.69 17.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -147.12 140.23 25.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -107.27 141.14 39.06 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.586 0.708 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -117.32 126.36 52.58 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.48 128.53 46.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.451 0.644 . . . . 0.0 109.471 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -111.86 117.33 32.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.6 tp -95.63 127.74 41.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.634 0.731 . . . . 0.0 110.298 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 37.99 70.81 1.16 Allowed Pre-proline 0 N--CA 1.496 1.858 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.17 141.31 93.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.495 2.13 . . . . 0.0 111.855 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 46.2 p -87.42 -18.66 29.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.597 -0.689 . . . . 0.0 110.358 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.7 tt -66.68 2.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 109.676 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' THR . 86.5 mt -80.86 -8.74 59.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.7 -17.47 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 109.17 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -105.38 -50.48 3.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.499 -0.75 . . . . 0.0 109.585 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.54 157.6 45.85 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.371 -0.831 . . . . 0.0 109.936 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.9 t -77.34 164.74 25.25 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.621 0.724 . . . . 0.0 110.562 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -65.27 -37.51 87.42 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.442 0.639 . . . . 0.0 109.968 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.69 -16.64 63.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.458 -0.776 . . . . 0.0 109.776 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.74 -0.36 56.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 98.7 mt -94.51 118.0 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -0.93 . . . . 0.0 109.907 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -114.11 121.25 43.21 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.719 0.771 . . . . 0.0 109.458 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.82 177.25 3.47 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -132.66 137.33 46.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.77 -0.841 . . . . 0.0 109.042 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.18 111.48 23.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.816 0.817 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.418 ' C ' HD12 ' A' ' 55' ' ' ILE . 89.6 mt -99.93 125.95 46.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.752 -0.593 . . . . 0.0 109.566 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.703 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.7 mp -101.92 100.31 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.468 -0.77 . . . . 0.0 109.377 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -91.5 176.63 6.48 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.447 0.641 . . . . 0.0 109.89 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 45.8 p-10 -68.26 113.03 5.52 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.764 0.792 . . . . 0.0 110.297 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 57.38 31.5 20.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.756 0.788 . . . . 0.0 109.463 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.94 168.3 40.84 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.46 149.8 28.94 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.288 -1.125 . . . . 0.0 109.766 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.37 129.6 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.27 131.73 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 109.711 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 t -129.54 142.2 50.81 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.589 0.709 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -96.04 79.47 3.23 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.547 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 66' ' ' VAL . 79.7 mm-40 -141.57 -105.03 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.605 -0.684 . . . . 0.0 109.592 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' GLU . 4.8 t 57.92 113.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.603 0.716 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -126.97 116.53 20.92 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.687 0.756 . . . . 0.0 109.099 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.83 137.26 26.71 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -107.5 124.39 49.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.775 -0.838 . . . . 0.0 108.94 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' C ' HD12 ' A' ' 71' ' ' ILE . 78.7 m-85 -101.02 123.3 45.0 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.56 0.695 . . . . 0.0 110.3 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 71' ' ' ILE . 2.9 mp -107.74 119.81 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.671 0.748 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.21 33.75 22.83 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.455 0.645 . . . . 0.0 110.404 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.64 34.3 39.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.417 ' NH2' ' OG1' ' A' ' 76' ' ' THR . 56.5 ttp85 -152.44 132.75 7.43 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.151 -1.205 . . . . 0.0 109.723 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.81 89.54 0.75 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.6 2.2 . . . . 0.0 111.103 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.433 ' HB ' HD13 ' A' ' 71' ' ' ILE . 6.7 m -105.5 -15.02 15.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.476 -0.765 . . . . 0.0 109.754 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.27 42.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.091 -1.006 . . . . 0.0 110.307 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.6 mt -133.61 158.59 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 78' ' ' ILE . 43.0 tt0 -139.42 156.76 46.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 110.142 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.82 148.3 31.75 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.368 0.604 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 m -122.0 132.75 54.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.54 0.686 . . . . 0.0 109.505 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 93' ' ' PHE . 47.2 t -109.85 130.56 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.659 0.743 . . . . 0.0 109.469 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.7 mm -98.97 121.59 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.405 0.621 . . . . 0.0 109.559 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.466 HD11 ' CD2' ' A' ' 93' ' ' PHE . 69.7 mt -107.8 65.75 0.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.576 HD22 ' CB ' ' A' ' 28' ' ' SER . 13.8 m120 -64.99 -39.5 93.57 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.587 0.708 . . . . 0.0 109.647 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.8 m -72.36 152.51 42.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 110.535 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.513 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 21.1 mt-30 -76.26 -58.28 1.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.845 -0.534 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 19.6 Cg_endo -56.19 -29.67 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.24 1.96 . . . . 0.0 111.611 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.96 -34.95 78.87 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.436 0.636 . . . . 0.0 109.596 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -46.54 89.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.347 -0.846 . . . . 0.0 109.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.74 -42.7 97.83 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.528 -0.732 . . . . 0.0 109.394 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.43 -40.87 93.82 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.641 0.734 . . . . 0.0 109.049 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CD2' HD11 ' A' ' 84' ' ' LEU . 9.7 t80 -60.94 -42.54 98.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.648 0.737 . . . . 0.0 109.244 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -61.72 -41.39 97.57 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.562 0.696 . . . . 0.0 109.624 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.56 -39.83 94.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.426 -0.796 . . . . 0.0 109.328 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.528 ' CE2' ' HB1' ' A' ' 2' ' ' ALA . 28.3 t80 -58.63 -44.5 90.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.625 -0.672 . . . . 0.0 109.645 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 13.4 ttt -61.5 -43.92 98.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.982 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.13 -43.33 71.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.328 -0.858 . . . . 0.0 109.637 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -66.27 -42.14 88.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.404 -0.81 . . . . 0.0 109.514 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.05 -43.62 98.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.8 . . . . 0.0 109.839 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.42 -36.73 93.54 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.44 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -1.034 . . . . 0.0 109.855 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.25 -37.07 71.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 . . . . . 0 N--CA 1.499 2.002 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 -179.257 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -117.31 155.55 29.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.539 -0.725 . . . . 0.0 109.664 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.42 127.8 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.637 -0.665 . . . . 0.0 109.219 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -129.67 124.22 33.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.749 -0.594 . . . . 0.0 109.427 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -106.58 -11.32 15.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -168.36 -153.44 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.038 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -69.9 134.59 48.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 110.83 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.1 -88.76 0.05 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t 53.9 95.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.488 -1.007 . . . . 0.0 109.883 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.67 56.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 110.705 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -100.22 32.79 2.86 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 m -69.09 -20.49 64.08 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 p -71.15 -19.11 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.766 -0.584 . . . . 0.0 110.353 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' VAL . 1.4 p 34.05 95.53 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 122.105 -0.372 . . . . 0.0 110.311 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.67 157.31 31.89 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.238 1.959 . . . . 0.0 112.869 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -92.01 152.89 19.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.096 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.77 133.47 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.569 -0.707 . . . . 0.0 109.262 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -128.57 144.22 51.11 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.8 mt -110.81 132.37 54.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.678 -0.639 . . . . 0.0 109.413 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.3 m -154.57 164.38 38.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.55 -0.719 . . . . 0.0 109.598 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -89.61 141.9 28.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.608 -0.683 . . . . 0.0 109.861 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.686 0.755 . . . . 0.0 110.757 -179.524 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.484 ' CB ' HD22 ' A' ' 85' ' ' ASN . 5.6 t . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.864 0.84 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.18 161.2 53.31 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.72 175.95 12.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.288 -1.125 . . . . 0.0 109.577 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.55 146.34 34.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.61 145.15 38.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.501 0.667 . . . . 0.0 109.955 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -112.44 121.25 44.3 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -96.2 123.76 39.95 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.445 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 2.1 m-85 -114.58 126.68 55.19 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.443 0.639 . . . . 0.0 109.308 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.2 tp -110.27 116.27 31.19 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 110.023 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' A' ' 39' ' ' THR . 52.2 mm-40 30.5 66.62 0.83 Allowed Pre-proline 0 N--CA 1.501 2.119 0 CA-C-O 120.877 0.37 . . . . 0.0 111.891 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 40' ' ' ILE . 33.3 Cg_exo -65.54 16.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.89 2.393 . . . . 0.0 111.404 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.528 ' H ' ' C ' ' A' ' 37' ' ' GLU . 37.0 p 50.39 14.36 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.645 -0.66 . . . . 0.0 109.498 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.427 ' N ' ' C ' ' A' ' 38' ' ' PRO . 3.4 tp -90.88 -14.87 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.908 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.39 -41.79 96.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.17 -35.07 77.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.992 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.31 -64.25 1.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 40' ' ' ILE . 80.0 mm-40 -117.45 143.24 46.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.595 -0.691 . . . . 0.0 109.785 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.5 m -73.95 162.23 29.28 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.529 0.68 . . . . 0.0 110.325 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.417 ' HG1' ' HZ ' ' A' ' 70' ' ' PHE . 44.2 p -65.83 -34.65 78.64 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 51.9 p-10 -67.96 -25.3 65.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.838 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 56.8 t0 -83.06 -9.15 59.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.067 -1.021 . . . . 0.0 109.302 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -96.59 111.07 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 108.748 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -126.82 126.26 43.07 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.567 0.698 . . . . 0.0 109.868 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 155.4 1.31 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.6 ttp -117.88 132.93 56.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.907 . . . . 0.0 109.291 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -108.71 119.65 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.69 -0.631 . . . . 0.0 109.497 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.7 mt -99.34 107.55 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.598 HG22 ' N ' ' A' ' 56' ' ' ASP . 96.5 mt -115.4 165.46 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.643 -0.661 . . . . 0.0 109.838 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.598 ' N ' HG22 ' A' ' 55' ' ' ILE . 64.2 t0 -151.9 -117.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 0.0 109.882 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 97.5 m-20 -79.48 -21.7 45.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.419 -0.8 . . . . 0.0 109.955 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -175.38 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 147.22 46.06 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.25 147.42 33.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -1.127 . . . . 0.0 109.64 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.494 ' C ' HD12 ' A' ' 62' ' ' ILE . 87.7 mt -128.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.837 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.6 mp -105.04 129.77 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.839 . . . . 0.0 109.675 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 65' ' ' GLU . 94.9 m -122.3 129.5 52.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 48.7 mmm-85 -112.17 46.47 1.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.9 mp0 -143.85 80.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.23 134.75 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.699 -0.626 . . . . 0.0 109.591 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -127.18 141.58 51.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.52 139.5 14.53 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -90.43 105.71 18.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 108.442 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.417 ' HZ ' ' HG1' ' A' ' 46' ' ' THR . 66.4 m-85 -94.77 135.36 36.35 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.393 0.616 . . . . 0.0 110.119 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 45.9 mm -115.11 131.83 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.33 0.586 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 71' ' ' ILE . 23.2 p30 44.08 16.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.957 -0.464 . . . . 0.0 110.339 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 109.38 -24.15 21.04 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 71' ' ' ILE . 16.3 ptp180 -100.72 147.24 33.37 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.145 -1.209 . . . . 0.0 110.122 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.78 143.35 66.95 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.652 2.234 . . . . 0.0 112.715 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.406 ' OG1' ' CG1' ' A' ' 71' ' ' ILE . 4.3 m -140.87 -29.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 35' ' ' PHE . . . -156.43 171.55 20.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 109.615 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.2 mt -131.85 144.29 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.572 0.701 . . . . 0.0 110.34 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -128.07 142.7 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.41 143.89 32.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 0.0 108.966 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -123.63 134.39 53.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.631 . . . . 0.0 109.665 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.62 130.73 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.5 mm -88.25 123.87 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.512 -0.743 . . . . 0.0 110.04 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.8 mt -98.62 56.83 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.484 HD22 ' CB ' ' A' ' 28' ' ' SER . 11.3 m120 -64.42 -39.99 94.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.437 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -83.29 145.65 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 110.048 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -71.61 -46.49 12.85 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 46.3 Cg_exo -54.9 -28.45 58.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.152 1.901 . . . . 0.0 111.323 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -59.47 -37.54 78.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.457 -0.777 . . . . 0.0 109.421 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -57.87 -37.35 73.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -59.55 -45.0 93.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -64.76 -40.67 95.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.373 -0.829 . . . . 0.0 109.612 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -65.81 -39.58 91.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 54.7 ttp -59.87 -45.5 92.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.945 . . . . 0.0 110.171 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -64.83 -38.29 90.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.396 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 96' ' ' PHE . 17.6 t80 -59.69 -46.9 87.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 36.5 ttm -65.56 -39.5 91.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.01 -52.5 23.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.23 -54.43 29.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.533 -0.73 . . . . 0.0 109.846 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -64.05 -45.12 90.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.31 -34.34 89.17 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.62 95.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -1.12 . . . . 0.0 109.561 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -68.71 -38.38 80.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.3 p30 . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.399 179.751 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.452 ' HB1' ' CE1' ' A' ' 96' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.482 0.658 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -155.57 153.24 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.414 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -111.13 128.52 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' HG2' HD13 ' A' ' 55' ' ' ILE . 21.5 pt20 -152.41 161.37 42.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.045 -1.034 . . . . 0.0 109.615 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.37 -31.06 9.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 t -113.45 132.33 55.69 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.538 0.685 . . . . 0.0 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -67.26 135.65 53.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.766 . . . . 0.0 110.346 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.25 -13.28 67.09 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.27 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.77 90.36 8.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.632 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.22 136.68 46.44 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.881 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 5.28 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.246 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -55.97 141.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.975 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.92 84.32 13.1 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.554 -0.716 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.0 150.85 23.6 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.931 2.421 . . . . 0.0 112.893 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -92.96 139.25 30.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 33' ' ' PHE . 21.8 t -99.03 129.71 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.291 -0.881 . . . . 0.0 109.953 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.464 ' C ' HD22 ' A' ' 20' ' ' LEU . 1.3 mpp_? -132.23 145.76 51.54 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.622 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.6 mm? -96.67 121.39 38.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 31' ' ' ALA . 53.3 m -109.1 167.52 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.573 -0.704 . . . . 0.0 109.651 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -126.31 138.65 53.61 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.594 0.711 . . . . 0.0 110.045 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 110.769 -179.424 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.418 0.627 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.43 149.09 44.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttp -151.87 144.75 24.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.178 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 21' ' ' SER . . . -143.08 147.77 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 108.691 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -119.4 144.55 46.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.319 0.58 . . . . 0.0 110.181 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 18' ' ' VAL . 81.3 m-85 -116.52 131.82 56.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -105.52 127.81 53.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.643 -0.66 . . . . 0.0 109.245 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.21 117.34 32.95 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 37' ' ' GLU . 50.4 tp -92.75 128.96 38.8 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.346 0.593 . . . . 0.0 110.517 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 36' ' ' LEU . 94.0 mt-10 35.84 71.78 0.84 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-O 121.083 0.468 . . . . 0.0 111.161 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.75 141.03 93.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.613 2.209 . . . . 0.0 112.217 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.0 p -83.29 -18.61 38.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 0.0 109.74 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.18 1.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 109.736 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.84 -9.41 58.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.035 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.64 -17.89 23.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.81 -47.92 3.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 109.449 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.6 153.6 48.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.398 -0.814 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -72.58 158.36 35.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.628 0.728 . . . . 0.0 110.327 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -64.23 -26.9 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 44.4 p30 -67.31 -19.82 65.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 94.5 m-20 -79.74 -5.09 54.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.11 118.46 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -0.33 14.69 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.26 179.4 42.47 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.421 ' CE ' HD21 ' A' ' 54' ' ' LEU . 63.9 ttp -132.5 141.61 48.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.434 -1.039 . . . . 0.0 109.763 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -111.35 118.64 36.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.416 0.627 . . . . 0.0 109.54 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 55' ' ' ILE . 78.4 mt -101.52 122.52 43.96 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -105.77 120.83 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.509 -0.744 . . . . 0.0 109.012 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -102.12 -153.95 0.48 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 109.807 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -73.33 -6.06 43.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.891 . . . . 0.0 109.603 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -174.15 -54.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 108.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.96 166.21 54.39 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -145.62 147.58 32.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -1.128 . . . . 0.0 109.182 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.94 131.51 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.653 -0.654 . . . . 0.0 109.508 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -113.96 128.98 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.9 133.76 47.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.544 0.688 . . . . 0.0 109.679 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -94.94 -3.52 48.46 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -84.66 76.12 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.78 133.41 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.653 -0.654 . . . . 0.0 109.4 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -127.48 140.58 52.05 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.1 142.35 16.42 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -104.62 111.27 23.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.499 -1.001 . . . . 0.0 108.723 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 22.8 m-85 -101.93 125.81 48.7 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.5 mt -111.71 120.93 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.7 m120 57.13 33.44 23.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.578 -0.701 . . . . 0.0 109.323 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.46 25.38 74.86 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -130.58 100.19 18.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.291 -1.123 . . . . 0.0 109.694 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -46.97 93.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.263 1.975 . . . . 0.0 112.055 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 m -112.65 -15.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.722 . . . . 0.0 109.754 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.86 157.89 43.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.736 -1.228 . . . . 0.0 110.737 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.85 138.05 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -117.7 147.05 43.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.293 -0.879 . . . . 0.0 109.758 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.59 143.18 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.6 m -126.36 130.93 51.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.666 -0.646 . . . . 0.0 109.465 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.451 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.0 t -115.56 129.95 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.534 0.683 . . . . 0.0 109.252 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.722 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.8 mp -94.44 123.1 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -0.76 . . . . 0.0 109.706 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.58 110.52 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -95.9 -0.92 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.143 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.07 152.85 48.23 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.474 -0.766 . . . . 0.0 109.998 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.584 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.6 tp-100 -76.69 -40.29 2.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.621 -0.674 . . . . 0.0 110.801 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.4 Cg_exo -55.25 -30.54 72.31 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.151 1.901 . . . . 0.0 111.413 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -64.99 -40.92 95.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.668 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.617 ' CZ3' HD12 ' A' ' 20' ' ' LEU . 25.3 m95 -56.63 -36.74 69.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.488 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.4 -41.33 98.59 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.36 -44.31 91.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.179 -0.951 . . . . 0.0 109.473 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.25 -42.35 93.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.476 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -61.39 -46.09 91.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.594 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -68.84 -43.27 75.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 109.223 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.452 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 91.2 t80 -62.12 -46.05 90.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.456 -0.777 . . . . 0.0 109.411 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 63.7 ttp -63.99 -40.12 95.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.597 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.11 -49.8 68.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -66.19 -42.38 88.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 104' ' ' ASN . 79.0 t80 -63.72 -41.5 98.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.36 -36.81 93.06 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.16 95.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.362 -1.081 . . . . 0.0 109.536 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.08 -36.99 75.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.303 -0.873 . . . . 0.0 109.669 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 100' ' ' TYR . 7.8 m120 . . . . . 0 N--CA 1.501 2.102 0 O-C-N 121.5 -0.75 . . . . 0.0 109.884 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.782 0.801 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.79 149.9 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.33 130.41 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.72 -0.612 . . . . 0.0 109.418 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -127.81 133.37 49.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.565 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.34 -67.02 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -111.86 14.44 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 60.19 126.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.871 0.844 . . . . 0.0 111.187 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.33 7.96 69.01 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 m -110.73 141.73 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.586 -0.949 . . . . 0.0 110.011 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.584 ' H ' ' HZ3' ' A' ' 43' ' ' LYS . . . -61.86 140.9 58.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.635 0.731 . . . . 0.0 110.771 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' O ' ' OG1' ' A' ' 13' ' ' THR . 49.9 tp10 -97.95 -65.95 0.93 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.548 -0.72 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 12' ' ' GLU . 7.0 p 51.01 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.578 0.704 . . . . 0.0 110.432 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' THR . 53.2 t 57.73 148.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.582 0.706 . . . . 0.0 110.439 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 15' ' ' VAL . 7.4 p -105.1 105.04 50.16 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.87 143.87 33.83 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.555 2.17 . . . . 0.0 112.692 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 56.4 mp0 -97.18 142.74 28.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.453 -0.78 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.512 HG22 ' CE2' ' A' ' 33' ' ' PHE . 3.7 t -106.15 126.53 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.409 0.623 . . . . 0.0 109.35 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -110.65 145.04 38.63 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.608 0.718 . . . . 0.0 109.654 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.9 mm? -95.39 139.74 31.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.666 0.746 . . . . 0.0 109.712 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -153.38 167.48 29.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.49 -0.756 . . . . 0.0 109.929 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.32 152.07 24.03 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.679 0.752 . . . . 0.0 109.97 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.857 0.837 . . . . 0.0 110.873 -179.078 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.423 ' OG ' ' ND2' ' A' ' 85' ' ' ASN . 41.1 t . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.772 0.796 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.74 149.63 48.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.2 ttt -141.66 130.21 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -1.11 . . . . 0.0 108.96 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 145.42 50.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 109.27 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.84 149.38 42.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.512 ' CE2' HG22 ' A' ' 18' ' ' VAL . 58.1 m-85 -122.6 139.63 53.71 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -114.58 123.36 49.15 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 118.98 36.67 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.25 107.93 19.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.762 0.792 . . . . 0.0 110.185 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 39' ' ' THR . 64.4 mm-40 47.83 61.81 13.1 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.842 -0.536 . . . . 0.0 110.625 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HG2' HG22 ' A' ' 40' ' ' ILE . 37.6 Cg_endo -66.83 15.38 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.335 2.023 . . . . 0.0 110.854 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 37' ' ' GLU . 25.7 p 51.86 22.29 1.7 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.518 HG22 ' HG2' ' A' ' 38' ' ' PRO . 14.4 tt -97.08 -13.75 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.311 -0.868 . . . . 0.0 109.228 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.44 -40.14 89.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.383 -0.823 . . . . 0.0 109.475 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.59 -14.63 59.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.557 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.584 ' HZ3' ' H ' ' A' ' 11' ' ' ALA . 54.2 mtpt -99.55 -63.24 1.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.709 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -119.93 138.91 53.16 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.76 0.79 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 m -71.33 150.67 44.89 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.714 0.769 . . . . 0.0 110.709 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.4 p -59.27 -40.69 86.84 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.421 0.629 . . . . 0.0 109.819 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.17 -15.86 62.5 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -0.764 . . . . 0.0 109.691 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.52 -7.72 49.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 92.1 mt -91.46 114.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.123 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.83 125.4 35.6 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.883 0.849 . . . . 0.0 109.642 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.77 157.02 15.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.4 ttt -132.73 127.57 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -109.18 108.07 18.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.65 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.7 mt -99.28 129.03 45.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.623 -0.673 . . . . 0.0 109.325 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.88 127.95 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.353 0.597 . . . . 0.0 110.171 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 18.5 p-10 -99.21 -132.45 0.24 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.676 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.461 ' N ' ' CG ' ' A' ' 56' ' ' ASP . 99.7 m-20 -63.13 -43.21 99.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -149.25 -50.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.365 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.75 168.73 13.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -140.29 155.52 46.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -1.028 . . . . 0.0 110.283 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.05 136.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.72 132.52 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.604 -0.685 . . . . 0.0 109.761 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 t -143.63 151.59 40.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.832 . . . . 0.0 109.614 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -104.25 3.52 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -81.5 79.32 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 109.316 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.1 t -125.81 135.37 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.62 -0.675 . . . . 0.0 109.795 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.9 136.86 48.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.5 -0.75 . . . . 0.0 109.582 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.55 141.59 15.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.98 106.94 18.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.501 -1.0 . . . . 0.0 109.443 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.6 143.9 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.643 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 93.5 mt -120.88 134.12 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 71' ' ' ILE . 46.3 m-80 -37.74 92.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.65 0.738 . . . . 0.0 110.538 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 148.44 -60.6 0.45 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -174.84 154.45 1.8 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.61 138.77 10.74 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.09 1.86 . . . . 0.0 112.099 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.442 ' CB ' HD12 ' A' ' 71' ' ' ILE . 66.8 m -132.7 -30.01 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.691 . . . . 0.0 109.918 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.17 164.04 38.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.682 -1.262 . . . . 0.0 110.577 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -128.54 150.24 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.19 151.0 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.611 0.719 . . . . 0.0 109.695 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.87 144.56 35.36 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.6 m -123.21 133.5 54.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.666 -0.646 . . . . 0.0 109.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.63 130.31 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mm -98.83 123.91 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.625 0.726 . . . . 0.0 109.795 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.11 83.02 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.423 ' ND2' ' OG ' ' A' ' 28' ' ' SER . 11.9 m120 -91.54 8.14 37.99 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.18 44.48 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.823 . . . . 0.0 109.195 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.589 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.0 mm100 -65.5 -40.87 45.68 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.706 -0.621 . . . . 0.0 110.549 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.9 Cg_exo -56.72 -36.61 98.5 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.369 2.046 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -32.39 70.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.452 0.644 . . . . 0.0 109.646 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -60.36 -47.28 86.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.68 -44.5 90.14 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.488 -0.758 . . . . 0.0 109.666 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 56' ' ' ASP . 62.8 ttm-85 -66.63 -41.1 88.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.478 -0.764 . . . . 0.0 109.441 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -60.2 -44.75 94.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.488 -0.757 . . . . 0.0 109.952 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -63.82 -41.7 97.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.35 -0.844 . . . . 0.0 109.986 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.9 -44.14 86.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.0 -49.75 73.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.432 ' SD ' ' C ' ' A' ' 97' ' ' MET . 14.1 tmm? -68.44 -41.58 80.1 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.439 -0.788 . . . . 0.0 110.139 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 81.4 tt0 -66.54 -49.21 67.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 110.179 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.42 -43.28 81.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 110.265 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.39 -52.34 65.0 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.78 . . . . 0.0 110.329 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.489 ' O ' ' ND2' ' A' ' 104' ' ' ASN . . . -76.63 -33.32 47.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 98' ' ' GLU . . . -48.94 -50.35 35.81 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.906 -1.35 . . . . 0.0 108.492 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 104' ' ' ASN . 96.8 mt-10 -71.49 -36.69 71.21 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.635 0.731 . . . . 0.0 109.111 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 101' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 122.233 1.016 . . . . 0.0 111.019 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 121.737 0.78 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' THR . 17.1 pt-20 -155.68 165.25 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 mp -106.8 128.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.542 0.687 . . . . 0.0 109.617 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -150.01 131.38 14.67 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.734 0.778 . . . . 0.0 109.532 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -63.64 -43.78 95.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.7 m -119.19 120.48 37.2 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.813 0.816 . . . . 0.0 109.292 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.49 137.48 56.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.855 0.836 . . . . 0.0 111.043 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.66 -13.94 53.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.21 164.79 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.55 52.36 9.93 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.612 0.72 . . . . 0.0 109.642 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.564 ' C ' ' HG1' ' A' ' 13' ' ' THR . 17.8 pt-20 -76.24 174.28 10.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.213 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.564 ' HG1' ' C ' ' A' ' 12' ' ' GLU . 72.0 p 55.24 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.612 0.72 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 12' ' ' GLU . 2.4 t 56.6 155.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.839 0.828 . . . . 0.0 110.526 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.7 66.24 72.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.71 -0.619 . . . . 0.0 109.401 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.41 145.61 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.173 2.582 . . . . 0.0 112.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -88.82 147.65 24.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.679 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.435 HG22 ' CE2' ' A' ' 33' ' ' PHE . 71.4 t -117.1 130.97 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.648 0.737 . . . . 0.0 109.378 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.1 145.44 50.73 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.29 142.98 34.1 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.748 0.785 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 p -151.79 162.86 40.34 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.711 -0.618 . . . . 0.0 109.512 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.43 135.06 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.767 0.794 . . . . 0.0 109.746 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 121.617 0.723 . . . . 0.0 110.246 -179.555 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.973 0.892 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.55 156.84 53.17 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -147.32 156.93 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.107 . . . . 0.0 110.345 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.26 141.94 48.5 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -111.86 134.16 53.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.454 0.645 . . . . 0.0 109.934 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CE2' HG22 ' A' ' 18' ' ' VAL . 74.2 m-85 -112.95 144.18 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.546 0.689 . . . . 0.0 109.713 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -131.33 125.04 31.69 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.416 0.627 . . . . 0.0 109.387 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 46.3 m-85 -110.98 119.79 40.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.66 0.743 . . . . 0.0 109.333 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.0 tp -93.76 119.36 32.63 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.901 0.858 . . . . 0.0 110.512 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 39.06 56.73 5.79 Favored Pre-proline 0 N--CA 1.492 1.672 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.042 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.86 149.58 72.66 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.275 1.983 . . . . 0.0 111.988 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 41' ' ' LEU . 39.1 p -71.29 -17.11 62.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.1 tp -63.44 2.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 109.79 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 39' ' ' THR . 91.1 mt -95.17 -18.42 20.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 108.87 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.64 -20.0 18.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.33 -75.02 0.53 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.321 -0.862 . . . . 0.0 109.639 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -101.96 141.81 34.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.5 t -68.42 157.0 36.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.782 0.801 . . . . 0.0 110.353 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -65.59 -32.74 74.49 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.501 0.667 . . . . 0.0 109.925 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.0 -17.18 62.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.395 -0.816 . . . . 0.0 109.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -85.65 -7.09 59.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.15 127.85 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.129 -0.982 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -151.14 32.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.77 5.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.2 ttm -114.11 133.27 55.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.617 -0.931 . . . . 0.0 109.451 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -112.22 121.16 44.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.685 0.755 . . . . 0.0 109.168 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.558 ' C ' HD12 ' A' ' 55' ' ' ILE . 73.8 mt -99.45 125.38 45.17 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.728 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -107.04 125.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 109.318 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 58' ' ' GLU . 65.5 t0 -125.85 17.4 7.98 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 64.31 -62.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.348 0.594 . . . . 0.0 110.242 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' ASP . 96.3 mt-10 -72.98 -0.85 14.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.83 173.57 36.71 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.92 148.57 34.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -1.077 . . . . 0.0 109.761 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.25 133.62 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.538 0.685 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.9 126.36 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.773 . . . . 0.0 109.264 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' N ' ' A' ' 64' ' ' ARG . 6.2 m -137.27 160.79 38.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.817 0.818 . . . . 0.0 109.316 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.475 ' N ' HG22 ' A' ' 63' ' ' THR . 84.5 mmt-85 -102.92 -116.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' ARG . 79.8 mm-40 35.75 77.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.601 0.715 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.92 131.95 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.83 138.58 52.13 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.582 0.706 . . . . 0.0 109.407 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -103.39 132.93 11.23 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -99.58 108.26 20.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -1.002 . . . . 0.0 108.685 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -102.61 145.09 30.16 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.679 0.752 . . . . 0.0 109.998 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.4 mt -122.71 135.13 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 71' ' ' ILE . 9.3 p30 -37.79 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.894 0.854 . . . . 0.0 110.735 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 150.69 -62.44 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -178.54 150.72 0.7 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.243 -1.151 . . . . 0.0 109.531 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -37.49 118.66 0.26 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.632 2.221 . . . . 0.0 111.779 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.446 ' CB ' HD12 ' A' ' 71' ' ' ILE . 45.1 m -110.93 -33.57 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 0.0 110.238 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.87 161.11 41.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.773 -1.204 . . . . 0.0 110.836 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.426 HD11 HD21 ' A' ' 41' ' ' LEU . 96.7 mt -128.16 152.42 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.558 0.694 . . . . 0.0 109.376 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -137.93 153.15 49.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.578 0.704 . . . . 0.0 109.568 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -151.4 154.03 35.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.41 0.624 . . . . 0.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.9 131.94 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.561 HG22 ' ND2' ' A' ' 85' ' ' ASN . 14.0 mm -96.25 122.63 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.927 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 81.2 mt -110.0 108.21 18.37 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.547 0.689 . . . . 0.0 109.497 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.561 ' ND2' HG22 ' A' ' 83' ' ' ILE . 6.5 m-80 -110.26 -54.85 2.53 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.541 0.686 . . . . 0.0 109.524 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.02 145.82 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.683 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -67.02 -43.22 45.94 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.64 -0.663 . . . . 0.0 110.526 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 52.5 Cg_exo -53.78 -36.31 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.074 1.85 . . . . 0.0 111.317 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.86 -41.96 99.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.629 -0.67 . . . . 0.0 109.632 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.54 -38.92 91.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.27 -0.893 . . . . 0.0 110.009 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.64 -48.46 81.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 108.959 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -69.07 -41.89 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.728 0.775 . . . . 0.0 109.376 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -61.25 -45.35 94.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 53.9 mtt -64.19 -39.57 94.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -61.45 -41.38 97.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -60.44 -44.02 96.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.831 . . . . 0.0 109.73 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.7 mtp -63.46 -40.37 96.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.68 -46.47 72.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -66.63 -43.62 84.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 109.915 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -64.74 -42.05 95.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.481 -0.762 . . . . 0.0 109.691 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.98 -40.95 94.07 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.85 -39.76 94.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.514 -0.992 . . . . 0.0 109.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -39.69 76.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 109.517 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 N--CA 1.501 2.083 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.362 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.527 ' OE2' ' NE2' ' A' ' 5' ' ' GLN . 18.5 pt-20 -156.88 165.92 34.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.73 130.35 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.502 -0.749 . . . . 0.0 109.147 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.527 ' NE2' ' OE2' ' A' ' 3' ' ' GLU . 78.1 mt-30 -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.699 0.761 . . . . 0.0 109.886 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -70.97 -74.62 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.82 0.819 . . . . 0.0 110.055 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.6 t -94.63 136.01 35.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.72 138.52 57.45 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.75 0.786 . . . . 0.0 110.823 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.69 -11.94 69.29 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.4 t -97.41 113.28 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.286 -1.126 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.13 39.18 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.633 0.73 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -172.56 135.97 0.73 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 14' ' ' VAL . 62.1 m -92.18 -70.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.52 -0.738 . . . . 0.0 109.758 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 15' ' ' VAL . 58.5 t 54.32 162.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.415 -0.803 . . . . 0.0 110.704 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.535 ' N ' HG12 ' A' ' 14' ' ' VAL . 57.9 t -133.76 81.78 52.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.332 -0.855 . . . . 0.0 109.517 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.24 148.02 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.229 2.62 . . . . 0.0 112.615 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 58.7 mp0 -93.67 141.73 28.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.39 -0.818 . . . . 0.0 109.482 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.03 127.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.477 -0.765 . . . . 0.0 110.274 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 20' ' ' LEU . 48.2 mmm-85 -127.4 143.48 51.2 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 109.092 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -95.48 138.33 33.31 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.879 0.847 . . . . 0.0 110.378 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 t -134.54 144.18 47.85 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -123.43 142.16 51.27 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.931 0.872 . . . . 0.0 109.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 C--N 1.302 -1.458 0 CA-C-O 121.833 0.825 . . . . 0.0 110.472 -179.215 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.499 2.02 0 CA-C-O 121.93 0.871 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.81 143.24 36.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 40.6 ttm -155.96 144.39 20.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.292 -1.123 . . . . 0.0 109.933 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.62 144.93 36.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -116.94 149.18 40.59 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.606 0.717 . . . . 0.0 110.377 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -123.75 143.87 50.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -116.23 118.3 32.42 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.397 0.618 . . . . 0.0 109.628 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CE1' ' CE ' ' A' ' 52' ' ' MET . 63.9 m-85 -110.26 118.59 36.76 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.32 0.581 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.56 122.99 47.79 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.839 0.828 . . . . 0.0 110.094 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 39' ' ' THR . 85.9 mt-10 47.55 52.39 12.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.966 -0.459 . . . . 0.0 110.734 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 28.4 Cg_endo -63.57 9.09 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.57 2.18 . . . . 0.0 110.93 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 37' ' ' GLU . 71.4 p 51.01 19.21 0.63 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.764 -0.585 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.439 HG22 ' HG2' ' A' ' 38' ' ' PRO . 15.2 tt -97.4 -13.61 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -66.29 -38.84 88.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.471 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.94 -12.9 59.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.478 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -105.48 -16.31 14.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.366 -0.834 . . . . 0.0 108.861 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' ILE . 80.4 tt0 -171.43 139.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.52 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -74.67 158.6 33.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -64.91 -31.2 72.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.636 -0.665 . . . . 0.0 110.284 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 109.912 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -72.4 -17.13 61.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 109.278 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.72 118.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -149.25 42.77 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.6 139.5 4.53 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.472 ' CE ' ' CE1' ' A' ' 35' ' ' PHE . 45.1 ttm -130.66 128.72 41.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.685 -0.891 . . . . 0.0 108.668 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -111.28 125.79 54.2 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.842 0.829 . . . . 0.0 109.969 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -96.56 124.08 40.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.661 -0.649 . . . . 0.0 109.276 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.759 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -101.16 125.85 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.759 0.79 . . . . 0.0 109.785 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -108.92 -149.46 0.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.359 0.6 . . . . 0.0 109.641 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 58' ' ' GLU . 44.1 p-10 -64.1 -34.15 77.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.774 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.533 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 83.9 tt0 -156.63 -43.56 0.07 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 108.865 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.42 169.87 53.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.19 156.91 42.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -1.088 . . . . 0.0 110.142 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.475 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.3 mt -112.41 134.64 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.504 0.669 . . . . 0.0 109.295 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.829 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.3 mp -100.04 122.87 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.8 m -124.3 127.28 47.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.516 0.674 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -107.87 -4.16 18.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.5 mp0 -89.48 78.93 7.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.18 132.38 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.649 -0.657 . . . . 0.0 109.372 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.95 142.58 51.51 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.866 0.841 . . . . 0.0 109.639 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.45 142.0 15.82 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' CE ' ' OE1' ' A' ' 79' ' ' GLU . 68.0 mmtt -103.97 113.04 26.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.654 -0.909 . . . . 0.0 108.79 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 23.9 m-85 -98.34 144.63 27.52 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.847 0.832 . . . . 0.0 110.113 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' GLY . 96.5 mt -122.17 136.93 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 71' ' ' ILE . 59.5 m-80 -38.49 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.854 0.835 . . . . 0.0 110.421 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 149.3 -62.36 0.42 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -177.62 154.94 1.07 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.575 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.5 134.59 21.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.337 2.025 . . . . 0.0 112.447 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -147.05 -25.11 0.4 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.484 -0.76 . . . . 0.0 109.817 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.38 51.81 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 110.411 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.93 135.32 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' OE1' ' CE ' ' A' ' 69' ' ' LYS . 46.2 tt0 -116.81 151.57 36.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.71 144.97 32.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.564 -0.71 . . . . 0.0 109.529 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -117.54 129.06 55.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.553 -0.717 . . . . 0.0 109.975 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.98 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.764 0.792 . . . . 0.0 109.543 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 85' ' ' ASN . 27.2 mm -85.69 126.23 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.653 -0.654 . . . . 0.0 109.699 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.48 36.9 2.91 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.425 ' H ' HG22 ' A' ' 83' ' ' ILE . 5.4 m120 -63.46 -40.39 97.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.822 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -76.67 153.78 34.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.205 -0.934 . . . . 0.0 110.373 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -70.06 -48.78 20.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.467 -0.77 . . . . 0.0 110.497 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 40.9 Cg_exo -52.17 -37.87 70.38 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.9 1.733 . . . . 0.0 111.392 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 83' ' ' ILE . 97.6 mt-10 -64.55 -40.74 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.567 0.699 . . . . 0.0 109.851 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -61.69 -44.82 96.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.288 -0.882 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -60.99 -46.61 90.05 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.354 -0.841 . . . . 0.0 109.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -67.56 -39.52 84.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.668 0.747 . . . . 0.0 109.438 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -62.6 -48.14 80.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.408 -0.808 . . . . 0.0 110.07 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.92 -42.09 85.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.971 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -67.57 -44.52 78.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.901 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.22 -47.09 85.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.373 -0.829 . . . . 0.0 109.359 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.4 ttt -66.69 -39.15 87.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.659 0.743 . . . . 0.0 109.066 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.2 -51.53 60.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.0 109.686 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -68.23 -40.0 82.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -63.1 -48.63 77.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.502 -0.749 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 -35.15 89.44 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.53 94.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -1.108 . . . . 0.0 110.044 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.71 -56.53 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 109.819 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 109.742 -179.714 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 96' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.271 0.558 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.516 ' CD ' HE21 ' A' ' 5' ' ' GLN . 21.0 pt-20 -154.91 158.86 39.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.065 -1.022 . . . . 0.0 109.365 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -110.26 130.97 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.582 -0.699 . . . . 0.0 109.192 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.516 HE21 ' CD ' ' A' ' 3' ' ' GLU . 78.8 mt-30 -137.35 122.87 19.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.32 -39.32 85.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.845 . . . . 0.0 109.644 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 10' ' ' VAL . 72.5 m -127.02 153.25 46.17 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.711 0.767 . . . . 0.0 110.223 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -71.47 137.5 48.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.592 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.22 -2.66 71.71 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 7' ' ' SER . 69.2 t -70.84 -50.4 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -1.139 . . . . 0.0 109.682 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' VAL . . . 58.95 144.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 110.595 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 13' ' ' THR . 8.6 tm-20 58.14 -88.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.909 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.531 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 1.4 m 81.87 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -172.77 179.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.482 ' H ' HG22 ' A' ' 14' ' ' VAL . 96.3 t -115.13 86.35 13.84 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -78.25 154.15 28.38 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.984 2.456 . . . . 0.0 112.873 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -81.01 155.46 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -111.13 128.63 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.601 -0.687 . . . . 0.0 109.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.413 ' C ' HD22 ' A' ' 20' ' ' LEU . 79.2 ttt-85 -134.74 132.8 39.22 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -97.28 135.53 39.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.511 ' CB ' ' HZ3' ' A' ' 32' ' ' LYS . 40.3 m -123.99 150.0 45.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.25 142.9 50.53 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 109.823 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.523 -0.735 . . . . 0.0 110.089 -179.65 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.664 ' CB ' HD21 ' A' ' 85' ' ' ASN . 17.6 m . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.473 0.654 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.25 145.37 28.06 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -161.06 167.45 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.274 . . . . 0.0 109.147 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.14 143.71 38.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.351 -0.843 . . . . 0.0 108.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.511 ' HZ3' ' CB ' ' A' ' 21' ' ' SER . 64.4 mttp -111.83 146.37 37.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.74 131.69 54.21 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.36 128.3 53.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -112.25 114.95 28.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.49 -0.756 . . . . 0.0 109.428 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' GLU . 39.7 tp -95.4 122.43 38.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 36' ' ' LEU . 50.9 mm-40 39.45 57.25 6.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.751 -0.593 . . . . 0.0 111.034 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.69 145.78 91.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.449 2.099 . . . . 0.0 112.379 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 41' ' ' LEU . 64.0 p -69.46 -24.38 63.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.379 -0.826 . . . . 0.0 110.292 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 tp -59.44 1.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.068 . . . . 0.0 109.859 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 39' ' ' THR . 89.2 mt -91.24 -6.9 52.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 109.22 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.74 -26.63 13.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.457 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HZ1' HG22 ' A' ' 10' ' ' VAL . 52.0 mtmt -96.06 -75.89 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.275 -0.891 . . . . 0.0 110.018 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.05 151.71 20.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.423 -0.798 . . . . 0.0 110.395 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -74.71 163.1 28.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 p -66.53 -32.69 74.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.565 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.34 -18.55 63.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -79.31 -5.18 53.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.05 117.83 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.41 ' HB ' ' HE ' ' A' ' 64' ' ' ARG . 19.2 p -114.25 0.2 14.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.51 178.22 45.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.3 ttp -130.32 137.99 50.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.591 -0.947 . . . . 0.0 108.716 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.409 ' CE2' HD12 ' A' ' 62' ' ' ILE . 91.2 m-85 -106.18 123.12 47.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.32 -0.862 . . . . 0.0 110.035 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.521 ' C ' HD12 ' A' ' 55' ' ' ILE . 88.6 mt -99.15 125.95 44.82 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.803 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.9 mp -107.14 129.06 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.628 -0.67 . . . . 0.0 110.081 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 92' ' ' ARG . 41.9 p-10 -150.79 120.61 7.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.222 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' N ' HH12 ' A' ' 99' ' ' ARG . 66.4 t0 59.92 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.626 -0.671 . . . . 0.0 109.983 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' ASP . 81.1 tt0 -145.53 -38.64 0.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 108.886 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.83 171.85 53.38 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.5 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 2.2 pm0 -152.08 156.08 39.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.261 -1.14 . . . . 0.0 109.435 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.63 135.45 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.604 -0.685 . . . . 0.0 109.175 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.409 HD12 ' CE2' ' A' ' 53' ' ' TYR . 21.2 mm -101.78 125.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.3 m -123.45 125.97 45.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.568 -0.708 . . . . 0.0 109.258 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.41 ' HE ' ' HB ' ' A' ' 50' ' ' THR . 7.7 tpt180 -97.72 -7.98 29.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE1' HD11 ' A' ' 83' ' ' ILE . 96.2 mt-10 -83.86 84.0 7.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 110.017 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.78 134.57 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.452 -0.78 . . . . 0.0 109.452 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -125.57 142.09 51.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.57 -0.706 . . . . 0.0 109.263 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.58 140.39 14.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -107.23 102.77 12.06 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -102.32 146.1 28.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.588 -0.695 . . . . 0.0 109.776 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.7 mt -121.17 133.09 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 7.9 p30 -38.03 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 154.09 -60.86 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -177.04 150.9 0.91 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.331 . . . . 0.0 109.158 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -40.16 118.68 0.57 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.267 1.978 . . . . 0.0 111.861 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.404 ' CB ' HD12 ' A' ' 71' ' ' ILE . 12.2 m -111.22 -33.85 6.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.28 164.39 37.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 110.901 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 79' ' ' GLU . 94.4 mt -126.87 164.1 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.54 ' N ' HG22 ' A' ' 78' ' ' ILE . 15.5 tm-20 -140.12 148.5 41.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.463 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.76 143.81 35.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.501 -0.749 . . . . 0.0 108.981 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -122.87 130.33 52.73 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.567 -0.708 . . . . 0.0 109.582 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.3 t -110.81 129.71 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.492 -0.755 . . . . 0.0 109.414 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.45 HD11 ' OE1' ' A' ' 65' ' ' GLU . 30.0 mm -82.66 129.0 38.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 86.9 mt -117.52 38.02 3.72 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.664 HD21 ' CB ' ' A' ' 28' ' ' SER . 13.4 m120 -63.36 -40.67 97.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.377 -0.827 . . . . 0.0 109.332 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 151.06 35.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.27 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.586 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -73.2 -41.12 6.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.517 -0.739 . . . . 0.0 110.437 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 47.0 Cg_exo -56.08 -35.81 95.38 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.203 1.935 . . . . 0.0 111.632 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.57 -39.27 88.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.43 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.8 m95 -60.28 -42.12 94.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.63 -49.33 78.15 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.749 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.51 ' NH2' ' OD1' ' A' ' 56' ' ' ASP . 17.4 mmm180 -69.06 -39.77 78.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -61.68 -44.66 96.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.336 -0.853 . . . . 0.0 109.282 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.1 mmm -62.64 -41.49 99.06 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 108.881 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -64.89 -45.39 86.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.056 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.415 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 74.3 t80 -61.22 -45.85 92.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.415 ' SD ' ' C ' ' A' ' 97' ' ' MET . 2.0 tmt? -62.14 -41.54 98.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.481 -0.762 . . . . 0.0 109.725 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.3 -46.15 77.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.121 -0.987 . . . . 0.0 109.318 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.448 HH12 ' N ' ' A' ' 57' ' ' ASP . 83.5 mtp180 -65.63 -41.68 92.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.143 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.47 -48.42 79.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.47 -0.769 . . . . 0.0 109.695 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.85 -36.31 86.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.09 98.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.07 -42.16 66.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.347 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.484 -179.913 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.105 0.479 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -134.79 136.98 42.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.784 0.802 . . . . 0.0 109.651 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.4 129.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.2 135.8 51.16 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.792 0.806 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -106.76 -56.08 2.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.537 0.684 . . . . 0.0 109.394 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' LYS . 32.5 t -93.42 11.21 29.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 109.359 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.6 mttm 57.88 124.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.771 0.796 . . . . 0.0 110.76 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.72 11.15 64.2 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 10' ' ' VAL . 3.0 m -96.04 135.02 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.499 -1.0 . . . . 0.0 110.09 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -92.88 -159.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.437 0.637 . . . . 0.0 110.599 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 56.53 -76.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 11' ' ' ALA . 4.5 p 65.29 6.38 3.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.745 HG22 ' H ' ' A' ' 15' ' ' VAL . 12.8 p 44.07 177.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.891 0.853 . . . . 0.0 111.202 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.745 ' H ' HG22 ' A' ' 14' ' ' VAL . 81.9 t -115.14 91.8 28.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.878 . . . . 0.0 108.959 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.04 145.02 17.22 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.75 2.3 . . . . 0.0 112.673 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.12 149.7 39.0 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.571 -0.705 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.72 127.43 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.462 ' C ' HD12 ' A' ' 20' ' ' LEU . 59.1 ttp180 -132.06 119.84 21.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 19' ' ' ARG . 7.0 mp -104.79 132.5 50.96 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.9 m -127.37 152.29 47.68 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.378 0.608 . . . . 0.0 109.683 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.3 131.11 57.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.652 0.739 . . . . 0.0 109.559 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.767 -0.583 . . . . 0.0 110.132 -179.634 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.407 ' OG ' ' ND2' ' A' ' 85' ' ' ASN . 1.5 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.734 0.778 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.45 ' HA3' ' HE1' ' A' ' 90' ' ' TRP . . . -67.92 140.42 36.27 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.33 149.54 41.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.423 -1.045 . . . . 0.0 109.993 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.0 144.89 45.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 142.46 51.49 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.652 0.739 . . . . 0.0 109.953 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.93 137.95 54.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -120.68 125.34 47.45 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.688 0.756 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 32.3 m-85 -110.12 114.39 27.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 37' ' ' GLU . 51.8 tp -88.77 132.31 34.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.397 0.618 . . . . 0.0 110.565 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' LEU . 41.0 mt-10 32.76 68.81 0.91 Allowed Pre-proline 0 N--CA 1.5 2.032 0 CA-C-O 121.177 0.513 . . . . 0.0 111.127 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.52 140.71 92.74 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.66 2.24 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -83.14 -19.4 36.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.561 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.43 1.87 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 109.398 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' THR . 95.2 mt -81.85 -13.27 57.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.19 -13.78 21.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.37 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -107.84 -44.84 4.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -134.62 147.59 50.22 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.6 m -75.79 158.39 32.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.753 0.787 . . . . 0.0 110.535 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -64.98 -32.16 73.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -72.45 -17.47 61.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -88.73 -7.56 56.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.235 -0.915 . . . . 0.0 109.251 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.86 122.14 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.754 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -124.42 122.77 38.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 109.562 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.14 -171.06 18.95 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.5 ttp -141.45 133.64 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.56 -0.965 . . . . 0.0 108.961 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.421 ' CD2' HD12 ' A' ' 62' ' ' ILE . 70.3 m-85 -108.35 109.29 20.58 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.723 0.773 . . . . 0.0 109.726 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.69 111.47 23.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 mm -109.25 131.02 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.031 0.919 . . . . 0.0 110.366 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD1' ' CD2' ' A' ' 96' ' ' PHE . 2.7 m-20 -138.6 -160.73 1.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.486 0.66 . . . . 0.0 109.408 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -81.45 104.66 12.04 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.926 0.869 . . . . 0.0 110.319 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 60.62 89.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.643 0.735 . . . . 0.0 110.592 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.57 142.97 5.77 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.28 147.68 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.999 . . . . 0.0 109.108 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.77 133.7 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 109.578 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' CD2' ' A' ' 53' ' ' TYR . 30.2 mm -108.02 126.99 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 109.196 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 65' ' ' GLU . 76.3 m -125.4 125.66 43.75 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.64 0.733 . . . . 0.0 109.295 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -97.8 -1.77 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' H ' HG22 ' A' ' 63' ' ' THR . 96.8 mt-10 -85.26 75.24 10.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.457 -0.777 . . . . 0.0 109.426 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.0 t -126.7 133.83 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.679 0.752 . . . . 0.0 109.338 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -132.82 141.13 48.3 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.97 141.24 15.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -106.01 119.23 38.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.604 -0.939 . . . . 0.0 108.875 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -107.98 144.59 35.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.583 0.706 . . . . 0.0 110.064 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mm -121.05 131.38 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 57.66 14.92 2.61 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.453 0.644 . . . . 0.0 110.07 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -17.86 58.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -100.4 150.37 36.88 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.452 -1.028 . . . . 0.0 110.05 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.92 143.25 90.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.576 2.184 . . . . 0.0 112.129 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 m -149.12 -41.47 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.973 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.85 164.59 35.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.762 -1.211 . . . . 0.0 111.077 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.02 152.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -135.34 145.28 47.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.011 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.22 46.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.689 1.233 . . . . 0.0 110.004 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.4 m -126.65 131.62 51.4 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.671 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.9 t -119.62 130.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 mm -87.7 126.71 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.542 0.687 . . . . 0.0 109.919 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.64 41.64 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.407 ' ND2' ' OG ' ' A' ' 28' ' ' SER . 3.9 m120 -63.59 -39.75 95.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.73 . . . . 0.0 109.363 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.58 158.18 27.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.555 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 7.5 mm-40 -79.85 -41.42 1.43 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.802 -0.561 . . . . 0.0 110.832 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.8 Cg_exo -56.14 -37.5 96.39 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.823 1.682 . . . . 0.0 111.259 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -68.28 -39.04 82.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.637 -0.664 . . . . 0.0 109.433 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.45 ' HE1' ' HA3' ' A' ' 29' ' ' GLY . 1.8 m95 -61.32 -40.62 94.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.52 -44.56 95.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.189 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -69.55 -39.01 77.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 109.119 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.83 -45.97 91.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.37 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.6 ttt -62.56 -47.04 85.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.59 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -65.69 -41.72 92.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.461 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.48 ' CD2' ' OD1' ' A' ' 56' ' ' ASP . 3.4 m-85 -64.15 -46.89 82.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.2 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.8 ttp -63.03 -39.58 95.18 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -66.35 -40.45 89.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.507 -0.746 . . . . 0.0 109.443 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -65.88 -42.36 90.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 81.8 t80 -60.05 -46.47 89.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.482 -0.761 . . . . 0.0 109.269 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.31 94.73 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.52 72.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -1.053 . . . . 0.0 109.849 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.78 -42.78 69.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.518 -0.739 . . . . 0.0 109.763 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.412 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 62.0 m-20 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.561 -0.712 . . . . 0.0 109.569 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.563 ' CD ' HE21 ' A' ' 5' ' ' GLN . 43.7 tt0 -145.16 134.05 22.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 109.095 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.38 129.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.634 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.563 HE21 ' CD ' ' A' ' 3' ' ' GLU . 76.5 mt-30 -140.31 124.87 17.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.298 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.41 -2.88 58.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.133 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 8' ' ' LYS . 29.6 t -155.86 43.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.436 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' SER . 47.2 pttt 31.81 43.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.433 0.635 . . . . 0.0 110.853 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.43 26.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -97.8 132.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -1.11 . . . . 0.0 110.092 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.16 142.26 58.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 14' ' ' VAL . 57.4 mp0 -85.47 -116.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.597 -0.689 . . . . 0.0 110.379 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.3 p 57.35 0.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.566 ' H ' ' C ' ' A' ' 12' ' ' GLU . 74.9 t -67.91 -43.54 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.05 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 t 62.13 60.43 2.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.733 -0.604 . . . . 0.0 109.869 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -68.61 149.06 73.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.662 2.241 . . . . 0.0 112.256 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.82 154.09 23.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 110.087 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.88 132.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -127.63 140.69 51.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.14 143.0 43.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.604 -0.685 . . . . 0.0 109.684 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -149.92 151.86 34.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.042 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.61 133.58 55.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.688 0.756 . . . . 0.0 109.185 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.6 0.714 . . . . 0.0 110.724 -179.151 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.584 ' CB ' HD22 ' A' ' 85' ' ' ASN . 3.0 p . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 121.642 0.734 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.25 145.71 49.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.3 ttp -141.45 150.06 41.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -1.045 . . . . 0.0 109.796 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.35 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.444 -0.785 . . . . 0.0 109.01 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -125.61 140.72 52.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.541 -0.724 . . . . 0.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.53 119.33 38.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -95.99 124.43 39.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 109.138 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.92 124.8 52.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.644 -0.66 . . . . 0.0 109.709 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.8 tp -107.79 121.65 45.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.657 -0.652 . . . . 0.0 109.286 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 40.6 mt-10 42.65 55.43 10.39 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 110.315 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 36.0 Cg_endo -66.71 151.25 82.97 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.919 2.412 . . . . 0.0 112.749 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -84.28 90.85 7.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.638 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' GLU . 10.5 tp -173.48 -27.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -40.35 96.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.33 79.99 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 108.891 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -89.19 -69.58 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.619 -0.676 . . . . 0.0 109.286 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 40' ' ' ILE . 97.8 mt-10 -110.94 134.65 52.41 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.511 -0.743 . . . . 0.0 109.67 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -65.85 159.86 24.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.659 0.743 . . . . 0.0 110.436 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.435 ' H ' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -66.07 -33.46 75.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.648 -0.658 . . . . 0.0 109.65 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.2 -19.07 63.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.484 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -82.59 -5.62 58.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.1 mt -98.96 117.25 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.389 -0.819 . . . . 0.0 109.776 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 50' ' ' THR . 88.5 m -102.6 -7.11 22.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.63 -179.75 42.85 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.142 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.8 ttp -128.92 145.17 51.3 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.626 -0.926 . . . . 0.0 109.222 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.37 122.36 46.84 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.406 -0.809 . . . . 0.0 110.425 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 55' ' ' ILE . 52.4 mt -98.89 109.5 22.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.6 mp -105.47 163.15 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.041 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 55' ' ' ILE . 40.4 t0 -162.46 -179.2 6.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.541 -0.724 . . . . 0.0 109.407 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.481 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 97.8 m-20 -70.07 -15.64 63.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -169.55 97.71 0.32 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.374 -0.829 . . . . 0.0 109.285 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.3 146.15 8.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.78 144.45 23.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.5 mt -124.08 131.51 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.767 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.0 mp -101.97 132.16 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.0 m -120.32 123.32 42.84 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -97.79 -1.57 42.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.64 72.29 7.77 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.77 132.78 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.3 144.01 51.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.26 137.97 14.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.19 128.12 53.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.634 -0.921 . . . . 0.0 108.98 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -102.47 122.29 44.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.93 140.05 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 58.96 32.92 22.71 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.35 23.66 74.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -151.06 148.32 22.47 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.078 -1.248 . . . . 0.0 109.435 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.85 107.39 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.198 1.932 . . . . 0.0 111.228 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m -131.45 -10.25 3.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.538 -0.727 . . . . 0.0 110.059 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.71 154.47 41.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.957 -1.089 . . . . 0.0 110.306 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.7 mt -131.03 159.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 16.1 tm-20 -140.7 149.31 42.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.267 -0.895 . . . . 0.0 109.489 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.482 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.13 142.7 35.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.399 -0.813 . . . . 0.0 109.055 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -120.63 132.61 55.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.707 -0.621 . . . . 0.0 109.669 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.68 132.17 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.1 mm -95.38 122.5 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.336 -0.853 . . . . 0.0 110.116 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.4 mt -101.12 79.25 1.99 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.584 HD22 ' CB ' ' A' ' 28' ' ' SER . 11.9 m120 -87.3 -5.6 58.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.497 -0.752 . . . . 0.0 110.048 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 t -115.72 134.33 55.14 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.731 0.776 . . . . 0.0 109.764 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.0 mp0 -58.85 -60.65 9.79 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.752 -0.592 . . . . 0.0 110.579 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 3.0 Cg_endo -49.52 -21.52 5.25 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.993 1.795 . . . . 0.0 111.715 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -65.92 -38.17 87.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.694 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -58.67 -38.19 77.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.329 -0.857 . . . . 0.0 109.749 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -60.39 -44.2 95.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -67.51 -40.67 85.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.842 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.6 -48.9 78.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.359 -0.838 . . . . 0.0 109.794 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.08 -40.75 78.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CG ' HH12 ' A' ' 99' ' ' ARG . 63.3 ttm-85 -63.37 -49.11 75.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.797 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.519 ' CE2' ' OD2' ' A' ' 56' ' ' ASP . 6.2 m-85 -66.31 -42.02 88.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.468 -0.77 . . . . 0.0 109.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 59.4 tpp -64.98 -34.07 77.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.629 -0.669 . . . . 0.0 109.267 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.65 -54.52 41.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.136 -0.978 . . . . 0.0 110.156 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.411 HH12 ' CG ' ' A' ' 95' ' ' ARG . 95.9 mtm-85 -65.69 -46.83 77.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.947 . . . . 0.0 110.145 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -62.95 -44.78 95.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.21 -33.89 88.44 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.09 98.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.322 -1.105 . . . . 0.0 109.529 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.534 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 80.2 mm-40 -71.27 -56.35 6.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 103' ' ' GLU . 34.3 m120 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.218 -0.926 . . . . 0.0 109.811 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.628 0.728 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -153.14 149.26 27.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mp -110.34 130.45 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.469 0.652 . . . . 0.0 109.995 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -129.56 129.26 44.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.688 0.756 . . . . 0.0 109.513 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -88.09 -5.94 58.19 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 m -157.45 -168.85 2.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.6 133.74 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.865 0.84 . . . . 0.0 111.086 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 42.25 71.17 0.4 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.4 -47.92 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -1.001 . . . . 0.0 108.727 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.73 82.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.079 0.942 . . . . 0.0 109.152 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.11 124.22 30.89 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.738 0.78 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -96.4 -14.92 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 15' ' ' VAL . 59.3 t -55.66 159.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.292 -0.88 . . . . 0.0 110.091 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' N ' HG12 ' A' ' 14' ' ' VAL . 12.4 t -112.39 81.42 4.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.534 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.6 148.76 54.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.611 2.208 . . . . 0.0 112.554 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 18' ' ' VAL . 7.0 tm-20 -84.37 155.17 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.592 -0.692 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 55.4 t -117.62 129.62 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.561 0.696 . . . . 0.0 109.768 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -128.68 137.88 51.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.24 131.18 47.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.585 -0.697 . . . . 0.0 109.351 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 m -108.01 149.09 28.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.612 -0.68 . . . . 0.0 109.619 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.05 141.53 46.15 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.654 0.74 . . . . 0.0 109.589 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 p . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.649 . . . . 0.0 109.538 179.772 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.821 0.82 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.89 143.56 41.91 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttp -165.09 153.02 11.46 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -1.052 . . . . 0.0 109.663 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 21' ' ' SER . . . -142.89 153.18 42.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.653 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.06 147.55 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.452 0.644 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.32 136.85 54.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -114.27 122.05 45.55 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.456 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.19 114.28 27.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.0 tp -95.87 121.22 37.37 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.708 0.766 . . . . 0.0 110.027 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 48.55 60.21 15.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.982 -0.449 . . . . 0.0 110.623 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 40' ' ' ILE . 38.1 Cg_endo -69.68 1.36 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.346 2.031 . . . . 0.0 110.479 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m 54.74 5.03 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.28 0.562 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 38' ' ' PRO . 2.8 tp -73.48 -1.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 109.655 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.7 mt -84.42 -9.55 58.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 108.953 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.8 -18.6 22.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.332 -0.855 . . . . 0.0 109.382 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.45 -47.15 4.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.32 -0.863 . . . . 0.0 109.089 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.78 153.09 48.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.33 -0.856 . . . . 0.0 110.148 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 t -80.69 167.04 20.47 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.694 0.759 . . . . 0.0 110.373 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -62.93 -39.92 96.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.642 0.734 . . . . 0.0 109.423 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 50.0 p-10 -70.98 -21.91 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.524 -0.735 . . . . 0.0 109.682 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 96.4 m-20 -80.26 -6.23 57.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.95 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.22 123.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.984 -1.073 . . . . 0.0 109.939 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.418 ' OG1' ' CZ ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -116.15 91.01 3.47 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 0.0 109.369 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.93 174.71 37.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -127.62 149.15 50.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.709 -0.877 . . . . 0.0 109.375 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.79 108.84 20.56 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.621 0.724 . . . . 0.0 109.726 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.35 115.81 30.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.89 125.15 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.53 0.681 . . . . 0.0 109.602 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -104.01 -167.36 1.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.592 0.71 . . . . 0.0 110.376 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 33.2 p-10 -77.78 -5.23 50.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.728 -0.607 . . . . 0.0 109.658 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -108.75 -94.18 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.417 -0.802 . . . . 0.0 109.884 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' H ' ' NH1' ' A' ' 92' ' ' ARG . . . -106.12 -147.59 15.16 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -137.38 155.09 49.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.98 . . . . 0.0 110.091 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.45 138.86 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.407 0.622 . . . . 0.0 109.804 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.0 mm -110.34 129.27 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.8 m -120.18 123.85 44.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 109.581 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.418 ' CZ ' ' OG1' ' A' ' 50' ' ' THR . 18.2 tpt85 -98.82 -12.6 20.69 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -84.83 79.3 9.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.441 -0.787 . . . . 0.0 109.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.93 133.21 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.403 0.621 . . . . 0.0 109.476 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.05 143.25 50.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.73 0.776 . . . . 0.0 109.727 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.79 140.42 15.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -101.52 121.58 42.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.984 . . . . 0.0 109.185 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -104.62 119.33 38.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.631 0.729 . . . . 0.0 110.121 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.31 138.84 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.42 33.75 20.65 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.603 0.716 . . . . 0.0 110.192 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.24 27.55 73.07 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -155.1 148.19 18.22 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.143 -1.21 . . . . 0.0 109.523 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.07 113.96 3.23 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.6 2.2 . . . . 0.0 111.926 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m -126.98 -15.69 5.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.22 158.26 43.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 110.269 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -129.01 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.378 0.609 . . . . 0.0 109.463 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -129.59 148.05 51.45 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.604 0.716 . . . . 0.0 109.689 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.4 145.94 39.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.21 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -121.47 131.71 54.31 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.432 0.634 . . . . 0.0 109.946 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.08 129.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.612 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.4 mp -82.15 127.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.533 0.682 . . . . 0.0 109.655 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.494 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 84.5 mt -120.68 33.77 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.68 -40.04 95.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.529 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.7 m -70.47 145.61 50.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.044 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.502 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -71.58 -47.67 12.56 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.303 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 43.7 Cg_exo -54.36 -33.67 77.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.123 1.882 . . . . 0.0 111.819 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -66.04 -37.24 85.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.578 -0.701 . . . . 0.0 109.872 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.494 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.1 m95 -60.97 -39.81 91.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 109.944 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.58 -51.1 69.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.488 ' NH1' ' H ' ' A' ' 59' ' ' GLY . 63.2 ttm-85 -68.27 -42.68 79.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.43 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.29 -43.25 99.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ttt -59.02 -41.98 89.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.308 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.36 -40.48 93.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.523 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.55 -48.21 82.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.266 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.8 ttt -67.86 -39.09 83.81 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.646 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -64.3 -47.95 77.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.453 -0.779 . . . . 0.0 109.434 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -67.23 -42.34 84.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.825 . . . . 0.0 109.546 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.6 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 60.6 t80 -60.94 -46.18 91.73 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.801 0.81 . . . . 0.0 109.314 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.09 -30.91 79.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.38 93.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 109.812 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -89.24 -16.89 30.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.6 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 68.7 m-80 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.409 ' HB2' ' OD2' ' A' ' 56' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.59 0.71 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -155.39 138.98 15.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -0.814 . . . . 0.0 109.723 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.2 130.51 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.672 0.748 . . . . 0.0 109.399 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 10' ' ' VAL . 16.8 pt20 -149.05 145.71 27.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.511 -0.743 . . . . 0.0 109.674 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 53' ' ' TYR . 90.2 m-85 -63.39 -45.47 90.93 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.59 0.709 . . . . 0.0 109.404 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 m -104.99 158.06 16.8 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.672 0.748 . . . . 0.0 110.322 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -68.54 133.28 48.32 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.834 0.826 . . . . 0.0 110.507 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 45.37 86.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 44.4 t -101.96 -77.66 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -1.026 . . . . 0.0 109.296 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' N ' HG12 ' A' ' 10' ' ' VAL . . . -178.06 -99.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.458 -0.776 . . . . 0.0 110.068 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.7 143.03 31.98 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 110.805 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' VAL . 70.9 m -75.72 -17.88 59.77 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.321 0.581 . . . . 0.0 109.968 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' THR . 3.7 t 55.51 158.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.485 -0.76 . . . . 0.0 110.572 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.25 74.53 41.83 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.299 -0.875 . . . . 0.0 109.892 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.05 147.36 23.72 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.921 2.414 . . . . 0.0 112.522 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -74.86 161.63 29.38 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.767 0.794 . . . . 0.0 110.045 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -113.06 131.33 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.543 0.687 . . . . 0.0 109.324 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.425 ' C ' HD22 ' A' ' 20' ' ' LEU . 83.7 mtp180 -128.52 139.9 52.08 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.678 0.751 . . . . 0.0 109.579 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.1 mm? -97.42 135.22 39.61 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.641 0.734 . . . . 0.0 109.64 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.9 t -134.57 142.95 47.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.539 0.685 . . . . 0.0 109.714 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -100.77 159.08 15.48 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.054 0.931 . . . . 0.0 110.371 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.302 -1.468 0 CA-C-O 121.652 0.739 . . . . 0.0 110.295 -179.565 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.442 ' CB ' HD22 ' A' ' 85' ' ' ASN . 4.8 p . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.74 0.781 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.84 172.85 18.3 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.0 ptp -159.26 175.69 13.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -1.132 . . . . 0.0 109.679 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.54 143.91 45.97 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' NZ ' ' OG1' ' A' ' 81' ' ' THR . 68.3 mttm -117.18 142.9 46.45 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.626 0.727 . . . . 0.0 110.166 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.86 128.12 54.95 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -103.76 131.87 50.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.577 -0.702 . . . . 0.0 109.627 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -112.43 126.44 55.3 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.0 tp -100.68 125.32 47.09 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.681 0.753 . . . . 0.0 110.677 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 37.04 58.17 3.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.22 150.68 81.74 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.574 2.182 . . . . 0.0 112.525 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -76.5 -18.69 58.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.746 -0.596 . . . . 0.0 110.219 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.78 1.52 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.03 . . . . 0.0 109.707 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.0 mt -89.28 -8.94 52.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.027 -1.045 . . . . 0.0 109.169 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.98 -26.88 11.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.414 -0.804 . . . . 0.0 109.263 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.47 -74.34 0.45 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -0.921 . . . . 0.0 109.9 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.05 143.67 36.46 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.87 0.843 . . . . 0.0 110.408 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -76.5 169.4 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.918 0.866 . . . . 0.0 110.52 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.5 p -65.36 -31.09 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.02 -36.61 84.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.67 -8.99 58.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.4 mt -101.6 118.35 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.238 -0.914 . . . . 0.0 109.989 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.38 26.04 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.452 ' N ' HG21 ' A' ' 66' ' ' VAL . . . -176.99 164.97 34.72 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 44.3 ttm -135.63 133.58 38.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -1.09 . . . . 0.0 109.499 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 6' ' ' PHE . 4.3 m-85 -112.53 120.97 43.45 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.017 0.913 . . . . 0.0 109.723 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.489 ' C ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -96.37 110.36 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.753 ' N ' HD12 ' A' ' 55' ' ' ILE . 1.9 mp -98.81 126.99 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.508 -0.745 . . . . 0.0 109.623 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 66.4 t0 -172.5 134.99 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.557 0.694 . . . . 0.0 109.97 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 59' ' ' GLY . 97.8 m-20 57.97 42.86 22.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.974 -0.454 . . . . 0.0 110.077 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 67.82 -40.94 0.42 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.556 0.694 . . . . 0.0 109.543 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -69.66 153.48 52.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.62 149.03 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.463 -1.021 . . . . 0.0 109.91 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -119.36 133.34 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.532 0.682 . . . . 0.0 109.195 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mm -102.83 122.28 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.732 . . . . 0.0 109.698 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 65' ' ' GLU . 98.0 m -123.41 126.07 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.63 0.729 . . . . 0.0 109.395 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -101.24 41.24 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.201 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' H ' HG22 ' A' ' 63' ' ' THR . 96.2 mt-10 -133.05 86.44 2.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG21 ' N ' ' A' ' 51' ' ' GLY . 1.1 m -121.62 132.18 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -123.21 134.36 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.833 0.825 . . . . 0.0 109.021 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.7 133.37 11.54 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -105.76 110.4 22.69 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.631 -0.923 . . . . 0.0 108.604 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -104.42 139.75 38.91 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.423 0.63 . . . . 0.0 109.62 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.1 mt -117.96 126.15 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.58 0.705 . . . . 0.0 109.487 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.75 33.2 22.57 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.44 78.81 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 ttp85 -135.42 120.07 13.45 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.35 -1.088 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.55 138.2 32.0 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.321 2.014 . . . . 0.0 112.416 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -147.93 -34.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.32 158.96 44.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.841 -1.162 . . . . 0.0 110.533 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.0 mt -131.02 142.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -124.99 148.61 48.37 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.642 0.734 . . . . 0.0 109.464 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.88 147.7 41.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.505 ' OG1' ' NZ ' ' A' ' 32' ' ' LYS . 86.9 m -118.66 130.06 55.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.5 125.16 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.677 0.751 . . . . 0.0 109.531 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 25.0 mm -84.06 131.94 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 82.5 mt -121.72 47.94 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.442 HD22 ' CB ' ' A' ' 28' ' ' SER . 11.1 m120 -64.65 -40.38 95.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.41 -0.806 . . . . 0.0 109.447 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -74.19 145.32 44.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.488 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -73.34 -47.39 7.63 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.481 -0.762 . . . . 0.0 110.203 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 44.6 Cg_exo -54.72 -32.72 77.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.881 1.721 . . . . 0.0 111.306 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -67.03 -38.19 85.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.608 -0.682 . . . . 0.0 109.399 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.2 m95 -59.76 -41.46 91.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -62.73 -46.48 87.87 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -70.15 -41.69 73.51 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.802 0.81 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.36 -44.86 96.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 109.376 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.0 ttm -61.21 -41.84 97.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -66.94 -39.59 87.36 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.56 -46.52 85.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.296 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 62.6 ttp -66.45 -38.42 87.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.6 0.714 . . . . 0.0 109.663 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -61.76 -42.24 98.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.832 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.24 -39.46 86.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.73 -38.5 94.53 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.1 92.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -1.18 . . . . 0.0 110.371 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.75 -56.07 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.046 . . . . 0.0 109.961 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 . . . . . 0 N--CA 1.499 1.988 0 O-C-N 120.95 -1.094 . . . . 0.0 109.444 179.967 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.557 0.694 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -154.58 160.79 41.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.588 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.1 129.65 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -129.4 129.29 44.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 109.884 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.08 -5.67 59.16 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.4 t -161.1 -63.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.497 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 10' ' ' VAL . 53.7 mtpt -143.02 -160.82 1.15 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.91 5.22 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 8' ' ' LYS . 74.5 t -69.07 134.85 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.314 -1.109 . . . . 0.0 110.344 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 64.43 92.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.491 0.662 . . . . 0.0 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -130.33 -22.22 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -76.22 -1.0 24.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 108.924 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.95 136.52 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.551 -0.718 . . . . 0.0 109.898 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.46 79.41 29.08 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 109.272 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.04 153.21 32.2 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.918 2.412 . . . . 0.0 112.793 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -89.31 138.37 31.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.424 -0.797 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.7 t -88.26 131.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -127.37 144.43 51.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.621 0.724 . . . . 0.0 109.48 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.73 132.39 54.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.8 t -121.36 152.57 38.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.749 -0.594 . . . . 0.0 109.509 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -133.3 153.03 51.93 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.881 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 97.4 p . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.734 . . . . 0.0 109.426 -179.707 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.644 0.735 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.88 141.26 28.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttm -153.34 151.43 29.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -1.171 . . . . 0.0 109.531 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.88 148.15 36.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.31 146.25 50.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.11 140.23 49.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -118.88 125.67 50.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.28 121.39 45.17 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.0 tp -95.62 123.17 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.449 0.643 . . . . 0.0 109.985 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 36' ' ' LEU . 13.9 mm-40 37.35 57.69 4.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-O 120.966 0.413 . . . . 0.0 111.096 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.95 148.98 71.46 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.254 1.969 . . . . 0.0 111.795 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 t -75.92 -13.25 60.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 110.314 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.57 -1.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 109.738 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 78' ' ' ILE . 84.6 mt -90.71 -12.69 35.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.08 -21.88 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -87.47 -75.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.63 160.85 14.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.855 0.836 . . . . 0.0 110.562 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.4 p -76.17 165.77 24.43 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.742 0.782 . . . . 0.0 110.762 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.407 ' HA ' HD12 ' A' ' 49' ' ' ILE . 20.9 p -65.84 -31.53 72.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.489 0.661 . . . . 0.0 109.882 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.27 -18.26 63.13 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -93.59 -6.69 46.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 49' ' ' ILE . 86.8 mt -84.53 -7.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.142 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' ILE . 20.1 m -39.6 123.01 1.45 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.686 0.755 . . . . 0.0 110.834 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.27 160.26 32.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.6 ttm -135.19 143.94 46.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 62' ' ' ILE . 83.0 m-85 -118.12 109.82 16.87 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 0.0 109.522 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.04 131.44 34.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.176 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -121.37 133.69 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.503 0.668 . . . . 0.0 110.136 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' GLU . 97.0 m-20 -133.29 43.21 2.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 44.82 17.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.386 -0.821 . . . . 0.0 109.53 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' ASP . 79.8 tt0 -170.4 83.4 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.183 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.58 157.44 32.46 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.26 155.54 45.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -1.097 . . . . 0.0 109.829 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.8 132.62 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 53' ' ' TYR . 32.7 mm -103.31 120.7 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 63' ' ' THR . 4.3 t -127.81 125.49 39.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.46 0.648 . . . . 0.0 109.401 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -98.74 50.37 0.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -138.81 81.66 1.86 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.04 136.05 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.629 . . . . 0.0 109.461 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -128.74 134.85 48.56 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.556 -0.715 . . . . 0.0 109.572 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.1 143.45 16.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -96.71 101.07 12.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.467 -1.02 . . . . 0.0 108.366 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -91.91 152.84 19.87 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.621 0.724 . . . . 0.0 110.514 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 73' ' ' GLY . 89.3 mt -135.87 148.3 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.35 -0.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.971 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 71' ' ' ILE . . . -127.88 62.24 0.63 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 73' ' ' GLY . 68.9 ttp85 60.12 134.87 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.805 -0.82 . . . . 0.0 110.633 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -42.79 140.06 3.08 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.961 1.774 . . . . 0.0 112.102 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m -130.03 -16.84 3.58 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 166.69 30.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.708 -1.245 . . . . 0.0 110.72 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.552 HD11 HD21 ' A' ' 41' ' ' LEU . 83.7 mt -134.92 154.12 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -133.45 151.82 51.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.53 -0.731 . . . . 0.0 110.438 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.89 34.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.7 m -125.11 127.9 47.6 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.671 -0.643 . . . . 0.0 109.616 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.63 128.87 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.6 mp -87.21 127.59 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.654 -0.654 . . . . 0.0 109.579 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 82.5 mt -108.72 36.73 2.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.61 ' H ' HG22 ' A' ' 83' ' ' ILE . 93.0 m-20 -63.48 -39.37 94.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -68.13 153.49 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.421 -0.8 . . . . 0.0 110.297 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.489 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 5.5 mp0 -71.27 -57.3 4.71 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.713 -0.617 . . . . 0.0 110.774 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 11.7 Cg_endo -54.8 -33.28 80.45 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.653 1.568 . . . . 0.0 111.617 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.61 -39.88 88.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.737 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -64.53 -44.95 89.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.917 . . . . 0.0 109.773 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -62.46 -46.42 88.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.284 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -65.67 -38.4 89.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.498 -0.751 . . . . 0.0 109.275 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -62.22 -43.81 98.0 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.521 -0.737 . . . . 0.0 109.51 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.5 ttm -61.4 -38.14 85.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.823 . . . . 0.0 109.229 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.98 -38.71 92.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 109.236 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -61.24 -45.18 95.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 91.8 mtp -63.75 -41.23 98.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -71.29 -46.51 60.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -67.65 -41.89 83.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.474 -0.766 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 104' ' ' ASN . 59.3 t80 -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.143 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 -28.8 71.93 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.23 72.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.992 . . . . 0.0 110.168 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 104' ' ' ASN . 11.8 pt-20 -71.27 -48.74 49.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.702 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 103' ' ' GLU . 3.4 p-10 . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.747 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.493 ' N ' ' OE2' ' A' ' 103' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.507 0.67 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -155.64 148.7 24.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.819 . . . . 0.0 109.175 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.2 mt -108.72 128.48 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.148 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 9' ' ' GLY . 5.8 pt20 -146.31 155.08 42.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.227 -0.921 . . . . 0.0 109.634 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -111.18 -37.44 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 t -90.64 22.97 3.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.921 . . . . 0.0 109.376 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.416 ' NZ ' ' CE2' ' A' ' 53' ' ' TYR . 68.0 mttm 50.78 33.78 9.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 109.663 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 5' ' ' GLN . . . 157.58 40.73 0.02 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 98.8 t -57.36 -86.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -1.031 . . . . 0.0 109.925 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 179.23 -105.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.629 0.728 . . . . 0.0 109.474 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.92 146.59 46.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.473 -0.767 . . . . 0.0 110.489 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 14' ' ' VAL . 49.1 m -76.07 -11.01 59.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 108.999 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 15' ' ' VAL . 55.4 t 53.06 165.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.497 0.665 . . . . 0.0 110.711 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.592 ' N ' HG12 ' A' ' 14' ' ' VAL . 3.5 m -123.89 75.08 57.08 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.555 -0.715 . . . . 0.0 109.232 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 151.94 35.36 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.558 2.172 . . . . 0.0 112.437 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.63 152.55 25.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.512 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.62 130.76 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.055 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -132.27 141.16 48.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -109.07 130.54 55.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.195 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 t -126.98 133.26 50.62 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -127.5 135.94 51.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.626 0.727 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.8 m . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.548 -0.72 . . . . 0.0 110.474 -179.45 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.498 1.955 0 CA-C-O 121.536 0.684 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.539 ' N ' ' ND2' ' A' ' 85' ' ' ASN . . . -79.58 151.87 34.84 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.9 ptm -153.6 167.93 27.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.247 -1.149 . . . . 0.0 109.364 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.76 145.17 37.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.481 -0.762 . . . . 0.0 109.036 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -112.07 143.23 43.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.92 131.83 52.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -105.49 126.22 51.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.406 -0.808 . . . . 0.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -109.43 116.21 31.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.641 -0.662 . . . . 0.0 109.257 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.5 tp -100.9 118.32 36.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.561 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 39' ' ' THR . 57.4 mt-10 43.31 59.65 11.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HG2' HG22 ' A' ' 40' ' ' ILE . 37.4 Cg_endo -68.85 13.9 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.078 1.852 . . . . 0.0 110.202 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 37' ' ' GLU . 72.6 p 48.88 32.17 3.61 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.273 0.559 . . . . 0.0 110.05 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.4 HG22 ' HG2' ' A' ' 38' ' ' PRO . 11.1 tp -99.06 -22.06 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.181 -0.95 . . . . 0.0 109.14 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.7 -40.7 92.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -23.2 67.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -98.22 -52.21 3.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -136.89 149.1 47.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.33 -0.856 . . . . 0.0 110.214 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 p -73.0 163.51 28.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.6 p -66.42 -30.72 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.485 -0.759 . . . . 0.0 109.444 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.22 -16.52 63.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.629 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -85.34 -7.81 58.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.2 mt -100.96 116.33 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -0.774 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 p -125.5 15.01 8.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' N ' HG21 ' A' ' 66' ' ' VAL . . . -176.98 160.34 27.37 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -118.03 131.69 56.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.679 -0.895 . . . . 0.0 108.83 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.416 ' CE2' ' NZ ' ' A' ' 8' ' ' LYS . 94.9 m-85 -104.42 112.7 25.85 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.639 0.733 . . . . 0.0 109.721 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.6 mt -95.55 127.63 41.75 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.71 128.76 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.498 0.666 . . . . 0.0 109.504 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASP . 44.5 t0 -155.56 118.11 4.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.53 -0.731 . . . . 0.0 109.853 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 94.8 m-20 40.1 61.15 1.58 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.833 -0.542 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 68.81 -41.44 0.47 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -66.66 138.77 36.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.69 148.81 32.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -1.165 . . . . 0.0 109.997 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.7 mt -122.48 130.85 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.803 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.8 mp -107.58 129.52 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.49 -0.756 . . . . 0.0 109.57 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -128.73 128.09 43.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.588 -0.695 . . . . 0.0 109.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -90.78 4.94 50.29 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.31 78.67 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG21 ' N ' ' A' ' 51' ' ' GLY . 1.6 m -120.92 132.95 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.545 -0.722 . . . . 0.0 109.669 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -123.19 137.07 54.98 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.15 127.22 9.18 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -96.39 126.98 41.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -1.109 . . . . 0.0 108.907 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -102.46 138.29 39.58 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.374 0.607 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mm -115.37 132.46 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 57.5 32.37 21.71 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.496 0.665 . . . . 0.0 109.517 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -12.03 26.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -112.72 149.14 40.72 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.409 -1.053 . . . . 0.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.2 142.28 86.0 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.335 2.023 . . . . 0.0 112.215 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 m -157.95 -28.97 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.95 44.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.054 . . . . 0.0 110.207 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.4 153.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.522 0.677 . . . . 0.0 109.601 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -132.68 152.65 51.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.17 44.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 109.237 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.4 m -125.17 129.97 51.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.57 130.92 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.224 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.92 121.46 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.47 -0.769 . . . . 0.0 109.859 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.403 HD12 ' CZ2' ' A' ' 90' ' ' TRP . 55.8 mt -98.14 -75.63 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.937 0.875 . . . . 0.0 109.121 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.539 ' ND2' ' N ' ' A' ' 29' ' ' GLY . 3.2 m120 56.31 32.12 19.85 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.72 -0.613 . . . . 0.0 109.823 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 m -153.49 140.58 19.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.009 . . . . 0.0 109.335 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.504 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 9.6 mm-40 -62.38 -58.21 18.57 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.74 . . . . 0.0 110.32 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 13.0 Cg_endo -54.3 -36.04 85.53 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.955 1.77 . . . . 0.0 111.451 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -68.92 -38.76 79.76 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.349 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.403 ' CZ2' HD12 ' A' ' 84' ' ' LEU . 17.0 m95 -62.02 -46.33 89.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -42.65 99.65 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.199 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.77 -44.01 91.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.501 -0.749 . . . . 0.0 109.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.16 -44.01 96.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 0.0 110.193 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 40.0 ttm -58.0 -43.8 86.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.316 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.507 HH21 ' NH2' ' A' ' 99' ' ' ARG . 79.5 mtp85 -65.79 -38.3 88.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.09 -46.71 86.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.399 -0.813 . . . . 0.0 110.31 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.27 -39.28 94.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.838 1.304 . . . . 0.0 109.175 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -45.63 79.95 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.337 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 99.7 mtt180 -63.99 -41.9 97.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.092 -1.005 . . . . 0.0 109.17 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.0 -44.85 91.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.548 -0.72 . . . . 0.0 109.16 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.0 91.44 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.13 -38.15 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -1.158 . . . . 0.0 109.469 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.493 ' OE2' ' N ' ' A' ' 2' ' ' ALA . 96.2 mt-10 -68.74 -36.27 78.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 110.024 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 p30 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.749 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.94 160.17 42.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.904 0.859 . . . . 0.0 110.386 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.0 mt -108.79 128.43 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.696 0.76 . . . . 0.0 109.449 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.471 ' HG2' HD13 ' A' ' 55' ' ' ILE . 18.2 pt20 -148.51 149.65 32.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.926 0.87 . . . . 0.0 109.897 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.53 -65.75 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 m -75.35 164.76 26.08 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.587 0.708 . . . . 0.0 109.821 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.98 29.21 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.482 0.658 . . . . 0.0 109.672 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 10' ' ' VAL . . . -159.4 -44.28 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 9' ' ' GLY . 28.5 m 31.46 -135.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.192 0.52 . . . . 0.0 110.642 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.95 -139.4 0.05 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.592 0.711 . . . . 0.0 109.597 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.62 144.08 56.6 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.464 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 p -68.9 139.14 55.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.753 0.787 . . . . 0.0 110.559 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 15' ' ' VAL . 1.6 t -87.22 -145.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.416 0.627 . . . . 0.0 110.815 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.567 ' H ' HG12 ' A' ' 14' ' ' VAL . 17.5 t -146.45 66.27 10.91 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.649 -0.657 . . . . 0.0 109.242 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.92 149.75 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.024 2.483 . . . . 0.0 112.605 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.4 145.84 25.77 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.89 0.853 . . . . 0.0 109.921 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 t -103.71 131.65 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.839 0.828 . . . . 0.0 110.421 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -135.26 141.52 45.75 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.307 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 93' ' ' PHE . 84.6 mt -103.93 125.53 50.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.867 0.842 . . . . 0.0 110.081 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 m -94.91 164.19 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.641 0.734 . . . . 0.0 109.899 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.2 139.31 43.07 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.776 0.798 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.3 -1.552 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.485 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.531 0.682 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.95 153.36 13.66 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -157.79 176.24 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.962 . . . . 0.0 110.281 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.57 148.79 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.757 0.789 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -111.42 148.85 32.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.753 0.787 . . . . 0.0 110.035 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -126.37 135.98 52.13 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.608 0.718 . . . . 0.0 109.493 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -120.8 127.1 51.63 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.83 0.824 . . . . 0.0 109.747 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.67 120.23 41.73 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.726 0.774 . . . . 0.0 109.58 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' GLU . 37.2 tp -88.88 126.64 35.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.706 0.765 . . . . 0.0 110.404 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 36' ' ' LEU . 45.9 mm-40 36.53 68.7 1.4 Allowed Pre-proline 0 N--CA 1.493 1.691 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.785 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -58.94 145.38 97.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.273 1.982 . . . . 0.0 111.853 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 p -83.37 -17.43 42.33 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.016 0.436 . . . . 0.0 110.242 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.74 1.13 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.602 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.63 -11.59 58.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 109.281 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.45 -14.54 30.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.18 -58.39 1.89 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.795 . . . . 0.0 109.423 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.97 160.55 40.14 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.755 0.788 . . . . 0.0 110.242 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 26.7 t -63.57 -166.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.62 0.724 . . . . 0.0 110.476 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 p -99.03 -21.0 16.43 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -64.43 -36.9 85.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 109.163 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 45' ' ' SER . 25.1 p-10 -62.22 -40.3 95.67 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.514 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.2 mt -54.8 -88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.82 -0.55 . . . . 0.0 109.777 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.0 m 66.61 -43.18 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -96.9 144.68 17.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.4 ttp -126.37 125.65 42.58 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.581 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -108.51 111.01 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.958 0.885 . . . . 0.0 110.225 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 55' ' ' ILE . 58.6 mt -97.43 121.6 39.51 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.749 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -103.7 130.77 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.887 0.851 . . . . 0.0 110.404 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 38.0 m-20 -133.23 -156.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.726 0.774 . . . . 0.0 109.77 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 59' ' ' GLY . 42.8 p-10 -71.72 96.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.964 -0.46 . . . . 0.0 110.339 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 66.08 -39.88 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -88.95 160.24 29.65 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.596 ' N ' ' NH2' ' A' ' 92' ' ' ARG . 17.2 pt-20 -151.51 148.72 28.38 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 110.067 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.04 130.09 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.674 0.75 . . . . 0.0 109.527 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -123.49 133.47 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.836 0.826 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -142.06 150.7 41.58 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.734 0.778 . . . . 0.0 109.848 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -97.58 0.89 48.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.35 81.39 3.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.479 0.657 . . . . 0.0 109.286 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.42 133.57 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.855 0.836 . . . . 0.0 109.814 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.29 137.37 47.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.834 0.826 . . . . 0.0 109.47 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.27 131.01 10.42 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -103.5 117.14 33.75 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.818 0.818 . . . . 0.0 109.472 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.61 137.09 47.13 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.858 0.837 . . . . 0.0 110.036 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -119.06 128.65 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.675 0.75 . . . . 0.0 109.201 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.7 m120 59.65 30.74 20.37 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.315 0.578 . . . . 0.0 109.731 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.51 24.7 73.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -136.01 113.38 10.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.749 -0.853 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.88 104.62 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.211 2.608 . . . . 0.0 112.568 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.6 m -109.71 -35.72 6.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.739 -0.601 . . . . 0.0 110.092 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.81 159.81 40.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.054 -1.029 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.21 150.97 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.694 0.759 . . . . 0.0 109.655 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -130.66 148.51 52.45 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.99 0.9 . . . . 0.0 110.018 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.64 152.57 39.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.649 0.737 . . . . 0.0 109.92 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.1 m -120.57 132.59 55.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.776 0.798 . . . . 0.0 110.354 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.57 130.86 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.874 0.845 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.5 mm -87.22 124.85 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.771 0.796 . . . . 0.0 110.231 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -117.71 40.5 3.08 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -62.82 -39.93 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.598 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -81.26 152.81 27.44 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.75 0.786 . . . . 0.0 110.18 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.7 tt0 -70.48 -46.43 18.93 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.943 -0.473 . . . . 0.0 110.91 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 68.4 Cg_exo -52.52 -35.33 66.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.195 1.93 . . . . 0.0 111.512 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.88 -40.71 97.15 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -63.81 -41.95 97.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.644 -0.66 . . . . 0.0 109.512 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -59.36 -44.47 92.69 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.596 ' NH2' ' N ' ' A' ' 60' ' ' GLU . 83.3 mtp180 -66.23 -37.94 86.73 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 60.5 t80 -61.95 -46.6 88.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.74 -0.6 . . . . 0.0 109.84 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 97.5 mmm -62.76 -44.07 97.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.688 -0.632 . . . . 0.0 109.395 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -66.9 -41.74 86.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.309 0.576 . . . . 0.0 109.524 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 83.0 t80 -63.99 -44.91 91.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.359 0.6 . . . . 0.0 109.49 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.5 ttt -62.07 -41.66 98.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -67.15 -47.14 71.96 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.382 0.611 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.8 tpt85 -66.55 -44.56 81.99 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.844 -0.535 . . . . 0.0 109.657 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -63.14 -45.87 89.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.558 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.9 -34.54 90.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.12 92.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.806 -0.82 . . . . 0.0 109.338 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.39 -37.07 77.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.643 0.735 . . . . 0.0 109.847 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.486 0.66 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -148.28 157.25 43.37 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.807 0.813 . . . . 0.0 110.757 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.0 mt -109.31 131.4 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.51 0.671 . . . . 0.0 109.441 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -128.96 134.3 48.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.714 0.769 . . . . 0.0 109.624 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.83 -71.47 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 10' ' ' VAL . 44.9 m -107.0 122.95 47.46 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.863 0.84 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 7' ' ' SER . 25.8 mtmm 40.63 -168.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.818 0.818 . . . . 0.0 111.538 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.21 86.25 0.32 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 7' ' ' SER . 54.7 t -120.12 132.67 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.813 0.816 . . . . 0.0 109.632 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.77 143.66 46.42 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.6 0.714 . . . . 0.0 110.19 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' VAL . 48.6 tp10 -137.65 -77.57 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' GLU . 82.8 p 37.44 31.09 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.292 0.568 . . . . 0.0 110.217 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' GLU . 53.6 t -69.57 -19.93 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.725 -0.609 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.452 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 3.5 t 64.18 52.89 1.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.897 -0.502 . . . . 0.0 110.288 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 37.1 Cg_endo -65.14 150.81 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.617 2.211 . . . . 0.0 112.559 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.57 132.48 45.55 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.685 0.755 . . . . 0.0 110.211 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.13 128.3 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.62 0.724 . . . . 0.0 109.764 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.451 ' C ' HD22 ' A' ' 20' ' ' LEU . 42.1 ttm180 -134.14 136.48 43.86 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.733 0.778 . . . . 0.0 109.765 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.895 HD22 ' N ' ' A' ' 20' ' ' LEU . 1.1 mm? -104.92 124.52 49.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.606 0.717 . . . . 0.0 109.668 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.4 m -132.65 153.4 51.13 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.159 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -105.05 152.53 22.63 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.873 0.844 . . . . 0.0 110.223 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.746 0.784 . . . . 0.0 110.993 -179.164 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.705 0.764 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.57 142.55 23.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.7 ptp -153.84 166.42 32.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.946 -0.738 . . . . 0.0 110.298 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.25 143.18 49.74 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -109.63 143.61 39.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.793 0.806 . . . . 0.0 110.335 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -123.57 135.9 54.24 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.58 0.705 . . . . 0.0 109.626 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -120.04 126.81 51.71 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.783 0.801 . . . . 0.0 109.606 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.543 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 45.8 m-85 -108.21 119.29 39.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.464 0.65 . . . . 0.0 109.366 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.79 122.71 43.17 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.62 0.724 . . . . 0.0 109.939 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 40.71 56.74 8.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-O 121.036 0.446 . . . . 0.0 110.097 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.74 144.03 82.44 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.445 2.097 . . . . 0.0 112.783 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 41' ' ' LEU . 26.4 m -69.32 -21.64 63.84 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.108 0.48 . . . . 0.0 110.018 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 tp -60.61 0.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.424 -0.797 . . . . 0.0 109.594 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.2 mt -89.67 -12.25 40.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.09 -14.16 17.9 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.13 -49.82 3.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.488 -0.758 . . . . 0.0 109.488 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.0 155.47 48.82 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.779 0.799 . . . . 0.0 110.024 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -72.99 160.03 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 110.396 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -66.37 -34.55 78.23 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.39 -17.67 61.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.738 -0.601 . . . . 0.0 109.865 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -85.29 -1.7 57.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.11 123.78 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.448 -0.782 . . . . 0.0 110.391 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -119.52 91.85 3.65 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.802 0.81 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.24 54.37 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.7 ttp -134.19 132.22 39.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.917 -0.755 . . . . 0.0 109.643 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -106.5 110.65 22.92 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.911 0.862 . . . . 0.0 109.759 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.87 114.0 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.391 0.615 . . . . 0.0 109.483 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -111.42 129.72 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.63 0.729 . . . . 0.0 109.633 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 96' ' ' PHE . 99.0 m-20 -134.8 -80.88 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' GLY . 67.3 t0 -144.81 98.2 3.15 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.617 -0.677 . . . . 0.0 109.517 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 97.2 mt-10 65.05 -42.72 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.385 0.612 . . . . 0.0 109.684 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -87.43 137.35 14.55 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -143.26 144.45 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.897 -0.766 . . . . 0.0 109.99 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.2 132.97 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.548 0.69 . . . . 0.0 109.243 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.9 mp -107.03 132.21 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.683 0.754 . . . . 0.0 109.804 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 65' ' ' GLU . 87.7 m -117.86 122.35 43.12 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.782 0.801 . . . . 0.0 109.5 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -95.48 1.23 53.91 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.7 mp0 -96.25 71.07 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.03 132.87 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.653 0.739 . . . . 0.0 109.718 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -134.29 141.87 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.936 0.874 . . . . 0.0 109.826 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.73 142.21 28.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -109.47 119.9 40.85 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.788 0.804 . . . . 0.0 109.183 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.58 124.07 49.92 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.646 0.736 . . . . 0.0 109.811 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 95.6 mt -114.2 139.32 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.591 0.71 . . . . 0.0 109.304 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.8 m120 60.33 32.42 20.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.468 0.652 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.95 31.38 80.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -158.78 152.04 18.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 O-C-N 121.63 -0.924 . . . . 0.0 109.769 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -51.54 141.18 43.11 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.9 m -161.68 -35.63 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.512 -0.742 . . . . 0.0 109.874 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 35' ' ' PHE . . . -154.27 171.22 19.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 0.0 110.7 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.63 128.06 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.561 0.696 . . . . 0.0 109.331 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -109.4 143.82 38.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.644 0.735 . . . . 0.0 109.447 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.1 148.76 30.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.681 -0.637 . . . . 0.0 109.9 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -122.75 129.27 51.56 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.47 112.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.921 0.867 . . . . 0.0 109.296 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.629 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.5 mp -82.6 128.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.504 0.668 . . . . 0.0 109.768 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.6 mt -118.31 62.86 0.76 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.59 -38.82 90.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.73 -0.606 . . . . 0.0 109.544 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -62.08 148.42 44.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.457 -0.777 . . . . 0.0 110.212 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.429 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 1.8 mp0 -76.53 -62.28 0.68 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.982 -0.449 . . . . 0.0 110.479 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 12.1 Cg_endo -57.25 -26.77 71.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.078 1.852 . . . . 0.0 111.522 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -67.01 -35.55 80.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.888 -0.508 . . . . 0.0 109.665 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -44.79 96.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.754 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.93 -47.81 83.23 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.214 0.531 . . . . 0.0 110.043 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -64.7 -42.13 95.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.592 -0.693 . . . . 0.0 110.062 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -61.66 -42.72 99.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.733 -0.604 . . . . 0.0 109.755 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 tpt -62.54 -39.23 92.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.625 -0.672 . . . . 0.0 109.764 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.8 -45.78 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.707 -0.621 . . . . 0.0 110.104 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.441 ' CD1' ' OD2' ' A' ' 56' ' ' ASP . 37.6 m-85 -68.7 -37.64 79.68 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 29.9 mmt -64.58 -39.77 94.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.18 -46.08 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.647 . . . . 0.0 109.865 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -67.09 -41.95 85.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.52 ' CD1' ' OD1' ' A' ' 104' ' ' ASN . 54.4 t80 -61.72 -45.9 91.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.574 -0.704 . . . . 0.0 110.027 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.24 -36.03 92.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.4 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -1.126 . . . . 0.0 109.026 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.28 -42.92 68.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.52 ' OD1' ' CD1' ' A' ' 100' ' ' TYR . 13.8 m120 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.354 0.597 . . . . 0.0 109.466 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.78 0.8 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -154.47 135.02 13.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.797 0.808 . . . . 0.0 110.276 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.453 HD12 ' CZ ' ' A' ' 100' ' ' TYR . 97.2 mt -119.2 128.61 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.687 0.756 . . . . 0.0 109.698 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.674 HE22 ' H ' ' A' ' 9' ' ' GLY . 2.4 pt20 -153.63 159.51 42.11 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.676 0.75 . . . . 0.0 109.773 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -89.96 -1.57 58.0 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.544 ' OG ' ' N ' ' A' ' 8' ' ' LYS . 18.4 p -145.99 -134.07 0.08 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.376 -0.827 . . . . 0.0 110.001 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.544 ' N ' ' OG ' ' A' ' 7' ' ' SER . 8.6 mtmp? -146.52 102.2 3.55 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.874 0.845 . . . . 0.0 109.948 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.674 ' H ' HE22 ' A' ' 5' ' ' GLN . . . 104.91 3.65 42.37 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 10' ' ' VAL . 11.6 p -96.18 20.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.766 -0.844 . . . . 0.0 109.446 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 10' ' ' VAL . . . -33.21 112.44 0.12 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.686 0.755 . . . . 0.0 110.746 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.426 ' HB3' HG23 ' A' ' 14' ' ' VAL . 92.4 mt-10 -94.52 -8.01 39.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.8 p 53.26 14.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.405 0.621 . . . . 0.0 109.56 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 12' ' ' GLU . 55.8 t -69.33 155.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.651 0.739 . . . . 0.0 110.556 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 14' ' ' VAL . 11.0 t -115.36 84.88 12.26 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.68 153.33 26.3 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.943 2.429 . . . . 0.0 112.468 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.11 150.26 25.66 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.038 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 100.0 t -124.25 132.53 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.641 0.734 . . . . 0.0 109.837 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' C ' HD22 ' A' ' 20' ' ' LEU . 90.0 mtm180 -131.65 139.76 49.18 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.853 0.835 . . . . 0.0 109.721 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.9 mm? -96.43 144.02 26.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.674 0.749 . . . . 0.0 110.035 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -155.69 170.45 22.0 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.74 0.781 . . . . 0.0 109.882 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 23' ' ' SER . 52.0 mtmt -141.46 124.27 16.1 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.684 0.754 . . . . 0.0 109.914 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 22' ' ' LYS . 33.6 t . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.321 0.581 . . . . 0.0 110.142 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.96 0.886 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.97 139.91 37.13 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.1 ttm -155.2 151.57 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.003 0.906 . . . . 0.0 110.212 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 131.34 23.51 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -114.05 132.56 55.97 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.846 0.831 . . . . 0.0 109.991 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -116.69 132.27 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -115.89 118.94 34.37 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -109.68 119.84 40.64 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.531 1.158 . . . . 0.0 109.915 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.36 113.78 25.87 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.011 0.91 . . . . 0.0 110.146 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 50.87 75.14 0.69 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.588 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' O ' ' N ' ' A' ' 40' ' ' ILE . 4.3 Cg_endo -82.13 15.13 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.808 2.338 . . . . 0.0 111.178 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' PRO . 4.1 p 39.63 22.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.266 0.555 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' PRO . 18.5 tt -92.79 -1.44 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.1 -18.56 20.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.91 -35.08 6.73 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.84 141.25 31.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.38 -0.825 . . . . 0.0 110.032 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -77.84 167.29 21.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.732 0.777 . . . . 0.0 109.928 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -64.83 -32.11 73.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.94 -35.44 80.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.86 -19.15 63.45 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.85 124.35 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.456 -0.778 . . . . 0.0 109.538 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.53 12.91 1.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.7 175.15 46.37 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.596 ' SD ' HD21 ' A' ' 54' ' ' LEU . 18.0 ttm -137.12 144.42 43.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.702 -0.881 . . . . 0.0 109.433 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -108.9 113.18 25.87 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.925 0.869 . . . . 0.0 109.898 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.596 HD21 ' SD ' ' A' ' 52' ' ' MET . 75.4 mt -95.06 114.69 26.52 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.52 0.676 . . . . 0.0 109.336 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.741 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -99.17 109.4 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.776 0.798 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 96.1 m-20 -88.84 -87.85 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 66.2 m-20 -159.37 -62.23 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 109.246 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -104.22 13.96 31.27 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.14 -0.975 . . . . 0.0 108.614 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.42 174.02 45.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -147.95 147.73 30.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.57 -0.959 . . . . 0.0 109.823 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.3 131.44 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.652 0.739 . . . . 0.0 109.68 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.8 mp -115.37 131.35 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.514 0.673 . . . . 0.0 109.441 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -125.24 131.15 53.18 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.839 0.828 . . . . 0.0 109.975 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -92.53 3.63 55.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -90.53 73.12 6.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.43 133.07 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.749 0.785 . . . . 0.0 109.521 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -133.83 142.88 48.03 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.746 0.784 . . . . 0.0 109.947 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.79 149.8 21.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -110.05 131.08 55.38 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.956 0.884 . . . . 0.0 109.67 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.75 125.41 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.53 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 96.8 mt -123.15 133.13 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.798 0.809 . . . . 0.0 109.572 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 71' ' ' ILE . 4.6 p30 58.33 25.76 13.17 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.888 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.32 31.37 16.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.137 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -168.81 150.52 4.63 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.073 -1.251 . . . . 0.0 110.588 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.8 87.49 0.44 Allowed 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.207 2.605 . . . . 0.0 112.257 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -104.68 -14.62 15.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.716 -0.615 . . . . 0.0 109.74 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.08 151.66 44.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.27 135.82 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.499 0.666 . . . . 0.0 109.982 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -126.28 164.45 21.0 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.947 0.879 . . . . 0.0 110.202 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.2 37.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.77 0.795 . . . . 0.0 109.634 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.0 m -124.97 127.21 46.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.67 0.748 . . . . 0.0 109.545 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.8 t -114.89 132.42 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.874 0.845 . . . . 0.0 109.81 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.3 mm -94.79 123.91 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.707 0.765 . . . . 0.0 109.825 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.5 mt -110.66 75.53 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -96.85 1.92 51.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -116.82 143.55 45.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.991 0.901 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 mt-30 -66.51 -48.57 55.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.633 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.6 Cg_exo -51.9 -38.25 68.15 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.866 1.71 . . . . 0.0 111.133 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -66.73 -39.5 88.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -63.29 -37.87 88.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.71 -0.619 . . . . 0.0 109.787 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.35 -50.94 71.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.664 -0.647 . . . . 0.0 109.853 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 93' ' ' PHE . 18.7 ptp180 -75.35 -39.29 59.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.743 -0.598 . . . . 0.0 109.921 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.417 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 69.1 t80 -64.22 -44.79 90.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.508 -0.745 . . . . 0.0 109.221 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.1 tpp -60.72 -46.94 88.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -66.09 -40.57 90.92 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.273 0.558 . . . . 0.0 109.513 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 86.4 t80 -63.21 -44.24 95.88 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 11.3 tpt -62.6 -39.79 94.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.619 -0.675 . . . . 0.0 109.54 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -66.08 -52.73 46.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.759 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -66.34 -44.75 82.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.453 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 81.0 t80 -63.4 -46.99 83.89 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.419 0.628 . . . . 0.0 109.342 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.57 88.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.85 83.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.646 -0.914 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.63 -55.7 6.45 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 p30 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.748 0.785 . . . . 0.0 109.832 179.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 66.8 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' H ' ' NH1' ' A' ' 99' ' ' ARG . . . -66.79 135.98 54.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.591 -0.693 . . . . 0.0 110.013 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.542 ' CB ' ' NZ ' ' A' ' 110' ' ' LYS . 15.6 pt-20 -155.75 163.08 40.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.85 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 96.1 mt -108.52 130.51 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.632 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 98.1 mt-30 -129.43 135.02 48.14 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.495 -0.753 . . . . 0.0 109.808 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -95.54 -10.36 29.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.559 -0.713 . . . . 0.0 109.161 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 8' ' ' LYS . 22.7 m -150.64 22.56 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -0.891 . . . . 0.0 109.171 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 7' ' ' SER . 23.8 mtmm 56.53 120.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.806 0.812 . . . . 0.0 110.909 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.632 ' H ' ' NE2' ' A' ' 5' ' ' GLN . . . 99.13 -16.72 58.98 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.52 97.64 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -1.105 . . . . 0.0 109.611 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 131.73 40.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.641 -0.662 . . . . 0.0 109.874 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -110.87 122.39 47.73 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.618 0.723 . . . . 0.0 109.758 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -91.7 -3.74 55.92 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 15' ' ' VAL . 54.3 t -51.53 157.18 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.503 -0.748 . . . . 0.0 110.156 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.434 ' N ' HG12 ' A' ' 14' ' ' VAL . 60.0 t -115.68 80.97 8.77 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.599 -0.688 . . . . 0.0 110.069 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.33 151.64 29.82 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.795 2.33 . . . . 0.0 112.346 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -87.22 152.72 22.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.327 -0.858 . . . . 0.0 109.713 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.09 130.14 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.483 0.659 . . . . 0.0 109.309 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -132.6 145.72 51.32 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -102.19 140.43 36.48 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.509 -0.744 . . . . 0.0 109.625 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.6 m -152.25 167.06 29.84 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.56 -0.713 . . . . 0.0 109.605 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -105.25 166.95 10.05 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.603 0.716 . . . . 0.0 109.812 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -69.12 170.91 9.12 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.706 0.765 . . . . 0.0 110.439 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -61.8 -39.67 92.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.592 -0.692 . . . . 0.0 109.416 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -88.73 -2.18 58.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 109.016 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.65 16.88 77.82 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -80.23 -91.4 0.05 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -1.08 . . . . 0.0 110.645 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.611 ' CB ' HD22 ' A' ' 85' ' ' ASN . 22.1 m -78.93 149.27 32.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 110.558 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.38 162.01 43.45 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.1 ptm -159.87 171.56 19.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.531 -0.982 . . . . 0.0 109.227 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.79 148.9 48.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.487 -0.758 . . . . 0.0 109.388 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.42 148.12 31.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.71 -0.619 . . . . 0.0 109.666 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -126.81 136.2 52.06 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -113.25 123.49 50.29 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.797 -0.564 . . . . 0.0 109.645 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -111.31 122.83 48.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.3 tp -103.67 124.95 49.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.776 0.798 . . . . 0.0 110.582 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.409 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 56.4 mt-10 42.5 54.89 9.83 Favored Pre-proline 0 N--CA 1.492 1.665 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 38.3 Cg_endo -66.79 149.33 83.49 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.264 1.976 . . . . 0.0 111.947 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' LEU . 66.9 p -74.43 -19.9 60.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.55 -0.719 . . . . 0.0 110.264 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 40' ' ' ILE . 9.2 tp -59.96 0.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.172 -0.955 . . . . 0.0 109.734 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 39' ' ' THR . 94.1 mt -90.93 -9.66 45.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.955 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.36 -24.95 13.81 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 109.418 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -93.59 -73.28 0.57 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.248 -0.907 . . . . 0.0 109.977 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -104.36 148.11 26.76 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.824 0.821 . . . . 0.0 110.704 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.7 m -71.8 156.15 39.63 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.728 0.775 . . . . 0.0 110.449 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -65.86 -32.65 74.29 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.647 -0.658 . . . . 0.0 109.628 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -75.1 -8.05 55.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 109.688 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -92.89 -3.37 54.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 94.0 mt -95.47 122.94 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.192 -0.943 . . . . 0.0 109.802 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.1 m -121.31 -3.12 9.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -172.97 170.39 43.53 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.637 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.514 ' SD ' ' HB2' ' A' ' 80' ' ' ALA . 63.1 mtp -128.17 143.82 51.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.711 -0.876 . . . . 0.0 109.076 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -108.86 108.78 19.7 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.515 0.674 . . . . 0.0 109.785 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 55' ' ' ILE . 78.3 mt -93.59 110.28 21.88 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -98.05 111.81 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.326 -0.859 . . . . 0.0 109.89 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.05 176.91 6.15 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.603 0.716 . . . . 0.0 109.885 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.06 -39.08 93.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -88.91 -76.42 0.41 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.215 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.0 -154.94 10.81 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.498 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.6 pm0 -142.79 153.73 43.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.635 -0.92 . . . . 0.0 109.108 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.452 HD13 ' OE2' ' A' ' 89' ' ' GLU . 96.4 mt -119.22 135.5 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.491 -0.756 . . . . 0.0 109.939 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 mm -100.12 126.9 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.733 . . . . 0.0 109.447 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.6 m -121.76 125.21 46.03 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -108.26 -6.25 16.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -89.09 78.64 7.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.474 -0.766 . . . . 0.0 109.056 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 90.7 t -121.86 133.35 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.714 -0.616 . . . . 0.0 109.715 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.22 142.9 50.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.495 0.664 . . . . 0.0 109.73 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.63 143.26 16.41 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.14 106.73 17.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.676 -0.896 . . . . 0.0 108.667 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -100.55 143.81 30.29 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.371 0.605 . . . . 0.0 110.239 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -113.35 109.16 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m120 53.98 35.88 23.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.577 -0.702 . . . . 0.0 110.079 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.85 78.75 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -121.57 99.25 45.31 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.564 -0.963 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -50.86 130.4 30.9 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.339 2.026 . . . . 0.0 112.561 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.6 m -152.83 -29.9 0.14 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.644 -0.66 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.18 154.08 51.74 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.218 -0.926 . . . . 0.0 110.726 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.75 143.06 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 14.3 tm-20 -119.94 150.22 40.85 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.58 0.705 . . . . 0.0 109.909 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HB2' ' SD ' ' A' ' 52' ' ' MET . . . -139.4 145.35 38.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.7 m -125.29 132.62 52.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.675 -0.641 . . . . 0.0 109.698 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -111.08 130.48 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.667 -0.646 . . . . 0.0 109.307 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 32.3 mm -93.34 128.73 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.6 -0.687 . . . . 0.0 109.791 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 68.3 mt -108.4 55.3 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.611 HD22 ' CB ' ' A' ' 28' ' ' SER . 9.2 m120 -64.34 -40.65 96.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.616 -0.677 . . . . 0.0 109.31 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 m -84.27 154.96 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.391 -0.818 . . . . 0.0 110.452 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.9 mp0 -74.89 -59.43 1.42 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.799 -0.563 . . . . 0.0 110.914 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 2.8 Cg_endo -48.51 -17.48 1.05 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.713 1.608 . . . . 0.0 111.266 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.452 ' OE2' HD13 ' A' ' 61' ' ' ILE . 34.1 tp10 -64.9 -37.02 86.24 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.438 -0.789 . . . . 0.0 109.27 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -60.61 -36.52 78.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.487 -0.758 . . . . 0.0 109.815 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -58.32 -47.0 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.509 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -68.35 -39.9 81.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 109.617 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -62.28 -47.89 82.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 110.39 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 91.7 mmm -64.05 -43.21 96.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.637 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.45 -43.67 89.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.456 -0.778 . . . . 0.0 109.624 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -61.54 -47.67 84.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 tpt -65.71 -41.0 92.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.364 -0.835 . . . . 0.0 109.539 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -63.01 -53.16 58.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.702 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.587 ' NH2' ' N ' ' A' ' 1' ' ' MET . 78.2 ttt-85 -68.99 -43.34 75.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.434 -0.791 . . . . 0.0 110.16 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -62.67 -46.01 90.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.96 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.03 -36.23 93.18 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -41.43 95.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -1.137 . . . . 0.0 109.649 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.83 -43.59 71.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.875 . . . . 0.0 109.422 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.513 HD21 ' CB ' ' A' ' 110' ' ' LYS . 87.1 m-20 -121.12 127.64 51.79 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.639 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 107' ' ' GLY . . . -90.84 47.26 2.96 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 106' ' ' LEU . 10.4 mp 58.05 1.57 0.15 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.769 -0.842 . . . . 0.0 110.174 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 105' ' ' GLY . . . -135.42 -24.38 0.55 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -90.45 138.65 31.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -1.107 . . . . 0.0 110.476 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.5 m -76.32 145.71 39.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.703 0.763 . . . . 0.0 110.297 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.542 ' NZ ' ' CB ' ' A' ' 3' ' ' GLU . 31.0 ttpt -64.96 -35.68 81.96 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.566 0.698 . . . . 0.0 109.628 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 113' ' ' LEU . 20.0 p -62.27 171.36 1.88 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.501 -0.749 . . . . 0.0 110.136 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 65.31 -62.65 0.21 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.345 0.593 . . . . 0.0 109.557 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 111' ' ' SER . 89.4 mt -63.14 -41.87 99.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.857 . . . . 0.0 109.597 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -95.52 122.43 38.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 109.793 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -74.18 140.89 45.45 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.571 0.701 . . . . 0.0 110.41 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.29 156.36 24.34 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.571 -0.706 . . . . 0.0 109.783 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -137.99 148.23 44.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -66.07 -40.85 91.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.544 -0.723 . . . . 0.0 109.881 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.49 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 6.8 t-80 -70.15 130.0 40.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.336 -0.852 . . . . 0.0 110.317 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.49 ' CD2' ' CE1' ' A' ' 119' ' ' HIS . 69.0 m-70 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.361 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 3' ' ' GLU . 39.1 mmt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 32.1 -89.7 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 120.922 0.392 . . . . 0.0 110.775 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 1' ' ' MET . 49.8 tp10 -124.61 134.12 53.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.473 -0.767 . . . . 0.0 108.991 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.39 128.84 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -141.06 150.21 42.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.33 -0.856 . . . . 0.0 109.826 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -107.66 -7.78 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 8' ' ' LYS . 9.9 t -155.21 80.31 1.05 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.37 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.7 mttm 43.14 -168.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.708 0.766 . . . . 0.0 111.229 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.27 88.8 0.1 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 75.0 t -78.01 -94.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.406 -1.055 . . . . 0.0 109.221 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 175.67 55.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.445 -0.784 . . . . 0.0 108.935 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -163.67 121.49 1.86 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.6 m -93.33 88.87 6.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.176 -0.953 . . . . 0.0 109.279 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.6 t -78.64 135.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.399 -0.813 . . . . 0.0 110.592 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.94 80.88 15.1 Favored Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.581 -0.699 . . . . 0.0 109.754 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.72 158.73 24.89 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.733 2.289 . . . . 0.0 112.406 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.94 159.5 28.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.881 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.7 t -109.1 128.77 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.6 -0.687 . . . . 0.0 109.387 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -135.18 135.21 40.88 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 92.9 mt -102.28 135.74 43.35 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.426 -0.796 . . . . 0.0 109.735 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.8 t -132.91 140.06 47.67 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.09 129.42 45.21 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 25' ' ' ASN . 14.5 m -71.66 134.69 46.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 110.503 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 44.57 14.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.825 -0.547 . . . . 0.0 109.933 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 23' ' ' SER . 8.0 m120 52.29 34.1 14.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.666 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.47 55.66 0.03 OUTLIER Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -151.06 -56.38 0.15 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -1.087 . . . . 0.0 109.475 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 92.8 p -150.9 119.5 6.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.055 . . . . 0.0 109.736 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.07 139.85 25.69 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.4 ptt? -162.19 165.16 27.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -1.128 . . . . 0.0 108.865 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.36 140.33 50.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.555 -0.716 . . . . 0.0 109.072 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -106.99 145.3 32.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.641 -0.662 . . . . 0.0 109.235 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -117.38 133.78 55.58 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -104.0 125.37 50.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.602 -0.686 . . . . 0.0 109.869 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.2 114.82 28.85 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.8 tp -97.58 121.64 39.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.382 -0.824 . . . . 0.0 109.611 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' LEU . 49.6 mt-10 39.35 58.88 6.3 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.74 -0.6 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.0 Cg_endo -63.81 145.14 90.36 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.514 2.143 . . . . 0.0 112.532 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.2 p -81.35 26.78 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.069 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 40' ' ' ILE . 10.5 tp -102.73 -21.99 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.14 -41.1 97.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.562 -0.711 . . . . 0.0 109.484 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.88 76.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.54 -0.725 . . . . 0.0 109.582 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -88.45 -65.65 1.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 110.041 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -113.26 143.0 45.15 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.7 t -80.27 167.8 19.84 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.438 0.637 . . . . 0.0 110.098 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.9 p -65.01 -36.0 82.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 109.774 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -64.8 -39.1 93.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.814 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -65.02 -34.85 79.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.344 -0.848 . . . . 0.0 110.097 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.63 126.0 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 0.0 110.005 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 m -126.14 -0.17 7.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.97 -175.29 36.96 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.451 ' CE ' HD21 ' A' ' 54' ' ' LEU . 63.0 ttp -135.47 136.22 41.12 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.514 -0.992 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.421 ' CE2' HD12 ' A' ' 62' ' ' ILE . 92.4 m-85 -106.31 116.8 32.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.452 -0.78 . . . . 0.0 109.417 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.451 HD21 ' CE ' ' A' ' 52' ' ' MET . 91.6 mt -96.89 115.06 26.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.893 . . . . 0.0 108.907 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 55' ' ' ILE . 3.3 mp -108.53 132.75 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.406 0.622 . . . . 0.0 109.713 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.54 ' OD2' ' NH2' ' A' ' 99' ' ' ARG . 36.1 t0 -125.49 43.68 3.0 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.456 ' H ' HG22 ' A' ' 55' ' ' ILE . 66.9 m-20 54.86 5.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.808 -0.558 . . . . 0.0 109.619 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 56' ' ' ASP . 97.8 mt-10 -146.75 -105.46 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.336 -0.852 . . . . 0.0 109.514 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.23 164.36 52.58 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.29 153.27 47.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.27 -1.135 . . . . 0.0 110.232 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -117.4 135.23 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' CE2' ' A' ' 53' ' ' TYR . 37.2 mm -104.37 125.57 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.386 -0.821 . . . . 0.0 109.177 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.8 m -123.13 124.44 43.08 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -100.56 -9.26 22.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.578 -0.701 . . . . 0.0 109.18 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -83.38 75.74 9.96 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.234 -0.916 . . . . 0.0 109.275 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.03 134.32 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.553 -0.717 . . . . 0.0 109.724 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -126.37 138.97 53.62 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.96 136.1 12.58 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -102.66 125.43 49.39 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.495 -1.003 . . . . 0.0 109.144 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -109.05 144.21 37.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.757 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 90.8 mt -120.27 129.44 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.3 m120 57.54 32.45 21.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -0.759 . . . . 0.0 109.285 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.89 22.75 75.81 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -136.88 127.93 16.47 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.296 -1.12 . . . . 0.0 109.704 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.21 136.19 30.89 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 122.078 1.852 . . . . 0.0 112.539 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -154.34 -34.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.712 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.66 152.32 42.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.063 -1.023 . . . . 0.0 110.248 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 79' ' ' GLU . 94.0 mt -130.86 163.51 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' N ' HG22 ' A' ' 78' ' ' ILE . 45.5 tt0 -142.01 151.82 42.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.817 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.1 141.65 36.14 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.0 m -119.79 129.45 54.46 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.569 -0.707 . . . . 0.0 109.702 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.29 129.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.5 0.667 . . . . 0.0 109.518 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.2 mp -81.97 127.8 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.594 -0.691 . . . . 0.0 110.156 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 71.4 mt -119.07 40.12 3.38 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -62.95 -40.32 97.3 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.362 -0.836 . . . . 0.0 109.497 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.0 139.84 41.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.016 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.592 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.1 mm100 -66.32 -40.63 36.4 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.532 -0.73 . . . . 0.0 110.403 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.9 Cg_exo -58.88 -33.08 98.44 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.029 1.819 . . . . 0.0 110.743 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -67.11 -38.27 85.32 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.441 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 46.5 m95 -61.22 -41.82 97.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.18 -47.15 87.51 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.379 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -70.15 -42.09 72.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.487 -0.758 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -61.54 -45.83 92.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 84.9 mmm -64.78 -41.79 95.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 110.031 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.5 ' NH1' ' CZ ' ' A' ' 99' ' ' ARG . 70.2 ttp85 -64.62 -41.36 96.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.581 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.553 ' CD1' ' NH2' ' A' ' 99' ' ' ARG . 3.2 m-85 -59.63 -42.66 93.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.445 -0.785 . . . . 0.0 109.008 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.42 ' SD ' ' C ' ' A' ' 97' ' ' MET . 11.0 tmm? -61.7 -39.69 92.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.491 -0.755 . . . . 0.0 110.017 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -59.96 -48.34 82.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 110.052 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' CD1' ' A' ' 96' ' ' PHE . 88.8 mtm180 -66.03 -37.77 86.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.205 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.596 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 90.6 t80 -60.67 -44.97 95.84 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.43 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -63.54 -35.82 92.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.88 -38.81 92.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -1.073 . . . . 0.0 109.603 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -84.96 -10.25 57.25 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 76.0 m-20 -137.09 -150.45 0.36 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.349 -0.845 . . . . 0.0 109.473 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 107' ' ' GLY . . . -154.64 50.96 0.47 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 106' ' ' LEU . 3.0 mm? 39.07 26.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.737 -0.86 . . . . 0.0 109.937 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 105' ' ' GLY . . . -165.32 -147.31 5.1 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -74.35 143.49 44.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -1.041 . . . . 0.0 110.656 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 110' ' ' LYS . 14.5 p -160.66 -137.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 110.172 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' N ' ' OG ' ' A' ' 109' ' ' SER . 65.3 mttp -66.77 81.56 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 110.397 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.9 p -160.4 -75.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.368 -0.833 . . . . 0.0 109.518 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -85.48 -16.73 38.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 114' ' ' GLU . 4.5 mp -99.85 -63.19 1.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.36 -0.837 . . . . 0.0 109.3 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 113' ' ' LEU . 96.2 mt-10 41.28 63.7 1.18 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.618 0.723 . . . . 0.0 110.011 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -67.54 -39.53 85.02 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.47 -0.769 . . . . 0.0 109.216 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 55.57 91.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.633 0.73 . . . . 0.0 110.216 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.494 ' O ' ' ND1' ' A' ' 119' ' ' HIS . 73.0 m80 -67.03 -41.94 85.72 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.504 -0.747 . . . . 0.0 109.501 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.551 ' O ' ' CG ' ' A' ' 119' ' ' HIS . 84.4 t60 -66.53 -42.22 87.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.316 -0.865 . . . . 0.0 109.514 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 118' ' ' HIS . 39.9 p-80 41.97 -167.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.551 0.691 . . . . 0.0 110.712 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.862 -179.553 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.384 0.611 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.75 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.541 -0.725 . . . . 0.0 109.901 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -154.83 161.81 41.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.373 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.5 mt -113.33 128.0 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.618 -0.676 . . . . 0.0 109.524 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 7' ' ' SER . 4.2 pt20 -154.37 154.91 34.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.122 -0.986 . . . . 0.0 109.43 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -86.24 -4.52 59.19 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.348 -0.845 . . . . 0.0 109.106 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.504 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 42.8 t -167.82 147.09 4.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 109.285 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -65.21 138.82 58.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.342 -0.849 . . . . 0.0 110.484 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 97.54 -12.53 64.69 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 85.0 t -112.33 127.21 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.597 -0.943 . . . . 0.0 110.077 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 168.85 96.89 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' VAL . 51.1 tp10 -168.6 130.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.226 -0.921 . . . . 0.0 109.158 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m 70.08 -9.41 0.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.635 -0.666 . . . . 0.0 109.373 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' H ' ' C ' ' A' ' 12' ' ' GLU . 6.6 t -80.98 130.27 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.294 -0.879 . . . . 0.0 109.642 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.6 t -142.59 83.5 11.75 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.253 -0.905 . . . . 0.0 108.722 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -79.69 145.62 18.32 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.392 2.061 . . . . 0.0 112.867 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -89.3 157.71 18.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.487 -0.758 . . . . 0.0 109.239 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.6 t -112.62 130.82 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.463 -0.773 . . . . 0.0 109.084 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -132.28 143.04 49.62 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.493 -0.755 . . . . 0.0 109.167 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.3 mt -103.72 132.55 49.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.421 -0.8 . . . . 0.0 108.918 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 61.9 m -129.81 153.6 48.09 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.617 -0.677 . . . . 0.0 109.525 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -109.02 143.95 37.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.524 -0.735 . . . . 0.0 109.108 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.484 ' CB ' ' OG ' ' A' ' 28' ' ' SER . 67.1 m -72.94 155.03 40.28 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.735 0.779 . . . . 0.0 110.992 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -39.45 128.71 1.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.694 0.759 . . . . 0.0 111.139 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 59.8 26.25 15.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.72 -0.613 . . . . 0.0 110.06 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 40.68 54.72 3.4 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -104.03 -11.75 17.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -1.06 . . . . 0.0 109.253 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.484 ' OG ' ' CB ' ' A' ' 23' ' ' SER . 23.8 p -152.83 160.72 43.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.177 -0.952 . . . . 0.0 109.716 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.42 146.89 21.14 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.2 ttp -152.17 159.0 43.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -1.131 . . . . 0.0 109.407 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.23 150.09 36.08 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.9 145.66 46.49 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 0.0 109.88 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.41 137.24 54.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -119.42 127.22 52.9 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.4 122.17 46.79 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 37' ' ' GLU . 40.2 tp -93.45 125.5 38.09 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.497 -0.752 . . . . 0.0 110.009 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 36' ' ' LEU . 30.9 mt-10 40.32 71.85 1.15 Allowed Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.756 -0.59 . . . . 0.0 110.551 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.23 142.85 97.67 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.829 2.353 . . . . 0.0 111.997 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.8 p -86.25 -17.3 35.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.489 -0.757 . . . . 0.0 109.895 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -70.61 1.79 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 109.917 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.58 -7.36 59.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.048 . . . . 0.0 109.207 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.11 -23.96 16.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.333 -0.855 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -99.73 -73.18 0.64 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.466 -0.771 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.55 159.52 15.68 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.478 -0.763 . . . . 0.0 110.066 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -81.33 168.73 18.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.537 -0.727 . . . . 0.0 110.455 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -66.64 -37.28 84.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.554 -0.716 . . . . 0.0 109.804 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.27 -24.11 62.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -76.68 -5.54 48.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.572 -0.705 . . . . 0.0 109.706 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.3 mt -88.11 -87.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.546 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.3 m 66.94 -40.36 0.38 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -103.09 144.2 15.95 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -126.05 129.87 50.01 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -102.94 119.96 39.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.349 -0.845 . . . . 0.0 110.009 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 55' ' ' ILE . 24.7 mt -102.78 113.7 27.34 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.759 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -98.47 103.23 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 94.5 m-20 -95.12 176.24 6.31 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.644 0.735 . . . . 0.0 110.597 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -65.0 -36.61 84.96 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.729 -0.607 . . . . 0.0 109.786 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.19 -77.4 0.33 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.292 -0.88 . . . . 0.0 110.041 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.74 -145.52 6.79 Favored Glycine 0 N--CA 1.498 2.816 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.66 153.51 43.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.394 -1.063 . . . . 0.0 109.799 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.04 133.25 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.4 mm -107.47 128.79 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 109.305 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 65' ' ' GLU . 53.2 m -123.84 127.86 48.67 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.448 0.642 . . . . 0.0 109.691 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.8 mmm-85 -96.03 -3.71 44.38 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' H ' HG22 ' A' ' 63' ' ' THR . 96.2 mt-10 -86.36 83.53 7.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.52 -0.738 . . . . 0.0 109.541 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.9 t -125.16 133.58 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -127.49 137.89 52.78 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.571 -0.705 . . . . 0.0 109.25 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.88 138.08 13.97 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -105.86 105.81 16.03 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -98.82 147.15 25.21 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.226 0.536 . . . . 0.0 109.595 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 41.5 mm -125.24 135.66 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.431 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 12.2 p30 -38.89 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.697 0.761 . . . . 0.0 110.48 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 147.63 -60.77 0.46 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -175.26 154.53 1.66 Allowed Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.184 -1.186 . . . . 0.0 109.43 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.33 129.98 8.68 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.745 1.63 . . . . 0.0 112.056 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.1 p -113.7 -35.07 5.3 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.686 -0.634 . . . . 0.0 109.604 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.39 169.41 22.03 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.363 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.54 128.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -111.18 150.07 30.03 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.518 0.675 . . . . 0.0 109.668 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.91 38.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -113.46 129.24 56.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.55 132.33 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.398 -0.814 . . . . 0.0 109.018 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.6 mm -92.59 127.06 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.856 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 78.6 mt -113.28 40.59 2.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.45 -39.72 94.31 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.491 0.663 . . . . 0.0 109.691 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.3 m -66.32 150.04 49.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 110.487 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.493 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 4.1 mp0 -73.04 -57.48 2.91 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.878 -0.514 . . . . 0.0 110.152 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 12.7 Cg_endo -54.02 -34.9 79.23 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.777 1.652 . . . . 0.0 111.35 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.66 -39.08 88.03 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.156 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -63.14 -44.82 94.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 108.933 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.11 -43.35 99.03 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.435 -0.791 . . . . 0.0 109.14 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.6 -42.39 95.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.384 -0.822 . . . . 0.0 109.083 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -59.76 -46.86 87.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.513 -0.742 . . . . 0.0 109.634 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.8 tpp -60.75 -46.42 90.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -65.09 -42.72 93.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.426 -0.796 . . . . 0.0 109.212 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.462 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 73.5 t80 -62.12 -43.82 98.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.28 -42.7 91.87 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.435 -0.791 . . . . 0.0 109.938 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.05 -47.08 75.51 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.256 -0.903 . . . . 0.0 110.137 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -67.91 -42.71 80.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.083 -1.011 . . . . 0.0 110.015 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.402 ' O ' ' O ' ' A' ' 104' ' ' ASN . 89.6 t80 -62.05 -46.23 90.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.427 -0.795 . . . . 0.0 110.346 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.61 -36.33 93.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.422 ' HB3' ' OE1' ' A' ' 103' ' ' GLU . . . -60.65 -46.39 90.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.99 -1.3 . . . . 0.0 109.058 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -69.67 -50.35 44.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.508 -0.745 . . . . 0.0 109.206 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 100' ' ' TYR . 53.3 p30 -172.54 175.71 3.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.445 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.612 ' C ' HD12 ' A' ' 106' ' ' LEU . . . 126.81 -148.87 17.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 106' ' ' LEU . 3.4 mp 56.28 -159.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.845 -0.797 . . . . 0.0 110.789 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 108' ' ' PHE . . . -73.24 115.25 5.06 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 107' ' ' GLY . 96.6 m-85 39.55 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.906 -0.761 . . . . 0.0 110.174 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m -71.15 164.17 26.16 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.724 0.773 . . . . 0.0 110.378 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.0 pttm -96.37 -28.38 14.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.49 -0.756 . . . . 0.0 109.656 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 113' ' ' LEU . 40.6 t -73.21 138.51 45.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.0 110.131 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 64.52 -30.55 0.12 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.677 -0.639 . . . . 0.0 110.455 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.557 ' H ' ' C ' ' A' ' 111' ' ' SER . 0.2 OUTLIER -63.77 -43.75 95.46 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.168 -0.958 . . . . 0.0 110.009 -179.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -85.78 146.0 26.98 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.154 -0.966 . . . . 0.0 109.957 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -111.6 -171.18 1.79 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.685 -0.635 . . . . 0.0 109.837 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.6 m80 54.92 -176.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.599 0.714 . . . . 0.0 110.678 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -76.72 142.69 40.39 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.573 0.701 . . . . 0.0 110.398 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -66.75 -39.0 87.75 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.4 0.619 . . . . 0.0 109.549 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.1 t60 44.93 92.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.55 0.691 . . . . 0.0 110.325 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.876 -1.059 . . . . 0.0 108.959 179.17 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.547 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 41.77 93.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.67 0.747 . . . . 0.0 110.285 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.9 145.39 37.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.305 -0.872 . . . . 0.0 109.727 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 88.2 mt -108.18 127.29 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.705 -0.622 . . . . 0.0 110.0 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -152.28 158.68 43.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.339 -0.851 . . . . 0.0 109.534 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -103.99 -35.68 8.02 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.1 m -129.66 151.47 50.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.959 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.36 139.08 57.17 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.764 0.792 . . . . 0.0 110.717 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.09 28.94 26.89 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.0 t -111.15 133.21 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.441 -1.035 . . . . 0.0 109.844 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 142.71 52.91 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.849 0.833 . . . . 0.0 110.455 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 1.2 pm0 -101.32 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 p -95.03 -9.03 35.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.38 -0.825 . . . . 0.0 109.187 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -71.5 134.91 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.263 -0.898 . . . . 0.0 109.935 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -116.84 82.13 12.77 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.569 -0.707 . . . . 0.0 110.051 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.78 151.25 24.59 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.965 2.444 . . . . 0.0 112.459 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 56.2 mp0 -91.69 153.81 19.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.68 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' A' ' 33' ' ' PHE . 60.7 t -116.87 133.17 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.417 0.627 . . . . 0.0 109.569 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.481 ' NH2' ' OE2' ' A' ' 79' ' ' GLU . 90.5 mtm-85 -121.71 140.52 52.21 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.49 110.61 23.01 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.668 0.747 . . . . 0.0 109.295 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 86.3 p -83.82 168.34 16.24 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.706 -0.621 . . . . 0.0 109.815 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' NZ ' HD21 ' A' ' 25' ' ' ASN . 54.2 tttp -111.37 122.51 48.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.823 0.821 . . . . 0.0 109.824 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.446 ' H ' ' H ' ' A' ' 24' ' ' LYS . 2.9 p -178.3 3.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' H ' ' H ' ' A' ' 23' ' ' SER . 26.1 pttm -63.84 -37.36 87.11 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.432 HD21 ' NZ ' ' A' ' 22' ' ' LYS . 21.0 p30 -105.29 6.98 33.25 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.6 -59.63 0.67 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -153.7 -36.44 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -1.093 . . . . 0.0 109.483 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 23' ' ' SER . 27.9 m -170.34 110.54 0.39 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.11 -0.993 . . . . 0.0 109.75 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 141.17 41.8 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -162.91 168.95 20.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -1.102 . . . . 0.0 110.189 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.09 146.73 45.48 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.3 mttp -104.31 148.96 25.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.541 -0.724 . . . . 0.0 110.302 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.543 ' CE2' HG22 ' A' ' 18' ' ' VAL . 30.1 m-85 -117.66 129.92 56.04 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.99 123.48 43.32 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.53 0.681 . . . . 0.0 109.848 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.71 126.59 55.04 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.5 tp -117.29 117.97 30.99 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.341 0.591 . . . . 0.0 110.364 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 39' ' ' THR . 95.5 mt-10 31.91 70.4 0.71 Allowed Pre-proline 0 N--CA 1.497 1.905 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' ILE . 18.4 Cg_exo -65.53 12.48 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.769 2.313 . . . . 0.0 110.97 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 37' ' ' GLU . 1.8 m 67.7 -3.35 1.15 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.415 0.626 . . . . 0.0 109.462 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 38' ' ' PRO . 20.3 tt -86.03 -0.91 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.27 -9.81 59.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 109.208 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.9 -18.92 21.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.262 -0.898 . . . . 0.0 109.253 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -107.73 -41.76 4.92 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.502 -0.749 . . . . 0.0 109.82 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' OE1' ' OD2' ' A' ' 48' ' ' ASP . 79.3 mm-40 -136.0 138.11 41.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.325 -0.859 . . . . 0.0 110.253 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -77.23 168.89 19.3 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.855 0.836 . . . . 0.0 110.521 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.6 p -64.8 -32.47 74.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.586 -0.697 . . . . 0.0 109.713 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -65.22 -36.71 85.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.299 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.415 ' OD2' ' OE1' ' A' ' 44' ' ' GLU . 62.4 m-20 -64.41 -36.27 83.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 108.928 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.0 mt -76.64 129.07 37.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.41 -0.807 . . . . 0.0 109.966 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.0 t -144.77 49.06 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' N ' HG21 ' A' ' 66' ' ' VAL . . . 163.57 162.92 15.24 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.4 ttp -129.31 131.02 46.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.596 -0.944 . . . . 0.0 108.932 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' N ' ' CD1' ' A' ' 53' ' ' TYR . 29.6 m-85 -108.6 109.62 20.88 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.76 0.791 . . . . 0.0 110.127 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 55' ' ' ILE . 75.1 mt -100.58 121.72 42.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.756 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.5 mp -105.42 113.7 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.342 -0.848 . . . . 0.0 109.52 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 86.7 m-20 -92.39 171.98 8.69 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.459 0.647 . . . . 0.0 110.148 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' OD2' ' CZ ' ' A' ' 99' ' ' ARG . 39.6 p-10 -79.01 -4.76 51.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.507 -0.746 . . . . 0.0 109.877 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -124.44 -18.15 5.83 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 56' ' ' ASP . . . -173.89 -151.06 7.97 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -152.34 145.05 24.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.233 -1.157 . . . . 0.0 109.235 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.481 HD13 ' OE2' ' A' ' 89' ' ' GLU . 96.3 mt -114.7 129.56 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.517 -0.739 . . . . 0.0 109.114 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.8 mm -112.71 130.56 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.59 0.71 . . . . 0.0 109.765 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 t -138.99 145.27 39.5 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.535 0.683 . . . . 0.0 109.648 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 41.1 mmm-85 -100.89 4.26 42.52 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.603 0.716 . . . . 0.0 109.152 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -79.91 74.13 6.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.604 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.426 HG21 ' N ' ' A' ' 51' ' ' GLY . 3.7 m -123.09 134.41 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -127.8 129.18 46.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.628 0.728 . . . . 0.0 109.177 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.95 130.44 10.17 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -106.46 130.89 54.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.676 -0.896 . . . . 0.0 108.901 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -105.37 145.3 30.96 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.603 0.716 . . . . 0.0 110.068 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.44 ' O ' ' CG ' ' A' ' 72' ' ' ASN . 7.1 mm -122.58 147.41 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.721 HD21 ' NE ' ' A' ' 74' ' ' ARG . 6.6 p30 51.53 13.86 0.23 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.721 0.772 . . . . 0.0 109.405 -179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 71' ' ' ILE . . . 88.82 28.87 20.04 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.721 ' NE ' HD21 ' A' ' 72' ' ' ASN . 16.3 ptt85 -153.87 163.99 22.13 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.198 -1.178 . . . . 0.0 109.45 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.07 142.34 99.23 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.421 2.081 . . . . 0.0 112.172 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.3 m -166.03 -32.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.181 -0.95 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.16 153.18 35.87 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.666 -1.271 . . . . 0.0 110.802 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.6 mt -128.52 163.36 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.376 0.608 . . . . 0.0 109.518 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 78' ' ' ILE . 45.1 tt0 -139.99 152.06 45.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.357 -0.839 . . . . 0.0 109.75 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.38 146.21 32.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.433 -0.792 . . . . 0.0 109.443 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.6 m -123.06 132.84 54.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.386 0.612 . . . . 0.0 109.726 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -113.12 132.4 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.724 0.773 . . . . 0.0 109.339 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 85' ' ' ASN . 27.8 mm -76.16 130.67 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-O 121.446 0.641 . . . . 0.0 109.979 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.9 mt -122.81 35.77 4.8 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 83' ' ' ILE . 99.2 m-20 -64.57 -38.91 92.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.567 -0.708 . . . . 0.0 109.535 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.4 p -72.46 155.83 39.69 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.127 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.671 ' CD ' ' H ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -79.32 -42.59 1.63 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.646 -0.659 . . . . 0.0 110.823 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 39.9 Cg_endo -65.49 -24.88 56.03 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.859 1.706 . . . . 0.0 111.449 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.481 ' OE2' HD13 ' A' ' 61' ' ' ILE . 52.8 tp10 -70.83 -36.97 73.14 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.266 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 41.0 m95 -61.73 -42.92 99.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 0.0 109.576 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.47 -50.21 74.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.867 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -69.02 -40.71 78.5 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.734 0.778 . . . . 0.0 109.459 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -60.93 -46.14 91.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.751 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 63.8 ttp -63.25 -44.64 94.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 109.546 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -65.12 -37.7 88.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.516 -0.74 . . . . 0.0 109.857 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.527 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 85.3 t80 -59.74 -45.42 92.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 0.0 109.709 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.42 ' SD ' HG11 ' A' ' 18' ' ' VAL . 91.5 mtp -64.77 -39.9 94.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.284 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.89 -45.05 71.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.472 -0.768 . . . . 0.0 109.514 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.447 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 94.8 mtt-85 -67.04 -39.12 86.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.351 -0.843 . . . . 0.0 109.66 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CE2' ' OD1' ' A' ' 104' ' ' ASN . 90.1 t80 -61.15 -45.96 92.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.37 -34.51 89.54 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -38.77 90.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -1.128 . . . . 0.0 109.55 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -69.33 -38.28 78.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.609 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.476 ' OD1' ' CE2' ' A' ' 100' ' ' TYR . 15.2 m120 -81.24 -74.21 0.34 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.31 -0.869 . . . . 0.0 109.514 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 147.62 44.06 0.03 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 pp -167.9 129.01 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -1.061 . . . . 0.0 109.607 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -98.3 -66.45 0.88 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -78.48 143.67 36.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -1.033 . . . . 0.0 110.46 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.7 p -116.92 -88.14 0.6 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.615 -0.678 . . . . 0.0 109.631 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -143.13 -57.65 0.42 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.27 -0.894 . . . . 0.0 109.869 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -65.82 -15.32 62.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.951 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -68.15 -42.55 79.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.18 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 113' ' ' LEU . 10.5 mp -67.24 -44.01 80.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.268 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 113' ' ' LEU . 13.5 pt-20 28.44 57.0 0.11 Allowed 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.437 0.637 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 113' ' ' LEU . 30.7 m170 -130.36 139.21 50.68 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.721 0.772 . . . . 0.0 109.556 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -150.74 49.96 0.87 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -67.1 -37.88 84.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.358 -0.839 . . . . 0.0 109.186 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 51.75 -104.5 0.18 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.527 -0.733 . . . . 0.0 110.339 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 120' ' ' HIS . 83.2 t60 -149.45 16.41 0.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.044 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 97.5 m-70 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.528 ' HB1' ' CE2' ' A' ' 96' ' ' PHE . . . -83.02 119.33 24.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.541 -0.724 . . . . 0.0 109.854 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.547 ' CD ' HE21 ' A' ' 5' ' ' GLN . 18.7 pt-20 -155.84 159.64 39.54 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.489 -0.757 . . . . 0.0 109.642 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.0 mm -106.78 128.13 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.744 0.783 . . . . 0.0 109.443 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.547 HE21 ' CD ' ' A' ' 3' ' ' GLU . 78.4 mt-30 -138.94 136.88 35.91 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.425 ' O ' ' OG ' ' A' ' 7' ' ' SER . 46.1 m-85 -103.61 -13.6 16.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 6' ' ' PHE . 61.8 m -167.9 169.84 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.52 -0.738 . . . . 0.0 110.172 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -76.49 141.86 41.14 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.67 0.747 . . . . 0.0 110.904 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.63 23.67 52.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -109.44 -34.42 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.498 -1.001 . . . . 0.0 109.051 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.85 168.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.726 0.774 . . . . 0.0 110.43 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.421 ' O ' ' OG1' ' A' ' 13' ' ' THR . 17.6 pt-20 -80.47 139.39 36.44 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.586 0.708 . . . . 0.0 110.338 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.467 HG23 ' OE1' ' A' ' 114' ' ' GLU . 6.3 m -168.86 -35.17 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.7 t -81.49 135.85 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.685 -0.634 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -117.01 82.78 13.93 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.585 -0.697 . . . . 0.0 109.265 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -79.37 156.19 25.35 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 123.048 2.499 . . . . 0.0 112.83 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -85.24 149.16 25.68 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.707 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.9 132.05 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.455 0.645 . . . . 0.0 109.787 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -130.06 144.8 51.54 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.479 0.657 . . . . 0.0 109.45 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.3 mt -111.28 134.56 52.78 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.677 0.751 . . . . 0.0 109.884 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -158.21 167.77 28.89 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -117.83 142.07 47.72 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.716 0.769 . . . . 0.0 109.6 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.0 t -63.15 129.96 42.55 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.765 0.793 . . . . 0.0 110.363 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -66.59 -39.64 88.51 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.612 0.72 . . . . 0.0 109.652 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -71.38 -0.32 9.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.344 -0.847 . . . . 0.0 109.496 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 28' ' ' SER . . . 83.74 20.59 59.49 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -73.62 45.81 0.19 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.414 -1.05 . . . . 0.0 109.67 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.576 ' CB ' HD22 ' A' ' 85' ' ' ASN . 12.6 p 61.33 178.86 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.99 0.9 . . . . 0.0 111.158 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.77 156.68 49.03 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.4 ptm -154.32 172.69 17.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.335 -1.097 . . . . 0.0 110.191 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -147.12 140.23 25.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -107.27 141.14 39.06 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.586 0.708 . . . . 0.0 109.892 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -117.32 126.36 52.58 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -100.48 128.53 46.51 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.451 0.644 . . . . 0.0 109.471 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -111.86 117.33 32.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.6 tp -95.63 127.74 41.92 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.634 0.731 . . . . 0.0 110.298 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 37.99 70.81 1.16 Allowed Pre-proline 0 N--CA 1.496 1.858 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -61.17 141.31 93.15 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.495 2.13 . . . . 0.0 111.855 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 46.2 p -87.42 -18.66 29.45 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.597 -0.689 . . . . 0.0 110.358 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.7 tt -66.68 2.81 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.994 -1.066 . . . . 0.0 109.676 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' THR . 86.5 mt -80.86 -8.74 59.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.7 -17.47 23.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.771 . . . . 0.0 109.17 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -105.38 -50.48 3.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.499 -0.75 . . . . 0.0 109.585 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.54 157.6 45.85 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.371 -0.831 . . . . 0.0 109.936 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.9 t -77.34 164.74 25.25 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.621 0.724 . . . . 0.0 110.562 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -65.27 -37.51 87.42 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.442 0.639 . . . . 0.0 109.968 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -68.69 -16.64 63.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.458 -0.776 . . . . 0.0 109.776 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.74 -0.36 56.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 98.7 mt -94.51 118.0 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -0.93 . . . . 0.0 109.907 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -114.11 121.25 43.21 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.719 0.771 . . . . 0.0 109.458 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.82 177.25 3.47 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -132.66 137.33 46.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.77 -0.841 . . . . 0.0 109.042 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -107.18 111.48 23.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.816 0.817 . . . . 0.0 109.975 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.418 ' C ' HD12 ' A' ' 55' ' ' ILE . 89.6 mt -99.93 125.95 46.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.752 -0.593 . . . . 0.0 109.566 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.703 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.7 mp -101.92 100.31 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.468 -0.77 . . . . 0.0 109.377 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -91.5 176.63 6.48 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.447 0.641 . . . . 0.0 109.89 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 45.8 p-10 -68.26 113.03 5.52 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.764 0.792 . . . . 0.0 110.297 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 57.38 31.5 20.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.756 0.788 . . . . 0.0 109.463 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.94 168.3 40.84 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.46 149.8 28.94 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.288 -1.125 . . . . 0.0 109.766 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.37 129.6 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.3 mt -121.27 131.73 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.334 0.588 . . . . 0.0 109.711 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 t -129.54 142.2 50.81 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.589 0.709 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -96.04 79.47 3.23 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 109.547 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.409 ' O ' ' O ' ' A' ' 66' ' ' VAL . 79.7 mm-40 -141.57 -105.03 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.605 -0.684 . . . . 0.0 109.592 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 65' ' ' GLU . 4.8 t 57.92 113.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.603 0.716 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -126.97 116.53 20.92 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.687 0.756 . . . . 0.0 109.099 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.83 137.26 26.71 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -107.5 124.39 49.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.775 -0.838 . . . . 0.0 108.94 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' C ' HD12 ' A' ' 71' ' ' ILE . 78.7 m-85 -101.02 123.3 45.0 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.56 0.695 . . . . 0.0 110.3 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.788 ' N ' HD12 ' A' ' 71' ' ' ILE . 2.9 mp -107.74 119.81 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.671 0.748 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.21 33.75 22.83 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.455 0.645 . . . . 0.0 110.404 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.64 34.3 39.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.417 ' NH2' ' OG1' ' A' ' 76' ' ' THR . 56.5 ttp85 -152.44 132.75 7.43 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.151 -1.205 . . . . 0.0 109.723 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.81 89.54 0.75 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.6 2.2 . . . . 0.0 111.103 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.433 ' HB ' HD13 ' A' ' 71' ' ' ILE . 6.7 m -105.5 -15.02 15.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.476 -0.765 . . . . 0.0 109.754 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.47 154.27 42.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.091 -1.006 . . . . 0.0 110.307 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.6 mt -133.61 158.59 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 78' ' ' ILE . 43.0 tt0 -139.42 156.76 46.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.361 -0.837 . . . . 0.0 110.142 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.82 148.3 31.75 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.368 0.604 . . . . 0.0 109.379 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.9 m -122.0 132.75 54.68 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.54 0.686 . . . . 0.0 109.505 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 93' ' ' PHE . 47.2 t -109.85 130.56 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.659 0.743 . . . . 0.0 109.469 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.7 mm -98.97 121.59 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.405 0.621 . . . . 0.0 109.559 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.466 HD11 ' CD2' ' A' ' 93' ' ' PHE . 69.7 mt -107.8 65.75 0.65 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.576 HD22 ' CB ' ' A' ' 28' ' ' SER . 13.8 m120 -64.99 -39.5 93.57 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.587 0.708 . . . . 0.0 109.647 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.8 m -72.36 152.51 42.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.907 0.86 . . . . 0.0 110.535 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.513 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 21.1 mt-30 -76.26 -58.28 1.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.845 -0.534 . . . . 0.0 110.882 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 19.6 Cg_endo -56.19 -29.67 76.51 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.24 1.96 . . . . 0.0 111.611 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.96 -34.95 78.87 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.436 0.636 . . . . 0.0 109.596 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -46.54 89.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.347 -0.846 . . . . 0.0 109.715 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.74 -42.7 97.83 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.528 -0.732 . . . . 0.0 109.394 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.43 -40.87 93.82 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.641 0.734 . . . . 0.0 109.049 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CD2' HD11 ' A' ' 84' ' ' LEU . 9.7 t80 -60.94 -42.54 98.39 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.648 0.737 . . . . 0.0 109.244 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -61.72 -41.39 97.57 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.562 0.696 . . . . 0.0 109.624 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -64.56 -39.83 94.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.426 -0.796 . . . . 0.0 109.328 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.528 ' CE2' ' HB1' ' A' ' 2' ' ' ALA . 28.3 t80 -58.63 -44.5 90.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.625 -0.672 . . . . 0.0 109.645 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 13.4 ttt -61.5 -43.92 98.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 109.982 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -70.13 -43.33 71.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.328 -0.858 . . . . 0.0 109.637 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -66.27 -42.14 88.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.404 -0.81 . . . . 0.0 109.514 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -61.05 -43.62 98.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.8 . . . . 0.0 109.839 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -62.42 -36.73 93.54 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.44 98.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -1.034 . . . . 0.0 109.855 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.25 -37.07 71.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.806 . . . . 0.0 109.839 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -118.68 -130.83 0.3 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.535 -0.728 . . . . 0.0 109.966 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.55 125.71 1.37 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.577 HD22 ' N ' ' A' ' 106' ' ' LEU . 3.9 mm? -86.56 137.61 32.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.58 -0.953 . . . . 0.0 110.14 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.03 2.15 90.49 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -102.76 140.15 37.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.518 -0.989 . . . . 0.0 109.982 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.4 p -78.55 165.86 23.23 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.825 0.821 . . . . 0.0 110.648 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -59.43 129.37 41.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.65 0.738 . . . . 0.0 110.333 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -172.73 -101.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.465 0.65 . . . . 0.0 109.686 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.82 -10.24 59.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.476 -0.765 . . . . 0.0 109.519 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 114' ' ' GLU . 53.1 mt -64.93 -38.82 92.25 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.61 0.719 . . . . 0.0 109.351 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.467 ' OE1' HG23 ' A' ' 13' ' ' THR . 79.9 mm-40 -56.93 -110.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.548 -0.72 . . . . 0.0 110.168 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -155.23 152.05 28.85 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.274 -0.891 . . . . 0.0 110.066 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -141.95 151.47 42.6 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.613 0.72 . . . . 0.0 110.072 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -74.48 -7.39 52.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.697 -0.627 . . . . 0.0 109.685 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 76.2 m80 41.25 -117.39 0.34 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.69 0.757 . . . . 0.0 110.575 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 120' ' ' HIS . 85.4 t60 -164.94 100.84 0.77 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.407 -0.808 . . . . 0.0 109.128 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 119' ' ' HIS . 56.6 m170 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.768 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.598 ' H2 ' ' C ' ' A' ' 55' ' ' ILE . 6.8 ptm . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.63 -43.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.633 -0.667 . . . . 0.0 109.316 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -117.31 155.55 29.33 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.539 -0.725 . . . . 0.0 109.664 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.3 mm -103.42 127.8 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.637 -0.665 . . . . 0.0 109.219 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -129.67 124.22 33.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.749 -0.594 . . . . 0.0 109.427 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -106.58 -11.32 15.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 t -168.36 -153.44 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.829 . . . . 0.0 110.038 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -69.9 134.59 48.59 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 110.83 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.1 -88.76 0.05 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t 53.9 95.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.488 -1.007 . . . . 0.0 109.883 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.67 56.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.442 -0.786 . . . . 0.0 110.705 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -100.22 32.79 2.86 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.2 m -69.09 -20.49 64.08 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 p -71.15 -19.11 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.766 -0.584 . . . . 0.0 110.353 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.52 ' O ' ' NZ ' ' A' ' 110' ' ' LYS . 1.4 p 34.05 95.53 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 122.105 -0.372 . . . . 0.0 110.311 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.67 157.31 31.89 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.238 1.959 . . . . 0.0 112.869 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' A' ' 109' ' ' SER . 83.8 tt0 -92.01 152.89 19.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.096 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.77 133.47 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.569 -0.707 . . . . 0.0 109.262 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -128.57 144.22 51.11 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.8 mt -110.81 132.37 54.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.678 -0.639 . . . . 0.0 109.413 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.3 m -154.57 164.38 38.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.55 -0.719 . . . . 0.0 109.598 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -89.61 141.9 28.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.608 -0.683 . . . . 0.0 109.861 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.8 t -61.71 140.31 58.21 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.686 0.755 . . . . 0.0 110.757 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.86 -16.13 45.59 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.636 -0.665 . . . . 0.0 109.342 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -96.46 5.67 50.36 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.147 -0.97 . . . . 0.0 108.762 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.54 15.1 81.37 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -79.39 46.37 0.73 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.146 -1.208 . . . . 0.0 109.847 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.484 ' CB ' HD22 ' A' ' 85' ' ' ASN . 5.6 t 62.03 -169.3 0.18 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.864 0.84 . . . . 0.0 111.213 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.18 161.2 53.31 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -158.72 175.95 12.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.288 -1.125 . . . . 0.0 109.577 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.55 146.34 34.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.61 145.15 38.38 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.501 0.667 . . . . 0.0 109.955 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -112.44 121.25 44.3 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -96.2 123.76 39.95 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.445 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 2.1 m-85 -114.58 126.68 55.19 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-O 121.443 0.639 . . . . 0.0 109.308 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 37' ' ' GLU . 49.2 tp -110.27 116.27 31.19 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.226 0.536 . . . . 0.0 110.023 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' A' ' 39' ' ' THR . 52.2 mm-40 30.5 66.62 0.83 Allowed Pre-proline 0 N--CA 1.501 2.119 0 CA-C-O 120.877 0.37 . . . . 0.0 111.891 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 40' ' ' ILE . 33.3 Cg_exo -65.54 16.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.89 2.393 . . . . 0.0 111.404 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.528 ' H ' ' C ' ' A' ' 37' ' ' GLU . 37.0 p 50.39 14.36 0.15 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.645 -0.66 . . . . 0.0 109.498 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.427 ' N ' ' C ' ' A' ' 38' ' ' PRO . 3.4 tp -90.88 -14.87 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 108.908 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.39 -41.79 96.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.17 -35.07 77.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 109.992 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.31 -64.25 1.2 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.418 -0.801 . . . . 0.0 109.884 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 40' ' ' ILE . 80.0 mm-40 -117.45 143.24 46.23 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.595 -0.691 . . . . 0.0 109.785 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.5 m -73.95 162.23 29.28 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.529 0.68 . . . . 0.0 110.325 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.417 ' HG1' ' HZ ' ' A' ' 70' ' ' PHE . 44.2 p -65.83 -34.65 78.64 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 51.9 p-10 -67.96 -25.3 65.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.387 -0.821 . . . . 0.0 109.838 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 56.8 t0 -83.06 -9.15 59.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.067 -1.021 . . . . 0.0 109.302 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -96.59 111.07 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.247 -0.908 . . . . 0.0 108.748 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.5 m -126.82 126.26 43.07 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.567 0.698 . . . . 0.0 109.868 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 155.4 1.31 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 60.6 ttp -117.88 132.93 56.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.907 . . . . 0.0 109.291 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -108.71 119.65 40.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.69 -0.631 . . . . 0.0 109.497 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.7 mt -99.34 107.55 19.85 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.598 ' C ' ' H2 ' ' A' ' 1' ' ' MET . 96.5 mt -115.4 165.46 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.643 -0.661 . . . . 0.0 109.838 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.598 ' N ' HG22 ' A' ' 55' ' ' ILE . 64.2 t0 -151.9 -117.88 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 0.0 109.882 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 97.5 m-20 -79.48 -21.7 45.04 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.419 -0.8 . . . . 0.0 109.955 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -175.38 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 147.22 46.06 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -144.25 147.42 33.55 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.284 -1.127 . . . . 0.0 109.64 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.494 ' C ' HD12 ' A' ' 62' ' ' ILE . 87.7 mt -128.96 137.99 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.837 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.6 mp -105.04 129.77 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.839 . . . . 0.0 109.675 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 65' ' ' GLU . 94.9 m -122.3 129.5 52.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.413 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 48.7 mmm-85 -112.17 46.47 1.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 56.9 mp0 -143.85 80.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.23 134.75 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.699 -0.626 . . . . 0.0 109.591 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -127.18 141.58 51.71 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.52 139.5 14.53 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -90.43 105.71 18.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 108.442 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.417 ' HZ ' ' HG1' ' A' ' 46' ' ' THR . 66.4 m-85 -94.77 135.36 36.35 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.393 0.616 . . . . 0.0 110.119 -179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 73' ' ' GLY . 45.9 mm -115.11 131.83 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.33 0.586 . . . . 0.0 109.429 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 71' ' ' ILE . 23.2 p30 44.08 16.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.957 -0.464 . . . . 0.0 110.339 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 109.38 -24.15 21.04 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 71' ' ' ILE . 16.3 ptp180 -100.72 147.24 33.37 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.145 -1.209 . . . . 0.0 110.122 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.78 143.35 66.95 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.652 2.234 . . . . 0.0 112.715 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.406 ' OG1' ' CG1' ' A' ' 71' ' ' ILE . 4.3 m -140.87 -29.86 0.65 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 35' ' ' PHE . . . -156.43 171.55 20.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 109.615 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.2 mt -131.85 144.29 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.572 0.701 . . . . 0.0 110.34 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -128.07 142.7 51.14 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.41 143.89 32.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 0.0 108.966 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.4 m -123.63 134.39 53.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.631 . . . . 0.0 109.665 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.62 130.73 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.5 mm -88.25 123.87 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.512 -0.743 . . . . 0.0 110.04 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.8 mt -98.62 56.83 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.484 HD22 ' CB ' ' A' ' 28' ' ' SER . 11.3 m120 -64.42 -39.99 94.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.516 -0.74 . . . . 0.0 109.437 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -83.29 145.65 28.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 0.0 110.048 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -71.61 -46.49 12.85 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 46.3 Cg_exo -54.9 -28.45 58.74 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.152 1.901 . . . . 0.0 111.323 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -59.47 -37.54 78.44 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.457 -0.777 . . . . 0.0 109.421 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -57.87 -37.35 73.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -59.55 -45.0 93.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.23 -0.919 . . . . 0.0 109.422 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -64.76 -40.67 95.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.373 -0.829 . . . . 0.0 109.612 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -65.81 -39.58 91.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.321 -0.862 . . . . 0.0 109.865 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 54.7 ttp -59.87 -45.5 92.28 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.187 -0.945 . . . . 0.0 110.171 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -64.83 -38.29 90.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.916 . . . . 0.0 109.396 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 96' ' ' PHE . 17.6 t80 -59.69 -46.9 87.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 36.5 ttm -65.56 -39.5 91.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.228 -0.92 . . . . 0.0 109.404 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.01 -52.5 23.65 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.365 -0.835 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -65.23 -54.43 29.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.533 -0.73 . . . . 0.0 109.846 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -64.05 -45.12 90.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.412 -0.805 . . . . 0.0 109.562 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.31 -34.34 89.17 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.62 95.05 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.297 -1.12 . . . . 0.0 109.561 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -68.71 -38.38 80.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.261 -0.899 . . . . 0.0 109.308 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -160.57 117.13 2.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.399 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.72 144.13 48.65 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -100.84 -14.85 17.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.711 -0.876 . . . . 0.0 108.746 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 50.11 -175.14 0.05 OUTLIER Glycine 0 N--CA 1.487 2.048 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' C ' ' H ' ' A' ' 110' ' ' LYS . 61.9 m-85 -95.82 128.62 42.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.519 -0.989 . . . . 0.0 109.982 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.544 ' N ' ' OE2' ' A' ' 17' ' ' GLU . 2.9 p 71.67 -43.02 0.55 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.738 -0.601 . . . . 0.0 109.446 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 15' ' ' VAL . 28.4 ttpt 52.35 6.83 0.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 109.945 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 109' ' ' SER . 26.9 t -90.4 -16.26 29.42 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.337 -0.852 . . . . 0.0 109.038 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -139.46 -8.75 1.27 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.42 -0.8 . . . . 0.0 109.308 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 113' ' ' LEU . 10.5 mp -85.4 -5.48 59.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.342 -0.849 . . . . 0.0 109.538 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -118.14 72.09 0.85 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.468 -0.77 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -67.28 -41.87 84.77 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -131.37 123.04 27.39 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.429 ' CG ' ' O ' ' A' ' 117' ' ' HIS . 84.3 t60 -151.45 28.16 0.65 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -66.34 -38.78 88.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.611 -0.681 . . . . 0.0 109.239 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -72.27 136.46 46.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.295 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 61.9 m170 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.709 -179.92 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.43 0.634 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.452 ' HB1' ' CE1' ' A' ' 96' ' ' PHE . . . -76.82 121.55 23.53 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -0.822 . . . . 0.0 110.091 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -155.57 153.24 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.414 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -111.13 128.52 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' HG2' HD13 ' A' ' 55' ' ' ILE . 21.5 pt20 -152.41 161.37 42.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.045 -1.034 . . . . 0.0 109.615 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.37 -31.06 9.22 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.3 t -113.45 132.33 55.69 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.538 0.685 . . . . 0.0 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -67.26 135.65 53.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.766 . . . . 0.0 110.346 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.25 -13.28 67.09 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.46 116.27 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.274 -1.133 . . . . 0.0 109.868 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.77 90.36 8.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.632 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -72.22 136.68 46.44 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.273 -0.892 . . . . 0.0 109.881 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.7 p -99.92 5.28 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.246 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.9 t -55.97 141.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.975 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.92 84.32 13.1 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.554 -0.716 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.0 150.85 23.6 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.931 2.421 . . . . 0.0 112.893 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -92.96 139.25 30.72 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 33' ' ' PHE . 21.8 t -99.03 129.71 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.291 -0.881 . . . . 0.0 109.953 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.464 ' C ' HD22 ' A' ' 20' ' ' LEU . 1.3 mpp_? -132.23 145.76 51.54 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.622 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.6 mm? -96.67 121.39 38.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.133 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 31' ' ' ALA . 53.3 m -109.1 167.52 10.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.573 -0.704 . . . . 0.0 109.651 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -126.31 138.65 53.61 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.594 0.711 . . . . 0.0 110.045 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.423 ' HB2' HE21 ' A' ' 27' ' ' GLN . 6.9 m -58.91 175.23 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 110.769 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.4 -43.99 92.69 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.373 -0.83 . . . . 0.0 109.888 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.608 ' H ' HE22 ' A' ' 27' ' ' GLN . 13.0 m120 -108.1 -4.28 17.86 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.125 -0.984 . . . . 0.0 108.816 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.8 31.78 64.54 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.723 ' H ' ' NE2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -80.35 -8.18 59.39 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.087 -1.243 . . . . 0.0 109.547 -179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -160.4 160.23 32.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.003 -1.061 . . . . 0.0 110.135 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.43 149.09 44.85 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttp -151.87 144.75 24.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.331 -1.099 . . . . 0.0 109.178 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HA ' ' H ' ' A' ' 21' ' ' SER . . . -143.08 147.77 35.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.194 -0.941 . . . . 0.0 108.691 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -119.4 144.55 46.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.319 0.58 . . . . 0.0 110.181 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 18' ' ' VAL . 81.3 m-85 -116.52 131.82 56.84 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -105.52 127.81 53.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.643 -0.66 . . . . 0.0 109.245 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -111.21 117.34 32.95 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 37' ' ' GLU . 50.4 tp -92.75 128.96 38.8 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.346 0.593 . . . . 0.0 110.517 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 36' ' ' LEU . 94.0 mt-10 35.84 71.78 0.84 Allowed Pre-proline 0 N--CA 1.498 1.96 0 CA-C-O 121.083 0.468 . . . . 0.0 111.161 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.75 141.03 93.78 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.613 2.209 . . . . 0.0 112.217 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.0 p -83.29 -18.61 38.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.483 -0.76 . . . . 0.0 109.74 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.9 tt -66.18 1.1 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.19 -0.944 . . . . 0.0 109.736 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.84 -9.41 58.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.035 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.64 -17.89 23.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.922 . . . . 0.0 109.113 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -105.81 -47.92 3.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.609 -0.682 . . . . 0.0 109.449 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -138.6 153.6 48.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.398 -0.814 . . . . 0.0 110.177 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -72.58 158.36 35.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.628 0.728 . . . . 0.0 110.327 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -64.23 -26.9 68.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 0.0 109.234 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 44.4 p30 -67.31 -19.82 65.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 94.5 m-20 -79.74 -5.09 54.59 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.233 -0.917 . . . . 0.0 109.735 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 88.5 mt -97.11 118.46 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 109.599 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -0.33 14.69 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -170.26 179.4 42.47 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.421 ' CE ' HD21 ' A' ' 54' ' ' LEU . 63.9 ttp -132.5 141.61 48.85 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.434 -1.039 . . . . 0.0 109.763 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -111.35 118.64 36.41 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.416 0.627 . . . . 0.0 109.54 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 55' ' ' ILE . 78.4 mt -101.52 122.52 43.96 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -105.77 120.83 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.509 -0.744 . . . . 0.0 109.012 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -102.12 -153.95 0.48 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 109.807 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -73.33 -6.06 43.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.891 . . . . 0.0 109.603 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -174.15 -54.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 108.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.96 166.21 54.39 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -145.62 147.58 32.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -1.128 . . . . 0.0 109.182 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.94 131.51 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.653 -0.654 . . . . 0.0 109.508 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -113.96 128.98 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.9 133.76 47.06 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.544 0.688 . . . . 0.0 109.679 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -94.94 -3.52 48.46 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -84.66 76.12 10.23 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.78 133.41 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.653 -0.654 . . . . 0.0 109.4 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -127.48 140.58 52.05 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.1 142.35 16.42 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -104.62 111.27 23.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.499 -1.001 . . . . 0.0 108.723 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 22.8 m-85 -101.93 125.81 48.7 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.5 mt -111.71 120.93 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.7 m120 57.13 33.44 23.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.578 -0.701 . . . . 0.0 109.323 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.46 25.38 74.86 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -130.58 100.19 18.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.291 -1.123 . . . . 0.0 109.694 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -46.97 93.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.263 1.975 . . . . 0.0 112.055 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 m -112.65 -15.7 12.95 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.722 . . . . 0.0 109.754 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.86 157.89 43.76 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.736 -1.228 . . . . 0.0 110.737 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.85 138.05 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -117.7 147.05 43.3 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.293 -0.879 . . . . 0.0 109.758 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.59 143.18 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.6 m -126.36 130.93 51.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.666 -0.646 . . . . 0.0 109.465 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.451 ' C ' HD12 ' A' ' 83' ' ' ILE . 45.0 t -115.56 129.95 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.534 0.683 . . . . 0.0 109.252 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.722 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.8 mp -94.44 123.1 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -0.76 . . . . 0.0 109.706 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.58 110.52 22.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.47 -0.769 . . . . 0.0 109.209 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -95.9 -0.92 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 109.143 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.07 152.85 48.23 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.474 -0.766 . . . . 0.0 109.998 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.584 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.6 tp-100 -76.69 -40.29 2.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.621 -0.674 . . . . 0.0 110.801 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.4 Cg_exo -55.25 -30.54 72.31 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.151 1.901 . . . . 0.0 111.413 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -64.99 -40.92 95.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.668 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.617 ' CZ3' HD12 ' A' ' 20' ' ' LEU . 25.3 m95 -56.63 -36.74 69.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.11 -0.994 . . . . 0.0 109.488 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.4 -41.33 98.59 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.501 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.36 -44.31 91.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.179 -0.951 . . . . 0.0 109.473 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -65.25 -42.35 93.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 109.476 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -61.39 -46.09 91.61 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.594 -179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -68.84 -43.27 75.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.316 -0.865 . . . . 0.0 109.223 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.452 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 91.2 t80 -62.12 -46.05 90.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.456 -0.777 . . . . 0.0 109.411 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 63.7 ttp -63.99 -40.12 95.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.597 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.11 -49.8 68.54 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -66.19 -42.38 88.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.173 -0.954 . . . . 0.0 109.291 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.526 ' CZ ' ' OD1' ' A' ' 104' ' ' ASN . 79.0 t80 -63.72 -41.5 98.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.36 -36.81 93.06 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 -40.16 95.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.362 -1.081 . . . . 0.0 109.536 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.08 -36.99 75.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.303 -0.873 . . . . 0.0 109.669 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.526 ' OD1' ' CZ ' ' A' ' 100' ' ' TYR . 7.8 m120 -115.05 -140.42 0.38 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.5 -0.75 . . . . 0.0 109.884 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 106' ' ' LEU . . . -156.52 43.57 0.53 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.647 ' H ' HD22 ' A' ' 106' ' ' LEU . 3.4 mm? 39.14 92.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.679 -0.894 . . . . 0.0 110.914 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.67 -168.93 46.32 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.545 ' C ' ' H ' ' A' ' 110' ' ' LYS . 83.3 t80 -89.64 87.19 6.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.42 -1.047 . . . . 0.0 109.413 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 111' ' ' SER . 1.8 m 61.36 -5.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.617 -0.677 . . . . 0.0 109.881 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 108' ' ' PHE . 23.1 pttm 33.77 30.26 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.608 0.718 . . . . 0.0 110.552 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 109' ' ' SER . 79.9 p -89.7 -8.72 51.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.769 . . . . 0.0 109.429 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.52 -28.92 2.02 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.28 -41.19 97.02 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.53 -0.731 . . . . 0.0 109.113 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -76.06 140.48 41.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 110.665 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -86.71 138.83 31.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.41 -0.806 . . . . 0.0 110.32 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 43.4 81.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.765 . . . . 0.0 110.014 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -90.66 130.19 36.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.437 -0.789 . . . . 0.0 110.308 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -72.31 144.32 48.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.749 -0.594 . . . . 0.0 110.407 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -105.04 127.55 52.92 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.544 -0.722 . . . . 0.0 110.192 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.377 179.678 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 2' ' ' ALA . 77.6 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 56.39 113.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.782 0.801 . . . . 0.0 110.114 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -147.79 149.9 33.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.909 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.33 130.41 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.72 -0.612 . . . . 0.0 109.418 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -127.81 133.37 49.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 109.565 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.34 -67.02 0.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -111.86 14.44 20.99 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 60.19 126.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.871 0.844 . . . . 0.0 111.187 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.33 7.96 69.01 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 m -110.73 141.73 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.586 -0.949 . . . . 0.0 110.011 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.584 ' H ' ' HZ3' ' A' ' 43' ' ' LYS . . . -61.86 140.9 58.23 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.635 0.731 . . . . 0.0 110.771 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' O ' ' OG1' ' A' ' 13' ' ' THR . 49.9 tp10 -97.95 -65.95 0.93 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.548 -0.72 . . . . 0.0 109.455 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.503 ' CG2' ' CZ ' ' A' ' 108' ' ' PHE . 7.0 p 51.01 177.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.578 0.704 . . . . 0.0 110.432 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 13' ' ' THR . 53.2 t 57.73 148.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.582 0.706 . . . . 0.0 110.439 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 15' ' ' VAL . 7.4 p -105.1 105.04 50.16 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.87 143.87 33.83 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.555 2.17 . . . . 0.0 112.692 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 56.4 mp0 -97.18 142.74 28.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.453 -0.78 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.512 HG22 ' CE2' ' A' ' 33' ' ' PHE . 3.7 t -106.15 126.53 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 121.409 0.623 . . . . 0.0 109.35 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 80.5 mtp85 -110.65 145.04 38.63 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.608 0.718 . . . . 0.0 109.654 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.9 mm? -95.39 139.74 31.25 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.666 0.746 . . . . 0.0 109.712 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 m -153.38 167.48 29.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.49 -0.756 . . . . 0.0 109.929 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -106.32 152.07 24.03 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.679 0.752 . . . . 0.0 109.97 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 p -73.43 165.85 24.3 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.857 0.837 . . . . 0.0 110.873 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -62.54 -35.82 80.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.764 -0.585 . . . . 0.0 109.623 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -85.11 -0.26 53.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.17 -0.956 . . . . 0.0 108.921 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.85 62.98 5.39 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -155.1 -68.74 0.13 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -1.126 . . . . 0.0 109.351 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.423 ' OG ' ' ND2' ' A' ' 85' ' ' ASN . 41.1 t -71.25 148.8 46.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.344 -0.848 . . . . 0.0 110.774 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.74 149.63 48.85 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.2 ttt -141.66 130.21 22.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -1.11 . . . . 0.0 108.96 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.24 145.42 50.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.723 . . . . 0.0 109.27 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.84 149.38 42.66 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.512 ' CE2' HG22 ' A' ' 18' ' ' VAL . 58.1 m-85 -122.6 139.63 53.71 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -114.58 123.36 49.15 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 118.98 36.67 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.25 107.93 19.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.762 0.792 . . . . 0.0 110.185 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 39' ' ' THR . 64.4 mm-40 47.83 61.81 13.1 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.842 -0.536 . . . . 0.0 110.625 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HG2' HG22 ' A' ' 40' ' ' ILE . 37.6 Cg_endo -66.83 15.38 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.335 2.023 . . . . 0.0 110.854 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 37' ' ' GLU . 25.7 p 51.86 22.29 1.7 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.713 -0.617 . . . . 0.0 110.25 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.518 HG22 ' HG2' ' A' ' 38' ' ' PRO . 14.4 tt -97.08 -13.75 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.311 -0.868 . . . . 0.0 109.228 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.44 -40.14 89.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.383 -0.823 . . . . 0.0 109.475 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.59 -14.63 59.6 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.557 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.584 ' HZ3' ' H ' ' A' ' 11' ' ' ALA . 54.2 mtpt -99.55 -63.24 1.14 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.315 -0.866 . . . . 0.0 109.709 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -119.93 138.91 53.16 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.76 0.79 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 m -71.33 150.67 44.89 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.714 0.769 . . . . 0.0 110.709 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.4 p -59.27 -40.69 86.84 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.421 0.629 . . . . 0.0 109.819 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -71.17 -15.86 62.5 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -0.764 . . . . 0.0 109.691 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.52 -7.72 49.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.156 -0.965 . . . . 0.0 109.082 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 92.1 mt -91.46 114.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.123 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.83 125.4 35.6 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.883 0.849 . . . . 0.0 109.642 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.77 157.02 15.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.4 ttt -132.73 127.57 35.01 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -109.18 108.07 18.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.5 -0.75 . . . . 0.0 109.65 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.7 mt -99.28 129.03 45.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.623 -0.673 . . . . 0.0 109.325 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.88 127.95 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.353 0.597 . . . . 0.0 110.171 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.505 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 18.5 p-10 -99.21 -132.45 0.24 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.676 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.461 ' N ' ' CG ' ' A' ' 56' ' ' ASP . 99.7 m-20 -63.13 -43.21 99.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -149.25 -50.16 0.15 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.365 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.75 168.73 13.1 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -140.29 155.52 46.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -1.028 . . . . 0.0 110.283 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.05 136.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.72 132.52 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.604 -0.685 . . . . 0.0 109.761 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 t -143.63 151.59 40.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.368 -0.832 . . . . 0.0 109.614 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -104.25 3.52 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -81.5 79.32 8.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.349 -0.844 . . . . 0.0 109.316 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 87.1 t -125.81 135.37 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.62 -0.675 . . . . 0.0 109.795 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.9 136.86 48.99 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.5 -0.75 . . . . 0.0 109.582 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.55 141.59 15.68 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -99.98 106.94 18.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.501 -1.0 . . . . 0.0 109.443 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -101.6 143.9 31.0 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.643 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 73' ' ' GLY . 93.5 mt -120.88 134.12 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 71' ' ' ILE . 46.3 m-80 -37.74 92.51 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.65 0.738 . . . . 0.0 110.538 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 148.44 -60.6 0.45 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -174.84 154.45 1.8 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.179 . . . . 0.0 109.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -45.61 138.77 10.74 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.09 1.86 . . . . 0.0 112.099 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.442 ' CB ' HD12 ' A' ' 71' ' ' ILE . 66.8 m -132.7 -30.01 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.595 -0.691 . . . . 0.0 109.918 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -153.17 164.04 38.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.682 -1.262 . . . . 0.0 110.577 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -128.54 150.24 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.19 151.0 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.611 0.719 . . . . 0.0 109.695 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.87 144.56 35.36 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.6 m -123.21 133.5 54.21 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.666 -0.646 . . . . 0.0 109.882 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.2 t -111.63 130.31 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mm -98.83 123.91 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.625 0.726 . . . . 0.0 109.795 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.11 83.02 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.423 ' ND2' ' OG ' ' A' ' 28' ' ' SER . 11.9 m120 -91.54 8.14 37.99 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.93 141.18 44.48 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.827 0.823 . . . . 0.0 109.195 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.589 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.0 mm100 -65.5 -40.87 45.68 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.706 -0.621 . . . . 0.0 110.549 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.9 Cg_exo -56.72 -36.61 98.5 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.369 2.046 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.86 -32.39 70.74 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.452 0.644 . . . . 0.0 109.646 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -60.36 -47.28 86.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.5 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.68 -44.5 90.14 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.488 -0.758 . . . . 0.0 109.666 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.505 ' NH1' ' OD2' ' A' ' 56' ' ' ASP . 62.8 ttm-85 -66.63 -41.1 88.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.478 -0.764 . . . . 0.0 109.441 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -60.2 -44.75 94.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.488 -0.757 . . . . 0.0 109.952 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.8 mmm -63.82 -41.7 97.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.35 -0.844 . . . . 0.0 109.986 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.9 -44.14 86.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.0 -49.75 73.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 110.35 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.432 ' SD ' ' C ' ' A' ' 97' ' ' MET . 14.1 tmm? -68.44 -41.58 80.1 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.439 -0.788 . . . . 0.0 110.139 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 81.4 tt0 -66.54 -49.21 67.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 110.179 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.42 -43.28 81.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.163 -0.961 . . . . 0.0 110.265 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.39 -52.34 65.0 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.451 -0.78 . . . . 0.0 110.329 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.489 ' O ' ' ND2' ' A' ' 104' ' ' ASN . . . -76.63 -33.32 47.69 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 98' ' ' GLU . . . -48.94 -50.35 35.81 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.906 -1.35 . . . . 0.0 108.492 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 104' ' ' ASN . 96.8 mt-10 -71.49 -36.69 71.21 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.635 0.731 . . . . 0.0 109.111 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 101' ' ' GLY . 0.3 OUTLIER 56.18 157.22 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.233 1.016 . . . . 0.0 111.019 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.48 12.07 78.98 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.124 -1.591 . . . . 0.0 109.124 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 106' ' ' LEU . 10.1 mp -77.57 138.99 39.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.391 -1.064 . . . . 0.0 111.024 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.33 -55.51 0.01 OUTLIER Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.503 ' CZ ' ' CG2' ' A' ' 13' ' ' THR . 51.5 m-85 -99.01 119.34 37.63 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.194 -1.18 . . . . 0.0 110.417 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.4 p -100.88 -115.83 0.17 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.609 -0.682 . . . . 0.0 109.435 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -129.19 -19.4 3.53 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.514 -0.741 . . . . 0.0 109.76 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 113' ' ' LEU . 23.6 p -65.62 157.25 30.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.057 -1.027 . . . . 0.0 110.348 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 66.44 -43.01 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.407 0.623 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 111' ' ' SER . 65.4 mt -64.54 -41.65 96.21 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.271 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 116' ' ' HIS . 9.2 pt-20 -64.59 131.17 46.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.457 -0.777 . . . . 0.0 109.995 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.417 ' O ' ' O ' ' A' ' 116' ' ' HIS . 50.4 p-80 -102.65 -11.44 18.43 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.716 0.769 . . . . 0.0 109.047 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.48 ' NE2' ' CD ' ' A' ' 114' ' ' GLU . 93.4 m-70 43.64 -169.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.913 0.863 . . . . 0.0 111.411 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 50.94 46.83 25.77 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.672 0.749 . . . . 0.0 110.346 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 119' ' ' HIS . 11.0 p80 -67.68 -41.18 84.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.619 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.465 ' N ' ' CG ' ' A' ' 118' ' ' HIS . 39.5 t-80 -74.77 175.24 8.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.352 -0.843 . . . . 0.0 110.752 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.464 ' H ' ' CG ' ' A' ' 119' ' ' HIS . 96.6 m-70 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.851 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 ttm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.31 104.97 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.737 0.78 . . . . 0.0 110.329 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' THR . 17.1 pt-20 -155.68 165.25 37.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 110.995 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.9 mp -106.8 128.37 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.542 0.687 . . . . 0.0 109.617 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -150.01 131.38 14.67 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.734 0.778 . . . . 0.0 109.532 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -63.64 -43.78 95.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.7 m -119.19 120.48 37.2 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.813 0.816 . . . . 0.0 109.292 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -66.49 137.48 56.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.855 0.836 . . . . 0.0 111.043 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.66 -13.94 53.65 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.21 164.79 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 110.401 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.55 52.36 9.93 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.612 0.72 . . . . 0.0 109.642 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.564 ' C ' ' HG1' ' A' ' 13' ' ' THR . 17.8 pt-20 -76.24 174.28 10.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.551 -0.718 . . . . 0.0 110.213 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.564 ' HG1' ' C ' ' A' ' 12' ' ' GLU . 72.0 p 55.24 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.612 0.72 . . . . 0.0 110.069 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 12' ' ' GLU . 2.4 t 56.6 155.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.839 0.828 . . . . 0.0 110.526 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.7 66.24 72.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.71 -0.619 . . . . 0.0 109.401 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.41 145.61 18.87 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 123.173 2.582 . . . . 0.0 112.055 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -88.82 147.65 24.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 109.679 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG22 ' CE2' ' A' ' 33' ' ' PHE . 71.4 t -117.1 130.97 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.648 0.737 . . . . 0.0 109.378 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.1 145.44 50.73 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -105.29 142.98 34.1 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.748 0.785 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 p -151.79 162.86 40.34 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.711 -0.618 . . . . 0.0 109.512 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -116.43 135.06 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.767 0.794 . . . . 0.0 109.746 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t -64.5 135.84 56.44 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.617 0.723 . . . . 0.0 110.246 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -83.28 -14.65 52.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.495 -0.753 . . . . 0.0 109.147 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -92.91 6.62 47.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.285 -0.884 . . . . 0.0 108.851 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 28' ' ' SER . . . 80.57 14.82 79.34 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -74.03 40.51 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -1.094 . . . . 0.0 109.095 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 26' ' ' GLY . 11.9 t 58.45 -179.18 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.973 0.892 . . . . 0.0 110.891 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.55 156.84 53.17 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -147.32 156.93 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -1.107 . . . . 0.0 110.345 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.26 141.94 48.5 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -111.86 134.16 53.6 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.454 0.645 . . . . 0.0 109.934 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CE2' HG22 ' A' ' 18' ' ' VAL . 74.2 m-85 -112.95 144.18 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.546 0.689 . . . . 0.0 109.713 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -131.33 125.04 31.69 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.416 0.627 . . . . 0.0 109.387 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 46.3 m-85 -110.98 119.79 40.24 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.66 0.743 . . . . 0.0 109.333 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.0 tp -93.76 119.36 32.63 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.901 0.858 . . . . 0.0 110.512 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 39.06 56.73 5.79 Favored Pre-proline 0 N--CA 1.492 1.672 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.042 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.86 149.58 72.66 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.275 1.983 . . . . 0.0 111.988 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 41' ' ' LEU . 39.1 p -71.29 -17.11 62.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.1 tp -63.44 2.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 109.79 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 39' ' ' THR . 91.1 mt -95.17 -18.42 20.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.166 -0.959 . . . . 0.0 108.87 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.64 -20.0 18.61 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.849 . . . . 0.0 109.23 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -95.33 -75.02 0.53 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.321 -0.862 . . . . 0.0 109.639 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -101.96 141.81 34.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.427 -0.796 . . . . 0.0 110.074 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.5 t -68.42 157.0 36.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.782 0.801 . . . . 0.0 110.353 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.3 p -65.59 -32.74 74.49 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.501 0.667 . . . . 0.0 109.925 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.0 -17.18 62.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.395 -0.816 . . . . 0.0 109.344 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -85.65 -7.09 59.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.56 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.15 127.85 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.129 -0.982 . . . . 0.0 109.74 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -151.14 32.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.77 5.13 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 37.2 ttm -114.11 133.27 55.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.617 -0.931 . . . . 0.0 109.451 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -112.22 121.16 44.15 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.685 0.755 . . . . 0.0 109.168 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.558 ' C ' HD12 ' A' ' 55' ' ' ILE . 73.8 mt -99.45 125.38 45.17 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.728 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -107.04 125.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.478 0.656 . . . . 0.0 109.318 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 58' ' ' GLU . 65.5 t0 -125.85 17.4 7.98 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 64.31 -62.12 0.18 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.348 0.594 . . . . 0.0 110.242 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 56' ' ' ASP . 96.3 mt-10 -72.98 -0.85 14.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.83 173.57 36.71 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -144.92 148.57 34.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -1.077 . . . . 0.0 109.761 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.25 133.62 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.538 0.685 . . . . 0.0 109.258 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mp -107.9 126.36 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.722 0.773 . . . . 0.0 109.264 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' N ' ' A' ' 64' ' ' ARG . 6.2 m -137.27 160.79 38.02 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.817 0.818 . . . . 0.0 109.316 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.475 ' N ' HG22 ' A' ' 63' ' ' THR . 84.5 mmt-85 -102.92 -116.9 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' ARG . 79.8 mm-40 35.75 77.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.601 0.715 . . . . 0.0 110.192 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 71.7 t -124.92 131.95 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.83 138.58 52.13 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.582 0.706 . . . . 0.0 109.407 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -103.39 132.93 11.23 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -99.58 108.26 20.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.497 -1.002 . . . . 0.0 108.685 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -102.61 145.09 30.16 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.679 0.752 . . . . 0.0 109.998 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.4 mt -122.71 135.13 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 71' ' ' ILE . 9.3 p30 -37.79 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.894 0.854 . . . . 0.0 110.735 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 150.69 -62.44 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -178.54 150.72 0.7 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.243 -1.151 . . . . 0.0 109.531 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -37.49 118.66 0.26 Allowed 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 122.632 2.221 . . . . 0.0 111.779 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.446 ' CB ' HD12 ' A' ' 71' ' ' ILE . 45.1 m -110.93 -33.57 6.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 0.0 110.238 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.87 161.11 41.55 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.773 -1.204 . . . . 0.0 110.836 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.426 HD11 HD21 ' A' ' 41' ' ' LEU . 96.7 mt -128.16 152.42 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.558 0.694 . . . . 0.0 109.376 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -137.93 153.15 49.52 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.578 0.704 . . . . 0.0 109.568 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -151.4 154.03 35.86 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 m -123.96 131.24 53.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.41 0.624 . . . . 0.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.9 t -112.9 131.94 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.561 HG22 ' ND2' ' A' ' 85' ' ' ASN . 14.0 mm -96.25 122.63 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.927 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 81.2 mt -110.0 108.21 18.37 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.547 0.689 . . . . 0.0 109.497 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.561 ' ND2' HG22 ' A' ' 83' ' ' ILE . 6.5 m-80 -110.26 -54.85 2.53 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.541 0.686 . . . . 0.0 109.524 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.02 145.82 55.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.311 -0.868 . . . . 0.0 110.683 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.8 OUTLIER -67.02 -43.22 45.94 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.64 -0.663 . . . . 0.0 110.526 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 52.5 Cg_exo -53.78 -36.31 81.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.074 1.85 . . . . 0.0 111.317 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.86 -41.96 99.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.629 -0.67 . . . . 0.0 109.632 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.54 -38.92 91.89 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.27 -0.893 . . . . 0.0 110.009 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.64 -48.46 81.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 108.959 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -69.07 -41.89 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.728 0.775 . . . . 0.0 109.376 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -61.25 -45.35 94.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.495 -0.753 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 53.9 mtt -64.19 -39.57 94.26 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.232 -0.918 . . . . 0.0 109.594 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -61.45 -41.38 97.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 109.843 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -60.44 -44.02 96.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.831 . . . . 0.0 109.73 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.7 mtp -63.46 -40.37 96.96 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.253 -0.905 . . . . 0.0 109.546 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.68 -46.47 72.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -66.63 -43.62 84.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.363 -0.835 . . . . 0.0 109.915 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.494 ' CE1' HD11 ' A' ' 106' ' ' LEU . 48.6 t80 -64.74 -42.05 95.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.481 -0.762 . . . . 0.0 109.691 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.98 -40.95 94.07 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.85 -39.76 94.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.514 -0.992 . . . . 0.0 109.539 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -39.69 76.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.416 -0.802 . . . . 0.0 109.517 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -124.69 -94.23 0.49 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 149.05 95.27 0.14 Allowed Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.494 HD11 ' CE1' ' A' ' 100' ' ' TYR . 82.9 mt -104.17 129.44 51.91 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.48 -1.012 . . . . 0.0 109.647 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.48 -71.13 1.09 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -174.84 -127.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.62 -0.929 . . . . 0.0 109.928 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -72.64 148.91 44.36 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.9 0.857 . . . . 0.0 110.865 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -64.38 -39.83 94.63 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.422 0.63 . . . . 0.0 109.94 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.5 p -65.18 -20.1 66.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 0.0 109.3 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -88.52 -6.72 57.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.328 -0.857 . . . . 0.0 109.113 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -120.46 -132.39 0.3 Allowed 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.613 0.72 . . . . 0.0 109.805 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 56.4 25.5 9.62 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.86 0.838 . . . . 0.0 109.438 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.527 ' ND1' ' N ' ' A' ' 115' ' ' HIS . 0.1 OUTLIER -76.24 162.42 27.96 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.881 0.848 . . . . 0.0 110.262 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -66.57 -37.5 85.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.67 -0.644 . . . . 0.0 109.583 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.441 ' O ' ' NE2' ' A' ' 115' ' ' HIS . 5.2 t-160 -67.86 126.48 29.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 109.974 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -67.05 -41.13 87.01 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.679 -0.638 . . . . 0.0 109.426 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -139.69 143.91 37.3 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.305 -0.872 . . . . 0.0 109.876 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.09 -0.957 . . . . 0.0 108.991 179.668 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' ALA . 97.4 mtp . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.961 0.886 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 1' ' ' MET . . . -0.94 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.527 ' OE2' ' NE2' ' A' ' 5' ' ' GLN . 18.5 pt-20 -156.88 165.92 34.82 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.279 -0.888 . . . . 0.0 109.977 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.73 130.35 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.502 -0.749 . . . . 0.0 109.147 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' NE2' ' OE2' ' A' ' 3' ' ' GLU . 78.1 mt-30 -130.06 142.84 50.57 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.699 0.761 . . . . 0.0 109.886 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -70.97 -74.62 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.82 0.819 . . . . 0.0 110.055 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.6 t -94.63 136.01 35.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.413 -0.804 . . . . 0.0 110.563 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.72 138.52 57.45 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.75 0.786 . . . . 0.0 110.823 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.69 -11.94 69.29 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.4 t -97.41 113.28 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.286 -1.126 . . . . 0.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.13 39.18 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.633 0.73 . . . . 0.0 110.353 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -172.56 135.97 0.73 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 14' ' ' VAL . 62.1 m -92.18 -70.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.52 -0.738 . . . . 0.0 109.758 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 15' ' ' VAL . 58.5 t 54.32 162.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.415 -0.803 . . . . 0.0 110.704 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.535 ' N ' HG12 ' A' ' 14' ' ' VAL . 57.9 t -133.76 81.78 52.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.332 -0.855 . . . . 0.0 109.517 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.24 148.02 18.69 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.229 2.62 . . . . 0.0 112.615 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 58.7 mp0 -93.67 141.73 28.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.39 -0.818 . . . . 0.0 109.482 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.3 t -98.03 127.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.477 -0.765 . . . . 0.0 110.274 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.407 ' C ' HD22 ' A' ' 20' ' ' LEU . 48.2 mmm-85 -127.4 143.48 51.2 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.614 0.721 . . . . 0.0 109.092 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -95.48 138.33 33.31 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.879 0.847 . . . . 0.0 110.378 -178.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 t -134.54 144.18 47.85 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -123.43 142.16 51.27 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.931 0.872 . . . . 0.0 109.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 m -70.36 169.99 12.78 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.833 0.825 . . . . 0.0 110.472 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.21 -42.97 99.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.613 -0.68 . . . . 0.0 109.39 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -65.95 -40.28 91.2 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.129 -0.982 . . . . 0.0 109.516 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.45 -3.66 85.26 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -94.92 -5.76 44.08 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.206 -1.173 . . . . 0.0 109.259 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.8 t -111.36 122.64 48.37 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.93 0.871 . . . . 0.0 110.143 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.81 143.24 36.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 40.6 ttm -155.96 144.39 20.08 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.292 -1.123 . . . . 0.0 109.933 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.62 144.93 36.04 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -116.94 149.18 40.59 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.606 0.717 . . . . 0.0 110.377 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -123.75 143.87 50.03 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -116.23 118.3 32.42 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.397 0.618 . . . . 0.0 109.628 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.472 ' CE1' ' CE ' ' A' ' 52' ' ' MET . 63.9 m-85 -110.26 118.59 36.76 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.32 0.581 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.56 122.99 47.79 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.839 0.828 . . . . 0.0 110.094 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 39' ' ' THR . 85.9 mt-10 47.55 52.39 12.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.966 -0.459 . . . . 0.0 110.734 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 28.4 Cg_endo -63.57 9.09 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.57 2.18 . . . . 0.0 110.93 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 37' ' ' GLU . 71.4 p 51.01 19.21 0.63 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.764 -0.585 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.439 HG22 ' HG2' ' A' ' 38' ' ' PRO . 15.2 tt -97.4 -13.61 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.172 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.7 mt -66.29 -38.84 88.71 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.471 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.94 -12.9 59.69 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 109.478 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -105.48 -16.31 14.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.366 -0.834 . . . . 0.0 108.861 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' ILE . 80.4 tt0 -171.43 139.0 1.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.242 -0.911 . . . . 0.0 109.52 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -74.67 158.6 33.32 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 110.844 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.2 p -64.91 -31.2 72.32 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.636 -0.665 . . . . 0.0 110.284 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.95 -40.12 95.71 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.032 -1.043 . . . . 0.0 109.912 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -72.4 -17.13 61.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 109.278 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.72 118.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 p -149.25 42.77 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.6 139.5 4.53 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.472 ' CE ' ' CE1' ' A' ' 35' ' ' PHE . 45.1 ttm -130.66 128.72 41.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.685 -0.891 . . . . 0.0 108.668 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -111.28 125.79 54.2 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.842 0.829 . . . . 0.0 109.969 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 55' ' ' ILE . 4.9 mp -96.56 124.08 40.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.661 -0.649 . . . . 0.0 109.276 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.759 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -101.16 125.85 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.759 0.79 . . . . 0.0 109.785 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -108.92 -149.46 0.44 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.359 0.6 . . . . 0.0 109.641 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 58' ' ' GLU . 44.1 p-10 -64.1 -34.15 77.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.774 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.533 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 83.9 tt0 -156.63 -43.56 0.07 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.35 -0.844 . . . . 0.0 108.865 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.42 169.87 53.95 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -149.19 156.91 42.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -1.088 . . . . 0.0 110.142 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.475 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.3 mt -112.41 134.64 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.504 0.669 . . . . 0.0 109.295 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.829 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.3 mp -100.04 122.87 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.8 m -124.3 127.28 47.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.516 0.674 . . . . 0.0 109.456 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -107.87 -4.16 18.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.5 mp0 -89.48 78.93 7.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.345 -0.847 . . . . 0.0 109.411 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.18 132.38 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.649 -0.657 . . . . 0.0 109.372 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -126.95 142.58 51.51 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.866 0.841 . . . . 0.0 109.639 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.45 142.0 15.82 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' CE ' ' OE1' ' A' ' 79' ' ' GLU . 68.0 mmtt -103.97 113.04 26.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.654 -0.909 . . . . 0.0 108.79 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 23.9 m-85 -98.34 144.63 27.52 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.847 0.832 . . . . 0.0 110.113 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 73' ' ' GLY . 96.5 mt -122.17 136.93 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 71' ' ' ILE . 59.5 m-80 -38.49 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.854 0.835 . . . . 0.0 110.421 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 149.3 -62.36 0.42 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -177.62 154.94 1.07 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.575 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -47.5 134.59 21.03 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.337 2.025 . . . . 0.0 112.447 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 m -147.05 -25.11 0.4 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.484 -0.76 . . . . 0.0 109.817 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 151.38 51.81 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.973 -1.079 . . . . 0.0 110.411 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.93 135.32 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' OE1' ' CE ' ' A' ' 69' ' ' LYS . 46.2 tt0 -116.81 151.57 36.22 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 109.918 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.71 144.97 32.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.564 -0.71 . . . . 0.0 109.529 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -117.54 129.06 55.55 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.553 -0.717 . . . . 0.0 109.975 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.98 129.85 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-O 121.764 0.792 . . . . 0.0 109.543 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 85' ' ' ASN . 27.2 mm -85.69 126.23 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.653 -0.654 . . . . 0.0 109.699 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.2 mt -110.48 36.9 2.91 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.425 ' H ' HG22 ' A' ' 83' ' ' ILE . 5.4 m120 -63.46 -40.39 97.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.534 -0.729 . . . . 0.0 109.822 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -76.67 153.78 34.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.205 -0.934 . . . . 0.0 110.373 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -70.06 -48.78 20.14 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.467 -0.77 . . . . 0.0 110.497 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 40.9 Cg_exo -52.17 -37.87 70.38 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.9 1.733 . . . . 0.0 111.392 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 83' ' ' ILE . 97.6 mt-10 -64.55 -40.74 96.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.567 0.699 . . . . 0.0 109.851 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -61.69 -44.82 96.21 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.288 -0.882 . . . . 0.0 109.818 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -60.99 -46.61 90.05 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.354 -0.841 . . . . 0.0 109.361 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -67.56 -39.52 84.95 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.668 0.747 . . . . 0.0 109.438 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -62.6 -48.14 80.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.408 -0.808 . . . . 0.0 110.07 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.92 -42.09 85.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 109.971 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -67.57 -44.52 78.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.259 -0.901 . . . . 0.0 109.831 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -62.22 -47.09 85.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.373 -0.829 . . . . 0.0 109.359 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.4 ttt -66.69 -39.15 87.97 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.659 0.743 . . . . 0.0 109.066 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -65.2 -51.53 60.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.0 109.686 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -68.23 -40.0 82.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -63.1 -48.63 77.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.502 -0.749 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 -35.15 89.44 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.53 94.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -1.108 . . . . 0.0 110.044 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.71 -56.53 3.36 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 109.819 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -85.92 -85.11 0.15 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.254 -0.904 . . . . 0.0 109.742 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 45.59 91.35 0.01 OUTLIER Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mp -138.76 -160.39 1.06 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.461 -1.023 . . . . 0.0 110.288 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -138.9 -91.95 0.24 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -99.24 17.45 19.99 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.243 -1.151 . . . . 0.0 109.606 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.1 t -66.77 145.74 55.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 111.033 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 39.48 32.48 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.271 0.558 . . . . 0.0 110.523 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 112' ' ' GLU . 93.0 p -129.21 -77.24 0.55 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.544 0.688 . . . . 0.0 109.664 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.52 ' N ' ' OG ' ' A' ' 111' ' ' SER . 97.6 mt-10 -84.86 -9.93 57.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.575 ' O ' ' N ' ' A' ' 115' ' ' HIS . 41.0 mt -96.75 -80.14 0.44 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 43.79 13.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.6 -0.687 . . . . 0.0 110.241 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 113' ' ' LEU . 87.7 m-70 -104.25 -3.58 24.1 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.126 -0.984 . . . . 0.0 108.985 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.9 150.55 48.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.435 -0.79 . . . . 0.0 110.826 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 119' ' ' HIS . 20.5 t60 49.37 99.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.986 0.898 . . . . 0.0 110.193 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -62.39 -41.61 98.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.527 -0.733 . . . . 0.0 109.139 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' O ' ' CD2' ' A' ' 117' ' ' HIS . 61.9 t-80 -71.37 146.73 48.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.483 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.943 179.635 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.421 0.629 . . . . 0.0 109.775 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 96' ' ' PHE . . . -83.03 110.65 18.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.287 -0.883 . . . . 0.0 109.538 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.516 ' CD ' HE21 ' A' ' 5' ' ' GLN . 21.0 pt-20 -154.91 158.86 39.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.065 -1.022 . . . . 0.0 109.365 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 90.6 mt -110.26 130.97 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.582 -0.699 . . . . 0.0 109.192 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.516 HE21 ' CD ' ' A' ' 3' ' ' GLU . 78.8 mt-30 -137.35 122.87 19.65 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.32 -39.32 85.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.349 -0.845 . . . . 0.0 109.644 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.466 ' O ' HG23 ' A' ' 10' ' ' VAL . 72.5 m -127.02 153.25 46.17 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.711 0.767 . . . . 0.0 110.223 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -71.47 137.5 48.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.515 -0.741 . . . . 0.0 110.592 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.22 -2.66 71.71 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 7' ' ' SER . 69.2 t -70.84 -50.4 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -1.139 . . . . 0.0 109.682 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 10' ' ' VAL . . . 58.95 144.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.43 -0.794 . . . . 0.0 110.595 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 13' ' ' THR . 8.6 tm-20 58.14 -88.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.909 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.531 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 1.4 m 81.87 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -172.77 179.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.482 ' H ' HG22 ' A' ' 14' ' ' VAL . 96.3 t -115.13 86.35 13.84 Favored Pre-proline 0 N--CA 1.496 1.834 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -78.25 154.15 28.38 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.984 2.456 . . . . 0.0 112.873 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -81.01 155.46 26.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.2 t -111.13 128.63 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.601 -0.687 . . . . 0.0 109.195 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' C ' HD22 ' A' ' 20' ' ' LEU . 79.2 ttt-85 -134.74 132.8 39.22 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.0 mm? -97.28 135.53 39.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.375 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.511 ' CB ' ' HZ3' ' A' ' 32' ' ' LYS . 40.3 m -123.99 150.0 45.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.25 142.9 50.53 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.575 -0.703 . . . . 0.0 109.823 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.418 ' HB2' ' H ' ' A' ' 28' ' ' SER . 26.6 m -75.9 -177.33 3.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.523 -0.735 . . . . 0.0 110.089 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.426 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 0.5 OUTLIER -61.97 135.1 57.41 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.347 -0.846 . . . . 0.0 110.183 -179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 56.82 15.68 2.36 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.49 18.64 78.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -46.85 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.528 -0.984 . . . . 0.0 110.473 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.664 ' CB ' HD21 ' A' ' 85' ' ' ASN . 17.6 m -98.32 123.68 42.56 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.222 -0.923 . . . . 0.0 110.221 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.25 145.37 28.06 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.0 ptt? -161.06 167.45 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.035 -1.274 . . . . 0.0 109.147 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.14 143.71 38.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.351 -0.843 . . . . 0.0 108.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.511 ' HZ3' ' CB ' ' A' ' 21' ' ' SER . 64.4 mttp -111.83 146.37 37.79 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.469 -0.769 . . . . 0.0 109.842 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -121.74 131.69 54.21 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -105.36 128.3 53.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.553 -0.717 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -112.25 114.95 28.01 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.49 -0.756 . . . . 0.0 109.428 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 37' ' ' GLU . 39.7 tp -95.4 122.43 38.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.319 -0.863 . . . . 0.0 110.086 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 36' ' ' LEU . 50.9 mm-40 39.45 57.25 6.41 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.751 -0.593 . . . . 0.0 111.034 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.69 145.78 91.59 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.449 2.099 . . . . 0.0 112.379 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 41' ' ' LEU . 64.0 p -69.46 -24.38 63.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.379 -0.826 . . . . 0.0 110.292 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.9 tp -59.44 1.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.068 . . . . 0.0 109.859 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 39' ' ' THR . 89.2 mt -91.24 -6.9 52.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 109.22 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.74 -26.63 13.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.346 -0.846 . . . . 0.0 109.457 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HZ1' HG22 ' A' ' 10' ' ' VAL . 52.0 mtmt -96.06 -75.89 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.275 -0.891 . . . . 0.0 110.018 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -99.05 151.71 20.64 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.423 -0.798 . . . . 0.0 110.395 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -74.71 163.1 28.08 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.414 -0.804 . . . . 0.0 110.084 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.7 p -66.53 -32.69 74.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.565 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.34 -18.55 63.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.176 -0.952 . . . . 0.0 109.643 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -79.31 -5.18 53.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.917 . . . . 0.0 109.442 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.05 117.83 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -0.912 . . . . 0.0 109.54 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.41 ' HB ' ' HE ' ' A' ' 64' ' ' ARG . 19.2 p -114.25 0.2 14.11 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.51 178.22 45.53 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.3 ttp -130.32 137.99 50.22 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.591 -0.947 . . . . 0.0 108.716 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.409 ' CE2' HD12 ' A' ' 62' ' ' ILE . 91.2 m-85 -106.18 123.12 47.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.32 -0.862 . . . . 0.0 110.035 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.521 ' C ' HD12 ' A' ' 55' ' ' ILE . 88.6 mt -99.15 125.95 44.82 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.803 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.9 mp -107.14 129.06 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.628 -0.67 . . . . 0.0 110.081 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD1' ' NH2' ' A' ' 92' ' ' ARG . 41.9 p-10 -150.79 120.61 7.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.912 . . . . 0.0 109.222 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' N ' HH12 ' A' ' 99' ' ' ARG . 66.4 t0 59.92 -81.45 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.626 -0.671 . . . . 0.0 109.983 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 56' ' ' ASP . 81.1 tt0 -145.53 -38.64 0.25 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.19 -0.944 . . . . 0.0 108.886 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.83 171.85 53.38 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.5 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 2.2 pm0 -152.08 156.08 39.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.261 -1.14 . . . . 0.0 109.435 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -114.63 135.45 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.604 -0.685 . . . . 0.0 109.175 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.409 HD12 ' CE2' ' A' ' 53' ' ' TYR . 21.2 mm -101.78 125.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 0.0 109.5 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.3 m -123.45 125.97 45.91 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.568 -0.708 . . . . 0.0 109.258 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.41 ' HE ' ' HB ' ' A' ' 50' ' ' THR . 7.7 tpt180 -97.72 -7.98 29.63 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' OE1' HD11 ' A' ' 83' ' ' ILE . 96.2 mt-10 -83.86 84.0 7.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.341 -0.849 . . . . 0.0 110.017 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.78 134.57 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.452 -0.78 . . . . 0.0 109.452 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -125.57 142.09 51.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.57 -0.706 . . . . 0.0 109.263 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -98.58 140.39 14.99 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -107.23 102.77 12.06 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -102.32 146.1 28.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.588 -0.695 . . . . 0.0 109.776 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 73' ' ' GLY . 97.7 mt -121.17 133.09 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 72' ' ' ASN . 7.9 p30 -38.03 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 71' ' ' ILE . . . 154.09 -60.86 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -177.04 150.9 0.91 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.937 -1.331 . . . . 0.0 109.158 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -40.16 118.68 0.57 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.267 1.978 . . . . 0.0 111.861 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.404 ' CB ' HD12 ' A' ' 71' ' ' ILE . 12.2 m -111.22 -33.85 6.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 110.071 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.28 164.39 37.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 110.901 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.54 HG22 ' N ' ' A' ' 79' ' ' GLU . 94.4 mt -126.87 164.1 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.54 ' N ' HG22 ' A' ' 78' ' ' ILE . 15.5 tm-20 -140.12 148.5 41.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.463 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.76 143.81 35.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.501 -0.749 . . . . 0.0 108.981 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.6 m -122.87 130.33 52.73 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.567 -0.708 . . . . 0.0 109.582 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.3 t -110.81 129.71 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.492 -0.755 . . . . 0.0 109.414 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.45 HD11 ' OE1' ' A' ' 65' ' ' GLU . 30.0 mm -82.66 129.0 38.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.3 -0.875 . . . . 0.0 109.756 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 86.9 mt -117.52 38.02 3.72 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.664 HD21 ' CB ' ' A' ' 28' ' ' SER . 13.4 m120 -63.36 -40.67 97.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.377 -0.827 . . . . 0.0 109.332 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 151.06 35.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 110.27 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.586 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -73.2 -41.12 6.18 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.517 -0.739 . . . . 0.0 110.437 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 47.0 Cg_exo -56.08 -35.81 95.38 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.203 1.935 . . . . 0.0 111.632 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.57 -39.27 88.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.43 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.8 m95 -60.28 -42.12 94.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 109.902 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.63 -49.33 78.15 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.156 -0.965 . . . . 0.0 109.749 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.51 ' NH2' ' OD1' ' A' ' 56' ' ' ASP . 17.4 mmm180 -69.06 -39.77 78.91 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.225 -0.922 . . . . 0.0 109.411 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -61.68 -44.66 96.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.336 -0.853 . . . . 0.0 109.282 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 86.1 mmm -62.64 -41.49 99.06 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.374 -0.829 . . . . 0.0 108.881 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -64.89 -45.39 86.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.418 -0.801 . . . . 0.0 109.056 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.415 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 74.3 t80 -61.22 -45.85 92.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.272 -0.892 . . . . 0.0 109.573 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.415 ' SD ' ' C ' ' A' ' 97' ' ' MET . 2.0 tmt? -62.14 -41.54 98.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.481 -0.762 . . . . 0.0 109.725 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.3 -46.15 77.96 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.121 -0.987 . . . . 0.0 109.318 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.448 HH12 ' N ' ' A' ' 57' ' ' ASP . 83.5 mtp180 -65.63 -41.68 92.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.389 -0.819 . . . . 0.0 109.143 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -62.47 -48.42 79.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.47 -0.769 . . . . 0.0 109.695 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -67.85 -36.31 86.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.5 -43.09 98.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.07 -42.16 66.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.18 -0.95 . . . . 0.0 109.347 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -94.12 -70.98 0.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.861 . . . . 0.0 109.484 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 101' ' ' GLY . . . 83.89 45.3 6.4 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.5 mt -63.33 -43.5 97.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -1.199 . . . . 0.0 109.498 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.51 8.66 80.27 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' O ' ' N ' ' A' ' 110' ' ' LYS . 26.3 m-85 -105.78 17.5 23.62 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.238 -1.154 . . . . 0.0 108.575 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.618 ' C ' ' H ' ' A' ' 111' ' ' SER . 48.2 t -63.25 71.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.799 . . . . 0.0 109.238 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 108' ' ' PHE . 86.3 tttt 61.1 -23.94 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.621 -0.675 . . . . 0.0 110.245 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.618 ' H ' ' C ' ' A' ' 109' ' ' SER . 15.2 m -71.95 137.36 47.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.815 -1.178 . . . . 0.0 109.6 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' CB ' ' O ' ' A' ' 111' ' ' SER . 16.8 tp10 84.69 -31.89 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 113' ' ' LEU . 4.1 mm? -63.92 -42.27 97.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.817 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 115' ' ' HIS . 97.1 mt-10 -98.16 -5.51 33.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.161 -0.962 . . . . 0.0 109.277 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.408 ' O ' ' O ' ' A' ' 114' ' ' GLU . 98.7 m-70 58.18 116.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.608 0.718 . . . . 0.0 110.385 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.491 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 51.3 p-80 -60.74 -44.92 96.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 109.305 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.47 ' N ' ' CG ' ' A' ' 116' ' ' HIS . 49.1 t-80 51.86 75.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.49 -0.756 . . . . 0.0 109.812 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 116' ' ' HIS . 53.0 m80 -150.58 -40.31 0.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -67.42 -40.31 85.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 109.641 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.471 ' ND1' ' C ' ' A' ' 120' ' ' HIS . 2.2 p80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.247 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.572 ' O ' ' N ' ' A' ' 3' ' ' GLU . 12.7 mmt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.427 ' H ' ' HB2' ' A' ' 100' ' ' TYR . . . 58.71 -72.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.105 0.479 . . . . 0.0 109.868 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 1' ' ' MET . 17.6 pt-20 -134.79 136.98 42.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.784 0.802 . . . . 0.0 109.651 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.5 mt -107.4 129.94 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -127.2 135.8 51.16 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.792 0.806 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -106.76 -56.08 2.24 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.537 0.684 . . . . 0.0 109.394 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 8' ' ' LYS . 32.5 t -93.42 11.21 29.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.719 . . . . 0.0 109.359 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 7' ' ' SER . 68.6 mttm 57.88 124.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.771 0.796 . . . . 0.0 110.76 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.72 11.15 64.2 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 10' ' ' VAL . 3.0 m -96.04 135.02 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.499 -1.0 . . . . 0.0 110.09 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -92.88 -159.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.437 0.637 . . . . 0.0 110.599 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 56.53 -76.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 11' ' ' ALA . 4.5 p 65.29 6.38 3.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.745 HG22 ' H ' ' A' ' 15' ' ' VAL . 12.8 p 44.07 177.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.891 0.853 . . . . 0.0 111.202 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.745 ' H ' HG22 ' A' ' 14' ' ' VAL . 81.9 t -115.14 91.8 28.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.296 -0.878 . . . . 0.0 108.959 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.04 145.02 17.22 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.75 2.3 . . . . 0.0 112.673 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.12 149.7 39.0 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.571 -0.705 . . . . 0.0 109.576 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.72 127.43 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 109.318 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.462 ' C ' HD12 ' A' ' 20' ' ' LEU . 59.1 ttp180 -132.06 119.84 21.56 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 19' ' ' ARG . 7.0 mp -104.79 132.5 50.96 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.9 m -127.37 152.29 47.68 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.378 0.608 . . . . 0.0 109.683 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -116.3 131.11 57.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.652 0.739 . . . . 0.0 109.559 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 m -57.87 -86.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.767 -0.583 . . . . 0.0 110.132 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -107.07 -109.9 0.3 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.57 -0.707 . . . . 0.0 110.209 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -96.31 11.98 32.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.435 -0.791 . . . . 0.0 109.113 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.55 21.32 5.5 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -84.31 -7.3 59.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.473 -1.016 . . . . 0.0 109.189 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.407 ' OG ' ' ND2' ' A' ' 85' ' ' ASN . 1.5 t -159.77 101.23 1.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.45 ' HA3' ' HE1' ' A' ' 90' ' ' TRP . . . -67.92 140.42 36.27 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.33 149.54 41.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.423 -1.045 . . . . 0.0 109.993 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.0 144.89 45.58 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -125.36 142.46 51.49 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.652 0.739 . . . . 0.0 109.953 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -121.93 137.95 54.59 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -120.68 125.34 47.45 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.688 0.756 . . . . 0.0 109.861 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 32.3 m-85 -110.12 114.39 27.86 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 37' ' ' GLU . 51.8 tp -88.77 132.31 34.68 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.397 0.618 . . . . 0.0 110.565 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 36' ' ' LEU . 41.0 mt-10 32.76 68.81 0.91 Allowed Pre-proline 0 N--CA 1.5 2.032 0 CA-C-O 121.177 0.513 . . . . 0.0 111.127 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.52 140.71 92.74 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.66 2.24 . . . . 0.0 112.191 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -83.14 -19.4 36.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.561 -179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.1 tt -65.43 1.87 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 109.398 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' THR . 95.2 mt -81.85 -13.27 57.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.246 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.19 -13.78 21.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.37 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -107.84 -44.84 4.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.457 -0.777 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -134.62 147.59 50.22 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.36 -0.838 . . . . 0.0 110.255 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.6 m -75.79 158.39 32.26 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.753 0.787 . . . . 0.0 110.535 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -64.98 -32.16 73.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -72.45 -17.47 61.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -88.73 -7.56 56.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.235 -0.915 . . . . 0.0 109.251 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.86 122.14 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 109.754 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.4 m -124.42 122.77 38.57 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.743 0.782 . . . . 0.0 109.562 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.14 -171.06 18.95 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.5 ttp -141.45 133.64 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.56 -0.965 . . . . 0.0 108.961 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.421 ' CD2' HD12 ' A' ' 62' ' ' ILE . 70.3 m-85 -108.35 109.29 20.58 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.723 0.773 . . . . 0.0 109.726 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.69 111.47 23.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 mm -109.25 131.02 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 122.031 0.919 . . . . 0.0 110.366 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' OD1' ' CD2' ' A' ' 96' ' ' PHE . 2.7 m-20 -138.6 -160.73 1.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.486 0.66 . . . . 0.0 109.408 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -81.45 104.66 12.04 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.926 0.869 . . . . 0.0 110.319 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 60.62 89.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.643 0.735 . . . . 0.0 110.592 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.57 142.97 5.77 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.28 147.68 29.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.999 . . . . 0.0 109.108 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.77 133.7 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.507 0.67 . . . . 0.0 109.578 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' CD2' ' A' ' 53' ' ' TYR . 30.2 mm -108.02 126.99 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 121.546 0.689 . . . . 0.0 109.196 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 65' ' ' GLU . 76.3 m -125.4 125.66 43.75 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.64 0.733 . . . . 0.0 109.295 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -97.8 -1.77 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' H ' HG22 ' A' ' 63' ' ' THR . 96.8 mt-10 -85.26 75.24 10.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.457 -0.777 . . . . 0.0 109.426 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.0 t -126.7 133.83 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.679 0.752 . . . . 0.0 109.338 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -132.82 141.13 48.3 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.97 141.24 15.92 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -106.01 119.23 38.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.604 -0.939 . . . . 0.0 108.875 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -107.98 144.59 35.06 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.583 0.706 . . . . 0.0 110.064 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mm -121.05 131.38 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 57.66 14.92 2.61 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.453 0.644 . . . . 0.0 110.07 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.5 -17.86 58.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -100.4 150.37 36.88 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.452 -1.028 . . . . 0.0 110.05 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -62.92 143.25 90.98 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.576 2.184 . . . . 0.0 112.129 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.5 m -149.12 -41.47 0.15 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.29 -0.881 . . . . 0.0 109.973 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.85 164.59 35.89 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.762 -1.211 . . . . 0.0 111.077 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -126.02 152.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -135.34 145.28 47.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.011 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.22 46.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.689 1.233 . . . . 0.0 110.004 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.4 m -126.65 131.62 51.4 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.671 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 49.9 t -119.62 130.98 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.1 mm -87.7 126.71 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.542 0.687 . . . . 0.0 109.919 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 78.4 mt -119.64 41.64 3.09 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.407 ' ND2' ' OG ' ' A' ' 28' ' ' SER . 3.9 m120 -63.59 -39.75 95.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.73 . . . . 0.0 109.363 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.58 158.18 27.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.069 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.555 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 7.5 mm-40 -79.85 -41.42 1.43 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.802 -0.561 . . . . 0.0 110.832 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 37.8 Cg_exo -56.14 -37.5 96.39 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.823 1.682 . . . . 0.0 111.259 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -68.28 -39.04 82.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.637 -0.664 . . . . 0.0 109.433 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.45 ' HE1' ' HA3' ' A' ' 29' ' ' GLY . 1.8 m95 -61.32 -40.62 94.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.52 -44.56 95.91 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.189 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -69.55 -39.01 77.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.434 -0.791 . . . . 0.0 109.119 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -61.83 -45.97 91.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.37 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 7.6 ttt -62.56 -47.04 85.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.59 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -65.69 -41.72 92.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 0.0 109.461 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.56 ' HB3' ' H1 ' ' A' ' 1' ' ' MET . 3.4 m-85 -64.15 -46.89 82.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.2 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 49.8 ttp -63.03 -39.58 95.18 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -66.35 -40.45 89.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.507 -0.746 . . . . 0.0 109.443 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -65.88 -42.36 90.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.527 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.427 ' HB2' ' H ' ' A' ' 2' ' ' ALA . 81.8 t80 -60.05 -46.47 89.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.482 -0.761 . . . . 0.0 109.269 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.31 94.73 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.52 72.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -1.053 . . . . 0.0 109.849 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.78 -42.78 69.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.518 -0.739 . . . . 0.0 109.763 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.412 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 62.0 m-20 -107.66 115.2 29.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.561 -0.712 . . . . 0.0 109.569 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 106' ' ' LEU . . . -94.17 45.12 2.27 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 106' ' ' LEU . 9.9 mp 44.71 100.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.75 -0.853 . . . . 0.0 110.715 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.98 3.69 90.5 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CE2' ' O ' ' A' ' 109' ' ' SER . 88.3 t80 -72.37 141.62 48.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.526 -0.984 . . . . 0.0 110.237 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.49 ' O ' ' CE2' ' A' ' 108' ' ' PHE . 8.2 p -77.48 132.04 38.23 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.488 -0.758 . . . . 0.0 110.263 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 112' ' ' GLU . 66.2 tttm -172.86 73.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 112' ' ' GLU . 79.2 p 47.0 -82.86 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.666 0.746 . . . . 0.0 110.919 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 110' ' ' LYS . 73.0 mm-40 -53.72 -48.07 69.95 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.511 -0.743 . . . . 0.0 109.773 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 115' ' ' HIS . 93.9 mt -68.23 -93.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 110.351 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 41.75 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.491 0.662 . . . . 0.0 110.191 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 113' ' ' LEU . 59.8 t-80 43.35 83.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.634 0.731 . . . . 0.0 110.023 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.413 ' ND1' ' C ' ' A' ' 116' ' ' HIS . 6.1 p80 -153.39 165.89 34.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.468 -0.77 . . . . 0.0 110.059 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 118' ' ' HIS . 54.2 t-80 -74.64 171.64 13.52 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.592 0.71 . . . . 0.0 110.591 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.508 ' N ' ' CG ' ' A' ' 117' ' ' HIS . 59.8 m170 -68.67 137.47 54.19 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.761 0.791 . . . . 0.0 110.559 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.403 ' O ' ' OXT' ' A' ' 120' ' ' HIS . 62.6 t-80 -84.38 128.99 34.9 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.734 0.778 . . . . 0.0 110.069 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.403 ' OXT' ' O ' ' A' ' 119' ' ' HIS . 99.5 m-70 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.96 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtm . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.14 -18.52 16.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.518 -0.739 . . . . 0.0 109.205 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.563 ' CD ' HE21 ' A' ' 5' ' ' GLN . 43.7 tt0 -145.16 134.05 22.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.184 -0.948 . . . . 0.0 109.095 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.38 129.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.617 -0.677 . . . . 0.0 109.634 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.563 HE21 ' CD ' ' A' ' 3' ' ' GLU . 76.5 mt-30 -140.31 124.87 17.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.298 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.41 -2.88 58.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.133 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 8' ' ' LYS . 29.6 t -155.86 43.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.436 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 7' ' ' SER . 47.2 pttt 31.81 43.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.433 0.635 . . . . 0.0 110.853 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.43 26.68 0.03 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.6 t -97.8 132.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -1.11 . . . . 0.0 110.092 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.16 142.26 58.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.539 -0.726 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 14' ' ' VAL . 57.4 mp0 -85.47 -116.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.597 -0.689 . . . . 0.0 110.379 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.3 p 57.35 0.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.566 ' H ' ' C ' ' A' ' 12' ' ' GLU . 74.9 t -67.91 -43.54 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.05 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 105' ' ' GLY . 9.8 t 62.13 60.43 2.58 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.733 -0.604 . . . . 0.0 109.869 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -68.61 149.06 73.54 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.662 2.241 . . . . 0.0 112.256 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -83.82 154.09 23.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.371 -0.831 . . . . 0.0 110.087 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.88 132.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -127.63 140.69 51.94 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -112.14 143.0 43.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.604 -0.685 . . . . 0.0 109.684 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 m -149.92 151.86 34.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.403 -0.81 . . . . 0.0 109.042 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.61 133.58 55.21 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.688 0.756 . . . . 0.0 109.185 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 27' ' ' GLN . 90.7 p -43.9 108.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.6 0.714 . . . . 0.0 110.724 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -64.73 -40.55 95.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.599 -0.688 . . . . 0.0 109.418 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -90.02 6.25 43.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 109.216 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.07 107.06 0.49 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.483 ' O ' ' CB ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -163.16 28.21 0.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.51 -0.994 . . . . 0.0 108.93 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.584 ' CB ' HD22 ' A' ' 85' ' ' ASN . 3.0 p 79.58 -172.62 0.05 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.642 0.734 . . . . 0.0 110.684 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.25 145.71 49.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.3 ttp -141.45 150.06 41.79 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.423 -1.045 . . . . 0.0 109.796 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.35 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.444 -0.785 . . . . 0.0 109.01 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -125.61 140.72 52.49 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.541 -0.724 . . . . 0.0 109.958 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.53 119.33 38.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -95.99 124.43 39.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.429 -0.794 . . . . 0.0 109.138 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.92 124.8 52.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.644 -0.66 . . . . 0.0 109.709 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.8 tp -107.79 121.65 45.15 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.657 -0.652 . . . . 0.0 109.286 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 40.6 mt-10 42.65 55.43 10.39 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.651 -0.656 . . . . 0.0 110.315 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 36.0 Cg_endo -66.71 151.25 82.97 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.919 2.412 . . . . 0.0 112.749 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.6 m -84.28 90.85 7.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.638 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 44' ' ' GLU . 10.5 tp -173.48 -27.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.48 -40.35 96.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.34 -0.85 . . . . 0.0 109.226 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.33 79.99 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.325 -0.859 . . . . 0.0 108.891 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -89.19 -69.58 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.619 -0.676 . . . . 0.0 109.286 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 40' ' ' ILE . 97.8 mt-10 -110.94 134.65 52.41 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.511 -0.743 . . . . 0.0 109.67 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.1 t -65.85 159.86 24.49 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.659 0.743 . . . . 0.0 110.436 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.435 ' H ' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -66.07 -33.46 75.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.648 -0.658 . . . . 0.0 109.65 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.2 -19.07 63.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.484 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -82.59 -5.62 58.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 89.1 mt -98.96 117.25 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.389 -0.819 . . . . 0.0 109.776 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 50' ' ' THR . 88.5 m -102.6 -7.11 22.08 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.63 -179.75 42.85 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.142 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.8 ttp -128.92 145.17 51.3 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.626 -0.926 . . . . 0.0 109.222 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.37 122.36 46.84 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.406 -0.809 . . . . 0.0 110.425 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.445 ' C ' HD12 ' A' ' 55' ' ' ILE . 52.4 mt -98.89 109.5 22.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.666 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.6 mp -105.47 163.15 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.041 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' N ' HG22 ' A' ' 55' ' ' ILE . 40.4 t0 -162.46 -179.2 6.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.541 -0.724 . . . . 0.0 109.407 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.481 ' H ' ' CG ' ' A' ' 56' ' ' ASP . 97.8 m-20 -70.07 -15.64 63.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.472 -0.767 . . . . 0.0 109.141 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -169.55 97.71 0.32 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.374 -0.829 . . . . 0.0 109.285 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 117.3 146.15 8.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 60' ' ' GLU . 1.8 pm0 -152.78 144.45 23.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.5 mt -124.08 131.51 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.767 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.0 mp -101.97 132.16 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.0 109.551 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.0 m -120.32 123.32 42.84 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -97.79 -1.57 42.97 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.64 72.29 7.77 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.7 t -121.77 132.78 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.3 144.01 51.07 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.65 -0.656 . . . . 0.0 109.352 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.26 137.97 14.25 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -106.19 128.12 53.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.634 -0.921 . . . . 0.0 108.98 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -102.47 122.29 44.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.747 -0.596 . . . . 0.0 109.67 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.93 140.05 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 58.96 32.92 22.71 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.196 0.522 . . . . 0.0 109.817 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.35 23.66 74.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -151.06 148.32 22.47 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.078 -1.248 . . . . 0.0 109.435 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -67.85 107.39 1.48 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.198 1.932 . . . . 0.0 111.228 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.7 m -131.45 -10.25 3.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.538 -0.727 . . . . 0.0 110.059 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.71 154.47 41.45 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.957 -1.089 . . . . 0.0 110.306 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 79' ' ' GLU . 96.7 mt -131.03 159.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 16.1 tm-20 -140.7 149.31 42.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.267 -0.895 . . . . 0.0 109.489 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.482 ' N ' ' CD ' ' A' ' 79' ' ' GLU . . . -140.13 142.7 35.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.399 -0.813 . . . . 0.0 109.055 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -120.63 132.61 55.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.707 -0.621 . . . . 0.0 109.669 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.68 132.17 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.1 mm -95.38 122.5 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.336 -0.853 . . . . 0.0 110.116 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.4 mt -101.12 79.25 1.99 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.584 HD22 ' CB ' ' A' ' 28' ' ' SER . 11.9 m120 -87.3 -5.6 58.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.497 -0.752 . . . . 0.0 110.048 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 t -115.72 134.33 55.14 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.731 0.776 . . . . 0.0 109.764 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 3.0 mp0 -58.85 -60.65 9.79 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.752 -0.592 . . . . 0.0 110.579 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 3.0 Cg_endo -49.52 -21.52 5.25 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.993 1.795 . . . . 0.0 111.715 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -65.92 -38.17 87.98 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.694 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -58.67 -38.19 77.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.329 -0.857 . . . . 0.0 109.749 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -60.39 -44.2 95.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.424 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -67.51 -40.67 85.12 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.348 -0.845 . . . . 0.0 109.842 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -61.6 -48.9 78.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.359 -0.838 . . . . 0.0 109.794 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.08 -40.75 78.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.808 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' CG ' HH12 ' A' ' 99' ' ' ARG . 63.3 ttm-85 -63.37 -49.11 75.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.38 -0.825 . . . . 0.0 109.797 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.519 ' CE2' ' OD2' ' A' ' 56' ' ' ASP . 6.2 m-85 -66.31 -42.02 88.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.468 -0.77 . . . . 0.0 109.143 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 59.4 tpp -64.98 -34.07 77.55 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.629 -0.669 . . . . 0.0 109.267 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -61.65 -54.52 41.7 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.136 -0.978 . . . . 0.0 110.156 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.411 HH12 ' CG ' ' A' ' 95' ' ' ARG . 95.9 mtm-85 -65.69 -46.83 77.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.947 . . . . 0.0 110.145 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -62.95 -44.78 95.11 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.21 -33.89 88.44 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.09 98.01 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.322 -1.105 . . . . 0.0 109.529 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.534 ' O ' ' ND2' ' A' ' 104' ' ' ASN . 80.2 mm-40 -71.27 -56.35 6.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -0.879 . . . . 0.0 109.632 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 103' ' ' GLU . 34.3 m120 -159.59 -148.28 0.18 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.218 -0.926 . . . . 0.0 109.811 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.49 ' H ' HG13 ' A' ' 15' ' ' VAL . . . 76.48 -160.57 50.91 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 106' ' ' LEU . 7.7 mp 56.1 -95.11 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.295 0.569 . . . . 0.0 110.122 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.38 -2.09 73.8 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -98.03 146.65 25.31 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.455 -1.026 . . . . 0.0 109.808 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 86.8 p -103.09 -4.83 23.97 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.583 -0.698 . . . . 0.0 109.63 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -174.61 -30.26 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.396 -0.815 . . . . 0.0 109.408 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 113' ' ' LEU . 4.8 m -45.86 137.05 5.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.515 -0.74 . . . . 0.0 109.729 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 59.08 -68.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.103 0.478 . . . . 0.0 109.82 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.571 ' N ' ' O ' ' A' ' 111' ' ' SER . 0.1 OUTLIER -87.23 116.51 25.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.049 -1.032 . . . . 0.0 109.684 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -169.87 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.558 ' ND1' ' N ' ' A' ' 116' ' ' HIS . 57.5 t-80 41.64 -116.44 0.32 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.716 -0.615 . . . . 0.0 110.198 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.558 ' N ' ' ND1' ' A' ' 115' ' ' HIS . 97.0 m-70 -156.49 -49.81 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -142.61 53.73 1.41 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.146 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -74.4 -26.21 59.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.663 -0.648 . . . . 0.0 109.449 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.446 ' ND1' ' OXT' ' A' ' 120' ' ' HIS . 29.8 t-80 -68.32 131.66 45.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.408 -0.807 . . . . 0.0 110.266 -178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.446 ' OXT' ' ND1' ' A' ' 119' ' ' HIS . 52.4 p-80 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.86 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -45.17 115.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.628 0.728 . . . . 0.0 109.992 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -153.14 149.26 27.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.348 -0.845 . . . . 0.0 110.141 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mp -110.34 130.45 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.469 0.652 . . . . 0.0 109.995 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -129.56 129.26 44.22 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.688 0.756 . . . . 0.0 109.513 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -88.09 -5.94 58.19 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 m -157.45 -168.85 2.7 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.325 -0.859 . . . . 0.0 110.362 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -74.6 133.74 42.16 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.865 0.84 . . . . 0.0 111.086 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 42.25 71.17 0.4 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.3 t -107.4 -47.92 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.498 -1.001 . . . . 0.0 108.727 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.73 82.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.079 0.942 . . . . 0.0 109.152 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -84.11 124.22 30.89 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.738 0.78 . . . . 0.0 110.157 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.9 m -96.4 -14.92 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 15' ' ' VAL . 59.3 t -55.66 159.41 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.292 -0.88 . . . . 0.0 110.091 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' N ' HG12 ' A' ' 14' ' ' VAL . 12.4 t -112.39 81.42 4.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.534 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.6 148.76 54.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.611 2.208 . . . . 0.0 112.554 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 18' ' ' VAL . 7.0 tm-20 -84.37 155.17 22.44 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.592 -0.692 . . . . 0.0 109.964 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' A' ' 17' ' ' GLU . 55.4 t -117.62 129.62 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.561 0.696 . . . . 0.0 109.768 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -128.68 137.88 51.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.24 131.18 47.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.585 -0.697 . . . . 0.0 109.351 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.447 ' H ' ' HA ' ' A' ' 31' ' ' ALA . 29.8 m -108.01 149.09 28.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.612 -0.68 . . . . 0.0 109.619 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 24' ' ' LYS . 88.3 tttt -135.05 141.53 46.15 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.654 0.74 . . . . 0.0 109.589 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 p -71.51 14.57 0.17 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.662 -0.649 . . . . 0.0 109.538 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 26' ' ' GLY . 36.6 ttmt 64.89 91.8 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.662 0.744 . . . . 0.0 110.739 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 m120 55.05 6.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.611 0.72 . . . . 0.0 109.185 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 24' ' ' LYS . . . -83.82 165.39 41.96 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -99.6 74.07 1.86 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.296 -1.12 . . . . 0.0 109.686 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 p -164.11 101.14 0.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.361 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.89 143.56 41.91 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttp -165.09 153.02 11.46 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.412 -1.052 . . . . 0.0 109.663 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 21' ' ' SER . . . -142.89 153.18 42.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.653 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.06 147.55 46.59 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.452 0.644 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -120.32 136.85 54.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -114.27 122.05 45.55 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.456 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -111.19 114.28 27.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.0 tp -95.87 121.22 37.37 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.708 0.766 . . . . 0.0 110.027 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 48.55 60.21 15.85 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.982 -0.449 . . . . 0.0 110.623 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 40' ' ' ILE . 38.1 Cg_endo -69.68 1.36 4.45 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.346 2.031 . . . . 0.0 110.479 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 m 54.74 5.03 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.28 0.562 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 38' ' ' PRO . 2.8 tp -73.48 -1.75 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 109.655 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.7 mt -84.42 -9.55 58.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.113 -0.992 . . . . 0.0 108.953 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.8 -18.6 22.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.332 -0.855 . . . . 0.0 109.382 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.45 -47.15 4.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.32 -0.863 . . . . 0.0 109.089 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.78 153.09 48.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.33 -0.856 . . . . 0.0 110.148 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 t -80.69 167.04 20.47 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.694 0.759 . . . . 0.0 110.373 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -62.93 -39.92 96.06 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.642 0.734 . . . . 0.0 109.423 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 48' ' ' ASP . 50.0 p-10 -70.98 -21.91 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.524 -0.735 . . . . 0.0 109.682 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 96.4 m-20 -80.26 -6.23 57.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.95 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -92.22 123.86 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.984 -1.073 . . . . 0.0 109.939 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.418 ' OG1' ' CZ ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -116.15 91.01 3.47 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 0.0 109.369 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.93 174.71 37.43 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.2 ttp -127.62 149.15 50.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.709 -0.877 . . . . 0.0 109.375 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.79 108.84 20.56 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.621 0.724 . . . . 0.0 109.726 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.5 mt -100.35 115.81 30.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.89 125.15 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 121.53 0.681 . . . . 0.0 109.602 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -104.01 -167.36 1.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.592 0.71 . . . . 0.0 110.376 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 33.2 p-10 -77.78 -5.23 50.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.728 -0.607 . . . . 0.0 109.658 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -108.75 -94.18 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.417 -0.802 . . . . 0.0 109.884 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' H ' ' NH1' ' A' ' 92' ' ' ARG . . . -106.12 -147.59 15.16 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -137.38 155.09 49.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.534 -0.98 . . . . 0.0 110.091 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.45 138.86 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 121.407 0.622 . . . . 0.0 109.804 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.0 mm -110.34 129.27 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.8 m -120.18 123.85 44.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.744 0.783 . . . . 0.0 109.581 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' CZ ' ' OG1' ' A' ' 50' ' ' THR . 18.2 tpt85 -98.82 -12.6 20.69 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -84.83 79.3 9.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.441 -0.787 . . . . 0.0 109.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.93 133.21 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-O 121.403 0.621 . . . . 0.0 109.476 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -129.05 143.25 50.8 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.73 0.776 . . . . 0.0 109.727 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.79 140.42 15.03 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -101.52 121.58 42.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.528 -0.984 . . . . 0.0 109.185 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -104.62 119.33 38.74 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.631 0.729 . . . . 0.0 110.121 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.31 138.84 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.42 33.75 20.65 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.603 0.716 . . . . 0.0 110.192 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.24 27.55 73.07 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -155.1 148.19 18.22 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.143 -1.21 . . . . 0.0 109.523 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.07 113.96 3.23 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.6 2.2 . . . . 0.0 111.926 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.1 m -126.98 -15.69 5.28 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.22 158.26 43.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 110.269 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -129.01 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.378 0.609 . . . . 0.0 109.463 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -129.59 148.05 51.45 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.604 0.716 . . . . 0.0 109.689 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.4 145.94 39.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.552 -0.718 . . . . 0.0 109.21 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -121.47 131.71 54.31 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.432 0.634 . . . . 0.0 109.946 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.4 t -117.08 129.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.612 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.4 mp -82.15 127.01 40.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.533 0.682 . . . . 0.0 109.655 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.494 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 84.5 mt -120.68 33.77 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.68 -40.04 95.84 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.529 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.7 m -70.47 145.61 50.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 110.044 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.502 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -71.58 -47.67 12.56 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.303 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 43.7 Cg_exo -54.36 -33.67 77.48 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.123 1.882 . . . . 0.0 111.819 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -66.04 -37.24 85.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.578 -0.701 . . . . 0.0 109.872 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.494 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 49.1 m95 -60.97 -39.81 91.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 109.944 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.58 -51.1 69.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.587 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.488 ' NH1' ' H ' ' A' ' 59' ' ' GLY . 63.2 ttm-85 -68.27 -42.68 79.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.742 . . . . 0.0 109.43 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -62.29 -43.25 99.25 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.57 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.4 ttt -59.02 -41.98 89.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.745 . . . . 0.0 109.308 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -65.36 -40.48 93.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.487 -0.758 . . . . 0.0 109.523 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -61.55 -48.21 82.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -0.91 . . . . 0.0 109.266 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.8 ttt -67.86 -39.09 83.81 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.646 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -64.3 -47.95 77.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.453 -0.779 . . . . 0.0 109.434 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -67.23 -42.34 84.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.825 . . . . 0.0 109.546 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.6 ' CE1' ' ND2' ' A' ' 104' ' ' ASN . 60.6 t80 -60.94 -46.18 91.73 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.801 0.81 . . . . 0.0 109.314 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.464 ' CA ' HD11 ' A' ' 106' ' ' LEU . . . -65.09 -30.91 79.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.38 93.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 109.812 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -89.24 -16.89 30.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.6 ' ND2' ' CE1' ' A' ' 100' ' ' TYR . 68.7 m-80 -103.69 145.16 30.48 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.43 6.89 42.14 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 106' ' ' LEU . 10.4 mp 56.32 164.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.029 0.919 . . . . 0.0 110.658 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' SER . . . 175.37 129.58 1.22 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 40.73 22.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.876 -0.779 . . . . 0.0 110.011 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 107' ' ' GLY . 31.1 t -61.65 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.115 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -152.06 -55.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 109.893 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' A' ' 112' ' ' GLU . 78.4 p -62.27 -30.49 71.17 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.362 -0.836 . . . . 0.0 109.414 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 57.4 mp0 -95.54 -27.54 15.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 108.954 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.526 ' O ' HD23 ' A' ' 113' ' ' LEU . 1.0 OUTLIER -65.62 -42.72 91.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 0.0 109.716 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.56 6.15 24.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.092 -1.005 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.85 154.02 50.74 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.403 -0.811 . . . . 0.0 110.164 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -108.03 123.08 48.13 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.585 0.707 . . . . 0.0 109.939 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -66.98 -41.94 85.95 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.682 0.753 . . . . 0.0 109.481 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -89.36 127.41 35.81 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 0.0 109.981 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.5 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 48.6 p-80 -74.54 62.89 1.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.713 0.768 . . . . 0.0 109.828 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 119' ' ' HIS . 84.1 t60 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.314 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.517 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.671 0.748 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' HB2' ' OD2' ' A' ' 56' ' ' ASP . . . -67.64 139.06 56.81 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 110.395 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -155.39 138.98 15.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -0.814 . . . . 0.0 109.723 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.2 130.51 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.672 0.748 . . . . 0.0 109.399 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 10' ' ' VAL . 16.8 pt20 -149.05 145.71 27.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.511 -0.743 . . . . 0.0 109.674 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' O ' ' CD2' ' A' ' 53' ' ' TYR . 90.2 m-85 -63.39 -45.47 90.93 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.59 0.709 . . . . 0.0 109.404 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 m -104.99 158.06 16.8 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.672 0.748 . . . . 0.0 110.322 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -68.54 133.28 48.32 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.834 0.826 . . . . 0.0 110.507 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 45.37 86.54 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.512 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 44.4 t -101.96 -77.66 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.455 -1.026 . . . . 0.0 109.296 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' N ' HG12 ' A' ' 10' ' ' VAL . . . -178.06 -99.0 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.458 -0.776 . . . . 0.0 110.068 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -55.7 143.03 31.98 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 110.805 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' VAL . 70.9 m -75.72 -17.88 59.77 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.321 0.581 . . . . 0.0 109.968 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 13' ' ' THR . 3.7 t 55.51 158.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.485 -0.76 . . . . 0.0 110.572 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.25 74.53 41.83 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.299 -0.875 . . . . 0.0 109.892 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.05 147.36 23.72 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.921 2.414 . . . . 0.0 112.522 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 106' ' ' LEU . 79.2 mm-40 -74.86 161.63 29.38 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.767 0.794 . . . . 0.0 110.045 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -113.06 131.33 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.543 0.687 . . . . 0.0 109.324 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.425 ' C ' HD22 ' A' ' 20' ' ' LEU . 83.7 mtp180 -128.52 139.9 52.08 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 121.678 0.751 . . . . 0.0 109.579 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 20' ' ' LEU . 4.1 mm? -97.42 135.22 39.61 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.641 0.734 . . . . 0.0 109.64 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.9 t -134.57 142.95 47.11 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.539 0.685 . . . . 0.0 109.714 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -100.77 159.08 15.48 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.054 0.931 . . . . 0.0 110.371 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.4 p -67.03 165.75 15.09 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.652 0.739 . . . . 0.0 110.295 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -62.01 -40.08 94.44 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.649 0.738 . . . . 0.0 109.378 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -91.52 -6.26 52.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.909 . . . . 0.0 109.025 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.85 16.23 78.16 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -76.14 -78.11 0.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.484 -1.009 . . . . 0.0 109.957 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.442 ' CB ' HD22 ' A' ' 85' ' ' ASN . 4.8 p -78.44 -97.25 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.264 -0.897 . . . . 0.0 110.055 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.84 172.85 18.3 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.0 ptp -159.26 175.69 13.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -1.132 . . . . 0.0 109.679 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.54 143.91 45.97 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' NZ ' ' OG1' ' A' ' 81' ' ' THR . 68.3 mttm -117.18 142.9 46.45 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.626 0.727 . . . . 0.0 110.166 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.86 128.12 54.95 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -103.76 131.87 50.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.577 -0.702 . . . . 0.0 109.627 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -112.43 126.44 55.3 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.0 tp -100.68 125.32 47.09 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.681 0.753 . . . . 0.0 110.677 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 37.04 58.17 3.82 Favored Pre-proline 0 N--CA 1.497 1.885 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.259 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.22 150.68 81.74 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.574 2.182 . . . . 0.0 112.525 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -76.5 -18.69 58.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.746 -0.596 . . . . 0.0 110.219 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.78 1.52 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.051 -1.03 . . . . 0.0 109.707 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.0 mt -89.28 -8.94 52.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.027 -1.045 . . . . 0.0 109.169 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -105.98 -26.88 11.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.414 -0.804 . . . . 0.0 109.263 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.47 -74.34 0.45 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -0.921 . . . . 0.0 109.9 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -108.05 143.67 36.46 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.87 0.843 . . . . 0.0 110.408 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -76.5 169.4 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.918 0.866 . . . . 0.0 110.52 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.5 p -65.36 -31.09 72.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.545 -0.722 . . . . 0.0 109.637 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.02 -36.61 84.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.349 -0.844 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -76.67 -8.99 58.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.35 -0.844 . . . . 0.0 109.469 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.4 mt -101.6 118.35 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.238 -0.914 . . . . 0.0 109.989 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.38 26.04 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.452 ' N ' HG21 ' A' ' 66' ' ' VAL . . . -176.99 164.97 34.72 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 44.3 ttm -135.63 133.58 38.37 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.347 -1.09 . . . . 0.0 109.499 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 6' ' ' PHE . 4.3 m-85 -112.53 120.97 43.45 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 122.017 0.913 . . . . 0.0 109.723 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.489 ' C ' HD12 ' A' ' 55' ' ' ILE . 5.0 mp -96.37 110.36 22.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.753 ' N ' HD12 ' A' ' 55' ' ' ILE . 1.9 mp -98.81 126.99 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.508 -0.745 . . . . 0.0 109.623 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 66.4 t0 -172.5 134.99 0.68 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.557 0.694 . . . . 0.0 109.97 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 59' ' ' GLY . 97.8 m-20 57.97 42.86 22.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.974 -0.454 . . . . 0.0 110.077 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 67.82 -40.94 0.42 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.556 0.694 . . . . 0.0 109.543 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -69.66 153.48 52.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -139.62 149.03 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.463 -1.021 . . . . 0.0 109.91 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.6 mt -119.36 133.34 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 121.532 0.682 . . . . 0.0 109.195 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.7 mm -102.83 122.28 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.732 . . . . 0.0 109.698 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 65' ' ' GLU . 98.0 m -123.41 126.07 46.12 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.63 0.729 . . . . 0.0 109.395 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -101.24 41.24 1.21 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.61 -0.681 . . . . 0.0 109.201 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' H ' HG22 ' A' ' 63' ' ' THR . 96.2 mt-10 -133.05 86.44 2.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG21 ' N ' ' A' ' 51' ' ' GLY . 1.1 m -121.62 132.18 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -123.21 134.36 54.14 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.833 0.825 . . . . 0.0 109.021 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.7 133.37 11.54 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -105.76 110.4 22.69 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.631 -0.923 . . . . 0.0 108.604 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -104.42 139.75 38.91 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.423 0.63 . . . . 0.0 109.62 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.1 mt -117.96 126.15 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-O 121.58 0.705 . . . . 0.0 109.487 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 56.75 33.2 22.57 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.64 21.44 78.81 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 ttp85 -135.42 120.07 13.45 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.35 -1.088 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.55 138.2 32.0 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.321 2.014 . . . . 0.0 112.416 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 m -147.93 -34.01 0.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.32 158.96 44.62 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.841 -1.162 . . . . 0.0 110.533 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 97.0 mt -131.02 142.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -124.99 148.61 48.37 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.642 0.734 . . . . 0.0 109.464 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.88 147.7 41.01 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.45 -0.781 . . . . 0.0 109.023 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.505 ' OG1' ' NZ ' ' A' ' 32' ' ' LYS . 86.9 m -118.66 130.06 55.64 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.621 -0.674 . . . . 0.0 109.827 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.5 125.16 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-O 121.677 0.751 . . . . 0.0 109.531 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 25.0 mm -84.06 131.94 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' O ' ' NE1' ' A' ' 90' ' ' TRP . 82.5 mt -121.72 47.94 1.78 Allowed 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.442 HD22 ' CB ' ' A' ' 28' ' ' SER . 11.1 m120 -64.65 -40.38 95.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.41 -0.806 . . . . 0.0 109.447 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.6 m -74.19 145.32 44.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.231 -0.918 . . . . 0.0 110.144 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.488 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -73.34 -47.39 7.63 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.481 -0.762 . . . . 0.0 110.203 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 44.6 Cg_exo -54.72 -32.72 77.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 121.881 1.721 . . . . 0.0 111.306 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -67.03 -38.19 85.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.608 -0.682 . . . . 0.0 109.399 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 84' ' ' LEU . 37.2 m95 -59.76 -41.46 91.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.324 -0.86 . . . . 0.0 109.708 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -62.73 -46.48 87.87 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.189 -0.944 . . . . 0.0 109.296 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -70.15 -41.69 73.51 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.802 0.81 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -61.36 -44.86 96.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 109.376 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.0 ttm -61.21 -41.84 97.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 -66.94 -39.59 87.36 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.372 -0.83 . . . . 0.0 109.034 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.56 -46.52 85.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 0.0 109.296 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 62.6 ttp -66.45 -38.42 87.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.6 0.714 . . . . 0.0 109.663 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -61.76 -42.24 98.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.832 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.24 -39.46 86.17 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.001 . . . . 0.0 109.612 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -61.88 -46.4 89.58 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.73 -38.5 94.53 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.1 92.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -1.18 . . . . 0.0 110.371 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -80.75 -56.07 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.046 . . . . 0.0 109.961 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -93.18 -79.43 0.4 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.95 -1.094 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 140.87 143.85 4.36 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 106' ' ' LEU . 8.5 mp -74.12 -79.29 0.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.373 -1.075 . . . . 0.0 109.659 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 50.44 65.29 3.06 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -59.74 128.12 35.36 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.997 . . . . 0.0 110.276 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.3 m -75.55 149.8 38.26 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.789 0.804 . . . . 0.0 110.791 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.443 ' O ' ' CB ' ' A' ' 111' ' ' SER . 22.9 pttp -72.72 170.19 15.09 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.992 0.901 . . . . 0.0 111.414 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 4.2 p 77.93 -7.56 1.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -104.84 -27.04 11.98 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.363 -0.836 . . . . 0.0 109.576 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.968 ' H ' HD22 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -79.1 -43.28 24.43 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.923 0.868 . . . . 0.0 109.692 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -65.03 108.45 1.82 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.56 -0.713 . . . . 0.0 110.12 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -173.46 83.58 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.692 0.758 . . . . 0.0 109.013 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -154.35 -50.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 -150.41 168.2 24.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -0.952 . . . . 0.0 110.597 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -151.12 157.88 43.3 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 109.849 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -153.88 161.7 41.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 109.987 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.554 -179.759 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.612 ' N ' ' NH2' ' A' ' 99' ' ' ARG . 96.6 mtp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.42 143.14 55.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.562 -0.712 . . . . 0.0 110.499 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -154.58 160.79 41.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 0.0 109.588 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.1 129.65 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -129.4 129.29 44.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.641 0.734 . . . . 0.0 109.884 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.08 -5.67 59.16 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.4 t -161.1 -63.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.497 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 10' ' ' VAL . 53.7 mtpt -143.02 -160.82 1.15 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.91 5.22 0.2 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 8' ' ' LYS . 74.5 t -69.07 134.85 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.314 -1.109 . . . . 0.0 110.344 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 64.43 92.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.491 0.662 . . . . 0.0 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -130.33 -22.22 2.8 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -76.22 -1.0 24.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 108.924 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.95 136.52 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.551 -0.718 . . . . 0.0 109.898 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.46 79.41 29.08 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.614 -0.679 . . . . 0.0 109.272 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.04 153.21 32.2 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.918 2.412 . . . . 0.0 112.793 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -89.31 138.37 31.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.424 -0.797 . . . . 0.0 109.728 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.7 t -88.26 131.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.926 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -127.37 144.43 51.05 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.621 0.724 . . . . 0.0 109.48 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.73 132.39 54.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.8 t -121.36 152.57 38.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.749 -0.594 . . . . 0.0 109.509 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 24' ' ' LYS . 65.8 tttm -133.3 153.03 51.93 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.881 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 25' ' ' ASN . 97.4 p -65.52 0.74 1.43 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.525 -0.734 . . . . 0.0 109.426 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 22' ' ' LYS . 28.8 tptt 40.53 22.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.528 0.68 . . . . 0.0 110.079 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 23' ' ' SER . 64.8 t30 -167.45 23.71 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 179.9 175.76 46.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 28' ' ' SER . 55.9 tt0 -88.3 -9.65 52.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -1.094 . . . . 0.0 109.588 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 27' ' ' GLN . 4.7 t -42.23 117.23 0.95 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 110.617 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.88 141.26 28.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.0 ttm -153.34 151.43 29.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.21 -1.171 . . . . 0.0 109.531 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.88 148.15 36.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 109.199 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -126.31 146.25 50.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -117.11 140.23 49.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -118.88 125.67 50.03 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -110.28 121.39 45.17 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 37' ' ' GLU . 45.0 tp -95.62 123.17 39.04 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.449 0.643 . . . . 0.0 109.985 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 36' ' ' LEU . 13.9 mm-40 37.35 57.69 4.1 Favored Pre-proline 0 N--CA 1.494 1.762 0 CA-C-O 120.966 0.413 . . . . 0.0 111.096 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.95 148.98 71.46 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.254 1.969 . . . . 0.0 111.795 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 t -75.92 -13.25 60.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.45 -0.781 . . . . 0.0 110.314 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.57 -1.11 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 109.738 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.552 HD21 HD11 ' A' ' 78' ' ' ILE . 84.6 mt -90.71 -12.69 35.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.068 -1.02 . . . . 0.0 109.027 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.08 -21.88 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -87.47 -75.76 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.938 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.63 160.85 14.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.855 0.836 . . . . 0.0 110.562 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.4 p -76.17 165.77 24.43 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.742 0.782 . . . . 0.0 110.762 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.407 ' HA ' HD12 ' A' ' 49' ' ' ILE . 20.9 p -65.84 -31.53 72.53 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.489 0.661 . . . . 0.0 109.882 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -70.27 -18.26 63.13 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.241 -0.912 . . . . 0.0 109.763 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -93.59 -6.69 46.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 49' ' ' ILE . 86.8 mt -84.53 -7.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 109.142 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' ILE . 20.1 m -39.6 123.01 1.45 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.686 0.755 . . . . 0.0 110.834 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.27 160.26 32.62 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.6 ttm -135.19 143.94 46.7 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 62' ' ' ILE . 83.0 m-85 -118.12 109.82 16.87 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 0.0 109.522 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.1 mt -87.04 131.44 34.11 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.476 -0.765 . . . . 0.0 109.176 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mm -121.37 133.69 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.503 0.668 . . . . 0.0 110.136 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 58' ' ' GLU . 97.0 m-20 -133.29 43.21 2.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 44.82 17.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.386 -0.821 . . . . 0.0 109.53 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' ASP . 79.8 tt0 -170.4 83.4 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.425 -0.797 . . . . 0.0 109.183 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.58 157.44 32.46 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -142.26 155.54 45.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.335 -1.097 . . . . 0.0 109.829 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.8 132.62 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 CA-C-O 121.378 0.608 . . . . 0.0 109.589 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 53' ' ' TYR . 32.7 mm -103.31 120.7 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 63' ' ' THR . 4.3 t -127.81 125.49 39.9 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.46 0.648 . . . . 0.0 109.401 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -98.74 50.37 0.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -138.81 81.66 1.86 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.04 136.05 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.629 . . . . 0.0 109.461 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -128.74 134.85 48.56 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.556 -0.715 . . . . 0.0 109.572 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.1 143.45 16.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -96.71 101.07 12.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.467 -1.02 . . . . 0.0 108.366 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -91.91 152.84 19.87 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.621 0.724 . . . . 0.0 110.514 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 73' ' ' GLY . 89.3 mt -135.87 148.3 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -54.35 -0.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.971 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 71' ' ' ILE . . . -127.88 62.24 0.63 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 73' ' ' GLY . 68.9 ttp85 60.12 134.87 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.805 -0.82 . . . . 0.0 110.633 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -42.79 140.06 3.08 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 121.961 1.774 . . . . 0.0 112.102 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.8 m -130.03 -16.84 3.58 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.15 166.69 30.04 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.708 -1.245 . . . . 0.0 110.72 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.552 HD11 HD21 ' A' ' 41' ' ' LEU . 83.7 mt -134.92 154.12 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -133.45 151.82 51.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.53 -0.731 . . . . 0.0 110.438 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.89 34.78 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.7 m -125.11 127.9 47.6 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.671 -0.643 . . . . 0.0 109.616 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.63 128.87 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.6 mp -87.21 127.59 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.654 -0.654 . . . . 0.0 109.579 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 90' ' ' TRP . 82.5 mt -108.72 36.73 2.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.61 ' H ' HG22 ' A' ' 83' ' ' ILE . 93.0 m-20 -63.48 -39.37 94.26 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -68.13 153.49 43.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.421 -0.8 . . . . 0.0 110.297 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.489 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 5.5 mp0 -71.27 -57.3 4.71 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.713 -0.617 . . . . 0.0 110.774 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 11.7 Cg_endo -54.8 -33.28 80.45 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.653 1.568 . . . . 0.0 111.617 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.61 -39.88 88.55 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.446 -0.784 . . . . 0.0 109.737 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -64.53 -44.95 89.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.232 -0.917 . . . . 0.0 109.773 -179.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -62.46 -46.42 88.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.284 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -65.67 -38.4 89.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.498 -0.751 . . . . 0.0 109.275 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -62.22 -43.81 98.0 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.521 -0.737 . . . . 0.0 109.51 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 37.5 ttm -61.4 -38.14 85.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.823 . . . . 0.0 109.229 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -62.98 -38.71 92.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.796 . . . . 0.0 109.236 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -61.24 -45.18 95.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 91.8 mtp -63.75 -41.23 98.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -71.29 -46.51 60.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.403 -0.811 . . . . 0.0 109.614 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.612 ' NH2' ' N ' ' A' ' 1' ' ' MET . 10.1 tpt180 -67.65 -41.89 83.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.474 -0.766 . . . . 0.0 110.13 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 104' ' ' ASN . 59.3 t80 -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.143 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 -28.8 71.93 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.23 72.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.992 . . . . 0.0 110.168 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 104' ' ' ASN . 11.8 pt-20 -71.27 -48.74 49.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.702 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 103' ' ' GLU . 3.4 p-10 176.78 -166.91 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.575 -0.703 . . . . 0.0 109.747 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 107' ' ' GLY . . . 77.6 -51.46 3.38 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.691 HD12 ' N ' ' A' ' 106' ' ' LEU . 7.4 mp 44.65 22.14 0.05 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.532 -0.981 . . . . 0.0 109.406 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 105' ' ' GLY . . . -47.19 107.75 0.24 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -94.23 132.66 38.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.392 -1.063 . . . . 0.0 110.089 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 91.6 p -86.09 113.44 22.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.441 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 111' ' ' SER . 88.6 tttt -70.03 123.93 22.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.583 -0.698 . . . . 0.0 110.147 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 110' ' ' LYS . 0.9 OUTLIER 163.11 -72.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -100.02 -25.11 14.42 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.455 -0.778 . . . . 0.0 109.676 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.9 mt -64.52 -40.98 96.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.174 -0.954 . . . . 0.0 109.792 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -94.18 119.53 33.13 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -0.941 . . . . 0.0 110.059 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -155.61 -56.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.19 137.33 41.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.488 -0.757 . . . . 0.0 110.706 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -150.12 149.72 30.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.4 -0.812 . . . . 0.0 109.725 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.421 ' C ' ' N ' ' A' ' 120' ' ' HIS . 0.4 OUTLIER -156.16 163.79 39.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.326 -0.859 . . . . 0.0 110.431 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.447 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 83.5 t60 53.51 11.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.64 -0.662 . . . . 0.0 109.492 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.421 ' N ' ' C ' ' A' ' 118' ' ' HIS . 58.3 t-80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.905 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 tpp . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.491 ' N ' ' OE2' ' A' ' 103' ' ' GLU . . . -69.38 139.18 54.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.347 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -155.64 148.7 24.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.39 -0.819 . . . . 0.0 109.175 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 91.2 mt -108.72 128.48 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.532 -0.73 . . . . 0.0 109.148 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 9' ' ' GLY . 5.8 pt20 -146.31 155.08 42.38 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.227 -0.921 . . . . 0.0 109.634 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -111.18 -37.44 5.32 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 t -90.64 22.97 3.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.227 -0.921 . . . . 0.0 109.376 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' NZ ' ' CE2' ' A' ' 53' ' ' TYR . 68.0 mttm 50.78 33.78 9.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 109.663 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.526 ' N ' ' OE1' ' A' ' 5' ' ' GLN . . . 157.58 40.73 0.02 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 98.8 t -57.36 -86.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.447 -1.031 . . . . 0.0 109.925 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' VAL . . . 179.23 -105.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.629 0.728 . . . . 0.0 109.474 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.92 146.59 46.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.473 -0.767 . . . . 0.0 110.489 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 14' ' ' VAL . 49.1 m -76.07 -11.01 59.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 108.999 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 15' ' ' VAL . 55.4 t 53.06 165.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.497 0.665 . . . . 0.0 110.711 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.592 ' N ' HG12 ' A' ' 14' ' ' VAL . 3.5 m -123.89 75.08 57.08 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.555 -0.715 . . . . 0.0 109.232 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 151.94 35.36 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.558 2.172 . . . . 0.0 112.437 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -82.63 152.55 25.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.324 -0.86 . . . . 0.0 109.512 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -114.62 130.76 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.511 -0.743 . . . . 0.0 109.055 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -132.27 141.16 48.89 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -109.07 130.54 55.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.499 -0.751 . . . . 0.0 109.195 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 t -126.98 133.26 50.62 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.2 tttp -127.5 135.94 51.07 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.626 0.727 . . . . 0.0 109.212 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 25' ' ' ASN . 55.8 m -61.69 -129.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.548 -0.72 . . . . 0.0 110.474 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -72.39 19.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.67 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 23' ' ' SER . 71.7 m-20 57.9 35.15 25.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.393 -0.817 . . . . 0.0 109.7 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.72 26.36 0.09 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -135.73 -113.22 0.19 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.46 -1.024 . . . . 0.0 109.744 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.7 m -105.09 120.37 41.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.333 -0.854 . . . . 0.0 109.943 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.539 ' N ' ' ND2' ' A' ' 85' ' ' ASN . . . -79.58 151.87 34.84 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.9 ptm -153.6 167.93 27.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.247 -1.149 . . . . 0.0 109.364 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.76 145.17 37.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.481 -0.762 . . . . 0.0 109.036 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -112.07 143.23 43.44 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.508 -0.745 . . . . 0.0 109.626 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -125.92 131.83 52.23 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -105.49 126.22 51.88 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.406 -0.808 . . . . 0.0 109.488 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -109.43 116.21 31.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.641 -0.662 . . . . 0.0 109.257 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.5 tp -100.9 118.32 36.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.505 -0.747 . . . . 0.0 109.561 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 39' ' ' THR . 57.4 mt-10 43.31 59.65 11.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.593 -0.692 . . . . 0.0 110.504 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HG2' HG22 ' A' ' 40' ' ' ILE . 37.4 Cg_endo -68.85 13.9 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.078 1.852 . . . . 0.0 110.202 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 37' ' ' GLU . 72.6 p 48.88 32.17 3.61 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.273 0.559 . . . . 0.0 110.05 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.4 HG22 ' HG2' ' A' ' 38' ' ' PRO . 11.1 tp -99.06 -22.06 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.181 -0.95 . . . . 0.0 109.14 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.7 -40.7 92.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 109.586 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -23.2 67.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.664 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -98.22 -52.21 3.75 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.212 -0.93 . . . . 0.0 109.947 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -136.89 149.1 47.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.33 -0.856 . . . . 0.0 110.214 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.5 p -73.0 163.51 28.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.6 p -66.42 -30.72 71.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.485 -0.759 . . . . 0.0 109.444 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.22 -16.52 63.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.629 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -85.34 -7.81 58.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -0.932 . . . . 0.0 109.037 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.2 mt -100.96 116.33 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.461 -0.774 . . . . 0.0 109.11 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.4 p -125.5 15.01 8.23 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' N ' HG21 ' A' ' 66' ' ' VAL . . . -176.98 160.34 27.37 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 62.5 ttp -118.03 131.69 56.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.679 -0.895 . . . . 0.0 108.83 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.416 ' CE2' ' NZ ' ' A' ' 8' ' ' LYS . 94.9 m-85 -104.42 112.7 25.85 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.639 0.733 . . . . 0.0 109.721 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 72.6 mt -95.55 127.63 41.75 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.71 128.76 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.498 0.666 . . . . 0.0 109.504 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASP . 44.5 t0 -155.56 118.11 4.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.53 -0.731 . . . . 0.0 109.853 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' A' ' 99' ' ' ARG . 94.8 m-20 40.1 61.15 1.58 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.833 -0.542 . . . . 0.0 110.677 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 68.81 -41.44 0.47 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -66.66 138.77 36.02 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -146.69 148.81 32.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -1.165 . . . . 0.0 109.997 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 62' ' ' ILE . 96.7 mt -122.48 130.85 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.803 HD12 ' N ' ' A' ' 62' ' ' ILE . 2.8 mp -107.58 129.52 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.49 -0.756 . . . . 0.0 109.57 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 t -128.73 128.09 43.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.588 -0.695 . . . . 0.0 109.332 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -90.78 4.94 50.29 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -91.31 78.67 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG21 ' N ' ' A' ' 51' ' ' GLY . 1.6 m -120.92 132.95 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.545 -0.722 . . . . 0.0 109.669 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -123.19 137.07 54.98 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.15 127.22 9.18 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -96.39 126.98 41.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.315 -1.109 . . . . 0.0 108.907 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -102.46 138.29 39.58 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.374 0.607 . . . . 0.0 109.894 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mm -115.37 132.46 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 m120 57.5 32.37 21.71 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.496 0.665 . . . . 0.0 109.517 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -12.03 26.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -112.72 149.14 40.72 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 121.409 -1.053 . . . . 0.0 109.814 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.2 142.28 86.0 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.335 2.023 . . . . 0.0 112.215 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.9 m -157.95 -28.97 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.95 44.56 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.013 -1.054 . . . . 0.0 110.207 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.4 153.19 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.522 0.677 . . . . 0.0 109.601 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -132.68 152.65 51.65 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.17 44.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.466 -0.771 . . . . 0.0 109.237 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.4 m -125.17 129.97 51.21 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.57 130.92 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.224 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.92 121.46 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.47 -0.769 . . . . 0.0 109.859 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD12 ' CZ2' ' A' ' 90' ' ' TRP . 55.8 mt -98.14 -75.63 0.55 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.937 0.875 . . . . 0.0 109.121 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.539 ' ND2' ' N ' ' A' ' 29' ' ' GLY . 3.2 m120 56.31 32.12 19.85 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.72 -0.613 . . . . 0.0 109.823 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 m -153.49 140.58 19.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.086 -1.009 . . . . 0.0 109.335 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.504 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 9.6 mm-40 -62.38 -58.21 18.57 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.74 . . . . 0.0 110.32 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 13.0 Cg_endo -54.3 -36.04 85.53 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.955 1.77 . . . . 0.0 111.451 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -68.92 -38.76 79.76 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.349 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.403 ' CZ2' HD12 ' A' ' 84' ' ' LEU . 17.0 m95 -62.02 -46.33 89.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -42.65 99.65 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 109.199 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -64.77 -44.01 91.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.501 -0.749 . . . . 0.0 109.355 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -63.16 -44.01 96.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 0.0 110.193 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 40.0 ttm -58.0 -43.8 86.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.316 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.507 HH21 ' NH2' ' A' ' 99' ' ' ARG . 79.5 mtp85 -65.79 -38.3 88.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.617 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -63.09 -46.71 86.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.399 -0.813 . . . . 0.0 110.31 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.27 -39.28 94.13 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.838 1.304 . . . . 0.0 109.175 -178.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -45.63 79.95 Favored 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.337 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 99.7 mtt180 -63.99 -41.9 97.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.092 -1.005 . . . . 0.0 109.17 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -64.0 -44.85 91.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.548 -0.72 . . . . 0.0 109.16 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.02 -35.0 91.44 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.13 -38.15 90.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -1.158 . . . . 0.0 109.469 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' OE2' ' N ' ' A' ' 2' ' ' ALA . 96.2 mt-10 -68.74 -36.27 78.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 110.024 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -140.15 83.32 1.91 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -50.18 102.79 0.07 OUTLIER Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.94 150.68 35.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -1.073 . . . . 0.0 110.498 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.12 -6.28 88.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -146.31 97.99 3.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.207 -1.172 . . . . 0.0 109.147 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 110' ' ' LYS . 34.0 t -167.18 97.26 0.51 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.817 . . . . 0.0 109.266 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 111' ' ' SER . 73.3 tttt 52.06 168.54 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.037 0.922 . . . . 0.0 111.602 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 113' ' ' LEU . 2.2 t 61.53 136.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.361 0.601 . . . . 0.0 109.854 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 49.3 mp0 56.1 5.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 111' ' ' SER . 1.0 OUTLIER -95.73 -43.33 7.94 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.5 151.0 38.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.633 -0.667 . . . . 0.0 110.315 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -137.14 146.38 44.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 109.532 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.468 ' O ' ' NE2' ' A' ' 119' ' ' HIS . 37.6 m80 -133.48 140.32 47.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.637 -0.664 . . . . 0.0 109.231 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 116' ' ' HIS . 78.2 m80 54.57 163.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.777 0.798 . . . . 0.0 110.873 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -84.6 -6.76 59.39 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.468 ' NE2' ' O ' ' A' ' 116' ' ' HIS . 96.8 m-70 51.96 -174.44 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.684 0.754 . . . . 0.0 110.858 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.702 -179.747 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.5 mtp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.14 88.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.555 0.693 . . . . 0.0 109.906 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.94 160.17 42.66 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.904 0.859 . . . . 0.0 110.386 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.0 mt -108.79 128.43 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 121.696 0.76 . . . . 0.0 109.449 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.471 ' HG2' HD13 ' A' ' 55' ' ' ILE . 18.2 pt20 -148.51 149.65 32.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.926 0.87 . . . . 0.0 109.897 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -96.53 -65.75 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 m -75.35 164.76 26.08 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.587 0.708 . . . . 0.0 109.821 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.98 29.21 0.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.482 0.658 . . . . 0.0 109.672 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 10' ' ' VAL . . . -159.4 -44.28 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 9' ' ' GLY . 28.5 m 31.46 -135.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 121.192 0.52 . . . . 0.0 110.642 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.95 -139.4 0.05 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.592 0.711 . . . . 0.0 109.597 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.62 144.08 56.6 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.622 0.725 . . . . 0.0 110.464 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 p -68.9 139.14 55.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.753 0.787 . . . . 0.0 110.559 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 15' ' ' VAL . 1.6 t -87.22 -145.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.416 0.627 . . . . 0.0 110.815 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.567 ' H ' HG12 ' A' ' 14' ' ' VAL . 17.5 t -146.45 66.27 10.91 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.649 -0.657 . . . . 0.0 109.242 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.92 149.75 33.47 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.024 2.483 . . . . 0.0 112.605 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -97.4 145.84 25.77 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.89 0.853 . . . . 0.0 109.921 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.7 t -103.71 131.65 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.839 0.828 . . . . 0.0 110.421 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -135.26 141.52 45.75 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.551 0.691 . . . . 0.0 109.307 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD21 ' CZ ' ' A' ' 93' ' ' PHE . 84.6 mt -103.93 125.53 50.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.867 0.842 . . . . 0.0 110.081 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.8 m -94.91 164.19 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.641 0.734 . . . . 0.0 109.899 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.2 139.31 43.07 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.776 0.798 . . . . 0.0 109.821 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -159.23 25.35 0.2 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.65 -45.69 91.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.614 -0.679 . . . . 0.0 109.403 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -89.74 -1.63 58.05 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.67 -66.02 1.05 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -145.44 -42.78 0.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.605 -0.938 . . . . 0.0 108.943 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.4 m -175.98 -85.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.595 -0.691 . . . . 0.0 109.365 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -176.95 153.36 13.66 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -157.79 176.24 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.564 -0.962 . . . . 0.0 110.281 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.57 148.79 52.38 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.757 0.789 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -111.42 148.85 32.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.753 0.787 . . . . 0.0 110.035 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -126.37 135.98 52.13 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.608 0.718 . . . . 0.0 109.493 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -120.8 127.1 51.63 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.83 0.824 . . . . 0.0 109.747 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.67 120.23 41.73 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.726 0.774 . . . . 0.0 109.58 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 37' ' ' GLU . 37.2 tp -88.88 126.64 35.47 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.706 0.765 . . . . 0.0 110.404 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 36' ' ' LEU . 45.9 mm-40 36.53 68.7 1.4 Allowed Pre-proline 0 N--CA 1.493 1.691 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.785 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -58.94 145.38 97.45 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.273 1.982 . . . . 0.0 111.853 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.9 p -83.37 -17.43 42.33 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.016 0.436 . . . . 0.0 110.242 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 tt -70.74 1.13 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.687 . . . . 0.0 109.602 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.63 -11.59 58.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 109.281 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.45 -14.54 30.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -102.18 -58.39 1.89 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.429 -0.795 . . . . 0.0 109.423 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.97 160.55 40.14 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.755 0.788 . . . . 0.0 110.242 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 26.7 t -63.57 -166.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.62 0.724 . . . . 0.0 110.476 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 p -99.03 -21.0 16.43 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -64.43 -36.9 85.66 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 109.163 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 45' ' ' SER . 25.1 p-10 -62.22 -40.3 95.67 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.514 ' C ' ' H ' ' A' ' 51' ' ' GLY . 97.2 mt -54.8 -88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.82 -0.55 . . . . 0.0 109.777 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.407 ' N ' HG22 ' A' ' 49' ' ' ILE . 4.0 m 66.61 -43.18 0.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 49' ' ' ILE . . . -96.9 144.68 17.48 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.4 ttp -126.37 125.65 42.58 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.581 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -108.51 111.01 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.958 0.885 . . . . 0.0 110.225 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.531 ' C ' HD12 ' A' ' 55' ' ' ILE . 58.6 mt -97.43 121.6 39.51 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.749 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.1 mp -103.7 130.77 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.887 0.851 . . . . 0.0 110.404 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 38.0 m-20 -133.23 -156.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.726 0.774 . . . . 0.0 109.77 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 59' ' ' GLY . 42.8 p-10 -71.72 96.93 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.964 -0.46 . . . . 0.0 110.339 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 66.08 -39.88 0.32 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.542 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -88.95 160.24 29.65 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' N ' ' NH2' ' A' ' 92' ' ' ARG . 17.2 pt-20 -151.51 148.72 28.38 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 110.067 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.04 130.09 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.674 0.75 . . . . 0.0 109.527 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.6 mt -123.49 133.47 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.836 0.826 . . . . 0.0 109.808 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -142.06 150.7 41.58 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.734 0.778 . . . . 0.0 109.848 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -97.58 0.89 48.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -77.35 81.39 3.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.479 0.657 . . . . 0.0 109.286 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.42 133.57 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.855 0.836 . . . . 0.0 109.814 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.29 137.37 47.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.834 0.826 . . . . 0.0 109.47 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.27 131.01 10.42 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -103.5 117.14 33.75 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.818 0.818 . . . . 0.0 109.472 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.61 137.09 47.13 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.858 0.837 . . . . 0.0 110.036 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.8 mt -119.06 128.65 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.675 0.75 . . . . 0.0 109.201 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.7 m120 59.65 30.74 20.37 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.315 0.578 . . . . 0.0 109.731 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.51 24.7 73.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -136.01 113.38 10.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.749 -0.853 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.88 104.62 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.211 2.608 . . . . 0.0 112.568 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.6 m -109.71 -35.72 6.12 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.739 -0.601 . . . . 0.0 110.092 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.81 159.81 40.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.054 -1.029 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -122.21 150.97 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.694 0.759 . . . . 0.0 109.655 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -130.66 148.51 52.45 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.99 0.9 . . . . 0.0 110.018 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.64 152.57 39.11 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.649 0.737 . . . . 0.0 109.92 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.1 m -120.57 132.59 55.23 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.776 0.798 . . . . 0.0 110.354 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.57 130.86 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.874 0.845 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.5 mm -87.22 124.85 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.771 0.796 . . . . 0.0 110.231 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.1 mt -117.71 40.5 3.08 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -62.82 -39.93 95.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.566 -0.709 . . . . 0.0 109.598 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -81.26 152.81 27.44 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.75 0.786 . . . . 0.0 110.18 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 1.7 tt0 -70.48 -46.43 18.93 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.943 -0.473 . . . . 0.0 110.91 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 68.4 Cg_exo -52.52 -35.33 66.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.195 1.93 . . . . 0.0 111.512 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.88 -40.71 97.15 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 60.5 m95 -63.81 -41.95 97.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.644 -0.66 . . . . 0.0 109.512 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -59.36 -44.47 92.69 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.596 ' NH2' ' N ' ' A' ' 60' ' ' GLU . 83.3 mtp180 -66.23 -37.94 86.73 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.445 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 60.5 t80 -61.95 -46.6 88.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.74 -0.6 . . . . 0.0 109.84 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 97.5 mmm -62.76 -44.07 97.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.688 -0.632 . . . . 0.0 109.395 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -66.9 -41.74 86.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.309 0.576 . . . . 0.0 109.524 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.522 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 83.0 t80 -63.99 -44.91 91.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.359 0.6 . . . . 0.0 109.49 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.5 ttt -62.07 -41.66 98.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -67.15 -47.14 71.96 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.382 0.611 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.8 tpt85 -66.55 -44.56 81.99 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.844 -0.535 . . . . 0.0 109.657 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -63.14 -45.87 89.89 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.558 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -64.9 -34.54 90.16 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.12 92.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.806 -0.82 . . . . 0.0 109.338 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.39 -37.07 77.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -151.74 92.49 1.75 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.643 0.735 . . . . 0.0 109.847 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.12 98.35 0.26 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.7 mt -77.12 148.57 35.96 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.773 0.797 . . . . 0.0 110.064 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.23 4.56 17.95 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.428 ' O ' ' OG ' ' A' ' 109' ' ' SER . 94.6 m-85 -133.4 -129.8 0.17 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.697 -0.884 . . . . 0.0 109.973 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 110' ' ' LYS . 5.0 p 70.58 -60.75 0.49 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.537 ' N ' ' OG ' ' A' ' 109' ' ' SER . 20.6 ptmt -127.86 -38.1 1.88 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 113' ' ' LEU . 86.8 p -74.0 163.46 27.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.715 -0.616 . . . . 0.0 110.405 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 67.36 -58.38 0.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 111' ' ' SER . 86.0 mt -63.43 -42.73 98.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.579 -0.701 . . . . 0.0 109.915 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -83.69 160.96 21.2 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.67 0.748 . . . . 0.0 110.399 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -66.22 129.32 39.42 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.537 0.684 . . . . 0.0 110.14 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -88.3 122.88 32.32 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.632 0.729 . . . . 0.0 110.289 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -113.37 133.51 55.12 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.867 0.842 . . . . 0.0 110.161 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -71.45 134.81 46.85 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.684 0.754 . . . . 0.0 110.263 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.536 ' O ' ' CG ' ' A' ' 120' ' ' HIS . 48.5 t-80 -73.03 148.35 44.21 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.628 0.728 . . . . 0.0 110.129 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 51.3 p-80 . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.076 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.603 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 49.75 99.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.486 0.66 . . . . 0.0 109.696 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -148.28 157.25 43.37 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.807 0.813 . . . . 0.0 110.757 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 94.0 mt -109.31 131.4 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 CA-C-O 121.51 0.671 . . . . 0.0 109.441 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -128.96 134.3 48.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.714 0.769 . . . . 0.0 109.624 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.83 -71.47 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 10' ' ' VAL . 44.9 m -107.0 122.95 47.46 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.863 0.84 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' A' ' 7' ' ' SER . 25.8 mtmm 40.63 -168.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.818 0.818 . . . . 0.0 111.538 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.21 86.25 0.32 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 7' ' ' SER . 54.7 t -120.12 132.67 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.813 0.816 . . . . 0.0 109.632 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.77 143.66 46.42 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.6 0.714 . . . . 0.0 110.19 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 14' ' ' VAL . 48.6 tp10 -137.65 -77.57 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' GLU . 82.8 p 37.44 31.09 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.292 0.568 . . . . 0.0 110.217 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 12' ' ' GLU . 53.6 t -69.57 -19.93 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.725 -0.609 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.452 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 3.5 t 64.18 52.89 1.32 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.897 -0.502 . . . . 0.0 110.288 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 37.1 Cg_endo -65.14 150.81 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.617 2.211 . . . . 0.0 112.559 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.57 132.48 45.55 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.685 0.755 . . . . 0.0 110.211 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.558 ' H ' ' CD1' ' A' ' 106' ' ' LEU . 24.4 t -105.13 128.3 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 121.62 0.724 . . . . 0.0 109.764 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.451 ' C ' HD22 ' A' ' 20' ' ' LEU . 42.1 ttm180 -134.14 136.48 43.86 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.733 0.778 . . . . 0.0 109.765 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.895 HD22 ' N ' ' A' ' 20' ' ' LEU . 1.1 mm? -104.92 124.52 49.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.606 0.717 . . . . 0.0 109.668 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 65.4 m -132.65 153.4 51.13 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.576 0.703 . . . . 0.0 110.159 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -105.05 152.53 22.63 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.873 0.844 . . . . 0.0 110.223 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.0 t -52.15 176.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.746 0.784 . . . . 0.0 110.993 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -64.32 -42.3 96.39 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.71 -3.57 38.93 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.25 19.92 76.23 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -89.29 -4.45 58.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.788 -0.831 . . . . 0.0 109.073 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.7 m -146.22 121.19 10.02 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.705 0.764 . . . . 0.0 109.603 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.57 142.55 23.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.7 ptp -153.84 166.42 32.96 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.946 -0.738 . . . . 0.0 110.298 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -132.25 143.18 49.74 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.568 0.699 . . . . 0.0 109.689 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -109.63 143.61 39.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.793 0.806 . . . . 0.0 110.335 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -123.57 135.9 54.24 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.58 0.705 . . . . 0.0 109.626 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -120.04 126.81 51.71 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.783 0.801 . . . . 0.0 109.606 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.543 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 45.8 m-85 -108.21 119.29 39.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.464 0.65 . . . . 0.0 109.366 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 53.4 tp -99.79 122.71 43.17 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.62 0.724 . . . . 0.0 109.939 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 40.71 56.74 8.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 CA-C-O 121.036 0.446 . . . . 0.0 110.097 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.74 144.03 82.44 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.445 2.097 . . . . 0.0 112.783 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 41' ' ' LEU . 26.4 m -69.32 -21.64 63.84 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.108 0.48 . . . . 0.0 110.018 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 tp -60.61 0.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.424 -0.797 . . . . 0.0 109.594 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 39' ' ' THR . 92.2 mt -89.67 -12.25 40.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.09 -14.16 17.9 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -102.13 -49.82 3.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.488 -0.758 . . . . 0.0 109.488 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -138.0 155.47 48.82 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.779 0.799 . . . . 0.0 110.024 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 37.9 t -72.99 160.03 32.74 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.746 0.784 . . . . 0.0 110.396 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -66.37 -34.55 78.23 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.39 -17.67 61.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.738 -0.601 . . . . 0.0 109.865 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -85.29 -1.7 57.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.11 123.78 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.448 -0.782 . . . . 0.0 110.391 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.4 m -119.52 91.85 3.65 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.802 0.81 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.42 -176.24 54.37 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.7 ttp -134.19 132.22 39.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.917 -0.755 . . . . 0.0 109.643 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -106.5 110.65 22.92 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.911 0.862 . . . . 0.0 109.759 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.87 114.0 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.391 0.615 . . . . 0.0 109.483 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.6 mm -111.42 129.72 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.63 0.729 . . . . 0.0 109.633 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.441 ' OD2' ' CD1' ' A' ' 96' ' ' PHE . 99.0 m-20 -134.8 -80.88 0.44 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' GLY . 67.3 t0 -144.81 98.2 3.15 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.617 -0.677 . . . . 0.0 109.517 -179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 97.2 mt-10 65.05 -42.72 0.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.385 0.612 . . . . 0.0 109.684 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -87.43 137.35 14.55 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -143.26 144.45 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.897 -0.766 . . . . 0.0 109.99 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.2 132.97 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.548 0.69 . . . . 0.0 109.243 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.9 mp -107.03 132.21 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.683 0.754 . . . . 0.0 109.804 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 65' ' ' GLU . 87.7 m -117.86 122.35 43.12 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.782 0.801 . . . . 0.0 109.5 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.3 mmm-85 -95.48 1.23 53.91 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 65' ' ' GLU . 57.7 mp0 -96.25 71.07 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.03 132.87 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.653 0.739 . . . . 0.0 109.718 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -134.29 141.87 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.936 0.874 . . . . 0.0 109.826 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.73 142.21 28.5 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -109.47 119.9 40.85 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.788 0.804 . . . . 0.0 109.183 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -108.58 124.07 49.92 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.646 0.736 . . . . 0.0 109.811 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 95.6 mt -114.2 139.32 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.591 0.71 . . . . 0.0 109.304 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.8 m120 60.33 32.42 20.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.468 0.652 . . . . 0.0 109.876 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.95 31.38 80.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -158.78 152.04 18.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 O-C-N 121.63 -0.924 . . . . 0.0 109.769 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -51.54 141.18 43.11 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.9 m -161.68 -35.63 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.512 -0.742 . . . . 0.0 109.874 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 35' ' ' PHE . . . -154.27 171.22 19.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 0.0 110.7 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.63 128.06 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.561 0.696 . . . . 0.0 109.331 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -109.4 143.82 38.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.644 0.735 . . . . 0.0 109.447 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.1 148.76 30.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.681 -0.637 . . . . 0.0 109.9 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -122.75 129.27 51.56 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.47 112.58 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.921 0.867 . . . . 0.0 109.296 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.629 HD12 ' N ' ' A' ' 83' ' ' ILE . 1.5 mp -82.6 128.38 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 121.504 0.668 . . . . 0.0 109.768 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.6 mt -118.31 62.86 0.76 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.59 -38.82 90.58 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.73 -0.606 . . . . 0.0 109.544 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.9 t -62.08 148.42 44.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.457 -0.777 . . . . 0.0 110.212 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.429 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 1.8 mp0 -76.53 -62.28 0.68 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.982 -0.449 . . . . 0.0 110.479 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 87' ' ' GLN . 12.1 Cg_endo -57.25 -26.77 71.8 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.078 1.852 . . . . 0.0 111.522 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -67.01 -35.55 80.18 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.888 -0.508 . . . . 0.0 109.665 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -44.79 96.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.493 -0.754 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -61.93 -47.81 83.23 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.214 0.531 . . . . 0.0 110.043 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -64.7 -42.13 95.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.592 -0.693 . . . . 0.0 110.062 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -61.66 -42.72 99.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.733 -0.604 . . . . 0.0 109.755 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.7 tpt -62.54 -39.23 92.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.625 -0.672 . . . . 0.0 109.764 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.8 -45.78 91.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.707 -0.621 . . . . 0.0 110.104 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.441 ' CD1' ' OD2' ' A' ' 56' ' ' ASP . 37.6 m-85 -68.7 -37.64 79.68 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.605 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 29.9 mmt -64.58 -39.77 94.34 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -65.18 -46.08 82.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.664 -0.647 . . . . 0.0 109.865 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -67.09 -41.95 85.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.526 -0.734 . . . . 0.0 110.385 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.52 ' CD1' ' OD1' ' A' ' 104' ' ' ASN . 54.4 t80 -61.72 -45.9 91.97 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.574 -0.704 . . . . 0.0 110.027 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -63.24 -36.03 92.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.4 75.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -1.126 . . . . 0.0 109.026 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.28 -42.92 68.12 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.52 ' OD1' ' CD1' ' A' ' 100' ' ' TYR . 13.8 m120 -80.73 -75.69 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.354 0.597 . . . . 0.0 109.466 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 101' ' ' GLY . . . 92.61 46.24 3.51 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.666 ' H ' HD22 ' A' ' 106' ' ' LEU . 3.3 mm? 41.25 98.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.985 -0.715 . . . . 0.0 110.326 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 106' ' ' LEU . . . -39.72 100.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -64.64 -43.76 92.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.879 -0.777 . . . . 0.0 109.625 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' LYS . 55.2 p -162.06 50.38 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.564 -0.71 . . . . 0.0 109.519 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 111' ' ' SER . 51.7 mtmt 41.42 -168.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.713 0.768 . . . . 0.0 111.183 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 113' ' ' LEU . 2.0 m 55.2 158.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.188 0.518 . . . . 0.0 110.755 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 61.35 -63.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.39 0.614 . . . . 0.0 110.203 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 111' ' ' SER . 56.9 mt -62.08 -41.46 98.21 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.566 -0.709 . . . . 0.0 109.908 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -55.78 -80.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.564 -0.71 . . . . 0.0 109.943 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -81.02 137.28 36.06 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.746 0.784 . . . . 0.0 110.28 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -147.4 141.46 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.573 0.701 . . . . 0.0 109.795 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -104.99 130.91 53.09 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.804 0.811 . . . . 0.0 110.057 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -101.55 132.75 47.03 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.558 0.694 . . . . 0.0 109.755 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -105.39 135.12 47.35 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.66 0.743 . . . . 0.0 110.042 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.381 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.483 ' N ' HH21 ' A' ' 99' ' ' ARG . 4.4 mpp? . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.421 0.629 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.57 147.91 0.68 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.78 0.8 . . . . 0.0 110.056 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -154.47 135.02 13.46 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.797 0.808 . . . . 0.0 110.276 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.453 HD12 ' CZ ' ' A' ' 100' ' ' TYR . 97.2 mt -119.2 128.61 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.687 0.756 . . . . 0.0 109.698 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.674 HE22 ' H ' ' A' ' 9' ' ' GLY . 2.4 pt20 -153.63 159.51 42.11 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.676 0.75 . . . . 0.0 109.773 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -89.96 -1.57 58.0 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.544 ' OG ' ' N ' ' A' ' 8' ' ' LYS . 18.4 p -145.99 -134.07 0.08 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.376 -0.827 . . . . 0.0 110.001 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' N ' ' OG ' ' A' ' 7' ' ' SER . 8.6 mtmp? -146.52 102.2 3.55 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.874 0.845 . . . . 0.0 109.948 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.674 ' H ' HE22 ' A' ' 5' ' ' GLN . . . 104.91 3.65 42.37 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 10' ' ' VAL . 11.6 p -96.18 20.13 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.766 -0.844 . . . . 0.0 109.446 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 10' ' ' VAL . . . -33.21 112.44 0.12 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.686 0.755 . . . . 0.0 110.746 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.426 ' HB3' HG23 ' A' ' 14' ' ' VAL . 92.4 mt-10 -94.52 -8.01 39.55 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.8 p 53.26 14.02 0.48 Allowed 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.405 0.621 . . . . 0.0 109.56 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.426 HG23 ' HB3' ' A' ' 12' ' ' GLU . 55.8 t -69.33 155.67 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 CA-C-O 121.651 0.739 . . . . 0.0 110.556 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG13 ' H ' ' A' ' 105' ' ' GLY . 11.0 t -115.36 84.88 12.26 Favored Pre-proline 0 N--CA 1.496 1.827 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.68 153.33 26.3 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.943 2.429 . . . . 0.0 112.468 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.11 150.26 25.66 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.674 0.749 . . . . 0.0 110.038 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 100.0 t -124.25 132.53 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.641 0.734 . . . . 0.0 109.837 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' C ' HD22 ' A' ' 20' ' ' LEU . 90.0 mtm180 -131.65 139.76 49.18 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.853 0.835 . . . . 0.0 109.721 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.9 mm? -96.43 144.02 26.94 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.674 0.749 . . . . 0.0 110.035 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -155.69 170.45 22.0 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.74 0.781 . . . . 0.0 109.882 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 24' ' ' LYS . 52.0 mtmt -141.46 124.27 16.1 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.684 0.754 . . . . 0.0 109.914 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 25' ' ' ASN . 33.6 t 36.89 29.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.321 0.581 . . . . 0.0 110.142 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 22' ' ' LYS . 69.6 mmtt 58.91 1.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 23' ' ' SER . 4.8 p30 -153.28 -53.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 25' ' ' ASN . . . 149.95 98.16 0.18 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -172.79 -27.68 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.629 -0.924 . . . . 0.0 108.997 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 p -151.52 161.07 43.33 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.96 0.886 . . . . 0.0 110.045 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.97 139.91 37.13 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.1 ttm -155.2 151.57 28.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.003 0.906 . . . . 0.0 110.212 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 131.34 23.51 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -114.05 132.56 55.97 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.846 0.831 . . . . 0.0 109.991 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -116.69 132.27 56.73 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -115.89 118.94 34.37 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -109.68 119.84 40.64 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.531 1.158 . . . . 0.0 109.915 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.7 tp -98.36 113.78 25.87 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.011 0.91 . . . . 0.0 110.146 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 50.87 75.14 0.69 Allowed Pre-proline 0 N--CA 1.503 2.184 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.588 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' O ' ' N ' ' A' ' 40' ' ' ILE . 4.3 Cg_endo -82.13 15.13 2.05 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.808 2.338 . . . . 0.0 111.178 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 38' ' ' PRO . 4.1 p 39.63 22.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.266 0.555 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 38' ' ' PRO . 18.5 tt -92.79 -1.44 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.1 mt -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.1 -18.56 20.07 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.91 -35.08 6.73 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -142.84 141.25 31.56 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.38 -0.825 . . . . 0.0 110.032 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -77.84 167.29 21.75 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.732 0.777 . . . . 0.0 109.928 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -64.83 -32.11 73.65 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.94 -35.44 80.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.86 -19.15 63.45 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -91.85 124.35 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.456 -0.778 . . . . 0.0 109.538 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.53 12.91 1.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.7 175.15 46.37 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.596 ' SD ' HD21 ' A' ' 54' ' ' LEU . 18.0 ttm -137.12 144.42 43.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.702 -0.881 . . . . 0.0 109.433 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -108.9 113.18 25.87 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.925 0.869 . . . . 0.0 109.898 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.596 HD21 ' SD ' ' A' ' 52' ' ' MET . 75.4 mt -95.06 114.69 26.52 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.52 0.676 . . . . 0.0 109.336 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.741 ' N ' HD12 ' A' ' 55' ' ' ILE . 2.0 mp -99.17 109.4 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 121.776 0.798 . . . . 0.0 109.373 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 96' ' ' PHE . 96.1 m-20 -88.84 -87.85 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.549 0.69 . . . . 0.0 109.409 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 66.2 m-20 -159.37 -62.23 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.535 -0.728 . . . . 0.0 109.246 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -104.22 13.96 31.27 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.14 -0.975 . . . . 0.0 108.614 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -172.42 174.02 45.46 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -147.95 147.73 30.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.57 -0.959 . . . . 0.0 109.823 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.1 mp -116.3 131.44 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.652 0.739 . . . . 0.0 109.68 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.8 mp -115.37 131.35 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.514 0.673 . . . . 0.0 109.441 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -125.24 131.15 53.18 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.839 0.828 . . . . 0.0 109.975 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -92.53 3.63 55.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -90.53 73.12 6.88 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.43 133.07 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.749 0.785 . . . . 0.0 109.521 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -133.83 142.88 48.03 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.746 0.784 . . . . 0.0 109.947 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.79 149.8 21.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -110.05 131.08 55.38 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.956 0.884 . . . . 0.0 109.67 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -99.75 125.41 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.65 0.738 . . . . 0.0 109.814 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.53 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 96.8 mt -123.15 133.13 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.798 0.809 . . . . 0.0 109.572 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 71' ' ' ILE . 4.6 p30 58.33 25.76 13.17 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.888 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.32 31.37 16.83 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.137 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -168.81 150.52 4.63 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.073 -1.251 . . . . 0.0 110.588 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.8 87.49 0.44 Allowed 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 123.207 2.605 . . . . 0.0 112.257 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -104.68 -14.62 15.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.716 -0.615 . . . . 0.0 109.74 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.08 151.66 44.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.165 -0.959 . . . . 0.0 109.858 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.4 mt -133.27 135.82 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.499 0.666 . . . . 0.0 109.982 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -126.28 164.45 21.0 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.947 0.879 . . . . 0.0 110.202 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.03 150.2 37.86 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.77 0.795 . . . . 0.0 109.634 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 91.0 m -124.97 127.21 46.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.67 0.748 . . . . 0.0 109.545 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.8 t -114.89 132.42 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-O 121.874 0.845 . . . . 0.0 109.81 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.3 mm -94.79 123.91 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.707 0.765 . . . . 0.0 109.825 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.5 mt -110.66 75.53 0.93 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -96.85 1.92 51.17 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -116.82 143.55 45.55 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.991 0.901 . . . . 0.0 110.125 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 mt-30 -66.51 -48.57 55.14 Favored Pre-proline 0 N--CA 1.488 1.474 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.633 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 87' ' ' GLN . 49.6 Cg_exo -51.9 -38.25 68.15 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.866 1.71 . . . . 0.0 111.133 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -66.73 -39.5 88.0 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -63.29 -37.87 88.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.71 -0.619 . . . . 0.0 109.787 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -60.35 -50.94 71.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.664 -0.647 . . . . 0.0 109.853 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 93' ' ' PHE . 18.7 ptp180 -75.35 -39.29 59.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.743 -0.598 . . . . 0.0 109.921 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.417 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 69.1 t80 -64.22 -44.79 90.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.508 -0.745 . . . . 0.0 109.221 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 44.1 tpp -60.72 -46.94 88.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -66.09 -40.57 90.92 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.273 0.558 . . . . 0.0 109.513 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.537 ' CD1' ' OD1' ' A' ' 56' ' ' ASP . 86.4 t80 -63.21 -44.24 95.88 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 11.3 tpt -62.6 -39.79 94.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.619 -0.675 . . . . 0.0 109.54 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -66.08 -52.73 46.12 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.633 -0.667 . . . . 0.0 109.759 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.483 HH21 ' N ' ' A' ' 1' ' ' MET . 83.4 mtp180 -66.34 -44.75 82.42 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.453 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 81.0 t80 -63.4 -46.99 83.89 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.419 0.628 . . . . 0.0 109.342 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.28 -34.57 88.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.85 83.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.646 -0.914 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.63 -55.7 6.45 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 p30 -177.87 -160.69 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.748 0.785 . . . . 0.0 109.832 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.434 ' H ' HG13 ' A' ' 15' ' ' VAL . . . 93.22 14.88 53.38 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 106' ' ' LEU . 10.5 mp -85.08 3.73 37.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.66 -0.906 . . . . 0.0 109.138 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.82 -137.23 13.22 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 54.07 167.64 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.887 -0.772 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.2 t -66.2 140.17 58.16 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.937 0.875 . . . . 0.0 110.643 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -77.4 143.23 38.8 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.715 0.769 . . . . 0.0 110.887 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 112' ' ' GLU . 0.7 OUTLIER 172.79 -84.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.442 0.639 . . . . 0.0 109.82 179.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.453 ' N ' ' OG ' ' A' ' 111' ' ' SER . 96.0 mt-10 -85.37 -12.43 52.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 109.728 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 58.4 mt -67.48 -34.26 76.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.635 -0.666 . . . . 0.0 110.107 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.42 -42.42 99.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.425 -0.797 . . . . 0.0 109.399 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.687 ' CD2' ' H ' ' A' ' 116' ' ' HIS . 70.1 t60 -153.13 -130.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.681 0.753 . . . . 0.0 109.756 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.687 ' H ' ' CD2' ' A' ' 115' ' ' HIS . 58.0 t-80 -158.96 -60.06 0.07 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.52 -0.738 . . . . 0.0 109.058 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -77.95 141.47 38.97 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.885 0.85 . . . . 0.0 110.581 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -81.18 -3.3 51.78 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -59.19 -41.22 87.98 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.399 0.619 . . . . 0.0 109.567 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.904 -179.658 . . . . . . . . 0 0 . 1 stop_ save_